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The Human SPINK5 Gene Encodes Multiple LEKTI Isoforms Derived from Alternative
RNA Processing
M D’Alessio, A Tartaglia-Polcini A Micheloni, A Andre`, O Golisano, A Hovnanian, and G
Zambruno
Rome, Italy and, Toulouse, France
SPINK5, the mutated gene in the severe autosomal recessive ichthyosiform skin disorder,
Netherton syndrome, encodes the putative serine protease inhibitor LEKTI (lympho-epithelial
Kazal-type related inhibitor). Strongly expressed in the most differentiated viable layers of all
stratified epithelia, this protein is thought to be involved in different biological pathways
relevant to epithelial tissue homeostasis and possibly also to inflammation and anti-microbial
defense. LEKTI, as deduced from the nucleotide sequence of the cloned cDNA, consists of
1064 amino acids organized into 15 potential inhibitory Kazal-type domains (D1-D15)
preceded by a signal peptide, and is predicted to weight120 kDa. However, we recently
reported the detection of two N-glycosylated precursor proteins (145 and 125 kDa) and
three C-terminal proteolytic fragments (68, 65 and 42 kDa) in differentiated normal human
keratinocytes (HK). Here, we show that, following alternative processing of its pre-mRNA,
SPINK5 generates three classes of transcripts, each differing in the 3’ end portion of the
coding region. In addition to the previously described 3.7 kb mRNA, termed full-length, a
shorter transcript of 3 kb generated by the recognition of an intronic polyadenylation
signal, and a transcript carrying the insertion of a 90 bp cryptic exon located within intron 28
(exon 28 bis) were identified by screening a HK cDNA library. In keeping with SPINK5/LEKTI
expression in the uppermost differentiated layers of the epidermis, the expression level of all
SPINK5 transcripts significantly increases as HK differentiate in vitro. However, the ratio
among the different transcripts progressively changes during keratinocyte differentiation thus
suggesting that the alternative processing of the SPINK5 pre-mRNA is a differentiation-
regulated process. Still, dot blot and real-time RT-PCR analysis of RNA samples from various
human tissues showed that the three SPINK5 transcripts display a diverse tissue distribution.
Sharing the same transcription start site, the SPINK5 mRNAs are expected to result in three
LEKTI isoforms: the 1064 amino acids full-length protein containing the 15 inhibitory domains,
a shorter form lacking the last two domains (D14 and D15), and a longer form carrying the in-
frame insertion of 30 residues within the linker region between D13 and D14. Accordingly,
in addition to the previously described 145 and 125 kDa LEKTI precursor proteins, a
third isoform of 148 kDa could be detected in differentiated normal HK. Furthermore, a
polyclonal antibody raised against the protein domains D14-D15 recognized only the 148
and 145 kDa LEKTI isoforms indicating that the 125 kDa polypeptide represents the
translation product of the 3 kb SPINK5 transcript. These data suggest that the
transcriptional and post transcriptional mechanisms regulate, in human, LEKTI isoforms
expression. Since the bioactive forms of LEKTI appear to derive from the intracellular
cleavage of the precursor proteins, we hypothesize that the LEKTI bioactive fragments may
have a different target specificity.
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Characterization of Sequences Important for the Interaction of Desmoplakin (DP) and
Plectin (PL) with Desmin. Towards Understanding of the Molecular Basis of Inherited
Skin Disorders Associated with Myopathies (MD) and Cardiomyopathies (CM)
K Lapouge, L Fontao, Y Gontier, J -H Saurat, D Paulin1, K Green2, L Borradori
Clinique de Dermatologie, Hoˆpital Cantonal Universitaire, Geneva, Switzerland; 1Universite´
Paris-7, Paris, France; 2Feinberg School of Medicine, Northwestern University, Chicago,
USA
DP and PL, versatile cytolinkers of the plakin family, connect the intermediate filament (IF)
system to other cytoskeletal networks and/or distinct sites at the plasma membrane, such as
desmosomes and hemidesmosomes. Inherited defects of the DP or PL gene result in
epidermolysis bullosa (EB) or palmoplantar keratoderma (PPK) in association with MD and/or
CM. Despite their homology, the COOH termini of DP and PL have the ability to selectively
bind to distinct IF proteins. Although their association with epidermal keratins has been
previously characterized, their potential to interact with desmin has been poorly investigated.
We have here studied sequences within their tail important for binding to desmin by yeast
two-hybrid, cell transfection and overlay assays.
Our results indicate that: 1) DP interacts with desmin via a region encompassing the linker
region between the B and C subdomains. However, the COOH-terminal extremity and the B
and C subdomain also appear to contribute to binding; 2) a DP mutant carrying a substitution
in the tail, DP-BCG2375R, identified in a patient with PPK and CM, has lost the ability to interact
with desmin; 3) the B subdomain and linker region of PL can also associate with desmin,
whereas the C subdomain and COOH extremity do not. Notably, a truncated plectin molecule
lacking the last 35-amino acids of the tail cause disorganization of the desmin cytoskeleton in
a patient with EB-MD, suggesting that the COOH terminal portion also support binding; 4) the
interaction of DP and PL with vimentin, another type III IF protein, involve a set of sequences
similar to those important for desmin binding; 5) the potential of DP and plectin to interact
with desmin and vimentin in yeast appears to be differently affected by phosphorylation of
Ser 2849 and Ser 4532, respectively, within their COOH termini.
Together, these results demonstrate that DP and PL can directly interact with desmin and
that the linker region and COOH extremity of DP and PL contain recognition sites critical for
desmin binding. These observations provide novel insights into the cytoskeletal organization
of striated muscle cells and increase our understanding of plakin-related human diseases
associated with both skin and muscular defects.
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Mapping of BP230, Desmoplakin and Plectin Binding Sites on K5/K14 Heterodimer by
Yeast Three-Hybrid Assays and Impact of Keratin Mutations on their Association with
Plakins
L Fontao, M Berti, M Pereira, J-H Saurat, EB Lane, L Borradori
Clinique de Dermatologie, Hoˆpital Cantonal Universitaire, Geneva, Switzerland; CRC Cell
Structure Research Group. University of Dundee, UK
The bullous pemphigoid antigen 1 (BP230), desmoplakin (DP) and plectin (PL) are members of
the plakin protein family of cytolinkers. Despite their homology, their COOH termini selectively
bind to distinct intermediate filaments (IF). Previously, we have provided evidence indicating that
the binding specificity of plakins for various IF proteins depend on their linker region between
the highly homologous B and C subdomains and their COOH extremity. Furthermore, the
association of DP and BP230 with both epidermal and simple keratins is critically affected by the
tertiary structure induced by heterodimerization, and involves recognition sites primarily located
in the rod domain of these keratins. We have here started to map the binding sites for BP230, DP
or PL on keratins and analyzed the impact of pathogenic mutations of K5 and K14 on their ability
to heterodimerize and to associate with BP230, DP and PL in yeast three-hybrid assays. The
results indicate that: 1) the NH2-terminal half of K5 and K14 are sufficient to mediate binding to
BP230, DP and PL whereas the head and tail domain of K5 and K14 do not bind to BP230, DP
and PL. We show that the K5 mutations E168D and E168Q both located in the H1 subdomain of
the K5 head and the N177S mutation located in the 1A segment of the rod domain apparently
increase the ability of K5 to dimerise with K14 whereas the N176S mutation have no effect.
Furthermore we found that the K14 mutations R125H and L284P located respectively in the 1A
and 2A segment of the K14 rod respectively, had only minor impact on the ability of K14 to form
homodimers with K5, whereas the K14 V270M mutation located in the L12 segment of the K14
rod strongly affected the binding of K14 to K5; finally, 4) the substitution E168Q or N176S in K5
increased the interaction of K 5/K14 with DP, whereas the K14R125H mutant showed reduced
binding to BP230. In conclusion, we have found that the NH2-terminal half of the rod domain of
K5 and K14 contains the binding sites for three different members of the plakin family of protein,
BP230, DP and PL. Our findings obtained with different K5 or K14 mutants suggest that these
mutations not only affect the formation of K5/K14 heterodimers and hence the assembly of
keratin filaments but also interfer with the connection of IF to the plasma membrane by altering
their potential to associate with cytoskeletal linkers such as BP230, DP and PL. These findings
provide novel insights into the molecular mechanisms responsible for the disturbed cyto-
architecture and cell fragility associated with epidermolysis bullosa simplex.
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The Distorted Keratin Filaments are Transported and Re-Organized Using the Cytoplas-
mic Dynein Cargos
S Nobuhara, M Yonezawa, M Yasuda, T Idei, Y Miyachi and K Takahashi
Departments of Dermatology, Kyoto University and Johoku Hospital, Kyoto, Japan
Epidermolysis bullosa simplex with mottled pigmentation (EBS -MP) is a rare variant of EBS
and caused by a specific missense mutation located at the early head domain of keratin 5
(K5). The mechanism, which leads to the blister formation as well as pigment anomaly in EBS-
MP, is not yet understood at all. Last year we reported that a tctex1, a cytoplasmic dynein
light chain (DLC), bind to the critical region of K5 by yeast two-hybrid system. The interaction
of DLC with K5 was further confirmed by pull down as well as co-immuno-precipitation
assays. However, dynein complex did not consistently co-localize with keratin filaments in the
immuno-cytochemically observed non-treated keratinocytes. We then tried to observe and
determine the interaction of keratin, tubulin and dynein complex each other after various
stimuli on cultured keratinocytes. Various kinase or phosphatase inhibitor treatments
immediately induced the marked breakdown of keratin filaments to the granular deposition.
After washing out these chemicals, keratins were observed to gradually recover their
filamentous formation. During the recovery process, keratins and dynein complex were found
to well co-localize along the microtubule. The nocodazole treatment prior to the kinase
treatments completely disturbed this re-organization step of keratin filaments. Our ob-
servation above suggests that the dynein system is necessary for the dynamic maintenance
of healthy keratin networks, and the disturbance of this recovery process must be the cause
of blisters in EBS-MP patients.
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Derivation and Isolation of Ectodermal and Epidermal Progenitor Cells from Murine
Embryonic Stem Cells
D Aberdam, V De Thillot-Virolle, E Aberdam and M Rouleau
INSERM U634, Nice, France
Presence of multipotent stem cells allow physiological renewal of the cutaneous epithelium
and skin appendages (hair follicles, sweat and sebaceous glands). However the biopsy-
derived cultured keratinocytes, which are used for decades to treat deep extensive burn
wounds and chronic ulcers, do not form skin appendages in grafted epithelium. During
embryogenesis, ectodermal cells (the precursors of multipotent keratinocyte lineages) switch
their keratin production from K8/18 to K5/14. This embryonic transition is abolished in p63
knockout mice but rescued by exogenous expression of TAp63. We recently found culture
conditions to efficiently differentiate embryonic stem (ES) cells into keratinocytes that were
able to reconstitute in vitro a fully differentiated epidermis. The aim of our work was to isolate
both ectodermal K8/18 and epidermal K5/14 progenitor cell lines, from ES cells, that would
retain epidermal multipotency in vitro. ES cells committed to keratinocyte differentiation
recapitulate the in vivo embryonic epidermal fate since large amount of K8/K18 positive cells
were detected early in differentiation before appearance of K5/K14 keratinocytes. By serial
passages at clonal density, an ES-derived K8/18 cell line was isolated. The cell line
proliferates at normal rate, retains typical epithelial morphology and remains stable for its
keratin content. Gene expression profil analysis strongly suggests this cell line to be
characteristic of epidermal lineage and not to simple epithelia. Interestingly, exogenous
expression of TAp63 isoform, and not DNp63, was able to convert ES-derived K8/K18 cells
into K5/K14-expressing cells, demonstrating its ability to differentiate into early keratinocyte
stem cells. Grafting experiments are currently conducted to demonstrate the multipotency of
this cell line in vivo. The applications of this cellular model are to identify molecules essential
for the multipotent epidermal fates and to characterize the target genes of TAp63 during these
commitments.
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The Cystatin M/E – Legumain Balance: a Regulator of Epidermal Corniﬁcation
J Schalkwijk, I van Vlijmen, D Olthuis, P Zeeuwen
Nijmegen, The Netherlands
Cystatin M/E is a recently discovered cysteine protease inhibitor that is highly expressed in
cutaneous epithelia. We have previously found that homozygosity for null alleles of the
cystatin M/E gene causes the phenotype of the ichq mouse, which resembles a severe form
of human ichthyosis. Here we have studied the mechanism by which deficiency of cystatin M/
E leads to disturbed cornification, using in vivo and in vitro models. Absence of cystatin M/E
causes unrestricted activity of its target protease legumain in hair follicles and epidermis,
which is the exact location where cystatin M/E is normally expressed. Biochemical analysis of
stratum corneum proteins revealed a strong decrease of soluble loricrin monomers in skin
extracts of ichq mice, although loricrin was normally present in the stratum granulosum and
stratum corneum of ichq mice, as determined by immunohistochemistry. This suggested a
premature or enhanced crosslinking of loricrin monomers in ichq mice by transglutaminase 3
(TGase-3). In these mice we indeed found strongly increased levels of TGase-3 that was
processed into its activated 30 kDa and 47 kDa subunits, compared to wild type mice.
Legumain was found to mediate the activation of TGase-3 zymogen via lysosomal cysteine
proteases in vitro. This study shows that cystatin M/E and legumain form a functional dyad
in epidermis in vivo. Disturbance of this protease-antiprotease balance causes increased
enzyme activity of TGase-3 that could explain the observed abnormal cornification.
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The 27kD Heat Shock Protein and MAPK Signalling Regulate the Expression of
Differentiation-Associated Proteins in Human Keratinocytes
C Jonak, C Kokesch, G Klosner, M Mildner, I Kindas-Mu¨gge, F Trautinger
Vienna, Austria.
In human epidermal keratinocytes the expression of hsp27 is closely related to differentiation
in vitro and in situ. Hsp27 is a molecular chaperone and its protein binding activity is
associated with phosphorylation/dephosphorylation that is catalyzed through MAP-kinase
signalling. This project was aimed to gain further insight into the role of hsp27 in keratinization
by overexpression, co-localization studies, and inhibition of the key enzyme in hsp27
phosphorylation, p38/MAPK.
Co-localization of hsp27 with loricrin, filaggrin, transglutaminase1, actin, and keratins was
investigated by confocal laser scan microscopy in calcium-differentiated normal human
keratinocytes (NHEK), in ‘‘living skin equivalents’’, and in the squamous cell carcinoma cell
line A431 transfected with the human hsp27 gene. Protein expression was investigated by
Western blot. SB203580, a specific inhibitor of p38-MAPK, was used to investigate the role of
hsp27 phosphorylation in keratinocyte differentiation.
In accordance with its role as a molecular chaperone we found co-localization of hsp27
with differentiation antigens in A431, NHEK, and the epidermis of artificial skin. Artificial skin
behaved close to normal human epidermis regarding co-localization of hsp27 with other
proteins. Both, overexpression of hsp27 in A431 and inhibition of the hsp27-phosphorylation
by SB203580 in NHEK changed the expression of differentiation associated proteins. A
further novel result of this study is that inhibition p38-MAPK not only inhibits phosphorylation
but also leads to decreased expression of hsp27 in NHEK. These results provide evidence
that hsp27, probably through its function as a chaperone, is involved in the regulation of the
coordinated expression of differentiation associated proteins in keratinocytes. Furthermore,
hsp27 might provide a molecular link between MAPK activation and keratinocyte dif-
ferentiation. Pharmacologic inhibition of hsp27 phosphorylation and expression as described
here will not only help to further investigate the differentiation process but also provides a
new potential target for therapeutic intervention.
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Drebrin, an Actin-Binding Protein of Diagnostic Potential in Dermatology: Induction and
Localization in Epithelial Skin Tumors and Cultured Keratinocytes
WK Peitsch1,2, I Hofmann2, J Bulkescher1,2, M Hergt2, H Spring3, U Bleyl4, S Goerdt2, WW
Franke2
1Department of Dermatology, Medical Center Mannheim, University of Heidelberg,
Mannheim; 2Division of Cell Biology, 3Structure Analysis Group, German Cancer Research
Center, Heidelberg; 4Department of Pathology, Medical Center Mannheim
Drebrins are actin-binding proteins originally identified in neuronal cells and thought to be
involved in the formation of neuronal cell processes. More recently, we have detected that the
isoform drebrin E2 also occurs in many different non-neuronal cell types where it is enriched
both in cell processes and at intercellular junctions. Here we report on the distribution of
drebrin in normal and pathologically altered human skin as well as in keratinocytes in cell
culture. In normal human skin the keratinocytes contain almost no drebrin; however, this
protein is enriched in the companion layer and outer root sheath of hair follicles. Interestingly,
the intercellular junctions of basal cell carcinomas are extremely rich in drebrin, as shown by
immunohistochemistry and immunoblot analysis. Using confocal laser scanning microscopy,
we have observed colocalization of drebrin with actin and partially also with plaque proteins
of adhering junctions. In squamous cell carcinomas and precancerous lesions the distribution
of drebrin can be rather heterogeneous, with drebrin-rich and drebrin-negative tumor regions.
Under cell culture conditions, primary human keratinocytes synthesize significant amounts
of drebrin, accumulating again along adhering junctions. When cultured epithelial cells
containing no endogenous drebrin, i.e. A-431 human vulvar carcinoma cells, have been
transiently or stably transfected with constructs of drebrin cDNA fused with EGFP, ac-
cumulation of the EGFP-tagged drebrin along the adhering junctions has been observed.
Moreover, immunoprecipitation experiments have shown biochemical interactions of drebrin
with certain plaque proteins of adhering junctions. Our results indicate an involvement of
drebrin in regulating intercellular adhesions of somehow ‘‘activated’’ keratinocytes. The strong
upregulation of this protein in basal cell carcinomas, also arguing for their follicular origin, points
to the possibility of diagnostic application.
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Retinaldehyde-Induced Epidermal Hyperplasia via Heparin Binding Epidermal Growth
Factor is CD44-Dependent
G Kaya1, C Tran1, O Sorg1, R Hotz1, D Grand1, P Carraux1, L Didierjean1, I Stamenkovic2
and J-H Saurat1
1Department of Dermatology, DHURDV, University Hospital of Geneva, Geneva, Switzerland
2Institute of Pathology, University Hospital of Lausanne, Lausanne, Switzerland
CD44 is a multifunctional polymorphic proteoglycan involved in broad cellular processes.
CD44 functions as the principal cell-surface receptor for hyaluronate (HA). Retinoids are
known to inhibit keratinocyte differentiation and to stimulate epidermal hyperplasia. Heparin
binding epidermal growth factor (HB-EGF) activation of keratinocyte ErbB receptors has been
proposed to mediate retinoid-induced epidermal hyperplasia in human skin organ cultures.
It has been shown that a heparan sulfate-bearing variant of CD44 (CD44v3) recruits
proteolytically active matrix metalloproteinase 7 (MMP-7), the precursor of HB-EGF (pro-HB-
EGF) and one of its receptors, ErbB4 to form a complex on the surface of some tumor cell
lines, uterine and mammary gland epithelium, and uterine smooth muscle. In this study we
first analyzed the effect of a retinoid, retinaldehyde (RAL), on in vitro proliferation of
keratinocytes from SKH1 hairless, DBA/1 and CD44-deficient (CD44/) mice. Treatment of
primary keratinocyte cultures of SKH1 hairless and DBA/1 mice with RAL resulted in slight
but significant increase in keratinocyte proliferation whereas no proliferation was observed
in CD44/ cells. RAL also induced in vitro HA production by keratinocytes. While HB-
EGF stimulated normal and CD44-deficient keratinocytes to proliferate, blocking antibodies
against HB-EGF and erbB1, and tissue inhibitor of metalloproteinase-3 (TIMP-3) which
inhibits the effect of metalloproteinases including MMP-7, abrogated the RAL-induced
keratinocyte proliferation. We then analyzed the effect of RAL on epidermis in SKH1 hairless,
DBA1 and CD44/ mice. Topical application of 0.05% RAL for 3 days resulted in a significant
epidermal hyperplasia and keratinocyte proliferation as determined by quantitation of Ki67 in
the back skin of SKH1 hairless and DBA/1 mice, whereas no epidermal hyperplasia and
keratinocyte proliferation was observed in CD44/ mice. Topical application of RAL also
significantly induced the CD44 protein expression in the follicular and interfollicular epidermis
and increased the epidermal HA in SKH1 hairless and DBA/1 mice, as determined by
immunohistochemistry and ELISA, respectively. Western blot analysis of RAL-treated epi-
dermis showed an increase of CD44v3, active HB-EGF and erbB1 protein expression when
compared to vehicle-treated epidermis in SKH1 hairless mice. Our results indicate that RAL-
induced in vitro and in vivo proliferative response of keratinocytes is a CD44-dependent
phenomenon and requires the presence of HB-EGF, erbB1 and matrix metalloproteinases.
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CD44-Dependent Mouse Skin Hyperplasia Induced by Topical Hyaluronate Fragments
G Kaya1, C Tran1, O Sorg1, R Hotz1, D Grand1, P Carraux1, L Didierjean1, I Stamenkovic2
and J-H Saurat1
1Department of Dermatology, DHURDV, University Hospital of Geneva, Geneva, Switzerland
2Institute of Pathology, University Hospital of Lausanne, Lausanne, Switzerland
Hyaluronate (HA) is a major glycosaminoglycan component of the extracellular matrix, and
present mainly in dermis and also in epidermis. In its native form HA exists as a high
molecular weight polymer but is cleaved to lower molecular weight fragments during
inflammatory processes. High molecular weight HA is capable of immobilizing the water in the
tissue and therefore of changing the dermal volume and elasticity to maintain the extracellular
space. Several studies have suggested that high and low molecular weight HA may exhibit
different biological effects on cells and in tissues. Many of the functions of HA are thought to
be mediated by its cell surface receptor, CD44. CD44 is a polymorphic transmembrane
glycoprotein and was shown to form a complex with matrix metalloproteinase 7 (MMP-7),
heparin binding epidermal growth factor (HB-EGF) precursor (pro-HB-EGF) and one of its
receptors in mouse uterine and mammary epithelia. In this study we first examined the effect
of HA fragments (HAF) of different size that we generated from high molecular weight HA by
sonification, enzymatic digestion and size exclusion gel filtration, on in vitro proliferation of
keratinocytes from SKH1 hairless, DBA/1 and CD44-deficient (CD44/) mice. Treatment of
primary keratinocyte cultures of SKH1 hairless and DBA/1 mice with HAF of intermediate
(HAFi; 50,000-400,000 Da) but not of small (HAFs; 1,000-50,000 Da) or large (HAFl; 400,000-
1,000,000 Da) size resulted in a significant increase in keratinocyte proliferation whereas no
proliferation was observed in CD44/ cells. HB-EGF stimulated the proliferation of normal
and CD44-deficient keratinocytes whereas blocking antibodies against HB-EGF and its
receptor, erbB1, and tissue inhibitor of metalloproteinase-3 (TIMP-3) which inhibits the effect
of metalloproteinases including MMP-7, abrogated the HAFi-induced keratinocyte prolifera-
tion. We then examined the effect of HAFi on epidermis in SKH1 hairless, DBA/1 and CD44/
mice. Topical daily application of 0.2% HAFi but not of HAFs or HAFl for 3 days to the back
skin of SKH1 hairless and DBA/1 mice resulted in a marked epidermal hyperplasia and
keratinocyte proliferation as determined by quantitation of Ki67, and in structural dermal
alterations and an increase in the number of dermal cells, mainly of fibroblasts visualized by
electron microscopy. Topical application of HAFi also significantly induced the CD44 protein
expression in the follicular and interfollicular epidermis as determined by immunohistochem-
istry. Topical HAFi also increased the HA content and induced the mRNA expression of
hyaluronate synthase-2 (HAS2) and HAS3 in the epidermis and dermis of SKH1 hairless and
DBA/1 mice, as evidenced by ELISA and Northern blot analysis, respectively. In contrast,
topical application of HAFi to the back skin of CD44-deficient (CD44/) mice did not reveal
any epidermal hyperplasia, keratinocyte proliferation or dermal alterations. Western blot
analysis of HAFi-treated epidermis showed an increase of CD44, pro- and active HB-EGF,
erbB1 and MMP-7 protein expression when compared to vehicle-treated epidermis in SKH1
hairless mice. These results suggest that HAFi-induced in vitro and in vivo proliferative
response of keratinocytes is mediated via a CD44-dependent pathway and requires the
presence of HB-EGF, erbB1 and matrix metalloproteinases.
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Protein Kinase C Isoforms have Different Effect on the Expression of Desmoglein 1, 3 and
P-cadherin in HaCaT Keratinocytes
A Szegedi, G Czifra, E Schmidt, J Hunyadi and T Bı´ro´
Debrecen, Hungary
Protein kinase C (PKC) comprises a family of serine/threonine kinases and emerging evidence
suggests a privotal role for these enzymes in the regulation of the proliferation and
differentiation of normal human epidermal keratinocytes. In addition, isoenzyme-specific
roles of PKC in keratinocyte proliferation and differentiation have been described. Our
laboratory has previously published the construction of stable PKC transfectants of HaCaT
cells and has presented clear evidence for the specific and antagonistic roles of certain
conventional (cPKC) and novel (nPKC) PKC isoforms in the regulation of proliferation and
differentiation of the human keratinocyte line HaCaT.
Epithelial cells utilize multiple adhesive mechanisms to maintain the structural integrity of
tissues, including adherens junctions and desmosomes. Adherens junctions consist of
classical cadherins like P-cadherin and desmosomes consist of desmosomal cadherins,
desmogleins (Dsg) and desmocollins. These molecules are expressed in a differentiation-
specific fashion in the epidermis, with Dsg3 and P-cadherin being present in the basal and
spinous layer and Dsg1 predominanly in the granular layer.
Our objective was to investigate the effect of overexpression of PKC isoforms on the
production of Dsg1, 3 and P-cadherin in HaCaT cells. We used Western blot analysis.
Our results indicate that the overexpression of PKC isoforms altered the expression of
desmosomal and classical cadherins. Overexpression of cPKCa and nPKCd increased the
expression of Dsg1 and decreased the production of Dsg3 and P-cadherin compared to
overexpression of cPKCb and nPKCe in HaCaT cells. Incubation of HaCaT cells with the
nPKCd inhibitor rottlerin, resulted in the stimulated production of Dsg3 and P-cadherin.
These finding are in good correlation with our previous results as PKC isoenzymes have
isoform specific roles in the regulation of various keratinocyte functions; cPKCa and nPKCd
stimulated cellular differentiation and in contrast cPKCb and nPKCe increased growth of cells.
012
Coordination Between Epidermal Cell Growth and Differentiation: Novel Mechanisms
J Zanet1, M Coisy2, S Pibre1, J Chiesa3, A Ramirez4, J-P Moles1, IM deAlboran5 and
A Gandarillas1
1Laboratoire de Dermatologie Mole´culaire. Institut Universitaire de Recherche Clinique.
Montpellier, France. 2Institut de Ge´ne´tique Moleculaire de Montpellier. CNRS. Montpellier,
France. 3Laboratoire de Cytoge´netique, CHU Nıˆmes, France. 4CIEMAT. Madrid, Spain.
5CNB. CSIC. Madrid, Spain
Human epidermis is a frequent target of hyperproliferative disease. However, the
mechanisms that link cell growth and differentiation and maintain epidermal homeostasis
are not understood. We have previously shown that primary differentiating keratinocytes
continue DNA synthesis and become polyploid in the absence of mitosis (endoreplication).
Cell growth, cell cycle, differentiation and genomic stability are thus tightly linked. We have
unravelled this phenomenon not only in primary cultured keratinocytes but also in human
epidermis in situ. To this aim, we have applied to human skin up-to-date techniques for the
study of cell cycle, DNA replication and genome amplification. This phenomenon is regulated
and stimulated by the proto-oncogene c-myc, and we are investigating the molecular
regulation. The results show a particular combination of cyclin/cdks, Rb, p53 and the p21
inhibitor that hallmarks a mitosis block and endoreplication in the onset of differentiation.
Finally, we have demonstrated the physiological importance of this control in epidermal-
specific c-myc knock-out mice. This novel phenomenon may be central in co-ordinating
proliferation with differentiation and in protecting epidermis against hyperproliferative
alterations.
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Migration Characteristics of laminin 5 Deﬁcient Keratinocytes
B Hartwig, B Borm, G Kirfel, L Bruckner-Tudermann, T Krieg, V Herzog and M Arin
Cologne, Germany, Freiburg, Germany and Bonn, Germany
Laminin 5 is an important extracellular matrix component involved in keratinocyte migration,
e.g. during epidermal wound healing. To determine the significance of laminin 5 for cell
migration in detail we quantified the main parameters of migration such as lamellipodia
protrusion and persistence, ruffle frequency as well as cell translocation velocity using the
stroboscopic analysis of cell dynamics assay. In laminin 5 deficient cells on fibronectin we
found a significantly (40-50%) reduced velocity of lamellipodia protrusion and persistence,
whereas the frequency of ruffle formation was about 3-fold higher than in wild type cells. In
spite of these findings, we observed no differences in the translocation velocity between
deficient and wild type cells. However, on glass the deficient cells showed normal dynamics
of lamellipodia and ruffles but a significantly decreased translocation velocity. To further
characterize the migration and adhesion process in laminin 5 deficient keratinocytes we
analyzed the formation of migration tracks at the rear of migrating cells. Keratinocyte
migration tracks consist of extracellular matrix components and integrin macroaggregates,
i.e. membrane bounded fragments that are enriched in different integrins and that result from
membrane ripping at the cell rear during the process of rear release. The ultrastructural
analysis of the migration track of laminin 5 deficient keratinocytes revealed a lack of spherical
and elongated tubular structures, that are thought to contain alpha6 beta4 integrin and
are regularly found in tracks of wild type cells. In spite of significant differences in the
mechanisms of cell migration laminin 5 deficient keratinocytes are capable of efficient cell
migration when fibronectin is used as substrate which obviously can compensate for the lack
of laminin 5.
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Cytokines Induce Neuropeptide Galanin Expression in Human Keratinocytes
B Kofler, S Schmiedhuber, K Moritz, E Voglas, R Santic, J W Bauer
Department of Pediatrics and Department of Dermatology, University Hospital Salzburg,
Austria
Galanin (GAL), a 29 amino acid neuropeptide, has multiple effects in both the central and
peripheral nervous system. In the human skin GAL is mainly detected in the epidermis and in
sweat glands in a non-neuronal distribution (Koﬂer et al J Invest Dermatol 2004, in press). RT-
PCR and northern blot analysis of human primary cultured epidermal foreskin keratinocytes
(KC) revealed detectable levels of GAL mRNA. In order to uncover a possible function of GAL
in the human epidermis we investigated the regulation of GAL gene expression in KC. The
known regulators of GAL mRNA expression PMA (50 nM) and leukemia inhibitory factor (LIF,
10 ng/ml) induced GAL mRNA in KC 6.1-fold and 4.5-fold, respectively. Upon stimulation of
KC with a combination of IL-1b (10 ng/ml) and TNFa (100 ng/ml) for 24 hrs a 2.2-fold induction
of GAL mRNA was detected. In addition, a 5-fold induction upon treatment with 100 ng/ml IL-
4 for 6 hrs was observed. Treatment of KC with Il-6, histamine, UV or heat did not alter GAL
mRNA levels. Interestingly, treatment of KC with the VR1 agonist capsiacine (1 mM) leads to a
2-fold down regulation of GAL mRNA. In contrast treatment of KC with the Vanilloid receptor
1 antagonist capsazepine (10 mM) resulted in a 3-fold up-regulation of GAL mRNA. The
regulation of galanin mRNA expression in human keratinocytes by cytokines and neuro-
modulatory factors suggests a role of GAL in inflammatory processes in the human skin.
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Expression of D-type Cyclins in HaCaT Keratinocytes
N Belso+1, A Pivarcsi2, M Sze´ll2, H Polya´nka1, A Dobozy12, L Keme´ny12, Z Bata-Cso¨rgo+12
1Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary,
2Dermatological Research Group of the Hungarian Academy of Sciences, University of
Szeged, Szeged, Hungary
Amongst the cell cycle regulator cyclins, only D-types are known to have different isotypes. A
strong a5 integrin expression appears in HaCaT keratinocytes when the cells leave the Go,
quiescent phase, and enter the cell cycle, indicating that a5 integrin regulates keratinocyte
proliferation. We were interested to see, whether in HaCaT keratinocytes, similar to normal
keratinocytes, D-type cyclins are expressed differentially in Go-G1/S and G1/S phases of the
cell cycle, and whether a5 integrin regulates the expression of D-type cyclins. We have forced
HaCaT cells into quiescent (Go) phase by serum withdrawal and high density culturing, then
released them into an almost synchronized highly proliferative state by passaging into serum
containing medium. The expression of D-type cyclins was determined with Real-Time RT-
PCR. The regulatory role of a5 integrin was examined by adding neutralizing anti-a5 integrin
monoclonal antibodies to the HaCaT cell culture. Our results showed that HaCaT keratino-
cytes expressed all three D-type cyclins (D1, D2 and D3). The Go-G1/S phase of the cell cycle
can be characterized by the appearance of D1 cyclin, while during the rapid turnover in highly
proliferating cells (G1/S transit) the expressions of cyclins D2 and D3 are much more
significant. Blocking the function of a5 integrin before the cells leave cell quiescence results in
a significant decrease in D1 cyclin expression, indicating that a5 integrin takes part in
regulating the cell cycle at this point.
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Peptidylarginine Deiminases: Genomic Characterization and Expression Analysis in the
Epidermis
M-C Me´chin1, R Nachat1, S Chavanas1, H Takahara2, A Kawada3, M Charveron4, G Serre1,
M Simon1
1CNRS-Toulouse III University UMR 5165, CHU Purpan, Toulouse, France. 2Dept of Applied
Biological Resource Sciences, Ibaraki University, Japan. 3Dept of Dermatology, Kinki
University, Osaka, Japan. 4 CERPER/Pierre Fabre, Toulouse, France
Peptidylarginine deiminases (PADs) convert arginine residues in proteins into citrullines. They
are suspected to be involved in multiple sclerosis and rheumatoid arthritis pathophysiology,
and they play a pivotal role in epidermis homeostasis. In humans, four isoforms encoded by
the genes PADI1-4 were known so far. Their substrate specificity and expression pattern in
the epidermis are still unclear. We characterized the human (355 kb) and mouse (240 kb) PADI
gene clusters on chromosomes 1p35-36 and 4E1, respectively. A yet unknown human gene,
PADI6, was identified which is expressed in ovary, testis and peripheral blood leukocytes,
and encodes a 694-amino-acid protein. The genes PADI1-6 may have duplicated from a
common ancestor and appeared to be under purifying selection, as suggested by their
nucleotide substitution rates (dN/dS). To gain more information on the physiological role of
PADs in the epidermis, we investigated their expression pattern. mRNA analysis, western
blotting and confocal laser microscopy analyses using anti-peptide antibodies highly specific
to each PAD isoform revealed that only PAD1-3 are expressed in the human epidermis. PAD1
was detected in the entire epidermis, including the stratum corneum (SC). PAD2 was found in
all the living layers, and accumulated at the keratinocyte periphery in the granular layer. PAD3
expression was found to be restricted to the granular layer and lower SC. PAD1 and PAD3 co-
localized with (pro)filaggrin. Such different patterns of expression indicated a fine regulation
of the PADI gene expression, and prompted us to search for possible regulators of PADI gene
expression at the genomic level. Comparative analysis of the PADI gene clusters identified
251 highly conserved non-coding segments predominantly clustered within the promoter
regions, the large (410 kb) first intron of each of the genes PADI1-3, and an 8 kb PADI1-2
intergenic region. The presence of numerous transcription factor binding sites suggests these
genomic regions are putative regulatory elements. Our results strongly suggest that each
epidermal PAD has a specific role in epidermis differentiation, and will help unravelling the
genomic bases of their co-ordinated expression in the skin. Also, this study is the first step
towards the substrate specificity of epidermal PADs.
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Differentiation of Murine Embryonic Stem Cells into Keratinocyte-Like Cells, their
Isolation and Cultivation
Haase, R Knaup, M Wartenberg, H Sauer and G Mahrle
University of Cologne, Germany
Embryonic stem (ES) cells are omnipotent; they can differentiate into every cell type of the
body. The signals that regulate differentiation into squamous epithelial cells are poorly
defined. In vitro production of large numbers of epidermal cells from embryonic stem cells
could be used in dermatology in order to cover large wounds, e.g. of burn victims. Elimination
of immunogenic determinants in ES cells prior to differentiation would eventually allow to
generate non-immunogenic epidermal cells that could be universally used for different
recipients. In order to understand the signals that regulate differentiation of ES cells into
squamous epithelial cells we have used embryoid bodies (EBs) formed from embryonic stem
cells as a system for in vitro differentiation. EBs were first cultured in suspension and then
plated onto tissue culture dishes. At day 17 of culture cells formed colonies of epithelial cells
within sheets of non-epithelial cells. These colonies expressed epithelial cadherin (E-
cadherin), a classical type I cadherin and a key regulator of epithelial cell-cell adhesion in
embryonic and adult tissues. During subsequent days a subset within the epithelial layer
started to express keratin 14, a type I keratin, which is constitutively present in basal
keratinocytes of the epidermis and stratified epithelia and in the outer root sheath of the hair
follicle. Many of these cells were larger than the surrounding cells and showed filamentous
keratin structures. Keratin 14 positive cells subsequently merged to form aggregates. We
were able to isolate such cells from the EBs and culture them in vitro for several days. Our
results show that embryonic stem cells that form an EB are able to differentiate into
keratinocyte like cells and that these cells can be isolated and cultured in vitro.
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Caspase-14 Derived From Stratum Corneum of Human Epidermis is Catalytically Active
L Eckhart, H Fischer, M Stichenwirth, M Ghannadan, M Dockal, E Tschachler
Department of Dermatology, Medical University Vienna, Vienna, Austria.
Caspase-14 is expressed by epidermal keratinocytes as a proenzyme which undergoes
processing to a large and a small subunit during terminal keratinocyte differentiation. Here
we demonstrate for the first time that caspase-14 present in human stratum corneum is
catalytically active. Stratum corneum was scraped off from plantar skin and extracted with
phosphate buffered saline. Western blotting revealed presence of caspase-14 subunits
whereas procaspase-14 was absent both in the soluble and the insoluble fraction. By
contrast, extracts from parakeratotic epidermis contained both cleavage products and
procaspase-14 indicative of incomplete proenzyme activation. Under kosmotropic salt
conditions, stratum corneum extracts displayed significant cleavage activity against the
synthetic tetrapeptide substrates WEHD-pNA and IETD-pNA as measured in a colorimetric
assay. This activity correlated with the concentration of processed caspase-14 and could be
specifically removed by immunodepletion of caspase-14. Our results indicate that, in normal
epidermis but not in parakeratotic epidermis, practically all procaspase-14 is converted to
caspase-14 subunits which have the potential to act proteolytically. The identification of
tetrapeptide sequences recognized by caspase-14 is likely to facilitate the identification of
the physiological substrate of this epidermis-specific enzyme.
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Expression of Skin Speciﬁc DNase1L2 is Linked to Terminal Differentiation of
Keratinocytes
H Fischer1, L Eckhart1, M Ghannadan1 and E Tschachler1,2
1Department of Dermatology, University of Vienna Medical School, Vienna, Austria, 2Centre
de Recherches et d’ Investigations Epidermiques et Sensorielles (CE.R.I.E.S.), Neuilly,
France
Degradation of nuclear DNA is a hallmark of terminal differentiation of keratinocytes. As
the enzymes mediating this process are unknown at present, we performed real-time PCR
screening of candidate DNases. While most DNase genes were expressed at comparable
rates in pre- and postconfluent keratinocytes, DNase1L2 was strongly upregulated during
keratinocyte differentiation. Moreover, the DNase1L2 mRNA level was found to be approx-
imately 100-fold higher in skin than in all other tissues examined. In skin, DNase1L2 mRNA
abundance increased significantly from the basal layer towards the granular layer of the
epidermis as demonstrated by in situ-hybridization. Recombinant expression of DNase1L2 in
Escherichia coli yielded inclusion bodies whereas expression in the yeast Pichia pastoris
allowed for production of a secreted enzyme that was able to degrade plasmid DNA in vitro.
Both protein preparations were used for the immunization of rabbits. The polyclonal
antibodies detected a specific band in Western blots of protein lysates from human skin
equivalents and revealed a gradient of increasing expression in the epidermis. The keratinocyte-
specific and differentiation-associated expression of DNase1L2 suggests that this enzyme
participates in DNA degradation during terminal differentiation of keratinocytes.
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Decreased Peroxisome Proliferator-Activated Receptor MRNA Expression in Cultured
Keratinocytes after UVB Irradiation
E Remenyik1, A Balogh1, G Paragh2,3, L Nagy2
Dept. of 1Dermatology and 2Biochemistry and Molecular Biology, University of Debrecen,
Medical and Health Science Center and 3Dept. of Dermatology of Semmelweis University of
Budapest
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription
factors that regulate the expression of target genes involved in cell differentiation, pro-
liferation, apoptosis, metabolic processes and immune response. The PPAR family consists
of PPAR alpha, PPAR delta and PPAR gamma isotypes all of which are expressed in
keratinocytes. According to previous studies PPAR delta is the predominant subtype in
human keratinocytes, whereas PPAR alpha and PPAR gamma are expressed at lower levels
but show significant increase upon keratinocyte differentiation. PPAR delta is upregulated
during keratinocyte proliferation. UVB light induces keratinocyte apoptosis, inflammatory
reaction and latter on keratinocyte proliferation in vivo. Few studies have been carried out to
understand the effects of PPARs during UVB irradiation. We used an in vitro system:
immortalized human keratinocytes (HaCaT cells) to study the expression of PPAR mRNAs
after UVB irradiation. mRNA expression was studied by quantitative RT-PCR reaction and
normalized to cyclophilin mRNA levels. Broad band UVB light source (FS20 tubes) was used
for 30-120 mJ/cm2 irradiation. Time course and dose dependence were determined. The
level of DNA damage of irradiated keratinocytes was measured by comet assay. Cell viability
was also determined and correlated with PPAR mRNA levels. Apoptotic and proliferative
effects of UVB were measured by flow cytometry. After UVB irradiation the expression of all
PPAR mRNAs was significantly decreased. Our results suggest that PPARs may play a role in
the regulation of the effects of UVB irradiation in human keratinocytes.
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Proteoglycans in the Intercellular Cores of Desmosomes and Corneodesmosomes
S Duhieu, M-A Le Bitoux, D Schmitt, H Suzuki, K Ishikawa, and M Haftek
Department of Dermatology, EA3732, Universite´ Claude Bernard Lyon 1 & CNRS, Lyon,
France,Nihon University School of Medicine andFaculty of Sciences, Shizuoka
University, Japan
Proteoglycans (PG) are complex glycoproteins composed of a protein core with specifically
attached sugar chains of glycosaminoglycans (GAG). Various forms of PG are present in
many different tissues, including human epidermis. We have previously defined desmosealin
(recognized by KM48 antibody) as an epidermal PG which differs from the others, mostly of
the heparan sulfate (HS) type, by its selective chondroitin / dermatan sulfate (CS/DS) GAG
expression. Desmosealin is also a constitutive desmosomal antigen showing an expression
pattern positively correlated with the keratinocyte differentiation. However, it disappears
rapidly in the lower portions of the horny layer. Another monoclonal antibody, 7C1, obtained
after immunization of mice with a whole desmosome fraction isolated from a normal human
epidermis, shows an expression profile very similar to KM48. Ultrastructural immunolocaliza-
tion on ultrathin cryosections of a normal human skin reveals the presence of both antigens
in the inter-keratinocyte spaces and their integration into the desmosomes. Biochemical
analysis demonstrates that 7C1 antigen also belongs to the PG family. However, its GAG are
not only of the CS/DS but also of the HS type. Cross-immunoprecipitation assays with
antibodies to syndecan-1, CD44/HCAM, KM48 and 7C1 do not reveal any cross-reactivity,
thus indicating that desmosealin and 7C1 antigen are different from the known epidermal PG
displaying a similar, pericellular distribution.
Although KM48 antibody proves difficult to use in immunoprecipitation assays, the surface
plasmon resonance (BIAcores) technology can be employed for ‘ligand fishing’ and opens up
the possibilities of subsequent mass spectrometry analysis of the studied antigens.
Provided the influence of PG on such fundamental biological events as cell recognition,
proliferation, and differentiation, and the evidence of the protective role of sugars against
the proteolytic degradation of desmosomes and corneodesmosomes, we speculate that the
desmosome-associated PG may be involved in the regulation of epidermal cohesion and
desquamation.
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Oxidative Stress-Induced Cell Death in Human Epidermal Keratinocytes is Dependent on
their Differentiation State
T Zuliani1,2, V Denis2, C Layat2, E Noblesse1, S Schnebert1, M Dumas1, MH Ratinaud2
1L.V.M.H. Recherche, 45804 Saint-Jean de Braye, France
2Lab. Physiol. Molec. Mitochondrial - Faculte´ de Me´decine, 87025 Limoges, France
Epidermis, is a multilayered structure composed of basal proliferating and suprabasal growth
arrested keratinocytes that differentiate into corneocytes. Due to their external position,
keratinocytes are particularly exposed to oxidative stresses among which H2O2 plays a
pivotal role. Apoptosis is a physiologic programmed cell death that occurs throughout the
epidermis contributing to epidermal protection and maintenance by removing damaged or
unwanted cells. Recent evidences suggest that keratinocytes susceptibly to apoptosis is
dependant on their differentiation state. The present study investigates the response of basal
and suprabasal human keratinocytes to a calibrated H2O2-induced cell death. On H2O2-
exposed skin explants, caspase-3, a key effector in apoptosis, was strongly activated in
basal keratinocytes double stained with b1-integrin antibody, since apoptotic single strand
DNA cleavage was restricted to the granular layer, the spinous layer being unresponsive. In
addition, using cytometric analysis, isolated basal human keratinocytes, selected on
adhesion criteria to type IV collagen, were more sensitive than non-adherent cells to H2O2-
induced apoptosis regarding mitochondrial transmembrane potential collapse and plasma
membrane integrity, respectively assessed with JC-1 and TOTO-3 probes. In the same way,
necrotic/late apoptotic cells were present at low levels only in adherent epidermal population.
We concluded that basal proliferating undifferentiated keratinocytes are much more sensitive
than suprabasal growth arrested differentiated ones to oxidative stress-induced cell death
and that apoptosis in human keratinocytes could occur via different pathways depending on
their differentiation state.
023
Apoptosis and Proliferation During Human Epidermal Aging after an Acute UV Exposure:
an In Vivo Immunohistological Study
T Zuliani1,2, N Lachman-Weber1, C Heusele1, S Schnebert1, M Dumas1 and MH Ratinaud2
1L.V.M.H. Recherche, 45804 Saint-Jean de Braye, France
2Lab. Physiol. Molec. Mitochondrial - Fac. de Me´decine 87025 Limoges, France
Ultraviolet radiations (UVR) participate to skin carcinogenesis and photoaging. When
epidermis, the outermost part of the skin, is exposed to UVR, damaged keratinocytes can
undergo apoptosis, a programmed cell death that removes them from the tissue contributing
to its protection and maintenance. Therefore the question related to a decrease of such a
phenomenon in human skin during aging raises. The aim of this study was to investigate,
depending on the age, apoptosis in normal skin following an acute solar simulated radiation
(SSR).
Apoptosis was assessed in the sun-exposed skin of the forearm of young (n¼12, mean
age¼ 25.5) and aged female volunteers (n¼ 12, mean age¼67.1) before and 24h after
a single SSR to a 3-fold minimal erythema dose (MED). Immunohistological studies
were carried out on 10 mm cryosections obtained from 3 mm skin biopsies. Apoptosis
and proliferation were investigated using antibodies against active caspase-3 and Ki-67
respectively.
The results indicate that the proliferation index (PI) is about two times greater in the young
than in the aged epidermis. However, 24 h after SSR exposure, while proliferation was greatly
inhibited in the young epidermis (PI from 216 to 68), it slightly decreased in the aged (PI from
115 to 85). Apoptosis was strongly induced by UVR in both groups with a greater sensitivity of
the young volunteers as opposed to the aged ones. For all volunteers, no spontaneous
apoptosis was observed before SSR exposure. In addition, double staining with b1 integrin, a
marker of basal epidermal keratinocytes, indicated a percentage of active caspase-3 positive
cells in the basal compartment greater in the aged volunteers than in the younger. Taken
together, these results indicate that an acute SSR exposure to 3 MED induced apoptosis
more strongly in young than in aged epidermis from chronically photo-exposed areas, and
that this greater sensitivity of young epidermis is associated with an arrest of basal cell
proliferation.
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Human Endogenous Retroviruses in Normal Human Skin
J-P Mole`s1, A Tesniere1, M Dumas2, F Bonte´2, J-J Guilhou1
1Laboratoire de Dermatologie Mole´culaire, Montpellier, France; 2LVMH recherche, Saint
Jean de Braye, France
A part of the Human genome consists of repeated sequences of unknown functions. Among
them, Human endogenous retroviruses represents up to 7%. They are reminiscent of
ancestral retroviral infection that lost their infectiosity through acquisition of point mutations
or deletions. However, these sequences still contain active promotor and ORFs that could
lead to the production of viral proteins. In the present work, we first evaluated which HERV
family was expressed in normal skin, detected viral proteins and tested their expression
under UV irradiation.
By using the pan-RetroPCR based on conserved sequence among reverse transcriptase,
we observed in normal human skin that most of the HERV transcripts belonged to the MLV-
like superfamily including HERV-W and HERV-E, the remaining transcripts belonging to the
MMTV superfamily, namely HERV-K. Interestingly, when we tested for a Mn2þ dependant
reverse transcriptase in normal human skin, we found a weak activity (mean¼ 61 mU/ml,
n¼ 10), above the cut-off of significativity.
At the protein level, numerous capside MLV-like proteins are detected with a predominant
protein at 55 kD. Also, HERV-E envelope protein is detected with a M.W. of 57 kD. Both
proteins were also detected in cultured keratinocytes. The expression of these proteins was
strongly down-regulated by UVB irradiations (30mJ/cm2).
These types of sequences were, so far, considered as non-conventional genes or ‘‘junk
DNA’’. These results suggested that they could be expressed, UV-regulated and functional for
at least some of them. Their role in skin physiology remains to be investigated.
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Scavenger Receptors Expression at the Cutaneous Level
MF Aries1, C Vaissiere1, L Bonesso, W Mevizou, O Calvayrac and M Charveron1
1Pierre Fabre Research Institute, Cutaneous Cell Biology Laboratory, Toulouse, France
Scavenger receptors (SRs) are a family of cell surface glycoproteins; they are expressed by
myeloid cells (macrophages and dendritic cells) and certain endothelial cells. They play an
important role in uptake and clearance of effete components, such as modified host
molecules and apoptotic cells. They are able to bind modified lipoproteins such as oxidised
and acetylated LDLs (oxLDL and acLDL). They bind and internalise microorganisms and their
products. Scavenger receptors are a broad family of transmembrane multidomain structures
classified into six subgroups based on their proposed tertiary structure : SR-A (SR-AI, SR-AII,
SR-AIII, MARCO), SR-B (CD36, SR-B1), SR-C, SR-D, SR-E (LOX-1), SR-F (SREC).
The aim of the present study was to investigate the potential expression of SR-A, MARCO,
SR-BI, and LOX-1 scavenger receptors at the cutaneous level by means of two models: human
keratinocyte cell line HaCaT for which SR expression was studied by immunohistochemistry,
flow cytometry, western-blot (WB) and real time PCR analysis; human skin explants for which
SR expression was studied by immunohistochemistry and real time PCR analysis.
The present results demonstrate that SR-A, MARCO, SR-BI, and LOX-1 are present in
cultured human keratinocyte cell line HaCaT. Furthermore, SR-A, SR-BI, and LOX-1 are also
expressed in human epidermis.
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2,3,7,8-tetrachlorodibenzo-p-dioxin Impairs Differentiation of Normal Human Epidermal
Keratinocytes in a Skin Equivalent Model
A Geusau, M Korchide, M Mildner, J Pammer, L Eckhart, E Tschachler
Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases
(DIAID), Dept. Pathology, Medical University of Vienna, Austria
Intoxication with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) causes a severe skin pathology
in humans called chloracne. Here we tested the effect of dioxin exposure on keratinocytes in
an in vitro skin equivalent (SE) model in which epidermal keratinocytes (KC) are cultured on
a fibroblast/collagen support at the air/liquid interface and differentiate into a stratified
epithelium. SEs were exposed to TCDD at concentrations of 108 and 107 M in the culture
medium for one week. Then they were subjected to histological analysis and Western blotting
for differentiation markers. TCDD treatment led to an increase in the thickness of the stratum
corneum and to parakeratosis, indicative of an accelerated but incomplete differentiation
process. P63 and Id-1, regulatory proteins specifically expressed in non-differentiated
keratinocytes, were downregulated by TCDD. While the levels of the spinous layer proteins
keratins 1 and 10 were strongly reduced, involucrin was upregulated. Strikingly, TCDD
increased the expression of profilaggrin but blocked its processing to filaggrin monomers.
Expression of caspase-14, a protease active in terminally differentiated KC, was suppressed
by TCDD. Taken together, our data show that TCDD accelerates some early KC differenti-
ation steps but prevents regular completion of the differentiation program in human skin
equivalents.
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Tight Junctions in Psoriasis
J Riehokainen1, K Pummi1,2, J Peltonen3,4, and S Peltonen1,2
1Department of Medical Biochemistry, University of Turku, 2Department of Dermatology,
Turku University Hospital, Turku, Finland; and 3Department of Anatomy and Cell Biology and
4Dermatolgy, University of Oulu, Finland
Tight junctions have recently been characterized in normal human epidermis. They are
localized to the granular cell layer and contain tight junction proteins such as occludin, ZO-1,
and several claudins. Our previous preliminary results have shown that in psoriasis lesion
ZO-1 and occludin spread to the acanthotic spinous cell layers (Pummi et al, 2001). In order
to add understanding of the role of tight junctions in the formation of diffusion barrier in
epidermis, we used psoriatic skin as a model.
Nine adult patients with plaque type psoriasis were included in the study which was
performed with approval of the joint ethic committee of the University of Turku and The Turku
University Hospital. The patients gave their written consent. 3-millimeter punch biopsies were
taken from (1) near vicinity of a psoriasis lesion and (2) from a psoriasis plaque. (3) The third
biopsy was taken 6-8 weeks later from a healed psoriasis plaque, either after treatment, or
from a spontaneously healed plaque. Psoriasis plaque was considered to be healed if there
was no scaling but only slight redness or postinflammatory pigmentation. The punch biopsies
were frozen in liquid nitrogen and cut into 7 mm frozen sections. The sections were used for
indirect immunolabelling for ZO-1, occludin and claudins 1 and 4. All the antibodies were
obtained from Zymed.
The results showed that in apparently normal skin next to the psoriasis plaque the
distribution of tight junction proteins corresponded to that described for normal skin (Pummi
et al, 2001; Brandner et al, 2002). Specifically, occludin and ZO-1 were restricted to the
granular cell layer, while claudins 1 and 4 were distributed to all living cell layers. This
indicates that the abnormal distribution of tight junction proteins in psoriasis is induced only
in the psoriasis plaque. In the psoriasis plaque, ZO-1 and occludin were detected in a wider
zone reaching the middle spinous cell layers, while claudins 1 and 4 were detected in all
viable cell layers. However, in some areas, the granular cell layer showed more intense
labelling. In healed psoriasis plaque, occludin and ZO-1 were again localized to the upper
epidermis. The results indicate that clinical healing of aberrant keratinisation in a psoriasis
plaque is associated with morphological normalization of the tight junctions. Furthermore,
these results suggest a compensatory role for tight junctions in acanthotic cell layers under
conditions when the corneal layer is not fully functioning.
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A Proteolytic Cascade of Kallikreins in the Stratum Corneum
M Brattsand, K Stefansson, C Lundh, T Egelrud
Umea, Sweden
We have found three epidermal proteases, stratum corneum chymotryptic enzyme (SCCE,
also named human kallikrein 7; KLK7/hK7), stratum corneum tryptic enzyme (SCTE or KLK5/
hK5) and kallikrein 14 (KLK14/hK14) present in catalytically active form in the epidermis. All
three enzymes, which may be involved in desquamation and skin inflammation, are produced
as zymogens, which can be activated by tryptic cleavage. In this study, we produce
catalytically active recombinant hK5, hK7 and hK14 in amounts sufficient to allow a further
characterisation of the catalytic properties of these proteins. The activity of recombinant
hK5 (rhK5), rhK7 and rhK14 was characterised with chromogenic peptide substrates and
inhibitors. Both rhK5 and rhK14 were found to have trypsin like primary substrate spe-
cificities, but rhK14 was much more efficient towards the substrates tested. rhK5 could auto
activate and convert both rpro-hK7 and rpro-hK14 to active forms. The activation of rpro-hK7
was at a low but significant rate with pH optimum around pH 5.6, although the pH optimum
for rhK5 activity with chromogenic substrates was alkaline. The rate of activation of rpro-
hK14 was faster around pH 6.5. We suggest that the slow activation rate and the acidic pH
optimum of rpro-hK7 and rpro-hK14 activation may have physiologic relevance, and propose
a model for a cascade reaction of the kallikreins in the epidermis starting from auto-activation
of pro-hK5.
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The Role of b-Catenin in Normal Human Keratinocytes and Involved and Uninvolved
Psoriatic Skin
P J Hampton and N J Reynolds
Dermatological Sciences, School of Laboratory and Clinical Sciences, Newcastle University, UK
b-Catenin is a 92Kda protein which has two distinct roles in epidermal cells. As a component
of the adherens junction b-catenin has a role in cell-cell adhesion. b-catenin when de-
phosophorylated is transcriptionally active and acts as a signalling molecule in the wnt
signalling pathway. Free b-catenin in the cytoplasm is usually phosphorylated by Glycogen
Synthase Kinase 3b (GSK 3b) and targeted for ubiquitination by the proteosome. In response
to Wnt signals, GSK-3b is inhibited and activated b-catenin is allowed to translocate to the
nucleus where it combines with members of the Tcf/Lef1 transcription factor family to
transcribe genes such as cyclin D1 and c-myc which are known to be involved in proliferative
responses. Hazan et al have shown elevated cytosolic phosphorylated b-catenin in involved
psoriatic epidermis and suggested that dysregulation of b-catenin may play a role in
regulating keratinocyte proliferation and migration in psoriatic skin. We are interested in the
possible effects of un-phosphorylated b-catenin on proliferation and differentiation in
psoriasis.
We have investigated the distribution of b-catenin in involved and uninvolved psoriatic
epidermis using antibodies against phosphorylated b-catenin and against activated b-
catenin. The skin tumour, pilomatricoma caused in most cases by b-catenin mutations, has
been used as a positive control. In these experiments we have shown a differential
distribution of activated b-catenin in involved and uninvolved psoriatic skin (n¼ 6).
We have used a Tcf/lef luciferase reporter to investigate the transcriptional activity of b-
catenin in primary cultures of unselected normal human keratinocytes, cultured in low
calcium MCDB153 medium. We have also investigated the role of activated b-catenin in
differentiation by examining the effect of b-catenin on a transglutaminase luciferase reporter.
Using a b-catenin-GFP construct we have studied the relationship between b-catenin and
involucrin.
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Imatinib Decreases the Basal and Interferon-c-Induced Expression of the Putative
Psoriasis Autoantigen Keratin 17 in vitro
R Bo¨ckelmann, H Gollnick, B Bonnekoh
Department of Dermatology and Venereology, Otto-von-Guericke-University Magdeburg,
Germany
Imatinib, formerly known as ST1571, is a protein-tyrosine kinase inhibitor which is effectively
used for the treatment of chronic myelogenous leukemia (CML) and metastatic gastro-
intestinal stromal tumors (GISTs). In a case of GIST imatinib treatment had been reported to
improve concomitantly existing psoriasis. Based upon the observation pointing to a keratin
17 (K17) epitope as possibly relevant psoriasis autoantigen, we have recently proposed a so-
called interferon-g (IFN-g) / K17 autoimmune loop as a positive feed back mechanism in the
etiopathogenesis of psoriasis. We now studied the effect of imatinib in a dose range between
5x107 and 1x105 M using a HaCaT keratinocyte model. A significant reduction of the basal
K17 expression and the K17 overexpression induced by 25U/ml IFN-g was observed for
imatinib at concentrations of X2 and 5 mM, respectively, as compared to the appropriate
drug-free controls. When the latter control conditions were set to 100%, the maximum
reductions of the basal and IFN-g-induced K17-expression under 5 mM imatinib were
73.2  4.4% and 83.5  15.4%, respectively. Thus, our experiments show that imatinib
might exert its presumptive antipsoriatic activity at least in part via suppression of psoriasis-
relevant K17 overexpression.
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Sodium Dodecyl Sulfate Increases Sensitivity of Hacat-Keratinocytes to Sidestream
Cigarette Smoke in vitro
T Reuther, M Kemper, M Kerscher
Division of Cosmetic Sciences, Department of Chemistry, University of Hamburg, Germany
Sidestream cigarette smoke (SS) can be regarded as a potential toxic influence for skin
barrier structures such as membranes and membrane lipids. Therefore the aim of the present
study was to investigate in vitro whether acute toxic effects of SS on HaCaT-keratinocytes are
enhanced by treatment with sodium dodecyl sulfate (SDS) using the neutral red dye release
assay (NRRA) that particularly reflects cell membrane alteration and leakage.
For the experiments HaCaT-keratinocytes were incubated 3h with neutral red in a phe-
nol-red free DMEM-medium and then exposed 15 min under PBS to SS that was collected
from three research cigarettes (2R4F) immediately before exposure. Finally the cells were
destained and the optical density (OD) of the resulting solution was measured at 540 nm.
Cells were exposed to 0,2, 0,4, 0,6, 0,8, 1,0 mmol sodium lauryl sulfate (SDS) before smoke
exposure, to 0,8 and 1,0 mmol after smoke exposure, and to SS without further treatment.
There were also cells which remained untreated.
There was an OD of 0,79 in the untreated control. Exposure with SS decreased OD to 0,71.
Treatment with 0,2 mmol SDS alone lead to an OD of 0,77. Increasing concentrations of SDS
decreased the OD to 0,59 after treatment with 1,0 mmol. Combined treatment with 0,2 mmol
before SS exposure decreased OD to 0,61. Increasing concentrations of SDS decreased the
OD to 0,24 after treatment with 1,0 mmol before SS exposure. Treatment with 0,8 mmol SDS
after SS exposure decreased OD to 0,43. OD after treatment with 1,0 mmol after SS exposure
decreased OD to 0,40.
The results indicate an increasing sensitivity of HaCaT-keratinocytes to SS after treatment
with SDS. The sensitivity increases with increasing concentrations of SDS. In consequence it
can be concluded that the sensitivity of membrane structures of the skin against SS might be
increased not only in vitro. Furthermore, even if in a more lesser extent SS also increases
sensitivity of the cells to SDS.
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Clusterin, Vitamin D, and growth regulation of melanoma cell lines
Seifert M1, Boothman D2, Tilgen W1, Reichrath J1
1Department of Dermatology, The Saarland University Hospital, 66421 Homburg, Germany,
and 2Laboratory of Molecular Stress Responses, Department of Radiation Oncology, Case
Western Reserve University, Cleveland, OH, USA
Clusterin is a glycoprotein that is implicated in various cell functions including cell growth, cell
adhesion and apoptosis. There are two known clusterin isoforms that are obtained by
alternate splicing, the nuclear (nClu) and the secretory (sClu). The proapoptotic nClu has been
shown to be involved in the regulation of cell-cycle progression and apoptosis. We have now
analysed expression of clusterin in various melanoma cell lines (e.g. MeWo, SkMel28). All
melanoma cell lines analysed revealed strong expression of clusterin mRNA and protein.
Interestingly, clusterin mRNA and protein levels were regulated time-dependently by
treatment of melanoma cells with 1,25-dihydroxyvitamin D3. Regulation of clusterin mRNA
expression by 1,25-dihydroxyvitamin D3 was confirmed by measuring clusterin promoter
activity (luciferase assay). Our findings indicate that (i) clusterin is strongly expressed
in melanoma cell lines, (ii) clusterin expression is regulated time-dependently by 1,25-
dihydroxyvitamin D3, (iii) antiproliferative effects of 1,25-dihydroxyvitamin D3 on melanoma
cell lines may be at least in part mediated via regulation of clusterin expression, (iv) clusterin
may be of importance for the growth characteristics of melanoma cells.
033
EDAR Signaling Through EDAR-Associated Death Domain (EDARADD)
M Shindo, Y Hagari, M Mihara and PM Chaudhary
Yonago, Japan and Dallas, USA
Two recent studies suggest the involvement of a novel death domain adaptor, designated
EDARADD/crinkled, in EDAR signaling. EDARADD possesses a C-terminal death domain via
which it interacts with the death domain of EDAR. EDARADD has been also reported to
interact with different TRAF family member and this interaction is believed to be mediated via
its N-terminal domain, which possesses the consensus TRAF-binding sequence Pro-X-Gln-
X-Thr. Although the deletion of this motif abolished the interaction of EDARADD with TRAF1,2
and 3 it retained the ability to activate the NF-kB pathway, suggesting that the interaction of
EDARADD with the above TRAFs is not needed for NF-kB activation. However, NF-kB activity
of EDARADD was abolished upon the complete removal of its N-terminal domain, suggesting
that a region other than the above TRAF consensus motif may be responsible for this activity.
A recent study has determined the consensus TRAF6-binding motif to be P-X-E-X-X-
(Aromatic/Acidic), which we have discovered in the cytoplasmic domain of XEDAR. Although,
a consensus TRAF6-binding site is not present in the cytoplasmic domain of EDAR, we have
discovered such a site (PVEDTD) in the N-terminal domain of EDARADD. Our hypothesis is
that while TRAF6 is recruited directly to XEDAR it may be recruited to EDAR via EDARADD
and thus may be involved in NF-kB activation via both EDAR and XEDAR. To test our
hypothesis, we begin by testing the recruitment of TRAF6 to EDAR using the technique of co-
immunoprecipitation. Second, we generated point mutants of EDARADD in the TRAF2 (aa
34–40) and TRAF6 (aa 17–22) consensus sites and tested their ability to activate the NF-kB
pathway and correlated the results with their interaction with different TRAF family members.
Finally, we checked the ability of the selected mutants to block EDAR-induced NF-kB in a
dominant negative fashion and correlated the results with their effect on the recruitment of
TRAF6 to EDAR. Point mutants of EDARADD in the TRAF2 (aa 34–40) and TRAF6 (aa 17–22)
consensus sites blocked NF-kB activity. One mutant stabilize the EDARADD protein while
the other mutant makes it unstablize. The TRAF binding sites of EDARADD seems to be
important as pathogenesis of Hypohidrotic Ectodermal Dysplasia (HED) and ectodermal
differentiation. But, EDARADD induced NF-kB activation is complicated and we need
additional study.
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All-trans Retinoic Acid is Dedifferentiating to Human Mast Cells Independent of their
Stage of Maturation
F Thienemann, S Guhl, C Rex, L Kirchhof, M Artuc, T Zuberbier, B M Henz, M Babina
Department of Dermatology and Allergy, Charite´ Campus Mitte, University Medicine Berlin,
Berlin, Germany
All-trans retinoic acid (ATRA) is a potential master regulator of haematopoiesis, where it
primarily affects immature and proliferative leukocytes. Here, we have analyzed the effects
of ATRA on human mast cells (MC) that span different stages of maturation, i.e. immature-
leukemic HMC-1 5C6 cells, intermediately matured LAD 2 cells, and terminally differentiated
skin MC. The expression of typical lineage markers was studied in parallel at the mRNA level
by RT-PCR and at the protein level by flow-cytometry. Histamine content was assessed by
EIA. ATRA exposure led to a striking downregulation of c-Kit protein expression by all MC
subtypes. Moreover, ATRA negatively impacted the expression of the typical MC proteases
tryptase and chymase. While neither L-histidine decarboxylase nor intracellular histamine
content were affected, protein expression of FceRI was substantially downmodulated, and
this could be attributed to a reduction of FceRIa and, to a lesser extent, g specific transcripts.
By downregulating most lineage markers, MC are apparently forced to dedifferentiate with
ATRA. When protein and transcript levels were compared, however, substantial differences
between c-Kit and the proteases were noted. c-Kit downregulation was more pronounced at
the protein level, whereas the opposite was found with the proteases. Further analysis
revealed the existence of a second mechanism of c-Kit downmodulation that proceeded
rapidly and independently of mRNA changes. This pathway was restricted to immature MC
and could be mimicked by cycloheximide, suggesting that altered translation may account for
the phenomenon. Taken together, our study indicates that MC are significant targets of ATRA
throughout their lifespan, but that the molecular events underlying downregulation of lineage
markers may be shifted in the course of MC differentiation.
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Comparison of Human Skin Mast Cells from Two Anatomical Sites – Strongly Diminished
Expression of FceRIa in Breast Skin Versus Foreskin Mast Cells
M Babina, S Guhl, B M Henz, T Zuberbier
Department of Dermatology and Allergy, Charite´ Campus Mitte, University Medicine Berlin,
Berlin, Germany
Mast cells (MC) are specialized resident tissue cells of hematopoietic origin implicated in
allergic inflammation and innate immunity. The heterogeneity of MC is well known, comprising
both species-specific and tissue-specific differences. Using MC from two different human
skin locations (breast skin and foreskin), we asked in the present study if MC heterogeneity
could be further extended to distinct parts of the same organ. When the levels of transcripts
that encode MC markers were compared, no difference between foreskin and breast skin MC
was detected with the majority of markers. This implies a high degree of stability in MC
characteristics irrespective of the precise source of the cells. In strong contrast, however, a
substantial and selective decrease of FceRIa was noted in breast skin versus foreskin MC,
while the mRNA for the b chain was only slightly diminished in the former with no detectable
difference for the g chain. This underlines that the genes encoding the three chains of FceRI
are obviously regulated independently. Cell surface expression of the FceRI protein complex
was similar between the two MC types, as evidenced by flow-cytometry, and so was anti-IgE
mediated mast cell histamine release, as detected by a histamine analyzer-based detection
method or by EIA. This suggests that the level of the a specific transcript in breast skin MC
may not be a limiting factor in protein expression and complex formation. Taken together, the
study shows that MC heterogeneity exists in the very same organ, but that it is restricted to
only certain characteristic elements of the lineage.
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Infrared Radiation Interferes with the Apoptotic Process by Modulating Early Events of
the Mitochondrial Pathway in Human Fibroblasts
S Frank1, L Oliver2, C Lebreton-De Coster1, C Moreau2, M-T Lecabellec2, L Michel1, F M
Vallette2, L Dubertret1 and B Coulomb1
1Inserm U532, Institut de Recherche sur la Peau, Pavillon Bazin, Hoˆpital St-Louis, Paris and
2Inserm U601, Nantes – France
Near-infrared (IR) pre-irradiation protects normal human dermal fibroblasts from ultraviolet
(UV) cytotoxicity in vitro, and partially inhibits UVB activation of caspase-9 and -3. In the
present study we analyse the effect of IR on mitochondria and related apoptotic pathway. As
a matter of fact, only few molecules can be chromophores for IR, and cytochromes present
within mitochondria are potential candidates.
Human fibroblasts grown in monolayer, or isolated rat mitochondria, were irradiated by IR
(1620 kJ/m2) under conditions permitting to monitor the temperature between 20–251C, using
a 250-W GE 27 IR lamp combined with a Schott RG 715 long-wave pass sharp-cut filter that
remove wavelengths shorter than 700nm. Analysis was made using immunochemistry,
confocal microscopy and Western blotting.
We firstly observed that IR radiation induced cytochrome c release either in fibroblasts or
isolated mitochondria, underlying a key role of mitochondria in the effects of IR.
Further experiments were run with fibroblasts, either on cell crude extracts, or on mito-
chondrial and cytosolic fractions, to study different elements of the mitochondrial apoptotic
pathway. Mitochondrial membrane potential (Dcm) was analysed by flow cytometry.
IR irradiation led to a partial release of cytochrome c and Smac/Diablo (but not apoptosis
inducing factor; AIF), a slight but transient decrease in the Dcm, and Bax protein accumu-
lation for up to 24 h. Early apoptotic events in the mitochondrial pathway thus occurred
despite a lack of caspase-9 and -3 activation by IR irradiation.
The Dcm then returns to normal, anti-apoptotic proteins (Hsp27, Bcl-2 and Bcl-xL)
accumulate, and the level of the pro-apoptotic protein Bax falls.
The arrest of the apoptotic process initially induced by IR radiation could thus be due to a
change in the balance between Bax, Bcl-2 and Bcl-xL which was pro-apoptotic during the
first 24 h after IR exposure, and became anti-apoptotic. Furthermore the induction of
the expression of heat shock protein (Hsp) 27 by IR, which has been shown to inhibit the
formation of the apoptosome, can also contribute to this arrest. Together, these actions could
aid to prepare the cell to resist to UVB-triggered apoptosis.
In conclusion, this work point out that mitochondria is a key element in the effect of IR and
reinforces the fact that at least one IR chromophore is located within mitochondria. This study
also indicates that various steps in the mitochondrial apoptotic pathway are modulated by IR
exposure. Further work needs to be made on IR-UVB interaction as well as on mutagenesis
and DNA repair to evaluate the IR beneficial effects to prevent apoptosis induced by UVB.
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Localisation of the Melanocortin 1 Receptor (MC1R) within Melanoma Cells Suggests that
MC1R is Present at the Melanosome
C Jackson, S Robinson and E Healy
Southampton, United Kingdom
The melanocortin 1 receptor (MC1R) is a key regulator of human pigmentation and is
expressed on the surface of melanocytes and melanoma cells. Alpha-melanocyte stimulating
hormone (aMSH), the ligand for MC1R, is synthesised from pro-opiomelanocortin (POMC)
through cleavage of this precursor by pro-hormone convertase (PC)-1 and PC-2. Recent
work has shown that aMSH and PC-1 and PC-2 are located within the melanosome (Peters
et al, J. Invest. Dermatol. 114: 430–437, 2000). The presence of aMSH in the melanosome
could imply a role for aMSH independent of MC1R in this organelle, but also raises the issue
of whether MC1R is also present at the melanosome. To address this question, we have
transfected B16G4F Mc1r-null melanoma cells with human MC1R tagged with enhanced
green fluorescent protein (EGFP), and have investigated the sub-cellular localisation of MC1R
within these cells.
B16G4F cells were stably transfected with wild type (WT) and separately Asp294His variant
human MC1R tagged at the C terminus with EGFP. aPEP-13 and aPEP-1 antibodies were
used to label Pmel-17 protein in early melanosomes and tyrosinase related protein-1 (TRP-1)
in late melanosomes respectively. An Alexa-fluor 633-conjugated secondary antibody
emitting far red fluorescence was employed for detection in order to ensure there was no
crossover into the EGFP excitation / emission spectra by these markers. Images were obtained
using laser scanning fluorescence confocal microscopy, and analysed with accompanying
Leica software for double positive fluorescence within pixels in Z planes.
Confocal microscopy demonstrated expression of EGFP-WT MC1R and separately EGFP-
Asp294His MC1R in a punctate pattern within the cell body as well as at the cell membrane.
Co-localisation of WT and Asp294His EGFP-MC1R was observed with both early and late
melanosome markers. Co-localisation of EGFP-MC1R was also detected with early and late
melanosomes along dendrites following induction of dendricity by culturing in the presence
of 103M IBMX. These results suggest that MC1R is present close to or within the melano-
some as well as at the cell surface, and suggests that part of the function of MC1R may be
mediated through its association with the melanosome.
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Inﬂuence of Physiological and Pathophysiological Pericellular Conditions on Endothelial
Cell Activation
T Goerge, A Niemeyer, R Ossig, P Rogge, V Huck, M Steinhoff, T A Luger, S W
Schneider
Department of Dermatology, Mu¨nster, Germany Department of Physiology, Mu¨nster,
Germany
Endothelial cells, localized at the interface between blood and tissue play a pivotal role in
the process of coagulation and inflammation. Within short periods of time, endothelial cells
have the ability to change from a generally anti-coagulatory and anti-inflamatory state to
acute endothelial cell activation (ECA). A reliable marker for ECA, is the exocytosis
of vonWillebrand-factor (vWF), a strong procoagulatory protein. Potent and well known
stimuli in the process of ECA are e.g. histamin or activators of Proteinase-activated receptors
(PARs). So far, little is known about the influence of altered physiologic parameters such as
hypoxia, temperature and protonconcentration on endothelial cell activation. Therefore in the
present study, we tried to assess the role of altered pericellular conditions on ECA. This is
important for the understanding of cellular aspects in diseases such as scleroderma,
Raynauds-disease and wound-healing, where recurrent ischemic conditions are present.
Alterations in skinperfusion lead to reduced levels of oxygen, changes in pericellular
temperature and subsequent acidosis. In an especially designed incubating chamber that
allows to manipulate pericellular perfusion conditions we were able to determine ECA under
physiological and pathophysiological conditions. We found that acute hypoxia leads to an
immediate release of procoagulatory vWF. Furthermore, the proinflammatory protein P-
Selectin is also expressed on endothelial cell surface. This exocytotic process is mediated by
intracellular calcium increase. Hypothermic and acidotic conditions seem to have a protective
effect on cell survival by reduced ECA, whereas hyperthermia (fever) significantly increases
ECA. We deduce that pericellular conditions are able to inhibit endothelial cells to initiate
or enhance inflammatory processess. Therapeutical intervention by altering pericellular
conditions is an interesting approach for modifying the local inflammatory, coagulation and
perfusion process.
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Epitope-speciﬁc Antibody Response to Mel-CAM Induced by Mimotope Immunization
C Hafner, S Wagner#, J Jasinska#, D Allwardt#, O Scheiner, K Wolff, H Pehamberger,
U Wiedermann#, and H Breiteneder#
Department of Dermatology, Division of General Dermatology, Medical University of
Vienna, Austria; #Department of Pathophysiology, Division of Applied Experimental
Pathology, Medical University of Vienna, Austria; Under the Auspices of the Center of
Excellence in Clinical and Experimental Oncology of the Medical University of Vienna
Peptide mimotopes of tumor antigen epitopes have been proposed as components of tumor
vaccines. In this study we determined the immunogenicity of melcam mim1 and melcam
mim2, peptide mimics of an epitope of the melanoma cell-adhesion molecule Mel-CAM.
BALB/c mice were vaccinated either with mimotopes or mimotopes coupled to tetanus
toxoid. The antibody responses of mice to melcam mim1, melcam mim2 and recombinant
Mel-CAM were analysed by an enzyme linked immunosorbent assay and immunoblot
analyses. Tetanus toxoid coupled mimotopes led to high titers of IgG mainly of the IgG2a
subclass to melcam mim1 and melcam mim2. Immunization with each of the mimotope
formulations induced Abs that cross-reacted with recombinant Mel-CAM. Uncoupled
mimotopes induced lymphocyte proliferation and cytokine production in spleen cell cultures
indicating that both peptide mimotopes also contained T-cell epitopes. Tetanus toxoid
coupled mimotopes induced Th1 (IL-2, INF-g) and Th2 (IL-4, IL-5) cytokines, whereas un-
coupled mimotopes induced a Th1 biased T-cell response. Our results suggest that
mimotopes potentially represent a novel vaccine approach to induce a tumor antigen specific
humoral and cellular response.
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Integrins and Angiogenesis: Characterization of an Endothelial Cell Growth Suppression
Signal
A Mettouchi, B Domange, N Johnsson, G Meneguzzi
INSERM U634, Faculte´ de Me´decine, Nice
Angiogenesis is a complex process that takes place physiologically and pathologically during
foetal development of some organs, in adult female reproductive cycle, during cutaneous
wound healing and tumor development. This process involves steps of proliferation and
migration of endothelial cells from pre-existing vessels together with third dimension
organisation into mature blood vessels. Our aim is to study the molecular basis of neo-
angiogenesis control mediated by the extracellular matrix and its integrin receptors. For this
purpose, we analysed an in vitro model of angiogenesis, in which primary human endothelial
cells harbor either a proliferative or sprouting phenotype depending on the extracellu-
lar matrix protein they contact. We observed that laminin, a component of basement
membranes, induces a growth arrest signal that overcomes the proliferative effect of
fibronectin present in provisional matrices during wound healing. In order to define the
signaling pathways involved, and assess the eventual occurrence of specific partners of
laminin integrin receptors, we have adapted a yeast two hybrid type of genetic screen applied
to transmembrane proteins named ‘‘Split-Ubiquitin’’. This approach has allowed the isolation
of several partners, among which the tetraspanin CD9 protein. Our studies demonstrate that
this interaction is important for the adhesion dependent control of cell cycle progression in
our model of angiogenesis.
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The Effects of Topical Application of Honey on Wound Healing in Mice: An Experimental
Study
R Ghaderi, M Afshar
Department of Dermatology, Birjand University of Medical Sciences, Birjand, Iran
Background: Management of patients with full thickness wound of skin continues to
challenge physicians and surgeons in area of cosmetic dermatologic surgery. At the present
time, there are some medications that can be used to accelerate the healing of full thickness
wound of skin.
Based on studies that have demonstrated improved burn wound healing with honey
treatment, we anticipated that honey would accelerate healing of full thickness wound of
skin. It is evident from preliminary data, that honey may be an effective, simple, natural,
inexpensive and safe therapeutic agent for accelerating wound healing.
Objective. The aim of research proposal is to evaluate the efficacy of honey in accelerating
healing of full thickness wound of skin in mice.
Methods. Design: experimental study Animals: male N.mRi mice Sample size: 6 per study
group Surgery: two mm full thickness wound of skin in back of mice under general anesthesia
Treatment groups: Control group: simple dressing, Honey group: daily topical application
honey Study Period: mice were euthanized on days 4, 7 and 10 post-operation to reflect
different phases of wound healing Assay: 1- gross pathology of the skin noting presence of
infections, dehiscence and repair 2- histological evaluation of the wound site for degree of
healing 3-finally the wounds were tested for:
Resilience¼ ability of the wound to stretch and then resume shape without incurring any
tissue damage, ultimate tensile strength¼maximum pressure a wound can tolerate before it
start to weaken and toughness¼ total amount of pressure a wound can tolerate before
rupturing.
Results. Honey increased: 1) formation of granulation tissue 2) density and activation of
fibroblasts 3) keratinization in surface of wound 4) thickness of basement membrane and
epidermis 5) thickness of collagen fiber. Honey decreased infection, inflammation, edema
and dehiscence.
Finally Honey increased resilience, ultimate tensile strength and toughness of wound in
mice.
Conclusion. We conclude that honey accelerates healing of full thickness wound of skin in
mice.
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Expression of Aquaporins in Cells from Human Skin
M Boury-Jamot1, M Tailhardat2, B Le Varlet2, M Dumas2, J-M Verbavatz1
1Service de Biophysique des Fonctions Membranaires, DBJC, CEA/Saclay Gif-sur-Yvette,
France 2LVMH Recherche, St Jean de Braye, France
Aquaporins (AQPs) are a family of transmembrane channels for water and small solutes.
Eleven aquaporins, named aquaporin-0 (AQP0) through aquaporin-10 (AQP10), have been
identified in mammals. In human skin, the AQP3 protein is abundant in keratinocytes. AQP1
and AQP5 mRNA were detected in rodent skin and the AQP5 protein was localized to mouse
sweat glands. In the present study, we investigated by RT-PCR the mRNA expression of the
11 known human AQPs in a variety of normal human skin cell types including keratinocytes,
melanocytes, dermal fibroblasts (HDF), dermal microvascular endothelial cells, white pre-
adipocytes (HWP), monocytes and monocyte-derived dendritic cells (MDDCs). Like in other
tissues, we found AQP1 mRNA in dermal endothelial cells. AQP1 was also detected
in fibroblasts and melanocytes. In addition to AQP3, AQP10 mRNA was detected in
keratinocytes. AQP9 mRNA was found in monocytes and MDDCs, but monocytes also
expressed AQP10, whereas MDDCs exhibited AQP3 mRNA. Finally, AQP9 mRNA was also
detected in preadipocytes by RT-PCR. AQP expression was not investigated in cells from
sweat glands. These results confirm the expression of AQP1 and AQP3 in human skin cells
and provides a more comprehensive pattern of expression of these 2 channels in this tissue.
In addition, AQP9 and AQP10 mRNA were found in several human skin cell types. Therefore,
up to 5 different AQPs (AQP1,3,5,9,10) may be selectively expressed in human skin cells.
Whereas AQP1,5 are strictly water channels, AQP3,9,10 belong to the aquaglyceroporin
group, also permeable to some small solutes such as glycerol. In the present study we often
found mRNA for 2 of the aquaglyceroporins per cell type. The physiological consequences of
this distribution of aquaporins will now be investigated.
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IL-3 Induces Expression of Lymphatic Phenotypic Markers
M Gro¨gera,b, R Loewea, W Holnthonerb, R Embachera,b, M Pillingera,b, G S Herronc,
K Wolffa,b, P Petzelbauera,b
aDepartment of Dermatology, Division of General Dermatology, University of Vienna Medical
School, Vienna, Austria, bLudwig Boltzmann Institute for Angiogenesis, Microcirculation and
Inflammation, Vienna, Austria, cDepartment of Dermatology, Palo Alto Medical Clinic, Palo
Alto, CA
Factors determining lymphatic differentiation in the adult organism are yet not well
characterized. We have made the observation that mixed primary cultures of blood (BEC)
and lymphatic (LEC) endothelial cells grown under standard conditions change to a 100%
lymphatic phenotype during subculture. After passage 6 they uniformily express LEC-specific
markers Prox-1 and podoplanin. We show that LEC but not BEC constitutively express IL-3
and that IL-3 is responsible for the differentiation of BEC into LEC. Using sorted BEC, IL-3
induces Prox-1 and podoplanin expression and expression persists after subsequent
withdrawal of IL-3. Using sorted LEC, blocking IL-3 activity by IL-3R alpha chain antibodies
results in a loss of Prox-1 and podoplanin expression. To analyze the situation in vivo, IL-3
was injected into melanomas subcutaneously grown on the backs of SCID mice. In this
model, IL-3 significantly increased numbers of podoplanin positive vessels, which were all
positioned within the lymphatic vascular tree, whereas numbers of blood vessels remained
constant. In conclusion, IL-3 is a novel factor capable of inducing lymphatic differentiation.
045 [Oral 038]
Fibroblast Growth Factor-2 Effects on Wnt Target Genes in Endothelial Cells
W Holnthoner, R Embacher, M Gro¨ger, F Kratochvill, K Wolff and P Petzelbauer
Division of General Dermatology, Department of Dermatology, Medical University Vienna,
Vienna, Austria and Ludwig Boltzmann Institute for Angiogenesis, Microcirculation and
Inflammation, Vienna, Austria
Beta-catenin is a component of the Wnt signaling pathway, it transduces signals to Lef/Tcf
transcription factors and upregulates genes like cyclin D1. Recently we found that in human
endothelial cells beta-catenin is translocated into the nucleus upon stimulation with FGF-2.
Increased nuclear beta-catenin leads to upregulation of cyclin D1 promoter expression in a
Lef/Tcf dependent fashion. EMSA analysis demonstrates binding of Tcf-4 and beta-catenin to
the Lef/Tcf binding site in the cyclin D1 promoter. We next analyzed effects of FGF-2 on
matrilysin, which is thought to be another target of the Wnt pathway. As seen with cyclin D1,
FGF-2 induces matrilysin promoter activity and mRNA expression. In contrast to cyclin D1,
this FGF-2 effect is Lef/Tcf independent: There is only negligible Tcf-4 binding to the two Lef/
Tcf sites in the matrilysin promoter, beta-catenin overexpression or mutations of the Lef/Tcf
sites do not alter FGF-2-induced promoter activity. In contrast, overexpression of a dominant
negative Stat3 mutant significantly reduces FGF-2-induced matrilysin promoter activity. This
is no direct Stat3 effect, because we could not detect Stat3-binding to several putative Stat3-
binding elements. The dominant negative Stat3 mutant appears to inhibit matrilysin promoter
activity indirectly by inhibiting AP-1-related gene transcription. In conclusion, although both,
cyclin D1 and matrilysin are thought to be Wnt/Lef/Tcf targets, in endothelial cells FGF-2
induces only cyclin D1 but not matrilysin in a Lef/Tcf dependent manner.
046 [Oral 058]
TNF/TNFRI-mediated Psoriasiform Dermatitis in Conditional IkappaB-alpha-deﬁcient
Mice Depends on Ubiquitous Inactivation of IjB-a
B Rebholz1, B Eckelt1, D Kuprash2, M Flaig1, I Fo¨rster3, Klaus Pfeffer4, R A Rupec1
1Department of Dermatology, University of Munich, Germany 2Engelhardt Institute of
Molecular Biology, Russian Federation 3Technical University, Dep. of Microbiology, Germany
4 University of Du¨sseldorf, Dep. of Microbiology, Germany
The inhibitor of NF-kB, IkB-a, is degraded following phosphorylation by the IkB kinase (IKK)
signalosom, thus inducing activation of NF-kB. Several studies suggested a role for NF-kB
and IkB-a in epidermal differentiation. Nevertheless, the exact function of NF-kB and IkB-a in
the epidermal skin compartment remains under discussion. Here we used Cre/loxP-mediated
gene targeting in order to investigate the function of IkB-a in the epidermal compart-
ment. Newborn mice with a ubiquitous deletion of IkB-a (ikbaD/D) develop an inflammatory
skin disease with a psoriasis-like phenotype. The skin disease is tumor necrosis factor/
TNFRI-mediated. In contrast, specific deletion of IkB-a in epidermal keratinocytes utilizing
K5-Cre resulted in hyperproliferation without inflammation. Moreover, deletion of IkB-a in
T-cells, monocytes or neutrophilic granulocytes neither perturbed epidermal homeostasis
nor induced inflammation. Our results suggest, that IkB-a is necessary for the regulation
of epidermal keratinocyte response to exogenous inflammatory stimuli and epiderimal
homeostasis.
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Stroma-Mediated Dysregulation of Liver and Bone Marrow Myelopoiesis in Mice Lacking
IjB-a
R A Rupec1, F Jundt2, B Rebholz1, B Eckelt1, S Moosmann3, B Do¨rken2, I Fo¨rster4, R Huss3,
K Pfeffer5
1University of Munich, Department of Dermatology, Germany 2Max-Delbru¨ck-Center for
Molecular Medicine, Germany 3University of Munich, Department of Pathology, Germany
4Technical University, Dep. of Microbiology, Germany 5University of Du¨sseldorf, Dep. of
Microbiology, Germany
During perinatal development, hematopoietic maturation occurs in the liver and the bone
marrow. Newborn mice with a ubiquitous deletion of IkB-a (ikbaD/D) develop a severe
hematological disorder characterized by a hypergranulopoiesis with an increase of CFU-
GEMM. Here we report that the development of this particular myeloproliferative disturbance
is mediated by continuous perinatal expression of Jagged1 in IkB-a-deficient hepatocytes
resulting in a permanent activation of Notch1 in neutrophils. In contrast, in mice with a
specific deletion of IkB-a only in the myeloid lineage (ikbamyD/myD) and in fetal liver cell
chimeras (ikbaFLD/FLD) a cell-autonomous induction of the myeloproliferative disease was not
observed. Co-culture of IkB-a-deficient hepatocytes with wild-type bone marrow cells
induced a Jagged1-dependent increase in CFU-GEMM. In summary we show that a pre-
malignant hematopoietic disorder with consecutive transformation can be initiated by non-
hematopoietic cells.
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Regulation of Epidermal Tight Junctions During Staphylococcal Skin Infection
P Houdek, U Ohnemus, M Horstkotte, I Moll, JM Brandner
Hamburg, Germany
Tight junctions (TJ) play a central role in epithelial barrier function. Recently, their proteins
such as claudins, occludin and ZO-1 were identified within the epidermis. Although TJ
proteins are known as targets for bacteria and their toxins in simple epithelia and the skin
being a major target of microbial assaults, there is no data available about the regulation of TJ
proteins during skin infection. Therefore, we investigated the influence of the pathogen
Staphylococcus aureus and the commensal Staphylococcus epidermidis on epidermal TJ
expression. We established a porcine skin infection model: punch biopsies were infected for
24 hours with Staphyloccus aureus (w54 and wt) and Staphylococcus epidermidis (1457)
being in the postexponential phase. Subsequently, expression of the TJ proteins claudin 1,
ZO-1 and occludin were determined by immunohistochemical stainings. We found, that
compared to the control group, S. aureus induced a down regulation of claudin 1 and ZO-1,
whereas S. epidermidis exerted no such effects. With respect to the expression of occludin
we observed no alterations after staphylococcus infection. TUNEL stainings revealed a slight,
non significant up-regulation of apoptosis within infected compared to control skin. These
results demonstrate for the first time that S. aureus induces down-regulation of TJ proteins
and suggest that these effects may be relevant during skin infection.
049 [Oral 037]
Hair Follicle Nestin-Expressing Stem Cells Give Rise to Nascent Blood Vessels in the
Skin
Y Amohwz L Li, M Yang, P Jiang, A R Moossaz, K Katsuokaw, S Penmany, and
RM Hoffmanz
AntiCancer, Inc., San Diego, CA; wDepartment of Dermatology, Kitasato University School
of Medicine, Sagamihara, Japan; zDepartment of Surgery, University of California San
Diego, CA; yDepartment of Biology, Massachusetts Institute of Technology, Cambridge,
USA
We have previously demonstrated that the neural-stem cell marker nestin is also expressed in
hair follicle stem cells in transgenic mice as visualized by nestin-driven green fluorescent
protein (GFP). Since it is known that blood vessels can express nestin, the present study was
designed to determine if blood vessels in the skin were related to hair follicles. In the nestin-
GFP transgenic mice, the hair follicles are linked by a network of nestin-GFP positive vessels.
When a red fluorescent protein (RFP)-expressing B16 melanoma was transplanted to the
nestin-GFP mice, nestin-expressing vessels grew from the nestin-expressing stem cells hair
follicle bulge area into the growing melanoma. Fibrissa hair follicles were transplanted from
nestin-GFP C57BL6 mice to nude mice. After transplantation, nestin-GFP was visualized by
fluorescence in nascent vessels growing from the transplanted hair follicles in the nude
mouse skin. Nestin-GFP hair follicles were also observed to give rise to GFP-expressing
vessels in RFP-expressing B16 melanoma after both were transplanted to nude mice. Nestin-
expressing vessels were also visualized by GFP fluorescence growing from hair follicles in
healing wounds in the nestin-GFP mice. Immunohistochemical staining showed that the
endothelial-cell-specific markers CD31 as well as von Willebrand factor (vWF) and nestin
colocalize in the nestin-GFP-expressing nascent vessels both in the nestin-GFP mice and in
nude mice transplanted with nestin-GFP-expressing vibrissa hair follicles. The data thus
suggest har follicles give rise to blood vessels in the skin. This model enables very early
events in skin angiogenesis, including skin-tumor angiogenesis to be visualized, and to used
for antiangiogenesis drug screening. The results of the present study suggests the
pluripotency of hair follicle nestin-expressing stem cells which can form blood vessels as
well as much of the hair follicle structure and epidermis.
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Control of the Intracellular Localization of CD1e
B Maitre, C Ange´nieux, J Salamero, P Schu, D Fricker, J -P Cazenave, D Hanau, H de la
Salle
INSERM 0345 EFS-Alsace, Strasbourg, CNRS UMR 144, Institut Curie, Paris, France,
Zentrum fu¨r Biochemie and Molekulare Zellbiologie, Universita¨t Go¨ttingen, Go¨ttingen,
Germany
CD1b and d are cell surface expressed, and cycle between the plasma membrane and
endosomes. Their localization in endosomes is controlled by tyrosine motifs in their short
cytoplasmic domain, which bind AP3. In contrast, CD1e accumulates in Golgi compartments,
then reaches CD1bþ late endosomes, where it remains in a soluble form, due to a proteolytic
cleavage. Its long cytoplasmic domain does not display known targeting motifs. We explored
how the transport of CD1e is controlled. Deletion and substitution mutants were engineered
and expressed in normal and AP-deficient cells. We demonstrated that the cytoplasmic
domain is sufficient to actively target CD1e towards late endosomes, using an AP3-
independent pathway. In contrast, a role of AP-1 in the biosynthesis of CD1e could be
demonstrated. Deletion mutants revealed a role of different parts of the cytoplasmic domain
in the retention of CD1e in TGN, and its intracellular retention, facilitating its routing towards
late endosomes. Mutations that allowed cell surface expression of CD1e, including the
substitution of the cytoplasmic domain by artificial sequences, did not abrogate the targeting
towards endosomes. A 27kD protein co-immunoprecipitated with CD1e when the acidifica-
tion of endosomes was blocked by bafilomycin. Experiments showed that the cleavage of
CD1e in endosomes only occurs when it associates with p27. Thus, CD1e reaches late
endosomes and is not expressed on the plasma membrane, using a cellular pathway not
shared by other CD1 molecules. This distinct pathway may provide an additional means of
immunological surveillance of cellular compartments by an AP3 independent mechanism.
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The Murine Dermis CONTAINS Cells with in vitro Clonogenic Potential
S Meindl, A Elbe-Bu¨rger
DIAID, Dept. of Dermatology, Medical University of Vienna, Austria
Evidence exists that the mammalian dermis contains multi- or pluripotent stem cells (SC) with
the capacity to differentiate into various cell types. The phenotype of these SC is still unclear.
We wanted to determine if cell-surface markers of hematopoietic stem cells (HSC) as Sca-1,
CD117 and CD34 can be used to identify and enrich dermal SC. FACS analysis of freshly
isolated newborn and adult dermal mouse cells revealed that a small portion of CD45þ cells
co-expressed Sca-1 and CD117 molecules, suggesting the presence of a small reservoir
of stem cells. When testing the in vitro clonogenic capacity of unpurified newborn and
adult dermal cells in methylcellulose supplemented with cytokines inducing hematopoietic
differentiation, we identified different colonies, including adipocytes and sebocytes as
determined by red oil and K14 staining, respectively, and colonies with a myeloid phenotype
(e.g. toluidine blue positive mast cells). In contrast, culturing peripheral blood cells under
identical conditions failed to generate colonies. The culture of lineage-depleted newborn
dermal cells revealed that most outgrowing colonies were of adipocyte and sebocyte
phenotype. Using a plate-bound technique, lineage-depleted dermal cells were further
enriched for markers present on HSC. The vast majority of purified Sca-1þ (98%) cells were
CD34þ and failed to express CD45 molecules. These cells gave rise only to adipocytes and
sebocytes. This work is the first to demonstrate a strategy to phenotype and highly enrich
cells from the dermis with clonogenic capacity.
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K1b - a New Member of The Human Type II Keratin Gene Family is Speciﬁcally Expressed
in Eccrine Sweat Gland Ducts
L Langbein1, M A Rogers2, S Praetzel1, B Cribier3, N Gassler4 and J Schweizer2
1Division of Cell Biology and 2Section of Normal and Neoplastic Epidermal Differentiation,
German Cancer Research Center, Heidelberg, 3Clinique Dermatologique, Strasbourg,
France and 4Institute of Pathology, University of Heidelberg, Germany
The recent completion of a reference sequence of the human genome now allows a complete
characterization of the type II keratin gene domain on chromosome 12q13.13. This, domain,
ca. 790 kb in size, contains 26 keratin genes and 8 pseudogenes. 23 of these genes and four
pseudogenes have been previously described and therefore this domain comprises 3 new
functional genes: K1b, K5b, and K6l. Northern analysis of the keratins in mRNA of major
organs as well as in specific epithelial subtypes shows singular expression of these keratins in
skin, hair follicle and tongue, respectively. The expression of K1b is characterized in this
study. Using specific 3’-probes for in situ hybridization and specific antibodies K1b for
indirect immunofluorescence, K1b is specifically expressed in the eccrine sweat gland ducts.
In more detail, as these ducts are stratified in two layers this protein is detectable in the
luminal layer only. The glandular part of this appendage is negative. Moreover, other glands
and their ducts investigated including e.g. apocrine sweat glands, mammary glands, salivary
glands, Bartolini glands or sebaceous glands were also negative.
In tumors of eccrine sweat glands K1b is a suitable ‘‘marker’’ for the characterization of the
origin and state of differentiation of these neoplasms.
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Membrane Estrogen Receptor Mediates Acute Nitric Oxide Release in Dermal Endothelial
Cells
S Sevrain-Verdier and J Li
Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami,
Florida U.S.A, F. Bonte´, LVMH Recherche Saint Jean de Braye, France
It is known that estrogens play an important role in regulating vascular endothelial function.
This effect is mediated by the two estrogen receptors: ERa and ER b via classic genomic
pathway involving nuclear estrogen receptors (ERa and ER b) and also nongenomic pathway
involving a plasma membrane estrogen receptor (ERa). This estrogen vascular effect has
been well determined for endothelial cells derived from large and small vessels but the
estrogen effect on human dermal microvascular endothelial cells (HDMECs) function is not
documented. In the present study, by Western blot analysis, we showed that HDMECs
expressed both estrogen receptors (ERs): 66 kDa- ERa and 59 kDa- ER b proteins. By
fluorescence microscopy using ERa specific antibody, we found immunoreactive sites on
plasma membrane of nonpermeabilized HDMECs in a distribution similar to that reported for
human umbilical vein endothelial cells (HUVEC) while permeabilized cells exhibited intense
nuclear fluorescence. This demonstrated the presence of ERa as a membrane associated as
well as nuclear receptor in HDMECs. In contrast, using ER b specific antibody, fluorescence
microscopy revealed only nuclear staining. Furthermore, treatment of HDMECs with estradiol
-17 b (E2) at physiologic concentration (109 M) and with the membrane impermeable E2-
BSA rapidly induced nitric oxide (NO) release with maximum induction (2.5 to 3 fold) within
10 min of treatment. These results suggested that release of NO in HDMECs by estrogens is
mediated via estrogen receptor localized on the plasma membrane. Since NO is known as a
critical mediator of angiogenesis, this study supports the angiogenic activity of estrogens on
HDMECs.
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Differential Interaction of Tight Junction-Proteins with Inﬂammatory Cells in the
Epidermis
J M Brandner1, E Wsladykowski1, P Houdek1, I Moll1
1Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf
Tight junctions (TJ) are occluding cell-cell junctions which are known to form and maintain
barriers in simple epithelia and endothelia. They have also been identified in murine and
human skin and various reports suggest that they play an important role in barrier function of
the epidermis too. TJ proteins are known to interact with inflammatory cells in simple epithelia
and endothelia, but nothing is known regarding the epidermis.
We investigated TJ proteins, i.e. claudins 1 and 4, occludin, JAM-1 and protein ZO-1,
in inflammatory skin diseases by using immunofluorescence microscopy. Moreover we
investigated adherens junction- and desmosomal proteins in comparison. In psoriasis we
observe a downregulation of TJ proteins as well as of desmosomal and AJ proteins in
areas with transmigrating inflammatory cells. The cell-cell junctions seem to reseal
after inflammatory cells passed through. In lichen ruber and eczema a downregulation of
cell-cell junction-proteins was only found in cells with direct contact to inflammatory cells.
Referring to these results we discuss the putative differential influence of neutrophils
and lymphocytes on cell-cell junctions during inflammatory diseases and their role in
pathogenesis.
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A Scanning Electron Microscopic Study of the Effect of Some Hair Care Products on
Human Scalp Hair Shaft
Hala A Ibrahim, Ghada M Mourad, Sanaa H Radi
Dept. of Dermatology & Venereology, Dept. of Histology; aculty of Medicine, Alexandria
University
The general purpose of hair care products and hair styling manoeuvers is to restore the
natural beauty of hair, giving it volume, softness and shine. However, a large number of these
proucts fail to achieve their purposes. To the contrary, they may exaggerate the damage
induced by environmental factors. The present work aims at throwing a close view on the
surface appearance of human scalp hair shafts exposed to some hair care products. It also
aims at investigating the effect of these factors on the normal trace element content of hair.
Samples from human scalp hair shafts were exposed to certain commercial hair shampoo,
gel, conditioner, hair bleacher as well as subjected to perm and fair processes. The treated
samples were examined by the scanning electron microscope and subjected to X-ray
microanalysis for quantitative estimation of the elementary concentrations compared to
control samples. The normal overlapping appearance of the cuticle and the clefts between
the cuticular scales were disturbed particularly in hair shafts exposed to gel, fair, perm and
hair bleacher. Hair straightening using the fair revealed the gravest insults to the hair not only
through the structural damage but also by causing burning of the hair cuticle and deformity of
the hair cylinder. X-ray computer analysis of the hair elements revealed that sulphur, cupper
and zinc were most affected. Correlation of the quantitative elementary results with the
morphological changes of hair shafts could explain the mechanism of action of such hair care
products in damaging the human hair.
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TNF-a and IL-1b Stimulation of HepG2 Cells Leads to a Time Dependent Shift in the
Composition of the NF-jB Dimers and in the NF-jB Binding Afﬁnity
M Kirchheiner, B Gesser, L Iversen, K Kragballe
Marselisborg hospital, Aarhus University, Denmark
The purpose of this study was to determine the composition of the NF-kB dimer and the NF-
kB binding activity to IL-8 and p53 promoters in TNF-a or IL-1b stimulated Hepato-carcinoma
cells (HepG2 cells) as a function of time. Lawrence et al (2001) showed that NF-kB activation
is essential for both initiation and resolving inflammation. Kunsch et al (1992) showed that the
specific sequence of the kB binding motif in the promoter region of a gene determine which
NF-kB dimer/dimers that can bind and initiate or inhibit transcription.
HepG2 cells were stimulated with either IL-1b (20 ng/ml) or TNF-a (50 ng/ml) and then
harvested at different time points (0–72 h). DNA-protein binding of nuclear extract was
analyzed using EMSA with DNA oligo sequences identical to the NF-kB binding of the human
IL-8 and p53 promoters. Supershifts were performed with hp50 and hp65 antibodies.
Transcriptional activity of p53 and IL-8 genes were analyzed by a reporter gene assay (using
plasmid constructs containing the NF-kB binding elements from either the IL-8 or p53
promoters). Protein expression was determined by western blotting using ap50 and ap65.
The reporter gene assay showed an activation of the IL-8 reporter gene which was maximal
(20 fold) after 3 hours of stimulation with TNF-a or IL-1b. Then it declined and reached basal
levels after 12 hours. The p53 reporter gene expression was also maximal (5 fold) after 3–6 h
stimulation. Interestingly the decline in p53 gene expression was much more slow than IL-8. It
hadn’t reached basal levels after 72 hours of stimulation. The difference in activation between
the IL-8 and p53 plasmid after TNF-a or IL-1b was highly significant (po0.05).
EMSA’s revealed a difference in the composition of the NF-kB dimers binding to the IL-8 kB
and p53 kB binding motif. The IL-8 kB binding motif binds the p65:p65 homodimer and
p50:p65 heterodimer, whereas the p53 kB binding motif, binds the p50:p50 homodimer and
the p50:p65 heterodimer. The p50:p65 heterodimer showed no significant difference in the
binding activity to either the IL-8 or the p53 oligo. The induction was biphasic with a peak
after 15–30 min and a new peak 3-6 hours after stimulation. The increased binding activity of
the p65:p65 homodimer seemed not to last more than 1 hour, whereas the increased binding
activity of the p50:p50 homodimer seemed to be sustained throughout the 72 hours study
period. Western blot of nuclear extracts confirmed that the p65 subunit was removed faster
from nucleus than the p50 subunit over the 72 h study period.
Because the IL-8 and p53 reporter plasmids only contained the NF-kB binding sequence of
the promoters the prolonged activation of the p53 plasmid compared to the IL-8 plasmid is
regulated by NF-kB. Our data also demonstrate that the time dependent difference in NF-kB
binding to the IL-8 and p53 kB binding motif is due to a change in the composition of the NF-
kB dimers. In the initial phase of NF-kB activation after IL-1b or TNF-a stimulation p50/p65
and p65/p65 are the dominating dimers whereas the p50/p50 homodimers dominates in the
latter phases.
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Identiﬁcation of Aminopeptidase N (APN/CD13) as a New Target to Regulate Sebocyte
Growth, Differentiation and Cytokine Production in vitro
A Thielitz1, D Reinhold2, R Vetter1, U Lendeckel3, ChC Zouboulis4, M Helmuth5, S Ansorge5,
H Gollnick1
1Dept. of Dermatology and Venereology, 2Institute of Immunology, 3Institute of Experimental
Internal Medicine, Otto-von-Guericke University Magdeburg, 4Department of Dermatology,
Charite` University Medicine Berlin, Campus Benjamin Franklin, Berlin, 5Institute of Medical
Technology Magdeburg, Germany
The ectopeptidase aminopeptidase N (APN, CD13, E.C.3.4.11.2) is expressed on endothelial
cells, cells of the myelo-monocytic lineage, activated T cells, fibroblasts and keratinocytes. In
addition to its proteolytic function it is involved in the regulation of various physiologic
functions such as proliferation, cytokine production, cell-cell interaction and angiogenesis. In
this study we demonstrate for the first time that APN/CD13 is present on human SZ95
sebocytes and is involved in the regulation of proliferation, differentiation and IL-1RA
production in vitro.
By RT-PCR, flow cytometry, immunohistochemistry and Ala-pNA hydrolysis we found a
high expression of APN on the mRNA, protein and enzyme activity level (CD13 expression
100%, APN activity 205  54 pkat/106 cells). The APN inhibitors Actinonin and Bestatin
suppressed the enzymatic activity of SZ95 sebocytes in a dose-dependent manner. After
24 h of incubation with these inhibitors, the DNA synthesis, measured by 3H-thymidine
incorporation, was significantly and dose-dependently reduced (Actinonin IC25 2.5 mM, IC50
15 mM; Bestatin IC25 3 mM). The differentiation of SZ95 sebocytes measured by nile red
fluorescence intensity was increased after 48 h of incubation with different inhibitor
concentrations. Furthermore, the inhibitors significantly enhanced the production of IL-1RA
mRNA and protein as detected by ELISA in SZ95 sebocyte supernatants and RT-PCR by
1.4–2.6 fold.
Our data provide evidence that Aminopeptidase N represents a new target for the
regulation of sebocyte proliferation, differentiation and cytokine production. Therapeutic
application of APN inhibitors maybe beneficial in acne and/or other diseases with sebaceous
hyperproliferation.
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Localized MMP2 Secretion Induced by Melanoma Epithelial Cell Interaction
E M Schna¨ker, R Ossig, H Oberleithner, T Goerge, T A Luger, S W Schneider
Department of Dermatology, Von-Esmarch-Str. 59, 48149 Mu¨nster, Germany Department
of Physiology, Robert-Koch-Str.42, 48149 Mu¨nster, Germany
Matrix metalloproteinases (MMPs) are known to play a crucial role in tumour cell invasion. In
previous experiments using the immunofluorescence technique we could show that human
melanoma cells store MMP2 in small vesicles associated with the microtubule system. Co-
localisation studies using MMP2 and kinesin specific antibodies showed that 81.9  2.3%
(n¼ 5) of all MMP2 containing vesicles are associated with kinesin. The motor protein kinesin
is known to transport cargo along microtubules towards its plus end, indicating that these
vesicles are conveyed along microtubules by kinesin. Destruction of microtubule function by
paclitaxel leads to an impaired secretion of MMP2 and MMP9 and diminishes invasive
properties of melanoma cells. Moreover paclitaxel treated MMP2 vesicles were found to
accumulate in the perinuclear region as observed by immunofluorescence microscopy. In a
further step MMP2 exocytosis during cell-cell interaction with epithelial MDCK-C7 cells was
investigated. For this purpose we co-cultivated both cell lines and stained surface-localized
MMP2 on the plasma membrane of the non permeabilized cells. We found MMP2
concentrated in those areas of melanoma cells that were in close neighbourhood of epithelial
cells. Via atomic force microscopy we visualized cell surface topography. Perfectly in line with
the immunofluorescence studies this technique revealed pore-like structures indicating fusion
events of exocytotic vesicles. These pores were predominantly found in those areas of
melanoma cells that were in direct contact to epithelial cells.
We conclude: i. Interaction between melanoma cells and epithelial cells stimulates
localized MMP2 release. ii. Paclitaxel reduces exocytosis of MMP2 and MMP9 and thus
diminishes invasive properties of human melanoma cells.
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The Hair Follicle as a Source and Target of Melatonin
H Kobayashi1,2, Arno Kromminga3, T W Dunlop4, B Tychsen1, F Conrad1, A Memezawa2,
N Suzuki2, S Aiba2, C Carlberg4, and R Paus1
1Hamburg, Germany, 2Sendai, Japan, 3Hamburg, Germany, 4Kuopio, Finland
The aim of this study was to investigate a) whether hair follicles are peripheral melatonin
targets (i.e. express membrane melatonin receptors [MT1, MT2] and a mediator of nuclear
melatonin signaling, RORa), b) whether melatonin exerts functional effects on murine and/or
human hair follicles in situ, and c) whether the hair follicle is an extrapineal site of melatonin
synthesis. Real time PCR for MT1, MT2 and RORa revealed that MT2 and RORa are
transcribed in murine skin in a hair cycle-dependent manner. By immunohistology, RORa like
immunoreactivity was detected in dermal papilla and hair follicle keratinocytes in a hair cycle-
dependent manner. Functionally, melatonin (0.01 to 1 nM) significantly inhibited the follicular
keratinocyte apoptosis in short term-mouse skin organ culture. Furthermore, melatonin
decreased gene and/or protein expression of estrogen receptors in mouse and human hair
follicle in vitro. By immunohistochemistry, melatonin-like immunoreactivity was found in the
outer root sheath of murine and human hair follicles. Liquid chromatography/mass
spectrometry and radioimmunoassay revealed that norepinephrine (i.e. the key stimulus for
melatonin synthesis in the pineal gland) substantially increased the melatonin content of
murine skin and human hair follicles in vitro. In conclusion, we provide evidence that murine
and human hair follicles are prominent targets for melatonin bioregulation through MT2 and
RORa, whose stimulation also affects the well-appreciated hair growth-regulatory receptors
(here: downregulation of estrogen receptors), and that the hair follicle is also an extrapineal
source of melatonin. These evidences indicate that melatonin may play a role in the
endogenous controls of hair follicle cycling.
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Characterization of Kallikrein Activities in Human Stratum Corneum
K Stefansson, B Glas, T Egelrud and M Brattsand
Umea, Sweden
The overall aim of this study was to further characterize the activity from three human
kallikreins in stratum corneum, among them human kallikrein 14 (hK14), a kallikrein previously
not known to exist in epidermis. In our group, two epidermal serine proteases, hK5 (SCTE)
and hK7 (SCCE), have been cloned and charachterized. They are believed to be involved
in stratum corneum turnover through a proteolytic cascade ending in the breakdown of
desmosomal proteins. It was found that a major part of the trypsin-like activity, measured by
cleavage of chromogenic peptide substrates, in extracts from plantar stratum corneum, could
not be ascribed to hK5. In search for yet another serine protease we have now purified hK14
from human plantar stratum corneum through reversed phase chromatography. A panel of
nine individuals were subjected to tape stripping of superficial non palmo-plantar stratum
corneum. Protein contents of tape strips were extracted. Western blot of extracts revealed
the presence of hK14 in all individuals tested. Quantification experiments of the relative
amounts of hK5, hK7 and hK14 in human epidermis showed that the enzymes are present in
a ratio of approximately 3:10:1. a1-antitrypsin inhibitor analysis showed that the major part of
hK14 in human stratum corneum is present in active form. We have also noted that active
hK5, hK7 and hK14 are present in sweat. This finding might have relevance for patients
suffering from atopic dermatitis as these often experience a more pronounced itch when
sweating. We hereby conclude that hK14 is present in human stratum corneum. hK14 is a
major contributor to the trypsin-like activity in human stratum corneum, indicating that hK14,
in addition to hK5 and hK7, is likely to have an important function in the physiology of human
stratum corneum.
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Glycosaminoglycans and Skin Repair
S Garcia, V Chassefie`re, P Kern, D Papy-Garcia, JP Caruelle
CNRS FRE-2412, Cre´teil France
The aim of this study was to precise the role of GAG in wound healing which consists
in precise processes encompassing a set of complex interlocking and overlapping
phases, including inflammation, angiogenesis, matrix deposition and epithelialization. These
processes are mediated by interacting molecular signals such as cytokines and growth
factors. Matrix-generating fibroblasts contribute to lay down and remodel their new own
matrix components. Glycosaminoglycans moieties (GAGs) of proteoglycans play important
roles in tissue healing by their capacity to interact with enzymatic proteins and to store
heparin binding growth factors (HBGF). We have used engineered polymers called Re-
GeneraTing Agents (RGTAs) as they stimulate in vivo tissue repair. These compounds mimic
the protecting and potentiating effects of heparan sulfate (HS) toward HBGF and modulate
enzymatic activities of inflammatory and matrix remodelling phases.
This experimental study was performed using a standardised doxorubicin-induced skin
necrosis in mice. This model reproduces extravasation effects of chemotherapeutic agents,
which occur in the most frequent complications in cancer patients. The GAG-mimic
compound used was RG-1250b, a carboxymethyl O-sulfonate dextran (Mr 85 000; degrees of
substitution of carboxylate (0,53) and O-sulfonate (1,24) per glucosidic unit. RG-1250b
in saline buffer was administered, day eleventh after doxorubicin-intradermal injection
corresponding to the maximum of necrotic area development, simultaneously weekly by
intra-muscular way (1,5 mg/kg) and, topically each two days (0.1 mg/mL).
Two days after RGTA treatment, a very significant increased of ulcer enclosure (50% of
original area) is observed as compared to control group (less than 10%). Collagen I, III and V
biosynthesis were measured by ex vivo (3H)proline incorporation in necrotic skin biopsies. In
untreated ulcerated skin, relative collagen III proportion was largely amplified, reflecting
fibrosis-related alterations. RG-1250b restored collagen III biosynthesis to control values. The
quantitative evolution of HS and chondroitin sulfate (CS) were determined during formation
and enclosure of the skin ulcer by the DiMethylMethylene Blue method, with and without
nitrous acid treatment. In healthy skins, CS and HS represented respectively 20% and 80% of
total GAG quantities. A dramatic decrease of GAG content was observed during skin
ulceration followed by a rapid two-fold increase detected at the starting point of spontaneous
skin repair. Normal GAG levels were restored eighteen days after ulcer induction. RG-1250b
treatment showed to enhance skin healing by restoring GAG content after only two days of
treatment. RG-1250b modulates GAG synthesis and especially HS synthesis. Transcript’s
expression of several enzymes involved in HS metabolism, including EXT-1 and 2, NDST-1
and 2, 2-OST, 6-OST, 5-epimerase and heparanase by real-time RT-PCR, are currently
studied.
In conclusion, RG-1250b exhibits powerful anti-fibrotic and regenerative activities on
ulcered skins. RGTA constitute a new class of puissant therapeutics agents in the treatment
of skin ulcers and can be used as tools to better understand physiological role of endogenous
GAG.
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Beta-endorphin Modulates Lipogenesis in Human Sebocytes
M Bo¨hm1, Z Li1, M Ottaviani2, M Picardo2, Ch C Zouboulis3, S Sta¨nder1, and T A Luger1
1Department of Dermatology and Ludwig Boltzmann Institute for Cell Biology and
Immunobiology of the Skin, University of Mu¨nster, Mu¨nster, Germany, 2Instituto Dermato-
logico San Gallicano, Rome, Italy, and 3Department of Dermatology, University Medical
Center Benjamin Franklin, The Free University of Berlin, Berlin, Germany
Previous research in our laboratories has demonstrated that the human sebaceous gland is a
target organ for several stress hormones including alpha-melanocyte-stimulating hormone
(alpha-MSH) and corticotropin-releasing hormone (CRH). To further investigate the role of
stress hormones in acne, we examined the expression of opioid receptors (OR) and the
biological actions of beta-endorphin (beta-ED), a natural high-affinity ligand for the mu-OR
(MOR) and low-affinity ligand for the delta-OR (DOR), in human sebocytes. RT-PCR, Western
immuno-blotting and immunofluorescence studies identified the MOR but not the DOR in the
human sebocyte cell line SZ95. Expression of the MOR was also confirmed in the sebaceous
gland in normal human adult skin and was detectable primarily in peripherally located
sebocytes. SZ95 sebocytes did not express the beta-ED precursor pro-opiomelanocortin
(POMC) as shown by RT-PCR analysis and Western immunoblotting and stimulation of cells
with prototypical POMC inducers such as tumor necrosis factor-alpha, alpha-MSH, dbcAMP,
phorbol ester and CRH failed to induce POMC. On the functional level beta-ED significantly
suppressed the growth of SZ95 sebocytes induced by epidermal growth factor in chemically
defined calcium-rich medium. On the other hand, beta-ED enhanced lipogenesis as shown by
Nile red staining and gas chromatography. Accordingly, beta-ED dramatically increased the
amount of C16:0, C16:1, C18:0, C18:1 and C18:2 fatty acids in an extent similar to linoleic
acid used a positive stimulus. Our data show that human sebocytes express the MOR and
respond to beta-ED with reduced in vitro proliferation and increased lipogenesis. Our data
further demonstrate another link between stress and acne at the biochemical level.
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Carnitine is Synthesized in the Epidermis and Supplies the Energy Necessary for
Epidermal Permeability Barrier
O Tanno1, N Hashimoto2, M Matsumoto1, S Inoue1
1Basic Research Laboratory, Kanebo cosmetics Inc., Odawara Japan, and 2Advanced
Science Research Center, Kanazawa University, Kanazawa, Japan
Carnitine is an essential cofactor in the transport of long-chain fatty acids across the inner
membranes of mitochondria. As such, carnitine, plays an important role in the supply of
energy via b oxidation. Carnitine homeostasis in mammals is maintained by both endogenous
synthesis and exogenous intake from dietary sources. The endogenous synthesis takes place
exclusively in the liver, kidney, and brain, while other depend on active uptake via carnitine
transporter. Relatively little is known about the role and biosynthesis of carnitine in the skin.
The aims of this study were as twofold: 1) to clarify the importance of carnitine by elucidating
its synthesis in epidermis; 2) to clarify the role of carnitine in the supply of energy via b
oxidation, a process requisite for the epidermal permeability barrier, one of the most
important epidermal functions.
Two findings indicated that carnitine may be synthesized in keratinocytes. Firstly, reverse
transcription polymerase chain reaction (RT-PCR) confirmed the expression of three enzymes
for carnitine biosynthesis in cultured normal human keratinocytes (trimethyllysine hydro-
xylase, trimethylaminobutyraldehyde dehydrogenase, butyrobetaine dioxygenase). Secondly,
14C-carnitine synthesis was observed in keratinocytes cultured with 14C-lysine. Carnitine
culture also significantly increased the b oxidation in keratinocytes, and treatment with
carnitine increased the synthesis of intercellular lipids in a skin-equivalent model.
In the last stage of our study we investigated the efficacy of topical application of carnitine
with dry skin volunteers. Transepidermal water loss (TEWL) was significantly decreased when
a cream containing carnitine was topically applied to the shins of the dry skin volunteers for 6
weeks. In tests performed after stripping the lipids from the stratum corneum by acetone-
ether treatment, TEWL was lower in skin treated with the carnitine cream than in skin treated
with vehicle (placebo cream). It thus appeared that the topical application of carnitine
suppressed the increase of TEWL induced by the acetone-ether treatment. The formation of
epidermal permeability barrier was apparently accelerated following the increase of b
oxidation of the epidermis with the topical application of carnitine.
These observations confirmed that carnitine plays an important role in epidermis and
supplies the energy necessary for epidermal permeability barrier via b oxidation.
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Nuclear Microscopy and Electron Microscopy Studies of Percutaneous Penetration of
Nanoparticles in Mammalian Skin
E Gontier1,2, C Habchi1, T Pouthier1, P Aguer1, P Barberet1, Y Barbotteau1, S Incerti1, MD
Ynsa1, JE Surleve-Bazeille2 and P Moretto1
1CENBG-IN2P3/CNRS Gradignan, France. 2DMPFCS, Universite´ Bordeaux 1, Talence,
France.
The ion microbeam techniques, Scanning Ion Transmission Microscopy (STIM), developed in
our laboratory were associated with Particle Induced X-ray Emission (PIXE) in order to
determined the presence and content of mineral ions and exogenous elements in the different
strata of the skin of several mammals: mice, pig and human. PIXE and STIM were associated
with Transmission Electron Microscopy to implement this analysis. PIXE and STIM allow
respectively to map most elements present in epidermal sections, which appeared highly
compartmentalized in the different skin strata, and to image the skin structure on the basis of
its density contrast. Micro-PIXE analysis allows the simultaneous mapping of a dozen of
elements (Na, Mg, S, Cl, K, Ca, Ti, Zny) in tissues sections. STIM delivers images of tissues
with sub-micrometer resolution, both rapidly and non destructively, authorizing localization of
cellular structure. In addition, it allows the measurement of the sample mass to normalize X-
ray data in terms of concentration. STIM method may be applied on un-embedded sections,
cryofixed and freeze-dried. This sample preparation is undoubtedly an advantage when
addressing percutaneous penetration studies. In new solar cream, nanoparticles of TiO2,
ZnO, Al2O3, are included to provide protection againts UV. The aim of this work is to deter-
mine the potentiality of percutaneous penetration of such particles. We focused our study on
formulations containing solely TiO2 nanoparticles. When such formulations were applied on
skin, TiO2 particles were solely detected in the intercellular spaces between the corneocytes
of the outermost layers of the stratum corneum. The TEM and PIXE studies never revealed
the presence of particles within the cells of the living layers. These complementary tech-
niques appear to be useful in providing clues to the percutaneous penetration.
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Induction of Aquaporine 3 Expression and Filaggrin Degradation in Human Epidermis
after Skin Barrier Disruption
P Gasser1, E Lati1, M Dumas2
1Laboratoire Bio-EC, ACMO Parc, Clamart, France 2L.V.M.H. Recherche, Saint-Jean de
Braye, France
Aquaporin 3 (AQP-3) is a small transmembrane channel protein involved in water and glycerol
transport in the epidermis. Filaggrin (FG) is an histidine-rich protein triggering microfilament
compaction inside epidermal cells, keratinocyte differentiation into corneocytes, and
providing, after hydrolysis, the natural moisturizing factor (NMF). Epidermis is a stratified,
keratinised and cornified epithelium that forms the main barrier to body water loss. AQP-3
expression level has been previously shown to be coordinated with other epidermal proteins
such as claudine-1, a tight junction protein, and with CD44, the receptor for hyaluronate,
suggesting a tight control of water homeostasis inside epidermis. The present study
investigates from a kinetic point of view, the effect of a superficial skin barrier disruption on
both AQP-3 and FG expression. Barrier disruption was performed on human skin biopsies
maintained at the air-liquid interface using serial tape stripping (n¼10) or lipid removal with a
mixture of (ether/acetone) 1/1 v/v. AQP-3 and FG were immunostained on (7 mm) frozen skin
sections and their expression measured for up to 4 days. The results showed that
keratinocytes of control non-stripped skin expressed AQP-3 from the basal to the most
superficial living cell layers, mainly in their plasma membrane, since FG was present only in
the cytoplasmic compartment of granular cells. After barrier disruption, we observed a strong
short term (3h and 24 h) decrease of FG expression. FG was then restored to a normal level at
the basis of the stratum corneum after 24 h. In the same time, an important increase of AQP-3
expression was noted in the cytoplasmic compartment of the keratinocytes, mainly in basal
cells, then, after 4 days, in their plasma membrane and in the entire epidermis. These results
show that human epidermis responds to stratum corneum barrier disruption by inducing a
coordinated FG degradation and AQP-3 biosynthesis and that a rapid restoration of NMF
together with an important aquaporin-mediated glycerol and water flux are required to
generate a rich moisturizing environment allowing barrier reconstruction by epidermal cells.
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Regulation of NHE1 Expression Through Barrier Requirements
M J Behne, J Brandner, T Mauro, I Moll
Universita¨tskrankenhaus Hamburg Eppendorf, Germany, and UCSF Dermatology Depart-
ment, San Francisco, California, USA
We previously demonstrated the functional role of the Sodium-Hydrogen antiporter 1 (NHE1)
for epidermal barrier homeostasis and repair. Fluorescence lifetime imaging (FLIM) visualized
its effects on Stratum corneum (SC) pH directly, while electron microscopy revealed structural
and functional consequences via SC pH. Subsequently, we showed how changes in NHE1
expression correlate to postnatal acidification of newborn SC. We found that during the
immediate postnatal period NHE1 expression is reduced to presumably steady-state levels
necessary after birth.
As NHE1 has been shown to be a housekeeping gene regulating intracellular pH in most
tissues, a role it also has in epidermis with the notable addition of contributing to, if not being
the main source of, acidity for the SC. We here investigated whether barrier requirements
could alter expression levels despite the housekeeping/steady state expression to be
expected in epidermis.
Following tape stripping, we observed a steady increase in suprabasal expression for up to
48 hrs, becoming detectable by immunohistochemistry as early as 6 hrs post-tape-stripping.
As transepidermal water loss (TEWL) is the single most important signal regulating barrier
repair through lipid secretion and processing, we studied whether a dry or humid environment
could affect NHE1 expression and localization. We found that humidity up-regulates
suprabasal expression, while it is down-regulated in mice exposed to a dry environment.
Similarly, fetal rat explants in vitro demonstrate that the up-regulation of NHE1 following
exposure of the explant to the air-medium interface is further enhanced by occlusion.
In addition, numerous prior studies have shown that barrier repair initiates immediately
following the insult and that by TEWL approximately 50% of experimentally induced damage
is repaired within the first 5 hrs. This effect can be delayed, but not blocked by external pH-
buffering, while pharmacologic blockade of NHE1 further delays barrier recovery.
As the observed changes in NHE1 expression are late events relative to barrier repair, or
occur within the time of several days at the corresponding conditions, we conclude that
NHE1 expression changes based on tissue turnover or chronic effects that affect SC pH.
More immediate metabolic requirements, e.g. the rapid initial recovery in tape-stripping
experiments, may be better and faster addressed by increased activity of the antiporter, a
parameter which to date cannot be studied directly.
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PA 102, a Fatty Acid Regulator of Epidermal Terminal Differentiation: Examination of
Biological Mechanisms
L Fort-Lacoste, I Ceruti, MF Aries, H Duplan, M Charveron and AM Schmitt
(CERPER/IRPF Hotel Dieu, 2 rue Viguerie, 31025 Toulouse France)
In mammals, epidermal differentiation and barrier homeostasis are critical components of
skin barrier function. Both are coordinately regulated and the responses that occured after
perturbations, used various operative signalling pathways. Previously, we showed that the
fatty acid PA 102 profoundly influenced both morphological and biochemical aspects of
epidermal differentiation in vitro : profilaggrin and filaggrin like most other differentiation
markers of keratinocytes were up-regulated. Profilaggrin is an abundant component of
keratohyalin granules and form the precursor of filaggrin, the keratin-associated protein of the
stratum corneum.
Here we studied the effects of topically applied PA 102 in an in vivo model of barrier
function disruption following a diet with essential fatty acid (EFA) deprivation, using histo-
logical and ultrastructural analysis of epithelium. Morphologically, PA 102 supplementation
enhanced the normal wavy pattern of the stratum corneum and the number of keratohyalin
granules found in epithelial granular layer. Histological data from cutaneous epithelium
showed that PA 102 could decrease the mitotic cell number, limit the inflammatory infiltrate
and regulate the epidermal differentiation with a marked effect on the filaggrin expression.
Recently expression of PPARs transcription factors in keratinocytes were demonstrated
and ligands were found to enhance epidermal maturation. So we experimented PPAR-g
activation by PA 102 in HaCat keratinocytes and our data showed here that PA 102 activated
the transcription factor in a dose-dependant manner.
In conclusion, in this in vivo model of a EFA-deprivated diet, inducing barrier disfunction
with generation of cutaneous inflammation and epidermal hyperplasia, topical applying of PA
102 could restore skin barrier function through PPARs activation. By supporting physiological
mechanisms to maintain a healthy skin barrier, PA 102 could be used for the treatment of dry
skins associated with aged, atopic and psoriasis conditions.
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Less Permeation Of Pimecrolimus Through Normal, Inﬂamed Or Corticosteroid Pre-
Treated Porcine Skin As Compared To Tacrolimus
JG Meingassner, H Fahrngruber, H Aschauer, A Billich
Novartis Institute for BioMedical Research Vienna, Austria
The barrier function of the skin plays a pivotal role in the percutaneous absorption of
epicutaneously applied drugs. Various inflammatory conditions or iatrogenic interventions are
associated with disturbed barrier function and, therefore, can result in increased skin
permeability and consequent enhanced systemic exposure to topically applied drugs. In a
side-by-side comparison we evaluated the penetration and permeation of pimecrolimus and
tacrolimus in normal, inflamed, and corticosteroid (CS) pre-treated porcine skin. Inflammation
was induced locally by a 48-hr occlusive application of 5% sodium lauryl sulfate (SLS). CS
pre-treatment was performed with hydrocortisone (1%), mometasone furoate (0.1%), or
clobetasol-17-butyrate (0.01%), applied twice daily for 5 days prior to dissection of skin
samples. Inflamed, CS pre-treated and contra-lateral normal pig skin samples were then
used in Franz-type diffusion chambers in vitro. Pimecrolimus and tacrolimus were applied
epicutaneously either as solutions (at 1.0% in propylene glycol/oleyl alcohol 9:1), or as the
marketed formulations (Elidel 1% cream, Protopic 0.1% ointment). The latter were used in
studies with CS pre-treated skin. Neither inflammation nor pre-treatment with CS significantly
enhanced the levels of the two drugs in the skin (i.e. the penetration into the epidermis and
upper dermis). SLS–induced inflammation, however, was associated with immediate passage
of the compounds through the skin, as opposed to a latency period of approx. 17 hrs in
normal skin; also, a significantly higher permeation rate through skin was observed (by
factors up to 6.2). The permeation rate of pimecrolimus through irritated skin was similar
to the rate of tacrolimus through normal skin (173 vs. 166 ng/ml/hr). With skin that was
pre-treated with CS, permeation was increased by factors of 3.6 (pimecrolimus) and 1.7
(tacrolimus) as compared to normal untreated skin. These factors were independent of
the potency of the CS used. The permeation of tacrolimus was 5.9 times higher through
hydrocortisone pre-treated skin, 7.1  higher through mometasone pre-treated skin and
3.5  higher through clobetasol pre-treated skin than that of pimecrolimus. Since low
permeation in vitro predicts low plasma levels and thus low systemic drug exposure in vivo
after topical application to patients these findings appear be of clinical importance.
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Skin Roughness Induces and Enhances Wrinkle Formation
Y Matsunaga, Y Ogura, J Hatori, M Ooguri, Y Masuda, T Hirao and S Amano
Shiseido Research Center, Yokohama, Japan
Fine wrinkles often increase in number and depth during periods when skin is rough. In order
to explore the mechanism involved, we experimentally induced rough facial skin in 8 healthy
male volunteers by washing the skin with soap 5 times per day for 1 week. Transepidermal
water loss (TEWL), water content in the cornified layer and skin elasticity were evaluated, and
skin surface textures and wrinkle formation were analyzed by video microscopy and on
photographs of skin negative replicas taken on days 3, 5, 7 and 14 (1 week after last
washing). The water content in the cornified layer decreased gradually from day 3 and
showed the lowest value at day 7 after washing. Conversely, TEWL increased from day 3 and
peaked at day 7. Both had recovered by day 14. The skin elasticity decreased in terms of Uf
values (corresponding to final distension, which is related to skin extension) measured on a
Cutemeter, from day 3 through day 14. As regards skin texture, rough patterns were observed
from day 3 through day 14, and crow’s-feet (wrinkles at the outer corners of the eyes) and
wrinkles at the lower eyelid became deeper from day 5 through day 14 in most volunteers.
We conclude that the repeated washing with soap caused epidermal permeability barrier
disruption and dryness of the cornified layer (typical skin roughness) in facial skin, leading to a
decrease of skin elasticity, and these cutaneous changes appear to induce and enhance
wrinkle formation.
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Characterisation of Axillary Skin Surface pH and its Changes after Washing
S Williams, M Davids, T Reuther, D Kraus, M Kerscher
Hamburg, Germany
The skin surface pH is an important parameter of skin physiology and influences various other
factors such as composition of stratum corneum lipids, hydration, barrier function and
growths of microorganisms. While data on skin surface pH on the forearm and certain other
parts of the body are easy to find in the literature, only very few studies exist which concern
pH values in the axilla. The aim of our study was to characterise the axillary in vivo pH in men
and women and to evaluate the influence of washing.
After a standardized run-in period of 7 days, the in vivo skin surface pH was measured in 20
healthy volunteers in three distinct locations of each axilla using a calibrated CK pH Meter PH
900. The pH value was measured at baseline and up to 6 hours after a standardized washing
procedure with tap water.
There were no significant differences of skin surface pH between the central, proximal and
distal part of the arm pit or between the left and right axilla. However, there was a statistically
significant difference in axillary skin pH between male and female probands on both sides
with more acidic values in women compared to men. After washing with water, the mean
axillary pH significantly decreased in women. In men, the axillary pH slightly increased after
washing.
In summary, there is a gender difference in axillary skin surface pH, the exact pathogenetic
factors of which remain to be revealed in future research. Washing with water further
increased the difference between male and female pH values.
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Human Facial Pore Area And Sebum Are Affected By The Menstrual Cycle
K Takada, T Iida, Y Gozu, M Moriyama, K Sakai, S Haze, S Yoshida, T Iikura, and S Inomata
Shiseido Research Center, Japan
Noticeable pores are one of the facial problems that concern women of various ages. We
have investigated the physiological characteristics of the cheek skin of healthy women
volunteers. The group with larger pores was found to have more parakeratotic corneocytes
and higher transepidermal water loss (TEWL) values. This suggests that women with large
facial pores may have immature corneocytes. The group with larger pores was also found to
have larger amounts of sebum, especially unsaturated free fatty acids such as palmitoleic
acid and oleic acid. However, little is known about the effects of seasonal change or the
menstrual cycle on facial pores.
Sequential observations revealed that the area of pores and the amount of sebum remained
comparatively constant throughout the year. Further, the effect of hormonal changes on
female facial pores and sebum was precisely observed throughout the phases of the
menstrual cycle. The area of pores of woman in the luteal phase was larger than that in any
other phase. Increases in the number of parakeratotic corneocytes and in the amount of
sebum were also seen in the luteal phase. These results suggest that fluctuations of sex
hormone during the menstrual cycle might affect the condition of facial pores, sebum and the
skin.
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Implication of Collagen Type Vii In The Regulation of Motility and Invasion of Skin
Keratinocytes
C Baldeschi, L Fantin, L Gagnoux, L Turchi, G Ponzio and G Meneguzzi
INSERM U634, Faculty of Medicine, University of Nice-Sophia Antipolis, France
Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited skin blistering disorder
caused by mutations in the gene coding for the collagen type VII (colVII), the major
component of the anchoring fibrils. In RDEB, absent expression of colVII results in aggressive
squamous cell carcinomas (SCC) associated with the unremitting healing of the skin lesions.
Primary RDEB keratinocytes display altered migration and invasion properties ex vivo, which
indicates a possible proneness to tumor progression. To explore the relationship between
collagen type VII expression and the behavior of RDEB keratinocytes, we have analyzed
RDEB cell cultures before and after transduction with a wild-type collagen type VII cDNA. Cell
migration and invasion in haptotactic assays in Boyden chambers showed that RDEB
keratinocytes display a 3-fold invasive capacity and a 2,5-fold hypermotility compared with
normal keratinocytes. In contrast, the reverted r-RDEB cells behaved like the normal control.
Expression of colVII in rRDEB cells or addition of exogenous collVII revert the hypermotility
and invasion capacity of RDEB cells. The invasive potential of RDEB keratinocytes was
neutralized by chemical inhibitors of the matrix metalloproteinases (MMPs) and urokinase
plasminogen activator (uPa). Consistently, enzymatic assay showed a high MMP and uPA
activity in RDEB keratinocytes that was reduced in the rRDEB counterparts. Western blot
analysis using a panel of antibody specific to each MMP detected down regulation of MMP3,
upregulation of MMP9 and overexpression of MMP1.
Our results show that collagen type VII plays a major role in keratinocyte migration with the
involvement of specific MMPs including MMP1 and uPA.
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Trans-splicing in GABEB Keratinocytes
A Klausegger, L Mitchell, H Hintner, J Bauer
Dept. Of Dermatology, Paracelsus Medical University Salzburg, Austria Intronn Inc.
Gaithersburg, MD, USA
Gene therapy in skin diseases is often restricted by the integration limits of commonly used
viral and non-viral vectors in recessive diseases and the lack of promising strategies in
dominant disorders. To overcome this problem the size of the therapeutic insertions can be
reduced by a novel strategy defined as spliceosome-mediated RNA trans-splicing (SMaRT),
which provides intron-specific gene-correction at the pre-RNA level by replacing mutant
exons. Mutations in the COL17A1 gene, coding for a 6,5kB mRNA, are involved in the
pathogenesis of Generalized Atrophic Benign Epidermolysis Bullosa (GABEB; nonHerlitz
junctional EB). In previous experiments a b-galactosidase (b-gal) double transfection trans-
splicing assay in 293T cells was evaluated, which was established using intron 51 of the
COL17A1 gene as the target for trans-splicing. We observed expression of the b-gal protein
only in cotransfected cells. Sequence analysis showed accurate splicing junctions (Dallinger
et al, Exp. Dermatol 2003 Feb;12(1): 37–46). In this study we provide information about the
feasibility of trans-splicing in the mutated endogenous gene responsible for GABEB.
Transfection of a pre-trans-splicing molecule (PTM) harbouring exons 52–56 of the COL17A1
gene demonstrated replacement of the complete 3’-end of the COL17A1 gene in almost 50%
of analysed clones. Correct trans-splicing and the correction of the 4003delTC mutation
could also be verified by sequencing. Furthermore, cultured GABEB keratinocytes
transfected with exon 52–56 PTM’s resulted in the expression of type 17 collagen protein
on the surface of the GABEB cell line shown by immunofluorescence. To test whether SMaRT
produced mature COL17A1 protein, western blotting was performed with lysates of PTM-
transfected cells. A 97kD band was detected by antibody LAD-1 recognizing the extracellular
portion of type XVII collagen. These observations suggest that SMaRT may represent a
feasible tool for reprogramming sequences of KC specific transcripts.
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Detection of Human Serum Autoantibodies Against BP180 NC16a Domain by Surface
Plasmon Resonance
S Boulinguez, C Be´dane, F Lopez, G Di Zenzo, M Drouet, G Zambruno, M Cogne´
Laboratoire de Dermatologie, Faculte´ de Me´decine, Limoges (France), Institut Louis
Bugnard, Toulouse (France), Instituto Dermapatico dell’immacolata, IDI-IRCCS, Rome
(Italy), Laboratoire d’Immunologie UMR CNRS Limoges(France)
Introduction: Among immunological assays for the detection of autoantibodies in auto-
immune bullous diseases Surface Plasmon Resonance (SPR) appears to be a novel useful
biosensor instrument that is efficient, sensitive, accurate and reproducible. Intrinsec
specificity of SPR is to measure binding kinetics of antigen-antibody interaction. Mapping
of affinity constants (association or dissociation constants) can be performed simultaneously
for three epitopes. Most of studies based on antigen-antibody interaction by SPR used
monoclonal antibodies immobilized on chips. On the opposite, studies using antigen
immobilization for the detection of polyclonal antibodies in human serum are rare.
Objective. To evaluate efficacy, sensitivity and reproducibility of SPR for detection of serum
human antiBP180 NC16a antibodies.
Materials and methods. Twenty sera containing antibodies against BP180 were selected.
They were previously characterized by immunoblot on epidermal extract (11 bullous
pemphigoid, 2 pemphigoid gestationis, 7 cicatricial pemphigoid). Indirect immunofluores-
cence on salt split skin was performed for all sera. Indirect or direct immunoelectron
microscopy were performed for most of them. Control sera provided from 2 healthy subjects,
from 1 patient with pemphigus vulgaris and 1 patient with superficial pemphigus. A GST-
recombinant NC16a peptide was used. A ELISA assay with the GST-recombinant NC16a
peptide was finalized according to previously published techniques. Detection of antibodies
by SPR (Biacores) was performed with the GST-recombinant NC16a peptide and with GST
alone as control.
Results. Detection of serum antibodies against BP180 NC16a by SPR was possible and
reproducible (variation of 12%). High level of proteins and antibodies in human serum did not
interfere until 1/50 dilution. Sensitivity of SPR was quite lower than sensitivity of ELISA.
Therefore it was enhanced with the introduction of secondary antibodies (human anti-IgG).
Elisa and SPR results were concordant for bullous pemphigoid patients. Curves of sera were
unusual for pemphigoid gestationis. Sera of cicatricial pemphigoid, lowly positives by ELISA
were systematically negatives by SPR.
Discussion. Detection of serum antibodies against BP180 NC16a is possible by SPR. SPR is
a fast (10 minutes) and reproducible technique. Optimizing parameters of SPR (concentration
of antigen on the chip, flow rate), SPR should be as sensitive as ELISA. Therefore SPR is
especially useful to measure binding affinity constants. Using this ability, SPR allows an
original approach to study polyclonal immune response in autoimmune bullous diseases.
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Induction of Dermal-Epidermal Separation In Mice by Passive Transfer of Antibodies to
Type Vii Collagen
C Sitaru1, S Mihai1, C Otto2, M T Chiriac1, I Hausser3, B Dotterweich4, H Saito5, C Rose4, A
Ishiko5, and D Zillikens1
Departments of Dermatology, Universities of1Lu¨beck, 3Heidelberg, and 4Wu¨rzburg, Germany,
and 5Keio University, Tokyo, Japan; 2Department of Surgery, University of Wu¨rzburg, Germany
Autoimmune conditions are characterized by autoreactive T cells and/or autoantibodies that
can transfer the disease. Epidermolysis bullosa acquisita is a subepidermal blistering disease
associated with tissue-bound and circulating autoantibodies to type VII collagen, a major
constituent of the dermal-epidermal junction. Previous attempts to transfer the disease to
mice by injection of patient autoantibodies have been unsuccessful, possibly due to their
reduced reactivity with murine skin. To study the pathogenic relevance of antibodies to type
VII collagen, we generated a recombinant form of murine type VII collagen which was used to
immunize rabbits. Antibodies from these rabbits bound to the lamina densa of murine skin
and immunoblotted type VII collagen. When purified rabbit IgG to type VII collagen was
passively transferred into adult BALB/cnu/nu mice (n¼12), all animals, in contrast to control
mice (n¼ 4), developed widespread skin blisters. By direct immunofluorescence microscopy,
tissue-bound rabbit IgG was detected that fixed murine C3 to the dermal-epidermal junction.
Histopathological examination of mouse lesional skin revealed dermal-epidermal separation
accompanied by an inflammatory infiltrate dominated by neutrophils. By electron microscopy,
the cleavage plane was shown to localize to the sublamina densa. In the serum of injected
mice, titers of rabbit IgG to type VII collagen correlated with the extent of skin disease. This
novel animal model duplicates the key findings in patients with epidermolysis bullosa
acquisita. It should greatly facilitate the further dissection of the pathogenesis of this disease
and the development of new therapeutic strategies.
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Laminin 5-speciﬁc IgG Autoantibodies in Mucous Membrane and Bullous Pemphigoid
V Bekou, S Thoma-Uszynski, O Wendler, W Uterw, S Schwietzke, T Hunzikery, Ch C
Zouboulis#, G Schuler, L Sorokinz, M Hertl
Department of Dermatology, Interdisciplinary Center for Clinical Research (IZKF),
Nikolaus Fiebiger-Center for Molecular Medicine, wDepartment of Medical Informatics,
Biometry and Epidemiology, Friedrich-Alexander-University Erlangen-Nu¨rnberg (FAU),
Erlangen, Germany; yDepartment of Dermatology, University Hospital, Bern, Switzerland;
#Department of Dermatology, Campus Benjamin Franklin, Charite´ Universitity of Medicine,
Berlin, Germany; and zDepartment of Experimental Pathology, University of Lund, Lund,
Sweden.
Mucous membrane pemphigoid (MMP) is a chronic autoimmune bullous disease which
mainly affects mucous membranes leading to scarring of the affected tissue. Patients with
MMP have serum antibodies (ab) that preferentially recognize two components of the
dermoepidermal basement membrane zone (BMZ), BP180 and laminin 5 (LN5). Since the
detection of serum auto-ab is critical for establishing the diagnosis of MMP, we sought to
develop a novel ELISA with native LN5 derived from squamous carcinoma cell (SCC-25)-
conditioned medium. A total of 24 MMP, 72 BP and 51 control sera were analysed for LN5-
specific auto-ab. By ELISA, 18/24 (75%) MMP and 29/72 (40.3%) BP sera contained IgG
reactive with LN5. Thus, the sensitivity and specificity of LN5 ELISA were for MMP 75% (95%
CI: 53.3–90.2%) and 84,3% (95% CI: 71.4–93.0%) respectively, and for BP 40,3% (95% CI:
28.9–52.5%) and 88,2% (95% CI: 76.1–95.6%) respectively. In the MMP patients, the titers of
LN5-reactive IgG correlated well with clinical disease severity. As an example, in a patient
with severe MMP, the serum IgG titers were closely related to clinical disease activity. In
contrast, there was not such a relationship between LN5-reactive IgG and clinical severity in
the LN5-reactive patients with BP. Furthermore, LN5 IgG responsiveness of the MMP and
BP sera was not significantly associated with IgG reactivity against other components of
the BMZ, such as BP180 and/or BP230. The established LN5 ELISA is highly sensitive and
specific and holds great promise as a novel diagnostic and prognostic parameter in MMP.
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Novel COL17A1 Mutations In Junctional Epidermolysis Bullosa Patients From The
Netherlands
A M G Pasmooij,1 H H Pas,1 H H Lemmink2 and M F Jonkman1
1Centre for Blistering Diseases, Department of Dermatology, and 2Medical Genetics,
Groningen University Hospital, The Netherlands
Mutations in the gene COL17A1, coding for type XVII collagen, cause non-Herlitz junctional
epidermolysis bullosa (nH-JEB), although occasionally features of epidermolysis bullosa
simplex (EBS) are observed. Here we give an overview of 10 epidermolysis bullosa patients
from the Netherlands with mutations in COL17A1. Immunofluorescence antigen mapping with
monoclonals 1A8C and 1D1, specific for respectively the intracellular and extracellular
domain, revealed absence of type XVII collagen in the 8 patients with a classic nH-JEB
phenotype. In contrast, reduced expression of type XVII collagen was observed in the 2
patients (1877-2A4C/3432delT and 2356C4T/3432delT) with a mild form of the disease. The
splice-site mutation in intron 21 (1877-2A4C) generated different mRNA transcripts resulting
in the deletion of exon 22, while in case of the 2356C4T mutation type XVII collagen was
rescued by deleting the premature termination codon containing exon 30. Accordingly, in
both cases a smaller type XVII collagen protein could be detected on immunoblot.
Ultrastructural analysis demonstrated junctional cleavage through the lamina lucida in 9
patients. One child (1877-2A4C/3432delT), however, had an intra-epidermal (‘pseudojunc-
tional’) cleavage level fitting EBS rather than nH-JEB. Furthermore, genomic DNA analysis
identified in the patient group four novel deletions, all leading to a premature termination
codon. A 2-year-old girl had the deletions 1365delC in exon 16 and 3600-3601delCT in exon
49. Another mutation, 1284delA in exon 15, was present in a 5-year-old boy, in addition to the
known regional 3432delT mutation. The last deletion, 3236delC in exon 46, was found in a 45-
year-old woman of consanguineous not-affected parents. Besides these new findings, DNA
analysis also showed that the mutations 2342delG, 3432delT and 3781C4T were each
occurring in three unrelated patients. Our data give further insight into genotype-phenotype
correlation in patients with mutations in COL17A1.
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Anti-plectin Autoantibodies in Pemphigoid
J J A Buijsrogge1, M C J M de Jong1, G J Kloosterhuis1, H J Meijer1, J Koster2,
M H Vermeer3, M F Jonkman1 and H H Pas1
1Centre for Blistering Diseases, Department of Dermatology, Groningen University Hospital,
2Netherlands Cancer Institute, Amsterdam and 3Department ofDermatology, Leiden
University Medical Centre, The Netherlands
Hemidesmosomal protein components may become autoimmune targets in pemphigoid
diseases. Well-known auto-antigens are the intracellular plaque protein BP230, the trans-
membrane component BP180 and its shed extracellular domain LAD-1. Here we show that
plectin, another hemidesmosomal intracellular plaque protein, may also become an auto-
antigen. This study had three goals: to establish the existence of anti-plectin antibodies in
pemphigoid patients, to determine the incidence of these antibodies, and to map the
distribution of epitopes over the plectin molecule. By routine immunoblotting analysis of
patient sera, we found among 283 cases 12 patients with an immunoblot staining pattern
identical to that obtained with anti-plectin monoclonal HD121. When these serum antibodies
were affinity-purified by eluting them from the blot, they bound to normal human skin in
a pattern typical for plectin: along the epidermal basement membrane, in keratinocytes in
the epidermis and in myocytes in the musculus erector pili consistent with the expression
of plectin in epithelial and muscular tissue. The affinity-purified antibodies did not bind
to plectin-deficient skin of a patient with epidermolysis bullosa simplex with muscular
dystrophy, supporting their pure anti-plectin nature. To map the epitopes on the plectin
molecule, recombinant constructs of different plectin domains were expressed in COS-7 cells
and used for immunoblotting with anti-plectin patient sera. The central coiled-coil rod domain
appeared an immunodominant hotspot as 7 out of 9 (78%) sera with anti-plectin antibodies
reacted with it. Most patients had accompanying antibodies against other pemphigoid
antigens as BP230 and BP180, making it difficult to disclose the pathogenicity and the clinical
manifestations of anti-plectin auto-antibodies. However, one patient had an IgA and IgG
response to plectin only, which manifested as a mild serpenginous vesicular skin eruption
resembling linear IgA dermatosis. Plectin is the fourth auto-antigen in pemphigoid, of which
humoral auto-immune reactions may cause the subepidermal autoimmune bullous disease.
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Autoantibodies to Human a6 Integrin in Patients with Bullous Pemphigoid
M Kiss1, A Pere´nyi1, S Husz1, I Marczinovits2, J Molna´r2, A Dobozy1
1Department of Dermatology and Allergology, 2Department of Physiology, University of
Szeged, Szeged, Hungary
Bullous pemphigoid (BP), an IgG-mediated autoimmune blistering disease, is characterized
immunologically by tissue-bound and circulating autoantibodies targeting the hemidesmo-
somal cytoplasmic plaque protein BP230 and the transmembrane protein BP180. The a6b4
heterodimer is an integrin family of adhesion receptors, which mediate basal keratinocytes to
extracellular matrix interactions. It was earlier demonstrated that a6 integrin is a BP180
binding partner in the hemidesmosomal multimolecular complex and that this connection is
essential for the function of hemidesmosomes. Recent evidence suggested a pathophysio-
logical role for autoantibodies against a6 integrin in the subepidermal blister formation of oral
pemphigoid. The objective of our study was to investigate the presence of anti-a6 integrin anti-
bodies in patients with BP. The autoantibody profiles of 30 patients with BP, 5 patients with
pemphigus vulgaris and 10 healthy persons were identified. With the use of PeptideStructure
and PlotStructure software, antigenic epitopes for a6 integrin were predicted. One intracellular
(NKDA 1045-1073) and three extracellular antigenic epitopes (TPAC 477–489; SVLP 585–601;
and SPDA 681–695) were chosen. The coding sequences of these antigenic epitopes were
chemically synthetized and inserted as homo- or hetero-oligomeric forms into fusion-expres-
sion plasmids (PGEX-4T, Pharmacia). Fusion products were expressed and purified from E. coli
cells by affinity chromatography. Sera were tested for a6 integrin autoantibodies with the fusion
recombinant proteins in an ELISA system. 28% of the BP sera reacted with the construct
containing the intracellular epitope, but positive reactions (32 and 36%) were demonstrated
more frequently against the recombinant proteins containing the extracellular antigenic
peptides of a6 integrin which are close to the transmembrane region. Altogether, 52% of the
patients with BP displayed circulating antibodies against at least one recombinant protein. The
healthy persons and the patients with pemphigus vulgaris did not exhibit immune reactivity nor
recombinant constructs. As the BP patients with autoantibodies against a6 integrin did not
reveal mucosal involvement of their disease, the presence of a6 integrin autoantibodies might
be a secondary autoimmune event, a consequence of epitope spreading. However, the
pathogenic role of anti-a6 integrin autoantibodies in BP demands further investigations.
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Cytoskeletal Protein Network Environment of Bullous Pemphigoid Antigen 2 (BPAG2)
Validated by a New Computational Protein Interaction Methodology
K O¨nder, T Kern, W Strasser, H Hintner, J W Bauer
Department of Dermatology, Paracelsus Medical Private University, Austria; Upper Austrian
University of Applied Sciences Department for Research and Technology Transfer
BPAG2 is a transmembranous hemidesmosomal collagen (Col17A1) associated with human
diseases such as generalized atrophic benign and junctional epidermolysis bullosa. The main
cellular function of BPAG2 is the adhesion of keratinocytes to the basement membrane and
the maintenance of the structural integrity of the cell. An exhaustive yeast two-hybrid screen
with BPAG2 gene as the bait revealed numerous putative novel protein interaction partners.
We used a human keratinocyte prey library and identified twenty-nine different annotated and
seventeen so far unknown gene sequences as presumptive interaction partners. The majority
of these interaction partners are structural components of the cytoskeleton. A highly
concentrated actin related environment for BPAG2 was noticed. Since in eukaryotic cells a
network of proteins which constitute microtubules, actin filaments and intermediate filaments
is responsible for structural integrity, cell motility and adhesion, it is not surprising to identify a
main core of proteins related to the cytoskeleton. Shot gun experiments like the yeast two-
hybrid system often deliver a wealth of biological information which have to be put into a
correct perspective and eliminated for false positives. Therefore protein sequence homology
based computational approach was designed and used for a rapid selection and validation of
experimentally collected protein interaction data. These experiments constitute the initial
series on the pathway to the keratinocyte proteome.
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Performances of the SCORTEN During the First Five Days of Hospitalisation
S Gue´gan, S Bastuji-Garin, E Poszepczynska-Guigne´, J-C Roujeau, and J Revuz
Departments of Dermatology and Public Health, Hoˆpital Henri Mondor, Universite´ Paris XII,
Cre´teil, France
Introduction: The SCORTEN calculated within 24 hours of admission, is a severity-of-illness
score validated for toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS).
Our purpose was to assess the performances of successive SCORTENs and to determine the
influence of admission delay.
Methods. Medical charts of patients admitted for TEN, SJS or TEN/SJS overlap syndrome in
our dermatology intensive care unit between 1993 and 2003, and not included in a thera-
peutic trial, were reviewed. The SCORTEN parameters (age X40 years, cancer, epidermal
detachment X10%, tachycardia X120/mn, serum urea 410 mmol/l, serum glucose 414
mmol/l, serum bicarbonate o20 mmol/l) collected from Day 1 to Day 5, as well as the
SCORTENs, were compared between deceased patients (n¼ 28,19.4%) and survivors
(n¼ 116). The performances of the score, calibration (Hosmer-Lemeshow test) and
discriminatory power (ROC curves) were assessed from D1 to D5. Admission delays (D1–
Day of first cutaneous or mucous symptoms) were compared between these two
populations, and the D1 SCORTEN was adjusted for this delay.
Results. Data of 144 patients (74 men/70 women), aged 46.8y (  19.7) were analysed. All
seven SCORTEN parameters, on whichever day collected, were associated with a higher
mortality rate. The SCORTEN rose slightly during hospitalisation with a significant difference
between D1-D2 (0.006) and between D1-D4 (0.001). Predictive and discriminatory values of
the SCORTEN were good from D1 to D5, with few differences between the expected and
observed numbers of death, and with areas under ROC curves (AUC) all above 80%.
The admission delay did not differ between deceased patients and survivors: 86% of the
deceased and 80% of the survivors had a delay p7 days. Delay adjusted SCORTEN was
close to the crude SCORTEN.
Discussion. We established an additional validation of the SCORTEN (2/3 of the patients
were included in the initial study) and demonstrated that the SCORTEN performances are not
altered during the first 5 days of hospitalisation. The SCORTEN is a good predictor even for
late deaths. The admission delay had no significant role on prognosis nor on SCORTEN’s
value. This could be explained by early pre-admission deaths, and moreover by a later
admission of less severe cases.
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Coexistence of IgA Antibodies to Desmogleins 1 and 3 in Pemphigus Vulgaris,
Pemphigus Foliaceus and Paraneoplastic Pemphigus
L F Mentink, M C J M de Jong, G J Kloosterhuis, M F Jonkman, and H H Pas
Centre for Blistering Diseases, Department of Dermatology, Groningen University Hospital,
The Netherlands
Pemphigus is a bullous mucocutaneous autoimmune disease characterized by IgG
autoantibodies to desmoglein 1 (Dsg1) and/or desmoglein 3 (Dsg3). Occasionally direct IF
of pemphigus skin reveals IgA depositions with an intra-epidermal intercellular pattern in
addition to IgG. In this study we investigated if pemphigus patients also generate IgA
antibodies to Dsg1 and Dsg3. Therefore we tested 96 pemphigus patients and 28 bullous
pemphigoid controls by IgA-ELISA to the recombinant extracellular domains of Dsg1 and
Dsg3. Pemphigus patients were selected on clinical grounds and positive IgG-ELISA index
values for Dsg1 and/or Dsg3. The 96 pemphigus patients were divided as follows: 33 had
pemphigus foliaceus (PF) with IgG to Dsg1, 28 had pemphigus vulgaris (PV) with IgG to Dsg3,
28 had PV with IgG to both Dsg3 and Dsg1, and 7 had paraneoplastic pemphigus (PNP). The
results were as follows: IgA antibodies to Dsg1 were found in 14 (42%) of the PF patients, in
10 (18%) of the PV patients, and in none of the PNP patients. IgA antibodies to Dsg3 were
found in 1 (3%) of the PF patients, in 24 (43%) of the PV patients, and in 3 (43%) of the PNP
patients. In most cases the specificity of the IgA followed the specificity of the IgG, although
in a minor number of cases IgA was present against the desmoglein not recognized by IgG.
This study shows that in a considerable number of supposedly IgG-mediated pemphigus
patients also IgA to Dsg1 and Dsg3 is present. In order to fully understand the pathogenesis
of pemphigus it will be necessary to investigate if this IgA contributes to the pathological
mechanism of blister formation in pemphigus.
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Laser Scanning Confocal Microscopy Study in a Case of Atypical Pemphigoid with
Antibody Against 200kd protein
K Wozniak, T Hashimoto, C Kowalewski
Medical University of Warsaw, Poland and Kurume University School of Medicine, Kurume,
Japan
We present a 54-year-old female with tense blisters forming targetoid-like lesions on the
flexural surfaces of the upper limbs, inner tighs, wrists and the presence of in vivo bound and
circulating IgG anti basement membrane zone antibody (aBMZAb) disclosed by immuno-
fluorescence (IF) study. Skin lesions poorly responded to prednisone 60 mg/daily for 2
months. While on steroid treatment she developed erythema gyratum repens-like lesions,
however laboratory investigations did not reveal internal malignancy. The aim of the study
was to characterize the target antigen, its ultrastructural localization and the localization of
in vivo bound IgG at the BMZ. Laser scanning confocal microscopic (LSCM) study was
performed to compare the localization of in vivo bound IgG to the localization of various BMZ
markers. Immunoglobulins were visualized by labeling with FITC-conjugated goat anti-human
IgG antibodies, whereas basement membrane zone markers were labeled with Cy5-
conjugated anti-mouse antibodies. IF images were overlaid by an image processing system
integrated in the LSCM and photographed. Confocal microscopic examination disclosed the
presence of in vivo bound IgG above collagen IV and on the level of laminin-5, which
corresponded to their ultrastructural localization at the lamina lucida-lamina densa border.
Serum study on salt split skin showed reactivity with the floor of the blister. LSCM study
disclosed the localization of target antigen above the collagen type IV, at the level of laminin-
5. Western immunoblot study performed on dermal extract showed reactivity of patient’s
serum with 200 kDa protein. IF study performed on the skin derived from generalized
epidermolysis bullosa dystrophica showed lack of expression of 200kD antigen in
comparison to normal human skin, which may suggest a functional relationship between
collagen VII and protein 200kD at the BMZ. Our LSCM study showed that in vivo bound aBMZ
antibody and target antigen 200kD are localized at the lamina lucida-lamina densa border.
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Multiforme-like Adverse Skin Reactions in Association with the Use of Bextras
(valdecoxib)
CL Wiesend1, M Grosber1, J Schlingmann1, S Blaschke2, R Vetter3, R Hinrichs4, JM Weiss4,
M Mockenhaupt1
1Dept. of Dermatology, University of Freiburg, Germany, 2Intensive Care Unit of Internal
Medicine, Dept. of Nephrology and Rheumatology, University of Go¨ttingen, Germany, 3Dept.
of Dermatology, University of Magdeburg, Germany, 4Dept. of Dermatology, University of
Ulm, Germany
Bextras is a new COX-2 inhibitor with valdecoxib as its pharmacological component. Like
sulfonamide antimicrobials valdecoxib contains a sulfonamide structure. Sulfonamide anti-
microbials (especially co-trimoxazole) are known for inducing severe skin reactions like
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Since March 2003
Bextras has been introduced into the EU pharmacological market and since May 2003 it can
be obtained in Germany.
Between July and October 2003 the German registry of severe skin reactions has evaluated
4 suspected cases of SJS after the use of valdecoxib. These patients developed moderate to
severe adverse skin reactions 5 to 11 days after daily intake of Bextras . Clinically they all
showed a generalized erythema in the beginning and during the course a maculopapular
exanthema with a tendency to develop target-like lesions (3/4) and blisters (2/4), emphasizing
the trunk. In addition some patients had fever up to 39 degree Celsius (3/4), mild dyspnea (2/
4), facial edema (4/4), pruritus (2/4) as well as mild mucosal involvement (3/4).
These skin reactions do not fit into the consensus definition of SJS and TEN. Moreover, it
seems that the pattern of the reaction described after the intake of COX-2 inhibitors is that of
specific multiforme-like drug reactions. In this evaluation we focused on valdecoxib, but very
similar drug reactions are also known after the use of celecoxib, another COX-2 inhibitor
introduced into the pharmacological market in 2000.
Since drug reactions to Bextras have been observed already shortly after its introduction
to the market and similar reactions have been described for other COX-2 inhibitors, the drug
seems to have a potential to induce cutaneous adverse reactions.
Taking into account other published case reports, COX-2-inhibitors seem to induce class-
specific multiforme-like skin reactions and perhaps also more severe adverse reactions like
SJS and TEN. Therefore, COX-2-inhibitors should be carefully monitored in terms of
cutaneous adverse reactions.
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Expression of Matrilysin-1 (MMP-7) in Cutaneous Squamous Cell Carcinoma in Recessive
Dystrophic Epidermolysis Bullosa
A Kivisaari, J A McGrath, JW Bauer, R Konigova, D Sawamura, K C Sato-Matsumura and V-
M Ka¨ha¨ri
Turku, Finland, London, UK, Salzburg, Austria, Prague, Czech Rep., Sapporo, Japan
Cutaneous squamous cell carcinoma (SCC) occurs frequently in chronic ulcers in patients
with recessive dystrophic epidermolysis bullosa (RDEB). Although the cutaneous SCCs in
RDEB are in general histologically well differentiated they are characterized by rapid invasion
and development of metastases resulting in poor prognosis. In this study, we wanted to
elucidate the role of extracellular matrix degrading enzyme matrilysin-1 (matrix metallopro-
teinase-7; MMP-7), in these carcinomas.
Formalin-fixed, paraffin embedded samples were obtained from 8 cutaneous SCCs and 2
lymph node metastases from 6 RDEB patients (ages between 12 to 44 years, 2 Hallopeau
Siemens RDEBs, 2 non Hallopeau Siemens RDEBs, 2 not specifically defined RDEBs). Tumor
sections were stained by immunohistochemistry using mouse monoclonal antibodies against
MMP-7 and cell surface protein syndecan-1, a substrate for MMP-7. Negative control
stainings were performed without primary antibody.
Of the 8 SCCs examined, 7 tumors were histologically well differentiated and 1 tumor was
moderately differentiated. In tissue sections from all 8 SCC cytoplasmic staining for MMP-7
was seen in tumor cells but not in stromal cells. MMP-7 expression was also detected in
tumor cells in both lymph node metastases examined. MMP-7 was also expressed by
exocrine epithelial cells in sweat glands where as no staining was noted in normal epidermis
or in negative control stainings. Abundant expression of syndecan-1 was noted in the cell
surface of keratinocytes in stratum spinosum of normal epidermis. Syndecan-1 expression in
tumor cells in SCCs was focal, irregular and clearly diminished, as compared to normal
epidermal keratinocytes.
These results show that the expression of MMP-7 is specifically induced in malignantly
transformed keratinocytes in this aggressive subset of cutaneous SCCs as well as in their
lymph node metastases suggesting a role for MMP-7 in early SCC development and metasis.
These results also indentify MMP-7 as a potential therapeutic target to inhibit growth and
invasion of SCCs in patients with RDEB.
086 [Oral 064]
Processing of the Short Arm of the Laminin gamma2 Chain Modulates Adhesive,
Migratory and Growth Capacity of Laminin 5
O Pommeret1, C Baudoin1, M Kreft, G Zambruno2, A Sonnenberg3, G Meneguzzi1,
L Gagnoux-Palacios1
1Faculty of Medicine, U634 INSERM, Nice, France. 2Molecular and Cell Biology Laboratory,
IDI-IRCCS, Rome, Italy. 3The Netherlands Cancer Institute, Division of Cell Biology,
Amsterdam, The Netherlands
Laminin 5 is the major adhesive ligand of epithelial cells which has been also involved in the
regulation of various cellular processes including migration, proliferation and apoptosis.
Extracellular laminin 5 harboring two distinct proteolytical forms of the gamma2 chain is
generated by cleavage in the NH(2)-terminal short arm of the gamma2 polypeptide that
reduces the size of gamma2 chain from 155 to 105 kDa or 80 kDa. The 105 and 80 kDa
polypeptides are found respectively in the basement membrane under physiological
conditions and in remodeling tissue or carcinoma. However, the specific function of these
molecules remains obscure. To address the biological role of the gamma2 chain processing,
both in vitro and in vivo, we expressed the unprocessed and processed forms of the gamma2
chain into primary gamma2-null keratinocytes and generated a knock-in mice that exclusively
expressed laminin 5 molecules harboring an unprocessed gamma2 chain by mutation in the
proteolytic cleavage site. Analysis of the transgenic animal shows accumulation of laminin 5
and other components of the ECM in the basement membrane which correlates with a lamina
densa thickening. In vitro studies confirmed that the laminin 5 with the unprocessed gamma2
form is actively integrated in the extracellular matrix, supports cell adhesion, activates
epithelial migration but inhibits cell proliferation. Interestingly, expression of the 80 kDa
gamma2-null keratinocytes failed to revert the adhesion defect of the recipient cells but
activates keratinocyte proliferation and migration, strenghtening the role of this molecule in
tumor progression. In conclusion, our results clarify the cellular fonction of the gamma2 chain
processing and elucidates the specific role of the different extracellular forms of the laminin 5
in a physiological and pathological context.
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The Laminin 5-binding Domain of BP180/collagen XVII is Important for Structural Integrity
and Adhesive Functions
C-W Franzke, C Has, C Schulte, M Aumailley, B-R Balda, and L Bruckner-Tuderman
Freiburg, Germany,Cologne, Germany, and Augsburg, Germany
Collagen XVII, a transmembrane component of the hemidesmosomes, mediates adhesion of
the epidermis to the underlying basement membrane by binding to laminin 5. Genetic defects
of collagen XVII are associated with epidermal detachment in junctional epidermolysis
bullosa (JEB). Here we analyzed the biologic consequences of a spontaneous deletion of the
distal C-terminus of collagen XVII in a JEB patient. The underlying mutation was a
homozygous duplication of four nucleotides in exon 54 of the COL17A1 gene. It resulted in a
frame shift, an adjacent nonsense sequence of 18 amino acids, a premature termination
codon and elimination of 43 most C-terminal amino acids of the collagen XVII ectodomain,
including the laminin 5 binding domain. The mutation led to expression of a truncated
molecule, albeit at a somewhat lower level. Immunofluorescence staining with antibodies to
N-terminus of collagen XVII resulted in a positive signal in JEB skin, but an antibody against
the distal C-terminus remained negative, indicating that a deleted molecule was stable in situ.
Immunoblots revealed both truncated collagen XVII forms in JEB keratinocyte cultures, the
transmembrane form and the shed ectodomain. Analysis of the thermal stability by limited
trypsin digestion showed that the helix-to-coil transition temperature was significantly lower
for the truncated collagen XVII than for wild type controls, indicating abnormal folding of the
mutant molecule. Analysis of keratinocyte migration by cell scattering assays showed the
JEB cells to be more motile than normal keratinocytes, but in an undirected manner.
Comparable motility characteristics have been observed before with collagen XVII deficient
keratinocytes. These findings demonstrate that the deletion of the laminin 5-binding domain
of collagen XVII causes abnormal folding, inhibits physiologic ligand binding, and possibly
increases the susceptibility of the ectodomain to proteolytic degradation. The findings
underline the role of the distal ectodomain of collagen XVII in binding to laminin 5, epidermal
adhesion and etiopathogenesis of JEB.
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Morphogenesis of Dermo-epidermal Junction in a Model of Reconstructed Skin:
Beneﬁcial Effects of Vitamin C
C Marionnet, C Vioux-Chagnoleau, C Pierrard, J Sok, D Asselineau, F Bernerd
L’Oreal Recherche, Clichy, France
In skin, cohesion between dermis and epidermis is ensured by the dermal-epidermal junction
(DEJ). It is also required for normal control of epidermal growth and differentiation.
Reconstructed skin comprising both a fully differentiated epidermis and a dermal equivalent
with human fibroblasts is a model of choice to study DEJ.
In this study we showed that addition of vitamin C optimised the DEJ formation in an in vitro
human reconstructed skin model leading to DEJ structure closer to that of normal human
skin. In comparison with classical culture conditions, vitamin C treatment led to a better
organization and architecture of basal keratinocytes, an increase in fibroblast number and a
faster formation of DEJ. Actually, by imunolabeling, we observed that vitamin C accelerates
deposition at the DEJ of several basement membrane proteins, like type IV and VII collagen,
laminin-1, type I and III procollagens, Tenascin and Fibrillin. Mechanism of action of vitamin C
was investigated by real time PCR on the sub-cited basement membrane markers, in
fibroblasts and keratinocytes respectively. Our results showed that 1- gene modulation
induced by vitamin C was dependent on the cellular type: the fibroblast for modulation of col I
a1, col III a1, fibrillin and laminin g1, the keratinocyte for col VII a1, col IV a2 and laminin b3; 2-
vitamin C effects on DEJ passed in part through a transcriptional pathway for procollagen I
and III, Fibrillin and for laminin g1; whereas effects on the other DEJ markers appeared to
happen at the traductional and/or post-traductional level. These data reinforced the
knowledge on vitamin C effect on DEJ formation and bring new insights on the potential
use of such molecule to improve or regenerate this zone.
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Hair Cycle-Dependent Expression of a Novel Component of the Hair Follicle-Dermis
Junction, Collagen XXII
K Tasanen, M Koch and L Bruckner-Tuderman
Oulu, Finland, and Freiburg and Cologne, Germany
Collagen XXII is a novel member of the FACIT protein family (fibril associated collagens with
interrupted triple helices), which was first identified by screening an EST database,
subsequently expressed as a recombinant protein and characterized as an authentic tissue
component and cell adhesion ligand. It has a uniquely restricted expression pattern at tissue
junctions in the skin, muscle, heart and articular cartilage. In the skin it is localized in the
basement membrane zone between the hair follicle and the dermis, but not below the
interfollicular epidermis. In both human and murine skin, collagen XXII is located in the lower
segment of the anagen hair follicle, between the outer root sheath keratinocytes and the
myofibroblast layer surrounding the lower follicle. Immunoelectron microscopy demonstrated
gold particles along the interdigitated basement membrane. Intriguingly, the expression of
collagen XXII is hair cycle-dependent. During the first hair cycle of newborn mice and during
synchronized hair cycles, the expression was strongest during anagen growth phase on day
1–12, then slowly diminished during the catagen phase and became negative in the telogen
phase by day 18–22. In vitro collagen XXII is synthesized by HaCaT keratinocytes and smooth
muscle cells, as assessed by RT-PCR analysis and immunofluorescence staining. This sug-
gests that both the epithelial and mesenchymal tissue compartments contribute to collagen
XXII synthesis in the skin. Taken together, the restricted expression in the transient regions of
the hair follicle basement membrane and the absence during the involution and resting stages
of hair cycles suggest that collagen XXII reflects and/or influences epithelial-mesenchymal
interactions during hair follicle morphogenesis and cycling.
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Collagenase-3 in Fibroblast-mediated Collagen Matrix Remodelling
M Toriseva, R Ala-aho, A H Baker, V Marjoma¨ki, J Heino, and V-M Ka¨ha¨ri
Turku, Finland; Glasgow, Scotland, UK; Jyva¨skyla¨, Finland
Collagenase-3 (MMP-13) is a matrix metalloproteinase (MMP), which is not present in normal
adult human skin wounds but is expressed by fibroblasts in non-scarring adult gingival and
fetal skin wounds. We have studied the role of MMP-13 and tissue inhibitors of MMPs (TIMPs)
in fibroblast-mediated contraction and remodelling of collagen matrix, a process that takes
place during acute wound healing in skin.
We have used adenovirus-mediated gene delivery of MMP-13, TIMP-1 and TIMP-2 to
human adult skin fibroblasts and studied their contraction capacity and morphology in
floating 3D collagen lattice.
Adenoviral expression of human MMP-13 increased the collagen contraction capacity of
dermal fibroblasts by 60% when compared to control virus infected cells. The contraction
was partly inhibited by adenoviral co-expression of TIMP-1 and TIMP-2. Addition of human
recombinant MMP-13 also induced collagen contraction by dermal fibroblasts. Adenoviral
expression of MMP-13 caused fibroblasts to form shorter but more complex actin-containing
cell extensions than the control cells in 3D collagen. The results suggest that MMP-13
induces the reorganization of collagen by fibroblasts. The inhibitory effect of TIMP-1 and -2
on MMP-13 induced collagen contraction and the changes in actin cytoskeleton of fibroblasts
expressing MMP-13 suggest that partial degradation of collagen and probably enhanced
interaction between fibroblasts and collagen are involved in the process. We conclude that
MMP-13 may also in vivo enhance wound contraction and even promote scarless healing of
adult gingival and fetal skin wounds by enhancing matrix remodelling.
091 [Oral 008]
Tenascin-X: An organizer or stabilizer of the extracellular matrix?
D F Egging, J Schalkwijk, M C Zweers
Nijmegen, The Netherlands
Tenascin-X (TNX) is a large 450 kDa extracellular matrix (ECM) protein. All members of the
tenascin family have a similar domain structure consisting of multiple EGF-like and fibronectin
III (FNIII) repeats and a C-terminal fibrinogen-like domain. TNX deficiency leads to a recessive
form of Ehlers-Danlos syndrome (EDS), characterised by hyperextensible skin and joint
hypermobility. In this study we have investigated skin biopsies of these patients to elucidate
possible alterations in their connective tissue. In addition we have started to map possible
interaction sites of TNX with other ECM components. We show that TNX deficient patients
have abnormal elastic fibers and reduced collagen content in the dermis. The coarse elastic
fibers of the reticular dermis appeared clumped and fragmented, while the fine elastic fibers
of the papillary dermis are less branched and reduced in number and size compared to
healthy individuals. At the ultrastructural level immature and irregularly shaped elastin fibers,
some devoid of microfibrils, were observed. This indicates an important role for TNX in the
organization or stabilization of the ECM. Using a solid-phase assay, we show that a 100 kDa
C-terminal part of TNX, encompassing the last six FNIII repeats and the fibrinogen-like
domain, binds to collagen type I and tropoelastin. Recombinantly expressed TNX fibrinogen-
like domain shows binding to tropoelastin but fails to show binding to collagen type I. This
suggests that the collagen binding site is located within the FNIII domains.
It remains to be investigated whether the interaction of TNX with other ECM molecules is
involved in the initial assembly of ECM structures or serves as a factor in maintenance and
turnover.
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Novel Glycine Substitutions in the Largest Collagenous Domain Col15 Decrease the
Thermal Stability of Collagen XVII
L Va¨isa¨nen, C Has, T Hurskainen, L Bruckner-Tuderman and K Tasanen
Oulu, Finland and Freiburg Germany
Collagen XVII is a hemidesmosomal transmembrane component with a globular cytoplasmic
domain and a large extracellular domain with interrupted collagenous subdomains. Mutations
in COL17A1 gene lead to junctional epidermolysis bullosa, a heritable disorder with features
of skin fragility, abnormal hemidesmosomes and diminished epidermal adhesion. Most
COL17A1 mutations described lead to premature termination codon and cause absence
of collagen XVII in the skin. In contrast, missense mutations or deletions of collagen XVII
are more rare and the genotype-phenotype correlations of these mutations are poorly
understood.
Here we report two novel glycine substitution mutations, G609D and G612R, which are
located in the largest collagenous domain, Col15, of collagen XVII. The effects of the
mutations on the triple-helical structure and function of collagen XVII were analyzed by
generating mutations in an expression vector coding for full-length collagen XVII using site-
directed mutagenesis. The mutated collagens were expressed by transfection in COS-7 cells
and their thermal stability was assessed using trypsin digestions at increasing temperatures
as a probe. Both glycine substitutions G609D and G612R destabilised significantly the
ectodomain of collagen XVII which manifested as about 161C lower Tm (the midpoint of the
helix-to-coil transition) in the trypsin assay. This is comparable to effects of two other,
previously published mutations, G627V and G633D, which decreased the Tm of the
ectodomain by 201C. Thus glycine substitution mutations of Col15 domain interfere with the
proper tight folding of the triple-helix and render the ectodomain of collagen XVII sensitive to
non-specific degradation.
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Contact of High-Invasive but not Low-Invasive Melanoma Cells to Collagen I Induces
Increased Release of Pro- and Mature Cathepsin B
A Klose1, A Wilbrand-Hennes1, G van Muijen2, T Krieg1, C Mauch1, N Hunzelmann1
1University of Cologne, Department of Dermatology, Cologne, Germany 2UMC St. Radboud,
Department of Pathology, Nijmegen, The Netherlands
The expression of the lysosomal cysteine protease cathepsin B in malignant tumors is highly
upregulated and the localization of the protease is altered. In addition to its localization in
perinuclear vesicles, previous studies indicate that cathepsin B is also secreted and becomes
associated with the cell surface. Tumor cells secrete procathepsin B and both active forms of
cathepsin B, but yet the mechanisms underlying these processes are not well understood.
Therefore, we investigated to which extent the interaction of tumor cells with the extracellular
matrix component, collagen type I, regulates the expression and especially the release of
cathepsin B. Four melanoma cell lines (MV3, SkMel28, SkMel23, WM164) differing in their
invasiveness were cultured for 48h either as monolayers or in 3D collagen I lattices. After a
24h serum-free incubation period the supernatants were analyzed via immunoblotting. Low-
invasive cells (SkMel23 and WM164) showed no remarkable release of cathepsin B, even
after they were seeded into collagen I lattices. SkMel28 cells (intermediate-invasive) released
both active forms of the protease after contact to collagen I. Cultured as monolayers, only the
high-invasive MV3 cells constitutively released procathepsin B. Due to cell-collagen I
interaction the amount of released proform was strongly increased and the release of both
active forms was induced. Furthermore, we could assess the proteolytic activity of released
cathepsin B by the use of our recently described technique of gelatine zymography under
acidic conditions. The zymogramms also demonstrated that the melanoma cell lines release
in addition other active lysosomal cysteine proteases, but to a lesser amount when compared
to cathepsin B. Based on these results we propose, that release of mature cathepsin B is
non-selective and a consequence of lysosomal exocytosis induced by the interaction of
invasive melanoma cells with collagen I. Increased release of procathepsin B is exclusively
observed in high-invasive cells and might be due to alterations in normal trafficking pathways
enhancing their invasive capacities in the extracellular matrix.
094
Induction of Lysyl Hydroxylase 2 and Formation of Skeletal Type Collagen Cross-links in
the Skin of Systemic Scleroderma Patients: a Potential Role for Interleukin-4?
J Brinckmann, S Kim, J Wu, DP Reinhardt#, H Notbohm#, RA Bank’, T Krieg , N
Hunzelmann
Department of Dermatology, #Department of Medical Molecular Biology, University of
Lu¨beck, Department of Dermatology, University of Cologne, Germany, ’TNO Prevention
and Health, Gaubius Laboratory, Leiden, The Netherlands
Sclerotic skin diseases like lipodermatosclerosis or keloids are characterized by substantial
changes in the mode of cross-linking of collagen molecules. This process leads to an
accumulation of hydroxylysine-derived cross-links in the skin which are typical for skeletal
tissues. In the present study, we analyzed the crosslink pattern and the transcriptional activity
of collagen modifying enzymes in systemic scleroderma. Furthermore, we determined the
modulatory impact of interleukin 4, which has been implicated in the pathogenesis of
systemic scleroderma, on the profile of cross-links.
The concentrations of hydroxylysine-derived collagen cross-links were significantly
increased in systemic scleroderma. However, the concentrations of lysine-derived cross-
links were not changed. Accordingly, a marked increase of the transcriptional level of lysyl
hydroxylase 2 was found, while the gene expression of lysyl oxidase, lysyl hydroxylase 1 were
unchanged. In long-term dermal fibroblast cultures, interleukin-4 induced an increase of
hydroxylysinederived collagen cross-links and of the gene expression of lysyl hydroxylase 2.
The cross-link pattern of collagen in systemic scleroderma is characterized by an increase
in hydroxylysine-derived cross-links, which are typical for skleletal tissues. This change in
cross-link pattern appears to be due to an increase in the transcriptional activity for lysyl
hydroxylase 2, and can be induced in cell culture by interleukin-4.
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Expression of Transforming Growth Factors b and their Receptors in Keloid and
Hypertrophic Scarring
O Bock1, H Yu2, S Zitron2, A Bayat3, MWJ Ferguson3, U Mrowietz2
1Primary Health Care Center, Jo¨nko¨ping, Sweden; 2Department of Dermatology, University
of Kiel, Kiel, Germany and 3School of Biological Sciences, University of Manchester,
Manchester, UK
Keloids are benign skin tumors occurring during wound healing in genetically predisposed
patients. They are characterized by an abnormal deposition of extracellular matrix com-
ponents, in particular collagen. There is evidence that transforming growth factor-beta (TGFb)
is involved in keloid formation. It is unclear how TGFb signalling is connected to the
pathogenesis of keloids. Therefore we investigated the expression of TGFb1, 2 and 3 and
their receptors in keloids, hypertrophic scars and normal skin.
Dermal fibroblasts were obtained from punch-biopsies of patients with keloids,
hypertrophic scars and normal skin of healthy individuals. Total mRNA was isolated and
the expression of TGFb1, 2 and 3 and of TGFb receptors I and II (TGFbRI and II) was analysed
by real-time PCR using the Lightcycler technique. Biopsies of keloids, hypertrophic scars and
normal skin were used for immunohistochemistry staining with antibodies against TGFb1, 2
and 3 and TGFbRI and II.
Our data demonstrate significantly higher TGFb2 mRNA expression in keloid fibroblasts as
compared to fibroblasts derived from hypertrophic scars (po0.05). By contrast, significantly
lower TGFb3 mRNA expression was found in keloid fibroblasts in comparison to hypertrophic
scar derived fibroblasts (po0.01). TGFbRI mRNA expression was significantly decreased in
hypertrophic scar fibroblasts (po0.01) and TGFbRII mRNA expression was decreased in
keloids compared to normal fibroblasts (po0.001). The ratio of TGFbRI/TGFbRII expression
was decreased in keloid fibroblasts. As recently supposed a decreased TGFbRI/ TGFbRII
ratio could promote fibrosis.
Therefore our data support a possible role of TGFbRI and TGFbRII as fibrosis inducing
factors in keloids.
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Tretinoin Pre-Treatment but not Direct Treatment Shows a Beneﬁcial Effect on Wound
Healing in Diabetic Mice
W Hans, U Ghermai, A Gosslar, M Bittner, A Fu¨rst, K Jacob, S Mestermann, A Goppelt
SWITCH Biotech AG, Neuried, Germany
There is circumstantial evidence that topical pre-treatment with tretinoin (all-trans retinoic
acid) might improve the healing of human ulcers. Especially in diabetic patients with long
lasting ulcers the delayed healing process is a persistent problem. We investigated and
compared the effect of tretinoin pre-treatment and direct treatment on impaired wounds in
genetically diabetic mice. Wounds of db/db mice are display delayed wound healing due to
lessened wound contraction and delayed granulation tissue formation.
In first experiments, mice were pre-treated with tretinoin for 5 consecutive days and after
a 2 day pause incisional wounds were made on the back of the mice. The tretinoin treated
skin of the mice showed severe signs of irritation such as redness and intense scaling. A
significant increase in the tensile strength of the tretinoin treated animals compared to the
vehicle treated ones was observed 5 days after wounding. Furthermore, positive effects on
skin thickness, wound contraction and collagen density were detected upon histological
examination.
In further experiments the direct treatment of incisional wounds with tretinoin was
examined. Treatment with tretinoin started the same day as wound setting and was continued
for 5 consecutive days. Tensile strength was measured on day 7 and day 10 after wounding.
In contrast to the results obtained with tretinoin pre-treatment, a decrease of tensile strength
in the tretinoin treated animals was observed in the direct treatment of existing wounds.
The differing results of the two treatments are assumed 1) to be due to the irritation caused
by the retinoid that counteracts the beneficial effect of tretinoin and 2) to be the result of
treatment kinetics: when treatment and wounding start at the same time, positive effects, like
thickening of skin, increase of collagen and wound contraction, set in too late to be beneficial
in this wound healing model.
In conclusion, the incisional wound healing model with pre-treatment of the skin of db/db
mice can be used to investigate the effects on tensile strength of retinoids and their
derivatives, of which those lacking the extremely irritating properties of tretinoin would be the
most promising drug candidates for ulcers that are often observed in diabetic patients.
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Pathological Scar Cells Fail To Undergo a Form of Apoptosis Speciﬁcally Induced During
Collagen Gel Contraction – Role of Tissue Transglutaminase Activity
C Linge, C Vigor, J Richardson, B Hardas, C Panchal, K Rolfe and R Sanders
The RAFT Institute of Plastic Surgery, Mount Vernon Hospital, Middlesex, UK
Keloid and hypertrophic scarring are severe excessive scars that commonly arise during
cutaneous wound healing. The exact aetiology is unknown. These pathological scars are
characterised by excess collagen and prolonged presence of myofibroblasts. Normally,
towards the end of the fibroproliferative phase myofibroblasts disappear via apoptosis. A
failure of pathological scar cells to undergo this process may well underlie their pathology.
Published studies that examine this possibility give contradictory findings, however, the
methodologies used had little relevance to the wound-healing context. The normal trigger for
this ‘‘switching off’’ process is unknown, however recently, Fluck et al described a potential
role for fibrillar collagen in the regulation of apoptosis; where dermal fibroblasts seeded into
contractile but not anchored collagen gels underwent apoptosis. We therefore hypothesised
that pathological scar cells fail to undergo this specific form of wound-healing-related
apoptosis. Fibroblasts derived from normal scar (n¼8), hypertrophic scar (n¼6) and keloids
(n¼ 6) were placed into 3D-collagen (type I) gels and maintained anchored or allowed to
contract the gels, and apoptosis was assayed. Although normal scar cells underwent
significant (po0.001) apoptosis (40–50%) after 3 days, all pathological scar cells failed to
undergo apoptosis under these circumstances. Furthermore this phenomenon was found to
be specific since pathological scar cells could be induced to undergo apoptosis by multiple
other modalities. We further hypothesised that this phenomenon might be due to the matrix
of pathological scar being refractive to enzymatic breakdown, since chronic fibrotic tissue
is excessively crosslinked and hypertrophic scars overexpress tissue transglutaminase
(tTgase), an enzyme that stabilises new ECM. We therefore manipulated tTgase activity in
cell-containing collagen gels using putrescine to inhibit endogenous enzyme activity or the
addition of exogenous tTgase to increase activity, and found that tTgase inhibition in HTS
cells normalises their behaviour of collagen contraction-induced apoptosis. Whereas, treat-
ment of collagen gels with exogenous transglutaminase completely abrogates collagen-
contraction-induced apoptosis of normal scar cells.
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Passive Transfer of Human Extracellular Matrix Protein 1 Autoantibodies From Lichen
Sclerosus Sera Into Neonatal Mice
N Oyama, Y Kawakami, I Chan, IP South, MM Black, F Kaneko, JA McGrath
Dept of Dermatology, Fukushima Medical Univ, Japan and KCL, United Kingdom
The precise immunopathological basis of lichen sclerosus (LS) is not known. However, we
have demonstrated presence of IgG autoantibodies to the glycoprotein ECM1 in 75% of
LS sera. Moreover, antibody titre, as determined by ELISA, correlates to some extent with
disease severity and duration. Despite these findings, there are currently no data about the
possible pathogenic relevance of these anti-ECM1 antibodies. In this study, we performed
passive transfer experiments using affinity-purified IgG from LS sera (n¼ 6). Individual mice
ears were injected intradermally every 4 days for up to 28 days, either with anti-ECM1
antibodies or with non-immune human IgG as controls. Biopsies were taken at different time
points up to 28 days. In the anti-ECM1 antibody-injected sites distinct histological changes
were evident from 14 days onwards. These comprised oedema, epidermal acanthosis,
dilated dermal blood vessels, and interstitial and perivascular chronic inflammatory infiltrates.
These dermatopathological abnormalities were not present in control injected ear skin. IF
labelling with FITC-conjugated anti-human IgG showed positive staining in the lower mouse
epidermis and around blood vessels, i.e. at sites corresponding to the known distribution of
ECM1 in mouse and human skin. Thus, although the passive transfer of human anti-ECM1
IgG antibodies did not fully recapitulate the LS histopathology (e.g. no hyalinosis) within the
time-frame studied, we were able to show that this human IgG can access native ECM1 in
vivo. In short, this study provides the first direct evidence for the possible role of humoral
autoimmunity to ECM1 contributing to the disease process/mechanism underlying LS.
A16 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
099 [Oral 065]
Elucidation of the Antiﬁbrogenic Effector Mechanisms of Alpha-Melanocyte-Stimulating
Hormone
M Bo¨hm, I Wolff and T A Luger
Department of Dermatology and Ludwig Boltzmann Institute for Cell Biology and
Immunobiology of the Skin, University of Mu¨nster, Mu¨nster, Germany
Melanocortins elicit a plethora of biological effects on skin cells including pigmentation,
immunomodulation, modulation of oxidative stress, and lipogenesis. We recently reported
that human dermal fibroblasts express functional receptors for alpha-melanocyte-stimulating
hormone (alpha-MSH). Application of alpha-MSH suppressed the fibrogenic effect of trans-
forming growth factor-beta1 (TGF-beta1) on collagen synthesis in vitro and in vivo (Bo¨hm
et al, J. Biol. Chem. 2004). In contrast to artificial cAMP inducers which antagonize the effect
of TGF-beta1 in rat fibroblasts by suppressing collagen synthesis at the transcriptional level,
alpha-MSH in human dermal fibroblast does not act in an analogous manner. TGF-beta1-
induced nuclear translocation of smad2/3 is unaffected by alpha-MSH and alpha-MSH does
not affect ligand-induced smad2 phoshorylation in these cells. In addition, time-kinetic
studies on smad7 using real-time PCR failed to demonstrate any modulatory effect of alpha-
MSH on this anti-smad member. As demonstrated by high-density oligonucleotide arrays
using Affymetrix HuGeneFL gene chips and validation by real-time PCR analysis, alpha-MSH,
however, modulated the expression of a number of effector/target molecules involved in
fibrogenesis including members of the matrix metalloproteinase family (i.e., MMP1, MMP19)
growth factors (e.g. basic fibroblast growth factor) or intracellular signalling mediators (e.g.
inducible nitric oxide synthase). Taken together, our data show that alpha-MSH does not
affect TGF-beta1-induced smad signalling in human dermal fibroblasts being consistent with
its previously reported lack of any effect on collagen type I transcription. In contrast, alpha-
MSH may elicit its antifibrogenic effects by targeting other effector/target molecules of TGF-
beta1, some of which are crucially involved in degradation of collagen.
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(-)-Muscone and Saffron Extract Selectively Regulate Hyaluronan Synthesis at the MRNA
Level in Human Skin Cells
H Yoshida, T Sayo, A Kusaka, M Furukawa, M Okui, R Komaki, S Inoue
Basic Research Laboratory, Cosmetic Laboratory, Kanebo Cosmetics INC., Odawara,
Japan
Hyaluronan (HA), a high-molecular-weight linear glycosaminoglycan, is well known for its
ability to hold water and maintain the extracellular space. The HA content in the skin is
reported to decline with age, possibly contributing to wrinkle formation and the decreased
elasticity of aging skin. Among the family of HA synthase genes (HAS 1, 2, 3) so far identified,
our group has demonstrated that the expressions of HAS2 and HAS3 play crucial roles in the
regulation of HA synthesis in human skin fibroblasts and keratinocytes, respectively, but
the precise regulatory mechanisms are still unknown. In the present study, we discovered that
two novel regulators, (-)-muscone and saffron extract, selectively regulate the HAS gene
expressions in human skin cells.
(-)-Muscone, a major odoriferous constituent of natural musk, up-regulates HA synthesis in
cultured human skin fibroblasts specifically and dose-dependently, but it exerts no such
effect in cultured human keratinocytes. Saffron extract, the extract of the dry stigmas of the
plant Crocus sativus, dose-dependently enhanced HA synthesis in both keratinocytes and
fibroblasts, though to a smaller degree in the latter. In Northen blot analysis, (-)-muscone
and saffron extract induced the expressions of HAS2 and HAS3 mRNAs in fibroblasts and
keratinocytes immediately after the stimulation, respectively. It thus appears that both (-)-
muscone and saffron extract control HA synthesis at a transcriptional level but do so via
different mechanisms, the former exerting an effect for HAS2 expression in fibroblasts, the
latter exerting an effect specific for HAS3 expression in keratinocytes.
In previous studies, we demonstrated that TGF-b1 up-regulates HA synthesis in fibroblasts
by inducing the expression of HAS mRNAs, generally HAS2 mRNA1). For this reason, we
hypothesized that the regulation of HAS2 expression by (-)-muscone might involve a TGF-b
signaling pathway. To elucidate this possibility, we investigated the effect of (-)-muscone
on collagen synthesis upregulated by TGF-b1 in fibroblasts. Failing to find any increase
in collagen production in response to the (-)-muscone stimulation, we speculated that
(-)-muscone might control the HA synthesis via a mechanism unrelated to that of TGF-b1.
On the other hand, the active ingredients of saffron extract are now under investigation.
Further study focusing on the controls of HAS2 expression by (-)-muscone in fibroblasts
and HAS3 expression by saffron extract in keratinocytes may lead to the discovery of a new
system for the regulation of HA synthesis in human skin fibroblasts.
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Isometric Tensile Forces Stimulation of Human Dermal Fibroblasts by Hydroxyprolin
Rich Glycoproteins Extract
M Dumas1, C Viennet2, T Zuliani1, C Gondran1, F Bonte´1, P Humbert2
1LVMH Recherche, Saint Jean de Braye, France 2Laboratoire d’Inge´nierie et de Biologie
Cutane´e, EA 3183, UFR Me´decine-Pharmacie, Besanc¸on, France
Myofibroblasts (MF), a specific phenotype of human dermal fibroblasts have the ability to
develop tensile strengths inside the dermal extracellular matrix due to a well-developed
cytoplasmic microfilament network particularly rich in a-smooth muscle actin (a-SMA).
Dermal Internal tension forces have been previously shown to influence the texture of skin
tissues. The present work investigates the effects of an hydroxyproline rich hydrolyzed soy
flour extract (SF) treatment on (i) isometric tensile strengths developed by dermal equivalents
(DE) and (ii) human fibroblast differentiation into myofibroblasts. DE composed of human
dermal fibroblasts and type I collagen were placed in the GlaSboxs registration chamber
allowing measurement of isometric forces. On SF treated DE, isometric tensile forces
increased in a dose dependent manner from 2000 mN (control) to 3000 mN and 4000 mN with
0.75 mg/ml and 1.5 mg/ml SF respectively. In the same time, TGF-b1 (2.5 ng/ml), a potent
inducer of MF phenotype also stimulated the tensile strength to 5000 mN.
In order to confirm the role of MF in the stimulation of isometric tensile forces, DE were
immunostained for a-SMA and an increase in a-SMA positive fibroblasts in SF and TGF-b1
treated DE was shown. In addition, SF treated human dermal fibroblasts monolayer cultures
revealed a strong dose dependant increase in a-SMA up to 1.75 times at SF 1.5 mg/ml. These
results demonstrate that the stimulation of the isometric tensile strengths of dermal
equivalent by an hydrolyzed soy flour extract is mediated by myofibroblasts and that this
extract may be proposed to reinforce dermal mechanobiological properties and matrix
remodelling.
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A First Missense Mutation in the Type II Hair Keratin hHb3 is Associated with Monilethrix
M van Geel, P M Steijlen, R S Bladergroen, M A M van Steensel
Department of Dermatology, University Hospital Maastricht, Maastricht, The Netherlands
Monilethrix is an autosomal dominant disorder characterized by periodic beading of hair
shafts and pronounced hair fragility leading to hair loss and eventual scarring alopecia.
Several familial cases of monilethrix were previously shown to be caused by mutations in the
basic (type II) hair keratins hHb1 and hHb6. In the related type II hair keratin family member
hHb3, disease-causing mutations have so far not been described. Here we report a first
heterozygous missense mutation associated with monilethrix in exon 7 of hHb3 leading to the
substitution of a glutamic acid by a lysine (E407K). The hHB3 mutation is located in the keratin
helix termination motif, which is a mutational hotspot in hHb1 and hHb6. In two other patients
with a typical monilethrix phenotype, one was associated with a known mutation in hHb6
(E402K) while no mutations in hHb1, hHb3 or hHb6 were found in the other patient.
Our findings show for the first time that besides hHb1 and hHB6, also hHB3 is associated
with monilethrix. In addition, one of our patients indicates genetic heterogeneity in monilethrix,
which confirms previous data from other studies.
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A Compound Heterozygous Mutation in VEGFR3 Does Not Cause a More Severe Form of
Nonne-Milroy Lymphedema
V L R M Verstraeten, M A M van Steensel, J C J M Veraart, R S Bladergroen, P M Steijlen,
M van Geel
Department of Dermatology, University Hospital Maastricht, Maastricht, The Netherlands
Nonne-Milroy lymphedema or congenital hereditary lymphedema I (MIM #153100) is a
chronic progressive, disfiguring and often disabling swelling of the extremities caused by
dysfunction of the lymphatic system. Mutations in the FLT4 gene that codes for vascular
endothelial growth factor receptor 3 (VEGFR3) cause this autosomal dominant form of
hereditary lymphedema. VEGFR3 and its ligands VEGF-C and VEGF-D are important for the
formation of the lymphatic system. Almost all mutations found so far have been heterozygous
missense mutations affecting the VEGFR3 tyrosine kinase domains. A genotype-phenotype
correlation has not been established, as the phenotype is highly variable.
We report a family with two affected siblings, a two-year-old boy and his eleven-year-old
sister. Both children are related by their mother, having different fathers. All parents are
clinically unaffected. Examination of the daughter showed a bilateral lymphedema of the
lower limbs and feet, next to insufficiency of the saphenofemoral crosse and the greater
saphenous vein on both sides, accompanied by prominent phlebectasias on the medial side
of the legs. The son is less severely affected than his older sister, having a unilateral
lymphedema of the left lower limb and foot. A diagnosis of Nonne-Milroy disease was made.
We screened both affected individuals for VEGFR3 mutations. In both siblings we identified
a known nucleotide change (2797 G4C) leading to a G933R substitution. The mutation was
inherited from the mother. The son inherited an additional nucleotide change from his father
(3145 G4A) leading to a D1049N substitution. Each mutation affects one of the two tyrosine
kinase domains, the catalytic part of the receptor.
It is striking that the phenotype of the compound heterozygote mutation is less severe than
the one caused by the G933R substitution alone. It is known that the G933R mutation has a
variable penetrance. One possibility might be that the D1049N mutation interferes with the
effect of the G933R substitution. Since primary lymphedema is a progressive disease,
difference in phenotype could also be an age-related effect. However, when she was her
brother’s age, the sister was more severely affected than he is now.
Here, we show that compound heterozygous missense mutations are not associated with a
more severe phenotype. Hence, the phenotype of Nonne-Milroy disease may be influenced
by genetic background rather than by specific mutations.
To our knowledge, this is the first case of a compound heterozygote mutation in VEGFR3
causing primary congenital lymphedema. Insufficiency of the saphenofemoral crosse and
greater saphenous vein due to a VEGFR3 mutation has never been described before. From
this and other reports, VEGFR3 seems to be involved in venous patterning as well.
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Hereditary Angioedema in Consequence of a 150 bp Deletion in the 30UTR of C1-inhibitor
Gene
M Laimer, A Klausegger, W Aberer, V Wally, CM Lanschuetzer, H Hintner, JW Bauer
Department of Dermatology, General Hospital Salzburg and Department of Dermatology,
University of Graz
30 untranslated regions (30UTRs) are of great importance in the regulation of gene expression.
Situated between the termination codon of a gene and it’s poly-A-tail, specific sequences
modulate cleavage of the transcript by endonucleases influencing translation, transport and
stability of the transcript. Furthermore it contains binding regions for a number of trans-acting
proteins possessing translation enhancing functions. Rarely, the significance of these cis-and
trans-acting factors has been demonstrated in pathophysiological models.
We report on a family suffering from hereditary angioedema, of which three members
(mother, son and daughter) were analyzed for alterations in the C1-inhibitor (C1-INH) gene.
Hereditary angioedema (HAE) is a autosomal dominant inherited disease, characterized by
angioedema of face and extremities, as well as episodes of abdominal pain and oedemas of
the laryneal mucosae. Reduced levels of functional C1-inhibitor protein due to mutations
leading to a quantitative reduction of the protein or the synthesis of dysfunctional molecules
can be found as the cause. All exons of the C1-INH gene were analyzed by means of
polymerase chain reaction (PCR) and subsequent sequence analysis, revealing a hetero-
zygous 155bp deletion located in the 30UTR, 100bp downstream of the termination codon in
exon 8. No other mutations could be detected in the coding region of the gene. Expression
analysis at the cDNA-level revealed a clear reduction of C1-INH cDNA. The mutation was not
found in 30 control cDNA’s. Reduced protein levels of C1-INH protein and C4 was
demonstrated in all three patients. Therefore a correlation between the deletion in the 30UTR
and the expression level of the C1-INH mRNA respectively can be assumed, leading to
haploinsufficiency of the respective enzyme levels. This deletion constitutes the largest
deletion in the 30UTR of a gene leading to pathological condition.
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Identiﬁcation and Expression of Two Novel Splice Variants of Human p38a
ZH Wu and JM Schroeder
Kiel, Germany
The p38a gene plays an important role in regulating the development and proliferation of cells
and in response to disease and tissue injury. Four alternatively spliced transcript variants of
this gene encoding distinct isoforms have been reported. We hypothesised that this gene
should have more splice variants which are differentially expressed in response to
environmental stress and proinflammatory cytokines. Here we report the identification and
partial characterization of two novel splice variants of p38a, namely p38a-v5 and p38a-v6, by
RACE-PCR using mRNA derived from foreskin-derived human primary keratinocytes.
Comparative analysis of intron/exon organization of all the six p38a variants revealed that
the two novel variants each contains a different exon 1 which is located within the intron 1 of
p38a. The distinct transcriptional starting sites (TSSs), resulting from the distinct exon 1
among p38a-v5, p38a-v6 and the other four known isoforms, suggest that the p38a gene has
at least three distinct promoter regions in response to different stresses. The full-length cDNA
of p38a-v5 is the same as that of MAPK14 transcript variant 2 (or CSBP2) except for its exon
1 and contains an open reading frame of 849 bp encoding a N-terminus-truncated CSBP2 of
283 amino acids. The full-length cDNA of p38a-v6 contains an open reading frame of 1005 bp
which is predicted to encode an 335-amino-acid isoform that has a different N-terminus as
compared to CSBP2. RT-PCR indicated that they showed different tissue distribution unlike
the ubiquitous expression of p38a within the tested 18 human tissue samples. Both of p38a-
v5 and p38a-v6 are expressed in the spleen, thymus, small intestine, bone marrow, stomach,
lung skin, and bronchial epithelial cells but not in the tonsil, tongue, polyp, salivary gland, or
nasal epithelial cells. However, in contrast to p38a-v6, p38a-v5 is also expressed in the
neutrophils, colon and uterus whereas but p38a-v6 is in the adenoid and tracheal epithelial
cells. Real-time RT-PCR revealed that there are only low expression changes observed in the
tissues mentioned above as well as in cultured human primary keratinocytes stimulated with
TNFa, IL-1b, H2O2, phorbol–myristate-acetate, P. aeruginosa culture supernatants, and
MAPK inhibitors SP600125, SB202190 or PD98059. These results indicate that relatively
parallel expression level among p38a-v5, p38a-v6 and the other four variants are crucial in a
specific tissue. This is the first report on the identification of two novel splice variants of p38a
and the demonstration that the p38a gene exists with different TSSs. Our findings may help to
elucidate in more detail its protein function and imply that it can be regulated through its
transcription induction in addition to its protein activation by the MKKK-MKK-MAPK
phosphorylation module or TAB1-mediated autophosphorylation.
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Identiﬁcation of 900 Genes Expressed by the Human Granular Keratinocyte
E Toulza, F Galliano, G Serre and M Guerrin
Toulouse, France
Investigation of the late transcriptionnal events taking place in the course of epidermis
terminal differentiation is critical to comprehension of cornification and barrier function. Trans-
criptome analysis of granular keratinocytes is a first step towards such goals. We isolated four
cell populations, from basal to the most superficial epidermal layers, by repeated trypsin
incubations of human epidermis fragments. The analysis of KRT14 (specifically expressed in
the basal layer) and SCCE (specifically expressed in the granular layer) mRNAs by quantitative
RT-PCR in each cell batch confirmed the progressive enrichment in granular keratinocytes.
Starting with cell batch corresponding to the most superficial layers we obtained 2000 high-
quality Open Reading Frame EST (ORESTE) and clustered them with public sequences to
produce an index of approximately 900 genes that includes 100 genes encoding hypothetical
proteins. Analysis of gene expression levels by EST frequency identifies genes that
characterize squamous differentiation thus providing potential markers as well as clues to
the functional features of cornification.
A complete analysis of expression of this set of genes in the course of epidermis
differentiation will allow us to distinguish the genes expressed in all epidermis layers that might
correspond to house keeping genes, from the late expressed genes that are likely to encode
proteins candidate for being involved in barrier function. The EST recovered in this work will
provide a comprehensive resource for genes functioning in establishment of the epidermis
barrier function.
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Functional Characterization of PRINS, a Newly Identiﬁed Psoriasis Susceptibility Related,
Stress-Induced Non-Coding RNA Gene
M Sze´ll1, E Sonkoly2, Z Bata-Cso¨rgo1,2, A Pivarcsi1, L Keme´ny1,2, A Dobozy1,2
1Dermatological Research Group of the Hungarian Academy of Sciences, University of
Szeged, Hungary 2Department of Dermatology and Allergology, University of Szeged,
Hungary
In order to identify transcriptional level differences between psoriatic non-involved and
healthy epidermis contributing to psoriasis susceptibility, differential display experiments
were carried out. One of the identified transcripts that showed elevated expression in
psoriatic non-involved epidermis had 100% homology to a cDNA sequenced from a human
10-week-old foetal cDNA library, with GeneBank Acc. No. AK022045. This gene is localised
on chromosome 10, harbours two Sq subtype Alu elements and in silico translation resulted in
no translatable protein product on its nucleotide sequence. Using either the pol II inhibitor, a-
amanitin or the specific pol III inhibitor, tagetitoxin, we have demonstrated that PRINS is an
RNA polymerase II transcribed gene. Because this gene harbours Sq subtype Alu elements,
that is characteristic of RNA genes induced by stress, we named the full-length cDNA PRINS
that stands for Psoriasis-susceptibility Related RNA Gene Induced by Stress. To study
whether PRINS expression was affected by different stress conditions, in vitro cultures of
HaCaT immortalised keratinocytes were subjected to various stresses and the expression
level changes of PRINS were measured by Q-RT-PCR. PRINS expression was induced by
the translational inhibitor cycloheximide, and by HSV-1 infection, also known to cause
translational inhibition. Upregulation by translational inhibitors is characteristic of genes
containing Alu elements (such as PRINS) and may be part of a general stress response. Co-
incubation with microbial compounds, such as lipopolysaccharide, tuberculin, peptidogly-
cane and Candida albicans resulted in elevated PRINS expression that peaked after 12 hours
incubation with each compound. UV-B irradiation of HaCaT keratinocytes increased the
expression of PRINS that also peaked 12 hours after the irradiation. Serum factors also
strictly regulate the expression of PRINS. RNA silencing experiments in HeLa cells revealed
that silencing of the PRINS gene expression affects the survival of the cells, indicating its
protective role in stress response.
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Differential Processing of Dominant Mutants Of Connexin 26 In Transgenic Mouse
Epidermis Is Associated With Distinct Phenotypes
G Bakirtzis1, T Aasen1, S Bryson2, S Forrow2, L Tetley3, ME Finbow4, J Kennedy1,
S Jamieson1, DA Greenhalgh1, MB Hodgins1
1Dermatology, Division of Cancer Sciences and Molecular Pathology, University of Glasgow;
2Beatson Institute for Cancer Research, Glasgow; 3Faculty of Biomedical and Life Sciences,
University of Glasgow, 4Department of Biomedical Sciences, Glasgow Caledonian University
An increasing body of evidence indicates that intercellular communication via gap junctions
plays an important role in regulation of epidermal differentiation and growth. Dominantly
acting mutations in genes encoding gap junction proteins, connexins (Cx) 26, 30, 31 and 30.3,
are associated with skin disease but underlying pathomechanisms remain unclear. While
Cx26(D66H) causes a severe palmoplantar keratoderma (Vohwinkel syndrome), Cx26 (del
42E) causes a milder form. To investigate the mechanisms of action, the two Cx26 mutants
were expressed in cultured keratinocytes and in the suprabasal epidermis of transgenic mice,
employing a K10 promoter. While Cx26(D66H) failed to traffic to the plasma membrane and
accumulated in the Golgi apparatus of cultured epithelial cells, Cx26(del 42E) trafficked
normally and formed large junction plaques at intercellular contacts, although these gap
junctions did not transport the tracer Lucifer yellow-CH. Similarly, when expressed in the
mouse epidermis, Cx26(D66H) accumulated in keratinocyte cytoplasm, while Cx26 (del 42E)
accumulated in plasma membranes, although overall abundance of the mutated connexins
appeared similar, as assessed by immunofluorescence staining. These differences in intra-
cellular distribution were associated with subtle differences in phenotype of the transgenic
mice. Commencing at postnatal day 4, K10-Cx26(D66H) mice showed a severe keratoderma
of trunk, tail and limbs, progressing on the tail to constriction rings which caused
autoamputation. In contrast, K10-Cx26(del 42E) mice showed no phenotype until postnatal
day 7, when a series of distinct kinks appeared in the tail; these persisted until about
postnatal day 14. The kinks were associated with bands of epidermal hyperkeratosis
restricted to the dorsal side of the tail. Thus it appears that Cx26(D66H), when expressed in
suprabasal keratinocytes causes a severe, widespread hyperkeratosis, while Cx26(del 42E),
which assembles into gap junction plaques, has a more subtle effect, manifest in transgenic
mice only by the disturbance of epidermal differentiation during the period of rapid tail
elongation. These new transgenic mice will provide useful models for detailed analysis of the
mechanisms underlying the phenotypic effects of different Cx26 mutants and whether these
mechanisms involve direct disturbance of the epidermal gap junction network or of other
properties of endogenous connexins. Particularly intriguing is the question of whether the tail
autoamputation caused by Cx26 (D66H) or the kinking caused by Cx26 (del 42E) are the
direct results of disrupted epidermal structure or are secondary to altered release of
epidermal factors which influence the growth of underlying connective tissue and bone.
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Transcriptional Responses to Conventional and Pegylated Interferon-alpha Inhibiting
Tumor Growth in a Human Melanoma SCID Mouse Xenotransplantation Model
C Krepler, U Certa, V Wacheck, K Wolff and H Pehamberger
Vienna, Austria and Basel, Switzerland
Interferon-alpha (IFN-a) is widely used for the treatment of viral infections and primary
cancers. In the present study we investigated whether the anti-proliferative activity of IFN-a is
capable of inhibiting melanoma tumor development in the absence of protective immune
responses in a SCID mouse model. Mice treated with either regular (100 mg/ 3 times per week)
or pegylated (300 mg/ once weekly) human IFN-a 2a showed a marked reduction in tumor
weight after 4 weeks of treatment. Tumor weight in pegylated and conventional IFN-a treated
animals was reduced by 61% and 67% respectively as compared to saline control (both
pp0.01). A decrease of proliferation and an increase of apoptotic tumor cells were observed
in IFN treated tumors.
DNA microarrays were applied to analyse transcriptional responses in tumors after 4 weeks
of treatment and a subset of about 90 genes was differentially expressed. 24 novel and 5
known interferon inducible genes were up- and 65 genes down-regulated.
A direct comparison of IFN-a and pegylated IFN-a did not reveal any significant differences
in tumor growth inhibition indicating that this novel and more stable class of IFN’s is
functionally equivalent. Despite the structural difference between pegylated and conventional
IFN-a both agents caused similar transcriptional responses in human melanoma xenotrans-
plants.
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UPAR Inhibition in Melanoma Cells by Small Interfering RNAs
R Besch, T Schuh, C Berking, C Kammerbauer, K Degitz
Department of Dermatology, Ludwig-Maximilian-University, Mu¨nchen, Germany
The plasminogen activator system affects invasion and metastasis of several cancer types. In
melanoma, the expression of the urokinase-type plasminogen activator (uPA) and its receptor
(uPAR) is increased in advanced stages and positively correlates with the invasive potential
of melanoma cells. Moreover, interference with uPA/uPAR expression or function reduces
invasion and/or metastasis in animal models of melanoma. For further characterization of the
role of the plasminogen activator system in melanoma, we have developed small interfering
RNAs (siRNAs) for uPAR as a molecular tool and as a potential anti-metastatic strategy.
Suitable siRNA target sequences were identified in the uPAR mRNA, and siRNAs were
designed. Effective transfection into the metastatic melanoma cell line 1205Lu was
established with an FITC-labeled siRNA and flow cytometry. Basal uPAR surface expression
as assessed by flow cytometry was reduced 24 h after transfection of uPAR siRNAs, where-
as sequence-controlled siRNAs had no effect. Additionally, PMA induction of uPAR was
prevented by siRNA resulting in a 75% reduction of uPAR expression compared to PMA-
induced cells treated with the control siRNA. The inhibitory effect was confirmed at the mRNA
level by quantitative RT-PCR showing up to 90% reduction of basal and 70% reduction of
PMA-induced uPAR mRNA expression. Taken together, we designed uPAR siRNAs that effect-
ively and specifically inhibit uPAR expression in a melanoma cell line. The siRNAs will be utilized
to further investigate the role of uPAR in melanoma invasion and metastasis and might lead to
the development of a new molecular therapy for melanoma.
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The 30 Untranslated Regions of the Two Alternative Type XVII Collagen mRNA Transcripts
Have Different Effects on Translation Efﬁciency
S van Zalen, A D van der Meer, A M Nijenhuis, M F Jonkman and H H Pas
Center for Blistering Diseases, Department of Dermatology, Groningen University Hospital,
The Netherlands
Type XVII collagen is a transmembrane component of the hemidesmosome coded for by the
COL17A1 gene. Transcription generates two alternative mRNA’s both with the full coding
sequence, but with different 30 untranslated regions (30UTR’s). The difference is a deletion
of 610 nucleotides, which results in a transcript of 5.8 kb and a smaller transcript of 5.2 kb.
The ratio of the two transcripts varies between different cells. While in normal human
keratinocytes and skin the larger 30UTR is dominantly present, it is the minor transcript in the
squamous cell carcinoma line UMSCC-22B. Compelling evidence suggests that 30 UTR
sequences might have various regulatory functions involving among other things translational
control and cell development. We have investigated whether the two different type XVII
collagen mRNA 30UTR’s have different effects on the translation efficiency of the preceding
coding sequence. Plasmids were constructed with the 30UTR’s cloned behind the firefly
luciferase coding sequence. These constructs were transfected in several cell lines and firefly
luciferase protein expression was measured by adding luciferase substrate, which results in a
stable luminescent signal. Renilla luciferase plasmids functioned as internal expression
markers. Luciferase expression appeared very low in cells transfected with the smaller 30UTR
in comparison with cells transfected with luciferase plasmids with the entire 30UTR. This
different effect on expression was the same irrespective if type XVII collagen positive or type
XVII collagen negative keratinocyte cell lines were transfected. These results suggest that the
type XVII collagen 30UTR’s are involved in translational control and that keratinocytes are able
to direct the type XVII collagen protein level.
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Genotype-Phenotype Correlation for Ectodermal Dysplasia Syndromes and the Tail of
p63
I Chan, S Kivirikko, þPN Kantaputra, ^ AD Irvine and JA McGrath
Genetic Skin Disease Group, St John’s Institute of Dermatology, London, UK; The Family
Federation of Finland, Helsinki, Finland; þDepartment of Pediatric Dentistry, Chiang Mai
University, Thailand and ^Our Lady’s Hospital for Sick Children, Dublin, Ireland
More than 170 different forms of ectodermal dysplasia (ED) have been described, many of
which remain a molecular mystery. However, some autosomal dominant ED syndromes have
been shown recently to result from mutations in the gene encoding the p63 transcription
factor. p63 is expressed in basal keratinocytes and in embryonic apical ectodermal ridge and
is believed to have a dual role in the development and maintenance of the epidermis. The tail
region of p63, encoded by exons 13 and 14 of the gene, contains a sterile alpha motif (SAM),
relevant to protein-protein interactions, and an inhibitory domain. Moreover, a small number
of mutations in this region have been shown to underlie ankyloblepharon, ectodermal
dysplasia, clefting (AEC) syndrome and Rapp-Hodgkin (RH) syndrome. In this study, we
assessed genotype-phenotype correlation by screening for p63 mutations in 12 subjects with
a clinical diagnosis of AEC syndrome and two with RH syndrome, all from unrelated families.
All AEC individuals had heterozygous missense mutations in the SAM domain. These
comprised: G505T, L514F, L518V, C522W, C522G, G530V, T533P, Q536L (twice), I537T (twice)
and L545P. In the two RH patients, one had a heterozygous missense mutation, S541P, while
the other had a heterozygous frameshift mutation, 1787delG, in exon 14. This frameshift leads
to a delayed termination codon, changing the reading frame of the last 46 amino acids and
extending the p63 tail by a further 68 amino acids. Clinically, AEC and RH syndromes share
many clinical features including cleft lip/palate, hypohidrosis, and a characteristic facies with
a narrow nose and a small mouth. An erosive scalp dermatitis and ankyloblepharon may
favour a diagnosis of AEC syndrome, but there appears to be a spectrum of clinical signs
common to both disorders. Moreover, this study shows that the clinical syndromes are
associated with overlapping p63 gene pathology. Most cases of AEC syndrome appear to
have missense mutations in the p63 tail and this also occurs in RH syndrome, although the
delayed termination codon may be a feature of RH syndrome. Clearly, genotype-phenotype
correlation will need to be extended in further patients, but these initial data suggest that
AEC and RH syndromes may well be the same clinical entity, sharing similar molecular
pathologies.
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Allele Variations in the OCA2 Gene (Pink-Eyed-Dilution Locus) are Associated with
Genetic Susceptibility to Melanoma
N Soufir1, AS Jannot2, R Meziani1, B Ge´rard1, V Descamps3, N Basset-Seguin4, C Lebbe4,
P Saiag5, F Clerget-Darpoux2, B Grandchamp1 and ‘‘Melan-Cohort’’
1Laboratoire de Biochimie Hormonale et Ge´ne´tique, Hoˆpital Bichat-Claude Bernard, Paris,
France, 2Unite´ d’Epide´miologie Ge´ne´tique INSERM 535, Hoˆpital Paul Brousse, Villejuif,
France, 3Service de Dermatologie, Hoˆpital Bichat-Claude Bernard, Paris, France, 4Service
de Dermatologie, Hoˆpital Saint-Louis, Paris, France, 5Service de Dermatologie, Hoˆpital
Ambroise Pare´, Boulogne Billancourt, France
The OCA2 gene, localized at 15q11, encodes a melanosomal transmembrane protein that is
involved in the most common form of human occulo-cutaneous albinism, a human genetic
disorder characterized by fair pigmentation and susceptibility to skin cancer. We wondered
whether allele variations at this locus could influence both human pigmentation character-
istics and susceptibility to melanoma (MM). Ten intragenic single nucleotide polymorphisms
(SNPs) were genotyped in 113 patients with melanomas and in 105 Caucasian control
subjects with no personal or family history of skin cancer. The effect of OCA2 on susceptibility
to MM and on pigmentation characteristics was assessed using both a classic statistical
method (comparison of SNPs allelic frequencies) and the recently developed ‘‘combination
test’’. We show by both statistical approaches that MM and OCA2 are associated (respective
p values¼ 0.0056 and 0.030 after correction for multiple testing), suggesting that the risk of
melanoma is determined by several SNPs, possibly interacting, on OCA2. In addition, the
OCA2 genotype was also found to be strongly associated with eye color (p¼0.0035 after
correction for multiple testing, OR¼5.58 [1.96–16.7]). Finally, the effect of OCA2 on
melanoma risk persisted after stratification for eyes color, and was also detected using a
logistic model taking into account the MC1R genotype, a gene strongly involved in MM and
all pigmentation characteristics. Our data demonstrate that a second pigmentation gene, in
addition to MC1R, is involved in susceptibility to melanoma and in human pigmentation.
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Mutations of the RNA-speciﬁc Adenosine Deaminase Gene (ADAR1) are Involved in
Dyschromatosis Symmetrica Hereditaria
N Suzuki1, T Suzuki1, Y Miyamura1, K Inagaki1, M Kono1, S Ito1, K Fukai2, H Takama3,
Y Tomita1
1Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya,
Japan, 2Department of Dermatology, Osaka City University Medical School, Osaka, Japan,
3Takama Dermatology Clinic, Aichi, Japan
Dyschromatosis symmetrica hereditaria (DSH, reticulate acropigmantation of Dohi) has been
reported mainly in Japan, although it occurs in families of every ethnic origin all over the
world. The patients have pinpoint, pea-sized hyper- and hypo-pigmented macules on the
back of the hands and the top of the feet. These abnormalities are otherwise asymptomatic
and do not affect the general health. DSH generally shows an autosomal dominant pattern of
inheritance with high penetrance. Many clinical and morphological investigations have been
reported, but the cause and the pathogenesis have not yet been clarified. We succeeded in
mapping and positionally cloning the DSH gene. We performed a genome-wide search in
three families (41 affected and 47 unaffected), and mapped the DSH locus to chromosome
1q21.3. To further refine the localization, we identified novel single nucleotide polymorphisms
and integrated the genetic and physical maps of the region. The final genetic interval was
approximately 500kb in which 9 genes ware mapped. To detect the pathological mutations,
affected individuals from each of the 3 pedigrees named Pedigree 1, 2 and 3, plus new
pedigree named Pedigree 4, were screened by PCR-SSCP and direct sequencing. The
results showed that they were heterozygous for mutation alleles of double-strand RNA-
specific adenosine deaminase gene (ADAR1), R474X, L923P, K952X and F1165S respec-
tively. None of these four mutations were found in 55 unaffected individuals in any of the four
pedigrees or in 116 unrelated normally pigmented Japanese adults that were surveyed. Thus,
we concluded that those four mutations are not polymorphic but are the pathologic ones
causing the disease. Additionally, we identified seven novel mutations, H216ins.CC, K433ins.TG,
R426X, Q600X, P727del.C, V906F and K1201del.A in new seven cases of DSH. We compared
the clinical features among the patients with the mutations identified in eleven cases, but no
clear correlation was established between genotypes and phenotypes. And the eleven kind of
mutations identified in our studies did not suggest any founder effect. ADAR catalyses the
deamination of adenosine to inosine in double-stranded RNA substrates that result in the
creation of alternative splicing sites. We speculate that the failure of correct RNA editing may
induce differentiation of melanoblasts to hyper- or hypo-active melanocytes colonizing in an
irregular distribution in the skin lesions during the development.
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Altered Expression of Actin and Focal Adhesion-Associated Proteins in Kindler
Syndrome
JR McMillan, M Akiyama, K Yasukawa, JA McGrath# and H Shimizu
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo,
Japan; #Genetic Skin disease Group, GKT Medical School, London UK
Kindler syndrome (KS; OMIM173650) is an unusual, autosomal recessive skin disorder
associated with trauma-induced blisters in early life followed by photosensitivity, poikilo-
derma, and an increased risk of malignancy. Recently, defects in the actin/focal adhesion
associated protein kindlin (also known as kinderlin) encoded by the gene KIND1 have been
shown to cause this disease. In human epidermis, kindlin is expressed in epidermal
keratinocytes, particularly within basal keratinocytes and at the dermal-epidermal junction
(DEJ). We have undertaken a detailed ultrastructural and immunohistochemical study in KS
(n¼ 2) and control skin (n¼ 3) to examine DEJ morphology and the labeling patterns of
various basement membrane, actin cytoskeletal and focal contact-associated proteins.
Transmission electron microscopy of KS skin showed disruption and reduplication of the
lamina densa, together with sub-lamina densa cleft formation. The number and structure of
hemidesmosomes and anchoring filaments appeared normal, although there was focal
disruption in desmosome- and hemidesmosome-keratin filament attachment. This disruption
in normal keratin filament assembly was most obvious at sites of dermal clefts and was
associated with an abundance of substratum-associated, disorganized bundles of actin
filaments. Immunofluorescence microscopy showed increased epidermal expression of actin,
a actinin, talin, vinculin, tenascin C and RACK-1 in KS skin but no change in labeling with
antibodies to filamin, tensin, focal adhesion kinase, paxillin or tropomyosin. Immunostaining
for protein kinase C was markedly reduced in basal keratinocytes in KS skin compared to
control. Taken together, our findings reveal a close spatial and functional relationship between
kindlin, actin, some focal contact proteins and regulatory molecules that link the actin
skeleton to the integrin extracellular matrix receptors. We hypothesize that the function of
kindlin might be to bind to the terminal ends of actin microfilaments, linking focal adhesion
proteins to the integrin receptors, thereby limiting the elongation of actin microfilaments.
Conversely, a lack of kindlin might disrupt focal adhesion linkage and allow the unregulated
proliferation of actin microfilaments causing perturbations in the associated actin and keratin
cytoskeletal networks.
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Spink5 knockout Mice Demonstrate a Key Role for Lekti in Epidermal Integrity
P Descargues, C Deraison, C Bonnart, M Kreft{, G Zambrunoz, A Sonnenberg{ and
A Hovnanian
INSERM U563, Toulouse, France; {The Netherlands Cancer Institute, Amsterdam, The
Netherlands; zImmacolata Dermatological Hospital, Rome, Italy
SPINK5 is the defective gene in the severe autosomal recessive ichthyosiform skin condition,
Netherton syndrome. SPINK5 encodes the putative multi-domain serine protease inhibitor
LEKTI, which is a marker of epithelial differentiation, strongly expressed in the granular layer
of the epidermis. To investigate its role in vivo, we have genetically engineered mice with
a targeted disruption of Spink5. The targeted locus was confirmed by Southern blot
hybridization. Loss of expression of Lekti was demonstrated by absence of immunostaining
in the epidermis of the knockout mice. Homozygous mutant mice displayed a marked skin
fragility with superficial peeling and died shortly after birth. These lesions were predominant
on the limbs, the tail and the trunk. Hair development was impaired, resulting in the absence
of erupted vibrissae and hair canal. The visible scarce hair shafts were misoriented and
had an altered curving. Histological analysis of the vibrissal follicle demonstrated loss
of intercellular contacts in the inner root sheath and a shrunk hair shaft. Ultrastructural
examination of the epidermis showed detachment between the granular layer and the stratum
corneum. Intercellular spaces in the upper granular layer presented with abnormal globular
material and split desmosomes. Stratum corneum detachment led to a severe skin barrier
defect as measured by penetration of external dyes and increase of transepidermal water
loss. Our study provides the first in vivo evidence for a role of Spink5 in the desquamation of
the epidermis through the regulation of cell-cell adhesion between terminally differentiated
keratinocytes. These results also demonstrate that Spink5 is essential for hair development.
Spink5 knockout mice features are very close to Netherton syndrome and therefore provide a
useful model to elucidate the pathophysiological pathways of Netherton syndrome.
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Development of Potential Microbicides Based on RNA Interference of DC-SIGN
J-F Arrighi1, M Pion1, M Wiznerowicz2, TB Geijtenbeek3, E Garcia1, Y van Kooyk3, D Trono2
and V Piguet1y
1Department of Dermatology and Venerology, University Hospital of Geneva, Geneva,
Switzerland 2Department of Genetics and Microbiology, CMU, Faculty of Medicine,
University of Geneva 3Department of Molecular Cell Biology and Immunology, VUMC,
Amsterdam, The Netherlands
In order to develop a microbicide based on RNA interference, downregulation of cellular
receptors for HIV attachment and transfer must be achieved. DC-SIGN mediates HIV
attachment on dendritic cells that are the first targets during the course of HIV infection
as well as transfer to CD4þ T cells. For this purpose, we developed lentiviral vectors that
express short hairpin RNA (shRNA) for the delivery of small interfering RNA (siRNA) capable of
conditionally suppressing DC-SIGN expression. Selectivity of inhibition on DC-SIGN, L-SIGN,
chimpanzee or Rhesus macaque DC-SIGN was obtained by the use of distinct siRNAs.
Suppression of DC-SIGN expression inhibited the attachment of the gp120 envelope
glycoprotein of HIV-1 to DC-SIGN transfectants, as well as transfer of HIV-1 to target cells
in trans. Furthermore, shRNA-expressing lentiviral vectors were capable of efficiently
suppressing DC-SIGN expression in primary human DCs. DC-SIGN-negative DCs were
unable to enhance transfer of HIV-1 infectivity to T cells in trans, demonstrating an essential
role for this receptor in transferring infectious viral particles from DCs to T cells. The present
system is a first step towards the use of RNA interference of DC-SIGN as potential
microbicide for HIV as well as other pathogens also recognized by this receptor such as HCV.
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Gene Expression Proﬁling of Skin and Lymph Nodes of Rats Affected with Contact
Hypersensitivity
B Hartmann, H Fahrngruber, N Hartmann, J G Meingassner
Novartis Institutes for BioMedical Research, Vienna, Austria Basle, Switzerland
The transcriptional changes in skin and draining lymph nodes of rats during the elicitation
phase of contact hypersensitivity (CH) were examined. Female Sprague Dawley rats,
sensitized against 2,4-dinitrofluorobenzene (DNFB), were challenged with 0.5% DNFB on the
flanks and the involved skin and the draining lymph nodes dissected 8 or 24 hrs after the
challenge. The challenge resulted in an increase by 1.1 mm (8 hrs) and 0.9 mm (24 hrs) in skin
thickness and by 2.5 mg (8 hrs) and 26.8 mg (24 hrs) in lymph node weight. The RNA from the
affected tissues and from corresponding tissue samples from naı¨ve animals (controls) was
extracted and hybridized on GeneChip microarrays (Affymetrix RU34A, 8799 gene probe
sets). Genes which were significantly differently expressed with p  0.001 in challenged
mice and in controls were analyzed. From 1882 genes retrieved 309 genes exhibited a 3-fold
different expression pattern at 8 or 24 hrs after challenge. Clustering these 309 genes
revealed 117 genes up-regulated in skin (Sþ ) and 114 genes down-regulated (S) whereas
in lymph nodes 19 genes were up- (Lþ ) and 31 genes were down-regulated (L). Twenty
eight genes were up-regulated in both tissues (SLþ ). Among those genes, genes related to
signal transduction [e.g. Tle-4 (Lþ ), Ptpn-16 (Lþ ), Jak-2 (Sþ )], apoptosis [e.g. Casp-3 (Sþ ),
Casp-2 (SLþ ), Dnase31 (S)], stress [e.g. Hsp-70 (Sþ ), Mapk-9 (SLþ )], extracellular matrix
[e.g. Mmp-3, -19, -12, -13(Sþ ), decorin (L), Col1a1 (Lþ )], cell adhesion [C-CAM-4 (Sþ ),
Tnc (Sþ ), Sell (Sþ )], and genes related to inflammatory reactions [as CD14 (SLþ ), MRP-8
(SLþ ), iNos (Sþ ), MRP-14 (Sþ )] as well as genes of interleukins and chemokines [as IL-6
(Sþ ), IL-1a (S), Gro-1 (Sþ ), MCP-1 (Sþ ), IP-10 (SLþ )] were detected. Their expression
levels was in most cases time-dependent. The validated transcriptional signatures of the
responses of involved tissues will give insights into the diverse molecular cascades in CH
which underlay the cellular events and result in allergic contact dermatitis.
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Genetic Correction of Xeroderma Pigmentosum : New Approaches Compatible with
Patients Therapy
V Bergoglio1, M Fre´chet1, F Bernerd2, O Chevallier-Lagente1, A Sarasin1 and T Magnaldo1
1Institut Gustave Roussy, CNRS UPR 2169 Genetic instability and Cancer Unit, Villejuif.
2L’Oreal Advanced Research, Clichy Cedex France
Xeroderma pigmentosum (XP) is a rare hereditary disease transmitted with autosomal and
recessive traits. XP patients are characterized by an extreme photo-sensitivity and a high
predisposition to skin cancer development from keratinocyte origin. Nucleotide excision
repair (NER), the most versatile repair mechanism of UV-induced DNA lesions, is deficient in
XP cells. Seven classical complementation groups of XP cells have been identified and
corresponding genes (XPA to XPG) have been cloned.
In the absence of any efficient pharmacological treatment, our objective is to restore ex
vivo the repair capacity of XP keratinocytes after genetic correction using retroviral vectors.
As a first attempt, small surface epithelial sheets obtained from genetically corrected XP
keratinocytes will be engrafted onto consentent XP patients. To this end, a first set of
encouraging results have been obtained in the laboratory, demonstrating for the first time full
phenotypic reversion of the XP-C phenotype using classical retroviruses expressing the XPC
DNA repair gene and the G418 resistance gene (neo). Corrected keratinocytes recovered
normal DNA repair and cell survival capacities as well as proliferation and differentiation
defects previously revealed upon the first reconstuction of XP-C skin in vitro.
To refine this approach and in order to fulfil therapeutical requirements and compatibility
with XP patients, we have now developed a new generation of retroviral vectors. In these
vectors, the neo gene has been replaced by a natural cell surface marker of post-mitotic/
suprabasal epidermal keratinocytes, CD24. After transduction using a LTR-CD24-ires-GFP
retrovirus, CD24 could be ectopically expressed at the surface of proliferative/basal keratino-
cytes. Using an anti CD24 antibody and magnetic beads enabled us to selectively select in a
single step 98% of transduced keratinocytes and also fibroblasts. 100% of cells selected for
CD24 expression also stably expressed the GFP marker. On this basis, vectors encoding
XPC instead of GFP were constructed and are currently used to revert the phenotype of XP-C
keratinocytes and then to reconstruct in vitro genetically corrected XP skin. Our strategy
should help minimizing immune responses connected to the expression of exogenous
resistance markers, thus opening the first realistic prospect of retrovirus-mediated cutaneous
gene therapy of the XP.
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In vitro Reconstruction of Skin From Nevoid Basal Cell Carcinoma Syndrome Reveals
Impact of PATCHED Mutations in Cutaneous Homeostasis
F Brellier1, O Chevallier-Lagente1, M-F Avril2, P Gorry4, A Spatz3, A Sarasin1 and
T Magnaldo1
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4Laboratoire de Ge´ne´tique Oncologique, Institut Bergonie´, Bordeaux, France
Gorlin syndrome, or naevoid basal cell carcinoma syndrome (NBCCS), is a rare autosomal
dominant disorder characterised by a range of developmental abnormalities and a high
proneness to the major type of non melanoma skin cancer, basal cell carcinoma. In most
cases, clinical halmarks of Gorlin syndrome results from mutation of the PATCHED gene
which encodes the putative transmembrane receptor of SONIC HEDGEHOG (SHH). In the
general population, the role of PATCHED in the maintenance of epidermal homeostasis has
remained poorly documented. Also, it is still unclear how germinal mutation of PATCHED
may result in the high predispostion to BCC of NBCCS patients. Ultraviolet and gamma
irradiations have often been evoked as possible etiological agents of BCC development
in NBCCS patients. Recently, we provided evidence that ultraviolet irradiation represses
PATCHED gene transcription, suggesting that genotoxic stresses impact the SHH/PTC
pathway. In the present study, we generated primary fibroblasts and keratinocytes strains
from skin of consentent NBCCS patients harboring a known germinal PATCHED mutation.
We determined cell survival and DNA repair capacities of NBCCS epidermal keratinocytes
toward UVB and gamma irradiations and showed that these cells are neither photosensitive
nor radiosensitive. Using NBCCS fibroblasts and keratinocytes, we successfully recon-
structed NBCCS skin in vitro. At first sight, the stepwise process of stratification appeared
normal. However, presence of NBCCS fibroblasts in the dermal equivalent and of normal
keratinocytes in the epidermal compartment led to the formation of frequent clefts at
the dermal epidermal junction. The occurrence of clefts was exaggerated in the presence of
NBCCS cells in both cutaneous compartments. Labelling of molecules involved in
cohesiveness between basal keratinocytes and basement membrane revealled a stricking,
spontaneous increase of laminin and beta-1 integrin. Numerous apoptotic keratinocytes
could be revealed above these mechanically fragilized regions. These results suggest the
crucial role of abnormal mesenchymal/epithelial interactions in exacerbated predisposition of
NBCCS patients toward BCC development. Currents investigations aim at the determinations
of molecular clues involved in this newly documented phenotype of the NBCCS skin
reconstructed in vitro in the absence or following UVB irradiation.
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Expression Proﬁles of Inﬂammatory Skin Diseases: results of a SAGEt and Microarray
Analysis
B Peters1, M Birth1, B Schaffrath1, K Hofmann1, C Mauch2, J M Baron3, T Krieg2, H Merk3,
T Bieber4, A Bosio1
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As part of a large-scale study, we have generated the disease specific expression profiles of
skin affected with psoriasis, atopic and contact dermatitis, or Lichen planus, and healthy skin
by SAGEt analysis. In addition, we performed an initial microarray analysis using PIQORt
Skin microarrays. The SAGEt analysis revealed altogether 201 differentially expressed genes
when compared to healthy skin (po0.01). Among these genes, 25 were specific for psoriasis,
23 for atopic dermatitis, 24 for contact dermatitis, and 52 for Lichen planus. The suitability of
those genes as universal marker genes or drug targets will be validated by microarray
experiments of single patient samples, as the SAGEt libraries were generated based on
patient pools. An initial set of 10 microarray experiments per indication proved that clustering
of diseased and healthy skin on basis of whole skin biopsies is possible. The stable and
reproducible results confirmed the suitability of our protocols for biopsy excision, storage
and analysis. When we compared the results of the two expression profiling methods for
120 genes that showed a significantly altered expression in at least one indication in the
SAGEt analysis, we found a good overall concordance of SAGEt and microarray data.
The exhaustive analysis of skin disease specific expression profiles, correlated with medical
histories and histopathology data will allow the stratification of patients and help to develop
new diagnostic and prognostic tools for skin diseases.
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Possible New Complementation Group(s) of Xeroderma Pigmentosum
S Moriwaki1, H Sugimura2 and M Takigawa3
1Photon Medical Research Center, Hamamatsu University School of Medicine, Hamamatsu
Japan 2Department of Pathology, Hamamatsu University School of Medicine, Hamamatsu
Japan 3Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu
Japan
Xeroderma pigmentosum (XP) is an autosomal recessive photosensitive disease with
abnormal pigmentation and an extremely high incidence of skin cancers. Cells from patients
with XP are hypersensitive to killing by ultraviolet (UV), which is associated with impaired
ability to repair UV-induced DNA damages. There are genetically different seven nucleotide
excision repair (NER) deficient groups (AG) and a NER proficient form (XP variant). We have
been receiving more than 200 clinical samples for the diagnosis of XP for these five years and
70 patients were newly diagnosed as having XP in our laboratory. Among them, we found
three unusual Japanese XP cases (XP29HM, XP30HM and XP36HM). Those patients (17 y.o.
female, 35 y.o. male and 55 y.o. male) are not related and have mild clinical features with a
few skin cancers in areas exposed to sunlight and so far any evidence for neurological
abnormalities was not detected. Fibroblasts derived from those patients were hypersensitive
to UV irradiation compared to cells from normal subjects and less sensitive to UV than XP-A
XP-C and XP-D cells, while the levels of post-UV unscheduled DNA synthesis (UDS) in those
patients were 26%, 23% and 12% of normal, respectively. Complementation test by cell
fusion technique and a plasmid host cell reactivation assay revealed that those patients did
not belong to XP group A, B, C, D, F and G. DNA repair studies and gene analysis indicated
that those patients were not in XP group E and XP variant. Cell fusion analysis using those
three cell strains implied that there were at least two more new XP complementation groups.
Molecular and biochemical analyses using the cells from those patients should give a new
insight in NER pathway.
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Deﬁning the Transcriptional Control Elements that Regulate Keratinocyte-Speciﬁc
Expression of p63
S Sinha and R-A Romano
Dept of Biochemistry, University at Buffalo, SUNY, Buffalo, NY, USA
The development and differentiation of the mammalian skin epidermis is governed by a
number of critical transcription factors including p63, a homolog of the tumor suppressor p53.
Recent gain-of-function and loss-of-function studies in mice have underscored the important
role of p63 in sustaining the progenitor cell populations in stratified epithelium of the skin
epidermis and in maintaining the balance between proliferation and differentiation.
Interestingly, by utilizing alternate promoters, the p63 gene gives rise to 2 classes of
transcripts: transcripts, which encode for an amino terminal transactivation domain (TA) and
transcripts that lack this domain (N). The expression of these two isoforms is spatio-
temporally regulated during development of the embryonic mouse skin. In addition, it has
been postulated that keratinocytes make choices to proliferate, differentiate or stratify based
on the relative levels of these two isoforms. However, very little is known about the
transcriptional control mechanisms that govern the expression of p63 in keratinocytes. In
order to identify the cis-elements that regulate p63, we have analyzed the cell-type specific
chromatin conformation of the mouse p63 gene by DNase I hypersensitive site mapping.
These studies along with cross-species genome sequence comparisons have allowed us to
uncover critical regulatory domains that are important for directing the expression of p63 in
keratinocytes. We have performed functional assays of these regulatory domains by testing
them for transcriptional activation in transient transfection experiments and in transgenic
mice. These studies have identified a critical regulatory segment that harbors most of the
transcriptional activity of the p63 promoter. Molecular and biochemical characterization of
these elements by Electrophoretic Mobility Shift Assays and mutation analysis has revealed
critical roles for members of several well-studied transcription factor families. Collectively,
our data provide novel insights into the complex regulatory mechanisms that control the
expression of p63 isoforms during epidermal development and differentiation.
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Laminin-5 Mutation Survey and Genotype-Phenotype Correlation in Italian Patients with
Junctional Epidermolysis Bullosa
P Posteraro, N De Luca, G Meneguzzi, M El Hachem, C Angelo, T Gobello, G Tadini, G
Zambruno, and D Castiglia
Rome and Milan, Italy. Nice, France
Junctional epidermolysis bullosa (JEB) is a rare genodermatosis characterised by dermal-
epidermal separation and caused by mutations in the genes encoding hemidesmosomal
components and laminin-5, the major epithelial adhesion ligand. We have examined a cohort
of 19 Italian JEB patients presenting defective laminin-5 expression, 11 of them affected with
the lethal Herlitz (H JEB) and eight with the mild non-Herlitz variant of JEB (non-H JEB). JEB
patients were diagnosed on the basis of clinical features, immunofluorescence antigen
mapping and ultrastructural examination of skin biopsies. Mutational analysis of the LAMA3A,
LAMB3 and LAMC2 genes encoding the three chains of laminin-5 was performed by
heteroduplex analysis of genomic PCR fragments or by RT-PCR and direct sequencing of the
amplified cDNA products. Through these screening methods, an overall mutation detection
sensitivity of 95% was obtained. Eighteen mutations, seven of which novel, were identified
and their consequences analysed at the mRNA and protein level. H JEB patients carried
premature termination codon (PTC) mutations in 20 out of 22 mutant alleles, with a
prevalence of mutations in LAMC2, whereas splicing or missense mutations compatible with
a reduced synthesis of mutant laminin-5 were prevalent in non-H JEB patients. However, in
one case, a homozygous PTC mutation in LAMB3 was associated to illegitimate splicing
leading to non-H JEB. In addition, we characterised a large intragenic duplication within
LAMC2 in a H JEB patient, a genetic defect so far uncovered in laminin-5 genes. Collectively,
five mutations appeared to be frequent in laminin-5 JEB patients (R635X, 29insC, E210K,
W143X in LAMB3 and R95X in LAMC2), two of which (R95X and W143X) being so far detected
only in patients from southern Italian regions. These recurrent mutations account for
approximately 44% of laminin-5 JEB alleles in Italian patients: screening at first for these
mutations will allow to accelerate molecular diagnosis in new Italian JEB patients.
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Expression Proﬁling of Melanoma Correlates Active TGFb Signaling with Molecular
Patterns of Increased Metastatic Potential
K S Hoek, N C Schlegel and R Dummer
Department of Dermatology, University Hospital of Zu¨rich, Switzerland
Melanoma is an aggressive tumor originating from melanocytes either in normal skin or within
melanocytic nevi. Despite growing awareness of the disease the incidence of melanoma
continues to increase world-wide. Most importantly, melanoma is recognized as being the
most dangerous of skin cancers. Once metastasis has been confirmed patient prognosis is
extremely poor, and successful treatment has hitherto relied solely on removal of the primary
tumour before the onset of invasive metastasis.
We have recently conducted a series of large-scale DNA microarray experiments on a
subset of established human melanoma cultures. The raw data (44500 probe-set signal
intensity measurements per sample) was normalized, filtered using fold-change criteria and
then used for hierarchical clustering. Clustering revealed that the molecular signatures of the
melanomas were distributed among three well defined cohorts, these cohorts were termed
quiet, intermediate and active according to their increasing molecular signature divergence
from the control (melanocyte culture) group. Analysis of the available literature strongly
suggests that the quiet and active cohorts are representative of melanomas which are,
respectively, poorly and strongly metastatic. Additionally, clinical data indicates an improved
survival for patients yielding quiet cohort melanomas.
The original normalized dataset was refiltered using a statistical (ANOVA) selection for
probes which distinguish the three cohorts to reveal 2819 cohort-specific probe-sets. The
signal intensity expression patterns of these, across the full range of melanomas and
melanocyte controls, was used for self-organizing map (SOM) clustering in order to
distinguish the main expression pattern groups. Extensive literature analysis of the principal
genes composing one of three major expression pattern motifs, for which genes are
upregulated in the intermediate and active cohort melanomas, show that TGFb signaling is
being activated in these melanomas. Incubation of quiet cohort melanomas with exogenous
TGFb shows that this signalling pathway is intact. This suggests that there is a TGFb signal
block mechanism which is active in quiet melanomas and not (or less so) in the intermediate
and active cohorts.
Our current work focuses on the hypothesis that increased metastasis is driven in part by a
reduction in TGFb signal control.
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Novel COL7A1 Mutations in Dystrophic Epidermolysis Bullosa and Genotype-Phenotype
Correlations
J S Kern, G Gru¨ninger, L Bruckner-Tuderman, C Has
Freiburg, Germany
Dystrophic epidermolysis bullosa (DEB), a hereditary skin disorder characterized by
subepidermal blistering, is caused by mutations in the type VII collagen gene, COL7A1.
Molecular diagnostics of DEB remain complex due to the large size of COL7A1, large variety
of mutations and heterogeneity of the phenotypes. Here we report the mutations of 20 cen-
tral European patients with various DEB forms and genotype-phenotype correlations. All 118
COL7A1 exons were amplified from genomic DNA by PCR and submitted to auto-
mated sequencing. The expression of mutated collagen VII was examined by RT-PCR, IF-
staining and immunoblotting, allowing the assessment of genotype-phenotype correlations.
We found 5 novel glycine substitutions: G1522R (4564G4C), G1525R (4573G4A), G1616R
(4846G4A), G2689R (8065G4A), G2737R (8209G4A) situated in exons 45–51 and 109–110.
All lead to reduced levels of collagen VII in the skin, as shown with IF staining. The mutations
were associated with different clinical phenotypes. Furthermore, a novel splice site mutation
426þ1G4A was disclosed in intron 3 donor position þ 1. As recurrent mutations, the non-
population-specific, frequent splice site mutation 425A4G and the nonsense mutation
R1933X (5797C4T) were identified. These data allow us to set up an efficient strategy for
COL7A1mutation analysis in central European patients. Further studies on protein level will
contribute to better understanding of the molecular pathomechanisms leading to the different
clinical and biological phenotypes.
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Expression of PRINS, a Newly Identiﬁed Non-Coding RNA Gene in Psoriasis and in
Various Human Tissues
E Sonkoly1, M Sze´ll2, Z Bata-Cso¨rgo1,2, A Pivarcsi2, L Keme´ny1,2, A Dobozy1,2
1Department of Dermatology and Allergology, University of Szeged, Hungary 2Dermatolo-
gical Research Group of the Hungarian Academy of Sciences, University of Szeged,
Hungary
Using differential display we have recently isolated a transcript that is overexpressed in
psoriatic uninvolved epidermis. The gene coding for this transcript is localised on chromo-
some 10 and in silico translation resulted in no translatable protein product on its nucleotide
sequence. Sequence analysis revealed that the gene harbours two Sq type Alu elements
and in vitro experiments with immortalised HaCaT keratinocytes demonstrated that the
expression of this gene is upregulated under different stress conditions. Therefore, we named
the full-length transcript Psoriasis-susceptibility Related RNA Gene Induced by Stress,
PRINS. In order to check the tissue specificity of PRINS, its expression was tested by Q-RT-
PCR in samples from 16 different human organs and tissues. Our results showed that PRINS
was expressed in all human tissues examined and the abundance of PRINS mRNA showed
big differences in the various tissues (lowest in cardiac muscle, highest in veins). Reverse-
Southern and Q-RT-PCR experiments proved that the expression of PRINS was 25 times
higher in the non-involved epidermis of psoriatic patients (n¼5) compared to healthy
epidermis (n¼ 10). However, the expression in psoriatic plaques (n¼ 8) was only 8 times
higher than in healthy epidermis. When normal (n¼ 5) and psoriatic non-involved (n¼ 5)
epidermises were treated with a T-lymphokine mixture, that has been showed to induce a
hyperproliferative response in non-lesional, but not in normal keratinocytes, the expression of
PRINS in normal epidermis was not affected, at the same time PRINS expression in psoriatic
non-involved epidermis was downregulated to the level of expression found in the psoriatic
lesional epidermis. In synchronized HaCaT keratinocytes, PRINS was substantially down-
regulated in proliferating, and upregulated in differentiated HaCaT keratinocytes. The
overexpression of PRINS in the psoriatic non-lesional keratinocytes may reflect an altered
regulatory extracellular milieu, but it is also possible that PRINS plays a regulatory role in the
hyperproliferation in psoriasis.
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Stress Response in Epidermis from Patients with Keratin Genodermatoses invokes
Phosphorylation of Hsp27 at Serine 82
M S Jehani1, R A Quinlan2 and P E Bowden1
1Dermatology, UWCM, Cardiff, U.K and 2Biological Sciences, University of Durham, UK
Epidermal strength and resilience is dependent on expression and organisation of keratin
intermediate filaments (IF), a major component of the cellular cytoskeleton. However, keratin
mutations produce altered proteins that weaken structural stability in a dominant negative
manner and so cause a variety of genodermatoses affecting the epidermis and its
appendages. Stress placed on epithelial cells causes collapse of the IF network which leads
to blistering, hyperproliferation, and hyperkeratosis. Stress initiates a cellular protective
response and various molecular chaperones are up-regulated and activated. In human
epidermis, a small heat shock protein family member (Hsp27) has a specific affinity for keratin
IF proteins and activation of Hsp27 by phosphorylation at serine 82 is observed in normal
granular cells. We have now demonstrated increased phosphorylation of Hsp27 at serine
82 as part of the stress response to IF collapse and cellular disruption in several geno-
dermatoses. Eight cases of clinically and genetically characterized genodermatoses (2 EBS,
2 EHK, 1 EPPK, 2 IBS and 1 LEN) and 3 normal volunteers were studied. Serial 5 mm sections
of paraffin embedded tissue were treated with mouse mAbs to Hsp27 or Hsp27-p82 (detects
phosphorylated active form) and visualised with DAB. In all eight cases, an increase in Hsp27
expression was observed compared to normal as well as a dramatic increase in levels of
phosphorylated Hsp27 (p82). This activated form is normally limited to the granular layer but
general and intense staining was observed in all suprabasal cells. We conclude that the
cellular disruption caused by keratin IF collapse invokes a stress response that leads to the
up-regulation and specific phosphorylation of Hsp27.
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Association of Apolipoprotein E Polymorphisms with Psoriasis
E Campalani1, M Allen1, D Fairhurst2, H Young2, D Burden3, C Griffiths2, M Crook4,
J Barker1, C Smith1
1St John’s Institute of Dermatology, London, 2The Dermatology Centre, University of
Manchester, Hope Hospital, Manchester, 3Department of Dermatology, Western Infirmary,
Glasgow, 4Department of Clinical Biochemistry, University Hospital Lewisham, London
Apolipoprotein E (apoE) is a lipid transport protein which regulates the metabolism of
cholesterol and endogenous and dietary triglycerides (TG). Hyperlipidaemia, particularly hyper-
triglyceridaemia, changes in lipoprotein composition and a high prevalence of cardiovascular
disease are well documented in patients with psoriasis. ApoE was elevated in 31 Chinese
psoriasis patients and one specific polymorphic apoE variant showed association with
psoriasis in a Japanese cohort of patients. Three common alleles, e2, e3 and e4, defined by
exonic single nucleotide polymorphisms (SNPs) T3937C and C4075T, encode the three major
isoforms E2, E3 and E4. ApoE2 is protective against hyperlipidaemia and cardiovascular
disease, whereas the apoE4 isoform is associated with high cholesterol and is over
represented in hyperlipidaemic and heart disease populations.
Our aim was to identify any novel SNPs in Caucasian psoriasis patients and investigate the
frequency of coding SNPs T3937C and C4075T in patients with chronic plaque psoriasis (CPP)
(n¼ 212), guttate psoriasis (GP) (n¼ 94), palmoplantar pustular psoriasis (PPP) (n¼ 101) and
healthy controls (n¼ 137). DNA was obtained from patients and controls and genotyped using a
radioactive hybridisation technique. Allelic frequencies were analysed by the chi-squared test.
Only SNPs defining e2, e3 and e4 were detected by DNA sequencing of 30 patients with
severe CPP. Patients with CPP and GP showed significantly increased frequency of the
þ 3937C SNP (19.6% and 17.80%, p¼ 0.002 and 0.02) and the e4 allele (3937C/4075C)
(18.40% and 18.10%, p¼ 0.008 and 0.029) compared with controls (10.8% and 10.9%
respectively). There was no significant difference between the þ4075C and þ4075T SNPs in
patients and controls. CPP and GP show strong association with PSORS1 (in contrast to PPP).
When CPP and GP cases were combined the þ3937 C SNP (p¼0.002) and the e4 allele
(p¼ 0.006) were significantly more frequent in cases (19% and 18.3%) than controls [OR 1.82
(1.18–2.80)]. There was no significant difference in apoE SNP or allele frequencies between
PPP patients (10.5% and 10.7%) and controls.
These data demonstrate that the apo e4 allele is more common in individuals with psoriasis
and suggest a possible pathogenic role of the apoE lipoprotein. Furthermore, the increased
frequency of the apo e4 allele in psoriasis may account for the high prevalence of cardio-
vascular disease observed in these patients.
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Therapeutic Potential of Placenta Growth Factor in Diabetic Wound Healing
T Odorisio, F Cianfarani, L Brogelli, F Sera, S Truffa, M Pesce, C M Failla, M Napolitano,
M C Capogrossi and G Zambruno
IDI-IRCCS, Rome, and CCM-IRCCS, Milan, Italy
Placenta growth factor (PlGF) is a member of the vascular endothelial growth factor (VEGF)
family that has been found to play an important role in adult angiogenesis. Such feature has
led to consider PlGF as a potential candidate for therapeutic modulation of angiogenesis, and
PlGF treatment of ischemic tissues proved beneficial in inducing angiogenesis and collateral
vessel growth by mobilizing/recruiting bone marrow-derived precursors cells. In cutaneous
wound healing PlGF is expressed by migrating keratinocytes and proliferating endothelium
during the angiogenic phase, and wound closure is delayed in PlGF-deficient mice indicating
that this factor plays a role in skin repair. In this study, we have tested the therapeutic
potential of PlGF in streptozotocin-induced diabetic mice, as a model of altered skin repair
associated with reduced angiogenesis. We first addressed the involvement of PlGF in
diabetic cutaneous wound healing by analyzing PlGF expression at different time points after
injury. We found that PlGF induction was greatly reduced in diabetic mice compared to non
diabetic controls, both at the mRNA and protein level. We then investigated the potential role
of PlGF in improving wound healing in transgenic mice overexpressing this factor in the skin
under the control of the human keratin 14 promoter (K14-PlGF transgenic mice), rendered or
not diabetic by streptozotocin treatment. While K14-PlGF mice did not show an improved
healing compared to wild-type controls, in K14-PlGF diabetic mice wound healing was
significantly accelerated compared to diabetic non transgenic littermates. We finally
investigated the effect of treatment with an adenoviral vector carrying the human PlGF-1
gene (AdCMV.PlGF) topically applied on excisional wounds in diabetic mice. AdCMV.PlGF
significantly improved the healing process and accelerated wound closure compared to the
control vector (AdCMV.LacZ) or saline. The histological analysis of wound specimens, taken 7
days after injury, revealed that granulation tissue formation was delayed in AdCMV.lacZ-
treated and saline-treated diabetic mice compared to Ad.CMVPlGF-treated mice. Further,
immunohistochemical PECAM /CD31 staining showed that the average area of the vessels
within the granulation tissue was significantly increased in AdCMV.PlGF-treated mice
compared to controls. All together our findings underline the importance of the angiogenic
factor PlGF in cutaneous wound healing and indicate that PlGF gene transfer may have a
therapeutic potential for the treatment of diabetic ulcers.
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Examination of Single Nucleotide Polymorphisms of the Fibroblast Growth Factor
Receptor 2 Gene in Patients with Leg Ulcer
N Nagy1, M Sze´ll2, G Szolnoky1, G Szabad1, A Dobozy1,2, L Keme´ny1,2
1Department of Dermatology and Allergology, University of Szeged, Hungary 2Dermatolo-
gical Research Group of the Hungarian Academy of Sciences, University of Szeged,
Hungary
Fibroblast growth factors (FGFs) have potent mitogenic activity to the vast majority of
epithelial cells through specific binding to fibroblast growth factor receptors (FGFRs). Thus
FGFs and their receptors are important mediators of a wide variety of biologic activities
including wound healing. The aim of our study was to identify single nucleotide poly-
morphisms (SNPs), which may play a role in the pathomechanism of prolonged wound
healing in patients with leg ulcer. There have been 397 SNPs identified on the full length
FGFR2 genomic sequence from which we chose 5 for further studies that may have effect(s)
on gene function. For the SNP analysis experiments we have used the Assay-on-Demand kit
of Applied Biosystems. Comparing the SNP data of 73 leg ulcer patients with 71 healthy
individuals we could not find significant difference in the distribution of alleles between the
two groups (Chi2 test p40.05) concerning the SNP in the promoter region (2753T!C), in
exon 5 (103A!G, Thr!Met), in exon 6 (64C!T, Val!Val) and the SNP in intron 6
(91C!T). However, the SNP located in the 30 untranslated region (UTR) of the mRNA
(2451A!G; 900 bp downstream from the ORF) showed significant difference in the allelic
distribution between patients suffering from leg ulcer and healthy individuals (Chi2 test
p¼ 0.01). We hypothetize that this SNP might alter the stability of the mRNA, results in
decreased FGFR2 protein amount, thus to receptor disfunction that leads to prolonged
wound healing in patients with leg ulcer.
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Polymorphisms in the Promoter of the Interleukin-4 Receptor Alpha Chain Gene are
Associated with Atopic Dermatitis and Psoriasis in Japan
N Hosomi1, K Fukai1, N Oiso1, A Kato1, M Ishii1, H Kunimoto2, K Nakajima2
1Department of Dermatology and 2Department of Immunology, Osaka City University
Graduate School of Medicine, Osaka, Japan
The trait of enhanced IgE responsiveness has been linked to chromosome segment 16p12,
where the interleukin-4 receptor alpha chain (IL4R) gene is located. Recently, Ober et al
suggested that variations outside the coding region of the IL4R gene might influence
susceptibility to atopy and asthma. We sought to find promoter polymorphisms of the IL4R
gene that might influence the transcription level of the gene. We found six polymorphisms;
3112C4T, 1803 T4C, 327C4A, 326A4C, 186G4A and 184A4G, numbered
from the transcriptional initiation site. A case-control association study demonstrated
significant association at 3112C4T (p¼ 0.0075), 1803T4C (p¼ 0.0034), 327C4A
(p¼ 0.00033), 326A4C (p¼ 0.0031) and 186G4A (p¼ 0.0031) between patients with
atopic dermatitis and normal control subjects. Furthermore, we found significant association
between psoriasis and IL4R 326A4C and 186G4A variants. For 326A4C the genotype
AA is more frequent (po0.0001), and for 186G4A, the genotype GG is more frequent
(po0.0001) in psoriasis. Interestingly, these allelic associations are the reverse of those we
found in Japanese patients with atopic dermatitis. Nevertheless, none of these IL4R promoter
variants had any effect on transcriptional activity when tested fused to a luciferase reporter
gene. Thus, although we observed strong association between IL4R promoter polymorph-
isms and atopic dermatitis, the biological mechanism of action of these variants is not yet
clear.
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Maternal Germline Mosaicism, LAMB3 hotspot mutation R635X and Prenatal Testing in
Herlitz Junctional Epidermolysis Bullosa
M Csiko´s1,3, E Ra´cz1,3, R Benko+1,3, A Bo´na1,3, A La´szik2, O Szaka´cs2, A Horva´th1,
S Ka´rpa´ti1,3
1Department of Dermato-Venereology and Dermatooncology, 2Institute of Forensic
Medicine, Semmelweis University, Budapest, Hungary; 3Hungarian Academy of Sciences-
Semmelweis University Dermatological Research Group of Genetics and Immunology,
Budapest, Hungary
Herlitz junctional epidermolysis bullosa (H-JEB, OMIM 226700) is a lethal, autosomal
recessive disorder characterized by blister formation at the level of the lamina lucida within
the cutaneous basement membrane zone. H-JEB is frequently associated with premature-
termination-codon (PTC) mutations in both alleles of one of the three genes LAMA3, LAMC, or
LAMB3) encoding the subunit polypeptides a3, b3, g2 of laminin 5. The majority of the laminin
5 mutations reside in LAMB3 gene on chromosome 1 (GeneBank accession number L25541).
LAMB3 has a hotspot PTC mutation 1903C4T, R635X in exon 14. The newborn male from
healthy, non-consanguineous parents had extensive blistering and demonstrated negative
immunofluorescence staining for laminin 5 b3 chain, and relevated tissue separation within
lamina lucida of the dermal-epidermal junction, diagnostic for H-JEB. Mutation analysis was
performed by amplification of genomic DNA with polymerase chain reaction using LAMB3-
specific primers, heteroduplex analysis, and direct nucleotide sequencing. For family screen-
ing and mutation verification restriction endonuclease digestion (BglII) was applied. We
detected a heterozygous hotspot PTC mutation 1903C4T, R635X. The mother of the
proband was found to be a heterozygous carrier for this mutation, whereas the mutation in
the father remained unknown. Nonpaternity was excluded by use of microsatellite markers
from different chromosomes. Based on these results, DNA-based prenatal diagnosis was
performed by chorionic villus sampling for subsequent second pregnancy in the family. The
fetus was found to be negative of the R635X mutation, indicating that they was phenotypically
unaffected. Hapoltype analysis with intragenic LAMB3 polymorphisms and using micro-
satellite markers surrounding the LAMB3 gene showed that the first patient and the fetus
carry the same maternal and paternal chromosome 1/LAMB3 haplotype, without R635X in the
fetus. In that case, an unaffected child was predicted and the mother gave birth to a helthy
male. We concluded that the mutation is most likely present in a percentage of the maternal
germline, responsible for this unusual mode of inheritance in H-JEB.
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Gene Expression Studies in Sezary Syndrome Using Real-Time Polymerase Chain
Reaction
E M Wain, T J Mitchell, R Russell-Jones and S J Whittaker
Skin Tumour Unit, St. John’s Institute of Dermatology, London, UK
Detailed allelotyping studies have identified two mutually exclusive regions of deletion on
chromosome 10q in Sezary syndrome (SS) and mycosis fungoides at 10q23.33–10q24.1 and
10q24.33–10q25.3.1 Genes mapped to these regions of deletion were identified from the
genome database and include the transcription factor HHEX, a lymphoid specific helicase
(HELLS), a tumour suppressor gene (MXI1), a member of the apoptotic cascade (CASP7) as
well as two recently identified genes: programmed cell death 4 (PDCD4) and cutaneous T-cell
lymphoma tumour antigen (FLJ10188). Real-time PCR was performed to assess expression
of each gene in SS. Total RNA was isolated from fresh peripheral blood mononuclear cells
from 18 SS patients and 5 normal controls. Real-time PCR on cDNA was performed for each
of the above genes using assays-on-demand from Applied Biosystems, Foster City, CA, USA.
Results were analysed for statistically significant differences in gene expression between
each SS sample and the mean gene expression of the 5 normal controls. A statistically
significant reduction in gene expression (at the 99% confidence level) was seen in 78% of SS
patients with HHEX, 33% with HELLS, 50% with MXI1, 44% with PDCD4, 67% with CASP7
and 61% with FLJ10188 which was independent of disease burden (measured by Sezary
count, CD4:CD8 ratio and total CD4 count) and treatment regime at the time of sampling.
When the mean gene expression of the SS patients was compared with the mean gene
expression of the normal controls using unpaired t-tests, the only gene to demonstrate a
significant difference in expression was PDCD4 (po0.05). Loss of heterozygosity (LOH)
analysis using microsatellite markers adjacent to the genes of interest was undertaken in 12
patients in whom gene expression studies were performed. LOH was found in conjunction
with under-expression of HHEX in 3 patients, HELLS in one, MXI1 in 4, PDCD4 in 2, CASP7 in
4 and FLJ10188 in 4 patients respectively. All six genes analysed demonstrated aberrant
gene expression in SS which in some patients with LOH may be explained by allelic loss
alone producing haplotype insufficiency. Additional mechanisms including mutations or
epigenetic phenomena (such as promoter hypermethylation) occurring in patients with or
without LOH are also likely to be implicated in aberrant gene expression by producing biallelic
events.
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Mutation Analysis of Keratin 5 and Keratin 14 genes in Patients with Epidermolysis
Bullosa Simplex
A Bo´na,1,2, M Csiko´s,1,2, R Sajo´,1, A Horva´th,1, S Ka´rpa´ti1,2
1Department of Dermato-Venerology and Oncology, Semmelweis University, Budapest
2Dermatological Research Group of Genetics and Immunology, Hungarian Academy of
Sciences–Semmelweis University, Budapest
Epidermolysis bullosa simplex (EBS) is a group of blistering skin disorders caused by defects
in one of the two keratin genes, KRT5 and KRT14. The disease is typically inherited by an
autosomal dominant way. All cases of EBS are characterized by mechanical stress-induced
blistering of the skin, as a result of keratin filament abnormality and cytolysis in the basal
keratinocytes. Our purpose was to identify mutations underlying the clinical symptoms and to
compare with skin histology in order to define a phenotype-genotype correlation more
precisely. We have investigated genomic sequences of KRT5 and KRT14 for mutations in 11
pedigrees from the register of the Hungarian Epidermolysis Bullosa Center. In five EBS
pedigrees the disease inherited autosomal dominantly, however in the other six families only
the probands but no other family members were affected. Four patients with the most severe
form of EBS, Dowling-Meara, have generalized herpetiform skin blistering beginning within a
few days after birth. The other seven patients had Weber-Cockayne subtype of EBS, the
milder form with blistering confined to the hands and feet. We report two novel KRT5 amino
acid substitutions (S528G, G543S) both located in the tail domain of the keratin 5, and four
nucleotide changes without any amino acid substitution (742C!T, 1602T!C, 1704G!A,
5584T!C). These substiutions add to those previously and provide further evidence of
phenotype-genotype correlation in EBS.
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Two Novel Mutations in the EBP gene in Conradi-Hu¨nermann-Happle Syndrome
K Becker, A Bo´na, M Csiko´s, S Ka´rpa´ti
Dept. of Dermatology, Semmelweis University, and Dermatological Research Group of
Genetics and Immunology of the Hungarian Academy of Sciences, Budapest, Hungary
The X-linked dominant Conradi-Hu¨nermann-Happle (CDPX2, MIM 302960) syndrome belongs
to the rare, heterogenous group of diseases called chondrodysplasia punctata. The disease
has been recently connected with deficiency of the 3b- hydroxysteroid-D8-D7-isomerase
(EBP), catalysing an intermediate step in the conversion of lanosterol to cholesterol.
The two female proband’ s parents are healthy. At birth both children had erythematous,
scaly skin symptoms on the back and extremities lasting only for a few months. Patient 1 has
had repeated small bone-fractures with epiphyseal stippling at the age of 3, as well as vertebral
malformation with secondary scoliosis and shortening of the right leg. We saw the 12-year-old
patient because of rare, coarse hair. The diffuse scarring alopecia, the facial dysmorphy, the
linear depigmented ichthyosis along the lines of Blaschko and the linear follicular atrophoderma
on the arms brought us to the diagnosis of CDPX2. Ultrastructural study of the skin revealed
membrane coated empty vesicles in the basal and suprabasal keratinocytes in close
connection to keratin filaments, as well as within the keratohyalin granules, further supporting
the diagnosis. Patient 2 has been diagnosed to have an asymmetric shortening of the limb in
utero, and based on her epiphyseal stippling and mild skin symptoms after birth the diagnosis
of CDPX2 was proposed. At the age of 1.5 years mild whorled ichthyosis, follicular atrophic
areas, mild patchy alopecia and facial dysmorphy were present.
The entire coding system of the EBP gene was amplified and exon 4 was selected in both
patients by heteroduplex analysis for direct nucleotide sequencing. The 321 bp PCR fragment
contained in Patient 1 a new heterozygous G-to-A transition at nucleotide position 387, leading
to a nonsense mutation at codon 129, confirmed by BsmFI restriction analysis, too. Patient 2
proved to have a G nucleotide insertion at position 406 of exon 4 of the EBP gene, leading to
premature termination upstream of the mutation.
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Single Cell Suspensions of Allogenic Keratinocytes as Gene Transfer Vehicle in Wound
Healing
D Hoeller1, JJ Vranckx2, P Velander2, C Theopold2, N Petrie2, E Eriksson2, F Yao2
1RWTH Aachen, Germany 2Brigham & Women’s Hospital, USA
Objectives. Large wounds often require treatment with allogenic skin grafts, if autologous
are not available. This will result in rejection of the grafted tissue, leaving epithelial defect.
We investigated whether a single cell suspension of allogenic keratinocytes (KC) applied to
porcine full-thickness wounds can serve as a temporary wound coverage and facilitate the
formation of a normal epithelium by ingrowths of autologous KC, and serve as gene transfer
vehicles.
Methods. 1.5  1.5 cm full-thickness wounds were created in five Yorkshire pigs, 4-months
old and filled with single cell solutions with either 2.5  105 allogenic, autologous, or EGF-
transfected allogenic KC. Control wounds received normal saline. Wounds were covered with
vinyl chambers, ensuring a wet wound environment. Wound fluid was collected daily, wound
contraction was measured every third day. H&E sections from biopsies taken on day 9, 14, 21
and 30 were examined to determine re-epithelialization. EGF in wound fluids was measured
by ELISA.
Results. On day 9, re-epithelialization was 50.9% in wounds receiving allogenic KC, 61.8%
with autologous KC, 63.3% with hEGF-transfected KC, and 37.3% in saline control wounds.
On day 14, 21 and 30 all wounds were 100% re-epithelialized, no defects were present in
allogenic KC group. Differences between KC treated groups and the saline control, and
between allogenic and EGF-transfected KC wounds were statistically significant. No
statistically significant difference could be detected between allogenic or autologous KC
nor between autologous or hEGF-transfected KC wounds.
Wound contraction did not differ between the groups.
Wound fluid showed elevated hEGF levels in hEGF-transfected allogenic KC wounds,
ranging from 920 pg/ml on day 1 to 37 pg/ml on days 5 to 9. No hEGF expression could be
detected in the other wounds.
Conclusion. We were able to demonstrate that a single cell solution of allogenic KC enhanced
wound healing in this model. Furthermore, allogenic KC can function as gene transfer
vehicles for EGF cDNA and are able to further improve the rate of reepithelialization.
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Lack of Association of Major CARD15 Variants with Psoriasis and Psoriatic Arthritis
M Weichenthal, J Hampe, JT Elder, R Nair, JJ Voorhees, S Schreiber, D Kabelitz, E
Christophers, and S Jenisch
Kiel, Germany, and Ann Arbor, Michigan
Psoriasis has a strong genetic component in the development of the disease as indicated by
familial occurrence and a high concordance rate among monozygotic twins. In genome-wide
scan for psoriasis several susceptibility loci have been detected, but the disease causing
genes have not yet been identified.
A recent scan, performed on psoriatic arthritis (PsA) which occurs in about 15 percent of
psoriasis patients showed a significant locus on chromosome 16 in a region that was already
described by genome scan for psoriasis. CARD15, a major susceptibility gene for Cohn’s
disease (CD) on chromosome 16q, is an interesting candidate gene for psoriasis, because
there is a documented clinical association of Crohn’s disease with psoriasis, and recently the
association of CARD15 mutations with PsA was reported in a Newfoundland population.
We investigated the association of this variant with PsA and the overall psoriasis genotype
in our cohort of 360 independent patients with plaque type psoriasis in comparison to 361
age and sex-matched controls. In addition, a second cohort of 89 independent North
American PsA patients was included. The diagnosis of psoriasis was made by a dermatol-
ogist based on standard clinical criteria. In these patients, PsA was defined as an inflam-
matory joint disease, negative rheumatoid factor, and lack of another causative condition
for arthritis.
Using case-control analysis, the G908R mutation was weakly associated with psoriasis and
PsA, but due to the low frequency of this mutation statistical significance was not reached. All
other variants inluding leu1007fsinsC and R702W did not show any association with psoriasis
or PsA.
In conclusion, a disease causing role for CARD15 mutations could not be confirmed in
German or American subjects with PsA.
139
Report of a Chinese family with Marie-Unna Hereditary Hypotrichosis and Exclusion of
Linkage at 8p21
K-L Yan1,2,3, P-P He1,2,3, S Yang1,3, M Li1,3, Q Yang1,3, Y-Q Ren1,3, Y Cui1,3, M Gao1,3, F-L
Xiao1,3, W Huang2 and X-J Zhang1,3
1Institute of Dermatology & Department of Dermatology at No.1 Hospital, Anhui Medical
University, Hefei, China 2Chinese National Human Genome Center at Shanghai, Shanghai,
China 3Key Laboratory of Genome Research at Anhui, Hefei, China
Marie-Unna hereditary hypotrichosis (MUHH) is a rare autosomal dominant disorder with
progressive hair loss starting in early childhood and aggravating at puberty. Several studies
have mapped MUHH gene to chromosome 8p21. Here we reported a Chinese MUHH family
with variable phenotypes. All affected individuals have anomalies affecting both hair density
and hair shafts. Major Clinical characteristics, disease history and histological examination
supported the diagnosis of MUHH. But the features of scarring in this kindred are modest and
all patients have no vertex hair loss, which are distinct from typical MUHH. In this study, we
performed genotyping and linkage analysis using 11 polymorphic microsatellite markers
spanning the MUHH locus at 8p. Two-point linkage analysis using these markers revealed
significant exclusion of this locus ( LOD scores 42 ) at y¼ 0 . These indicated that there is a
range of clinical presentation in MUHH, and more than one genetic locus are responsible for
MUHH.
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Antigen-Transduced Dendritic Cells are Superior to Peptide-Pulsed Dendritic cells for the
Induction of Cellular Anti-Melanoma Immunity in Mice
J Steitz, J Lenz, A Ferrer, D Tormo, D Schweichel, E Gaffal, S Bu¨chs, and T Tu¨ting
Laboratory of Experimental Dermatology, Department of Dermatology, University of Bonn,
Germany
Currently, melanoma vaccines utilizing cultured human dendritic cells (DC) as nature’s
adjuvant are being tested for patients with metastatic melanoma in early clinical trials. The
most effective antigen-loading strategy of cultured DC is still a matter of debate. In the
present study we directly compared the efficacy of DC-based melanoma vaccines using
synthetic peptides and recombinant adenovirus in an experimental mouse model. We show
that adenovirus-transduced are superior to peptide-pulsed DC in mediating protective
immunity against experimentally induced metastatic-like growth of B16 melanoma cells in the
lungs. We provide evidence that adenovirus-transduced DC present antigen for a much
longer time period in vitro and stimulated stronger cytotoxic T cell activity in vivo than
peptide-pulsed DC. We conclude that melanoma vaccines consisting of antigen-transduced
DC are significantly more effective than peptide-pulsed DC in an experimental mouse
melanoma model. Our results provide a possible explanation for the lack of efficacy in human
clinical studies using peptide-pulsed DC and suggest that antigen-loading strategies for DC-
based melanoma vaccines need to be optimised.
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Plasminogen Activator Inhibitor 2 (PAI-2) Expression in Netherton Syndrome and
Lamellar Ichthyosis: Transglutaminase-1 Up-regulated Versus Transglutaminase-1
Deﬁcient Epidermis
V Oji, M E Oji, N Adamini, K Aufenvenne and H Traupe
Department of Dermatology, University of Mu¨nster, Germany
Plasminogen activator inhibitor 2 (PAI-2), a member of the ov-serpin subfamily, shows a
strong presence in the stratum granulosum of the epidermis and in the cornified cell envelope
(CE). It is considered to confer protection against apoptosis implicating a substantial role for
terminal differentiation. Netherton syndrome (NTS) is a severe congenital ichthyosis with
epidermal deficiency of the serine protease inhibitor LEKTI due to mutations in SPINK5.
Lamellar ichthyosis (LI) is a heterogeneous cornification disorder often caused by autosomal
recessive mutations in the transglutaminase-1 gene (TGM1). In at least 50% of all LI patients
immunohistochemical studies reveal a thin or absent CE with drastically reduced trans-
glutaminase-1 activity.
We analyzed the epidermal transglutaminase-1 activity and the presence of PAI-2 antigen
(#3750, American Diagnostica, Greenwich, CT) in different types of LI compared with NTS,
psoriasis vulgaris (PV) and atopic dermatitis (AD). AD skin sections (n¼ 6) showed normal
transglutaminase-1 activity and normal expression of PAI-2 antigen in the stratum granulo-
sum. In contrast, skin from PV (n¼ 8) and NTS (n¼ 6) patients displayed a grossly enlarged
activity zone of transglutaminase-1 as well as a broadened zone of pericellular PAI-2
expression. Interestingly, epidermis of all 6 patients suffering from transglutaminase-1
deficient LI showed a clear lack of PAI-2 expression or a very faint intracellular
immunostaining.
PAI-2 contains three acceptor sites, Gln83, Gln84, and Gln86, for transglutaminase-
catalyzed amine incorporation as has been shown for tissue transglutaminase (TGM2) and
factor XIIIa. Considering the fact that PAI-2 does not show pericellular staining in trans-
glutaminase-1 deficient epidermis, we propose that PAI-2 is in vivo incorporated in the CE by
transglutaminase-1 suggesting a potential role in LI and other cornification disorders.
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Stimulation of the Uncoupling Protein 2 Gene, A Fat-Burning Adipocyte Protein
M Bonnet-Duquennoy, F Pellicier, M Juan, R Kurfu¨rst, S Schnebert, J Franchi, C Mahe´
LVMH, R&D Parfums et Cosme´tiques, Saint Jean de Braye, France
Eukaryote cells generate ATP in their mitochondria by oxidative phosphorylation. The
oxidative reactions of the respiratory chain generate an electrochemical proton gradient
across the inner membrane of the mitochondria which is then used by the enzyme ATP
synthase to phosphorylate ADP to give ATP. Cell respiration is only partially coupled to
ADP phosphorylation in mitochondria. Uncoupling proteins (UCP) are carrier proteins in
mitochondria that cause protons to re-enter the matrix, thus destroying the electrochemical
proton gradient. The energy liberated is then dissipated as heat and less ATP is synthesized.
UCP2 is abundant in white adipose tissue and can be regulated by fatty acids. UCP2 is thus
a potential target for drugs used to treat obesity, as it may promote energy production and
diminish metabolic efficiency. Therefore, we have developed a real-time quantitative RT-PCR
assay to measure the UCP2 mRNA in 3T3-F442A adipocytes. The quantity of UCP2 mRNA
was referred to that encoding the ribosomal S26 protein. The RT-PCR experimental
conditions were optimized to detect and quantify 10 copies of the UCP2 transcripts. This
assay was checked by measuring the effects of reagents known to influence the transcription
of the UCP2 gene. We showed that TNF alpha inhibited quantity, while insulin stimulated
UCP2 mRNA transcript number in adipocytes. We used these methods to study the effect of
linoleic acid and a polar lipid complex rich in linoleic acid (50%). The amount of UCP2 mRNA
was increased by linoleic acid (þ49% at 30 mg/ml and þ 57% at 60 mg/ml). The polar lipid
complex also enhanced the amount of UCP2 mRNA in adipocytes (þ 214% at 120 mg/ml and
þ 252% at 240 mg/ml).
With a specific, rapid, sensitive and quantitative RT-PCR methods, we identified different
molecules which could be modulated the UCP2 transcripts, a fat burning gene, in adipocytes.
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Real Time QRT-PCR Approach for Gene Expression Study on Skin and Different
Cutaneous Models
M Bonnet-Duquennoy1, K Lazou1, C Gondran1, M Tailhardat1,2, S Bosset1,2, B Le Varlet1, J
F Nicolas2, K Kurfu¨rst1, S Schnebert1 and C Mahe´1
1LVMH, R&D Parfums et Cosme´tiques, Saint Jean de Braye, France. 2INSERM U503, Lyon,
France
Gene expression study is one of strategies developed to understand biological processes.
Real time quantitative RT-PCR (QRT-PCR) is a suitable tool for studies on differential gene
expression and is characterized by wide dynamic range of quantification, high sensitivity and
high precision. This technique provides the high accuracy and reproducible results necessary
for mRNA quantification experiments.
To investigate cutaneous mechanisms, we have established different QRT-PCR assays on
skin biopsies and models like culture cells isolated epidermis, reconstructed epidermis, equi-
valent dermis models like collagen lattice. All QRT-PCR were performed in conditions to
obtain a detection level of 10 copies and an efficacy up to 90% with standard curves and
samples.
We studied expression of different genes on the major human skin culture cells: melano-
cytes, keratinocytes, fibroblasts, adipocytes, dendritic cells. On keratinocytes, we measured
the induction of interleukin transcripts (interleukin-1 alpha and 1 beta) with retinoic acid
treatment and identified potential retinoic acid like compounds. We studied, on human normal
melanocytes, expression of the melanogenesis gene tyrosinase and the inhibitory effect of
lactic acid (43% at 5mM during 24 hours). To study differentiation of epidermis, we
compared the expression level of gene on reconstructed epidermis models (RHE) and normal
human keratinocyte (NHK) culture. In this way, we showed that involucrin transcripts amount
was dramatically increased in RHE than NHK (þ 1500%).
To study human skin in vivo, we developed a RNA extraction protocol and different QRT-
PCR from frozen skin biopsies or isolated epidermis. We used this technique to investigate
epidermal markers of the photo-ageing process for the face skin. We identified a decrease in
expression of interleukin-1beta and beta 1 integrin in photo-aged skin showing immune and
structural alterations. Then beta1A integrin transcripts measurement was used to evaluate, in
vivo, the effect of a cosmetic formula. And we showed that topical application of this anti-
wrinkle cosmetic product was able to significantly increase the expression of beta 1 integrin.
In dermis, because of less number of cells and the poor quality of RNA after extraction,
expression study in vivo was difficult. Fibroblasts cultivated in three-dimensional tissue-like
collagen matrix were a good model for investigation. We developed, in this model, a method
to detect gene expressed in dermis like talin. We showed that induction of contraction with
PDGF was correlated with a decrease of talin amount (50% at 5 ng/ml during 12 days).
In conclusion, real time QRT-PCR gives way to investigate healthy skin and its alterations
and to identify new active compounds.
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Fluconazole Upregulates SconC Expression and Inhibits Sulphur Metabolism in
Microsporum canis
A Uthman1, M Dockal2, J So¨ltz-Szo¨ts1, and E Tschachler1,2
1Ludwig Boltzmann Institute for Venero-Dermatological Infection, and 2Department of
Dermatology, University of Vienna Medical School, Vienna, Austria
Recently we reported that fluconazole downregulates the expression of the fungal metallo-
thionein gene, and increase copper cytotoxicity in Microsporum canis, suggesting that
besides interfering with ergosterol synthesis, azole derivatives also act on other biological
circuits of fungal cells.
We used Differential display to detect gene regulation in fluconazole treated and untreated
M. Canis. The fragment is extracted and used as a probe to detect and sequence the gene
from cDNA library.
We reports here the isolation and the structural organization of M.canis sulphur metabolism
negative regulator gene (sconC) an SKP1 family homolog and its regulation by fluconazole.
The genomic DNA sequence of 1284 bp M.canis sconC contains five introns. Four of them
(52, 60, 47 and 70 bp) interrupting the ORF of 724 bp, encoding a protein of 165 amino acids.
The fifth intron (56 bp) localized upstream of the ATG transcription initiation sites. Furthermore
we found that fluconazole upregulates sconC mRNA expression and protein transcription,
and inhibits sulphur metabolism in M.canis, most likely due to sconC upregulation. This data
confirm our previous conclusion that in addition to its action on ergosterol synthesis,
fluconazole acts on other biological pathways in fungal cells. These works help to optimize
the antifungal action of azoles.
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Identiﬁcation of Novel Mutations In Two Hungarian Patients With Hailey-Hailey Disease
E Racz, M Csikos, S Karpati
Department of Dermatology, Semmelweis University, Budapest, Hungary
Hailey-Hailey disease (HHD) is a rare hereditary condition characterized by development of
blisters at the sites of friction and in the intertriginous areas. Mutations in the ATP2C1 gene
have been identified in the background of the disease. The objective of this study was to
detect ATP2C1 mutations in Hungarian patients with HHD. PCR amplification of the entire
coding region of ATP2C1 was performed. Mutation detection strategies included hetero-
duplex scanning by conformation-sensitive gel electrophoresis and direct nucleotide
sequencing. We found two distinct, heterozygous mutations, both of which were novel. In
a 65-year-old male patient with a 41-year-long history of severe recurrent symptoms a novel
insertion, Ains1085 was detected. In a woman with symptoms mainly in the inguinal region a
27-nucleotide-long deletion of the promoter region of the ATP2C1 gene was identified. These
mutations did not occur in 50 healthy control patients. Our study further illustrates the
diversity of mutational events in the background of HHD.
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New KIT Mutations in Patients with Piebaldism
T Murakami1,2, K Fukai1, N Oiso1, N Hosomi1, A Kato1 and M Ishii1
1Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka
Japan 2Department of Dermatology, Izumi Municipal Hospital, Izumi, Japan
Piebaldism is a relatively rare, autosomal dominantly inherited disorder, characterized by
congenital leukoderma, most commonly involving the forehead, abdomen, and knees. The
leukoderma is usually stable throughout life, although pigmented macules may develop at the
margins and even within the white macules. Most patients with piebaldism have mutations of
the KIT gene, which encodes the stem cell growth factor (SCF) receptor, a type III trans-
membrane receptor tyrosine kinase with an extracellular domain that binds SCF. In the skin,
KIT is expressed in mast cells and melanocytes. When activated by ligand binding, KITstimul-
ates proliferation of melanocytes and is essential for melanocyte development. A mouse
model for human piebaldism, o dominant white spotting, similarly results from mutations
involving the murine Kit locus. Twenty-one missense mutations, two nonsense mutations, five
frameshift mutations, four splice site mutations, one in-frame mutation, and various complete
and partial large deletions of the KIT gene have been reported in human piebaldism. Here, we
describe six novel mutations(142delG, 1768–1769delAG, 2139delC, 2246–2249delAAAG,
M541L and Y870C) that result in piebaldism, augmenting our knowledge of genotype-
phenotype correlation in this disorder.
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Foxp3 Expressing Regulatory CD4þCD25high T-cells in Human Metastatic Melanoma
Lymph Nodes
M Viguier12, F Lemaıˆtre1, O Verola3, L Dubertret2, P Kourilsky1, H Bachelez2, L Ferradini1
1Unite´ de Biologie Mole´culaire du Ge`ne, INSERM U277, Institut Pasteur 2Service de
Dermatologie I, INSERM U532, Institut de Recherche sur la Peau, Hoˆpital Saint-Louis
3Laboratoire d’Anatomopathologie, Hoˆpital Saint-Louis. Paris, France
Thymic-derived CD4þCD25high regulatory T-cells (Treg) have been recently shown to play a
critical role in the immune tolerance and the control of auto-immunity. Since tumor cells
express at least partly auto-antigens, Treg might also impair antitumor immune responses
directed toward these cells. Indeed, in murine tumor models, tumor rejection is increased
upon elimination of Treg. We investigated herein the idea that Treg could be involved in the
control of the local immune response in human metastatic melanoma. In a group of 12
patients with stage III melanoma which received no treatment other than surgery, we
demonstrated that CD4þCD25high T-cells were overrepresented with a two-fold increased
frequency in metastatic lymph nodes, compared to both non metastatic lymph nodes and
autologous PBMCs. These tumor infiltrating CD4þCD25high T-cells expressed the Foxp3
transcription factor, which is at this time the only specific marker available for Treg. They
displayed a phenotype of activated T-cells (high CTLA-4, CD69 and CD27 levels) and
inhibited in vitro the proliferation and cytokine production (IL-2, IFNg) of autologous infiltrating
CD4þCD25 and CD8þ through a mechanism which appears to be dependent on both cell
contact and immunomodulatory cytokines (TGFb, Il-10). Thus, they behave as previously
described CD4þCD25high Treg. Infiltrating CD4
þCD25high Treg expressed a largely polyclonal
TCR repertoire and not a repertoire restricted to a low number of antigenic epitopes. We also
found that infiltrating CD4þCD25 T-cells secreted IL-10 and/or TGFb and suppressed the
proliferation and IFN-g production of infiltrating CD8þ T-cells, providing evidence that cells
with a Tr1/Th3-like phenotype were also present in melanoma metastatic lymph nodes.
Moreover, as recently described for murine lymph nodes and as expected, we also found
activated CD4þCD25high T-cells displaying some suppressive activity in tumor-free lymph
nodes. Altogether, Treg are a major dominant immunosuppressive component of the micro-
environment of human metastatic melanoma lymph nodes. These data provide a new basis
for the design of future immunotherapeutic strategies aiming to counteract in vivo the effects
of Treg in patients with melanoma.
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Rab11 is Required for Birbeck Granule Biogenesis
R McDermott1, H Bausinger2, D Spehner2, D Lipsker2, F Proamer2, J-P Cazenave3, B
Goud1, H de la Salle2, J Salamero1 and D Hanau2
1UMR 144 CNRS-Institut Curie, Paris; INSERM 2E 0345 and 3U 311, EFS-Alsace,
Strasbourg, France
Birbeck granules (BGs) are organelles specific to Langerhans cells (LCs). This exclusive
cellular distribution is dependent on the expression of Langerin, a C type lectin. In a first study
we suggested that BGs form where Langerin accumulates, i.e., in the LC tubular endosomal
recycling compartment. However, the molecular mechanisms underlying this segregation
remain obscure. To identify potential molecular partners of Langerin involved in the
biogenesis of BGs, we first reconstituted Langerin traffic and BG formation in the endosomal
pathway of the human melanoma cell line M10. In the selected Langerin transfected cell line,
M10-Langerin, at the steady state, Langerin mainly concentrated in membranes related to the
Rab11þ endosomal recycling compartment. Langerin also recycles in M10-Langerin cells
and drives BG biogenesis in the tubular endosomal recycling compartment. We then
transfected the M10-Langerin cells with Rab11 wild type and mutants to evaluate ensuing
effects on BG formation. Expression of Rab11 constitutively active mutant led to a
redistribution of Langerin and of the BGs from the peri-centriolar area towards cell periphery.
In contrast, transfection with a dominant negative Rab11 mutant led to the formation of a
Langerin positive tubular network, similar to that seen after treatment with Brefeldin A.
Importantly, while BGs were still part of the network induced by Brefeldin A, in the absence of
an active Rab11 BGs were no longer present. We conclude that Langerin distribution is
dependent on Rab11 activity and that the biogenesis of BGs itself is dependent on the
presence of an ‘‘active’’ Rab11 molecule, indicating a new role for Rab proteins in organelle
biogenesis.
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Efﬁcacy of the Fully Human Monoclonal Antibody MOR102 Against ICAM-1 in the
Psoriasis SCID Mouse Model
W-H Boehncke1, M Urban2, A Popp2, D Waldherr2, FR Ochsendorf1, J Haunschild2,
T Litzenburger2
1Department of Dermatology, Johann Wolfgang Goethe-University, Frankfurt am Main,
Germany MorphoSys AG, Lena-Christ Str. 48, 82152 Martinsried, Germany
Skin-homing memory T lymphocytes play an important role in the pathogenesis of psoriasis
by interacting with vascular adhesion molecules and trafficking into lesional skin. Thus an
attractive option for targeted therapy of this disease would be blockade of lymphocyte
extravasation. We have generated the fully human monoclonal antibody MOR102 against
intercellular adhesion molecule 1 (ICAM-1) involved in lymphocyte adhesion to endothelial
cells, lymphocyte extravasation and co-stimulation of T cells. MOR102 was selected from the
Human Combinatorial Antibody Library (HuCALs) and then converted to the human IgG4
format. The antibody demonstrated efficient inhibition of lymphocyte adhesion to recombi-
nant ICAM-1 with an IC50 of  3 nM. In addition, MOR102 reduced lymphocyte proliferation
in mixed lymphocyte cultures by 50% at concentrations as low as 0.5 mg/ml. Sub-
sequently, the in vivo efficacy of MOR102 was tested on grafts derived from lesional
skin of three patients with chronic plaque-stage psoriasis transplanted onto SCID mice.
Intraperitoneal injection of 10 mg/kg of MOR102 antibody every other day over a period of 4
weeks resulted in reconstitution of orthokeratotic differentiation and a significant (po0.05)
reduction in epidermal thickness as well as marked reduction in the inflammatory infiltrate
when compared to PBS treated grafts. The effects observed in vivo were comparable to
those of dexamethasone (0.2 mg/kg, daily intragastric administration) used as positive
control.
Based on the efficacy of the fully human monoclonal antibody MOR102 demonstrated in
vitro as well as in vivo in the psoriasis SCID mouse model, initiation of clinical studies is
indicated.
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Induction of Heme Oxygenase-1 (HO-1) Inhibits Dendritic Cell Differentiation and
Adaptive Immunity
J Listopad, T Ritter, R Sabat, K Asadullah, WD Doecke
CRBA Dermatology, Schering AG & Institute of Medical Immunology, Humboldt University,
Berlin, Germany
The strong immunosuppressive potency of the stress protein HO-1 has been proven in
several models of autoimmunity and transplantation. The underlying immune mechanisms,
however, are poorly characterised. In our study, the potent HO-1 inducer Cobalt-
Protoporphyrine IX (Co-PPIX) strongly suppressed T-cell proliferation in mixed lymphocyte
reaction (MLR). As possible mechanism we demonstrated a selective Co-PPIX induced
increase of HO-1 expression in monocytes associated with depression of accessory
molecule expression and stimulatory cytokine secretion. The likewise induction of HO-1 in
monocyte-derived dendritic cells (MDDC) by Co-PPIX was associated with an almost
complete inhibition of the differentiation, maturation, and function of MDDC. So, a strong
decrease of the expression of DC markers (CD1a, CD83) and accessory molecules (HLA-DR,
CD86) was observed. Whereas IL-12 secretion was inhibited, IL-10 production increased.
The antigen-presenting capacity of Co-PPIX-treated MDDC was strongly diminished in
lymphocyte transformation assay and MLR. The specifity of these effects was demonstrated
by HO-1 transduction in immature MDDC. Additional investigations regarding effects of Co-
PPIX on genome-wide gene expression and signal transduction pathways in monocytes and
DC are ongoing. Together these changes indicated a swith of the DCs to an immature, non-
stimulatory phenotype. In vivo, Co-PPIX treatment before challenge dose-dependently
deressed ear inflammation in DNFB (Type 1) and TMA (Type 2) induced contact dermatitis in
mice. Remarkably, Co-PPIX even more strongly inhibited T-cell-dependent inflammation
when applied around sensitisation. We hypothesise that the inhibition of DC differentiation,
maturation, and function is a crucial mechanism for the suppression of adaptive immunity by
HO-1 induction in vitro and in vivo.
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Relative Contributions of Different Immunocyte Populations to the Development of a
Psoriasis Like Inﬂammatory Skin Disease in Mice with Epidermis Speciﬁc Deletion of I
Kappa B Kinase 2 Stratis
T Krieg, I Haase
University of Cologne, Germany
Nuclear factor kappa B (NF-kB) proteins play an important role in immune responses and
cellular survival. Activation of NF-kB is mediated by the I kappa B kinase (IKK) complex. IKK
is composed of the IKK1 and IKK2 catalytic subunits and the regulatory subunit NEMO (NF-
kB Essential Modulator). Mice with an epidermis specific deletion of IKK2 (IKK2EKO) exhibit a
severe skin disease shortly after birth that is characterised by pronounced acanthosis, hyper-
and parakeratosis, intraepidermal pustule formation, dilated blood vessels in the dermis and
a dense inflammatory infiltrate consisting of T lymphocytes, macrophages, granulocytes
and mast cells in the upper dermis. Macroscopic and histological features of this disease
are reminiscent of human psoriasis. Akin to psoriatic skin, epithelium lining macrophages are
present in the skin lesions of IKK2EKO mice. The development of the inflammatory response in
the skin depends on the presence of the type I receptor for tumor necrosis factor and can be
delayed by systemic application of TNF neutralizing proteins. We are currently investigating
further pathogenic mechanisms involved in the onset of this skin disease. Using genetic and
pharmacological approaches we have selectively eliminated different types of inflammatory
cells from the skin of IKK2EKO mice: ab T lymphocytes, macrophages and granulocytes.
Whereas elimination of ab T lymphocytes had no influence on the course of the disease, both
elimination of skin macrophages by injection of liposome encapsuled clodronate subcuta-
neously and inhibition of granulocyte invasion by targeted deletion of the CD18 gene
attenuated the inflammatory phenotype, although to different degrees. Comparative analysis
of skin changes in the absence of macrophages or granulocytes indicates that skin
inflammation in IKK2EKO mice is primarily driven by skin macrophages.
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VLA-1 Dependent Intraepidermal T Cell Expansion is Necessary for the Development of
Psoriasis
C Conrad1, O Boyman1, A de Fougerolles2, V Kotelianski2, H Gardner2 and FO Nestle1
1Department of Dermatology, University Hospital of Zurich, Switzerland; 2Biogen Inc.,
Cambridge MA, USA
Psoriasis is a chronic relapsing T cell-mediated skin disorder. Activated T cells migrating into
the epidermis seem to be required for disease formation. Trafficking of leukocytes within
tissue and thereby generating an inflammatory response is critically dependent on
interactions with extracellular matrix (ECM) proteins such as collagens. We investigated the
functional expression of a major collagen-binding receptor: a1b1 integrin (VLA-1) in psoriasis.
VLA-1 was exclusively expressed by infiltrating epidermal but not dermal CD8þ and CD4þ
T cells in active psoriasis lesions. To determine the in vivo relevance of VLA-1 expression on
activated T cells in psoriasis we took advantage of a recently described xenotransplantation
model with spontaneous development of psoriasis. Uninvolved human skin from patients with
psoriasis was engrafted onto AGR mice, mice deficient in type I and type II interferon
receptors in addition to being RAG/. A time course experiment revealed that the expansion
of the epidermal T cell pool correlated well with the onset of a psoriatic phenotype indicating
that epidermal T cells are major effectors in psoriasis. In vitro, migration of human activated,
VLA-1 expressing T cells through collagen IV could significantly be blocked by adding anti
VLA-1 antibodies. Therefore we tested the potential of anti VLA-1 treatment to block T cell
migration through the basal membrane and thereby to inhibit the expansion of epidermal T
cells in vivo. Upon transplantation, mice were treated with either murine anti-human a1-
integrin mAb or isotype control antibody. Compared to isotype control, anti VLA-1 treatment
led to a significant and almost complete blockade of epidermis infiltrating T cells. Given that
epidermal T cells are key effectors we wanted to know if inhibiting the migration of dermal T
cells into the epidermis would also block psoriasis development. Skin grafts on mice
receiving control antibody developed a fully-fledged psoriasis after 6 weeks as expected. In
contrast, blockade of VLA-1 inhibited psoriasis formation in 6 out of 6 mice (n¼ 3 patients).
Anti VLA-1 treatment resulted in a significant reduction of both acanthosis and papillomatosis
index.
Our findings suggest a crucial role for intraepidermal VLA-1 expressing T cells in psoriasis
and might provide the basis for new strategies in psoriasis treatment focusing on T cell/ECM
interactions.
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Blockade of Extracellular-Signal-Regulated Kinases 1/2 Deranges Chemokine Expression
in Keratinocytes Leading to Enhanced Skin Inﬂammation
S Pastore, F Mascia, F Mariotti, C Dattilo and G Girolomoni
Rome, Italy
Prominent epidermal growth factor receptor (EGFR) activation is a common feature of T cell-
driven inflammatory skin disorders, and is directly responsible of epidermal hyperplasia and
thickening. We have recently demonstrated that EGFR activation also participates in the
control of chemokine expression in human keratinocytes, by augmenting IL-8/CXCL8
expression and down-regulating MCP-1/CCL2, RANTES/CCL5 and IP-10/CXCL10. Here
we investigated the intracellular mechanisms involved in EGFR-mediated control of TNF-a-
driven chemokine expression. When associated to TNF-a, exogenous TGF-a efficiently
induced a persistent potentiation of Extracellular-Signal-Regulated Kinases (ERK)1/2 and a
modest, transient increase in JNK and p38 MAPK activity. By contrast, EGFR functional
blockade by specific inhibitors prevented ERK1/2 activation completely, without relevant
effects on JNKs and p38 MAPKs. Selective inhibition of either EGFR or ERK produced a
similar decrease of IL-8 and increase of MCP-1, RANTES and IP-10 expression. Reporter
gene analysis demonstrated that both the inhibitors strongly suppressed TNF-a-driven IL-8
promoter activity, whereas they did not affect the transactivation of MCP-1 promoter. These
results suggested that ERK1/2 was directly involved in the control of the transcription of IL-8,
but not of MCP-1 gene in human keratinocytes. Also, they indicated that the increased
expression of MCP-1 mRNA following EGFR or ERK1/2 inhibition could rather depend on
post-transcriptional events. Indeed, mRNA decay kinetics performed in the presence of
mRNA synthesis inhibitors demonstrated that EGFR or ERK1/2 blockade was associated to
prominent stabilization of MCP-1 mRNA. Finally, skin application of a selective ERK1/2
inhibitor led to worsening of both irritative and allergic contact dermatitis in mice, with
significant increase of edema and macrophage/monocyte infiltration in both the dermis and
epidermis. In conclusion, ERK1/2 activation appears to mediate important anti-inflammatory
functions in the skin. Its inactivation causes enhanced expression of several potent epidermal
chemokines, which potently attract leukocytes and lead to enhanced skin inflammation.
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Identiﬁcation of Toll-like Receptors and Characterisation of the Signal Transduction
Pathway During Candida albicans Infections
G Weindl, A Roeder, M Schaller, H C Korting, R A Rupec
Department of Dermatology, Ludwig-Maximilian-University, Frauenlobstr. 9-11, D-80337
Munich, Germany
Recognition of the human pathogenic fungus Candida albicans by the innate immune system
is the first approach to activate a rapid immunological response. It takes place by Toll-like
receptors (TLRs) which are specialized for recognition and binding of evolutionary conserved
pathogen associated molecular patterns (PAMPs). Activation of TLRs upon PAMP binding
leads to the induction of transcription factors such as nuclear factor (NF)-kB, and to a
subsequent inflammatory response which is crucial for the successful defeat of candidosis.
Here we analyzed the role of Toll-like receptors (TLRs) by using TLR2, TLR4, TLR2/4-
deficient murine macrophages, respectively, and human embryonic kidney (HEK) 293 cells
transfected with human TLR2 or TLR4-expression plasmids upon stimulation with two C.
albicans preparations, viable and antimycotics (AM)-treated C. albicans. We found that both
TLR2 and TLR4 were involved in recognition of viable C. albicans wild-type strains, whereas
C. albicans treated with a mixture of three antifungal drugs (i.e. amphotericin B, nystatin, and
itraconazole) mainly employed TLR2 in murine macrophages and transfected HEK293 cells.
In both cell types, preincubation of macrophages with the stimulating cytokine interferon
(IFN)-g led to the ability of TLR2 to sense viable C. albicans cells in the absence of TLR4, while
AM-treated C. albicans still were sensed by TLR2 in a TLR4- and IFN-g-independent manner.
The differences in the TLR activation pattern of viable C. albicans as compared to C. albicans
treated with cytoplasmic membrane-interacting antimycotics suggest specific recognition of
different cell wall PAMPs by TLRs in innate antifungal responses.
Analysis of the signal transduction cascades following viable C. albicans recognition
demonstrated phosphorylation and degradation of IkB-a, the inhibitory subunit of NF-kB.
Moreover we could show, that c-Jun NH2-terminal kinase (JNK) and c-Jun, a component of
the transcription factor AP-1, as well as the mitogen activated protein (MAP) kinases p38 and
p44/42 were activated. Our work shows that in addition to NF-kB, AP-1 is involved in the
cellular response to C. albicans and points towards a cross-talk between these transcription
factors which enables the host to fine-tune the innate immune response to fungal challenges.
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Pseudomonas aeruginosa Protease IV Induces Proinﬂammatory Mediators and Antibiotic
Peptides in Keratinocytes
G Schmeling, L Schwichtenberg, O Wiedow
Universita¨ts-Klinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany
Intact human epidermis is rarely colonized by Pseudomonas aeruginosa. Culture super-
natants of this gram-negative bacterium are supposed to contain pathogen-associated
molecules responsible for the induction of expression of proinflammatory cytokines and
antimicrobial peptides in human epithelia. Several substances are released by the organism
into the environment. Among them bacterial exoproteases are good candidates for the
stimulation of cellular activities in keratinocytes. Culture supernatants of P. aeruginosa strain
ATCC 11440 were partially purified by sequential ultrafiltration in steps of 300 kDa, 30 kDa
and 3 kDa. Investigation of the 30–300 kDa fraction revealed a trypsin-like enzymatic activity
and calcium-mobilizing activity in HaCaT keratinocytes. Further purification by p-amino-
benzamidine affinity chromatography led to a compound with lysine-specific proteolytic
activity with steady calcium-mobilizing activity in keratinocytes. The specific cleavage of
tosyl-glycyl-prolyl-lysine-pNA, the typical inhibitor profile and detection in SDS-PAGE proved
the identity to protease IV from P. aeruginosa. It could be shown by single cell fluorescence
imaging microscopy, that the purified enzyme induced calcium-influx in HaCaT keratinocytes
as well as in primary keratinocytes with similar time course and potency as compared with
trypsin and thrombin. Pre-stimulation of HaCaT keratinocytes with thrombin and trypsin
abolished a subsequent response to protease IV. This points towards a possible involvement
of protease-activated receptors on keratinocytes. RT-PCR and real-time-PCR analysis
showed that protease IV induced pronounced mRNA-expression of the proinflammatory
cytokines IL1b, IL-8 and TNFa and the antimicrobial peptides HBD-2 and RNase-7 in HaCaT
keratinocytes. Protease IV could be defined as a pathogen-associated molecule which is
secreted into the environment. By utilization of a calcium-dependent signalling pathway the
enzyme induces epidermal defence mechanisms such as cytokine and antimicrobial peptide
expression in human keratinocytes. Thus, protease IV seems to be involved in the recognition
of cutaneous P. aeruginosa colonization by keratinocytes followed by the initiation of innate
immune responses.
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Depletion of Human CD4þ T Cells in Peripheral Blood and Skin by HuMax-CD4
LS Villadsen,1 CEG Havenith,2 L Skov,1 TN Dam,3 F Dagnc´s-Hansen,4 J Rygaard,5 J
Schuurman,2 JGJ van de Winkel,2,6,7 O Baadsgaard,6 and PWHI Parren2
1Department of Dermatology, University of Copenhagen, Gentofte Hospital, Denmark.
2Genmab B.V., Utrecht, The Netherlands. 3Department of Dermatology, University of
Aarhus, Marselisborg Hospital, Denmark. 4Department of Medical Microbiology, University
of Aarhus, Denmark. 5Bartholin Institute, University Hospital of Copenhagen, Denmark.
6Genmab A/S, Copenhagen, Denmark. 7Department of Immunology, University Medical
Center Utrecht, The Netherlands
CD4þ T cells are involved in inflammatory skin diseases and are the malignant T cells in the
majority of Cutaneous T cell Lymphomas. Targeting CD4 may, therefore, inhibit or eliminate
disease-driving T cells, which could be a useful approach in the treatment of inflammatory
and malignant T cell driven skin diseases. In this study we used HuMax-CD4, which is a fully
human antibody against CD4. First, 20 human volunteers were treated with either placebo, or
one of four doses of HuMax-CD4 (0.5, 1, 2, or 4 mg/kg) iv. once. HuMax-CD4 treatment
resulted in a dose-dependent decrease in the number of circulating CD4þ T cells with
maximum at 4 mg/kg 12 hours following injection (placebo: 3.5 (27; 22); HuMax-CD4: 75
(83; 19) (median (range) of change in percent from baseline)). Then we investigated
whether HuMax-CD4 depleted skin infiltrating CD4þ T cells in a human inflammatory skin
disease model, the human psoriasis SCID mouse xenograft model. HuMax-CD4 treatment
resulted in a significant reduction in numbers of skin infiltrating CD3þ T cells (PBS:
39.9  16.4 (n¼ 8); HuMax-CD4: 4.7  0.9 (n¼ 7); P¼0.001 (mean  SEM)). The reduction
in CD3þ T cells was not due to a reduction in the subgroup of CD8þ T cells (PBS (n¼ 8):
15.5  6.5; HuMax-CD4 (n¼7): 12.6  4.6; P¼ 0.82 (mean  SEM)), but due to a
significant decrease in the CD4þ T cells measured by a non-competing CD4 antibody
(NCL-CD4-368) (PBS (n¼ 8): 18.2  5.9; HuMax-CD4 (n¼ 7): 3.0  1.0; P¼ 0.003 (mean
 SEM)). Mechanisms behind HuMax-CD4’s ability to deplete T cells were investigated in
vitro. HuMax-CD4 did not induce complement-dependent cytotoxicity or apoptosis of CD4þ
T cells but was highly effective in triggering antibody-dependent cell-mediated cytotoxicity
with natural killer cells as effectors (14–90% specific lysis (n¼ 10)). Furthermore, HuMax-CD4
inhibited T cell activation and proliferation in a dose-dependent manner. The ability of HuMax-
CD4 to deplete CD4þ T cells in peripheral blood and skin makes the antibody a candidate for
therapy of inflammatory and malignant skin diseases involving CD4þ T cells.
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Generation of Regulatory T cells by Retroviral Gene Transfer of Foxp3
K Loser1, W Hansen2, A M Westendorf2, D Bruder2, J Buer2, S Beissert1,2
1Department of Dermatology, University of Mu¨nster, Mu¨nster; 2Department of Cell Biology
and Immunology, German Research Center for Biotechnology, Braunschweig
Immunological unresponsiveness to self is mediated in part by regulatory CD4þCD25þ T
cells (Treg), which can actively suppress self-reactive T cells that have escaped thymic
selection. The isolation of large numbers of Treg is difficult, since CD4þCD25þ cells
constitute only a small subset of CD4þ T cells. Recently, the transcription factor Foxp3 has
been identified to be a key regulatory gene for the development of Treg. The Foxp3 cDNA was
cloned into a MCSV-based retroviral vector encoding eGFP under control of an IRES site and
used to transfect the GPE86 packaging cell line. For controls a retrovirus containing only
eGFP was employed. Retrovirus-containing culture supernatants were utilized for Foxp3 gene
transfer into murine naive CD4þCD25 T cells to investigate if these cells would develop
a regulatory phenotype. Control virus-transfected T cells proliferated, whereas Foxp3
transfected T cells were anergic. Flow cytometry analysis of Foxp3 transfected T cells
revealed expression of CD25, CTLA-4, and neuropilin-1, all molecular markers associated
with Treg. Subsequently, GFPþ T cells were added to CD4þCD25 T cells to study their
suppressor function. Naive CD4þCD25 cells that were control virus-treated failed to inhibit
T cell proliferation. In contrast, naive T cells that had been transfected with the Foxp3
containing retrovirus showed strong suppressor activity. A mechanism by which Treg
suppress other T cells is the production of IL-10. Only Foxp3 gene-transfected T cells but
no control virus-treated T cells expressed IL-10. We are currently using Foxp3 transfected T
cells for the treatment of systemic autoimmunity in K14-CD40L transgenic mice in order
to ameliorate disease. Together, gene transfer of Foxp3 converts naive T cells towards
a regulatory phenotype similar to that of natural Treg. Furthermore, Foxp3 gene transfer may
be useful to generate large numbers of Treg for immunotherapy of autoimmune disorders.
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Immunization with Peptide or Protein Onto Ultraviolet Irradiated Skin to Induce Antigen-
Speciﬁc Cd8þ T Cell Unresponsiveness
M Ghoreishi and J P Dutz
Dept. of Medicine and BC Research Institute for Children’s & Women’s Health, University of
British Columbia, Vancouver, BC
In a murine model, repeated cutaneous exposure to low doses of ultraviolet B (UVB) impairs
the induction of contact hypersensitivity response to haptens and induces hapten-specific
suppressor T lymphocytes. We investigated whether UVB can be used to induce antigen-
specific unresponsiveness to protein or peptide antigens. Using an adoptive transfer model,
we have determined that UVB induces in vivo suppression of antigen-specific CD8þ T cell
proliferation, IFNg production and cytotoxic capability in response to ovalbumin (OVA) protein
immunization in C57BL/6 mice. This effect is strictly IL-10 dependent as no UVB suppression
of CD8þ T cell responses to protein antigen is noted in IL-10 deficient mice. Immunization
on UV irradiated skin further induces antigen –specific CD4þ regulatory cells since transfer of
CD4þ T cells from UVB irradiated and OVA-immunized but not control protein –immunized
mice suppresses the CD8þ T cell response to OVA immunization in non-irradiated mice.
Phenotypic analysis of these CD4þ T cells reveals that the suppressor effect of the CD4þ /
CD25þ T cell subset is dominant and depletion of this subset abrogates the adoptive transfer
of suppression. Further, immunization of UVB irradiated mice with an I-Ab –restricted OVA
peptide, induces the generation of regulatory T cells that prevent the priming of CD8þ T cells
to full OVA protein. Epidermal sheet staining of mouse skin after UV irradiation shows
depletion of I-Aþ Langerhans cells in the epidermis. In contrast to the effect on immunization
with protein antigen, UVB failed to induce suppression of CD8þ T cell priming in mice
immunized with the Kb- restricted OVA peptide, SIINFEKL. We suggest that UVB alters the
functional maturation of cutaneous dendritic cells resulting in the induction of CD4þ /CD25þ
regulatory T cells that inhibit antigen-specific CD8þ T cell priming and in the generation of
APC that fail to prime CD8þ T cells to protein antigen. The ability to generate antigen-specific
suppression using UVB to limit CD8þ T cell responses may be of therapeutic value to prevent
CD8þ T cell mediated auto-immune disease and transplantation rejection.
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Human Beta-Defensin-2 Induction in Keratinocytes is Controlled by Nuclear Factor-jB
Family and Activating Protein-1
K Wehkamp, L Schwichtenberg, J M Schro¨der and J Harder
Kiel, Germany
Human beta-Defensin-2 (hBD-2) is an inducible peptide antibiotic and part of the innate
chemical defence barrier of human skin which controls the physiological flora and protects us
in a very effective, fast responding way against invading microorganisms. The expression of
hBD-2 in keratinocytes is induced by proinflammatory cytokines and bacteria, especially by
IL-1b and Pseudomonas aeruginosa (PA). Since little is known about the signal transduction
pathways leading to hBD-2 gene induction, we investigated the transcription factors involved
in IL-1b and PA-mediated gene induction of hBD-2. We transfected HaCaT keratinocytes with
mutation constructs of hBD-2 promoter-driven luciferase reporter plasmids. Stimulation was
performed using supernatants of mucoid PA or IL-1b. The mutation of three potential NF-kB
binding sites resulted in a strongly diminished induction of promoter activity with the mutation
of the binding site next to exon-1 being the most reducing. Mutation of a potential AP-1
binding site reduced promoter activation by more than 70%. A combination of all four
mutations completely abolished hBD-2 promoter activity following IL-1b or PA treatment. To
further analyse the influence of NF-kB and AP-1 on hBD-2 gene induction, we investigated
the effect of the NF-kB inhibitor Helenalin and inhibitors of the three AP-1 inducing MAP-
kinase cascades (ERK1/2 pathway, JNK pathway and p38 pathway). Realtime PCR and
ELISA studies following stimulation of HaCaT and primary keratinocytes with PA or IL-1b and
co-incubation with the specific pathway inhibitors confirmed the involvement of NF-kB and
AP-1: the specific NF-kB-inhibitor Helenalin almost completely abolished hBD-2 induction;
the JNK-Inhibitor SP600125 suppressed hBD-2 induction by approximately 60%; the p38
MAP-kinase inhibitor SB202190 diminished hBD-2 induction by approximately 50%, but
ERK1/2-inhibitor PD98059 showed no modulating effect on PA or IL-1b-mediated hBD-2
induction. To determine the NF-kB subunits, responsible for hBD-2 induction, we established
a transcription-factor ELISA: nuclear extracts of PA or IL-1b treated primary keratinocytes
were incubated with oligonucleotides matching the NF-kB sequence of hBD-2 promoter.
Subsequently binding of NF-kB subunits was analysed using specific antibodies. These
studies revealed an increased binding of the NF-kB family members p65 (RelA) and p50 to the
NF-kB consensus sequence next to exon-1 of the hBD-2 gene. Binding of NF-kB subunits
p52, RelB and C-Rel was not affected. Our data indicate that the NF-kB family, especially
subunits p65 (RelA) and p50, is essential for hBD-2 induction following IL-1b or PA
stimulation. In addition to NF-kB, AP-1 also seems to be involved in IL-1 or PA mediated
hBD-2 induction following activation of the JNK and p38 pathway. We conclude that the
synergistic activation of NF-kB and AP-1 is essentially required for fully IL-1b or PA mediated
hBD-2 promoter activation in human keratinocytes.
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Analysis of Cutaneous Immune Surveillance in Transgenic Mice Expressing Ova in the
Skin
M Holcmannyw, G Stinglyw and M Sibiliayw
yDIAID, Department of Dermatology, Medical University of Vienna and wCompetence Center
for Biomolecular Therapeutics, BMT, Brunnerstrasse 59, A-1235 Vienna, Austria
Cutaneous immune surveillance seems to be important in host defence mechanisms.
However, the surveillance function of the skin has never been definitively proven to be
operative in vivo under physiological conditions. Depending on the cellular and molecular
microenvironment, immune responses generated by skin associated lymphoid tissues can
lead not only to protective immunity against pathogens, but also to tolerance.
To study immune responses to a de novo expressed antigen in the skin under homeostatic
conditions in vivo, we have generated transgenic mice expressing the surrogate antigen
ovalbumin (OVA) in a Cre-inducible manner in keratinocytes (K5-loxP-YFP-loxP-OVA-IRES-
CFP). Expression of OVA is either induced around embryonic day 14.5 with a constitutively
expressed K5-Cre transgenic line or in adult mice with an inducible K5-CreTM transgenic line
after tamoxifen administration. Several transgenic lines have been obtained, which, in an
uninduced state, express the yellow fluorescent reporter gene (YFP) but not the OVA gene in
epidermal cells. After Cre-mediated excision of YFP, OVA can be induced, as evidenced by
the expression of the OVA257–264 peptide SIINFEKL on keratinocytes by FACS analysis.
Moreover, these keratinocytes are able to stimulate the TCROVA specific T-cell hybridoma cell
line 4B10 to produce IL-2. Although OVA is efficiently expressed and presented, the
transgenic mice do not develop any obvious disease symptoms like hair or weight loss.
Moreover, no differences in thymic and peripheral T-cell numbers can be observed after Cre-
mediated OVA expression. After immunization with OVA and complete Freund’s adjuvant
there is no significant difference in ear swelling compared to controls. To monitor CD8þ T-
cell mediated immune responses the transgenic mice were crossed with OT1 mice
expressing a TCR specific for SIINFEKL-H2kb on all T-cells. No differences in the numbers
of antigen specific T-cells could be seen in the periphery, although we find activation of
antigen specific T-cells as indicated by upregulation of CD44.
Taken together our results suggest that expression of a de novo antigen in the skin and
thymus of newborn and/or adult mice does not affect the development and reactivity of
antigen specific T-cells. We are currently investigating whether an additional danger signal is
required to get an anti-OVA-specific immune response. Moreover, we are also comparing the
effects of peripheral (keratinocytes) versus central (DC) OVA expression in transgenic mice
expressing a Cre-inducible OVA from the CD11c promoter in DCs.
161
Relevance of b2-integrins in the Reverse Arthus Reaction
A Sindrilaru1, S Seeliger2, T Peters1, J Roth2,3, C Sorg3, K Scharffetter-Kochanek1,
C Sunderko¨tter1
1Department of Dermatology, University of Ulm, Germany, 2Department of Pediatrics,
University of Mu¨nster, Germany, 3Institute of Experimental Dermatology, Mu¨nster, Germany
The Arthus reaction is a classical experimental model of type III hypersensitivity, character-
ized by leukocytoclastic vasculitis of small blood vessels due to deposition of immune
complexes. The consequent tissue injury is mediated by inflammatory cell infiltration that is
highly regulated by various adhesion molecules. b2-Integrins are of critical importance for
leukocyte recruitment and extravasation through vascular endothelia. However, the specific
roles of these molecules in hypersensitivity vasculitis have not been clearly defined.
To assess the contribution of integrins in this pathogenic process, the cutaneous reversed
passive Arthus reaction was examined in mice lacking the b2-integrin subunit, CD18. Edema
and haemorrhage were severely suppressed and tissue damage, revealed by extravasation of
fluorescent-labelled bovine serum albumin, was significantly reduced in CD18(/) mice
compared with controls. Histological examinations showed the typical picture of leukocy-
toclastic vasculitis only in CD18(þ /þ ) mice, while CD18(/) mice showed low number of
infiltrating leukocytes, and no signs of vasculitis. Functionally, we found no differences
between CD18(þ /þ ) and CD18(/) granulocytes in their capacities of degranulation and
producing oxidative burst when bound to immune complexes. The inhibited vasculitic
reaction could be restored after injecting CD18(þ /þ ) viable granulocytes in CD18(/) mice
intravenously, but not after subcutaneous administration. This suggests that, although
immune-complex deposition occurs at both sides of the vessel wall, the damaging processes
take place only via immune complexes deposited at the luminal site, during diapedesis of
leukocytes. However, deposition of immune complexes alone is not sufficient to produce
leukocytoclastic vasculitis. Even though the capacity of granulocytes to degranulate is not
altered in CD18(/) mice and, consequently, CD18 is not directly involved in immune
complex-mediated endothelial damage, absence of CD18 sufficiently prevents granulocytes
from exerting their deleterious effect on vessel walls. This is due to impaired recruitment of
granulocytes in the skin in CD18 deficiency.
We here dissect basic mechanisms also underlying the therapeutical blocking of CD18 in
vasculitis and autoimmunity.
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Identiﬁcation, Isolation and Characterization of the Release Kinetics of a Distinct Rantes-
Containing Secretory Granule System In Human Lymphocytes – Relevance for the Atopy
Syndrome
A Ambach, A Weren, J Fang, H Roland, B Bonnekoh, W Ko¨nig, B Schraven, B Ko¨nig,
H Gollnick
Magdeburg, Germany
The beta-chemokine RANTES is stored in granules of platelets and eosinophilic granulocytes.
We now describe the discovery, characterization, isolation and release kinetics of a unique
pan-lymphocytic RANTES-granule system. Flow cytometry, laser scan microscopy, ELISA,
sucrose gradients, western blotting, activation of cells using various stimuli and various
inhibitors was employed. These RANTES-granules did not colocalize with known markers
of endosomes, lysosomes, secretory lysosomes or the MHCII-compartment. They were of
different density than granzyme-B contaning granules and could be mobilized to the cell
surface within one hour after an appropriate secregous stimulus like a combination of phorbol
ester and calcium ionophore, and/or anti-CD3 crosslinking in the case of T cells. The release
into the supernatant was independent of protein neosynthesis and was significantly faster as
known secretory organelles of lymphocytes like lytic granules of cytotoxic T lymphocytes or
natural killer cells. Investigating the peripheral blood from atopic patients, where RANTES is
supposed to play an important role in pathophysiology, their RANTES-granule system was
found to be significantly altered as compared to healthy individuals, namely a RANTES-
hyperreleasability is described. Taken together, a new secretory cell organelle in lymphocytes
is described which is stuffed with RANTES. The discovery of a RANTES-hyperreleasability in
atopic patients supports the idea of a cell type independent defect of secretory granules as a
major factor in the pathogenesis of atopy syndrome.
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Can Deletion Of Autoreactive T Cells Protect From Autoimmune Pancreatitis?
C Weigert1, K Ghoreschi1, M Muders2, G Baretton2, H Braumu¨ller1, M Ro¨cken1
1Department of Dermatology, University Medical Center, Eberhard Karls University
Tuebingen, Germany, 2Department of Pathology, Carl Gustav Carus Medical Faculty,
Dresden University of Technology, Germany
It is widely accepted, that organ-specific autoimmune diseases, such as multiple sclerosis,
psoriasis, rheumatoid arthritis and autoimmune diabetes are mediated by interferon (IFN-)g
producing Th1 cells targeting organ-specific antigens. Yet, recent models of autoimmune
diabetes suggest that beta cell destruction can proceed in the absence of beta cell surface
antigen recognition by specific T cells. To investigate the role of autoreactive Th1 cells in
organ-specific autoimmune disease and the protection provided by clonal deletion, we used
a mouse model of autoimmune pancreatitis. 415-EL-I-E C57BL/6 mice express MHC II I-E
exclusively on the exocrine pancreas. T cell reactivity to this ‘non-self’ MHC class II I-E
antigen is associated with T cell receptor containing vb5 chain and in 415-EL-I-E mice 4% of
the CD4þ T cells express the vb5 chain. In these mice TCR-vb5þ CD4þ T cells are not
clonally deleted and proliferation as well as IFN-g production of vb5þCD4þ T cells was
normal in 415-EL-I-E C57BL/6 mice. Histological analysis of the pancreas showed
inflammation in 50% and destruction in another 40% of 415-EL-I-E mice. To prevent
autoimmune pancreatitis we crossed 415-EL-I-E mice to 107-I-E mice, expressing MHC class
II I-E on B cells, macrophages, dendritic cells and thymic epithelium. In 415-EL-I-E107-I-E
F1 mice vb5þ T cells were decreased up to ten fold and did not proliferate in response to
mAb. Yet, deletion of autoreactive vb5þ T cells did not prevent pancreas destruction in 415-
EL-I-E107-I-E mice. To study the role of cross-reactive T cells we further crossed 415-EL-I-
E mice to immune deficient C57BL/6 RAG-2/ mice. Flow-cytometric analysis of the
lymphatic tissues of 415-EL-I-ERAG-2/ mice showed complete absence of T cells.
Surprisingly, pancreas destruction in 415-EL-I-ERAG-2/ mice was even enhanced. All
mice had completely destroyed pancreata. We conclude that autoimmune organ destruction
can develop in the absolute absence of T cells. The data raise the question of whether
autoreactive T cells are really harmful, or whether they can protect against inflammatory
autoimmune disease, at least under certain conditions, where organ destruction may be
caused by immune cells like macrophages or NK cells.
164
JAM-B and JAM-C are Required For Development Of Cutaneous Inﬂammation
R Ludwig1, TM Zollner2, HH Radeke3, S Santoso4, K Hardt1, R Kaufmann1, M Podda1,
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A hallmark of inflammation is leukocyte extravasation, which is mediated by adhesion
molecules expressed on leukocytes and endothelial cells in a stepwise process. In contrast
to the first steps (rolling, activation and adhesion), molecular mechanisms of leukocyte
transendothelial migration are less understood. Recently, much attention has been attributed
to junctional adhesion molecules (JAMs) in leukocyte transmigration. JAMs are adhesion
molecules of the Ig gene superfamily. JAM-A is located at intercellular junctions of endothelial
cells and is ligand for the b2-integrinLFA-1. JAM-B and -C are also expressed by endothelial
cells and bind VLA-4 or Mac-1, respectively. Since JAM-A antibodies were shown to inhibit
leukocyte migration to the skin, we sought to assess if JAM-B and -C contribute to
recruitment of leukocytes in cutaneous inflammation. For this purpose mice were sensitized
and challenged with DNFB. After development of delayed-type hypersensitivity (DTH, 24 h)
ears were snap frozen. Immunofluorescent quantitation of JAM-B and -C expression in
histological sections showed a constitutive expression in numerous vessels. No further
increase could be observed in DNFB- vs. vehicle-treated ears. However, this does not rule out
an involvement of JAM-B and -C in cutaneous inflammation, since at least JAM-A shows a
phosphorylation-depended binding and translocation from intercellular junctions to the apical
side of the endothelium following an inflammatory stimulus. A blockade of JAM-B or -C 1 hour
before DNFB-challenge with blocking antibodies lead to a significant decrease in ear swelling
(control Ab: 20.9, anti JAM-B: 4.1, anti-JAM-C 7.1 mm103; n¼ 8/group). In conclusion,
JAM-B and -C are constitutively expressed in murine vasculature and their expression pattern
seems unchanged upon inflammation. Blocking of JAM-B or JAM-C inhibits development of
a DTH reaction in mice. Hence, JAM-B and JAM-C may be involved in the pathogenesis of
chronic-inflammatory skin diseases, such as psoriasis or atopic dermatitis.
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Mature, but not Immature Plasmacytoid Dendritic Cells Induce Hapten-Speciﬁc T-Cell
Proliferation
C Bangert, S Graffi, S Altrichter, G Stingl, T Kopp
Department of Dermatology, DIAID, Medical University of Vienna, Austria
Plasmacytoid dendritic cells (pDC) are known to play a critical role in the innate and adaptive
immune response against viruses. We have recently detected these cells in the epidermal and
dermal infiltrate of allergic contact dermatitis elicited by epicutaneous patch tests (EPT). In
the dermis they represented a substantial proportion of the entire DC infiltrate and were
in close apposition to T-cells, suggesting interactions between pDC and infiltrating T-cells.
Further phenotypic analysis revealed that approximately 50% of pDC in EPT lesions express
the maturation markers CD83 and CD86.
In this study, we investigated the capacity of immature and mature pDC to stimulate hapten
specific T-cells. As a positive control, pDC were compared to CD1cþ myeloid dendritic cells
(mDC), which represent the major dendritic cell population in EPT lesions. Nickel-specific
CD4þ T-cell lines from nickel-allergic individuals were co-cultured with autologous blood-
derived pDC and mDC for 72 h. Before co-culture, both pDC and mDC were exposed to
nickel and either left immature or matured by using TNF-a and IL-3 and TNF-a and GM-CSF,
respectively.
Nickel-pulsed mature, but not immature mDC acted as strong stimulators of hapten-
specific T-cells, thus confirming previous observations. Importantly, nickel-pulsed mature
pDC induced a nickel-specific T-cell response comparable in magnitude to that elicited by
mDC. As expected, neither unpulsed mature nor immature pDC and mDC were able to
stimulate hapten-specific T-cells.
In conclusion, following exposure to nickel, mature pDC acquire the capacity of inducing a
hapten-specific T-cell proliferation, indicating that they may act as prominent amplifiers of the
adaptive immune response in allergic contact dermatitis. Whether the inability of immature
pDC to evoke a proliferative T-cell response reflects their potential to induce T-cell un-
responsiveness or even anergy remains to be determined.
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CD1e Undergoes a Double Processing in Endosomes: An N-Terminal Propeptide is
Cleaved in Concomitantly to the Conversion of Membrane Associated CD1e into a
Soluble Molecule
B Maitre, C Ange´nieux, J Reinbolt, D Fricker, J-P Cazenave, D Hanau, H de la Salle
INSERM0345 EFS-Alsace, CNRS UPR 9002, IBMC, Strasbourg, France
The alignment of the cDNA-deduced aminoacid sequences of CD1e from several species
suggests that CD1e includes an N-terminal extension of 9–12 aminoacids, as compared to
other CD1 molecules. Partial protein data about sheep suggest that endosomal CD1e does
not include such an extension. This raises the question as whether CD1e includes an N-
terminal extension. A plasma membrane targeted CD1e form was expressed in mammalian
transfected cells, as well as a CD1e-eGFP fusion protein, which was localized and cleaved in
endosomes, as natural CD1e. Plasma membrane-associated and soluble endosomal CD1e
were purified from both types of transfectants. Their N-terminal sequences showed that
the membrane-associated CD1e includes an N-terminal extension, which was absent on
endosomal soluble CD1e. Presence of the N-terminal extension on neosynthezised CD1e
was confirmed using antibodies rose against a synthetic peptide. To define the cellular
compartment where the N-terminal end of CD1e is processed, we compared the biosynthesis
of recombinant complete and a propeptide-free CD1e. Biochemical experiments showed
that the propeptide is cleaved after the Golgi compartment, in a bafilomycin sensitive
compartment, quite concomitantly with the cleavage of CD1e into a soluble form. Additional
experiments using a non cleavable mutated CD1e suggested that the cleavage of the
propeptide and the solubilization of CD1e occurs in substructures of the endosomal compart-
ments. These data demonstrate that CD1e has the unique property of undergoing a double
processing in late endosomes. Such a pro-protein structure has implications on the function
of CD1e.
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Anti-SC5 a Unique Monoclonal Antibody Reactive to Vimentin Expressed on Cell Surface
Membrane of Sezary Cells
D Huet, M Bagot, A Bensussan
INSERM 448 and Service de Dermatologie, Hoˆpital Henri Mondor, Cre´teil, France
Cutaneous T cell lymphoma (CTCL) represents a heterogeneous group of malignant mature T
cell proliferations. The most common forms are the mycosis fungoides and its leukemic
counterpart, the Sezary syndrome (SS). Until now, only few cell surface markers are available
to identify circulating Sezary cells. Recently, we have raised a monoclonal antibody (mAb)
against a molecule named SC5, present on the extracellular membrane and in the cyto-
plasmic part of Sezary cells. Cell surface staining revealed that CD4þSC5þ circulating
lymphocytes in SS patients are significantly increased in comparison with normal individuals
and are correlated with the percentages of morphologically detected Sezary cells in
peripheral blood. We have identified the SC5 molecule as the intermediate filaments vimentin.
This unexpected cell surface expression of cytoskeleton molecule is related to its transport to
surface membrane in early response to activation and its secretion into the extracellular
space. Vimentin has been clearly localized on surface of intact fresh Sezary cells and Sezary
cell lines by confocal microscopy and flow cytometry analysis. We have also shown
seroreactivity against vimentin in some patients with Sezary syndrome and transformed
mycosis fungoides. Binding assays and immunoprecipitation assays have shown that SC5 is
associated with actin, leucocyte specific protein 1 (LSP1), and a-actinin 4 in Sezary cells and
activated lymphocytes. Vimentin is a phosphorylated protein on serine and threonin, which is
involved in several signalling pathways and cellular regulation. Thus vimentin cell surface
expression suggests a cytoskeletal reorganization that may influence many structural pro-
cesses like cell morphology, cell adhesion or migration and also proliferation. SC5 mAb could
be a novel tool to better understand molecular pathogenesis of the malignancy. Finally SC5
mAb should offer a better identification of circulating malignant CD4 cells, and so
improvements of patients follow up.
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Are they Different? Langerhans Cells in the Steady State Versus Inﬂammation
P Stoitzner, #S Saeland, N Romani
Department of Dermatology, University of Innsbruck, Innsbruck, Austria, #Laboratory for
Immunological Research, Schering-Plough, Dardilly, France
Migrating Langerhans cells (LC) may induce immunity or – in the steady state – maintain
peripheral tolerance. A contact allergy model was employed to investigate changes in
migrating LC in steady state versus inflammation. We applied 2,4,6-trinitro-1-chlorobenzene
(TNCB) onto skin to induce migration of LC to lymph nodes. Dendritic cells (DC) isolated from
skin-draining lymph nodes of TNCB-treated and control mice were compared in phenotype
and function. In response to TNCB increased numbers of LC, as determined by anti-Langerin/
CD207 staining, appeared in the nodes. Nearly all of the LC already expressed CD80 and
CD86 in the steady state, the other members if the B7 family were found just on part of the
cells. After induction of inflammation more CD40-, B7-H1 (PD-L1)-, and B7-DC (PD-L2)-
positive LC were found in the lymph nodes. Furthermore, levels of costimulatory molecules on
LC were slightly enhanced in inflammation. Another B7 family member possibly involved in
tolerance induction, ICOS-L, was never detected on LC. When isolated lymph node DC were
stimulated with LPS- and anti-CD40 mAb the LC within this population produced IL-12p40
which was increased significantly during inflammation. The augmented IL-12 production
correlated with more IFNg being produced by T cells in lymph nodes draining inflamed skin.
After epicutaneous application of ovalbumin protein lymph node DC/LC presented peptides
on MHC II to antigen-specific CD4þT cells in vitro and in vivo. Furthermore, after the
induction of inflammation the proliferation of the CD4þT cells was strongly enhanced. Thus,
phenotypical differences between LC in steady state and inflammation may not be the
predominant markers for immunogenic versus tolerogenic LC. However, cytokine profiles
differ strongly and may be a decisive factor for the immunogenicity of LC.
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Study of Constitutive Expression, Cytokinic Modulation and Functional Capacity of
Toll-like Receptors (TLRs) in Normal Human Epidermis. Upregulation in Psoriatic Skin
E Begon, L Michel, B Flageul, F Jean-Louis, I Beaudoin, H Bachelez, L Dubertret,
Ph Musette
INSERM U532, Institut de Recherche sur la Peau, Hoˆpital Saint-Louis, Paris. 1Departement
de Dermatologie, Hoˆpital de Rouen, Rouen, France
Recent data gave evidence that TLR play a key role in both innate and adaptive immune
response. The human skin is consistently exposed to a wide range of exogenous stimuli
and can exhibit anti-infectious properties. The aim of the present work was to investigate the
expression of TLRs in human epidermis, to study its modulation by proinflammatory
cytokines and to characterize the function of these receptors within the epidermis in
physiological and pathological conditions. Primary cultures of keratinocytes established from
normal skin biopsies and an epithelial cell line (NCTC 2544) were studied for the expression of
TLRs by semi-quantitative RT-PCR, immuno-blot, immuno-cytochemistry and flow cytometry.
Alteration in TLR basal expression was quantified after cell exposure to various concentra-
tions (1 to 1000 U/ml) of cytokines (IFNgamma, TNFalpha) during 24 to 72 h. TLR function was
studied in the presence of pathogen-specific molecular patterns [PAMPs: peptidoglycans
(PGN) for TLR2, double stranded RNA poly (I:C) for TLR3, lipopolysaccharide (LPS) for TLR4]
and quantification of NF-kappa B translocation to the nucleus was measured by nuclear
DNA-binding activity by electrophoretic mobility shift assay (EMSA) or reporter gene analysis
after transfection of NF-kB gene reporter. The production of NF-kB-related cytokines
(TNFalpha and IL-8) by keratinocytes was measured in response to TLR stimulation. TLR
expression was analysed by immunohistochemistry on biopsies from normal human skin and
psoriatic lesions. Our results demonstrate that a large repertoire of TLRs is expressed in
normal skin as shown by RT-PCR. Immunohistochemical analysis of skin section showed an
expression of TLR3 and TLR4 in the cytoplasm of basal keratinocytes predominantly and
TLR2 staining was observed throughout the epidermis. By flow cytometry analysis, human
cultured keratinocytes and NCTC 2544 cells were shown to express TLRs with an intense
intracytoplasmic localization contrasting with a low level surface expression of TLR2, TLR3
and TLR4. Exposure of keratinocytes to IFNgamma increased intracytoplasmic expression
of TLR4 without affecting ectopic expression, whereas TNFalpha stimulated a partial
translocation of TLR2 to the cell surface. Stimulation of keratinocytes by PGN, poly (I:C) and
LPS led to the nuclear translocation of NF-kB as demonstrated by EMSA and luciferase
assay. Moreover, TLR stimulation induced the release of IL-8 and TNFalpha by keratinocytes.
The histological comparison of normal and psoriatic skin showed that TLR2 was strongly
upregulated in lesional psoriatic skin. In conclusion, we demonstrated that human
keratinocytes express a large repertoire of TLRs and functional TLR 2, 3 et 4. These results
suggest that the triggering of TLR2 by specific PAMS, i.d. PGN from Gram-positive bacteria,
is involved in the pathogenesis of psoriasis through the activation of a pro-inflammatory
program.
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TRANCE and its receptors TRANCE-R and OPG are Expressed in Epidermis: Implications
for Langerhans Cell Longevity
J-B Barbaroux, J B Mee, #C G Mueller, R W Groves
Dermatology Section, Division of Medicine, Imperial College London, UK and #INSERM
U255, Institut Biome´dical des Cordeliers, Paris, France
Recent data indicate that epidermal Langerhans cells (LC) have a marked capacity to survive
for long periods of time in the periphery. A newly described TNF superfamily signalling
pathway consisting of TRANCE, a decoy receptor, osteoprotegerin (OPG), and a functional
receptor, TRANCE-R (also known as RANK) has been associated with numerous activities
including regulation of dendritic cell (DC) function. We and others have shown that TRANCE-
TRANCE-R interactions support DC survival, allowing prolonged persistence of TRANCE-
treated DC in draining lymph nodes as well as extending survival of interstitial DC involved in
antigen surveillance. We hypothesised that this system might be of relevance to the
prolonged survival ability of LC and in this study sought to define expression of TRANCE and
its receptors in epidermis.
mRNA was prepared from normal human skin (n¼ 3) and from second passage
keratinocyte cultures (n¼ 3) and examined by semi-quantitative RT-PCR using primers
specific for TRANCE, TRANCE-R and OPG following normalisation with an epidermal
housekeeping gene. These studies demonstrated the presence of mRNA encoding TRANCE
and both receptors both in vivo and in the in vitro keratinocyte cultures. We then sought to
define the presence of soluble TRANCE protein by ELISA in keratinocyte cultures and
TRANCE-R by immunofluoresence of human skin. High levels of soluble TRANCE were
detected in 24 hr keratinocyte culture supernatants in vitro. In vivo, TRANCE-R was strongly
expressed by dendritic cells in the epidermis and in the superficial dermis. Double labelling
studies demonstrated that all CD1aþ ve epidermal and superficial dermal LC expressed
TRANCE-R.
These data indicate that TRANCE, OPG and TRANCE-R are all present within epidermis at
both protein and mRNA levels and lend support our hypothesis that this system may be
critically involved in the regulation of epidermal LC survival. The distribution of TRANCE
(produced by KC) and TRANCE-R (expressed on LC) suggests a cross-talk between these
two cell types and implies a further key regulatory role for keratinocytes in the cutaneous
immune response.
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Stem Cell Factor (SCF) Controls Mast Cell Accumulation At Sites Of Chronic
Inﬂammation But Not Tumor Development
F Siebenhaar1, J Knop1, M Maurer1,2
1Departments of Dermatology, University Hospital Mainz and 2Charite Berlin, Germany
Skin mast cells (MC) are known to accumulate at sites of chronic inflammation and tumor
development. However, the mechanisms of MC hyperplasia in these processes is not yet fully
understood. Stem cell factor (SCF) has been implicated to contribute to MC increases in
various settings including chronic inflammation and tumor development via effects on its
receptor kit expressed on MC. Here, we have used mice that do (Kitþ /þ ) or do not express
functional kit (KitW/KitW-v) to characterize the role of SCF in MC hyperplasia associated with
chronic inflammation and tumor development. Normal mice were treated with TPA twice
weekly, which resulted in pronounced inflammatory responses as assessed by quantitative
histomorphometry and FACS analysis. Confirming previous reports we found that the
induction of chronic inflammation is associated with markedly increased skin MC numbers,
i.e. 5.5  0.2 MC per microscopic field (MF) in untreated skin versus 33.9  2.9 MC/MF in
week 9 of treatment. Similar increases of MC numbers were found in the vicinity of developing
skin tumors induced by topical DMBA/TPA treatment (6-fold increase at weeks 15 and 25).
Interestingly, chronically inflamed skin in kit-deficient mice did not exhibit significantly
increased MC numbers (0.03  0.03 in week 0 and 0.2  0.1 in week 9), indicating that SCF
is required for MC hyperplasia at sites of chronic inflammation. Most notably, pronounced MC
hyperplasia was found at sites of tumor development in kit-deficient mice, where numbers of
MC were increased 125- and 260-fold in weeks 15 and 25, respectively. Our data show that
SCF controls MC accumulation at sites of chronic inflammation but not tumor development.
These findings suggest that skin tumor cells can induce MC hyperplasia by promoting MC
recruitment, differentiation, and/or proliferation independent of SCF.
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Expression of the Stem Cell Markers Sca-1, CD34, CD45 and c-kit in Neonatal Mouse Skin
A Wolnicka-Glubisz and F Noonan
Department of Environmental and Occupational Health, School of Public Health and Health
Services, the George Washington University Medical Center, Washington DC, USA
Multipotent stem cells have been identified in multiple tissues including the skin. We have
used FACS analysis to identify cells carrying stem cell markers in neonatal mice. Skin from
neonatal FVB mice, 1–7 days of age, was digested with liberase and single cell suspensions
prepared using the Medimachine (DakoCytomation). FACS analysis was carried out on fresh
suspensions using antibodies specific for the early haemopoietic markers Sca-1, CD34,
CD45 and c-kit. A major population of Sca-1þ cells was identified, the percentage of which
decreased with age from day 1 through day 7. In contrast, the percentage of c-kitþ cells was
constant over this time period. All Sca-1þ cells were c-kit, MHC Class II and consisted of
two populations Sca-1þCD34þ and Sca-1þCD34. About 2% of Sca-1þ cells expressed
the macrophage lineage markers CD45þ CD11bþ and were in the CD34 negative population.
These results indicate CD45c-kit cells expressing other stem cell markers in neonatal
mouse skin are of non-haemopoietic origin.
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Melanoma Antigens Are Cross-Presented In Draining Lymph Nodes to CD8þ T cells in
the Absence of CD4þ T Cell Activation : use of CD40-L to Correct the Defect
O Preynat-Seauve1, E Contassot1, P Schuler1, S Demotz2, P Schneider3, J Tschopp3,
L E French1 and B Huard1
1Louis Jeantet laboratory, Medical University Center, Geneva, 2Apoxis, Lausanne, 3Institute
for Biochemistry, Epalinges, Switzerland
Despite an apparent uncontrolled growth, host immune cells do not ignore tumors. However,
interactions between tumor and immune cells remain poorly characterized. In the present
work, we analyzed the spontaneous presentation of a model tumor antigen, ovalbumin (OVA),
expressed in B16 melanoma cells. Upon adoptive transfer of OVA-specific T cells, OVA
presentation in draining lymph nodes was observed in tumor-bearing mice. In this situation, a
cytoplasmic form of OVA was more potently presented to CD8þ T cells than a membrane or
a secreted form. This OVA presentation to T cells was dependent on host bone marrow-
derived cells, indicating a cross-presentation mechanism. Importantly, this cross-presenta-
tion of B16-associated OVA to CD8þ T cells was achieved in the absence of presentation to
CD4þ T cells. In this apparent absence of CD4þ T cell help, CD8þ T cells expanded but did
not acquire effector functions (IFN and cytotoxicity). A systemic treatment with soluble CD40-
L aimed at correcting the CD4þ T cell defect was shown to ameliorate the survival of B16-
bearing mice. Altogether, this indicates that spontaneous immune response to tumors occurs
but does not lead to the generation of cytotoxic effector T cells. This study indicates that
treatment with immunostimulators such as CD40-L may have therapeutic values for
melanoma.
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Early Recruitment of Cytotoxic CD8þ T Cell in Skin Lesion of Patients with Maculo-
Papular Exanthema to Amoxicillin
A Rozieres1, K Rodet1, S Bosset Saint-Mezard1, J Bienvenu2, J Kanitakis2, G Cozon3, F
Berard2, J-F Nicolas2
1INSERM U503, France 2CHU Lyon Sud, France 3Hopital de la Croix Rousse, France
Cutaneous delayed-type hypersensitivity (DTH) drug reactions presenting as maculo-papular
exanthema are due to activation in the skin of drug specific T lymphocytes. Penicillins, and
especially amoxicillin (amox) are the most frequent drugs involved in these DTH reaction.
However, the nature of effector T cells as well as the mechanisms by which they generate the
skin inflammatory responses are not known. In this study, using immunohistochemistry and
RT-PCR analysis, we followed the T cell recruitment and activation in the skin of positive
patch test reactions to amox in 5 patients which have developed amox-induced maculo-
papular exanthema. We show that CD8þ T cells are rapidly recruited in the skin at the site of
drug application, before the onset of clinical signs of skin inflammation. This early CD8þ T
cell recruitment is associated with: i) activation of effector T cells, assessed by transient IFN-g
mRNA expression and production of cytolytic proteins granzyme B and perforin; ii) apoptosis
of keratinocytes demonstrated by Tunel staining. Collectively, these data suggest that drug-
specific CD8þ T cells are effector cells in amox-induced DTH reactions in humans.
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Effects of Ageing on the Cutaneous Delayed Type Hypersensitivity Reaction to
Tuberculin Puriﬁed Protein Derivative
K Birch, M Vukmanovic-Stejic, J Reed, M Rustin, A Akbar
London, UK
It is well recognised that ageing is associated with increased risk of infection and it is
postulated that this occurs due to impaired cell-mediated immunity. The delayed type
hypersensitivity (DTH) reaction to cutaneous injection of antigens is a widely used method to
clinically assess cell-mediated immunity to infections such as tuberculosis. Previous studies
have shown an increased percentage of negative DTH reactions to PPD and other antigens
with age. We have previously demonstrated dissociation between the clinical DTH response
(as measured by cutaneous erythema, induration and palpability) and cellular responses to
tuberculin purified protein derivative (PPD) injection in the young. The aim of this study was
therefore to establish whether the reduced clinical DTH response observed in the elderly is
also associated with a reduced cellular response. One unit of PPD was injected in to the
forearms of healthy individuals over the age of 70. Suction blisters were then induced over the
site of injection at various time points. CD4þ T lymphocytes were isolated from the blister
fluid and stained for Ki67, CD69 and IFN-g after overnight stimulation with PPD. The cells
were analysed using flow cytometry. Peripheral blood mononuclear cells (PBMCs) were
collected prior to injection and stimulated with PPD overnight and for 5 days to assess for
antigen specific cells (IFNg staining) and cellular proliferation (thymidine incorporation)
respectively. No individual in the elderly group had a clinical response to PPD injection. In
particular, elderly individuals with good PBMC proliferative responses to PPD had low levels
of expression of Ki67 and CD69 and no antigen specific cells in the blister fluid. These results
were the same as those found in blister cells from elderly and young individuals with no
PBMC proliferation to PPD. We have previously demonstrated that in young individuals the
PBMC proliferative response to stimulation with PPD in vitro correlates well with the degree of
cell proliferation and number of antigen specific cells at the site of PPD injection. The absence
of clinical responses to PPD injection in the elderly is correlated with an absence of significant
cellular proliferation and accumulation of PPD specific cells at the site of injection in spite of
good PBMC responses to PPD. Thus, the DTH response may not accurately reflect cell-
mediated responses to infection in the elderly and may represent other parameters such as
changes in the local production of pro-inflammatory mediators, antigen presentation or cell
migration to the skin.
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The Heat Shock Proteins 60 and 70 of Propionibacterium acnes are Antigens
U Jappe, K T Holland#, E Ingham#, C Huebsch-Mueller, M D Farrar#
Heidelberg, Germany; #Leeds, United Kingdom
Propionibacterium acnes has been shown to be associated with the pathogenesis of
inflammatory acne via different mechanisms. Its lymphocyte stimulating activity is mediated
by mitogens and antigens. We have previously hypothesised that P. acnes heat shock pro-
teins (HSPs) may initiate such responses. Purified HSP60 and HSP70 of P. acnes were used
in a lymphocyte transformation assay time course experiment from day 3 to 7 with peripheral
mononuclear cells (PBMNC) from patients with inflammatory acne and from cord blood
(CBMNC) to investigate their T-cell stimulatory properties. A similar experiment was
performed with and without pre-incubation with TU¨39, a monoclonal mouse anti-human
MHC class II antibody, to block antigenic stimulation. 9/12 and 10/12 CBMNC were
stimulated by HSP 60 and 70, respectively with 5/9 showing an early response. 3/9 samples
showed two peaks of stimulation, suggesting two different mechanisms of lymphocyte
activation. In contrast, only 3/11 of the PBMNC samples were stimulated by HSP 60 and 70
from day 5 onwards. Lymphocyte stimulation could be blocked completely by TU¨39. It can be
concluded that P. acnes HSP 60 and 70 evoke an antigenic reaction and are not responsible
for mitogenic activity. This is in accordance with immune reactions induced by mycobacterial
HSP, which show a high degree of amino acid sequence homology with P. acnes HSP.
ABSTRACTS A29123 : 2 AUGUST 2004
177
Analysis of the Role for Type I Interferons in Psoriasis
L van der Fits, LI van der Wel, G van Dijk, M Kant and EP Prens
Erasmus MC, Rotterdam, The Netherlands
A common hypothesis states that the inflammatory skin lesions that characterise psoriasis
patients are caused by aberrant signalling in genetically pre-disposed keratinocytes following
triggers from cytokines or interactions with immune cells. Clinical case reports showed that
psoriasis can be initiated or exacerbated in patients receiving IFN-a therapy. We recently
demonstrated increased activation of the type I interferon (IFN-a/b) signalling pathway
in lesional psoriasis epidermis. Stimulation of this pathway in normal and pre-disposed
keratinocytes did not induce the inflammatory phenotype in keratinocytes. To study whether
the pathological effects of IFN-a/b are mediated via cells of the immune system, we assayed
the effects of IFN-a on skin antigen presenting cells (APC). APC that migrated from healthy
skin in the presence of IFN-a showed a more mature phenotype, and were capable to induce
T-cell proliferation in an allogeneic mixed leukocyte reaction. In addition, the effects of IFN-a
on peripheral blood mononuclear cells (PBMC) were determined. In PBMC from healthy
controls and psoriasis patients, IFN-a stimulation resulted in induction of a Th1-type cytokine
profile with high levels of IFN-g. Secretion of IL-10, a cytokine that plays an important role in
the termination of (skin) inflammatory responses, was induced by IFN-a in healthy PBMC. In
PBMC from psoriasis patients, however, IL-10 was not induced. Thus, since IFN-a/g exerts
many immunomodulatory effects, its pathological role in psoriasis is probably mediated via
various cellular mechanisms, for example via an impaired induction of the anti-inflammatory
IL-10.
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T Lymphocytes and NK Cells from Psoriasis Lesions Display a Distinct Chemokine
Receptor Repertoire and Chemokine Responsiveness
C Ottaviani, S Sebastiani, F Nasorri, G Girolomoni, A Cavani
Laboratory of Immunology, IDI-IRCCS, Rome, Italy
Psoriasis is a chronic inflammatory skin disease characterized by altered keratinocyte
differentiation and prominent leukocyte infiltration. Type 1 cytokines released by both T and
NK cells play a prominent role in disease expression. Immunohistochemical staining of acute
psoriatic lesions revealed large numbers of CD3þCD4þ and CD3þCD8þ T cells, as well as
CD56þCD3 NK cells in the papillary dermis and, to a lower extent, in the epidermis. A
relevant percentage of CD3þ T lymphocytes and NK cells were CD25þ and CD69þ ,
indicating their activation state. Interestingly, the majority of CD3þ T lymphocytes, but only
on a minor fraction (15%) of NK cells isolated form psoriatic lesions expressed the CLA
homing receptor. Chemokine receptors CXCR3 and CCR5 were highly expressed on skin
infiltrating NK cells, which strongly migrated in vitro to CXCL10 and CCL5. In contrast, CCR4
expression and CCL17/CCL22 responsiveness was restricted to the CD3þ T cell population.
In addition, CCR6 levels and migratory capacity to CCL20 greatly prevailed in CD3þ T
lymphocytes compared to NK cells. No significant differences in the expression of CCR1,
CCR2, CCR7 and CCR8, and in vitro chemotactic responses to the relevant chemokines were
observed between the two cell types. Our data indicate that NK and T cells are actively
recruited in psoriatic skin through distinct mechanisms. This finding can be relevant for the
refinement of therapeutic approaches for chronic inflammatory skin diseases aimed to target
leukocyte recruitment.
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Regulation of Th2 Cytokine Production by CD4þCD25þ T Cells Depends on Type and
Concentration of Allergen
I Bellinghausen, B Ko¨nig, I Bo¨ttcher, J Knop and J Saloga
University of Mainz, Department of Dermatology, Mainz, Germany
Recently, we have shown that regulatory CD4þCD25þ T cells (Treg) are functional in most
atopic patients with allergic rhinitis and are able to inhibit Th1 and Th2 cytokine production of
CD4þCD25 T cells. This study was set out to further analyze differences between atopic and
nonatopic donors and allergen specificity, as well as the effect of allergen concentration and
of the type of allergen. CD4þCD25 T cells from healthy nonatopic controls or from grass
pollen or wasp venom allergic donors were stimulated alone or in the presence of Treg with
autologous mature monocyte-derived dendritic cells which were pulsed with different
concentrations of the respective allergen. Treg from grass pollen allergic donors failed to
inhibit proliferation but not cytokine production of CD4þCD25 T cells at high antigen doses
while Treg from nonatopic donors did not. The suppressed proliferation and cytokine
production were almost antigen-unspecific. Proliferative responses and cytokine production
of CD4þCD25 T cells from wasp venom allergic patients were not inhibited at any
concentration of wasp venom even after initiation of venom immunotherapy. The use of wasp
venom- or phospholipase A2-pulsed DC for stimulation of CD4
þCD25 T cells from donors
which were not allergic to wasp stings did only result in an inhibited proliferation and Th2
cytokine production by Treg at ten fold lower than the optimal concentration compared to the
use of grass pollen allergen-pulsed DC, while IFN-g production was inhibited at all conditions.
These data demonstrate that in allergic diseases the function of Treg is dependent on the
concentration of the respective allergen with different thresholds for individual patients and
allergens.
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Peripheral Blood Natural Killer Lymphocytes mediate both Natural Killer Cell Lysis and
Antibody Dependent Cytotoxicity against Sezary Cells
JD Bouaziz, A Bensussan, M Bagot
Cre´teil, France
Although it has been shown that patients suffering from Sezary syndrome have a decreased
natural killer (NK) lymphocyte activity, nothing has been reported concerning the sensitivity of
Sezary cells to the granzyme B/perforin dependent cytotoxicity of NK cells. Since a
decreased NK lysis can explain the severity of the disease, it is important to evaluate whether
Sezary cells behave as potential targets for NK lymphocyte antitumoral activity and whether
this function can be enhanced. Freshly isolated and IL-2/IL-12 activated peripheral blood
purified NK cells were tested as effector lymphocytes against well-characterized Sezary
tumoral cell lines in a chromium release cytotoxic assay. Further, these effector lymphocytes
were studied for their ability to mediate antibody dependent cytotoxicity (ADCC), using the
monoclonal antibody (mAb) IgG2a AZ158 that specifically recognizes KIR3DL2/CD158k
expressed by Sezary cells. The results show that Sezary cells are susceptible to NK lysis with
a maximum of specific lysis of 30%. However, we found that NK lymphocytes of some
individuals were unable to kill Sezary cells, although these lymphocytes were functional. In
such cases NK activity against Sezary cells could be induced with either IL-2, IL-12 or when
incubating Sezary cells with an anti-MHC class I antibody F(ab)’2. Finally, we found that
adding the AZ158 mAb enhances the lysis of these lymphoma tumoral cells. These results
demonstrate for the first time that Sezary cells are susceptible to NK lysis. When the killing of
malignant cells is lacking, it can be related to NK inhibitory receptors that recognize MHC
class I antigens on the malignant cell. This inhibitory receptor effect is abolished when NK
cells are stimulated with either IL-2 or IL-12. Finally, the mAb AZ158 can improve NK lysis of
Sezary cells by ADCC. These findings raise the possibility to develop a novel therapeutic
strategy in Sezary syndrome patients by stimulating their innate immunity.
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Pimecrolimus and Tacrolimus have Similar Potencies to Inhibit the Cytokine Production
and Proliferation of Human T Cell Clones, Derived from Atopic Skin
FS Kalthoff, J Chung, P Musser, S Wang, and A Stuetz
Novartis Institute of BioMedical Research, Austria
Pimecrolimus cream 1% and tacrolimus 0.1% and 0.03% ointment have been recently
introduced into the market for the topical treatment of atopic eczema (AE) and efficacy of
these two calcineurin inhibitors has been shown also in other T cell mediated inflammatory
skin diseases. The objective of this study was to compare the in vitro potency of the two
compounds to inhibit the proliferation and the synthesis of inflammatory cytokines by
antigen-specific memory T cells, using cell clones derived from the skin of a patient suffering
from AE. T cell proliferation, induced by dendritic cells loaded with specific antigen, was
inhibited similarly by pimecrolimus and tacrolimus. The concentrations necessary to attain
50% inhibition (IC-50) differed by a factor of less than 2. In contrast, a ten- to twenty-fold
higher IC-50 value was observed with cyclosporine A, used as a reference. A similar picture
was obtained, when the effect of pimecrolimus and tacrolimus on cytokine synthesis (IL-2, IL-
4, IL-5, IL-10, IFNg and TNFa) was compared. The arithmetic means of the ratio IC-50
pimecrolimus / IC-50 tacrolimus were 1.53 (  0.26) or 1.66 (  0.36) when stimulating the T
cells by anti-CD3 monoclonal antibody plus phorbol ester or by antigen-presenting dendritic
cells, respectively. In conclusion, the intrinsic in vitro potency of pimecrolimus and tacrolimus
to inhibit T cell activation, a key step in the pathomechanism of AE, is very similar.
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Budesonide, but not Tacrolimus, Affects the Immune Functions of Normal Human
Keratinocytes
K Kis#; L Bodai; H Polya´nka; Gy Soo´s#; Zs Bata-Cso¨rgo+; L Keme´ny
#Department of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, Szeged,
Hungary: Department of Dermatology and Allergology, Faculty of Medicine, University of
Szeged, Szeged, Hungary
Immunosuppressant therapy is widely used in the treatment of inflammatory skin diseases
such as psoriasis and atopic dermatitis. Besides its therapeutic effects, application of topical
anti-inflammatory drugs may render the epidermis more vulnerable to invading pathogens by
suppressing innate immune responses in keratinocytes such as cytokine production or Toll-
like receptor (TLR) expression of cells.
In order to evaluate and compare the immunosuppressive effects of different immuno-
suppressant drugs on keratinocytes we treated lipopolysaccharide (LPS) stimulated and
unstimulated normal human keratinocytes with the synthetic corticosteroid budesonide and
the macrolide lactone tacrolimus. The expressions of the pattern recognition receptors
(PRRs) TLR2 and TLR4 were measured by quantitative RT-PCR and pro-inflammatory
cytokines IL-1a, IL-8 and TNF-a were monitored by quantitative RT-PCR and by ELISA.
In unstimulated normal human keratinocytes IL-8 and TNF-a mRNA expressions were
suppressed, TLR2 mRNA expression was induced by budesonide. Tacrolimus showed no
effect. In LPS induced keratinocytes budesonide slightly hindered the increase of IL-8 mRNA
expression and further increased (4–6 fold) the amount of TLR2 mRNA elevated by LPS.
There were no changes in TLR4 mRNA expressions. Suppressive effect of budesonide on IL-
8 gene expression was also revealed at protein level in LPS treated human keratinocytes.
Although tacrolimus and budesonide are both effective treatments in inflammatory skin
diseases, these data provide explanation for the difference observed in local adverse effects
of these two topical immunosuppressants.
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T-cell inﬁltration and Epidermal Proliferation In Lesional Plaque Psoriasis During Topical
Treatment With Clobetasol-17 Propionate Ointment
H J Bovenschen, W H P M Vissers, M M B Seyger, P C M van de Kerkhof
University Medical Center St. Radboud, Netherlands
In psoriasis the appearance of T-cell subsets and epidermal hyperproliferation are key
phenomena. It is known that CD8þ , CD45ROþ and CD2þ T-cells appear in an early phase
of the evolving psoriatic lesion. The dynamics of reduction of T-cell subsets in relation to the
decrease of epidermal proliferation in response to treatments are less well understood.
Therefore, our aim was to investigate the dynamics of changes in T-cell subsets in relation
to epidermal proliferation and clinical severity in lesional chronic plaque psoriasis during
topical treatment with the ultra-potent corticosteroid clobetasol-17 propionate ointment.
Seven psoriasis patients were treated for 14 days with clobetasol-17 propionate ointment,
twice daily. Four punch biopsies were taken at baseline and 3, 7 and 14 days after the start of
the therapy. PASI- and SUM-scores were calculated. Epidermal proliferation marker Ki-67
and CD4þ , CD8þ , CD45ROþ , CD2þ T-cells were quantified using immunohistochemical
techniques and compared with baseline values using image analysis.
The results show a rapid reduction of PASI and SUM-score, reaching a 54% and 60%
reduction after 2 weeks treatment, respectively (po0,01). Already after 3 days treatment a
47% reduction of Ki-67 positive nuclei was observed (po0,01). Only after 14 days, in the
epidermis, all investigated T-cell subsets were reduced significantly (po0,05). In the dermis,
however, treatment had resulted in a significant decrease of CD4þ , CD45ROþ and CD2þ
T-cells, with a selective persistence of CD8þ T-cells.
We conclude that in lesional psoriasis, reduction of clinical severity and epidermal
proliferation in the early phase of topical corticosteroid therapy cannot primarily be the result
of decreased subsets of T-cells. Furthermore, selective persistence of dermal CD8þ T-cells
after corticosteroid treatment was observed, which might account for relatively fast relapses
after cessation of treatment.
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Enhanced Expression of Skin Homing Molecules CLA and CCR4 on CD8þ T Cells in
Cutaneous Lupus Erythematosus
J Wenzel, S Henze, E Wo¨renka¨mper, J Steitz, T Bieber, T Tu¨ting
Laboratory of Experimental Dermatology, Department of Dermatology, University of Bonn
Introduction. Skin infiltrating T lymphocytes are supposed to play a major role in the
pathogenesis of cutaneous lupus erythematosus (LE), but little is known about their distinct
character and their skin homing properties.
Methods. The expression of the cutaneous lymphocyte antigen (CLA) and the chemokine
receptor 4 (CCR4) on lesional and circulating T cells in cutaneous LE patients was analyzed
by immunohistochemistry and flowcytometry.
Results. We found a strong expression of CLA and CCR4 in the skin of patients with chronic
discoid LE (CDLE) (CLA: 271 cells per high power magnification  32.3 in CDLE to 20  5
cells per HPM in healthy controls, po0.01; CCR4: 52  9 to 2.6  0.5, po0.01).
Histomorphologically, cytotoxic CD8þ T cells, largely expressing granzyme B, invaded
basal layers of the epidermis. CCR4 and CLA coexpression on circulating CD8 T cells was
upregulated specifically in disseminated CDLE (19.6%  0.6 in dCDLE to 1.5%  0.5 in
healthy controls, po0.01).
Discussion. We assume that the expression of CCR4 and CLA on CD8þ T cells plays an
important role in the pathogenesis of cutaneous LE. Our results suggest a role for CD8þ
CLAþ CCR4þ T cells in specific cytotoxic destruction of epidermal structures in scarring
CDLE.
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The Maturation And Migration Capacity Of Antigen Presenting Cells Of The Skin Remains
Unchanged After Treatment With Pimecrolimus
W Hoetzenecker, J G Meingassner, G Stingl, A Stuetz, A Elbe-Bu¨rger
DIAID, Department of Dermatology, Medical University of Vienna, Austria; Novartis Institute
for Biomedical Research Vienna, Austria
Migration of antigen-laden Langerhans cells (LC) into draining lymph nodes is a pivotal step in
the development of the primary immune response in contact hypersensitivity (CHS). We have
examined the effects of the calcineurin inhibitor pimecrolimus on the migration and
maturation capacity of LC in vitro and in vivo. Ears of BALB/c mice were treated topically
with 10 ml pimecrolimus 1% or with vehicle, twice at an interval of 8 h on day 1. Forty hours
later, the ears were dissected and the dorsal, mechanically separated, sides floated on
culture medium for 3 days prior to analysis. LC in epidermal/dermal sheets and migrated LC
and dermal dendritic cells (DDC) in the culture medium of pimecrolimus- and vehicle-treated
samples were similar, both in numbers and degree of maturation. Antigen-induced migration
of LC into the draining lymph nodes was studied in 12 mice each treated orally with 90 mg/kg
pimecrolimus or vehicle 2 h before and 4 h after FITC application. After 24 h, the proportion
of antigen-laden FITCþMHC IIþ cells in lymph nodes were not statistically different in
pimecrolimus- and vehicle-treated mice (1.40 vs. 1.54%). In 12 mice treated intraperitoneally
with 200 mg anti-LFA-1 antibody (M 17.4), used as a positive control, only 0.25% FITCþMHC
IIþ cells were detected in lymph nodes (p40.05). Thus neither topically nor systemically
administered pimecrolimus interferes with the migratory and maturation capacity of LC/DDC.
This is in line with previous data, which showed that oral treatment of mice with doses up to
120 mg/kg pimecrolimus did not impair the induction phase of CH in contrast to cyclosporine
A and tacrolimus, whereas the elicitation phase was potently inhibited with lower doses.
These data imply that pimecrolimus does not impair cutaneous immunosurveillance.
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Distinct Expression of Adhesion Molecules on Monocytes of Patients With Inﬂammatory
Skin Diseases
JJ Jockers, T Bieber and N Novak
Bonn, Germany
Monocytes are considered as direct precursor cells of inflammatory dendritic cell subtypes,
which are recruited from the blood into the skin in inflammatory skin diseases such as atopic
dermatitis and psoriasis. It is assumed that chemotactic signals initiate a multistep cascade
via different adhesion receptors which consists of ‘‘tethering’’ and ‘‘rolling’’ mediated by
selectins, a-integrins and b-integrins. The ‘‘arrest’’ of the cells is in main part dependent on
the activation of integrins. Furthermore it is hypothesised that cell activation and signalling
involves tetraspanins.
Since different activation signals play a pivotal role in the recruitment phase of allergic-
inflammatory skin diseases and these initial steps are of major interest for the development of
preventive therapeutic strategies we started to analyse the expression of adhesion molecules
on monocytes of patients at the exacerbation state of atopic dermatitis (n¼ 10) or psoriasis
(n¼ 9) in comparison to healthy, non-atopic control donors (n¼ 7). With the help of detailed
phenotypical analyses, differences in the surface expression of a-integrins, b-integrins,
selectins, tetraspanins, Fc receptors, costimulatory molecules and major histocompatibility
class I and II molecules have been evaluated.
An enhanced expression of the a-integrin CD49a, CD49b and CD49c and the b-integrin
CD41 and CD61 has been detected in both, monocytes from patients with atopic dermatitis
or psoriasis and is therefore considered as a common sign for inflammation. Characteristic
for monocytes of patients with atopic dermatitis was an increased expression of the
tetraspanin superfamily CD9, CD37, CD81 and CD151. In contrast, monocytes of patients
with psoriasis displayed a high surface expression of the selectin CD62L and CD62P and the
thrombospondin receptor CD36.
From these data we conclude, that (I) an increased expression of integrins on peripheral
blood monocytes of patients with inflammatory skin diseases might promote enhanced skin
homing of these cells, (II) high expression of tetraspanins observable on monocytes of
patients with atopic dermatitis might favour a rapid transendothelial migration of these cells
while (III) high levels of L- and P-selectin on the surface of monocytes of patients with
psoriasis might form the basis for a rapid recruitment process in which selectin-dependent
leucocyte rolling plays a major role.
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Therapeutic Efﬁciency of the Infusion of TIL Speciﬁc for Melanoma Antigens
N Labarrie`re1, B Dre´no2,3, H Benlalam1, MC Pandolfino3, A Khammari2, F Jotereau1
1Unite´ INSERM U601, Nantes, FRANCE. 2Unit of Skin Cancer, CHU of Nantes, Nantes,
FRANCE. 3Unite´ de the´rapie cellulaire et ge´nique, CHRU de Nantes, Nantes, France
Adoptive therapy of cancer has been tested mostly in advanced cancer patients using tumor-
infiltrating lymphocytes (TIL). Limited clinical success has been discouraging, although the
poor TIL specificity and/or the high tumor burden might explain it. We recently show the
efficiency of tumor reactive TIL infusion to prevent further development of the melanoma
disease in stage III melanoma patients, after complete tumor resection. Here we analyze the
survival without relapse of these same patients according to TIL specificity and lymph node
invasion. In this study, we show that survival without relapse correlates not only with tumor
burden but also with the presence of melanoma specific lymphocytes among infused TIL. We
also characterized the antigenic specificities recognized by these TIL in order to determine
which are the most interesting melanoma antigens to target in immunotherapy protocols.
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15-lipoxygenase is Expressed in the Skin of Patients with Atopic Dermatitis and Contact
Dermatitis
M Tengvall Linder1, E Melin1, G Jakobsson Ekman1, H-E Claesson2
1Clinical Allergy Research Unit and 2Department of Medical Biochemistry and Biophysics,
Karolinska Institute, Stockholm, Sweden
Background. The enzyme 15-liopxygenase (15-LO) catalyzes the conversion of arachidonic
acid to 15-HPETE and other related metabolites. The 15-LO has been shown to exist in
reticulocytes, dendritic cells, eosinophils, and also airway epithelial cells in asthma, where it
is believed to have a pro-inflammatory effect. Since the 15-LO is activated in asthma, and
since the metabolism of arachidonic acid is changed in the inflammatory disease psoriasis, it
would be of interesting to investigate 15-LO also in allergic skin disorders.
Objective. 1) to investigate the presence of 15-LO in the skin of patients with atopic dermatitis
(AD), contact dermatitis (CD), psoriasis and healthy individuals, 2) to explore whether 15-LO is
up regulated when the skin is stimulated with the allergens and 3) to find out which cells can
express 15-LO in the skin.
Material and methods. Biopsies were taken from normal and atopy patch tested (Malassezia)
skin from 15 patients with AD and 8 healthy controls, lesional skin from 11 AD patients,
normal and patch tested skin (Ni) from 5 patients with CD and normal and lesional skin from 5
patients with psoriasis.
Results. Few dermal cells expressed 15-LO in biopsies from normal skin of patients and
healthy controls. Positive epidermal cells were rarely seen in healthy skin. Even though an
increase in the number of dermal and epidermal 15-LOþ cells was seen after atopy patch
test in both patients with AD and healthy individuals, the number of 15-LOþ cells in the AD
group was significantly higher than in the control group. The number of 15-LOþ in lesional
AD skin was significantly higher than in non-lesional skin. Patients with CD showed a high
number of dermal and epidermal cells with strong expression of 15-LO after patch test with
Ni. In biopsies from lesional psoriasis skin only few cells were positive, mostly showing a
week 15-LO-expression. The number of 15-LOþ was sometimes lower than in non-lesional
skin from the same patient. Double stained biopsies taken from the eczema lesions and patch
tested skin from patients with AD and CD revealed that 15-LO was expressed by Cd1aþ
dendritic cells, eosinophils and a minority of the macrophages. Tryptaseþ mast cells and T
cells were 15-LO-.
Conclusion. Stimulation with an allergen induced 15-LO expression not only in patients with
allergic eczema, but also in healthy individuals. Nevertheless, the 15-LO expression was
higher in both AD and CD than in the skin of healthy controls. Since 15-LO is produced by
dendritic cells and eosinophils, cell types known to be present in allergic eczema, it might
play a role in inducing allergic skin inflammation.
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Identiﬁcation and Characterization of ‘‘pDC-like Cells’’ in Normal Mouse Skin and
Melanomas Treated with Imiquimod
F Palamaraywz, S Meindly, M Holcmannyw, P Lu¨hrsy, G Stinglyw and M Sibiliayw
yDIAID, Department of Dermatology, Medical University of Vienna and wCompetence
Center for Biomolecular Therapeutics, BMT, Brunnerstrasse 59, A-1235 Vienna, Austria.
zDepartment of Dermatology, University of Rome ‘‘Tor Vergata’’, Viale Oxford 81, 00133
Rome, Italy
Dendritic cells (DC) constitute a heterogeneous population of antigen-presenting cells (APCs)
found virtually in every tissue and organ. They link innate and adaptive immunity by inducing
appropriate immune responses upon the recognition of invading pathogens, thus acting as
‘‘nature’s adjuvant’’. Among the different subsets of DCs described in humans and mice,
epidermal Langerhans cells and dermal DCs represent the only DC populations resident in
normal skin.
Here, we describe a population of CD4þ /CD3 ‘‘plasmacytoid DC (pDC)-like cells’’ which
accumulate in the dermis and spleens of mice topically treated with Imiquimod, a low
molecular weight immune response modifier with potent anti-viral and anti-tumor activities.
These CD4þ /CD3 cells co-express GR-1, B220, MHC-II and, to a lesser extent, CD11c and
display phenotypic features of pDCs described in lymphoid organs. The accumulation of
pDC-like cells after Imiquimod treatment was not only detected in normal skin, but also in
intradermally-induced melanomas. Imiquimod treatment leads either to complete regression
or to a significant reduction of the tumors. The number of pDCs correlates well with the
clinical response of the tumors to the drug suggesting that the anti-tumor effects of
Imiquimod could at least partly be mediated by the recruitment of pDC-like cells to the skin.
Therefore, strategies aimed at activating and directing these cells into neoplastic tissues may
be a promising and novel approach for the immunotherapy of various types of cancer.
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Pimecrolimus Ameliorates Disease in a Prophylactic Mouse Model of Lupus
U McKeever, K Baier, R Pecanka, E Kowalsky, A Rot
Novartis Institute of BioMedical Research, Vienna
Systemic lupus erythematosus is a multisystem autoimmune disease with a high unmet
medical need that effects many organs including kidney and skin. Since oral pimecrolimus
(PIM) was found to be safe and effective for treatment of atopic dermatitis and psoriasis in
man and in animal models of arthritis and inflammatory bowel disease, we have investigated
its effect in the MRL/MpJ-Tnfrsf6lpr (MRL/lpr) model of SLE. We have compared the effects of
PIM with those of cyclophosphamide (CP), a drug that is used effectively for the treatment of
human lupus nephritis but that has severe side effects. Data from 2 independent studies
where mice were given 30 (PIM 30) or 50 (PIM 50) mg/kg/d PIM orally during an 8 week period
when disease symptoms develop suggest that both PIM and CP are equally effective in
reducing disease progression and severity. Proteinuria scores were significantly reduced at
PIM 50 (po0.01) and PIM 30 (po0.05). Glomerulopathology severity scores were similarly
reduced: PIM 50 (po0.001) and PIM 30 (po0.05). In MRL/lpr treated mice both CP and PIM
50 significantly decreased (po0.001) the lymph node population of CD4-CD8-CD3þ , double
negative T cells which is an abnormal T cell subset that accumulates over time due to the lpr
mutation. The reduction in the generalized hypergammaglobulinemia characteristic of MRL/
lpr mice which was greatly reduced by CP compared to placebo controls (po0.001) was seen
as a trend with PIM 50 as was the production of anti-ds DNA antibodies. A trend to lower
levels of Rheumatoid Factor was evident in the PIM 50 and CP groups versus placebo treated
controls. This study demonstrates that testing in the early stages of disease in the MRL/lpr
lupus mouse is a suitable and relatively fast prophylactic model for drug profiling.
Pimecrolimus improves key pathological parameters of lupus in this model which suggests
its therapeutic potential for lupus in man.
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CD4þ CD56þ Blastic Tumor Cells Express CD101/BC27 Antigen
E Poszepczynska-Guigne´1,2, N Meyer1, T Petrella4, J Wechsler3, M Bagot1,2, A Bensussan1
1Inserm 448, 2Paris XII University, Dermatology and 3Pathology 4Departments Cre´teil,
Pathology Dept, Dijon, France
CD4þCD56þ tumors are rare hematopoietic malignancies characterized by a frequent skin
and blood involvement and a rapid aggressive course with bone marrow infiltration. By
contrast with myeloid/NK cell acute leukemias, CD4þCD56þ malignancies usually lack the
expression of conventional myeloid and lymphoid T- and B-cell markers. Several recent
studies reported phenotypic and functional similarities between these CD4þCD56þ
leukemic cells and a subtype of dendritic cells (DC), so-called plasmacytoid dendritic cells
or type 2 dendritic cells (DC2). CD101 is a 200kDa disulfide linked homodimer. In normal
individuals, it is expressed by a minor subset of circulating T-lymphocytes, by intestinal
mucosal T-lymphocytes and by a major DC cells subset including DC2 cells. CD101 antigen
plays a major role in the activation of T-lymphocytes by DC and inhibits T-cell proliferation via
IL-10 secretion. In this study we analysed, using immunochemistry on cryostat tumor
sections, the CD101 expression in the cutaneous tumor infiltrate of 17 patients with
CD4þCD56þ malignancy. In addition, we performed three colour flow cytometry analysis on
the peripheral blood mononuclear cells (PBMC) in one of these patients. We found CD101-
stained cells with blastic morphology in 13 of 17 (76%) tumor cutaneous infiltrates. 90% of
PBMC, corresponding to circulating tumor cells, co-expressed CD101, CD4 and CD56
antigens in the analysed blood sample. In conclusion, we showed, for the first time that
CD4þCD56þ tumor cells express the CD101 marker. This expression is one more evidence
of the identity between DC2 cells and CD4þCD56þ tumor cells. Moreover, CD101 could
represent a useful tool for the diagnosis of the CD4þCD56þ blastic tumors. The next step
will be to determine the role of CD101 in the pathogenesis of this tumor. It can be speculated
that CD101 could promote the progression of the disease by inducing a tumor-specific
tolerance.
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Exposure To UVB Radiation Induces An Alteration In Blood Dendritic Cell Subtypes
J Narbutt, M Zak-Prelich, A Lesiak, A Wozniacka, A Sysa-Jedrzejowska, T Robak, P
Smolewski
Department of Dermatology and Department of Haematology, Medical University of Lodz,
Poland
Exposure to ultraviolet radiation (UVR) causes alterations of cutaneous and systemic
immunity. The aim of our study was to assess the influence of UVB radiation on the
phenotypes of blood dendritic cells (BDCs).
Healthy volunteers (30) were irradiated (whole body) with a dose of 0.7 MED (minimal
erythemal dose) of UVB for 10 consecutive days. 24 hours after a final exposure, local
irradiation (3 MED) on buttock skin was performed. Blood samples were taken before the first
exposure and 24 hours after final exposure of 0.7 MED and 24 hours after 3 MED irradiation.
The three main subsets of BDCs were distinguished by flow cytometry: BDCA-2þ /CD123þ /
HLA-DRþ (plasmacytoid, PDCs), and two myeloid subtypes: BDCA-1þ /CD1cþ /HLA-DRþ
(MDC1s) and BDCA3þ /CD86þ /HLA-DRþ (MDC2s). The percentages and absolute
numbers of DCs and their subsets were calculated.
The median percentage of particular DC subsets before irradiation was as following:
MDC1s- 0.34%, MDC2s –0.1%, PDCs-0.57% of PBMC. Both after 10 days of 0.7 MED and
after a single dose of 3 MED a slight increase in MDC1 subtype was noted (median-0.39 and
median-0.4, respectively), however not statistically significant. A statistically significant drop
of percentage of MDC2s was found after 10 days of irradiation (median-0.08) and after 3 MED
(median-0.05). PDC rate was also decreased both after 10 days and 3 MED irradiation
(median-0.52 and median-0.47; respectively), but the differences were not statistically
significant.
Conclusion. Exposure to UVB induced a drop in the percentage of BDCs in healthy human
individuals, especially apparent in the MDC2 subtype.
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Expression of Sensory Neuropeptides CGRP, Substance P and NK-1 Receptor in Human
Contact Dermatitis
H El-Nour, R Al-Tawil, L Lundeberg, K Nordlind
Unit of Dermatology and Venereology, Department of Medicine, Karolinska University
Hospital, Solna, Karolinska Institutet, Stockholm, Sweden
There is increasing evidence of an interaction between the nervous and the immune systems.
Sensory neuropeptides (CGRP, calcitonin gene-related peptide, and substance P) have been
shown to modulate allergic contact dermatitis in mice. The aim of this study was to
investigate the expression of CGRP, substance P and its NK-1 (neurokinin-1) R (receptor) in
human contact dermatitis by using immunohistochemistry and a streptavidin-biotin method.
Biopsies from positive epicutaneous patch test reactions to nickel sulphate (n¼ 10) and from
control skin (n¼ 9) in nickel-allergic patients, were fixed in 10% formalin with 0.2% picric acid
and processed for immunohistochemistry.
The number of CGRP immunoreactive nerve fibers in the papillary dermis showed a
tendency to a decrease in the eczematous (5.5  2.9 fibers/section) compared to control
(7.1  4.0) skin, while there was no difference between the number of substance P positive
fibers in the inflamed (4.2  1.7) compared to control skin (4.4  2.1). Semiquantification of
substance P and NK-1R positive papillary dermal mononuclear cells showed an increase in
the eczematous (þ þ þ ) skin in contrast to control (þ ) skin. In addition, NK-1R
immunoreactivity was higher in basal keratinocytes in inflamed compared to control skin.
The intensity of this immunoreactivity appeared to be increased with more intense
inflammation.
Our results indicate that CGRP and substance P participate in the pathophysiology of
human allergic contact dermatitis.
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Cyclophosphamide(Cy) Accelerates Atopic Dermatitis(AD) Like Eruptions in DS-Nh Mice
Y Ikezawa1,2, S Matsukura1, M Nakazawa2, M Minami2, K Takahashi1, T Hirasawa3, Z
Ikezawa1
1Department of Dermatology, Yokohama City University School of Medicine, Yokohama,
Japan 2Department of Immunology, Yokohama City University School of Medicine,
Yokohama, Japan 3Discovery Research Laboratories, Shionogi and Co. Ltd, Osaka, Japan
Background. DS-Nh mice raised under conventional condition spontaneously develop
dermatitis similar to human atopic dermatitis(AD), which is thought to be associated with
staphylococcal infection. In our previous study, we demonstrated DS-Nh mice, which had
received the treatment of TNCB, developed more severe AD-like skin eruptions earlier as
compared with the controls. Skin eruptions were observed not only on the area painted with
TNCB, but also on the face and neck areas on which were not painted, and the serum levels
of total IgE elevated in correlation with the severity of the clinical skin conditions.
Objective. To examine effect of Cyclophosphamide(Cy) treatment on AD-like eruptions of DS-
Nh mice, which were induced by TNCB sensitization.
Method. We applied Cy (200 mg/kg) intraperitoneally 2 days before TNCB sensitization. Then,
low dose of TNCB were applied epicutaneously once a week. We examined skin eruption
score, serum total IgE levels, and cytokine production from splenocytes and lymph nodes
cells cultured with SEB or ConA by ELISA. We also conducted Cy effect on the T cells by
FACS analysis.
Results & Conclusion. Mice treated with Cy developed severe AD-like skin eruptions in
comparison with non-treated ones. The levels of INF-gamma and IL-13 were elevated in the
Cy treated mice, although serum levels of total IgE were comparable between two groups.
Total cell number of Cy treated spleen and lymph nodes were decreased at day 3, and
proportion of CD25þCD4þ T cells in total CD4þ T cells were also significantly decreased.
In this experiment, we revealed that treatment of Cy accelerates the skin symptoms (AD-
like skin eruptions) induced by low dose of TNCB application. Moreover, the AD-like skin
eruptions continued more than 3 weeks after stopped applying TNCB, and the eruptions were
seen another lesion of TNCB applied area. Examined cytokine production, IFN-gamma that is
the Th1 type cytokine elevated rather than IL-4 (Th2 type cytokine). The amounts of IFN-
gamma and IL-13 production by splenocytes or lymph nodes cells from Cy treated mice were
significantly larger than those of control mice. It is presumed that Th1-predominant
mechanisms and CD25þCD4þ T regulatory cells might be involved in the development of
AD-like eruptions rather than IgE production.
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Lichen Sclerosus: Detection of Activated Cytotoxic Cells in the Cellular Inﬁltrates
R E Hunger, N Yawalkar, A Kappeler, C Mueller, L R Braathen
Dermatological Clinic and Institute of Pathology, University of Bern, Switzerland
Granzyme B and perforin messenger RNA (mRNA) expression has been shown to be a
specific in vivo activation marker for cytotoxic cells. The aim of this study was to assess the
contribution of cell-mediated cytotoxicity in the pathogenesis of lichen sclerosus. In situ
hybridisation and immunohistochemistry were performed on serial tissue sections of lesional
skin biopsies and normal skin as a control. Immunhistochemical staining showed that the
cellular infiltrate of diseased skin consisted predominantely of T cells (CD3þ ) and some B
cells (CD20þ ). Among T cells CD4þ cells were more abundant than CD8þ cells. In normal
skin samples perforin and granzyme B mRNA expressing cells were only rarely found. In
contrast, in skin biopsies from diseased tissue specimens a high percentage of infiltrating T
cells expressed mRNA for perforin and granzyme B. The perforin and granzyme B expressing
cells were found in the dermal infiltrate and intraepidermally in close proximity to
keratinocytes suggesting in situ activation of these cells. These findings provide evidence
that cell mediated cytotoxicity plays a significant role in tissue destruction in lichen sclerosus.
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Mature and Immature Langerhans Cells are Reduced in Vitiligo
Z Spanou, M Bro¨nnimann, N Yawalkar, RE Hunger, and LR Braathen
Dermatological Clinic, Inselspital, Bern, Switzerland
In vitiligo patients melanocyte-specific autoantibodies as well as cytotoxic T cells have
been found in the peripheral blood. The role of professional antigen-presenting cells, eg.
Langerhans cells (LCs), in the pathogenesis of vitiligo is still unknown. We investigated in the
present study subpopulations of LCs in vitiligo. Using immunohistochemistry we examined
CD1a and Langerin expression in 6 healthy controls and in lesional and non-lesional skin of 10
patients with vitiligo. The number of CD1aþ or Langerinþ LCs in the epidermis of lesional
skin was significantly reduced compared with non-lesional or control skin. Furthermore an
increased Langerinþ /CD1aþ ratio was observed in the epidermis. No difference in the
number of CD1aþ or Langerinþ cells of the dermis was noted between the different groups.
In lesional and non-lesional skin of vitiligo patients CD1aþ and Langerinþ cells were often
located in more basal layers of the epidermis than in control skin.
Our data demonstrate a reduction of mature, Langerinþ as well as immature, CD1aþ LCs
in lesional skin of vitiligo patients. This may either be explained by cytotoxicity or by
decreased immigration respectively increased emigration of LCs.
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Phenotypical Study of Lymphocytes Inﬁltrating the Skin in Atopic Dermatitis after
Expansion ex vivo
S Abecassis1,2, J Giustiniani1, E Guigne´1,2, A Bensussan1, M Bagot1,2
1Unite´ INSERM 448, Faculte´ de me´decine de Cre´teil, Universite´ Paris XII. Cre´teil 2Service de
dermatologie, Hoˆpital Henri Mondor, Cre´teil, France
Background. Atopic dermatitis (AD) is a frequent chronic inflammatory dermatological
condition. AD skin lesions are characterized by a T-cell infiltrate. However, AD pathogenesis is
not yet totally understood. Few studies have analysed the phenotypic characteristics of the
lymphocytes infiltrating the skin in AD, and most have been performed after cell expansion
ex vivo.
Objective. To investigate the phenotype of these cells, and to evaluate if the ex vivo culture
conditions induce the growth of selective lymphocyte subsets.
Methods. T lymphocytes were expanded from skin biopsies of AD (12 patients), non-AD
eczema (7 patients) and normal skin (2 patients), when cultured in RPMI 1640 medium with
10% human AB serum, antibiotics, fungicide and IL-2, initially associated to IL-4. In addition,
peripheral blood lymphocytes (PBL) from a healthy donor were divided in three groups and
cultured during 5 days under these same conditions unless for cytokines: IL-2 alone (group 1),
IL-2 and IL-4 (group 2), IL-4 alone (group 3). The phenotypic analysis was done by flow
cytometry using fluorescent monoclonal antibodies.
Results. We observed no difference between the phenotype of lymphocytes infiltrating the
skin in AD, non-AD eczema and normal skin. In most cases, there was a clear predominance
of CD4 over CD8 T-cells. Double positive CD4þ and CD8þ T cells could be detected in low
proportions only for some patients (3 AD, 6 non-AD eczema, 1 normal skin), as opposite to
what has previously been reported. All the tested patients presented double positive CD4þ
and Granzyme Bþ cells in significant proportions.
The three groups of differently cultured PBL presented different phenotypes: group 1
showed an increased proportion of double positive CD4þ and Granzyme Bþ (58,4%)
compared with the same cells before culture or with group 2 (16%) or group 3 (13%).
Conclusions. Culture conditions which enable the expansion of skin-infiltrating lymphocytes
can induce the growth of selective lymphocyte subset and the expression of cytotoxic
markers among CD4þ T-cells. Thus, only in situ phenotypic analysis are appropriate for
studying the phenotype of the skin infiltrating lymphocytes, in order to understand the
pathogenesis of the disease.
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In situ Expression Of LAT (Linker For Activation Of T-Cells) In Pathological Human Skin
With T-Lymphoid Inﬁltrate
M Alaibac, B Pigozzi, A Belloni Fortina, G Michelotto, A Peserico
Unit of Dermatology, University of Padua,Via C. Battisti 206, Padova, 35128, Italy
LAT is a 36-kD transmembrane protein that plays an important role in linking engagement of
the TCR to the biochemical events of T cell activation. It has been shown that LAT reacts with
human T cells in normal and neoplastic lymphoid tissues, without restriction to any T cell
subpopulation. These findings have suggested that the expression of LAT in vivo represents a
valuable addition to the panel of immunohistochemical markers that can be used for
immunostaining T-cells. The expression of LAT has not yet been studied in human
pathological skin conditions. In this study we present our experience concerning LAT
expression in both neoplastic and inflammatory dermatoses using an immunohistochemical
approach on frozen sections from 50 patients. In our study, a variable reduction in LAT
expression was observed in almost all the inflammatory and neoplastic skin conditions
investigated, irrespective of the particular disease. Our study indicates that LAT-negative T
cells are more common within the skin T-lymphoid infiltrate than was previously demon-
strated in both normal and neoplastic lymphoid tissues. These findings suggest that, using
a conventional immonoenzymatic approach on fresh frozen sections, LAT staining is an
unreliable marker for the identification of T cells in human pathological skin conditions.
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CXCR6 and its Ligand CXCL16 Mediate T Cell Recruitment into Psoriatic Skin
T Biedermann1,2, C Gu¨nther1, N Carballido1, S Fassl1, S Hinteregger1, J Kund1, and J M
Carballido1
1Department of Pharmacology, Novartis Research Institute, Vienna, Austria 2Department of
Dermatology, University of Tuebingen, Tuebingen, Germany
In recent years, much effort in research has focussed on the identification of tissue and
disease specific chemokine receptors. Targeting major receptors of an inflammatory process
will offer for the first time the possibility for disease specific therapeutic interventions. To this
end, chemokine receptor expression was analyzed in psoriatic skin derived T cell lines and
compared to PBL derived lines from the same donors. Remarkably, CXCR6 was expressed
more prominently in the skin derived T cell lines, both in the CD4 and CD8 subset. Moreover,
CXCR6 expression was exclusively found in the CCR7 population, marking them as effector
memory T cells ready to respond vigorously to activation. Indeed, these CXCR6 T cell lines
produced Th1 cytokines like IL-2 and IFN-g but no Th2 cytokines like IL-4. In the contrary, Th
cells from atopic dermatitis with a Th2 cytokine pattern were all CXCR6 negative. The
CXCR6þ CD4þ and CD8þ T cells from psoriatic skin responded to the CXCR6 ligand
CXCL16 as determined by intracellular Calcium mobilization assays. Moreover, psoriatic skin
derived T cells migrated to CXCL16 in vitro and, in vivo, CXCL16 recruited human T cells to
human skin grafts previously transplanted onto SCID mice. Analysis of expression profiles by
immunohistochemistry demonstrated the presence CXCR6þ T cells in psoriatic skin.
Comparing different leukocyte subsets as well as resident skin cells for the production of
CXCL16, monocytes were identified as the major source of CXCL16 by intracellular FACS
staining and ELISA. Consequently, CXCR6þ T cells migrated in response to monocyte
supernatants. As monocytes may produce several T cell attracting chemokines, the relevance
of this finding was further investigated by neutralizing CXCL16. Indeed, addition of blocking
anti-CXCL16 mAbs to the supernatants or CXCR6 desensitization by adding an excess of
CXCL16 to the T cells strongly inhibited this migration. These investigations indicate that
CXCL16 and CXCR6 are new and apparently important players in the process of psoriatic
inflammation. Thus, targeting CXCR6 in psoriasis may be a novel therapeutic approach which
not only reduces skin inflammation but is also devoid of systemic side effects as seen with
immunosuppressants.
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CCL18 is Selectively Expressed in Atopic Dermatitis and Mediates Skin Homing of
Human Memory T Cells
C Gu¨nther1, T Kopp3, T Biedermann1,4, C Bello-Fernandez2, J Kund1, N Carballido-Perrig1,
S Hinteregger1, G Lametschwandtner1, G Stingl3, and J M Carballido1
1Novartis Institutes for Biomedical Research (NIBR), Vienna, Austria 2Department of
Immunology, Vienna International Research Cooperation Center, Vienna, Austria 3Depart-
ment of Dermatology, Division of Immunology, Allergy and Infectious Diseases, Vienna
Medical University, Vienna, Austria 4Department of Dermatology, University of Tu¨bingen,
Germany
CCL18 is a homeostatic chemokine produced by human monocytes and dendritic cells (DC)
in lymphoid tissues. The expression of CCL18 is induced by IL-4, which is a cytokine
characteristically present in allergic reactions. Atopic dermatitis (AD) is an inflammatory skin
disease, which is characterized by lesional infiltrates of IL-4 producing Th cells and therefore
AD represents a suitable environment for CCL18 upregulation.
We found CCL18 expression in skin biopsies of AD patients but not in normal or psoriatic
skin. CCL18 was specifically expressed by monocytes and dendritic cells in the dermis of AD
skin and by Langerhans cells and inflammatory dendritic epidermal cells in the epidermis.
Furthermore, serum levels of CCL18 were significantly increased in AD patients compared to
healthy controls and a higher percentage of monocytes and dendritic cells secreted CCL18
in IL-4 stimulated PBMC of atopic donors compared to healthy individuals. Interestingly,
the higher CCL18 serum levels were observed in moderate compared to very severe dis-
ease stages, suggesting that CCL18 could be used as a biomarker for AD. In addition,
fluorescently labeled CCL18 bound not only to naı¨ve T cells in peripheral blood but also to
memory Th cells isolated from the skin of AD patients and induced the migration of these
memory Th cells in vitro and in human skin transplanted onto SCID-mice. These findings
reveal a novel inflammatory role of this chemokine mediating skin-homing of a subpopulation
of human memory T cells.
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Treatment with the Angiogenesis Inhibitor Vasostatin Resulted in Decreased Delayed-
Type Hypersensitivity Reactions in the Ear Skin of Mice
R Huegel, P Velasco, L Sierra, M Weichenthal, E Christophers, JM Schroder, G Tosato and B
Lange-Asschenfeldt
Kiel, Germany and Bethesda, MD, USA
Angiogenesis and increased vascular leakage are characteristic features in the context of
inflammation. The purpose of our study was to examine the effects of an antiangiogenic
treatment on inflammatory processes in vitro and in vivo. Vasostatin, an endothelial cell
inhibitory factor present in culture supernatants of Epstein-Barr-virus-immortalized cells was
recently identified as the amino terminal domain of Calreticulin (amino acids 1-180) and was
found to inhibit proliferation of endothelial cells and to suppress neovascularization and tumor
growth in vivo. We induced delayed-type hypersensitivity (DTH) reactions in the ear skin of
wildtype FVB mice with and without vasostatin treatment in order to study the extent of
vascularity, vascular leakage and leukocyte-recruitment. Twenty-four hours after the initial
challenge, the vasostatin-treated mice exhibited 38% less edema when compared to the
untreated mice. This trend was observed throughout the investigated recovery period of 7
days. In an Evans blue leakage assay we observed 43% less plasma leakage. Furthermore,
we found a significant decrease in blood vessel density in the inflamed ears of the vasostatin-
treated mice. Vessel spread analysis combined with three-dimensional vessel imaging using
whole mounts of ears following lectin perfusions demonstrated fewer larger vessels in the
treated group compared to the control animals. The observed decreased number of adherent
leukocytes in the lectin perfused ears of treated animals is in accordance with intravital
microcopy studies showing a significant decrease in the rolling fraction of leukocytes in
vasostatin-treated mice. Electron microscopy studies indicated that Vasostatin may prevent
leakage by maintaining the integrity of interendothelial junctions. Furthermore we investigated
the effect of Vasostatin on macromolecular permeability of human dermal microvascular
endothelial cell (HDMEC) monolayers stimulated with the permeability-inducing agent VEGF-
A. Vasostatin potently inhibited VEGF-induced permeability implying that the mechanism
responsible for the observed in vivo results may involve direct activity of vasostatin on the
endothelial cells. Our study suggests that therapeutic approaches using angiogenesis
inhibitors could prove beneficial in the treatment of cutaneous inflammation.
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Thrombospondin 1 Modulates Inﬂammation, Vascular Leakage and Vascular Remodeling
During Experimental Delayed-Type Hypersensitivity Reactions
P Velasco, R Huegel, J Harder, E Christophers, JM Schroder, J Lawler, M Detmar and B
Lange-Asschenfeldt
Kiel, Germany and Boston, MA, USA
Thrombospondin 1 (TSP-1) is a potent endogenous angiogenesis inhibitor that is thought to
play an important role in maintaining cutaneous vascular quiescence. However, TSP-1 has
been detected in inflammatory diseases such as arthritis and has been described as pro-
angiogenic and pro-inflammatory in some experimental models. To elucidate the function of
TSP-1 in a cutaneous inflammation, we studied the expression of TSP-1 in human allergic
contact dermatitis (ACD) induced by patch testing. 72 hours after the onset of the
inflammation, both TSP-1 protein and mRNA expression were potently upregulated in the
inflamed lesions when compared to normal skin taken from the same patient. In-situ
hybridization revealed that keratinocytes and endothelial cells were the main source of TSP-1
in ACD although some inflammatory cells were also positive. To functionally characterize the
role of TSP-1 in inflammation, we induced delayed-type hypersensitivity reactions by topical
application of oxazolone to the skin of mice with targeted epidermal TSP-1 overexpression, in
TSP-1-deficient mice and in wildtype mice. We found decreased edema formation in the
inflamed ears of TSP-1 transgenic mice associated with a significant decrease in the number
of enlarged blood vessels when compared to wildtype littermates. Conversely, TSP-1-
deficient mice exhibited a persistent reaction, characterized by a delayed resolution of the
inflammation and enhanced vascular remodeling, when compared to wildtype mice. Our data
indicate that TSP-1 suppressed vascular remodeling and vascular leakage during an ACD
and thereby decreased the extent of the experimental cutaneous inflammation, probably by
downmodulating the effects of pro-angiogenic factors such as vascular endothelial growth
factor A and by aiding in the resolution phase of the inflammation.
203 [Oral 036]
VEGF-A Plays a Key Role in the Induction of Chronic Inﬂammation and the Associated
Lymphangiogenic Response
R Kunstfeld1, S Hirakawa1, Y-K Hong1, V Schacht1, B Lange-Asschenfeldt1, P Velasco1, Y
Wu2, D Hicklin2, P Bohlen2 and M Detmar1
1Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General
Hospital and Harvard Medical School, Boston, MA; 2Imclone Systems Incorporated, New
York, NY
Vascular endothelial growth factor-A (VEGF-A) expression is upregulated in several inflam-
matory diseases including psoriasis, delayed-type hypersensitivity (DTH) reactions and
rheumatoid arthritis. To directly characterize the biological function of VEGF-A in inflamma-
tion, we evaluated experimental DTH reactions induced in the ear skin of transgenic mice that
overexpress VEGF-A specifically in the epidermis. VEGF-A transgenic mice underwent a
significantly increased inflammatory response that persisted for more than 1 month, whereas
inflammation returned to baseline levels within 7 days in wild-type mice. Inflammatory lesions
in VEGF-A transgenic mice closely resembled human psoriasis and were characterized by
epidermal hyperplasia, impaired epidermal differentiation and accumulation of dermal CD4-
positive T-lymphocytes and of epidermal CD8-positive lymphocytes. Surprisingly, VEGF-A
also promoted lymphatic vessel enlargement, which might contribute to the increased
inflammatory response, as lymphatic vessel enlargement was also detected in human
psoriatic skin lesions. Combined systemic treatment with blocking antibodies against VEGF
receptor-1 (VEGFR-1) and VEGFR-2 led to a decrease in lymphatic vessel size and potently
inhibited inflammation. Together, these findings reveal a central role of VEGF-A in promoting
lymphatic enlargement, vascular hyperpermeability and leukocyte recruitment, thereby
leading to persistent chronic inflammation. They also indicate that inhibition of VEGF-A
bioactivity might be a new approach to anti-inflammatory therapy.
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Induction of the Skin-Derived Antimicrobial Peptide Human Beta-Defensin-2 via NOD2/
CARD15
E Voss, K Wehkamp, J-M Schro¨der and J Harder
Kiel, Germany
Human skin protects itself by the release of inducible antimicrobial peptides like the human
beta-defensins hBD-2 and hBD-3. These beta-defensins are induced in keratinocytes upon
contact with bacteria. Nothing is known about the responsible cellular receptors involved in
the bacterial mediated induction of human beta-defensins in keratinocytes. Recently, a novel
intracellular signal transduction molecule termed NOD2 (CARD15) has been discovered.
NOD2 is composed of two N-terminal caspase recruitment domains, a nucleotide-binding
domain and multiple C-terminal leucine-rich repeats which are responsible for the recognition
of bacterial products. Recently, naturally occurring peptidoglycan fragments (i.e. muramyl
dipeptide, MDP) were identified as the microbial motifs sensed by NOD2. We hypothesized
that NOD2 might play a role in the chemical defense system of human skin. Therefore we
investigated the gene expression of NOD2 in keratinocytes using real-time PCR. Furthermore,
we cloned the NOD2 gene in an expression plasmid and used this construct to analyze the
function of NOD2. Luciferase gene reporter assays were used to investigate the influence of
NOD2 on hBD-2 promoter activation. Our results revealed that NOD2 mRNA is expressed in
foreskin-derived primary keratinocytes. Overexpression of NOD2 in keratinocytes activated
the transcription factor NF-kappaB as well as the hBD-2 promoter. Induction of hBD-2
through the NOD2 ligand MDP was increased in NOD2 overexpressing cells. Luciferase gene
reporter analyses and site directed mutagenesis experiments demonstrated that functional
binding sites for NF-kappaB and AP-1 in the hBD-2 promoter are required for NOD2-
mediated activation of the hBD-2 promoter upon MDP stimulation. Mutation of the proximal
NF-kappaB binding site in the hBD-2 promoter almost completely inhibited NOD2-mediated
hBD-2 promoter activation. Our data indicate that NOD2 could serve as in intracellular
receptor for bacterial ligands in keratinocytes. After activation by bacterial ligands NOD2
mediates the expression of inducible antimicrobial peptides like the human beta-defensin-2.
This is the first report demonstrating that NOD2 mediates the inducible expression of a
member of the human beta-defensin family.
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Recombinant Eucaryotic Osteopontin (OPN) Induces Dendritic Cell Migration and
Activation: Distinct Effects of Full Length OPN, N- and C-Terminal Fragments
A C Renkl1, Th Ahrens2, G Schulz1, T Eggers3, S Kon4, T Uede4, J C Simon5 and J M
Weiss1
1Department of Dermatology and Allergology, University of Ulm, Germany. 2Institute of
Biology, Basel University, Switzerland 3Department of Dermatology, University of Freiburg,
Germany 4Institute for Genetic Medicine Hokkaido University, Japan. 5Department of
Dermatology and Allergology, University of Ulm, Germany. Authors contributed equally
Osteopontin (OPN) is a secreted acidic, phosphoglycoprotein with a central GRGDS integrin
binding domain. We have previously shown that OPN mediates chemotactic migration of
Langerhans-/Dendritic Cells (LC/DC) to lymphnodes, thereby playing a central role during the
sensitization phase of allergic contact hypersensitivity. Thrombin cleavage of OPN, close to the
RGD sequence, results in two fragments of similar size but with distinct biological functions. The
N-terminal fragment contains the av binding RGD sequence, while the C-terminal fragment
contains the predicted CD44 binding domain. OPN has a modular structure with multiple
functional domains and its biological activity is influenced by its state of glycosylation and
phosphorylation. In vivo, OPN fragments cleaved at inflammatory sites may influence DC-
activation and migration. Here we investigated the secondary structure of recombinant
eucaryotic OPN and compared its biological activity with thrombin cleaved fragments,
neuraminidase treated OPN and a procaryotic OPN-GST-protein in its capacity to induce DC
activation and migration. 6xHistidin(His6)-tagged recombinant full length mOPN was expressed
by stable transfected human HEK-293-EBNA cells and mOPN was purified by its His6-tag. Full-
length mOPN was cleaved by thrombin and fragments were separated and purified by N-
terminal His6-tag. Sialic acid moieties were removed by neuraminidase. Analyzing the circular
dichroism of each protein, we found the eucaryotic protein and its fragments to be unstructured
in solution showing a spectrum characteristic for a random coil with a minimum at 200 nm, which
is in accordance to findings for OPN expressed in E. coli. Investigating the function of the full
length eucaryotic OPN, compared to E. coli derived GST-OPN, we found both forms to induce
DC activation, as measured by their expression of MHC-II and CD86. Interestingly, the DC
activating effect of eucaryotic OPN is more pronounced than the effect of bacteria derived GST-
OPN. Chemotaxis assays with immature BM-DC were performed with full length OPN and the
generated fragments demonstrated the eucaryotic OPN to be the more potent chemotaxin. The
most important domain mediating DC-migration seems to be located within the C-terminal half of
the molecule, which contains the CD44 binding domain, because the N-terminal fragment, with
the RGD-sequence, was a less effective chemoattractant. Neuraminidase treatment did not alter
OPN activity, indicating that the promigratory function of OPN on DC is not influenced by Sialic
acid residues. In conclusion we found eucaryotic OPN to have a random coil structure in
solution. Functionally, OPN cleavage, in vivo occurring at sites of inflammation may influence the
outcome of an immune response by differentially modulating DC activation and migration.
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Functional Analysis of the Suppressor of Cytokine Signaling 1 Promoter in Human
Keratinocytes
C Albanesi, C Scarponi and G Girolomoni
Istituto Dermopatico dell’Immacolata, IRCCS, Rome, Italy
We have previously shown that suppressors of cytokine signaling (SOCS) 1 is up-regulated by
IFN-g in normal human keratinocytes and is highly expressed in the epidermis of psoriasis
and allergic contact dermatitis lesions. SOCS1 overexpression inhibited IFN-g signaling in
keratinocytes by reducing IFN-g Ra phosphorylation and STAT1/3 activation. Forced
expression of SOCS1 impaired IFN-g-mediated membrane expression of ICAM-1 and HLA-
DR, and the release of CCL2, CXCL9 and CXCL10 by keratinocytes. In this study we
investigated SOCS1 promoter functionality in keratinocytes obtained from healthy subjects
and patients affected by psoriasis, and its response to IFN-g. The 50 genomic region of human
SOCS1 was cloned and reporter constructs bearing the 1950/þ297, 1620/þ 297, 819/
þ 297, 540/þ 297, 248/þ 297, 27/þ 297 and 1950/þ 31 promoter regions upstream
of the luciferase gene were prepared. In transiently transfected keratinocytes, derived either
from healthy or psoriatic donors, the deletion of promoter regions upstream of 248 and
downstream of þ31 resulted in a stonger luciferase activity, suggesting that these sequences
contain binding sites for functional repressors. Putative binding sites for the SOCS1
transcriptional repressor Growth Factor Indipendence-1 (GFI-1) were found in regions
between 1620 and 819, 819 and 540, 540 and 248, and þ 31 and þ297. However,
EMSA analyses performed with these fragments and keratinocyte protein extracts in the
presence of an anti-GFI-1 antibody or molar excess of oligonucleotides containing wild-type
or mutated GFI-1 binding sites revealed that GFI-1 binds efficiently only to its consensus
sequence in 819/540 and 248/þ 31 regions. Basal luciferase activity was increased by 3
folds in IFN-g-treated keratinocytes when the full SOCS1 promoter (1950/þ 297) was used.
Progressive 50 deletion of the SOCS1 promoter did not significantly alter responsiveness to
IFN-g, although we could detect different gel-retarded complexes in EMSA when nuclear
extract from unstimulated and IFN-g-treated keratinocytes were employed with the 540/
248 fragment. RNase protection experiments demonstrated that SOCS1 mRNA expresson
was decreased in psoriatic keratinocytes compared to cells from healthy controls, and this
decrement depended on a reduced SOCS1 promoter activity, as assessed in transiently
transfected cells. Reducing GFI-1 binding to the SOCS1 promoter can lead to upregulation of
SOCS1 gene transcription and thus prevent the expression of inflammatory genes in IFN-g
activated keratinocytes.
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Analysis of Antimicrobial Activity and Gene Regulation of the Skin-Derived RNase 7
B Rudolph, J D Monden, S Schubert, J-M Schro¨der and J Harder
Kiel, Germany
Healthy human skin is constantly exposed to various microorganisms, but usually not
infected. One reason for this high natural resistance might be the production and release of
endogenous antimicrobial proteins by keratinocytes. Recently, we isolated the antimicrobial
protein RNase 7 from stratum corneum extracts. The aim of this study was to explore the role
of RNase 7 in the chemical defence system of human skin. We analysed its antimicrobial
activity and studied its gene regulation in primary keratinocytes. For investigation of the
antimicrobial activity we used RNase 7 isolated from stratum corneum as well as recombinant
RNase 7 expressed as a fusion-protein in E. coli. RNase 7 exhibits a broad spectrum of high
antimicrobial activity against many pathogenic Gram-negative and Gram-positive bacteria
including Vancomycin-resistant Enterococcus faecium, Enterococcus faecalis and MRSA.
Deletion of the ribonuclease activity of RNase 7 by exchange of two amino acids in the active
center of the enzyme did not reduce its antimicrobial activity against E. coli suggesting that
the ribonuclease activity is not essential for killing of E. coli. Unlike the inducible human beta-
defensins hBD-2 and hBD-3, RNase 7 is expressed in normal skin at a very high level
(approximately 100–400 mg RNase 7 were purified from 50 g stratum corneum extracts). Real-
time RT-PCR revealed high constitutive gene expression of RNase 7 in primary keratinocytes.
The high gene expression of RNase 7 requires the single intron located in the 50-UTR as
shown by Luciferase gene reporter assays. Treatment of the cells with supernatants of
adherent cultures of P. aeruginosa and S. aureus further increased expression of RNase 7 in
primary keratinocytes (up to 50-fold induction) as well as treatment with 50 ng/ml phorbol-
myristate-acetate (100-fold induction). Interestingly, gene induction was almost completely
inhibited by co-treatment with all-trans retinoic acid. Taken together the high expression of
RNase 7 in keratinocytes combined with its high antimicrobial activity suggests, that RNase 7
might play an important role in the defence of the skin against various pathogenic bacteria.
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The Proteasome Inhibitor bortezomib (PS-341) Reverses Constitutive Activation of NF-
kappaB Pathway and Promotes Apoptosis in Human Cutaneous T Cell Lymphoma (CTCL)
A Sors, F Jean-Louis, L Dubertret, H Bachelez, L Michel
Unite´ INSERM U532, Institut de Recherche sur la Peau, Hoˆpital Saint-Louis, Paris, France
Advanced stages of CTCL are associated with a poor response to death-inducing
chemotherapeutic agents, including mitochondrial drugs. Since we previously demonstrated
that an activation of the nuclear Factor-kappaB (NF-kB) pathway plays a key role in this
resistance, we investigated the effects of bortezomib (PS-341), an inhibitor of the proteasome
which has shown potent anti-tumor properties. We evaluated the effects of PS-341 (5 to
50 nM) on the viability of CTCL cell lines (HUT78, SeAx, Myla) lines and tumor cells from
patients with Sezary syndrome (SS). The modifications of NF-kB activity were studied by
electrophoretic mobility shift assay (EMSA). The cellular localization of NF-kB proteins was
analysed by immunocytochemistry and confocal microscopy. The expression of cyto-
plasmic NF-kB inhibitors (I-kB) and of molecules of the Bcl-2 family was investigated
by immunoblotting.
Results demonstrate that PS-341 almost completely reverses the constitutive nuclear
translocation of NF-kB, as shown by EMSA and cytochemistry, in a dose- and time-
dependent fashion. In both CTCL cell-lines and tumor cells from SS patients, inhibition of
constitutive NF-kB by bortezomib led to rapid induction of apoptosis, as shown by annexin V/
propidium iodide staining and mitochondrial transmembrane potential alterations, as well as
by immunoblot analysis of procaspase 3 and of poly(ADP-ribose)polymerase cleavage.
Immunoblotting analysis revealed that bortezomib-induced apoptosis of CTCL cells was
associated with an up regulation of the pro-apoptotic Bax member of the bcl-2 family, while
expression of contra-apoptotic molecules such as Bcl-x(L) or Bcl-2 was not altered.
These results demonstrate that bortezomib (PS-341) is able to reverse in vitro the
constitutive activation of NF-kB, and to induce apoptosis in CTCL cells. This set of data
warrants further studies investigating in vivo the effects of bortezomib in CTCL patients
showing resistance to classical systemic treatments.
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Interleukin 4 Promotes TC1-Driven, Protective Anti-Cancer Immunity
P Lu¨hrs, T Biedermanny, G Stingl M Ro¨ckeny, A Schneeberger
DIAID, Dept. of Dermatology, Univ. of Vienna Med. School, Austria; yDept. of Dermatology,
Univ. of Tu¨bingen Med. School, Germany
Identifying agents that boost antigen-specific immune responses is an important goal of
researchers involved in cancer immunotherapy. Recently, we found that the co-administration
of the polycation poly-L-arginine (pR) and bgalactosidase (bgal; thereafter referred to as pR-
PV) yields substantially higher numbers of specific, IFNg-secreting, CD8þ T cells than s.c.
bgal-application. In addition, there are studies showing that IL-4 is capable of promoting the
activation of TH1 lymphocytes provided that it is applied early after the induction of the
immune response and at high doses. Based on these observations, we asked whether IL-4
can be used to augment the efficacy of the pR-PV. To test this hypothesis, BALB/c mice were
injected s.c. with the pR-PV either alone or admixed with IL-4. Seven days later, CD8þ Tcells
producing either IFNg or IL-4 in response to bgal were quantified by ELISPOT analysis.
Results obtained showed that co-administration of IL-4 significantly enhances the number of
vaccine-induced, specific CD8þ T lymphocytes producing IFNg. In addition, we found the IL-
4 treatment used to shift the specific immune response towards a TC1 phenotype. To
investigate the effect of IL-4 administration on the clinical efficacy of the pR-PV, BALB/c mice
were injected on days 0 and 14 with pR-PV þ / IL-4 and challenged on day 24 by the s.c.
inoculation bgal-expressing RENCA cells. None of the naive controls (n¼ 6) rejected the
tumor inoculum. S.c. administration of the pR-PV protected 3/6 (50%) animals. The highest
protection rate (5/6; 83%) was obtained by the combined use of the pR-PV and IL-4.
Together, these results demonstrate that IL-4 has the potential to act as a natural adjuvant
capable of inducing a protective TC1-driven anti-cancer immune response.
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Sex Hormones Modulate Interleukin-5 Production By Human Skin Mast Cells With Gender
Speciﬁc Differences
A Sta¨rke, M Babina, S Guhl, B M Henz, T Zuberbier
Department of Dermatology and Allergy, Charite´ Campus Mitte, University Medicine Berlin,
Berlin, Germany
Mast cells (MC) are localized in close vicinity to blood vessels and thereby exposed to high
levels of serum derived factors. We previously reported on differences between (female)
breast skin derived human MC (bsMC) as opposed to (male) foreskin derived MC (fsMC) in
terms of cytokine production. In the present study, we hypothesized that MC may be
significant targets of sex steroid action and that distinct hormonal networks may give rise to
divergent cytokine production by fsMC and bsMC. We also sought to clarify if responsiveness
to hormones differed among MC subsets. MC purified to homogeneity from both skin
compartments were first tested for the expression of sex steroid receptor transcripts by
semiquantitative RT-PCR analysis. MC expressed mRNA for androgen receptor (AR),
estrogen receptor (ER)a, ERb, and progesterone receptor (PR). The levels detected in MC
were higher than those found in other primary haematopoietic cells (PBL, monocytes,
granulocytes), with PR expression being even exclusively confined to MC. While levels of PR
and ERb displayed an even distribution among fsMC and bsMC, substantially higher levels of
ERa were associated with bsMC. Conversely, AR specific transcript was preferentially
expressed by fsMC. To study a possible impact on MC cytokine production, both bsMC and
fsMC were pre-cultured for two weeks with stem cell factor (100 ng/ml)þ interleukin (IL-)4
either in the absence or presence of progesterone (P, 1 mM), dihydrotestosterone (T, 500 nM),
or 17 b-estradiol (E, 200 nM), primed with human IgE, washed extensively and challenged by
anti-IgE at 1106/ml. The resulting supernatants were analyzed by ELISA for IL-1b and IL-5
levels. While IL-1b did not appear subject to regulation by sex hormones, IL-5 was
substantially reduced by P from 190.4  50.4 to 104  33.8 ng/ml/106 cells (n¼ 6, po0.02).
Interestingly, despite the presence of similar levels of PR in both MC subsets, the
downregulatory effect of P was strictly confined to bsMC. On the other hand, only fsMC
showed enhanced IL-5 production following T treatment from 260.4  23.2 to 395.9  35.6
ng/ml/106 cells (n¼ 4, po0.02). We conclude that MC in human skin are equipped with the
prerequisites to respond to sex steroids, that MC responses to these hormones display
gender specific differences, and that IL-5 production by MC may be favored by a ‘‘male’’, and
concomitantly inhibited by a rather ‘‘female’’ environment.
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Evidence for a Restricted Rather Than Generalized Stimulatory Response Of Skin-
Derived Human Mast Cells Towards Substance P
H-H Lee, S Guhl, M Babina, B M Henz, T Zuberbier
Department of Dermatology and Allergy, Charite´ Campus Mitte, University Medicine Berlin,
Berlin, Germany
The neuropeptide substance P (SP) is believed to impact mast cell (MC) function there-
by contributing to the bidirectional communication between MC and nerves. However,
MC heterogeneity is a well-known phenomenon that comprises species-, tissue-, and
differentiation-stage dependent differences among individual MC populations. Having
developed a technique to purify MC to homogeneity from human breast skin tissue, we
analyzed the direct effects of SP on degranulation and cytokine production of this MC subset.
As expected, SP dose-dependently induced histamine release, the extent of which (at an SP
dose of 30 mM) was only slightly lower than that induced by immunological stimulation via the
high affinity receptor for IgE (FceRI). When the two activation pathways were compared
directly for the production of proinflammatotory cytokines, both analogous and divergent
effects were found. Only the cross-linking of FceRI was able to trigger high-level TNF-a
secretion (100.1  28.5 pg/106 cells and ml after 24 h versus 10.1  0.8 at baseline, n¼ 8;
po0.02) and low (but significant) IL-8 increase (5.01  1.26 ng/106 cells and ml after 24 h
versus 4.36  1.23 at baseline, n¼8; po0.01), while SP (at 0.3–30 mM) remained without any
effect. Likewise, SP (at 30 mM) had no additional effect on these two cytokines when
combined with anti-IgE. We have shown previously that FceRI crosslinking suppresses the
levels of IL-6 accumulating in the supernatant of human skin MC. Interestingly, SP displayed
an even higher suppressive effect in this regard (31.2  12.8 pg/106 cells and ml after 24 h
with SP at 30 mM versus 48.0  12.9 at baseline, n¼ 7; po0.005). No additional effect from
anti-IgE was observed when combined with SP. To elucidate whether the decreased IL-6
concentration in the supernatant was driven by reduced levels of IL-6 specific mRNA, a
quantitative real time PCR technique using the SYBRGreen system was utilized. The amount
of mRNA copy numbers was assessed as (each per 25 ng total RNA): 2178 for IL-6 (base-
line) versus 2307 (SP). Likewise, SP had no effect on the concentration of either IL-8 (2665/
control versus 2461/SP) or TNF-a transcript (94/control versus 72/SP). This suggests that
the downregulation of IL-6 in the supernatant proceeds through a post-transcriptional
mechanism that may involve the recently described degradation of this cytokine by MC
tryptase released from MC granules on SP mediated degranulation. We conclude that SP
acts on human skin MC in a very selective manner by eliciting degranulation but without the
induction of proinflammatory cytokines. In addition, our data underline that IL-6 availability in
the vicinity of human MC can be regulated by mechanisms other than transcription.
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Papillomavirus-like Particle-Based Amyloid Beta Vaccine Induces Protective Autoanti-
body Response
A Handisurya1, S Shafti-Keramat1, E Zamora2, J C Troncoso2, R Kirnbauer1
1LVO, DIAID, Dep. of Dermatol., Medical University, Vienna, Austria; 2Dep. of Neurology,
Johns Hopkins Univ., Baltimore
Non-infectious virus-like particles (VLP) composed of major capsid protein L1 are successful
as vaccine to prevent human papillomavirus (HPV) infection and associated neoplasia. In
addition, chimeric VLP have been generated that incorporate foreign or self-antigens, and
immunizations have induced high levels of (auto-)antibodies (ab), whereas immunizations
with linear peptides were less effective. Ab were long-lasting and functionally active in
experimental animal models.
The neuro-degenerative disorder Alzheimer’s disease (AD), is characterized by neurofi-
brillary tangles and amyloid plaques, consisting of amyloid-beta (Abeta) fibrils. There is no
effective therapy to prevent/cure AD. Recent studies have focused on anti-Abeta ab to inhibit
fibril formation and/or to resolve Abeta-aggregates.
Chimeric bovine papillomavirus (BPV1) L1 was generated by inserting 9 amino acid (aa) N-
terminal peptide of Abeta into an immunogenic VLP surface loop (Abeta-VLP) and expressed
in Sf-9 cells. Electron micrographs demonstrated efficient self-assembly into capsomeric
VLP. Antigenicity of the inserted Abeta epitope was verified by Western blot. This peptide
shows aa sequence identity in human and rabbit representing a self-antigen for both species.
To examine whether Abeta-VLP are capable to break B-cell tolerance, NZW rabbits were
immunized with Abeta-VLP using Freunds adjuvant. After five months no signs of toxicity
were observed. By ELISA, rabbit inoculated with Abeta-VLP developed strong ab response
(titer410.000) to Abeta peptide 1-9, whereas control rabbit did not. Reactivity was specific
for the Abeta epitope and blocked by homologous, but not control peptide. Immune sera
revealed a weak but significant neuroprotective effect against pre-aggregated amyloid fibers
and recognized amyloid plaques in post mortem brains sections of AD patients.
These data support VLP as a tool to overcome tolerance to self-antigens with potential of
inducing therapeutically useful auto-ab responses in humans. This hypothesis is currently
evaluated by in vivo models of AD.
ABSTRACTS A35123 : 2 AUGUST 2004
213
CCL27-CCR10 Interactions Play an Important Role in Skin-Associated T Cell Priming
A Muller, F Winterberg, M Gombert, H Soto, T Ruzicka, A Zlotnik, and B Homey
Du¨sseldorf, Germany and San Diego, USA
The skin immune system provides essential sentinel functions at the interface between the
environment and the organism. Next to infectious agents, increasing numbers of xenobiotics
are constantly screened by cellular members of the skin immune system. After recognition,
processing, presentation and subsequent T cell priming, the recruitment of memory T cells to
the skin represents a critical step during the elicitation of effective immune responses against
foreign antigens. Recently, we identified the novel skin-specific chemokine CCL27 as well
as its receptor CCR10 and demonstrated that CCL27-CCR10 interactions regulate the
recruitment of antigen-specific memory T cells during the elicitation phase of hapten-induced
contact hypersensitivity. In the present study, we investigated the role of CCL27-CCR10
interactions during the sensitization phase of contact hypersensitivity. During the induction
phase of hapten-induced contact hypersensitivity neutralization of mCCL27 significantly
suppressed subsequent DNFB-induced elicitation responses. Re-challenge as well as
adoptive transfer experiments indicated that the blockade of CCL27-CCR10 interactions
significantly impaired the generation of hapten-specific memory T cells in vivo. Taken
together, findings of the present study suggest that chemokine ligand-receptor interactions
also play an important role in the afferent phase of immune responses.
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UV-Injury, Apoptosis, Chemokines and Leukocyte Recruitment: An Ampliﬁcation Cycle
Triggering Cutaneous Lupus Erythematosus
S Meller, F Winterberg, R Kubitza, H Kanzler, M Gilliet, MC Dieu-Nosjean, T Ruzicka,
P Lehmann, A Zlotnik, and B Homey
Du¨sseldorf, Germany; Berkeley, CA, USA; Zurich, Switzerland; Paris, France and San Diego,
USA
Lupus erythematosus (LE) is an autoimmune disease demonstrating photosensitivity,
increased apoptosis, and cutaneous leukocyte recruitment. In the present study, we identify
the CXCR3 ligands, CXCL9 (MIG), CXCL10 (IP-10), CXCL11 (I-TAC) being the most
abundantly expressed chemokine family members (n¼ 42) in cutaneous LE. Expression of
these ligands corresponded with a marked inflammatory infiltrate consisting of mainly
CXCR3-positive cells including CLAþ lymphocytes and CD123þ /BDCA2þ plasmacytoid
dendritic cells (pDC). Circulating pDCs express CCR5, CXCR3, and CXCR4 and produce high
levels of type I interferon as well as chemokines after stimulation with either virus, apoptotic
bodies or immunostimulatory DNA sequences (ISS). Type I interferons, in turn, are potent
inducers of CXCR3 ligands in cellular constituents of the skin such as keratinocytes, dermal
fibroblasts and endothelial cells. Furthermore, we show that UVB-irradiation induces a
distinct set of chemokines in keratinocytes including CCL5, CCL20, and CCL27. Taken
together our data suggest an amplification cycle with UV-injury inducing apoptosis and
chemokine production which in turn mediate the recruitment and activation of lymphocytes
and IFN–producing pDCs which subsequently release more effector cytokines and
chemokines finally leading to the development of cutaneous LE lesions.
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Synergistic Activation of the Chemokine CCL20/MIP-3a Expression in Dermal Cells by
Pro-Inﬂammatory Cytokines is Dependent on Activation of the Transcription Factors NF-
jB p65 and p52, as well as Stat1a
B Wolff, S Flo¨b, G Herzig
Novartis Institute for Biomedical Research, Vienna, Austria
The inducible CC chemokine CCL20/Macrophage Inflammatory Protein (MIP)-3a is over-
expressed in psoriatic lesions. Primary keratinocytes (KC), dermal fibroblasts (HDF),
microvascular endothelial cells and dendritic cells produce MIP-3a upon stimulation with,
e.g. TNF-a/IL-1b, IFN-g or IL-17, which are also overexpressed in psoriasis. We compared the
effects of TNF-b, IFN-b and IL-17 alone or in combination in primary human KC and HDF, as
well as keratinocyte and fibroblast cell lines (HaCaT, A431, 1BR3GN, HT1080). Primary KC
and HDF showed a synergistic induction of CCL20 in the presence of TNF-a and IFN-g or IL-
17, with the highest levels reached by the combination of these three cytokines. The same
pattern was observed also in 1BR3GN and HT1080 cells, but not in HaCaT and A431. For the
investigation of signal transduction pathways involved in this synergistic activation, we chose
HT1080 cells as a more convenient system than primary cells. The upregulation of CCL20 at
both mRNA and protein levels required between 6 and 24 hours of incubation. IL-17 alone
had no effect on any of the signalling pathways investigated (NF-kB, MEK1/2, MKK4, MKK3/
6, p38 MAPK, Stat proteins 1-6). TNF-a induced the activation of NF-kB p65, and IFN-g
activated Stat-1a. The combination of all three cytokines, in addition, led to an upregulation of
NF-kB p100/p52 mRNA and nuclear translocation of p52. Transfection of siRNAs directed
against NF-kB p65, NF-kB p100/p52 and Stat1 into HT1080 cells significantly inhibited
CCL20 expression after stimulation with the triple cytokine cocktail. These three signal
transduction mediators are thus involved in the synergistic activation of CCL20 in HT1080
cells and, given the similarity of expression patterns, potentially also in primary KC and HDF.
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Kinetic Study Of T Cells Phenotype In The Drug Hypersensitivity Syndrome
D Picard1,2, S Jacquot2, I Dutot2, F Tron2, P Joly1, Ph Musette1,2
1Service de Dermatologie – Hoˆpital Charles Nicolle CHU, Rouen, France 2Unite´ Inserm 519
– Faculte´ de Me´decine et de Pharmacie, Rouen, France
The drug hypersensitivity syndrome (DHS) or Dress (Drug reaction with eosinophilia and
systemic symptoms) is a severe toxic reaction associated with visceral manifestations
sometimes leading to death. Medications involved are mostly antiepileptics. Clonal T cell
expansions are found in 40% of patients.
Sixteen patients with DHS were included in our study. CD4þ and CD8þ T cells were
separated from PBMC using negative selection on MACS columns. A T lymphocyte repertoire
analysis was performed with the immunoscope technique using Vb and Cb specific primers.
Lymphocyte phenotype (activation markers: CD25, CD68, CD134, CD45RO, HLA DR, FasL;
cutaneous homing receptors: CLA, CCR4) and cytokine secretion (IL2, IL5, IFNg, TNFa, IL4,
IL8, IL13 and IL10) were analysed with a flow cytometer on blood samples collected at D5,
D30, D90, D180 and D360. When immunoscope analysis showed a repertoire bias (i.e. non
Gaussian) with an expanded lymphocyte population within a particular Vb family, a flow
cytometry analysis with an anti-Vb antibody was performed in a second time to characterize
the phenotype and the cytokine secretion profile of the expanded population. In order to
study the modifications of gene expression in DHS, we performed a DNA array of 901 genes
expressed in PBMC for 3 patients with DHS secondary to carbamazepine and minocycline.
In our multicentric and prospective study, we found that T cells presented an activated
phenotype, more remarkable within the CD8þ subset. CD4þ and CD8þ cells overexpress
cutaneous homing markers at the early stages of the disease. The cytokine profiling of CD4þ
T cells is Th1 orientated, the proportion of CD4þ and CD8þ T cells secreting IFNg and TNFa
increases between D5 and D90 which may be an explanation for relapses when
corticotherapy is decreased in this period. The analysis of expanded populations with anti-
Vb antibody showed that these cells express higher levels of activation markers and secrete
higher levels of IFNg, TNFa and IL2. The gene expression analysis on CD4þ and CD8þ
populations confirms the results obtained by flow cytometry analysis and more generally
shows overexpression of genes involved in cellular activation, apoptosis, cutaneous homing
and production of proinflammatory cytokines.
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TLR2 and TLR4 Mediate the Recognition of Pathogens in Vaginal Epithelial Cells
Pivarcsi, I Nagy, K Kis, L Bodai, Cs Szeg, M Sze´ll, Zs Bata-Cso¨rgo+, A Dobozy, L Keme´ny
Szeged, Hungary
Epithelial cells of the vagina are important in providing protection against various pathogenic
microorganisms, e.g. Candida albicans. Vaginal epithelial cells produce proinflammatory
cytokines and antimicrobial peptides, which mediate the killing of pathogenic fungi. Toll-like
receptors (TLRs) are known to be important in mediating mechanisms of innate host defence.
We aimed to explore whether TLR signalling pathway and activation of proinfalmmatory
cytokines and antimicrobial peptides could be responsible for the protection against
pathogenic microorganisms by vaginal epithelial cells.
TLR expression on vaginal sections was detected by imunohistochemical staining with
specific antibodies. Quantitative real time RT-PCR, flow cytometry and Western-blot analyses
were used to detect the expressions of TLR2 and TLR4 in immortalized vaginal epithelial cell
line (PK cells). Activation of NF-kB transcription factor in PK cell after challenge with microbial
products was examined using ELISA-based TransAMt assays. Quantitative real-time RT-
PCR was used to examine the expressions of pro-inflammatory cytokines (IL-8, TNFa, IL-1a
and the inducible human antimicrobial peptide (b-defensin 2)) after incubation with heat-killed
Candida albicans, zymosan, LPS and PGN. ELISA assay and fluorescent immunostaining
were used for detection of cytokines and human b-defensin 2 (hBD2) produced by vaginal
epithelial cells.
We found that TLR2 and TLR4 receptors are expressed in vivo in vaginal epithelia and
in vitro in PK vaginal epithelial cell line. Quantitative real time PCR showed that IL-8, TNFa and
hBD2 mRNAs were significantly (po0.05) up-regulated in PK cells 3 h after treating them with
LPS, PGN and Candida. Although we found that NF-kB had a constitutive activity in PK cells,
NFkB assay showed that LPS and PGN can further induce this transcription factor. In good
correlation with the results of real-time RT-PCRs, ELISA assays and immunostainings showed
that microbial compounds markedly induced the production of proinflammatory cytokines
and antimicrobial peptides in PK cells 12 and 24 h after treatment. In our work, we give an
evidence that recognition of pathogens by vaginal epithelial cells results in the production and
release of pro-inflammatory cytokines and antimicrobial peptides, which might lead to the
elimination of pathogens from the vaginal tract and activation of both innate and acquired
immune responses.
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Induction of Proinﬂammatory Cytokines and RNase 7 by Staphylococcus Aureus in
Human Keratinocytes
K Haisch, L Schwichtenberg, J Harder and J-M Schro¨der
Kiel, Germany
The gram-positive bacterium Staphylococcus aureus is a major cause for a variety of
skin infections. A proinflammatory response against S. aureus is described in human
keratinocytes, but little is known about the inducing pathogen-associated molecules (PAMs)
involved and their mode of activation. To analyse soluble PAMs released by S. aureus, we
investigated the supernatants of different strains cultured under various conditions for their
potential to induce proinflammatory cytokines and antimicrobial peptides in the human
keratinocyte cell line HaCaT as well as in primary keratinocytes. By Realtime-PCR analyses
we found that supernatants of different S. aureus-strains induced the proinflammatory
cytokines IL-8 and TNF-alpha and the antimicrobial protein RNase 7, but not human beta
defensin (HBD)-2. Supernatants of static or suspension bacterial cultures always resulted in
strong IL-8 induction. Interestingly, only supernatants of bacteria of 4–5 day cultivation under
static conditions, which corresponded to the late exponential growth phase, yielded high
induction of the S. aureus-killing RNase 7 and TNF-alpha as well as IL-8.
Partial purification and biochemical characterization experiments by size exclusion- and
ion-exchange-HPLC indicated that the S. aureus-derived RNase 7-inducer, which appears to
be anionic eluting upon size exclusion-HPLC in the void-volume, also induces IL-8, but not
HBD-2, an antimicrobial peptide that is not active against S. aureus.
Since toll-like receptors (TLRs) are important PAM-receptors and recognition through TLR2
was described as a major pathway for the activation of epithelial cells by staphylococci, we
over expressed TLR2 in HaCaT cells and primary keratinocytes prior to stimulation with S.
aureus supernatants. In both cases we found no increase of IL-8 production of cells over
expressing TLR2, indicating that TLR2 is not involved in the induction of IL-8 by soluble PAMs
produced by S. aureus in the late exponential phase under static conditions. We conclude
from these findings that – depending on culture conditions – S. aureus secretes PAMs that
can be recognised by skin keratinocytes leading to a rapid innate epithelial defense reaction
through induction of the staphylocidal protein RNase 7 and proinflammatory cytokines. The
mechanism of induction is not clear yet, but does not seem to involve TLR2.
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Inhibition of Pseudomonas Aeruginosa-Induced Human Beta-Defensin-2 Expression by
the Th2 Cytokines IL-4, IL-10 and IL-13 in Keratinocytes
M To¨teberg, K Wehkamp, J-M Schro¨der and J Harder
Kiel, Germany
Skin represents the first barrier in the defence system of human beings. Antimicrobial
peptides are part of this innate immune system. In healthy skin the concentrations of these
antimicrobial peptides are low but accumulate at sites of infection. Atopic dermatitis (AD) is a
common chronic inflammatory skin disorder. Bacterial or viral superinfection more often
occurs in patients with AD as compared to patients with Psoriasis. A recently published study
has shown that levels of Th2 cytokines like IL-4, IL-10 and IL-13 are elevated and levels of
antimicrobial proteins like human beta-defensin-2 (hBD-2) are decreased in the skin of
patients with AD. The expression of hBD-2 in keratinocytes is strongly induced by bacteria
like Pseudomonas aeruginosa (PA) leading to the hypothesis that the bacteria-mediated
induction of hBD-2 (and other inducible antimicrobial peptides) might be disturbed in AD
patients. Therefore, we investigated whether the PA-induced expression of hBD-2 in
keratinocytes is inhibited by the Th2 cytokines IL-4, IL-10 and IL-13. HaCaT and primary
keratinocytes were preincubated for 6 h with 40 ng/ml of IL-4, IL-10 or IL-13, respectively, or a
combination of 40 ng/ml IL-4 and 40 ng/ml IL-13 and subsequently treated with PA
supernatans for 15 h. The hBD-2 expression was analysed using real-time PCR, luciferase
gene reporter assays and enzyme-linked immuno sorbent assay (ELISA). Stimulation of
keratinocytes with PA supernatants resulted in a strong induction of hBD-2 which was
significantly decreased in the presence of some Th2 cytokines. IL-4 was found to be the
strongest inhibitor (decrease of hBD-2 induction by 80%–90%) followed by IL-13 (decrease
of hBD-2 induction by 70%–80%) and IL-10 (decrease of hBD-2 induction by 20%–30%).
Treatment using a combination of IL-4 and IL-13 inhibited hBD-2 induction by 70%–80%.
These results suggest that the low levels of antimicrobial proteins in the skin of AD patients
might be caused by the high levels of Th2 cytokines which strongly inhibit the bacteria-
mediated induction of antimicrobial proteins in keratinocytes. This might be one reason for
the susceptibility of AD patients to bacterial and viral superinfections and could lead to a new
clinical relevant view in preventing superinfections of patients with AD.
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Fumaric Acid Esters (FAEs) Mediate their in vitro Immunosuppressive Effects by
Glutathione (GSH) Depletion and Induction of Heme Oxygenase (HO-1)
J Lehmann, J Listopad, R Sabat, H Hennekes, K Asadullah, WD Doecke
CRBA Dermatology, Schering AG, D-13442 Berlin, Germany
Mixtures of FAEs are the most commonly used, orally applied systemic therapeutics for
psoriasis in Germany. Despite their clinical success, the molecular mechanisms of FAEs have
been not defined yet. In this study, we characterized the in vitro immunosuppressive activity
and mechanism of FAEs in primary human immune cells. Dimethyl fumarate (DMF) and diethyl
fumarate (DEF) [but not monomethyl fumarate (MHF), monoethyl fumarate (MEF), and fumaric
acid (FA)] exhibited potent depression of LPS-induced monokine secretion (TNF-alpha, IL-
1beta, IL-12) and PHA-triggered IFN-gamma secretion in hPBMC. Moreover, only DMF and
DEF were active in inhibiting T-cell proliferation after mitogen stimulation and in mixed
lymphocyte reaction (MLR). Since DMF had been described to induce oxidative stress via
depletion of reduced glutathione (GSH), we tested the expression of the potent anti-
inflammatory stress protein HO-1. Remarkably, only DMF and DEF led to a strong and dose-
dependent induction of HO-1 mRNA in monocytes. HO-1 induction was completely
prevented by exogenous GSH supplementation. GSH substitution was also active in
abolishing the immunosuppressive in vitro effects of DMF and DEF, i.e., the depression of
immunostimulatory cytokine secretion and T-cell proliferation. In summary, the in-vitro
immunosuppressive activity of DMF and DEF is mediated by a functional depletion of
reduced GSH and is associated with a strong induction of the antiinflammatory stress protein
HO-1. Further clarification of the mechanism of clinical successful FAEs may lead to new
approaches for therapy of psoriasis and other inflammatory and immune diseases.
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The Expression of Leukocyte-Chemoattractive Factors Suggest a Pathophysiological
Link Between Psoriatic Skin and Bone Disease
R Mo¨ssner,1 P Middel,2 U Kru¨ger,1 V Viereck,3 F Zschunke,2 C Neumann,1 K Reich1
Departments of 1Dermatology, 2Pathology and 3Gynaecology, Georg-August-University,
Go¨ttingen
Psoriasis is a chronic inflammatory disorder characterized by sterile infiltration of skin lesions
with inflammatory cells, primarily T cells and neutrophils. Up to 35% of patients also suffer
from concomitant joint disease. The similarities between skin and bone affection are
particularly prominent in a variant of psoriatic arthritis called chronic recurrent multifocal
osteomyelitis (CRMO). CRMO is typically associated with pustular psoriasis and presents as
a chronic relapsing primary aseptic osteomyelitis characterized by infiltration of the
metaphyses of tubular long bones, clavicles, or vertebrae with neutrophils and lymphocytes.
The factors involved in the influx of inflammatory cells in CRMO have not yet been clearly
identified.
Immunohistochemical and in situ hybridization studies of bone specimen obtained from a
patient with CRMO revealed the expression of several leukocyte-chemoattractive factors
including interleukin-8, interleukin (IL)-16 and lymphotactin (Ltn). While the expression of IL-
16 and Ltn was largely confined to infiltrating T cells, osteoblasts were also identified as
producers of chemotactic factors including IL-8 and MIP-3alpha. To further investigate the
posssible role of osteoblasts as sources of chemokines in CRMO, primary osteoblast cultures
(n¼ 5) were treated with TNF-a and IL-1b to mimick the proinflammatory environment present
in psoriatic arthritis. Investigation by cDNA array and quantitative real-time RT-PCR
techniques showed a strong induction of several chemokines, among them IL-8, MCP-1,
MCP-2, MIP-3alpha, IP-10 and RANTES. The cytokine-induced production of these factors
was confirmed on the protein level by ELISA, and could not be suppressed by co-incubation
of osteoblasts with cyclosporin or azithromycin, two drugs used in the treatment of CRMO.
Our study provides evidence for a role of leukocyte-chemoattractive factors in the
pathogenesis of CRMO. Under the influence of pro-inflammatory cytokines, osteoblasts, in
a certain analogy to the role of keratinocytes in psoriatic skin disease, may acquire non-
professional immune functions and contribute to the formation of bone lesions in psoriasis.
222
Expression and Activity of IL-17 in Cutaneous T Cell Lymphomas (CTCL)
L Michel1, A Cire´e2, F Jean Louis1, B Flageul1, W H Fridman2, H Bachelez1, E Tartour2
1Skin Research Institute, INSERM U532, Department of Dermatology, Hopital Saint Louis
AP-HP. Paris 2Unite´ d’Immunologie Biologique, Hopital Europe´en Georges Pompidou, AP-
HP, Paris, France
IL-17 is a pro-inflammatory cytokine mainly produced by activated CD4þ memory helper T
cells and we have previously shown in mice that IL-17 was able to act as a tumor growth-
promoting or -inhibiting factor, depending on the model. In the present work, we investigated
the expression and function of IL-17 in mycosis fungoides (MF) and Sezary syndrome (SS),
two types of CTCL usually bearing a CD4þCD45ROþ memory helper T cell phenoype.
Results from RT-PCR studies and from enzyme linked immunoassays demonstrate that CTCL
cell lines derived from MF (Myla) and SS (SeAx), as well as freshly isolated circulating tumor
cells from patients with SS, do express IL-17 mRNA and secrete this cytokine following
stimulation with PMA (100 ng/ml)þ ionomycin (1 mg/ml) or anti-CD3 (1 mg/ml)þanti-CD28 (5
mg/ml) antibodies. However, IL-17 does not act as a growth factor for MF or SS cell lines in
vitro. In addition, five out of 10 MF/SS biopsies expressed IL-17 mRNA, while this cytokine
was not detected in normal skin. In 2 patients with MF, IL-17 transcripts were not detected in
initial biopsies, whereas an upregulation of this cytokine was demonstrated during
progression of the disease. Furthermore, an association between IL-17 expression and
polymorphonuclear neutrophil infiltration was recorded in cutaneous lesions from 5 MF/SS
patients, including two cases presenting an unusual pustular form of CTCL. Results from RT-
PCR studies of CTCL lesions, which revealed a coexpression of IL-17 with IL-8, support the
contribution of IL-17 to the recruitment of neutrophils, most likely via a paracrine mechanism
involving keratinocyte-released IL-8. This study is the first demonstration of IL-17 production
by a human tumor, suggesting that synthesis of IL-17 within the tumor microenvironment
alters the development of the inflammatory reaction and may influence tumor phenotype and
growth.
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Human Leukocyte Elastase Induces Keratinocyte Proliferation by Epidermal Growth
Factor Receptor Activation
U Meyer-Hoffert, J Wingertszahn and O Wiedow
Stockholm, Sweden and Kiel, Germany
Epidermal hyperproliferation and neutrophil infiltration are major histopathological changes
observed in psoriasis. Neutrophils contain human leukocyte elastase (HLE), which is released
at sites of inflammation. Previous studies demonstrated that HLE is present in psoriatic
lesions and induces keratinocyte hyperproliferation in vitro and in vivo. To determine the
molecular mechanisms linking a proteolytic effect of HLE and epidermal hyperproliferation,
we examined the effects of HLE-induced signaling in human keratinocytes. Application of 100
nM HLE resulted in a transient calcium influx in FURA2-loaded human HaCaT keratinocytes
observed by single-cell fluorescence imaging. The calcium signal was concentration
dependent and was inhibited by addition of the HLE inhibitors elafin and secretory leukocyte
protease inhibitor (SLPI). The calcium signal was neither inhibited by pertussis toxin, cholera,
or by pre-stimulation with trypsin. Incubation with the tyrosine kinase inhibitor genistein, a
protein kinase C inhibitor (a myristoylated anti-epidermal growth factor receptor (EGFR)
fragment), as well as incubation with neutralizing EGFR antibodies abolished the HLE-
induced calcium influx. The supernatants of HLE-treated keratinocytes induced a calcium
signal in separately cultured keratinocytes. This could be inhibited by the addition of anti-
transforming growth factor alpha (TGF-alpha) antibodies. Application of HLE-induced
keratinocyte proliferation, which could be inhibited by neutralizing of anti-EGFR and anti-
TGF-alpha antibodies. Herein we demonstrate that HLE induces keratinocyte proliferation by
proteolytic activation of an EGFR signaling cascade involving TGF-alpha.
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The Distribution of GITR and GITRL in Atopic Dermatitis, Suggest Inhibition of
Regulatory T-Cells Locally in the Dermis
J Baumgartner-Nielsen1, C Vestergaard1, H Just1, K Thestrup-Pedersen1, B Deleuran2,
M Deleuran1
1Department of Dermatology and 2Rheumatology, Aarhus University Hospital, Denmark
Background. TARC (thymus and activation-regulated chemokine) is produced in the basal
keratinocytes of affected skin in AD and induces chemotaxis of CCR4þ cells, thereby
attracting skin homing lymphocytes. Recently, it has become clear that a defect in the
development of CD4þCD25þ regulatory T-cells (Tregs) results in eczema. The Glucocorti-
coid-Induced Tumor necrosis factor Receptor family-related gene (GITR) is expressed on
Tregs where binding to the ligand (GITRL) inhibits the function of Tregs. We therefore
examined the plasma levels and localization of GITR and GITRL in AD and correlated this to
TARC.
Methods. Heparinized blood samples were taken from 78 AD patients (43 female, age 17,6
year  14,1 year and 35 male age 21,3 year  15,8 year). The samples were centrifuged and
the plasma was stored at 801C. We measured the levels of TARC, GITR and GITRL in
plasma, in duplicates, using a sandwich ELISA. Immunohistochemical localization of GITR
and GITRL was done on biopsies from both involved and uninvolved skin. Values are
expressed as median with 25%–75% range.
Results. Plasma levels of GITRL were not increased in AD patients (984 pg/ml  281 pg/ml –
1827 pg/ml) compared to normal healthy volunteers (873 pg/ml 457 pg/ml – 1730 pg/ml).
P¼ 0,831. Neither were the soluble GITR, which inhibits GITRL, increased compared to
normal healthy volunteers (104 pg/ml vs. 82 pg ml) P¼ 0,149. We measured TARC in the same
samples, observing a significant correlation between high levels of TARC and high levels of
GITRL (r¼ 0,509, p¼ 0.01).
By immunohistochemistry, cells expressing GITR and GITRL were localized to the dermis of
AD patients, and never observed in the epidermis.
Conclusions: Patients with AD do not have increased levels of GITRL and of sGITR, but have
accumulation of cells expressing both GITR and GITRL in the dermis, suggesting that local
inhibition of Treg takes place in AD.
As Treg express CCR4, the receptor for TARC, and the fact that we observed a correlation
between TARC and GITRL, suggest that TARC attracts the Tregs, but the Tregs may not be
able to exert their local suppressive function on activated lymphocytes in the dermis,
because they are blocked by GITRL present in the dermis.
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Induction of Cytokine (IL-1a, TNFa) and Chemokine (CCL20, CCL27, CXCL8) Alarm
Signals after Allergen and Irritant Exposure
S W Spiekstra, M J Toebak, S Sampat-Sardjoepersad, P J van Beek, D M Boorsma, T J
Stoof, B M E von Blomberg#, R J Scheper#, D P Bruynzeel, T Rustemeyer and S Gibbs
Departments of Dermatology and Pathology, #VU University Medical Center Amsterdam,
The Netherlands
Topical exposure to chemicals damages the skin and generates alarm signals which are
produced by residential cells of the skin. The alarm signals call the immune system into
action. We examined the nature of these alarm signals after exposure of skin residential cells
to contact allergens and a contact irritant. Contact allergens (nickel sulphate and potassium
dichromate) and irritant (SDS) were topically applied to the stratum corneum of human skin
equivalents (fully differentiated epidermis on a fibroblast populated collagen gel) in a similar
manner to that done in vivo.
All chemicals tested resulted in an identical time- and concentration dependent increase in
pro-inflammatory cytokine (IL-1a and TNF-a) and chemokine (CCL20, CCL27 and CXCL8)
secretion. Exposure to nickel sulphate and SDS were investigated in more detail: similar to
chemokine secretion no difference was observed in the time- and concentration dependent
increase in pro-inflammatory cytokine (IL-1a and TNF-a) secretion. After allergen or irritant
exposure, neutralizing human antibodies to either IL-1a or TNF-a inhibited increased CCL20
and CXCL8 but not CCL27 secretion.
Our data shows that alarm signals consist of primary and secondary signals. IL-1a and
TNF-a are released as primary alarm signals, which trigger the release of secondary
chemokine (CCL20, CXCL8) alarm signals. However, some chemokines e.g.: CCL27 can be
secreted in an IL-1a and TNF-a independent manner. We suggest that skin residential cells
facilitate an allergic or an irritant contact dermatitis reaction by responding in a general
manner to danger and in doing so initiate infiltration of immune responsive cells into the skin.
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Induction of TNF and b-Defensins in Murine Skin by Staphylococcus aureus
M Schunck, N Linke, K Haisch, E Proksch
Department of Dermatology, University Hospitals of Schleswig-Holstein, Campus Kiel
The primary function of the skin is to form a barrier to prevent invasion of pathogenic
microorganisms. Besides the physical barrier a chemical barrier involving b-defensins is
important for host defence. b-defensins are cationic and cystein-rich antimicrobial peptides
that control bacterial growth in many organisms and species by permealizing bacterial
membranes. Recent studies have shown that murine b-defensin-1, -3 and -14 are
homologues to the well-characterized human b-defensin-1, -2 and –3 most, which are
important as defence against gram negative and positive bacteria. The functional
conservation of the peptides allows experiments in a mouse model to develop new
strategies for antimicrobial therapy. To investigate the induction of b-defensins, we applied
soluble factors of the gram-positive bacterium Staphylococcus aureus on murine skin and
determined at 1h, 3h, 6h, and 24h after treatment the mRNA expression of the
proinflammatory cytokine TNF and the b-defensins m bD-1, -3 and –14. TNF-mRNA was
significantly increased already 3h after Staphylococcus aureus application and still slightly
enhanced 6h. b-defensin 1 was constitutively expressed in normal mouse skin; surprisingly
an increase in the expression level occurred 6h after treatment. b-defensin-2 and -3 were not
found in normal skin, however, induced 6h after treatment. We hypothesize host defence
against Staphylococcus aureus leads to an early induction of TNF that in term may stimulate
defensin expression.
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Regulation of Interleukin-20 Gene Expression in Normal Human Keratinocytes in vitro
K Otkjaer, L Iversen, P L Nrby, H Just, J T Clausen and K Kragballe
Aarhus and Bagsværd, Denmark
Interleukin-20 (IL-20) is a recently discovered member of the IL-10-family of cytokines. The
skin of transgenic mice over expressing IL-20 show histological changes resembling some of
those seen in psoriasis; i.e. thickened epidermis, hyperkeratosis and a compact stratum
corneum. IL-20 mRNA has also been shown to be over expressed in psoriatic lesional skin
compared to non-lesional skin, where it was barely detectable, indicating a role for IL-20 in
the pathogenesis of psoriasis. At the same time keratinocytes were shown as the
predominant cellular source for IL-20 mRNA expression in lesional psoriatic skin. However,
the precise stimuli causing IL-20 gene expression in human keratinocytes has not yet been
studied. The purpose of this study was therefore to identify various factors that can induce IL-
20 gene expression in human keratinocytes, in vitro.
Cultured normal human keratinocytes were grown to approximately 70% confluency and
then stimulated in separate experiments with a panel of different stimuli (IL-1a, IL-1b, UVB,
bovine serum, IFN-g, LPS, IL-6, IL-20, TNF-a, calcium, spontaneous differentiation) for 2 and
6 hours. Total RNA was purified from the cells and qRT-PCR analysis carried out in order to
determine IL-20 mRNA-levels.
Stimulation with IL-1a, IL-1b, UVB and bovine serum lead to a pronounced and significant
increase in IL-20 gene expression compared to control whereas IL-6 and TNF-a only gave rise
to a small and insignificant increase in IL-20 gene expression. IFN-g, LPS, calcium, IL-20 and
spontaneous differentiation did not induce IL-20 gene expression. IL-1a (10 ng/ml) and IL-1b
(10 ng/ml) were the most potent inducers of IL-20 mRNA expression and lead to a 5-fold
increase compared to controls. IL-20 mRNA expression was maximal after 1 h of stimulation
and reached base-line level after 6 hours. The response was dose-dependent with a maximal
response 5ng/ml.
These results indicate that IL-20 gene expression in normal human keratinocytes is
regulated through specific signal transduction pathways because IL-1a and IL-1b potently
induced IL-20 mRNA expression whereas other inducers of inflammation such as TNF-a, LPS
and IFN-g were unable to induce IL-20 gene expression.
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Production of Human b-defensin-2 by Human Keratinocytes is Induced by Selective
Strains of Propionibacterium acnes
I Nagy1, A Pivarcsi1,2, A Koreck1, L Bodai1 and L Keme´ny1,2
1Department of Dermatology and Allergology, University of Szeged, Hungary 2Dermatolo-
gical Research Group of the Hungarian Academy of Sciences, University of Szeged,
Hungary
The Gram-positive, anaerobe bacteria Propionibacterium acnes (P.acnes) is found in normal
human cutaneous flora and is thought to play major role in acne, a chronic inflammatory
disease of the pilosebaceous unit. Although several lines of evidences suggest the direct role
of P.acnes in the pathogenesis of acne, little is known about the mechanism by which
P.acnes contributes in acne formation. In this study we investigated the capability of different
strains (n¼ 4) of P.acnes to activate the innate immune response of the skin and the role of
the antimicrobial peptide human b-defensin-2 (hBD2) as a possible regulator protein in
P.acnes infection. We found that distinct strains of the bacteria generate different patterns of
antimicrobial peptide and proinflammatory cytokine expression at both mRNA and protein
level. Two of the clinically isolated strains significantly (po0.05) up-regulated the expression
of hBD2, IL-8 and TNFa 3 hours after the treatment. In addition, P.acnes induced increase in
hBD2, IL-8 and TNFa gene expression could be inhibited by anti-TLR2 and/or anti-TLR4
neutralizing antibodies. In conclusion our findings demonstrate that distinct clinical isolates of
P.acnes up-regulate hBD2, IL-8 and TNFa expression in keratinocytes via the Toll like
receptors (TLRs). This activity of P.acnes may be particularly important in the acute infection
of the skin in which hBD2 participates in bacterial clearance. In addition, our findings stress
the importance of hBD2 as the possible key regulator protein in P.acnes infection and acne
formation.
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Characterization of Ovalbumin (OVA) Induced Atopic Dermatitis (AD) Murine Model
G Wang, A Lauerma and H Alenius
Finnish Institute of Occupational Health, Helsinki, Finland
Well-established AD murine model induced by OVA epicutaneous sensitization has been
used world wide for studying the mechanisms underlying the disease. Little has been known
about the progressing details of the model. The purpose of this study was to examine
kinetically the development of AD at different stages in the AD murine model.
BALB/c mice were epicutaneously sensitized with OVA (OVA group) or saline (SAL group)
for three weeks with a two-week-resting-interval between each sensitization week. Mice were
sacrificed after each sensitization week. The last groups of mice were killed two weeks after
the 3rd sensitization week. Cytokine and chemokine mRNA expressions in local skin tissue
were investigated by real time PCR. Skin morphology was examined by histology methods.
Total and specific antibody levels were studied by ELSA.
Compared with SAL groups, there were progressive and significant increases in both total
and OVA specific IgE levels in OVA groups after the 2nd and 3rd sensitization week. The
values dropped but kept significantly higher two weeks after the 3rd sensitization. Prominent
skin inflammation was observed in OVA groups after the 1st sensitization week, which
became most serious after the 3rd sensitization week. The skin recovered completely two
weeks after the 3rd sensitization week. mRNA expressions of Th2 type cytokines, several
chemokines and chemokine receptors were significantly higher in OVA groups with increasing
tendency following each sensitization week. The levels fell to normal two weeks after the 3rd
sensitization week.
In conclusion, skin inflammation and cytokine and chemokine mRNA expressions in OVA
induced AD murine model started early after 1st sensitization week. IgE antibody response
began after the 2nd sensitization week. The values were progressively increasing after each
sensitization week and tended to become normal two weeks after the last sensitization week.
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Interlukin-1 alpha and beta are Potent Inhibitors of Connective Tissue Growth Factor
Expression in Fibroblasts
D Nowinski1, A Koskela2, D Abraham3, A Holmes3, B Gerdin1 and M Ivarsson2
1Uppsala University, Sweden 2O¨rebro University, Sweden 3University of London, UK
Background. Connective tissue growth factor (CTGF) is intimately involved with tissue repair
and overexpressed in various fibrotic conditions. CTGF expression in fibroblasts is
upregulated by transforming growth factor (TGF)-beta, and there is evidence suggesting
that CTGF is mediating some of the profibrotic effects of TGF-beta. We have previously
shown that keratinocytes in vitro downregulate basal and TGF-beta-induced expression of
CTGF in fibroblasts by an interleukin (IL)-1alpha-dependent mechanism. Here, we
investigated further the mechanisms of this downregulation and analysed if the IL-1 beta
isoform also acts inhibitory on CTGF expression.
Methods. Human dermal fibroblasts and NIH 3T3 cells were treated with IL-1 alpha and beta
in presence or absence of TGF-beta 1. CTGF mRNA and protein levels were measured by
Northern and Western blotting, respectively. Activity of the CTGF promoter and TGF-beta-
responsive promoter elements was determined by transient transfections of luciferase
reporter constructs. Phosphorylated Smad 2/3 was analysed by immunoprecipitation and
Western blotting.
Results. Both IL-1 isoforms suppressed basal and TGF-beta-induced CTGF mRNA and
protein with a IC50 value of around 10 pg/ml. Pretreatment of cells with indomethacin did not
abolish the effect, suggesting that IL-1-mediated CTGF suppression is not mediated via
prostaglandins. CTGF promoter activity induced by TGF-beta was inhibited by IL-1alpha and
beta. Likewise, TGF-beta-induced activity of a synthetic minimal promoter containing Smad
binding CAGA elements was inhibited by IL-1 alpha and beta. Finally, TGF-beta-induced
Smad 2/3 phosphorylation was inhibited by IL-1 alpha and beta.
Conclusion. IL-1 alpha and beta were found to be potent inhibitors of CTGF expression at the
promoter, mRNA and protein levels. Our results support the view that IL-1 suppress TGF-
beta-induced CTGF expression by inhibiting Smad signaling pathways without affecting
prostaglandin production. These results add to the understanding of regulation of CTGF
expression, which may aid in elucidating the pathogenesis of fibrosis.
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Adduct Formation Between Nucleophilic Amino Acids and Hexahydrophtalic Anhydride
(HHPA), an Inducer of Both Type I and Type IV Allergy
SR Ahlfors, MH Kristiansson, CH Lindh, BAG Jonsson and C Hansson
Lund, Sweden
HHPA has a strong capacity to induce allergic asthma mediated by specific antibodies. It is
also a well-known contact hapten giving rise to allergic contact dermatitis. Although adducts
of HHPA to endogenous proteins have been described the epitope responsible for inducing
allergy has not been established. In this study we chemically characterise the adducts formed
in vitro between HHPA and nucleophilic amino acids and also towards a model peptide
including all essential nucleophilic amino acids. The adducts were analysed and purified by
HPLC and LS-MS. Their chemical structures were established by NMR and by nanospray
hybrid quadropole-time- of-flight mass spectrometry. We found addition of HHPA to nitrogen
as well as to sulphur giving major adducts to proline, lysine and cysteine. We also found that
the originally formed HHPA-cysteine adduct reacted with lysine giving a thermodynamically
more stable HHPA-lysine adduct. Studies on a model peptide with essentially all nucleophilic
amino acids showed a dominant addition of HHPA to the N-terminal proline but at molecular
excess of HHPA also addition to lysine and cysteine were registered. In this study we show
how HHPA can react with different amino acid moieties present in proteins. This variety of
reactivities gives rise to different epitopes. The knowledge is important in coming work on
synthetic complete antigens for production of specific T-cells hybridomas. If addition to
different types of amino acids or bonding atoms is essential for the type of allergic reaction or
if the same complete antigen can induce several types of allergies is a question of comming
research.
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Differential Expression of b-Defensins in Healthy Human Skin, Psoriasis and Eczema
E Wandel, B Rosin, M Sticherling
Department of Clinical and Experimental Dermatology, University of Leipzig, D-04103
Leipzig
Defensins are a group of small, cationic, cysteine-rich peptides with broad-spectrum
antimicrobial activity and were recently shown to represent an important part of the innate
immunity of the skin organ. In this study the expression of human -defensins (hBD) 2 and 3
was examined in skin samples obtained from different body sites and inflammatory skin
disorders. hBD-2 and hBD-3 mRNA was determined by in situ hybridisation using a specific
probe generated in house on paraffin sections of healthy human skin of different localisations
and in biopsies from patients with eczema, psoriasis and lichen ruber.
Expression of hBD-2 mRNA was found in only 50% of all samples tested, especially in
areas which are highly exposed to both microbial challenge and UV-radiation (e.g. nose,
forehead). In contrast, hBD-3 mRNA was determined in all skin samples tested. The
expression patterns of both b-defensins were equal with a hybridisation signal most
pronounced in the malpighian layer of the epidermis. In addition, in some samples sweat
glands were also stained positively.
Expression of hBD-2 mRNA was detected in all lesions of lichen ruber, in 83% of
eczematous skin but only in 40% of psoriatic skin. The intensity of the hybridisation signal
was strongest in biopsies of psoriatic skin. All suprabasal layers were stained positively,
whereas in samples from lichen ruber and eczema only the stratum granulosum showed
staining for hBD-2 mRNA. No staining of endothelial or inflammatory cells was observed.
HBD-3 expression was found in all biopsies of psoriasis and lichen ruber but in only 66% of
eczema lesions. The staining pattern was similar to that detected for hBD-2.
This study demonstrates the differential expression of hBD-2 and hBD-3 in healthy human
skin. Partly absent expression could be explained by the fact, that hBD-2 and hBD-3 are
inducible and not constitutively expressed antimicrobial peptides. Since hBD-3 is extremely
active against Staphylococcus aureus, its lower expression in eczema lesions may explain
the clinical experience, that atopic in contrast to psoriatic skin is prone to staphylococcus
aureus infections.
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Human Keratinocytes Respond to IL-18. Implication for the Course of Chronic
Inﬂammatory Skin Diseases
R Purwar, C Hartmann, A Kapp, T Werfel, M Wittmann
Department of Dermatology and Allergology, Ricklinger Str. 5, Hannover Medical University
Hannover, Germany
IL-18, initially termed IFNg-inducing-factor, has been described to decisively influence the
course of several inflammatory skin diseases such as eczema and psoriasis. In this study, we
aimed to further elucidate the keratinocytes role in the ‘‘IL-18’’ system. Here we show for the
first time that human keratinocytes do respond to IL-18. In this study we were able to show
that the expression of IL-18R alpha, responsible for IL-18 binding, is differentially expressed
on keratinocytes. There is a clear basal expression of the receptor. A marked up regulation is
induced upon stimulation with IFNg plus a second signal such as TNF alpha. IL-4 was able to
downregulate the IL-18R alpha expression. Keratinocytes showed activation of the NF-kB
signalling pathway upon IL-18 stimulation as detected by nuclear translocation. The main
biological effect of IL-18 was induction of MHC class I and II expression on human
keratinocytes, known as non-professional antigen presenting cells. The MHC II expression
was of functional significance as determined by stimulation of autologous CD4þ T-cells in
the presence of superantigen: CD4þ T cells cultured with MHC II expressing keratinocytes
induced by IL-18 and stimulated with SEB produced significantly higher amounts of IFNg as
compared to T cells from control cultures. In freshly isolated skin biopsies from patients with
epidermal inflammatory skin diseases we observed a markedly higher expression of the IL-
18R alpha on keratinocytes from atopic dermatitis and psoriasis patients as compared to
normal donors. In conclusion, we have shown evidence that keratinocytes – as the outermost
component of the skin – functionally respond to IL-18. The receptor is upregulated in
inflammatory skin diseases pointing to the fact that IL-18 could decisevely contribute to
chronification of skin diseases via the keratinocytes response.
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Tributyltin (TBT) Induces an Exacerbation of Atopic Dermatitis
T Uchida1,2, C Iwamura1, S Tatewaki1,2, M Nakazawa2, M Minami2, K Takahashi1, T
Hirasawa3, Z Ikezawa1
1Department of Dermatology, Yokohama City University School of Medicine, Yokohama
Japan 2Department of Immunology, Yokohama City University School of Medicine,
Yokohama Japan 3Discovery Research Laboratories, Shionogi and Co. Ltd, Osaka, Japan
Background. Tributyltin (TBT) has been used for antifoulants on boats, ships, quays, buoys,
crab pots, fishnets, and cages. TBT has been well known as an endocrine disrupture. It is
reported that it affects on human immune system. However, it is not clear how TBT affect on
human immune system. Recently, atopic dermatitis (AD) has been increasing in the
developed countries. It seems that endocrine disruptures, such as TBT, influence the ratio
of prevalence. TBT may have an influence on immune system, and cause atopic allergic
disease such as AD.
Objective. We investigated how TBT affects on Th1/Th2 balance in murine immune system
and on AD-like eruption in murine model of AD.
Method: We demonstrated DS-Nh mice, which spontaneously develop dermatitis similar to
human AD under conventional condition. After they were fed with or without TBT diet for 30
days, they received topical TNCB treatment on the dorsal skin surface. We examined the skin
eruption score, histology of skin with H-E staining, serum total IgE levels, and cytokine
production by splenocytes and lymphnode cells stimulated with SEB or ConA by ELISA. We
also counted the number of colonies of S.aureus on the skin surface, and examined T cell
subsets by FACS analysis.
Result & Conclusion. Mice treated with TBT showed severe AD-like skin eruption with
increased number of colonies of S.aureus in comparison with non-treated mice. However,
serum levels of total IgE of TBT treated group were decreased rather than increased
compared with that of control group. The mice exposed to TBT showed also decreased
amounts of IFN-g production by splenocyte or LN cells. The proportion of CD25þCD4þT
cells and NK cells were significantly decreased in TBT treated mice compared with control
mice. In contrast, only IL-13 production by splenocytes or LN cells from TBT treated mice
were significantly increased compared with that from control mice. Mice exposed to TBT for
30 days showed increased Th2 response and reduction in number of regulatory T cells
(CD25þCD4þT cells). These results indicate that TBT may contribute exacerbation of AD-
like eruption.
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Adherent, Mucoid Pseudomonas aeruginosa Release Pathogen-associated Molecules
Inducing Macrophage Inﬂammatory Protein-3a in Keratinocytes
L Schwichtenberg, B Goethel, JM Schro¨der
Universita¨tsklinikum, Kiel
Keratinocytes represent the first cellular line in the host defense against microorganisms like
Pseudomonas aeruginosa (PA). They are capable of producing antimicrobial agents like
defensins and releasing leukocyte chemoattractants to fight microbial infection. However,
little is known about the molecular interaction of pathogen associated molecules (PAMs) with
keratinocytes leading to immune responses. We hypothesize that Macrophage Inflammatory
Protein-3a (MIP-3a) released by keratinocytes upon contact with microorganisms, may play
an important role in initiating adaptive immune responses by recruiting immature dendritic
cells. We investigated whether bacteria release compound PAMs upon contact with skin,
which induce MIP-3a in keratinocytes. Initial experiments revealed indeed MIP-3a induction
by bacterial PAMs.
To investigate under which conditions bacteria release these PAMs the effect of bacterial
culture conditions on the production of MIP-3a-inducing PAMs was analysed. Supernatants
of PA cultured under unstressed or stress conditions (low oxygen, starving conditions) were
used to investigate the effects on MIP-3a-induction in HaCaT keratinocytes. RNA was
isolated and the relative MIP-3a mRNA expression was determined using gene-specific
primers in Realtime-PCR.
We found that supernatants of PA cultivated under stress conditions, which led to adherent,
mucoid phenotypes, induced expression of MIP-3a, whereas supernatants of unstressed
cultures lacked such MIP-3a-inducing PAMs.
Initial experiments to characterize MIP-3a-inducing PAMs by size exclusion chromato-
graphy revealed that these PAMs seem to be heterogeneous showing a molecular mass
between 200–600 kDa. Moreover, they seem to be different from PAMs inducing antimicrobial
peptides which elute from the column in the effluent corresponding to masses 4600 kDa.
Anion exchange chromatography revealed that MIP-3a-inducing PAMs have a slight anionic
charge.
Our investigations confirm that human skin keratinocytes recognise bacterial PAMs and
mount an innate defense by production of chemokines like MIP-3a and antimicrobial
peptides. Our results indicate that solely stressed adherent bacteria release such MIP-3a-
inducing PAMs. These bacterial PAMs are different from those inducing antimicrobial
peptides and proteins in keratinocytes.
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Pseudomonas Aeruginosa Represses Interleukin-1 Mediated Inﬂammatory Response
and Beta-Defensin-1 and -4 in Murine Epidermal Cells
R Panzer, M Schunck, R Ha¨sler1, E Proksch, J-M Jensen
Depts. of Dermatology and 1Internal Medicine, University Hospitals of Schleswig-Holstein,
Campus Kiel, Germany
Pseudomonas aeruginosa (PA) infections result in delayed wound healing or compromise
immunosupressive conditions, despite immune responses from the host organism. The
impacts of PA on keratinocyte gene regulation, signal transduction and immunity are not yet
established. We investigated changes in gene profiling after PA stimulation by treating murine
PAM212 keratinocyte cell line with PA culture supernatant and analysing gene expression
with a customised micro array technique. 24 hours after PA treatment, we extracted total RNA
through reverse transcription and generated in vitro cRNA probes. Fragmented cRNA was
hybridised to the micro array containing oligonucleotide probe sets representing more than
400 transcripts. The hybridised micro arrays were scanned and genes were filtered,
producing signals stronger than an arbitrary cut-off point for florescent signal intensity (more
than 1.4 fold increase or decrease and consistent expression of selected genes in three
analyses). After PA stimulation we found higher expression of proliferation associated mRNA
of angiotensin-2 receptor and small proline-rich protein-1, and down regulation of interleukin-
1 receptor-1 family signal molecules (inner ligands myd88, irak-1, and traf-6). The expression
of genes of the innate immunity system were also affected by PA stimulation: beta-defensin-1
and -4 and lipopolysaccharide binding protein were down-regulated. Expression of
differentiation markers filaggrin, desmoglein-1 and –3, envoplakin, periplakin, and transglu-
taminase processing cathepsin D was reduced. In summary, PA represses interleukin-1
mediated inflammatory response, beta-defensin-1 and -4, and cell differentiation. We
suggest that PA infection may persist due to down-regulation of the host immune response
targeted against the bacteria.
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Cytokines Expression of Human Epidermal Langerhans cells: An Update
M Peiser, R Wanner, G Kolde
Dept of Dermatology, Charite´, Berlin, Germany
Due to the difficulties in isolating pure preparations of epidermal Langerhans cells (LCs), their
production of inflammatory cytokines is still far from clear. We have recently established a
protocol for isolating and culturing ultrapure and viable human LCs with the morphologic,
phenotypic and functional characteristics of epidermis-resident immature cells. Our Multi-
plex-PCR analyses demonstrated that unstimulated LCs are characterized by constitutive
expression of IL-6, IL-8 and TGF-b. Stimulation with LPS induced transcription of IL-1b, TNF-
a and of GM-CSF, with transcripts for TGF-b and GM-CSF in 99% of the CD1a-positive LCs.
Data from gene array experiments revealed differential gene expression in LCs that were
stimulated by a combination of CD40 ligand and LPS for 4 h. Most interestingly, there was no
significant transcription of IL-12, but we found expression of the newly described
proinflammatory cytokine IL-27. After stimulation, the gene of the subunit p28 was expressed
by LCs and not by stimulated keratinocytes from the same donor. The LCs showed in addition
transcripts of IL-15 and IL-18. In conclusion, resting and stimulated human epidermal LCs are
characterized by distinct cytokine profiles, different from their in vitro-generated counterparts.
It will be of interest to determine the contribution of each of these cytokines in innate and
adaptive immune responses, and in particular, to study the role of IL-27 in Th1 development.
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The pro-inﬂammatory Cytokines, IL-1a and IFN-c Induce Distinct Transcriptome
Signatures in Human Keratinocytes
J B Mee, N Morar and R W Groves
Dermatology Section, Division of Medicine, Imperial College London, UK
As the predominant cell type within the epidermis, keratinocytes have been demonstrated to
be pivotal in the initiation maintenance and regulation of immune responses in the skin. We
were interested to determine the effect of IL-1a and IFN-g, two key cytokines relevant to
inflammatory skin disease, on the transcriptome of keratinocytes using Affymetrix GeneChip
technology. Both IL-1a and IFN-g are potent, pro-inflammatory and pleiotropic, but differ in
their association with the two major types of immune response; innate (IL-1a) and adaptive
(IFN-g). Therefore, in addition to acquiring comprehensive information about the transcrip-
tional response to these cytokines in keratinocytes, the study attempted to gain more general
insights into the two types of immune response in epidermis.
Second passage human keratinocytes, derived from normal adult donors undergoing
breast reduction surgery, were stimulated with either IL-1a (100 ng/ml) or IFN-g (20 ng/ml) for
24 hours prior to isolation of total RNA, first and second strand cDNA synthesis and
preparation of biotinylated cRNA (n¼3). Samples were subsequently hybridized to Affymetrix
U133A human microarrays (containing oligonucleotides representing approximately 22,000
transcripts), scanned and analysed using dChip software to identify transcripts showing a
consistent difference of at least 2-fold between any 2 arrays. Stimulation with IFN-g resulted
in consistent strong induction (45 fold) of a number of the CXCR3-binding ligands, CXCL9,
CXCL10 and CXCL11 and class II MHC genes, particularly those of the HLA DR family. By
contrast, the keratinocyte transcriptome resulting from IL-1a stimulation exhibited strong
induction of a number of proteins in the epidermal differentiation complex (EDC) (eg. S100 A7/
psoriasin), protease inhibitors (eg. SCCA1), antimicrobials including SKALP/Elafin and b-
defensin 2 and the chemokines IL-8 and CCL20. Further, direct comparisons between arrays
hybridised with the two cytokines revealed high specificity of the responses with markedly
different (at least 5-fold) expression of groups of transcripts representing T-cell chemokines
and MHC/antigen presentation molecules following IFN-g stimulation, compared with EDC
molecules, antimicrobials and markers of abnormal differentiation following IL-1a stimulation.
These findings demonstrate a marked difference in the transcriptome of keratinocytes
stimulated with two functionally distinct cytokines and suggest that innate and adaptive
immune responses within the epidermis involve the coordinated expression of groups of
related proteins with discrete functions. These findings are of added interest when compared
with previous microarray studies we have performed using psoriatic epidermal shave
biopsies, in which the lesional transcriptome displayed highly significant overlap with the
profiles seen following IL-1a stimulation in the present study, suggesting that the
inflammatory milieu in the epidermal microenvironment in psoriasis is more dependent on
an innate, rather than the expected adaptive response.
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Allelic Variation in the TGF-beta1 Gene T869C Polymorphism Does Not Explain
Fibroblast Activation And Collagen Synthesis in Systemic Scleroderma and Morphea
Patients
M Uhlig1,3, V Rembold1, G Bezold2, G Messer1 and K Kehe3
1Department of Dermatology and Allergology, University of Munich 2Laboratory for
molecular Dermatology, Neu-Ulm 3Bundeswehr Institute of Pharmacology and Toxicology,
Munich-Neuherberg
Systemic scleroderma (SSc) or progressive systemic sclerosis occurs sporadically, except
isolated cases with family history, suggesting a multifactorial genetic predisposition. Ohtsuka
et al. reported an significant association of the rare C-allele of the 869 bp T to C transition at
amino acid position 10 (Leu to Pro) of the human transforming growth factor (TGF)-beta1
gene in 59 patients with SSc (Br J Dermatol 147:458, 2002). TGF-beta has been formerly
identified as potent promoter of fibroblasts and collagen synthesis and is furthermore
involved in the pathogenesis of sclerosis of the skin and the lung tissue in SSc. To further
investigate the TGF-beta1 polymorphism in position 869 bp, we have isolated genomic DNA
from 50 patients with diffuse SSc (dSSc), 40 patients with limited SSc (lSSc), 13 morphea
patients and 53 healthy control individuals. A 288 bp fragment carrying a polymorphous
MspAII restriction site was amplified by standard PCR techniques and digested by the
enzyme. The C-allele was characterized by restriction of the amplificate and typed by gel
electrophoresis and DNA sequencing. The distribution of the rare C-allele in dSSc (C/C 8%,
C/T 54%) did not differ significantly from lSSc (C/C 10%, C/T 52.5%) and from the controls
(C/C 19%, C/T 49%). If regarded at severity and clinical features typical for SSc, like
sclerodactyly (N¼ 77), lung involvement (N¼ 39), kidney involvement (N¼31) and auto-
antibodies against topoisomerase I (Scl70, N¼ 33), again, no significant association of the
T869C polymorphism could be detected. The results presented here argue against a
particular involvement of the T869C polymorphism of the TGF-beta1 gene in the
pathogenesis of perturbed collagen synthesis in our sample of Caucasian patients with
SSc and morphea, although we investigated only a very limited number of morphea patients.
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Evaluation of the Potential Role of Cytokines in Toxic Epidermal Necrolysis
A Nassif1, H Moslehi2,4, S Le Gouvello3, M Bagot1,2, L Lyonnet3, L Michel4, L Boumsell1,
A Bensussan1, J-C Roujeau1,2
1Inserm U 448, Department of Dermatology 2Inserm U99 3Hoˆpital Henri Mondor, Cre´teil,
France and Inserm U 532 4Hoˆpital Saint-Louis, Paris, France
Toxic epidermal necrolysis (TEN) results from the widespread apoptosis of epidermal cells.
The mechanisms leading to this apoptosis are not yet elucidated.
We investigated whether the cytokines present in the blister fluid which accumulates under
necrotic epidermis originated from T-lymphocytes and may play a role in the propagation of
keratinocyte apoptosis. IFN-gamma was elevated in 12 cases, sTNF-alpha in 9, sFas-L in 9.
High concentrations of IL-10 were found in all 10 patients tested. In the control blister fluids
from 3 burned patients we found high concentrations of IL-18, slight elevations of IL 10 in 2
cases, of sTNF-alpha in one and normal levels of IFN-gamma and sFas-L.RT-PCR studies of
mononuclear cells present in the fluid of TEN patients indicated that only IFN-gamma and to a
lesser extent IL-18 were produced by these cells. That suggested that other cytokines also
present (TNF-alpha, sFas-L, IL-10) rather originated from activated keratinocytes. Fas-L was
actually over-expressed on the membrane of keratinocytes in lesional skin in situ as already
reported by others indicating that keratinocytes were the source of sFas-L in the blister fluid.
The expression of Fas in lesional skin was mainly limited to basal cells.
The Th1 profile of T-lymphocyte activation found in the blister fluid of patients with TEN is
consistent with a key role for the drug specific cytotoxic lymphocytes that we previously
found in the blisters. The CTL were only lytic on keratinocytes activated by IFN-gamma.
Blister fluid contained enough IFN-gamma to activate keratinocytes but did not incuce
apoptosis in the absence of CTL. We propose the hypothesis that the production of Fas-L,
TNF-alpha and IL-10 by keratinocytes is more a defense mechanism against cytotoxic
lymphocytes than a way of propagating apoptosis among epidermal cells.
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Expression of IL-23 by Keratinocytes in Healthy Skin and Psoriasis Lesions
G Piskin1, R Westland2, R M Sylva-Steenland1, E A Wierenga2, J D Bos1; M B M Teunissen1
1Department of Dermatology, Academic Medical Center, Amsterdam 2Department of Cell
Biology and Histology, Academic Medical Center, Amsterdam
Keratinocytes are known to contribute to the cutaneous immune responses by interacting
with immunocompetent cells and expression of cytokines. In addition to proinflammatory
cytokines, they were found to express type 1 cytokine, i.e. interferon (IFN)-g - inducing
cytokines, such as interleukine (IL-12) which is a heterodimer formed by p40 and p35
subunits. The newly defined IFN-g inducing cytokines IL-23 and IL-12 share the p40 subunit
in their heterodimeric structure. We investigated whether keratinocytes can express the p19
subunit of IL-23 and the biologically active heterodimer IL-23.
Skin biopsies from normal individuals (n¼ 13) and psoriatic patients (n¼16) were used in
this study. Keratinocyte cultures from normal, nonlesional and lesional psoriatic skin were
used to determine the expression of IL-23 at mRNA level using RT-PCR technique. Frozen
sections were used to perform immunostaining with antibodies against p19 and p40 subunits
of IL-23. Freshly isolated and cultured keratinocytes were immunostained with the same
antibodies as well. Supernatants and cell lysates from stimulated keratinocytes were used to
determine the expression of IL-23 by immunoblotting.
Both p40 and p19 subunits of IL-23 were expressed at mRNA and protein level in freshly
isolated and cultured keratinocytes as determined by PCR and immunostaining, respectively.
In situ, these subunits were expressed at a higher level in psoriatic lesional keratinocytes than
in nonlesional and normal keratinocytes. By immunoblotting, the active heterodimer of IL-23
was determined in supernatants and cell lysates of in vitro stimulated keratinocytes.
These findings demonstrate that keratinocytes are capable of producing p19 subunit and
the biologically active form of IL-23. Psoriasis is a chronic inflammatory skin disease
mediated by IFN-g expressing type 1 memory T cells. As IL-23 is important to activate
memory T cells to produce IFN-g, its augmented expression by keratinocytes can contribute
to the inflammatory changes which are observed in psoriatic skin.
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Lipid Oxidation Products Induce Expression of the Anti Inﬂammatory Protein Heme
Oxygenase –1 in Keratinocytes, Dermal Fibroblasts and Epidermal Equivalent
F Gruber1, M Mildner1, A Kadl2, P Mrass1, G Kroenke2, B R Binder2, N Leitinger2, E
Tschachler1,3
1Medical University Vienna, D.I.A.I.D., A1090 Vienna, Austria 2Medical University Vienna,
Dept. of Vascular Biology and Thrombosis Research, A1090 Vienna Austria 3CE.R.I.E.S,
92521, Neuilly, France
A specific class of phospholipid oxidation products i.e. oxidized L-alpha-palmitoyl-2-
arachidonoyl-sn-glycero-3-phosphorylcholin (OxPAPC) that have been found in cell mem-
branes of apoptotic cells, oxidized low-density lipoproteins, and at sites of inflammation,
have recently been shown to directly act as potent inhibitors of acute, LPS-dependent
inflammation. In addition, it was demonstrated that OxPAPC induces expression of Heme
Oxygenase-1 (HO-1), an enzyme with potent anti-inflammatory properties, adding an
unrelated mechanism by which oxidized phospholipids may influence inflammatory reactions.
When we studied the effects of lipid oxidation products on primary KC, dermal fibroblasts,
HACAT and in an epidermal equivalent model, we found that OxPAPC induced expression of
both HO-1 mRNA and protein. Addition of the radical scavanger bHT (butylated
hydroxytoluene) did not inhibit the induction of HO-1 expression, indicating this process
was not dependent on putative oxidative properties of OxPAPC. Since HO-1 has been
implicated to play a role in wound healing by degrading free heme and thereby preventing
free radical formation and lipid peroxidation, our data suggest that its induction by oxidized
phospholipids represents a potential new therapeutic approach in the treatment of skin
diseases associated with tissue damage mediated by oxidative stress.
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Inﬂuence of Chronic UVB Exposure on the Proinﬂammatory Cytokines’ Proﬁle Alteration
A Lesiak1, J Narbutt1, A Wozniacka1, J Smigielski2, J Lukamowicz3, A Sysa-Jedrzejowska1
1Department of Dermatology, 2Informatics and Statistics Unit, Medical University of Lodz,
3Laboratory of Immunochemical Research, CZMP, Lodz, Poland
Ultraviolet irradiation exposure causes inflammatory changes in the skin and an increase in
expression of proinflammatory cytokines. The aim of the study was to assess serum level of
proinflammatory cytokines (IL-1, IL-6, IL-8, TNF-alpha) after a 10-day exposure to
suberythemal dose of UVB and subsequent irradiation with an acute UVB dose. The study
included 30 healthy volunteers aged 18–53years old. Individual MED was assessed (mean
0.15 J/cm2). Later blood samples were taken from each subject and a 10-day exposure to 0,7
MED irradiation (whole body) started. 24 hours after a final irradiation blood sample was taken
and subsequently local irradiation (buttock, 3 MED) was applied. Next day third blood sample
was taken. Serum concentration of cytokines was determined by chemiluminescence assay
and the results were statistically analyzed. A statistically significant increase in serum
concentration of IL-8 (po0,005) and a tendency of increased TNF-alpha (p40.05)
concentration were found. Serum concentration of IL-8 and TNF-alpha after 3 MED
irradiation decreased to the base levels. No changes in IL-1 and IL-6 serum level were
found. Conclusion: Chronic suberythemal doses of UVB irradiation enhance IL-8 serum
concentration and they are likely to make adaptation in regard with biological effects caused
by acute irradiation.
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Long-term Treatment with Etanercept Signiﬁcantly Reduces the Number of Proinﬂam-
matory Cytokine-Secreting Peripheral Blood Mononuclear Cells
H Schotte1, B Schlu¨ter2, P Willeke1, E Mickholz1, MA Schorat1, W Domschke1, L
Grassnickel3, M Gaubitz1
1Medizinische Klinik und Poliklinik B 2Institut fu¨r Klinische Chemie und Laboratoriumsme-
dizin Universita¨tsklinikum Mu¨nster, Germany 3Wyeth Pharma GmbH, Clinical Research and
Development, Mu¨nster, Germany
Objective. Etanercept is effective in the treatment of chronic inflammatory diseases. The
present study analyzed the influence of etanercept treatment on the number of peripheral
blood mononuclear cells (PBMC) secreting immunoregulatory key cytokines in patients with
rheumatoid arthritis (RA). The cell counts were correlated to the therapy response.
Methods. Nineteen patients with longstanding, active RA were treated with etanercept as
monotherapy. Frequencies of PBMC secreting tumor necrosis factor (TNF)-a, interleukin (IL)-
1b, IL-6, IL-10 and interferon (IFN)-g were determined by ELISPOT analysis before and after 9
months of therapy and compared to healthy controls (HC). The clinical outcome was
assessed as defined by the American College of Rheumatology criteria.
Results. The clinical response to etanercept was excellent, after 9 months of therapy 15
patients fulfilled the ACR20, 7 patients the ACR50 and 2 patients the ACR70 criteria. Initially
elevated numbers of TNF-a and IL-1b secreting PBMC were reduced to HC levels, normal
numbers of IL-6 and low numbers of IFN-g secreting PBMC to below HC levels. The number
of IL-10 secreting PBMC did not differ from that in HC and did not change significantly over
time. The pretreatment IFN-g : IL-10 ratio correlated to reduction in the tender (r¼0.48;
Po0.05) and swollen (r¼ 0.51; Po0.05) joint count within 9 months.
Conclusion. Long-term treatment with etanercept significantly reduces the number of
proinflammatory cytokine secreting PBMC, while the number of IL-10 secreting cells is
unaffected. Although these immunologic alterations did not affect the safety or efficacy of
etanercept therapy, they may account for the long-term systemic effects. The pretreatment
IFN-g : IL-10 ratio may be of prognostic value in predicting the improvement in joint
symptoms.
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TNF-a, IL10, IL6 and IL1RA Gene Polymorphism in Leprosy in an Egyptian locality
S Nassar, A Abdel-Latif, S EL-Mongy, A Hassan, A Hassan, R EL Baz and A Settin
Departments of Dermatology and Venereology, Microbiology and Clinical Immunology,
Medical Biochemistry and Pediatric and Genetics of Tanta and Mansoura Universities
The variability of the host response to M.leprae infection seems to be genetically and
environmentally influenced. Many host genes are involved in a complex interplay of host gene
regulation that leads to disease. Cytokines evidently play a critical role in triggering host–
pathogen interaction. The aim of this work was to investigate the presence of certain cytokine
gene polymorphisms that may be important in the pathogenesis of leprosy. This study
included 47 leprosy patients and 42 healthy controls. By DNA extraction and PCR
amplification gene polymorphism for TNF-308; IL10-1064/-1082; IL6-174; IL1RA-VNTR were
studied. Although the combined genotype frequencies of all studied cytokine polymorphisms
showed that certain genotype {IL10 (1,2); IL-6(1,2); TNF(1,2); IL1RA(2,2)} was the most
common among the studied subjects being higher in controls than cases, the frequency of
the genotype {IL10(1,1);IL6 (1,2);TNF(1,2);IL1RA(2,2)} was higher in cases than controls. IL10
allele 1 and IL6 allele 2, TNF allele 2 and IL1RA allele 2 were more common among cases
compared to controls. A significant difference was detected between cases carrying those
alleles and others carrying the other alleles (P¼ 0.002) with variations regarding different
clinical types of leprosy. In conclusion, certain combined genotype frequencies may
determine susceptibility to develop clinical presentation of leprosy.
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Increased Expression of the Novel Proinﬂammatory Cytokine HMGB1 is Detected in
Cutaneous Lupus Erythematosus Lesions
K Popovic1, M Ek2, H Erlandsson-Harris2, M Wahren-Herlenius2, F Nyberg1
1Dept of Dermatology, Danderyds Hospital, 2Dept of Rheumatology, Karolinska Institutet,
Stockholm, Sweden
The aim of this study was to investigate the expression of proinflammatory cytokines in
lesions and unaffected skin of patients with cutaneous lupus erythematosus (CLE), to identify
factors of immunoregulatory importance in disease manifestations.
Cutaneous lupus erythematosus is an autoimmune disease associated with the presence of
Ro/SSA autoantibodies. Subacute cutaneous lupus erythematosus (SCLE) and chronic
cutaneous lupus erythematosus (CCLE) are subsets of CLE. Discoid LE (DLE) is the most
common form of CCLE. In the affected skin of these conditions mononuclear cell infiltrates
develop. The infiltrates consist mainly of T cells, which may be activated by expression of
proinflammatory cytokines. The novel cytokine HMGB1 (high mobility group box chromosomal
protein 1) is an intranuclear protein. One of its cellular functions is in organization of chromatin
and structuring of DNA. During inflammation, it is translocated to the cytoplasm in macrophages
and released extracellularily, to act as a proinflammatory cytokine. Secretion of HMGB1 is
induced by TNF and IL-1beta. TNF is an early mediator of inflammation, usually released within
minutes of stimulation, and can induce the release of both HMGB1 and IL-1beta. IL-1beta also
has broad proinflammatory activity. Like other proinflammatory cytokines, HMGB1 can activate
monocytes which in turn stimulate the release of TNF and IL-1beta, promoting a loop of immune
activation. To investigate factors of importance in activation of T cells within the skin lesions, we
studied the expression of proinflammatory cytokines.
Skin biopsy samples from affected and unaffected (buttock) skin of 10 patients with CLE
were investigated, of whom 6 had SCLE and 4 had DLE. Expression of HMGB1, TNF and IL-
1beta was analyzed by immunohistochemical technique of cryosections.
As a ubiquitous nuclear protein, HMGB1 was expressed in both affected and unaffected skin
specimens. In unaffected skin, HMGB1 was expressed in the epidermis as well as in and
around vessels in the dermis. In affected skin, consistently higher degree of expression was
observed intra- and extracellularily. The expression was predominately localized in and around
the mononuclear infiltrates in the dermis. TNF was detected almost exclusively in affected skin
specimen, and was predominately expressed in and around dermal mononuclear infiltrates. IL-
1beta was expressed in both affected and unaffected skin specimens. In unaffected skin IL-
1beta was expressed in the epidermis. In affected skin, IL-1beta was detected mostly in and
around mononuclear infiltrates in the dermis, but also to a lesser degree in the epidermis.
Analysis of consecutive sections demonstrated that IL-1beta and HMGB1 are widely
expressed and in the same areas of the infiltrates, while TNF expression was restricted to
subdomains of the infiltrates.
Our results suggest that HMGB1, together with TNF and IL-1beta, are of importance in the
pathogenesis of cutaneous lupus erythematosus and constitute potential therapeutic targets.
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Release of Interferon-Gamma (IFNc) to Multiple Drugs in Patients with Cutaneous
Adverse Drug Reactions (CADRs) – A Possible Manifestation of Multiple Drug Allergy
S Halevy, AD Cohen and N Grossman
Beer-Sheva, Israel
Multiple drug allergy syndrome is a clinical condition characterized by adverse reactions
against more than one different class of pharmacologically and structurally unrelated drugs.
The pathogenesis of multiple drug allergy is still unclear, although scanty data implied the
existence of delayed-type hypersensitivity (DTH).
The aim of the study was to evaluate the clinical relevance of drug-induced in vitro
interferon-gamma (IFNg) release to multiple drugs in patients with cutaneous adverse drug
reaction (CADRs).
The study comprised of a selected group of 15 patients with a variety of CADRs following
intake of drugs, in whom positive IFNg release tests for 2 or more drugs (per patient) were
obtained following incubation of peripheral blood lymphocytes with drugs. IFNg release was
detected in the supernatants using a commercial ELISA kit. Twenty two patients taking a
similar profile of drugs without developing an adverse reaction, served as controls. For each
drug tested the increase in IFNg release was calculated. A value higher than the mean
percentage increase of IFNgþ 2SD measured in controls was determined as a positive IFNg
test. Drugs taken by the patients were classified into 3 categories of clinical drug suspicion:
high, possible and low. In vivo tests (withdrawal and/or challenge) with drugs were evaluated.
The main types of eruptions observed were vasculitis, maculo-papular eruption and
urticaria. IFNg release for 58 drugs taken by the patients (101.6  100.8%) was higher
(po0.001) than that recorded for 54 drugs taken by the controls (22.8  25.9%). Positive
IFNg release tests were recorded towards 65.5% of the drugs, including mainly NSAIDs,
antimicrobials and analgesics. Positive IFNg tests were recorded for two drugs (67%), three
drugs (13%) and four drugs (20%). The percentage of positive IFNg responses was directly
related to the degree of clinical drug suspicion: 81.8%, 50%, and 42.1%, respectively. The
percentage of positive IFNg responses recorded for the high-suspicion drugs was higher
(P¼ 0.0065) than that recorded for the two other drug categories. Percent agreement
between the results of in vitro IFNg release tests and in vivo tests was 81.0%, kappa¼ 0.57,
which implies intermediate to good agreement.
Clinical relevance was attributed to in vitro release of IFNg to multiple drugs in patients with
CADRs. The study may further support the role of DTH and cell mediated immunity in the
pathogenesis of multiple drug allergy.
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Platelet-activating Factor Enhances Motile Activity of Immature B Lymphoblastoid Cells
T Takahashi, Y Kawachi, I Ando, K Tamaki and F Otsuka
Ibaraki, Kanagawa and Tokyo, Japan
Platelet-activating factor (PAF) is a biologically active ether phospholipid involved in
inflammatory and immune responses. PAF has been reported to elicit infiltration of
inflammatory cells into local environment via diverse pathophysiological actions including
chemotaxis of neutrophils, eosinophils and dendritic cells. However, PAF effect as a
chemoattractant for B lineage cells has not fully been explored despite of the fact that PAF
receptor (PAF-R) was evidenced in a part of peripheral blood B cells, tonsillar B cells, B
lymphoma cells and EB virus-transformed B lymphoblastoid cells (BLCs). In this study, we
examined PAF-R expression in immature and mature BLCs and the chemotactic effect of PAF
on BLCs. Flow cytometry analysis showed that PAF-R expression level was much higher in
immature BLCs than mature BLCs. Additionally, immature and mature BLC subsets were
examined for the number of functional PAF-R capable of binding to PAF by Scatchard
analysis. Specific [3H]PAF binding to immature subset was apparently higher compared with
that to mature subset, implying the feasibility of the higher susceptibility of immature BLC
subset to PAF effect. Chemotaxis analysis using modified Boyden chamber showed that PAF
enhanced a motile activity of immature BLCs but not that of mature BLCs. These results
suggest that PAF may serve as a chemotactic factor predominantly for immature B lineage
cells rather than mature B lineage cells including antibody-releasing B cells, leading to
relative increase of immature B lineage cells in inflammatory response or in B cell lymphoma
invasion.
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Increased Interleukin-12 Expression in Vitiligo
M Bro¨nnimann, N Yawalkar, S Karlen and LR Braathen
Dermatological Clinic, Inselspital, Bern, Switzerland
Interleukin 12 (IL-12) induces not only the production of type 1 cytokines like interferon-g, but
it also promotes cellular immune responses. In vitiligo patients melanocyte-specific
autoantibodies as well as cytotoxic T cells have been found in the peripheral blood. In the
present study we investigate the expression of IL-12 in vitiligo. Using real time quantitative
reverse transcriptase polymerase chain reaction and immunohistochemistry we examined IL-
12 in healthy controls and in lesional/perilesional and non-lesional skin of patients with
vitiligo. The number of positive cells with monoclonal mice anti-hIL-12 p35/p70, hIL-12 p40/
p70 and hIL-12 p70 antibodies was significantly increased in vitiligo lesions compared to
control skin. IL-12 immunoreactivity was mainly located in the cytoplasm of dermal dendritic
cells (DCs) and macrophages as well as in some epidermal Langerhans cells (LCs).
In conclusion our data suggest that the enhanced local production of IL-12 in DCs and
macrophages may be responsible for the activation of cytotoxic T cells in vitiligo. They
support the hypothesis that IL-12 may have a pivotal role in promoting melanocyte
destruction in vitiligo by cytotoxic immune responses.
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Microheterogeneity of Selected Acute Phase Proteins in Patients Suffering From Mycosis
Fungoides
M Sobieska, M Pawlaczyk, W Samborski, K Wiktorowicz
Dept. of Biology and Environmental Studies, Dept. of Physiotherapy and Rheumatology,
Karol Marcinkowski University of Medical Sciences, Poznan´, Poland
Mycosis fungoides (MF) is the most common form of cutaneous T-cell lymphomas (CTCL).
The disease is characterised by long term clinical progression from patch through plaque to
tumour stage. Erythrodermic variants also exist. Cytokine balance is considered to be of
major importance for pathogenesis of MF. The aim of the study was to evaluate glycosylation
profiles of selected acute phase proteins (APP) reflect the cellular processes in various stages
of MF. Acute phase proteins may serve as a laboratory marker of cytokine network function:
changes in APP level reflect changes in cytokine balance and are easier to follow analytically.
Sera samples were obtained from 52 patients with MF, aged from 33 to 82 years. Patients
were classified after the staging evaluation into four groups: 13 patients with MF in patch
stage (IAþ IB), 12 patients with plaque stage (IIA), 12 patients with tumour stage (IIB), 15
patients with erythroderma (IVA). Sera from 20 healthy subjects served as controls.
Concentrations of alpha1-acid glycoprotein (AGP) and alpha1-antichymotrypsin (ACT were
measured using Laurell rocket electrophoresis, whereas glycosylation profiles were
estimated using crossed affinity immunoelectrophoresis with Con A as ligand, acc. to Bog-
Hansen. Results were analyzed using STATISTICA 6.0 Software.
An inflammatory reaction clearly exists in all MF patients, as the concentrations of AGP and
ACT were increased. The lowest intensity of acute phase reaction is shown in plaque stage
(IIA) of MF. An increase in the concentration of AGP was described previously in many
inflammatory processes. Its synthesis is stimulated mainly by IL-6, suggesting a constant
production of this cytokine in all except the plaque stages of MF. ACT concentration is related
to necrotic processes or traumatic events with massive tissue damage. In patients with MF
the concentrations of AGP and ACT seem to increase in parallel, as if stimulated by the same
factor. Our results suggest that in a course of MF a generalised inflammatory reaction, known
as acute phase response, is present in all patients. The changes of glycosylation profiles were
seen in all except patients with patch stage MF, with the highest intensity for patients with
erythroderma. It suggests that in early stage of MF the inflammatory reaction seems to be
acute and changes during progression of the disease towards chronic image.
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Imiquimod Increased IL-6 Secretion from Normal Human Mixed Epidermal Cells
X Miao, D Luo, Y Xu, W Min
Department of Dermatology, the First Affiliated Hospital of Nanjing Medical University,
Nanjing 210029, PR. China
Key words: imiquimod, IL-6, epidermal cells
In order to better understand the immunoregulatory mechanism by imiquimod, one kind of
drugs widely used in the treatment of condyloma acuminatum (CA), we investigated the
effects of imiquimod on IL-6 secretion from normal human mixed epidermal cells under
culture condition. Single cell suspensions of normal human epidermal cells were prepared
utilizing standard techniques, then cells were cultured with culture medium alone or with the
medium containing 5mg/ml of imiquimod for 1, 2, 4, 8 and 12 hours. The cell-free and the
conditioned medium supernatants were harvested and IL-6 secretion in the supernatants was
assayed by using commercially available ELISA kits. We found that a low level of IL-6
secreted from mixed epidermal cells treated with the simple culture medium, but when
incubated with imiquimod, the mixed epidermal cells could secrete a large amount of IL-6. At
any time intervals, IL-6 secreted from imiquimod treated groups was higher than that from
control cells (po0.01). IL-6 secretion reached its peak (245.1pg/ml) 8 h after imiquimod
treatment compared with untreated group (97.2pg/ml). The results demonstrated that
imiquimod can enhance the secretion of IL-6 from normal human mixed epidermal cells. Our
data partially explain the immune regulatory mechanism of imiquimod.
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The Balance between Nuclear Factor-kappaB and c-Jun N-terminal Protein Kinase/AP-1
Activity Controls Dendritic Cell Life and Death
E Kriehuber,1,2 W Bauer,1,2 A-S Charbonnier,1 D Winter,1,2 G Stingl,1,2 and D Maurer1,2,
1Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases,
Medical School of Vienna, Vienna, Austria 2Center of Molecular Medicine (CeMM) of the
Austrian Academy of Sciences, Vienna, Austria
The duration of the lifespan of dendritic cells (DCs) must be tightly controlled for proper
function of adaptive immunity. Some signals leading to enhanced DC longevity have been
defined. Signaling pathways actively mediating DC death remained largely enigmatic. To
elucidate how decisions on the fate DCs are made we aimed at identifying relevant
transcriptional activators that positively or negatively regulate DC survival. We show in
CD34þ human progenitor cell derived DCs by means of reporter gene assays, that ligation of
TNF-R superfamily (TNFR-SF) members on DCs (CD40, CD95, TRAIL-R) as well as cognate
DC-T cell contact resulted in simultaneous and quantitatively balanced NF-kappaB and c-Jun
N-terminal kinase (JNK)-mediated AP-1 induction and strongly enhanced DC longevity. When
NF-kappaB activation was experimentally blocked by endogenous inhibitors (i.e. transfection
with IkappaBalpha(S32A/S36A), JNK and, consequently, AP-1 activity was drastically
augmented and TNFR-SF triggering and cognate T cell encounter resulted in DC apoptosis.
Inhibition of the JNK/AP-1 pathway by pharmacologic compounds or dominant-negative JNK
mutants rescued DCs from TNFR-SF member- and T cell-mediated death. We conclude that
JNK/AP-1 activity is subject to negative feedback inhibition by NF-kappaB and can execute
apoptosis in DCs if NF-kappaB activity is impaired. Thus, feedback-controlled signaling
amplitudes of two transcriptional pathways decide upon the fate of a DC.
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Immature, Semi-Mature and Fully-Mature Dendritic Cells Present in the Skin-Draining
Lymph Nodes
N Kanazawa and M B Lutz
Department of Dermatology, University of Erlangen, Germany
Dendritic cells (DCs) are characterized by their migration and maturation capacity. It is widely
believed that immature DCs are distributed in all organs and mature ones appear in the
secondary lymphoid organs. Here we show that in the steady state, there are phenotypically
immature and semi-mature DCs in the skin-draining lymph nodes (LNs), while in the spleen
only immature DCs are present. These semi-mature DCs are clearly distinguished from
immature ones by high expression levels of MHC class II, B7-2, CD40 and CCR7. Any of
myeloid, lymphoid and plasmacytoid DCs are included in both populations. The semi-mature
DCs are completely absent in CCR7/ mice and subcutaneous injection of pertusis toxin
decreased this population in the draining LN, indicating that they are migratory cells mostly
derived from the skin. In contrast, these semi-mature DCs are intact in TNFR1&2/,
MyD88/, CD154/ and germ-free mice, indicating that inflammatory stimuli, such as
TNFa, IL-1, CD40 ligation and bacterial colonization, are not responsible for appearance of
these DCs in the steady-state.
Immediately after subcutaneous injection of soluble protein (FITC-OVA), immature DCs
were much more efficiently labeled with FITC (maximum on 2 hours after injection) than semi-
mature ones, and antigen presentation became detectable 4 hours after injection. These
results indicate that immature DCs are resident in the LNs and work for uptake and
presentation of lymph-derived soluble antigens in the inflammatory condition. In contrast,
semi-mature DCs are considered to transfer self-antigens from the periphery and present
them in the steady state.
After painting hapten (FITC or TRITC) dissolved in irritant aceton/dibutylphtalate, only fully-
mature DCs were strongly labeled with hapten (maximum on 48 hours after paint) in the
draining LNs. Immediately after paint, immature DCs were more efficiently but weakly labeled
with hapten only when quite high dose of hapten was applied. In a dose which is usually used
for induction of contact hypersensitibity (5mg/ml), hapten-labeled fully-mature DCs appeared
only since 24 hours after paint, indicating that these DCs are newly-migrated ones
transferring antigen from the skin. These hapten-labeled fully-mature DCs were distinguished
from unlabeled semi-mature ones by higher expression levels of MHC class II and B7-2 but
lower expression of CCR7. The same results were observed when the DCs obtained by organ
culture of split ears were ex vivo stimulated with anti-CD40 antibody.
Thus, we can distinguish immature resident, semi-mature migratory and fully-mature
newly-migrated DCs in the skin-draining LNs.
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HHV8 Infection of Umbilical Cord-Blood-Derived CD34þ Stem Cells Enhances the
Immunostimulatory Function of their Dendritic Cell Progeny
V A Nguyen1, C Larcher2, C Fu¨rhapter1, S Ebner1, E So¨lder3, H Sto¨ssel1, N Romani1 and N
Sepp1
1Department of Dermatology and Venerology, Innsbruck Medical University, 2Institute of
Hygiene and Social Medicine, Innsbruck Medical University, 3Department of Gynecology
and Obstetrics, Innsbruck Medical University, Austria
Kaposi’s sarcoma-associated herpesvirus (KSHV) also called human herpesvirus 8 (HHV8) is
a gamma-2 herpesvirus and was first described in Kaposi’s sarcoma (KS) of AIDS-patients.
HHV8 is detected regularly in biopsies of all clinical forms of KS, classic, AIDS-related,
endemic, and post-transplantation, in spindle cells in the dermis, but also in the lungs, liver,
and intestine. Spindle cells are thought to originate from circulating peripheral blood
haemopoietic precursor cells. CD34þ stem cells carrying HHV8 have been described in the
peripheral blood of AIDS patients suffering from Kaposi’s sarcoma.
In this study we investigated the influence of HHV8 on the differentiation of CD34þ stem
cells. Native CD34þ cells derived from umbilical cord blood could be infected by a
laboratory strain of HHV8, as shown by immunofluorescence staining, PCR and transmission
electron microscopy, but no significant initial maturation/differentiation effects were
observed. In immunofluorescence experiments these infected cells were shown to
differentiate into immature and mature dendritic cells (DC) following cytokine induction with
rhGM-CSF, rhTNF-alpha and rhSCF which was demonstrated by upregulation of CD83 and
CD86 molecules. Subsequently the immunostimulating capacity of DC populations was
tested in a mixed lymphocyte reaction using allogenic T cells. The HHV8-infected CD34þ
progenitor cell-derived mature DC population showed a significantly enhanced antigen
presenting capacity as compared to not-infected DC, which was not observed with the
immature DC. This suggests stimulation of DC function by HHV8 infection. Since there is only
a small percentage of HHV8 positive DC in the preparations and it is not clear whether
infection is abortive or productive to some extent, this seems to be most likely due to an
indirect viral effect.
A42 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
255
Molecular Cytogenetic Analysis of Chromosomal Breakpoints in the IGH, MYC, BCL6 and
MALT1 Gene Loci In Primary Cutaneous B-cell Lymphomas
C Hallermann1, KM Kaune1, S Gesk2, JI Martin-Subero2, B Gunawan3, F Griesinger4, MH
Vermeer5, M Santucci6, N Pimpinelli7, R Willemze5, R Siebert2, C Neumann1
1Department of Dermatology, University Hospital Goettingen, Germany 2Institute of Human
Genetics, University Hospital Schleswig-Holstein Campus Kiel, Germany 3Department of
Pathology, University Hospital Goettingen, Germany 4Department of Hematology, University
Hospital Goettingen, Germany 5Department of Dermatology, Leiden University Medical
Centre, The Netherlands 6Department of Human Pathology and Oncology, University of
Florence, Italy 7Department of Dermatological Sciences, University of Florence, Italy
¼ share senior authorship
Chromosomal translocations affecting the IGH locus and various oncogene loci are recurrent
in many types of systemic B-cell lymphomas. However, hardly any data exist on such
translocations in primary cutaneous B-cell lymphomas. Here, a series of 29 primary
cutaneous B-cell lymphomas was investigated by interphase fluorescence in situ hybridiza-
tion with probes for the IGH, MYC, BCL6 and MALT1 loci. None of 6 follicle center cell
lymphomas and 9 marginal zone lymphomas showed evidence for any translocation affecting
these loci. In contrast, 11 of 14 large B-cell lymphomas of the leg harbored breakpoints in at
least one of the loci. Translocations involving the MYC locus were detected in 6 cases, 5 of
them derived from a MYC/IGH juxtaposition and 1 from a translocation involving a non-IG
gene partner. Rearrangements of the BCL6 locus were detected in 5 B-cell lymphomas of the
leg, and involved IGH (2 cases), IGL (1 case) and non-IG genes (2 cases). The present study
shows that large B-cell lymphomas of the leg display a pattern of chromosomal
translocations similar to their systemic counterparts whereas primary cutaneous follicle
center cell lymphomas and marginal zone lymphomas lack these typical chromosomal
translocations.
256
Tolerance to Intravenous Heparin in Patients with Delayed-type Hypersensitivity to
Heparins: a Prospective Study
Z Gaigl, P Pfeuffer, P Raith, EB Bro¨cker and A Trautmann
Department of Dermatology, University of Wu¨rzburg, Germany
In the course of subcutaneous heparin injections eczema-like plaques due to delayed-type
hypersensitivity may occur. Is intravenous administration of heparin contraindicated or a safe
alternative in these patients? 38 consecutive patients who were referred to our hospital for
suspected hypersensitivity to subcutaneous heparins between 1st of January 1998 to 31st of
December 2003 were subjected to a three-step diagnostic procedure including skin tests
(intradermal and patch test), subcutaneous and intravenous challenges. 27 patients with
delayed-type hypersensitivity accomplished all three diagnostic steps. Out of these 19 were
skin test-positive, whereas in 8 skin test-negative patients delayed-type hypersensitivity to
heparins was proven by subcutaneous challenge. Most important, the intravenous challenge
test with heparin was tolerated uneventfully by all 27 patients. Therefore, in case of
therapeutic necessity the simple shift from subcutaneous to intravenous administration of
heparin is justified.
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Timing of Exposure to Staphylococcal Enterotoxin B (SEB) is Critical to IgE Antibody
Production in an Animal Model of Atopic Dermatitis
AI Lauerma, T Tra¨skba¨ck and H Alenius
Helsinki, Finland
Staphylococcal enterotoxin B (SEB) has been shown to cause exacerbation of atopic
dermatitis. Bacterial products have also been shown to induce Th1-deviated response that
could prevent Th2-mediated responses. An animal model of atopic dermatitis was used to
study the effect of SEB on allergen-specific and total IgE. (1) Ovalbumin (OVA) was used to
induce the model. BALB/c mice were epicutaneously sensitized for three one-week-long
periods, separated by two-week intervals of no treatment, totalling 7 weeks. When treated
topically with SEB during three one-week-long sensitization-periods of the model, both OVA-
specific and total IgE were significantly and dose-dependently upregulated. (2) Animal model
was induced with OVA without SEB application during first 7 weeks, and continued for an
additional 6 weeks with two more one-week-long sensitization periods with OVA and with
combination of OVA and SEB. After these treatments SEB significantly down-regulated both
OVA-specific and total IgE levels. Bacterial superantigens may exacerbate IgE production
during the development of atopic dermatitis and downregulate serum IgE-levels in already
established atopic dermatitis.
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Chemokine Responses Distinguish Chemical-Induced Allergic From Irritant Skin
Inﬂammation
F Winterberg, AI Lauerma, M Koivoluta, A Mu¨ller, M Gombert, R Kubitza, H Soto, T Ruzicka,
A Zlotnik, and B Homey
Du¨sseldorf, Germany; Helsinki, Finland and San Diego, USA
Chemical-induced adverse effects such as contact allergy as well as irritancy are of major
importance in clinical dermatology and during the development of new pharmaceuticals or
industrial chemicals. Since clinical and histological features of allergic and irritant contact
dermatitis are similar, the differentiation between both types of dermatitis in the preclinical
and clinical evaluation of chemicals remains difficult. However, the underlying immunological
mechanisms are thought to be fundamentally different. Here we systematically studied the
involvement of chemokine superfamily members (n¼45) in the pathogenesis of both
chemical-induced allergic and irritant contact dermatitis in mice and humans. Chemokines
are small cytokine-like molecules binding G-protein coupled receptors and have been shown
to critically regulate leukocyte trafficking. Comprehensive analyses of the chemokine and
chemokine receptor expression during chemical-induced allergic and irritant skin responses
indicated that hapten-induced murine contact hypersensitivity represents a valid model for
human allergic contact dermatitis at the molecular level when compared with nickel sulfate
patch test or genuine allergic contact dermatitis lesions. Notably, the expression of CXCR3
ligands such as CXCL9 (Mig), CXCL10 (IP-10) and CXCL11 (ITAC) distinguished between
chemical-induced allergic and irritant skin responses in both murine and human models of
contact dermatitis. Furthermore, we could show that these inflammatory chemokines
synergize with the homeostatic chemokine CXCL12 (SDF-1) in recruiting skin homing CLAþ
memory T cells. Taken together, findings of the presents study provide important insights into
the molecular basis of chemical-induced allergic and irritant contact dermatitis, identify novel
markers for their differentiation and demonstrate the cooperation of inflammatory and
homeostatic chemokines in the recruitment of pathogenic leukocyte subsets.
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Imaging of Angiogenesis in Delayed Type Hypersensitivity Reactions by Positron
Emission Tomography and [18F]Galacto-RGD
M Kneilling, BJ Pichler, R Mailhammer, L Hu¨ltner, R Haubner, H Braumu¨ller, W Weber, M
Ro¨cken
Germany and USA
Angiogenesis plays a major role in organ-specific autoimmune diseases caused by delayed
type hypersensitivity reactions. Angiogenesis leads to an increase in the cellular traffic from
the blood stream to inflammatory tissue sites and is required for chronicity. Vascular cell
integrin avb3 mediates cellular adhesion to extacellular matrix proteins and is selectively
induced during angiogenesis. To better understand mechanisms of chronic inflammation, we
investigated the role of avb3-integrin in recurrent episodes of cutaneous DTHR using RGD-
peptide that selectively binds avb3-integrin. Mice were sensitized and challenged with
trinitrochlorobenzene (TNCB) to induce and elicit contact hypersensitivity reactions (CHSR).
To investigate T cell independent cutaneous inflammation mice were challenged with phorbol
myristate acetate (PMA). 12h after TNCB or PMA challenge animals were injected with
[18F]Galacto-RGD or [125I]Gluco-RGD peptide and scanned in vivo with the small animal
positron emission tomograph MADPET or uptake was determined by autoradiography. In vivo
MADPET images confirmed intense RGD peptide uptake after the second TNCB-challenge
but not after a single TNCB-challenge. No uptake was determined in mice pretreated with
unlabeld RGD peptide. The uptake ratio right ear (treated) versus left ear (untreated) was 2.9
after the 8th TNCB-challenge, no increase was detected after a single TNCB-challenge. Poor
RGD peptide uptake was observed after the 8th PMA challenge compared to TNCB-
challenged littermates. In contrast to PMA, TNCB-specific CHSR showed a decreased RGD-
peptide binding after the 8th TNCB-challenge. H&E stained sections confirmed an enhanced
angiogenesis in chronic CHSR. Thus, angiogenesis and avb3-integrin play an essential role in
chronic CHSR. Most important chronic hapten-specific CHSR is more efficient in inducing
avb3-integrin expression compared to antigen independent chronic inflammation. Our data
represent a new model to investigate angiogenesis in chronic antigen specific T cell mediated
immune responses such as atopic dermatitis or psoriasis.
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Sweat Induces IgE-mediated Allergic Reaction in Patients with Atopic Dermatitis
A Tanaka, T Tanaka, K Ishii, H Suzuki and M Hide
Department of Dermatology, Graduate School of Biomedical Sciences, Hiroshima
University, Hiroshima, Japan
Sweating has been recognized as one of the aggravating factors in atopic dermatitis (AD), but
the mechanism of such aggravation is unclear. We have recently demonstrated that 84% of
patients with AD showed positive skin reactions to autologous sweat samples, whereas only
11% of healthy subjects did so, suggesting that constituent(s) of sweat can provoke allergic
reactions selectively in patients with AD. In this study, we investigated the specificity of
sweat-induced reaction in in vitro basophil-histamine release tests and demonstrated crucial
involvement of IgE in this reaction. Sweat samples were collected from healthy volunteers,
pooled and purified by combination of chromatographies. The partially purified sweat
preparation induced histamine release from basophils of 50 of 66 (74.6%) patients with AD,
three of 28 (10.7%) healthy controls and none of 13 patients with psoriasis vulgaris showed
positive reaction. To know the mechanisms of sweat-induced histamine release from
basophils of the patients with AD, we purified IgE from the serum of a patient with AD and
examined its capability of mediating sweat-induced reaction in human mast cell line (LAD2),
rat basophil leukemia cell line transfected with human a-subunit of the high affinity IgE
receptor (RBL48), and human basophils of healthy volunteers. These cells showed
degranulation upon stimulation with the semi-purified sweat preparation when sensitized
with the patient-derived IgE, but not when sensitized with myeloma IgE, thus indicating the
presence of specific IgE against sweat antigen(s) in sera of patients with AD. These results
demonstrate that sweat may induce allergic reactions in patients with AD, resulting in the
aggravation of dermatitis. Sweat allergy should be a useful marker for the diagnosis of AD,
and a target for new therapeutics.
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A Diminished Th2 type but Enhanced Th1 type Response in the Atopic Dermatitis Mouse
Model with CCR5/ Mice
S Lehtima¨ki, AI Lauerma, H Alenius
Finnish Institute of Occupational Health, Helsinki, Finland
Clinical features of atopic dermatitis (AD) involve elevated total and allergen-specific IgE
levels, increased eosinophilia and Th2 type cell infiltration in the lesional areas of the skin. As
the disease becomes chronic, Th1-cells start to dominate in eczematous skin lesions. The CC
chemokine receptor 5 (CCR5) is expressed preferentially on Th1 cells. We used CCR5
deficient mice (CCR5/) to assess the role of CCR5 in a murine model of atopic dermatitis
induced by repeated epicutaneous sensitization with ovalbumin (OVA), and characterized by
eosinophil skin infiltration, local expression of Th2 cytokines and elevation of IgE antibodies.
Infiltration in CCR5 mice by mononuclear cells and eosinophils in OVA-sensitized skin was
comparable to that in wild-type (WT) controls. However, sensitized skin of CCR5/ mice
had decreased expression of Th2-type cytokines (IL-4, IL-5 and IL-13) but increased
expression of Th1 cytokines (IFN-gamma and IL-18) compared to WT controls. Moreover,
expression of CCL27 and CCL20 was elevated in sensitized skin sites of CCR5/ mice
compared to WT. Finally, allergen sensitized CCR5/ mice produced degreased levels
OVA-specific IgE compared to WT. These results suggest that CCR5 plays significant role in
the regulation Th1/Th2 balance in the skin and circulating allergen-specific IgE levels in an
animal model of atopic dermatitis.
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Stress Induces Plasticity of the Peripheral Peptidergic Innervation and Exacerbates
Neurogenic Inﬂammation: Pathomechanisms in Atopic Dermatitis?
E M J Peters1, E Hagen1, A Kuhlmei1, M Knackstedt1, R Paus2, B F Klapp1, PC Arck1
1University-Medicine Charite´, Virchow Hospital, Internal Medicine, Psychoneuroimmunol-
ogy, Biomedical Research Center R. 2.0549, Berlin, Germany; 2Department of Dermatology,
University Hospital Hamburg-Eppendorf, Hamburg, Germany
Stress is said to induce itchiness of the skin and exacerbate inflammatory skin diseases such
as atopic dermatitis. In this context, stress mediators such as the neuropeptide substance P
(SP) play a role as immunmodulators and in a wider sense growth factors. E.g. we were
recently able to show, that stress or treatment of mice with SP is associated with mast cell
degranulation, increased cutaneous inflammation and increased apoptosis in the hair follicle.
However, local interactions between the nervous and immune systems, especially under
perceived stress, have rarely been reported. Here we show, that sonic stress exposure
increases the number of SP-immunoreactive nerve fibres in the back skin of C57BL/6 mice
with all there hair follicles in the resting phase of the hair cycle (telogen – low numbers of
cutaneous nerve fibers). Such SP immunoreactive nerve fibres contacted mast cells more
frequently. At the same time the percentage of degranulated mast cells increased and
apoptotic cell number in the skin was upregulated. By semiquantitative rtPCR C57BL/6 mice
with experimentally induced allergic dermatitis showed increased cutaneous IL-4 and to a
lesser degree IFN-g production in the skin 48hrs after stress exposure and induction of
allergic dermatitis. Stress only mildly increased IL-4 but increased dermal infiltration e.g. by
eosinophils in allergic dermatitis mice over mice that were either stressed or had allergic
dermatitis as well as over untreated controls. Increased infiltration was associated with
epidermal thickening, and more VCAM-immunoreactive blood vessels. At the same time the
percentage of degranulated mast cells increased significantly and the number of SP-
immunoreactive peptidergic sensory nerve fibers decreased in the acute allergic dermatitis
lesions. Ultrastructural investigation showed unmyelinated peptidergic nerve fibres in a state
of deterioration close to degranulating mast cells and eosinophils in the skin of stressed mice
with allergic dermatitis, suggesting a decreased number of SP-immunoreactive nerve fibres
due to active release of SP in the course of neurogenic inflammation. This may lead to an
upregulation of endothelial adhesion molecules and increased infiltration by immunocytes to
the skin. These data provide first evidence for stress-induced exacerbation of cutaneous
allergic diseases such as atopic dermatitis by local interaction of the peripheral nervous
system with the immune system.
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A Hypoallergenic Recombinant Allergen-Derivative of the Major Timothy Grass Pollen
Allergen, Phl p 2 Obtained by a Mosaic Strategy
N Mothes1, S Stumvoll1, M Focke1, B Linhart1, M-T Kraut2, P Valent2, P Verdino3, W Keller3,
D Kraft1 and R Valenta1
1Dept. of Pathophysiology, 2Div. of Hematology and Hemostaseology, Dept. of Internal Med.
I, Vienna General Hospital, University of Vienna, Vienna, Austria. 3Institute of Chemistry, Div.
of Structural Biology, University of Graz, Austria
Summary. Approximately 200 million allergic patients are sensitized to group 2 grass pollen
allergens. Here we report the development of a recombinant Phl p 2 allergen derivative with
reduced allergenic activity for immunotherapy of grass pollen allergy using a novel mosaic
approach.
Methods & Results. First we have disrupted the three-dimensional b-sheet structure of the 10
kDa Phl p 2 molecule by synthesizing three peptides comprising the first, second and third
part of Phl p 2. Testing with IgE from Phl p 2 allergic patients and basophil histamine release
experiments showed that the three peptides had lost their IgE reactivity and allergenic
activity. Next we built an artificial Phl p 2 mosaic molecule by PCR-based gene soeing of
cDNAs coding for the three peptides in altered order. Circular dichroism experiments showed
that the recombinant Phl p 2 mosaic molecule had an altered three-dimensional structure
compared to Phl p 2 wildtype and showed a more than 100-fold reduced allergenic activity.
Immunization of rabbits with the rPhl p 2 mosaic induced IgG antibodies which inhibited the
binding of allergic patients IgE antibodies to the Phl p 2 wildtype allergen.
Conclusion. The Phl p 2 mosaic molecule is a candidate molecule for immunotherapy of grass
pollen allergy and the mosaic technology a general strategy for the production of allergy
vaccines.
Supported by grants F01801, F01805, F01809, Y078GEN of the Austrian Science Fund, by
the CeMM project of the Austrian Academy of Sciences and by a research grant from
BIOMAY, Vienna, Austria.
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Long-lived Th2 Immunological Memory in B cell Deﬁcient Mice
M Benkovzsky, G Dekanz, G Stingl and M M Epstein
Department of Dermatology, Medical University of Vienna, Vienna, Austria, Department of
clinical Pathology, Medical University of Vienna, Vienna, Austria
Elucidating the mechanisms underlying the maintenance of CD4 T cell memory is important
for developing improved immunomodulation therapies aimed at enhancing memory
responses to pathogens and inhibiting memory responses to allergens, self, and transplanted
tissue. Although the factors involved in maintaining CD4 T memory cell survival are unknown,
there is evidence that B cells may be necessary. We chose to test the role of B cells on Th2
memory using a mouse model of allergic asthma in which mice develop acute onset disease
upon exposure to soluble followed by nebulized antigen. These mice recover within 30 days
of acute disease but maintain chronic lung infiltrates consisting of CD4 T cells, B cells, and
macrophages for over 800 days after acute disease. Existence of memory CD4 T cells in
recovered mice is demonstrated by lifelong immune responses to aerosolized antigen leading
to lung eosinophilia, mucus hypersecretion, and elevated antigen-specific IgE. Lung CD4 T
cells from recovered mice respond to antigen in vitro and upon adoptive transfer can induce
allergic asthma in naı¨ve mice following aerosol antigen. To test whether B cells play a role in
the maintenance of long-lived memory Th2 cells, we induced acute allergic asthma in B cell
deficient mice and over 1 year later, evaluated recall responses to aerosol antigen. We
observed that mice lacking B cells had acute disease similar to wild type mice, excluding the
presence of B cells in lung infiltrates and immunoglobulin. The B cell deficient mice
maintained lung infiltrates containing memory Th2 memory cells, 1 year after recuperating
from acute disease. Furthermore, recovered B cell deficient mice developed disease relapse
characterized by allergic eosinophilic lung inflammation and mucus hypersecretion upon
aerosol antigen challenge. These data demonstrate that B cells are not necessary for the
maintenance of long-lived Th2 memory.
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The Dendritic Cell Repertoire of Atopic Dermatitis: Evidence for Two Non-Indigenous Cell
Populations
G Stary, C Bangert, G Stingl, T Kopp
Dept. of Dermatology, DIAID, Medical University of Vienna, Vienna, Austria
Because of their unique ability to initiate primary immune responses in T- lymphocytes,
dendritic cells are thought to play a key role in the pathogenesis of atopic dermatitis. To learn
more about the process initiating and propagating the cutaneous allergic reaction, we
phenotypically analyzed various dendritic cells subsets in both skin biopsies (n¼6; n¼ 5) and
peripheral blood (n¼ 10; n¼ 8) of atopic dermatitis patients and healthy controls. Our findings
confirm the presence of resident types of dendritic cells in normal human skin, namely
epidermal CD1aþ /Langerinþ Langerhans cells and CD1cþ dermal dendritic cells. In atopic
dermatitis lesions two non-indigenous dendritic cell subsets occurred besides increased
numbers of Langerhans cells and dermal dendritic cells: (i) CD1aþ /FceRIþ /CD1cþ dendritic
cells in the epidermis (inflammatory dendritic epidermal cells) and dermis and (ii) CD123þ /
BDCA-2þ /CD45RAþ /CD68þ cells in the dermis. These latter cells exhibit the phenotypic
features of plasmacytoid dendritic cells and, interestingly enough, display FceRI on their
surface. A detailed characterization of dendritic cell subsets in the skin and in the peripheral
blood including their activation status and their ability to bind IgE should form the basis for the
investigation of dendritic cell-mediated events operative in the pathogenesis of the
eczematous response.
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N-acetyltransferase 2 Acetylation Genotypes and Serum IgE Levels
Khan, E Tchekanda, H Dickel, T Bruckner, H F Merk, B Bloemeke
Aachen, Osnabrueck, Heidelberg and Trier, Germany
IgE mediated allergic reactions play a crucial role especially in industrialized societies. A role
of the N-acetyltransferase 2 (NAT2) phenotype and genotype has been investigated
previously in allergic diseases such as food allergies, allergic rhinitis, and atopic asthma.
We studied the NAT2 genotypes in persons with ‘high’ IgE levels. In 218 cases with high total
serum IgE-levels (4200 IU) and 192 controls the genotypes coding for slow and fast
acetylator NAT2 phenotypes were identified by real-time polymerase with hybridization
probes. Mutations at positions 341 (C -4T), 481 (C -4T), 590 (G -4A) and 857 (G -4A) of the
NAT2 gene were examined. The acetylation phenotype based on genotyping was defined as
the occurrence of at least one wild type allele. Allele frequencies were calculated according to
the Hardy-Weinberg equilibrium. Statistical analysis showed that 39.9% of the cases and
47.4% of the controls were fast acetylators based on genotyping, while 60.1% of the cases
and 52.6% of the controls were classified as slow acetylators. Five cases (2.3%) and 16
controls (8.3%) were classified as wildtypes, whereas 59 cases (27.1%) and only 31 controls
(16.1%) had a homozygous mutation at nucleotide position 481 (C -4T). Allele frequencies
for cases were: NAT24 (wild type): 17.2%, 5A/B: 48.9%, 5C: 5.7%, 6A/B: 25.9% and
7A/B: 2.3%. Allele frequencies for controls were NAT24: 25.6%, 5A/B: 42.4%, 5C: 4.7%,
6A/B: 24.7% and 7A/B: 2.6% compared favourably to published data. In contrast, we
found in the group with high total serum IgE levels a higher frequency of homozygous
mutations at position 481 (C -4T) compared to controls. These results suggest that certain
mutations in the NAT2 gene may be associated with high total IgE levels.
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Anti-Histamines: Implication as Immune Modulators
T Yudate, M Ashenager, Y Aragane
Kinki University School of Medicine, Japan
To date, it has been convinced that only immuno-pharmacological mechanism of anti-
histamines is its competitive inhibition to the type 1 histamine receptor (H1R). However, their
continuous use often results in prolonged remission of allergic skin disorders, such as atopic
dermatitis. Th1 type-immunity is thought to constitute pathology of acute deterioration phase,
while Th2-type immune response plays a causal role in its chronic stage. Interleukin (IL)-4 and
IL-12 is well known to initiate Th2 and Th1-type immune response, respectively. Hence, this
attempts us to examine modulatory impacts of anti-histamines on cellular events induced by
these cytokines. To address this issue, human peripheral blood-derived T cells were isolated
via density gradient centrifugation followed by nylon wool column-purification, leading to
recovery of 95% pure T cells. T cells were then pretreated for 15 min with various
concentrations of a different kind of anti-histamines (cetirizine, fexofenadine, loratadine and
olopatadine) and stimultated with 1–10 ng/ml recombinant human interleukin 4 (rhIL-4) or 1
ng/ml rhIL-12. Cells were harvested 3 hours poststimulation, and RNA was isolated, reverse-
transcribed and semi-quantitative RT-PCR performed using primers specific for IL-5 or
interferon (IFN)-g. While fexofenadine and loratidine downregulated IL-12-induced expression
of IFN-g mRNA, cetirizine and olopatadine failed to do so. By contrast, all anti-histamines
examined suppressed IL-5 mRNA expression upregulated by IL-4. To evaluate the effects at a
protein level, cultured supernatants were collected 24 hours after stimulation, and ELISA
assays were performed, demonstrating that cetirizine or fexofenadine, but not loratadine or
olopatadine suppressed IL-5 protein expression induced by IL-4. By contrast, all anti-
histamines except for cetirizine significantly suppressed IL-12-enhanced release of IFN-g.
Together, our present study demonstrates that in addition to conventional view, anti-
histamines may differently modulate Th1 or Th2 type immune response. Furthermore, this
might suggest that disease states should be taken into account in order to more efficiently
treat allergic skin disorders by anti-histamines.
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Levocetirizine Decreases VCAM-1 Expression Induced by TNF-alpha in Human Dermal
Endothelial Cells Through Down-Regulation of NF-kappaB Pathway
C Pellet, F Jean-Louis, S Boland, L Dubertret, L Michel
INSERM U 532, Institut de Recherche sur la Peau, Hoˆpital Saint-Louis, Paris, France.
The expression of adhesion molecules by endothelial cells is necessary for the recruitment of
eosinophils from the bloodstream to the skin and its pharmacological alteration might down-
regulate local tissue eosinophilia and persistence of allergic inflammation. In the present
work, we investigated the modulatory effect of levocetirizine on the regulation of the
expression of vascular cell adhesion molecule-1 (VCAM-1) in human dermal endothelial cells
(HDMEC) in response to cytokines in vitro. Since the regulation of adhesion molecules
expression involves the nuclear factor kappa B (NF-kB) pathway, we evaluated the possible
effect of levocetirizine on the NF-kB activation in vitro. HDMEC, obtained from normal adult
breast skin, and a SV40-transformed cell line (HMEC-1), were treated with levocetirizine (107
to 104 M, maximal 24h) before they were stimulated with 10–100 U/ml TNF-a for 4 to 24 h.
NF-kB activity was measured with the electrophoretic mobility shift assay (EMSA) and by
reporter gene analysis after specific transfection with NF-kB–luciferase plasmid reporters.
The cellular localization of NF-kB proteins was analysed by immunocytochemistry and
confocal microscopy. To further analyze the mechanisms of levocetirizine effect on NF-kB
pathway, the expression of cytoplasmic NF-kB inhibitors (IkB) was investigated by
immunoblotting. The synthesis and expression of VCAM-1 was studied by semi-quantitative
RT-PCR, immunoblot, immunocytochemistry and flow cytometry. Our results clearly showed
that the potent nuclear translocation of NF-kB induced by TNF-a in HDMEC was inhibited by
levocetirizine in a dose-dependent fashion, as shown by EMSA and cytochemistry. There was
no basal level of NF-kB in untreated HDMEC or in cells exposed to levocetirizine only.
Levocetirizine decreased VCAM-1 mRNA levels and VCAM-1 expression at the surface of
HDMEC, in a dose-dependent fashion from 104 to 107 M. This range of concentrations may
be found in vivo. This inhibitory effect may not be mediated through H1-receptors since TNF-
a alone was used as the stimulant for VCAM-1 up-regulation. In conclusion, these data
support previous work on anti-inflammatory effects of levocetirizine, which appear
independent of H1-receptor blockade, and suggest a possible mechanism whereby this
new anti-H1 may inhibit eosinophil accumulation in vivo.
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Anaphylaxis to Magnetic Resonance Contrast Media due to Type-I-Allergy to Meglumine
C Egger, K Eisendle, N Reider
Medical University of Innsbruck, Clinical Department of Dermatology, Innsbruck, Austria
Acute reactions to iodinated contrast media are common and considered pseudoallergic due
to non-specific complement activation, release of histamine and other mediators. In contrast,
reactions to Magnetic resonance (MR) contrast media (gadolinium chelates) are very rare, and
little is known about underlying mechanisms.
Case report. a 23-year old female patient underwent MRI because of being suspected of
osteoid osteoma. Within minutes after application of gadoterate meglumine (DOTAREM
s
),
she developed an anaphylactic reaction grade III according to Muller, with generalized
urticaria, bronchospasm and drop of blood pressure. She fully recovered after antiallergic
treatment at the intensive care unit of the hospital. The patient had tolerated iopromide
(ULTRAVIST
s
) earlier, but reported pruritus after gadopentetate dimeglumine (MAGNEVIST
s
)
several years before.
Test results. Skin prick-test (SPT) showed highly positive reactions to Dotarem
s
and other
contrast media and chemically different drugs (Micardis
s
and Novonorm
s
) containing
meglumine. Contrast media not containing meglumine were negative. In vitro evidence of an
IgE-mediated activation of basophiles by CD203c activation test is in preparation.
Discussion. Meglumine (also methylglucamine; CA Index Name D-Glucitol, 1-deoxy-1-
(methylamino)-(9Cl)) is used for stabilisation and reduction of toxicity of the gadolinium
compound in MR contrast media. It is also found as adjuvant in other pharmaceutical
products and meglumine antimonate is used in the treatment of leishmaniosis. Anaphylactic
reactions due to meglumine have not been described yet. The severe clinical picture and the
positive skin prick tests suggest an IgE-mediated mechanism.
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Double-Blind Randomised Trial Evaluation of a New Product Containing Mmp and Pkc
Inhibitors in Cutaneous Contact Hypersensitivity
B Chadoutaud1, JC Choulot2, N Piccardi2, Philippe Msika2 and Jean-Franc¸ois Nicolas3
1BC Consulting, Toulouse, France 2Laboratoires Expanscience, R&D center, Epernon,
France 3INSERM 503, Lyon, France
Matrix metalloproteases (MMPs) and PKC are implicated in several skin pathologies,
especially inflammatory cutaneous disorders such as psoriasis and contact hypersensitivity.
More over, several molecules regulate the migration of skin dendritic cells, which are potent
antigen presenting cells implicated in the primary T-cell-mediated immune response of the
skin, among which MMPs and PKC. We have previously shown that MMP and/or PKC
inhibitors are able to modulate the migration of skin dendritic cells both in vitro and in vivo.
Thus the aim of this study was to evaluate the clinical efficiency of an innovative topical
product containing both MMPs and PKC inhibitors (verum) on cutaneous contact
hypersensitivity (CHS).
A double-blind randomised trial was conducted by 10 dermatologists on 36 selected
volunteers (mean age 36 years) having repeated nickel allergy due to buckles. The panellists
have applied products on both ears (18 : placebo or 18 : verum) twice a day during 7 days,
and then buckles until CHS appears (at least for 14 days, 8 to 12h per day). An individual
board has to be filled by the panellist in order to assess the course and development of CHS.
At day 14, a final examination was performed by the dermatologist.
The first results showed that the preventive application of the verum allows to double the
time of buckles wearing compare to the placebo (6 days/13 days) and also to decrease more
significantly (vs placebo) the clinical signs of CHS.
In this trial, the verum has been proven to be more efficient than the placebo in preventing
and/or delaying CHS as well as in reducing its the clinical signs. This study underline for the
first time the effectiveness of MMP and PKC inhibitors in the management of allergic skin.
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Detection of Serum IgE Auto-Antibodies Against Epidermal Proteins in Severe Forms of
Atopic Dermatitis
S Altrichter, S J Graffi, T Kopp and G Stingl
Department of Dermatology, DIAID, Medical University of Vienna, Austria
Many symptoms of atopic diseases result from events initiated by cross-linking of cell-bound
IgE specific for exogenous allergens. Previous studies have shown that sera of patients with
severe atopic dermatitis (AD) may also contain IgE specific for self-proteins, supporting the
hypothesis of autoreactivity as pathogenic factor. In these studies IgE-autoreactivity was
detected against largely undefined proteins of an epithelial cell-line, cultured fibroblasts,
endothelial cells and peripheral blood-derived cells. Thus it remains unknown if sensitization
to skin-derived self-proteins may occur in atopic dermatitis. Addressing this question we
analyzed the sera of 202 atopic dermatitis patients, 36 patients with psoriasis and 26 healthy
donors for specific IgE antibodies against protein-extracts of normal epidermis, dermis and
the epithelial cell-line A431. Whereas only serum of one psoriatic patient and no sera from
healthy persons showed specific reactivity against A431-derived proteins, 21% of the atopic
dermatitis patients exhibited IgE-reactivity, thus confirming previous findings. Importantly,
23% of the AD patients revealed serum IgE with specificities against epidermal-extracts.
These proteins differed in their molecular weights from those identified in A431-extracts
indicating distinct IgE specificities. In contrast to the epidermis no IgE reactivity was
detectable against dermal protein-extracts in all sera tested.
These data demonstrate the presence of auto-reactive IgE antibodies against epidermal
self-proteins in a subgroup of patients with severe atopic dermatitis, and suggest that IgE
autoreactivity may function to maintain/augment the cutaneous allergic reaction.
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Expression of the Non-Receptor Associated Tyrosine Kinase p72syk Inﬂuences the
Metastatic Behaviour of Melanoma Cells
C Hoeller, C Thallinger, B Pratscher, E Heere-Ress, F Roka, M Bister, N Schicher, V Sexl, K
Wolff and H Pehamberger
Medical University of Vienna, Austria
Once human melanoma has spread to distant sites and has set metastases, every treatment
so far is primarily palliative. Therefore insight into the metastatic process in melanoma is very
important. p72syk (spleen tyrosine kinase), a member of the group of non-receptor
associated tyrosine kinases is well described as a signal transducing protein downstream
of immunoreceptors and integrins. In mammary malignancies, the absence of syk was shown
to be associated with an increased metastatic potential of the tumor cells. Based on this data
we investigated the expression of syk in melanoytes and melanoma cells and assessed the
impact of syk-expression on the metastatic behaviour of melanoma cells. Syk was expressed
in different batches of normal human adult epidermal melanocytes but was not expressed in
any of the melanoma cell lines tested. Plasmid driven expression of syk in melanoma cells
(Plasmids courtesy of Dr. S Mueller, Washington, DC) did not have any significant impact on
the growth speed of melanoma cells in a normal culture dish. In contrast, migration through
an artificial basement membrane layer (Matrigel-Assay, BD), was highly reduced in melanoma
cells expressing syk after transfection, as compared to wild type or control vector cells.
Injection of syk transfected melanoma cells in SCID mice led to a significant delay in tumor
take after subcutaneous injection and to a highly decreased number of metastatic tumot
lesions after injection into the tail vein. This data clearly positions syk as an important factor
influencing the metastatic behaviour of human melanoma cells.
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Tetraspanins are Implicated in Melanocyte Adhesion and Motility
P F Pen˜as, M A Garcı´a-Lo´pez, A Garcı´a-Dı´ez
Department of Dermatology, Hospital Universitario de la Princesa, Univ Auto´noma de
Madrid, Spain
Tetraspanins have been implicated in regulation of cell development, proliferation, activation
and motility and have been shown to couple to signal transduction pathways. CD9 may
regulate melanoma invasion. We have explored the role of tetraspanins CD9, CD81 and
CD151 in adhesion and migration of normal human melanocytes.
We performed adhesion experiments to collagen and fibronectin to study the influence of
tetraspanins in melanocyte adhesion. We found a stimulation of adhesion to collagen using
TS2/16 (anti-CD29 that activates b1 integrins) and inhibition using VJ1/14 (anti-CD29 that
inhibits b1 integrins). When we incubated melanocytes with anti-tetraspanin monoclonal
antibodies, we found an inhibition of adhesion in collagen at 20 min with CD9, CD81 and
CD151. When we incubate melanocytes with the monoclonal antibody for 1 hour, we found an
enhance of melanocyte adhesion with the anti-tetraspanin monoclonal antibodies,
On the other hand, we did not found any effect of anti-tetraspanin monoclonal antibodies
in adhesion to fibronectin, although statistical differences were found between TS2/16 and
VJ1/14.
We used the trasnwell migration assay to evaluate the influence of monoclonal antibodies
in melanocyte motility. We found that TS2/16 did not modify the motility of melanocytes while
VJ1/14 stimulates migration of melanocytes. Monoclonal antibodies against tetraspanin
molecules showed different behaviors. CD9 and CD151 enhanced melanocyte motility, while
CD81 did not modify the migration of melanocytes.
Published results suggest that tetraspanin are not involved in cellular adhesion in most
cells. We have found that tetraspanins CD9, CD81 and CD151 inhibited adhesion to collagen
at 20 minutes and enhanced it at 1 hour. This behavior has not been previously described for
tetraspanins in other cells.
We have found that anti-CD9 enhance the motility of melanocytes in the transwell migration
assay. In human melanoma cells expressing high levels of CD9, anti-CD9 slightly inhibit
transwell filter migration although anti-CD9 presented a strong inhibitory effect of
transendothelial migration. In human and mouse melanoma cells, low CD9 expression has
been related to enhanced motility, and transfection of mouse melanoma cells with CD9
lowered their metastatic potential and mobility. These results imply CD9 in the migration of
melanocytes and melanoma cells but its function is not clear. Anti-CD151 enhances the
motility of melanocytes in the transwell migration assay. In contrast, anti-CD151 inhibited
keratinocyte and endothelial migration in the wound-healing assay. Although anti-CD81
inhibited keratinocyte motility, no effect was found on melanocytes or endothelial cells.
It seems clear that each tetraspanin has different role in each tissue, and its functions are
specifically modulated.
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Leukocyte Adhesion to Activated Endothelial Cells Mediated by the Interaction Between
Thy-1 (CD90) and Mac-1 (CD11b/CD18) – a Competition for ICAM-1?
A Wetzela, M Sticherlinga, U F Hausteinb, U Anderegga,b, and A Saalbacha,b
aDepartment of Dermatology, University of Leipzig, Leipzig, Germany and bSaxon Academy
of Science, Leipzig, Germany
Human Thy-1 was shown to be a cell adhesion molecule expressed on the cell surface of
activated endothelial cells. In previous studies we could demonstrate, that human Thy-1
interacts with a corresponding ligand on the cell surface of polymorphonuclear cells (PMNC)
and monocytes, and of melanoma cells as well, mediating the adhesion of both leukocytes
and melanoma cells to activated human dermal microvascular endothelial cells (HDMEC)
expressing Thy-1. While the leukocyte integrin Mac-1 (aMb2, CD11b/CD18) was determined
as the counterreceptor of Thy-1 on human leukocytes, the corresponding ligand of Thy-1
expressed on melanoma cells was still unknown.
In this study we could demonstrate an interaction between human Thy-1 and the integrin
aVb3 (CD51/CD61) by the binding of purified human Thy-1 to aVb3-transfected cells as well as
by the specific interaction between the purified proteins Thy-1 and aVb3 in a cell-free system.
Since the expression of aVb3 is known to promote invasion and metastasis of melanoma cells,
we studied the functional role of Thy-1 / aVb3 interaction in cell adhesion of melanoma cells.
Thus, we could observe an adhesion of the melanoma cell line JPC to Thy-1 transfected cells,
that is inhibited by the previous binding of monoclonal antibodies against aVb3 to the cell
surface of JPC cells.
In conclusion these results indicate an interaction between human Thy-1 and the integrin
aVb3, mediating the adhesion of melanoma cells to Thy-1 transfectants and to activated
endothelial cells expressing Thy-1. Thus, the cell adhesion molecule Thy-1 was demonstrated
as a multi-ligand receptor interacting at least with two integrins – Mac-1 expressed on the cell
surface of leukocytes and aVb3 on melanoma cells as well. These various interactions
suggest, that human Thy-1 possibly plays an important role not only in leukocyte
extravasation into perivascular tissue, but also in melanoma cell invasion and metastasis.
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Narrow-Band UVB Stimulates Proliferation and Migration in Cultured Melanocytes
H-S Yu1 and C-S Wu2
1Department of Dermatology, National Taiwan University Hospital, National Taiwan
University College of Medicine; 2School of Technology for Medical Sciences, College of
Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan
Narrow-band UVB radiation is an effective treatment for vitiligo vulgaris. However, the
mechanisms of narrow-band UVB in inducing repigmentation of vitiligo lesions are not
thoroughly clarified. The purpose of our study was to investigate the effects of narrow-band
UVB irradiation on melanocyte proliferation and migration in vitro. Our results showed that the
cell counts as well as [3H]thymidine uptake of melanocytes were significantly enhanced by
narrow-band UVB irradiated keratinocyte supernatants. In these supernatants, a significant
increase in basic fibroblast growth factor (bFGF) and endothelin-1 (ET-1) release was noticed.
Basic fibroblast growth factor is a natural mitogen for melanocytes, whereas ET-1 can
stimulate DNA synthesis in melanocytes. This stimulatory effect of melanocyte proliferation
by supernatants derived from narrow-band UVB irradiated keratinocytes was significantly
reduced by a selective endothelin B receptor antagonist (BQ788), suggesting an essential
role of ET-1 on melanocyte proliferation. Our results of time-lapse microphotography revealed
a stimulatory effect of narrow-band UVB irradiation on melanocyte migration. Focal adhesion
kinase (FAK) plays a pivotal role in cell migration. Phosphorylated focal adhesion kinase
(p125FAK) expression on melanocyte was enhanced by narrow-band UVB irradiation. In this
study, narrow-band UVB irradiation stimulated a significant increase in MMP-2 activity in
melanocyte supernatant. Narrow-band UVB irradiation induced-migration of melanocytes
was significantly annihilated by addition of p125FAK inhibitor (herbimycin A) or MMP-2
inhibitor (GM6001). These results suggest that p125FAK and MMP-2 activity play important
roles in narrow-band UVB induced-migration of melanocytes. Our results provide a
theoretical basis for the effectiveness of narrow-band UVB irradiation in treating vitiligo.
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Investigation of Proliferation and Pigmentation in Normal Human Adult Epidermal
Melanocytes Cultured in Chemical-Free Medium
B Kormos1, A Kenderessy-Szabo´1, G Szabad1, E Sonkoly1, K Kiss3, L Keme´ny1,2, Z Bata-
Cso¨rgo+1,2
1Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary,
2Dermatological Research Group of the Hungarian Academy of Sciences, University of
Szeged, Szeged, Hungary, 3Department of Clinical Pharmacy, Faculty of Pharmacy,
University of Szeged, Szeged, Hungary
Culturing of human epidermal melanocytes is a well-known method since 1982. The standard
way of in vitro culturing for normal human melanocytes includes the use of chemical
mitogens, such as the tumor promoter 12-O-tetradecanoyl phorbol-13-acetate (TPA) and the
cyclic adenosine 3’, 5’ monophosphate (cAMP) enhancer cholera toxin (CT).
Previously we have established a new culture system that avoids chemical mitogens.
Using this more physiological in vitro environment, we aimed to investigate the effects of
soluble factors (GM-CSF, IFN-g, IL–1b, EGF and IL-10) and extracellular matrix proteins
(fibronectin, collagen, laminin) on normal human adult melanocyte proliferation.
All the examined matrix proteins, and of the cytokines, GM-CSF, IL-1b and EGF enhanced
melanocyte growth. We also found that autologous serum could replace the mitogenic effect
of animal derived factors (FBS, BPE) and the chemical mitogen, TPA.
During in vitro culturing melanocytes loose their pigment production. With repeated UVB-
irradiation (5.2 J/cm2, four-times) or IFN-g (1 ng/ml) addition cells regain pigmentation in vitro.
Because EGF exhibited a mitogenic effect on the melanocytes, we looked at the EGF
receptor mRNA expression. Melanocytes expressed EGF receptor mRNA. EGF itself did not
influence, but both repeated UVB-irradiation (5.2 J/cm2)and IFN-g (1 ng/ml) suppressed the
expression of EGF receptor mRNA in cultured normal human adult epidermal melanocytes.
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Prevention of UV-Induced Immunosuppression by IL-12 is Dependent on DNA Repair
A Schwarz, A Maeda, K Kernebeck, T Schwarz
Mu¨nster and Kiel, Germany
Ultraviolet radiation (UV) suppresses the induction of contact hypersensitivity (CHS) and
induces hapten-specific tolerance which is mediated via regulatory T cells (Tr). Interleukin (IL)-
12 is known to prevent the suppression of CHS by UV and even to break UV-induced
tolerance by yet unknown mechanisms. IL-12 recently was described to exhibit the capacity
to reduce UV-induced DNA damage presumably via the induction of nucleotide excision
repair (NER). UV-induced DNA damage is an essential molecular trigger for UV-mediated
immunosuppression, thus we studied whether the restoring effect of IL-12 is linked to its
capacity to reduce DNA damage. Injection of IL-12 into wild type mice (wt) which were
sensitized through UV-exposed skin restored the CHS response completely. In contrast, Xpa
knock out mice (Xpa/) which are deficient in NER were not able to mount an immune
response after UV exposure despite administration of IL-12. This implies that the prevention
of UV-induced suppression of CHS by IL-12 is dependent on properly functioning DNA repair.
In contrast, IL-12 exhibited the capacity break already established UV-induced tolerance
both in wt and Xpa/, indicating this effect to be independent of NER. Likewise, adoptive
transfer of suppression via injection of Tr into naı¨ve recipients was inhibited by IL-12 both in
wt and Xpa/. Inhibition of sensitization by UV is due to the depletion of Langerhans cells
(LC) which is triggered by UV-induced DNA damage. Accordingly, LC depletion by UV was
prevented upon injection of IL-12 into wt but not in Xpa/. In addition, immunofluorescence
staining revealed DNA damage carrying cells in the regional lymph nodes upon UV exposure.
The number of these cells was remarkably reduced when UV-exposed mice had received IL-
12. In turn, IL-12 did not reduce the number of DNA damage carrying cells in Xpa/ mice.
Taken together, these data indicate that the prevention of UV-induced inhibition of CHS by IL-
12 is linked to its capacity to induce NER. In contrast, breaking of UV-induced tolerance and
the activity of Tr by IL-12 is independent of NER and mediated via another yet to be
determined mechanism. These data demonstrate for the first time a link between NER and
the prevention of UV-induced immunosuppression by IL-12.
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Infusion of Apoptotic Cells by Photopheresis Induces Antigen-Speciﬁc Regulatory T
Cells
A Maeda, A Schwarz, K Kernebeck, D Peritt, T Schwarz
Mu¨nster and Kiel, Germany; Exton, PA, USA
The basis of extracorporeal photopheresis (ECP) is the reinfusion of leukocytes, which have
been exposed to 8-methoxypsoralen and UVA light. This treatment induces annexin Vþ /
7AAD apoptosis of nearly all leukocytes. Photopheresis has shown evidence of benefit for
the treatment of autoimmune diseases, solid organ transplant rejection and GvHD. The
underlying immunological mechanism for its effect remains unresolved. Since UV radiation of
the skin exhibits the capacity to induce tolerance via induction of antigen specific regulatory T
cells, we studied whether ECP might induce a similar state of tolerance following
extracorporeal treatment of leukocytes. For this purpose we utilized a murine model of
contact hypersensitivity (CHS). Splenocytes and lymph node cells of mice, which were
sensitized with dinitrofluorobenzene (DNFB), were exposed to experimental ECP in vitro.
Experimental ECP-treated cells were injected intravenously into naive mice, which were
subsequently skin sensitized with DNFB, and ear thickening measured following ear
challenge. Animals, which had received experimental ECP-treated cells, were significantly
suppressed in their CHS response. In contrast, mice which received cells which were
untreated or exposed to UVA light or 8-MOP alone were not suppressed in their CHS
response. Induction of suppression was lost when lymph node cells were depleted of
CD11cþ cells before experimental ECP treatment indicating that antigen presenting cells
may be a primary target for photopheresis. This suppression was cell-mediated and antigen
specific as demonstrated by the ability to transfer the tolerance to naive animals which could,
however, properly respond to the unrelated hapten oxazalone. Transfer of tolerance was lost
when cells were depleted of CD4þ or CD25þ subpopulations, indicating that experimental
photopheresis induces regulatory cells, possibly of the CD4/CD25 lineage. As few as 100,000
unfractionated splenocytes could protect a naı¨ve animal. The generation of increased number
and activity of regulatory cells was evident when animals were boosted with antigen and this
protection was dose dependent. Taken together, these data suggest that infusion of
experimental ECP induced apoptotic cells produces highly active antigen specific regulatory
cells. Further studies are underway to better understand the nature of these regulatory cells
and their mechanism of induction.
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Epidermal Turnover, an Alternative to UV-Induced Apoptosis in Removal of Arrested
Cells
G J Stout, D Calkhoven, O Pijper, D Westdijk, L H F Mullenders, R Willemze, F R de Gruijl
Leiden University Medical Center, Leiden, The Netherlands
The interplay between nucleotide excision repair (NER), apoptosis and cell cycle regulation in
the UV-exposed epidermis is extremely important to avoid mutations and malignant
transformation. In XPC/ mice (deficient in NER in global genome) a cell cycle arrest of
‘‘near 4N’’ (sub-tetraploid) cells was observed peaking 72 hours after UV exposure (Van
Oosten et al. PNAS, 2000). This arrest resolved without apoptosis (96–168 hrs). We surmised
that these ‘‘near-4N’’-arrested XPC/ keratinocytes were removed from the epidermis by
epidermal turnover.
A recently developed in vivo pulse-chase protocol, in which WTand XPC/ mice subjected
to 5 mg BrdU (i.p. T¼ 17) were sacrificed at various time points after UV exposure, was
applied to determine the fate of BrdU-positive cells. Such a BrdU pulse, duration of 2 hours,
enabled us to label 30% of the S/G2-cells (DNA contents 42N) in XPC
/ 72 hours after UV
exposure. From immunohistochemical analysis we concluded that epidermal turnover in WT
and XPC/ is completed within 7–10 days regardless of UV-exposure (no longer any
suprabasal BrdU-positive or DNA-damaged cells present). Interestingly, a major increase in
suprabasal cytokeratin 10-negative cells occurred only in UV-exposed XPC/ mouse
epidermis. In addition, we exclusively observed suprabasal cells positive for cytokeratin 5 (a
basal cell marker) in UV-exposed XPC/ epidermis. These observations clearly indicate an
aberrant epidermal differentiation in XPC-deficient epidermis after single UV exposure.
Flowcytometric analysis of single cell suspensions of UV-exposed XPC/ epidermis further
showed that the ‘‘near-4N’’ arrested cells retained cytokeratin 5. Combining these
observations lead us to conclude that the arrested ‘‘near-4N’’ cells become detached from
the basal layer without entering a proper differentiation programme, and are indeed
subsequently lost through the epidermal turnover. This constitutes an alternative route, next
to apoptosis, to eliminate DNA-damaged arrested cells from the epidermis.
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Cockayne Syndrome A and B Proteins and Repair of Oxidative Damage to Mitochondrial
DNA: Mechanism of Import and Functional Relevance In Vivo
M Fousteri1, V Ku¨rten2, M Ro¨cken3, L Mullenders1, J Krutmann2 and M Berneburg3
1Silvius Laboratory, Leiden University Medical School, Leiden, The Netherlands 2Institut fu¨r
Umweltmedizinische Forschung gGmbH at the Heinrich-Heine-University, Du¨sseldorf,
Germany 3Molecular Oncology and Aging, Department of Dermatology, Eberhard Karls
University, Tu¨bingen, Germany
Cockayne Syndrome (CS), characterised by neurodegeneration, photosensitivity and
premature aging, is caused by mutations in the CSA and CSB gene. We have previously
shown that the CSA and CSB proteins are localised in the mitochondrion (mt) and involved in
the repair of oxidatively induced mtDNA deletions. However, their mechanism of import into
mitochondria, exact type of repaired damage and functional relevance in vivo have not been
elucidated. Regarding localisation, both CSA and CSB miss a mitochondrial leader sequence
but computer based k-NN sequence analysis predicted 52.2% and 30.4% mitochondrial
localisation for CSA and CSB, respectively. Furthermore, co-immunoprecipitation showed
requirement of CSA/CSB proteins in a heterodimeric state to allow mitochondrial import.
Employing a reconstituted in vitro repair assay comprising fapy-glycosylase and endo III as
reporter enzymes for oxidative damage in pyrimidines and purines, respectively, we could
show that, after repetitive sublethal UVA irradiation, removal of thymine glycol from mtDNA
was defective in fibroblasts from CS patients. However, stable transfection of the CSB gene
reconstituted this defect. Semiquantitative PCR showed increased levels of mtDNA deletions
in CSB knockout mice in vivo compared to wild-type littermates in the brain but not in muscle,
cartilage spleen or testis, correlating with the neurodegenerative changes found in aging
animals. In aggregate, extending and corroborating previous findings, these results
strengthen the role of CS proteins in the repair of oxidative damage to mtDNA and indicate
a heterodimeric composition of both proteins as requirement for mitochondrial import.
Furthermore, the correlation of neurodegenerative symptoms and defective removal of
oxidatively induced mtDNA deletions in CS knockout mice indicates a close relationship of
oxidative stress, its repair by CSA and CSB and processes such as neurodegeneration and
aging.
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Requirement of a Thymic Route for UV-Induced Tolerance
Y Aragane, T Yudate, A Kawada, T Schwarz
Kinki University School of Medicine, Japan and University of Kiel, Germany
We currently showed that UV-induced tolerance is mediated by the induction of a new type of
T suppressor cells, called CD4þCD25þ T regulatory cells (Treg), which are recently
highlighted to counteract the onset of various autoimmunity, including experimental
autoimmune encephalomyelitis or type 1 diabetes. Treg, in general, ultimately require to be
maturated in thymus, leading to a concept of central tolerance. Although the involvement of
Treg in UV-induced tolerance is no doubt, it is still uncertain how and where UV-induced Treg
are generated. To address this issue, we generated athymic C3H mice, which were
thymectomized at an age of day 3 and grown to 8–10 wk. Using athymic mice we tested the
involvement of thymus in contact hypersensitivity (CHS) and its modulation by UV. Athymic
mice showed vigorous CHS response, indicating that the induction of T effector cells (Tef) was
not impaired. However, UV-induced tolerance was not observed in athymic mice, suggesting
requirement of thymus in this process. Even when T cells obtained from naive animals were
transferred intravenously to athymic mice, UV-radiation failed to induce tolerance, further
confirming the significant role of thymus in this process. Upon transplantation of age-
matched thymus into kidney capsules of adult athymic mice, they regained the ability to
undergo UV-induced tolerance. Collectively, the present study demonstrates the involvement
of thymus in UV-induced tolerance and thereby suggests that UV-induced tolerance is
acquired central (thymic) tolerance.
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UV Induced Hepatocyte Growth Factor from Dermal Fibroblasts Protects Keratinocytes
and Fibroblasts from UV-Induced Apoptosis
M Mildner, V Mlitz, C Ballaun, F Gruber and E Tschachler
Dept of Dermatology, Vienna Medical School, Austria
Hepatocyte growth factor (HGF), a multifunctional cytokine produced primarily by cells of
mesenchymal origin, is able to prevent UVB induced apoptosis of human keratinocytes (KC).
In the skin a continuous cross talk between dermal fibroblasts (FB) and epidermal KC is the
prerequisite for tissue homeostasis in health and disease. Therefore we investigated the
effects of cytokines released by KC after UV irradiation as well as the effects of direct UV
irradiation on the HGF production by human FB.
We found that the supernatant of UVB irradiated KC strongly induced HGF production by
FB and that this effects was mainly due to the presence of IL-1a. Like recombinant HGF, the
supernatant of these stimulated FB protected KC from UVB induced apoptosis. That the
protection was indeed due to HGF in the FB supernatant was shown by the fact that most of
the anti-apoptotic activity was blocked by anti-HGF antibodies. Direct irradiation of FB with
UVB had virtually no effect on the levels of HGF mRNA and secreted protein. In contrast UVA1
irradiation led to a strong up-regulation of HGF mRNA within hours and secretion of the
protein after 2 days. We hypothesized that the lag time for HGF secretion as compared to
mRNA induction was due to a auto-consumption of HGF by FB. Indeed when we added a
neutralizing anti-HGF antibody to the fibroblasts cultures after UVA1 irradiation we observed a
dramatic rise of FB apoptosis.
In conclusion we have shown for the first time that IL-1a released by KC after UVB
irradiation as well as direct UVA1 irradiation induce human FB to secrete HGF, which in an
autokrine and parakrine fashion acts anti-apoptotic for FB and KC respectively.
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UVA-Induced Oxidative Damage and Cytotoxicity Depend on the Mode of Exposure
H Merwald, G Klosner, C Kokesch, M Der-Petrossian, H Ho¨nigsmann, F Trautinger
Division of Special and Environmental Dermatology, Vienna Medical School, Austria
The reciprocity rule (Bunsen-Roscoe law) states that a photochemical reaction is directly
proportional to the total energy dose, irrespective of the dose distribution. This law is taken
for granted in photomedicine, although the influence of irradiation intensity and dose
distribution is largely unknown. We have examined in a tissue culture model the effects of
fractionated versus single dose UV exposure from a metal halide source on cell death, DNA
synthesis, glutathione and membrane damage. Exposure to fractionated UVA was followed
by an increase of cell death compared to the single dose, when intervals between the
fractions were short (10 to 60 minutes). Long intervals (4120 minutes) had the opposite
effect. Corresponding results were obtained for DNA synthesis. The increased cytotoxicity of
dose fractionation with short intervals could not be abrogated by non enzymatic antioxidants
(astaxanthin, ascorbic acid, a-tocopherol). Fractionated irradiation with short intervals led to
a higher depletion of glutathione and to enhanced formation of TBARS compared to an
identical single dose. Long intervals between the fractions induced the opposite effect. Taken
together, these data indicate that the oxidative effect of UVA and the antioxidative capacity of
its cellular targets depend on the mode of exposure.
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Inﬂuence of MC1R, GSTT1 and GSTM1 genotypes on UV sensitivity
U Kru¨ger,1 I R Ko¨nig,2 N Anders,1 U Schulz,1 G A Westphal,3 R Mo¨ssner,1 A Ziegler,2 R
Kaiser,4 K Reich1
Departments of 1Dermatology, 3Occupational Healthand 4Pharmacology Georg-August-
University Go¨ttingen 2Institute of Medical Biometry and Statistics, University of Lu¨beck
Variations in the melanocortin-1 receptor gene (MC1R) and in the glutathion-S transferase
genes mu1 (GSTM1) and theta 1 (GSTT1) are thought to influence UV-sensitivity at different
levels. MC1R is one of the major genes that determine skin pigmentation because the
melanocortin-1 receptor regulates eumelanin synthesis. GSTT1 and GSTM1 are expressed in
the skin and detoxify products of oxidative stress reactions occurring in response to UV-
irradiation. The possible influence of interactions of genetic MC1R and GST variants have not
been thoroughly investigated yet.
We determined the minimal erythema dose (MED) of ultraviolet B (UVB) irradiation as well
as the immediate pigmentation dose (IPD) and the delayed pigmentation dose (DPD) of
ultraviolet A1 (UVA1) irradiation in 93 healthy volunteers. Genetic variations of the coding
region of the MC1R gene were determined by direct cycle sequencing. GSTM1 and GSTT1
null genotypes were analyzed by multiplex PCR.
Six frequent and six rare variants of the MC1R gene were detected (allele frequency 46%
and o1.5%, respectively). The R151C and R160W polymorphisms were associated with red
hair, fair skin type and nevus count. R151C was also associated with a reported history of
severe sunburns before the fifteenth birthday. The R151C and R160W polymorphisms were
associated with DPD and IPD of UVA1, but this association was related to the association of
these polymorphisms with red hair and fair skin. Independent associations were found
between the V60L polymorphism and the MED of UVB (p¼ 0.0145), and between the V92M
polymorphism and the DPD of UVA1 (p¼ 0.0174). In contrast to earlier investigations, there
was no association between GSTT1 and M1 genotypes and UVB sensitivity. Lack of GSTT1
was associated with a higher IPD of UVA1. Our results confirm complex interactions between
MC1R variants and UV sensitivity that are partially independent of phenotypic characteristics.
There was no evidence for a significant interaction of MC1R with GST variants in UV
sensitivity.
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From Melanogenesis to Melanoma: Modulation by Telomere Homologous Oligonucleo-
tides (T-oligos)
IM Hadshiew, K Barre, A Thies, I Moll
Dept of Dermatology, University Hospital Eppendorf, Hamburg, Germany Institute for
Neuroanatomy, University Hospital Eppendorf, Hamburg, Germany
Pigmentation is a highly regulated process involving differentiation of melanocytes and
pigment production. Tanning, as it occurs after UV-exposure is part of a finely orchestrated
DNA-damage response. The exact molecular mechanisms and sensors involved in mediation
between cellular repair and pigmentation, however, remain to be elucidated.
We have shown that small DNA fragments homologous to the 3’overhang of telomeres are
capable of inducing pigmentation in the absence of DNA damage both in vitro and in vivo.
This response is regulated by p53.
Also, highly metastatic human melanoma cells (MV3, G361 and UISO Mel6) cells were
treated with T-oligos (20uM). In all 3 cell lines apoptosis could be induced within 48 hours as
demonstrated by TUNEL assay and subsequent FACS analysis. Results revealed an increase
in apoptosis between 50% and 70% compared to diluent treated controls, depending on cell
line. In detail, G361 cells revealed the strongest induction of apoptosis (69%) after T-oligo
treatment, compared to 57% in MV3 cells and 46% in UISO-Mel6 melanoma cells.
Although the exact mechanisms and downstream sensors by which T-oligos regulate
cellular differentiation and apoptosis are poorly characterized, common downstream
regulators, such as p53, p21 and the E2F transcription factor are involved. Potentially
differentiation as well as apoptosis as they occur after DNA damage and also after disruption
of the telomere loop structure may be an evolutionary preserved cancer prevention
mechanism. T-oligos might mimic these responses in the absence of DNA damage.
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Repression of Nuclear Hormone Receptors, their Target Genes and Co-Regulatory
Proteins by UVB Irradiation in Keratinocytes
M Schmuth x, P Lauþ , Z Xie#, Y Oda#, D D Bikle#, P M Eliasþ , K R Feingoldþ#
Department of Dermatology, Medical University Innsbruck, #Departments of Medicine and
þDermatology, niversity of California San Francisco
In the present study we evaluated whether ultraviolet (UV)B irradiation alters the expression of
nuclear hormone receptors and their ability to transactivate response elements in their target
genes. mRNA levels of PPAR-alpha and LXR-alpha were decreased by 50% 24 hours after
UVB treatment of primary cultured keratinocytes. As previously reported retinoid X receptor
(RXR)-alpha and vitamin D receptor (VDR) were also decreased 24 hours after UVB exposure.
In contrast PPAR-delta was increased, and LXR-beta, CAR, and TRs were unchanged. In
these experiments PPAR-gamma was not detectable on Northern blots in cultured
keratinocytes. Time course studies revealed that the mRNA repression occurred as early
as 6 hours after UVB exposure. In addition, mRNA levels of acetyl-CoA-oxidase, a target
gene for PPAR-alpha, and ATP-binding cassette transporter (ABC)-1, a target gene for LXR-
alpha, were similarly decreased after UVB exposure. Furthermore, cultured keratinocytes
transfected with a PPAR or LXR response element showed a marked decrease in promoter
transactivation following UV-B irradiation. This decrease was not restored by either ligand
treatment, over-expression of the receptor, or the combination of the two. Finally, we also
observed down regulation of the co-regulatory protein DRIP, suggesting that the inhibition of
gene expression by UV light is secondary to not only decreases in PPAR and LXR alpha but
also to post receptor mechanisms that link the binding of transcription factors to DNA with
increased transcription. The UV-induced down regulation of PPAR-alpha, LXR-alpha and
DRIP results in decreased expression of downstream target genes that could reduce the
movement of cholesterol out of cells and the oxidation of fatty acids thereby providing UV
injured cells with lipids for the synthesis of new membranes.
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Activation of P38 Map Kinase by Ultraviolet Irradiation Limits Early Activation of NF-jB,
Which is Required for Induction of Primary Cytokines IL-1b and TNF-a in Human
Keratinocytes
GJ Fisher, TH Quan; TY He, Y Shao; JJ Voorhees
Dermatology, University of Michigan, Ann Arbor, MI, USA
Primary pro-inflammatory cytokines IL-1b and TNF-a activate transcription factor NF-kB,
which in turn stimulates expression of IL-1b and TNF-a. This positive feedback loop is limited
by p38 MAP kinase, via phosphorylation of HSP27, which inhibits IkB kinase-b, thereby
blocking phosphorylation and degradation of the NF-kB inhibitor IkB-a. UV irradiation
induces IL-1b, TNF-a, and p38 MAP kinase in human skin in vivo. We have investigated the
role of p38 MAP kinase in UV-activation of NF-kB in human skin and cultured human
keratinocytes. We found that NF-kB activation, measured by nuclear localization, lags IL-1b
and TNF-a induction by 2–4 hours, in human skin. Similarly, UV irradiation does not cause
detectable NF-kB nuclear translocation prior to IL-1b or TNF-a induction, whereas treatment
with IL-1b or TNF-a causes readily detectable nuclear translocation, in human keratinocytes.
These data raise the question of whether UV activation of NF-kB is a consequence, or a
cause, of IL-1b and TNF-a induction. To address this question, we utilized adenovirus-
mediated expression of dominant negative inhibitors of NF-kB activators (IkB kinase-b, and
IkB-a). Dominant negative IkB kinase-b or IkB-a completely prevented UV induction of IL-1b
and TNF-a mRNA, indicating that the NF-kB pathway is required for UV induction of these
cytokines. Sensitive ELISA-based DNA-binding assay revealed that UV irradiation rapidly
induced a small (2-fold), but significant (po0.05) increase in DNA binding of p50/p65 NF-kB
heterodimers, in human keratinocytes. UV irradiation also activated p38 MAP kinase within 30
minutes (3-fold, po0.05). Inhibition of p38 MAP kinase with SB203580 augmented UV-
induced NF-kB DNA-binding 2-fold (po0.05). These data indicate that early activation of NF-
kB is required for UV induction of IL-1b and TNF-a. This early UV activation of NF-kB pathway
is limited by the actions of p38 MAP kinase, and difficult to detect by measurement of nuclear
translocation. p38 MAP kinase functions to negatively regulate NF-kB, and thereby prevent
excessive induction of IL-1b and TNF-a by UV irradiation in human skin.
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Phototherapy Inhibits Immediate Type Hypersensitivity Reaction in the Skin and Nasal
Mucosa
A Koreck1, Z Csoma1, F Ignacz2, Z Bor2, G Szabo2, L Bodai1, E Kadocsa3, M Aleksza4, A
Dobozy1, L Kemeny1
1Department of Dermatology and Allergology, University of Szeged, Hungary, 2Department
of Optics and Quantum Electronics, University of Szeged, Hungary, 3Department of Oto-
Rhino-Laryngology and Head-Neck Surgery, University of Szeged, Hungary, 4Third
Department of Internal Medicine, University of Debrecen, Hungary
Since phototherapy has been shown to exert both local and systemic immunosuppressive
effects, we investigated if it has also an influence on the immediate type hypersensitivity
reaction in the skin and nasal mucosa. A significant inhibition (more than 35%) of wheal
formation in skin prick test (SPT) was obtained only after irradiation with erythematous doses
of UVB light. Although, UVA (0.5–2 J/cm2) and visible (VIS) light (2–8 J/cm2) had no effect on
SPT, mixed irradiation with suberythematous doses of UVB (5%), low doses of UVA (25%)
and VIS (70%) referred as mUV/VIS, resulted in significant (more than 55%) inhibition of wheal
formation. To assess the effect of phototherapy on immediate type hypersensitivity in the
nasal mucosa, we conducted a double-blind, placebo-controlled study in 49 patients with
ragweed-induced allergic rhinitis. We performed intranasal irradiation 3 times a week for 3
weeks either with increasing doses of mUV/VIS (starting dose 1.7 J/cm2) or with low intensity
visible light (starting dose 0.06 J/cm2) as placebo. Phototherapy significantly decreased
scores for sneezing (p¼ 0.016), rhinorrhea (p¼ 0.007), nasal itching (p¼ 0.014) and total nasal
score (p¼0.004), whereas no improvement was observed in the placebo group. In nasal
lavage samples phototherapy resulted in a significant decrease of eosinophil cell counts
(p¼ 0.009), ECP (p¼ 0.028) and IL-5 levels (p¼0.047). In the circulation, significantly higher
serum IL-10 levels (p¼0.002) and IL10þCD4þT cells (p¼0.017) were found after
phototherapy compared to that of placebo treatment. In vitro irradiation of T cells and
eosinophils with mUV/VIS light induced dose-dependent apoptosis and inhibited the
mediator release from RBL-2H3 basophils. Our results showed that phototherapy inhibits
immediate hypersensitivity in the skin and nasal mucosa, acting at multiple point of the
immunological process and therefore opens new opportunities for the treatment of immune-
mediated skin and mucosal diseases.
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Effects of UV Irradiation on Cellular Responses and DNA Damage of Human
Keratinocytes Harbouring HPV16
S Mouret1, T Douki2, S Courdavault2, A Favier2, J-C Beani1 and M-T Leccia1
1Laboratoire Oligoe´le´ments et Re´sistance au Stress Oxydant induit par les Xe´nobiotiques
(ORSOX), UMR-E3, LRC7 CEA 8M, Domaine de la Merci, 38700 La Tronche, France;
2Laboratoire Le´sions des Acides Nucle´iques (LAN), SCIB/DRFMC, CEA, Grenoble, France
In Epidermodysplasia verruciformis and some immunocompromised patients such as organ
transplant recipients, cooperative effects of human papillomavirus (HPV) and ultraviolet (UV)
radiation have been postulated in the development of non-melanoma skin cancers. The
tumor suppressor protein p53 is a critical mediator of the cellular response to genotoxic
agents by inducing either growth arrest, DNA repair or apoptosis. Transforming activity of
high risk HPV is associated with loss of both cell cycle control and DNA repair systems. The
aim of our study was to determine the effects of UV irradiation on cellular responses and DNA
damage in HPV16 infected human keratinocytes. We used two keratinocyte lines, SKv-e and
SKv-l, established from a bowenoid papulosis lesion and different in their viral genome
integration, in vitro proliferative potential, and in vivo tumorigenicity in mice. Firstly, we
showed that the weakly proliferative and tumorigenic SKv-e cell line was more sensitive to
solar simulated radiation, more specifically to UV-induced apoptosis compared to the highly
proliferative and tumorigenic SKv-l cell line. We demonstrated that SKv-e cell line
accumulated strongly p53 and p21 proteins in their nucleus and that the p21 protein nuclear
accumulation resulted from a p53-dependent transcriptional activation after UV irradiation.
Moreover, we showed for the two SKv cell lines that UV irradiation induced the same level of
CPD and (6–4) photoproducts whereas, for a same UV dose, in SKv-e cell line higher level of
8-oxodG was formed. Interestingly, this higher oxidative DNA damage formation in SKv-e cell
line was related with low glutathione peroxidase activities and glutathione contents when
compared to SKv-l cell line. Furthermore, CPD and (6–4) photoproducts are repaired to the
same rate for the two cell lines although the repair of (6–4) photoproducts was most efficiently
achieved compared to CPD. On the contrary, 8-oxodG was not repaired for the two cell lines.
In conclusion, our results demonstrate that p53 remain inducible and functional in HPV16-
infected cells and confirm a cooperative role of HPV and UV in the transformation of
keratinocytes by allowing DNA damage accumulation in HPV infected cells.
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The Effect of UVA1, UVB and SSR on p53 Activation, and p21
Waf1/Cip1
PE Beattie, LE Finlan1,2, NM Kernohan1, G Thomson1, TR Hupp1,2, SH Ibbotson
Photobiology Unit, 1Division of Pathology and Neuroscience and 2Cancer Research UK
Laboratories- p53 Signal Transduction group, University of Dundee, Ninewells Hospital and
Medical School, Dundee, Scotland
High dose UVA1 therapy (doses in the order of 130 J/cm
2) has been used to effectively treat
atopic dermatitis and scleroderma. UVA1 has been shown to cause a dose dependent
increase in P53 expression in keratinocytes, but its effect on the activation of p53 by
phosphorylation, and on other downstream mediators of apoptosis such as P21 Waf1/Cip1, has
not been examined.
Five adult volunteers were exposed to geometric dose series of UVA1 (10-100 J/cm
2 from a
high output source (Dr Ho¨nle, Dermalight ultra 1, irradiance 70-77mW/ cm2)), TL-01 UVB (50-
550 mJ/cm2) and SSR (5.6-30 J/cm2) irradiation on the non-exposed buttock skin and the
minimal erythema dose (MED) for each was determined at 24 hours. Separate sites on the
buttocks were subsequently irradiated with a 3  MED dose of UVA1, TL-01 and SSR. At
24hr 4mm punch biopsies were taken from each irradiated site and an adjacent unirradiated
control site, fixed in paraffin and underwent immunohistochemical staining for p53 (Do-1),
activation of p53 (assessed by phosphorylation at serine 15 & 392) and p21. Cell staining was
expressed as the mean number of cells stained per 3 high power fields (HPF) and as a % of
1000 cells.
UVA1 produced relatively little staining of p53 (mean cell count per HPF 16 (SD10)) and no
evidence of p21 expression or p53 activation in contrast to TL-01 UVB (mean count per HPF
(SD) of 147 (62) for Do-1, 54 (50) for serine 15 and 54 (31) for p21) or SSR irradiation (mean
count per HPF (SD) of 137 (50) for Do-1, 35 (26) for serine 15 and 66 (28) for p21).
These data indicate that there are fundamental differences in the effects of UVA1 on p53
and its activation markers, and may explain in part, the differential effect of these
phototherapies.
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VEGF-A protects endothelial cells from UVB-induced cell death
C Barresi1, M Ghannadan1, H Rossiter1, E Tschachler12
1D.I.A.I.D., Department of Dermatology, University of Vienna Medical School, Vienna,
Austria; 2CE.R.I.E.S., Neuilly, France
Skin alterations observed after single and prolonged exposures to UVB include erythema,
dilation of dermal blood vessels, vascular hyperpermeability and epidermal hyperplasia.
Vascular Endothelial Growth Factor (VEGF) is one of several pro-angiogenic factors that are
induced in skin after UVB irradiation, and epidermal keratinocytes (KC) are the major source of
VEGF in skin. Using the Cre/LoxP system under the control of the Keratin 5 promoter, we have
generated mice in which VEGF has been inactivated in epidermal KC (VEGF-ADK5-cre/DK5-cre)
and used these animals to study the contribution of KC-derived VEGF to acute and chronic
UVB-induced photo-damage.
We have shown previously that high dose UVB irradiation induced superficial wounds in
mutant but not in control mice, and both after a single high dose and chronic low dose UVB
irradiation blood vessel response was impaired in the mutant mice.
Several reports have implicated VEGF as a major survival factor for endothelial cells exposed
to stress stimuli such as TNF-a, H202 and serum starvation. We found that exposure of
HDMVEC to UVB irradiation in the presence or absence of VEGF dose- and time-dependently
significantly protected the cells from death. This suggests that VEGF protects from cutaneous
photo-damage by preventing UVB-induced cell death in EC, thereby allowing enhanced
vascularization and KC survival.
Understanding more about the mechanisms contributing to this impaired blood vessel
response in the mutant mice may be used to better understand the biologic role of skin blood
vessels in the pathogensis of acute and chronic photodamage.
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Carboxyfullerenes Localize at the Intracellular Level and Prevents Caspase Cascade
Induced by UVB in Human Keratinocytes
C Fumelli, A Marconi, M Pignatti, C Vaschieri, A Giannetti and C Pincelli
Institute of Dermatology, Department of Medicine, University of Modena and Reggio Emilia,
Modena, Italy
Water-soluble derivatives of buckminsterfullerene (C60) are a unique class of compounds
with potent antioxidant properties. We have shown previously that carboxyfullerenes (CF)
protect human keratinocytes from ultraviolet (UV) light-induced apoptosis. The aim of the
present study was to evaluate the molecular mechanism underlying this effect. First of all, we
wanted to determine the subcellular localization of CF in human keratinocytes. To this
purpose, we added CF to keratinocyte cultures, stained them with an anti-CF monoclonal
antibody followed by incubation with a FITC-conjugated antimouse antibody, and examined
the cells under a confocal laser microscopy. CF appear to localize at the intracellular level in
the cytosol, close to the nucleous. Moreover, the addition of CF reduced the percentage of
depolarized mitochondria, as shown by JC-1 probe, and prevented the release of
cytochrome c induced by UVB irradiation. We also confirmed that CF protect human
keratinocytes from UVB-induced apoptosis. We next wanted to evaluate the influence of CF
on the caspase cascade induced by UVB. While UVB induced the cleavage of both initiator
and effector caspases at 24 hrs, CF prevented the activation of caspase-8, -9, -10. In
addition, CF up-regulated the group of inhibitor of apoptosis proteins (IAP), which in turn
inhibit caspase activation. These results demonstrate that CF protect human keratinocytes
from apoptosis through the modulation of caspase cascade. The antioxidant property, the
prevention of mitochondrial depolarization and release of cytochrome c together with the
intracellular location suggest that CF could indeed act at the mitochondrial level.
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Low-dose UVB Induces a p53-Dependent Gene Program that Increases the Resilience of
Keratinocytes Against Upcoming UVB-Insults
D Decraenez, L Declercq, D Gan#, T Mammone#, D Maes#, M Garmynz
zDepartment of Dermatology, University of Leuven, Belgium. Estee Lauder Coordination
Center, Oevel, Belgium. #Estee Lauder Companies, Melville, USA
In previous work we have shown that pre-exposure to a low dose of UVB-damage triggers an
adaptive response in keratinocytes, provided that the time-interval between consecutive
UVB-insults is long enough (24 h). This adapative response is discerned by an increase in
survival and a decrease of apoptosis. This study investigates the mechanism behind this
adapative response.
One protein central to the UVB-response of human keratinocytes is p53. By transactivating
genes involved in either cell cycle arrest or DNA repair, p53 has a leading role in the recovery
from UVB-damage. The possible role of two of these p53-target genes, p21 and p53R2, in the
adaptive response was examined. p21, an inhibitor of cyclin-dependent kinases, is an
important mediator of the p53-induced G1/S arrest following UVB-damage. p53R2, a
ribonucleotide reductase, facilitates DNA repair in response to UVB by creating a fresh supply
of deoxyribonucleotides. We found that, while p53 levels increase in response to both low (12
mJ/cm2) and high (32 mJ/cm2) UVB-doses, only low levels of UVB damage result in
upregulation of p21 and p53R2. Furthermore, we found that UVB-induced upregulation of
these genes takes time, and peaks 24 hours after the UVB-insult.
Untreated keratinocytes, exposed to a high dose of UVB, never show elevated levels of
either p21 or p53R2. By exception however, significantly increased basal levels of both p21
and p53R2 can be observed when these keratinocytes are first pre-exposed to a low dose of
UVB (8 mJ/cm2) 24 hours before the high-dose (32 mJ/cm2) exposure. Monitoring of both cell
survival and caspase-3 induced PARP cleavage confirms that these pre-exposed
keratinocytes are more resistant to higher levels of UVB damage compared to untreated
keratinocytes.
Similar results are found when a high dose (24 mJ/cm2) is fractionated into three low doses
of UVB (8 mJ/cm2) with a set amount of time (300 , 1 h, 3 h or 24 h) between subsequent UVB-
insults. Elevated p21 and p53R2 levels are only observed with longer intervals (24 h) between
subsequent UVB-insults. In parallel and thus consistent with the expression pattern of p21
and p53R2, stimulation of survival and decrease of apoptosis are also only observed with
these longer intervals.
These results indicate that the adapative response to UVB-irradiation, induced by a pre-
exposure with a low dose of UVB, is the result of a p53-dependent transcriptional activation
of genes with an active role in growth arrest and DNA repair. However, the adaptive response
only works optimal when the interval between consecutive UVB-doses is long enough (e.g. 24
hours), since upregulation of these p53-target genes requires time.
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Adaptive Response of Hairless Mouse Epidermis to Maintain Optimal Vitamin A
Concentration During Long Term UV Exposure
O Sorg, C Tran, D Grand, L Didierjean and J H Saurat
Department of Dermatology, University Hospital, Geneva (Switzerland)
The depletion of cutaneous vitamin A by a single exposure to UVB is well documented in
hairless mice. When a suberythemal UVB dose is received three times per week, tumours
develop after about 15 weeks. In this paradigm simulating long term UV, UVB act both as an
initiator and a promoter of skin cancer. In this study, we wondered whether the depletion of
cutaneous vitamin A was maintained during long term UVB exposure. Hairless mice were
exposed to a suberythemal UVB dose of 70 mJ/cm2 3 times per week for one, 5, 10 or 20
weeks. Skin tumours began to appear in the last group after 14 week, all mice beared
tumours after 18 weeks, and had an average number of 16 tumours larger than 1 mm per
mouse after 20 weeks. Vitamin A (retinol and its esters) and vitamin E (a-tocopherol) were
assayed by HPLC in the epidermis, the dermis, the plasma and the liver. A piece of skin was
fixed in formol and used for histological slices (H/E staining). In the UVB irradiated mice,
epidermal vitamin A concentration (basal value in non irradiated controls: 1.58  0.12 nmol/
g) decreased dramatically during the first week of UVB irradiation to 12% of that of non
irradiated controls, whereas after 5 weeks of irradiation it was similar to that of non irradiated
controls, and 180% of that of controls after 20 weeks of UVB irradiation. On the other hand,
dermal vitamin A (0.75  0.1 nmol/g) did not change significantly during the whole paradigm.
After 10 weeks of irradiation, there was no significant change in plasma (3.06  0.36 mM) or
liver (10.9  2.3 mmol/g) vitamin A. Epidermal vitamin E (37.8  1.2 nmol/g) was slightly
increased after one week UVB (55.5  3.5 nmol/g), but the difference between irradiated and
non irradiated mice decreased as a function of the duration of UVB irradiation. In summary,
there was a transient depletion of epidermal vitamin A at the beginning of the UVB irradiation
paradigm, then epidermal vitamin A levels were similar or higher to those of non irradiated
controls, especially at the time of cutaneous tumour development, whereas epidermal vitamin
E was never depleted during the whole paradigm. The adaptive response of the epidermis to
control vitamin A concentration during long term UVB irradiation suggests that epidermal
vitamin A could play a role in counteracting the deleterious action of long term UVB exposure.
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Cis-urocanic Acid Induces NFjB Activation in Primary Human Keratinocytes
U Smetana-Justy, S John, M Norval# and SL Walker
Division of Skin Sciences & Department of Immunobiology, King’s College London, UK;
#Department of Medical Microbiology, University of Edinburgh, UK yDivision of Special and
Environmental Dermatology, University of Vienna Medical School
Ultraviolet radiation (UVR)-induced suppression of cutaneous cell-mediated immunity plays
an important role in the development of photocarcinogenesis and susceptibility to infectious
diseases.
Photoisomerisation of urocanic acid (UCA) from its trans- to cis- isomer is a significant
event in the initiation of UVR-induced immunosuppression. The mechanisms by which cis-
UCA modulates immune responses are not yet fully defined. However, the expression of
many genes involved in immunological and inflammatory responses are under the control of
the transcription factor NFkB, which is strongly upregulated by UVR. We therefore
investigated the effect of UCA isomers on the activation of NFkB in order to determine a
possible involvement for this transcription factor in cis-UCA mediated immunosuppression.
Human primary keratinocyte cultures were established from biopsies of non-exposed
buttock skin from healthy white-skinned volunteers (n¼ 16). Keratinocytes were incubated in
100 mg/ml of cis- or trans-UCA in PBS. Nuclear extracts were performed after 2 h and 24 h
and analysed by electrophoretic mobility shift assay. Cis- but not trans-UCA stimulated the
release of NF-kB to the nucleus at both time-points and was greatest at 24 h (p¼ 0.0065).
The induction of immunosuppression by cis-UCA may involve the activation of the NFkB–
pathway in keratinocytes.
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Assessment of 4 Xeroderma pigmentosum Group C and G Gene Polymorphisms and
Risk of Cutaneous Malignant Melanoma: A Case-Control Study
S Blankenburg#, I R Ko¨nig, R Moessner#, P Laspe#, K-M Thoms#, U Krueger#, S G Khanz,
G Westphalz, M Volkenandty, K Reich#, A Ziegler, K H Kraemerz, C Neumann#, S Emmert#
#Department of Dermatology, Georg-August-University Goettingen; Institute of Medical
Biometry and Statistics, University Hospital Schleswig-Holstein – Campus Lu¨beck;
zDepartment of Occupational and Social Medicine, Georg-August-University Goettingen,
yDepartment of Dermatology, Ludwig-Maximilians-University Munich; zBasich Research
Laboratory, Center for Cancer Research, National Cancer Institute/NIH, Bethesda, MD, USA
Individuals with the rare nucleotide excision repair deficiency syndrome xeroderma
pigmento-sum (XP) are sun-sensitive and exhibit a 1000-fold increased risk for developing
skin cancers including malignant melanoma. Inherited polymorphisms of XP genes may, thus,
contribute to subtle variations in DNA repair capacity and genetic susceptibility to melanoma.
We investigated the role of three variant alleles of the DNA repair gene XPC and one variant
allele of the XPG gene in a hospital-based case-control study of 294 Caucasian patients from
Germany with malignant melanoma and 375 healthy control individuals from the same area
matched by sex. The polymorphisms G1580A (XPC exon 8; Arg492His), T1601C (XPC exon 8;
Val499Ala), G2166A (XPC exon 10; Arg687Arg), and C3507G (XPG exon 15; Asp1104His)
were not in linkage disequilibrium. The allele frequencies (cases : controls) were for 1580A
6.29% : 5.63%, for 1601C 79.08% : 78.28%, for 2166A 26.19% : 28.13%, and for 3507C
20.14% : 21.39%. No significant deviation of the observed genotype distributions from the
expected genotype distributions as predicted by the Hardy-Weinberg theory were detected.
We found no association of the homozygous 1580A, 1601C, 2166A, and 3507G genotypes
with increased risks of melanoma: OR 1.254 (95%-CI: 0.486–3.217), OR 1.108 (95%-CI:
0.629–1.960), OR 0.817 (95%-CI: 0.490–1.358), and OR 1.168 (95%-CI: 0.670–2.044),
respectively. Exploratory analyses of subgroups indicated no association of these genotypes
with increased risks for the development of multiple primary melanomas (n¼ 28), a negative
family history for melanoma (n¼277), melanomas in individuals with a low number of nevi
(n¼ 273), melanomas in individuals older than 55 years (n¼ 142), and melanomas thicker than
1mm (n¼ 126). Our results do not support the hypothesis that the four polymorphisms in the
XPC and XPG genes affect susceptibility to melanoma.
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Relationship Between Skin Typology and UV Sensitivity: Photoprotection Due to
Constitutive Pigmentation
S Del Bino, J Sok, D Asselineau, F Bernerd
L’Ore´al Research, Clichy, France
Sun exposures are responsible for deleterious effects ranging from sunburn, to photoaging
and skin cancer. These consequences are likely to be influenced by constitutive
pigmentation, as demonstrated by i) epidemiological studies on skin cancer incidence in
Caucasian and African American population ii) relationship between the MED (Minimal
Erythemal Dose) value and skin typology. The latter is commonly determined according to
Fitzpatrick’s classification based on erythema and tanning ability. Nevertheless this
classification has some limits in terms of quantification, ex vivo conditions and relevance
for Asian skin for example. Except for erythemal reaction, only few experimental data are
available on the relationship between UV sensitivity and skin typology. We analyzed 31 ex vivo
skin samples objectively classified in 6 groups (from very light skin to dark skin) according
to their values of Individual Typology Angle (ITA) based on colorimetric parameters. The BED
(Biologically Efficient Dose) was determined for each sample by quantifying the sunburn cells
after UV exposure (UVR solar simulation, UVBþUVA). Several typical biological markers
related to UV response, other than erythema, were analyzed such as DNA damages,
apoptosis, and p53 accumulation. We found a statistically significant correlation between ITA
and BED and between ITA and DNA damages. Interestingly, DNA damages were distributed
throughout the whole epidermal layers in light skin while they were absent in the basal layer of
dark skin. Our data support, at the cellular level, the relationship between UV sensitivity and
skin typology. They emphasize the impact of DNA damage accumulation in the basal in
relation with the prevalence of skin cancer. Moreover typological delimitations for skin
sensitivity to UV could be envisaged based on the ITA value.
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Genomic Scale Analysis of in vivo UVB-Irradiated Human Epidermis
M Hochberg, J Jacob, H Gal, N Amariglio, G Rechavi, D Givol, C D Enk
Department of Dermatology, The Hadassah - Hebrew University Medical Center, Jerusalem,
Department of Pediatric Hemato-Oncology and Functional Genomics, The Chaim Sheba
Medical Center and Sackler School of Medicine, Tel Aviv University, and Department of
Molecular Cell Biology, Weizmann Institute of Science, Rechovot, Israel
Background. Several recent studies have employed genomic scale analysis to study UVB
regulated gene expression in human skin. These studies are mostly based on UV irradiated,
cultured cells that differ substantially from the intact tissues they are supposed to imitate. The
purpose of the present study was to analyze the differential expression of UVB regulated
genes in intact human epidermis following in vivo UV irradiation.Methods:
The forearms of human volunteers were exposed to 4 MED of UVB in vivo, followed by
removal of suction blister roofs from exposed and non-exposed epidermis 2 h, 24 h, and 72 h
after irradiation. RNA samples were analyzed using oligonucleotide microarray (Affymetrix)
technology analyzing over 8,500 verified human genes from the NCBI RefSeq database
simultaneously. Verification of selected genes was performed by semi-quantitative RT-PCR.
Results. 615 common active genes were changed at least 2 fold in at least one time point
in all experiments. Classification of these genes into functional categories revealed that
multiple, biological processes are globally affected by UVB. The differentially regulated genes
included genes involved in signal transduction, cell proliferation and differentiation, cell
signaling, DNA repair, and apoptosis. Cluster analysis revealed that the majority of the UVB
regulated genes were found 24 hours after irradiation, suggesting that a single, low UVB
exposure of human epidermis results in only transient expressional changes.
Conclusion. Our results illustrate the power of global gene expression analysis of human
epidermis to identify molecular pathways involved in UV induced photodamage.
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Melanocortin 1 Receptor Genotype and Cutaneous Responses to a Single Dose Of
Ultraviolet Radiation
S Robinson, S Dixon, A Collins, C Gough and E Healy
Southampton, United Kingdom
Genetic variants of the melanocortin 1 receptor (MC1R) are associated with red hair, fair skin
and an increased susceptibility to skin cancer. This increased risk may result from both
pigmentary and non pigmentary effects of the variant receptor, however the exact mechanism
is unclear. In this study we have investigated whether MC1R variants alters the cutaneous
responses of human skin to a single dose of ultraviolet radiation (UVR).
Thirty subjects were recruited from patients due to undergo UVB therapy for psoriasis.
Untanned buttock skin was exposed to incremental doses of UV (
p
3) from a TL12 lamp. After
24 hours, UV induced erythema and basal melanin index readings were obtained using an
erythema-melanin index meter, and 6 mm biopsies were taken from unirradiated skin and
from skin exposed to 200 mJ/cm2 UV. The amount of DNA damage and cutaneous responses
to UV were assessed by immunostaining for cyclobutane pyrimidine dimers (CPD) and p53
respectively, and quantified by image analysis. Melanin content was assessed by Masson-
Fontana stain and expression of MC1 receptor within the skin determined by immunohis-
tochemistry. Subjects were genotyped at MC1R and designated as wild type (WT), single
variant allele, and two variant alleles at this locus; alleles containing MC1R variants which are
not thought to impair receptor function were designated as pseudo-wild type (pWT).
Twenty seven of 30 subjects were WT MC1R (14 individuals) or had a single variant MC1R
allele (13 individuals), and skin biopsies were obtained from 13 WT and 12 single variant
subjects. Basal melanin index, melanin content and expression of MC1R did not differ
significantly between subjects with WT and a single variant allele. At 24 hours there was no
significant difference in UV-induced erythema nor in the percentage of CPD positive
epidermal cells or p53 positive epidermal cells between subjects with WT and a single MC1R
variant.
The results suggest that there is no significant difference in the cutaneous responses to a
single dose of UVR between individuals with WT MC1R and subjects with a single variant
MC1R allele.
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The Effect of Photochemotherapy (PUVA) on Dermatoscopic Features of Melanocytic
Nevi
FJ Legat, I Zalaudek, S Grinschgl, A Hofer, I Kolm, H Kerl, P Wolf, R Hofmann-Wellenhof
Department of Dermatology, Medical University Graz, Austria
Photochemotherapy with psoralen and UVA (PUVA) is a very effective treatment for patients
with psoriasis. In the light of an increased long-term risk for the development of skin tumors
such as squamous and basal cell carcinoma, and as recently reported also for melanoma, we
studied the effects of PUVA therapy on dermatoscopic features of melanocytic nevi.
During an 8-weeks course of PUVA therapy a total of 103 nevi in 6 patients were followed
and dermatoscopic photographs were taken before and at the end of PUVA therapy. Follow-
up dermatoscopic photographs were taken 3 months after the last PUVA treatment. Two
blinded investigators compared the three images of each melanocytic nevus without knowing
whether the photographs were taken before or at the end of PUVA, or 3 months after PUVA
therapy. The evaluation of the dermatoscopic images comprised the following dermatoscopic
features: Total pigmentation, area, globules/dots, faded pigment network, asymmetry,
various colours, regression structures, and atypical pigment network. In a first step of
evaluation the presence of the particular features was determined. Then, the expression of
the respective features in the three images was compared and defined as equal, more, or
less. For nevi showing an increased expression of one of the features at the end of PUVA, it
was determined whether this feature was still present 3 months after PUVA therapy.
At the end of PUVA, in 103 nevi total pigmentation was increased in 14%, decreased in
15%, and was unchanged in 71%. Area increased in 22%, decreased in 11%, and was
unchanged in 67%. Of the other features, globules/dots (in 70 of 103) and faded pigment
network (in 60 of 103) were most frequently increased (i.e., 43% and 45%, respectively). In 13
(13%) nevi the expression of at least one feature suspicious for malignant transformation
such as asymmetry, various colours, regression structures, and atypical pigment network,
was increased at the end of PUVA. Three months after the end of PUVA in 10 nevi at least one
of these dermatoscopic feature was still present. Only in 4 nevi the expression of two or more
features suspicious for malignant transformation were increased at the end of PUVA, and
persisted throughout a three months-period after the end of PUVA therapy.
In conclusion, PUVA therapy is capable of altering dermatoscopic features of melanocytic
nevi. In a small number of nevi features suspicious for malignant transformation develop
during the course of PUVA and may persist for months after PUVA therapy.
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Apoptosis and Proliferation of Human Epidermal Keratinocytes After an Acute UV
Exposure: An in vivo Immunohistological Study
T Zuliani, N Lachman-Weber, C Heusele, S Schnebert, M Dumas, MH Ratinaud
LVMH Recherche, Saint Jean de Braye, France
Ultraviolet radiations (UVR) participate to skin carcinogenesis and photoaging. When
epidermis, the outermost part of the skin, is exposed to UVR, damaged keratinocytes can
undergo apoptosis, a programmed cell death that removes them from the tissue and
contributes to its protection and maintenance. Therefore the question related to a decrease of
such a phenomenon in human skin during aging raises. The aim of this study was to
investigate apoptosis in normal sun-exposed skin following an acute UV radiation depending
on the age. Apoptosis was assessed in the arm of young (n¼ 12, mean aged 25.5) and aged
female volonteers (n¼ 12, mean aged 67.1) before and 24 h after sun exposure to a 3-fold
minimal erythema dose (MED). Immunohistological study was carried out on 10 mm
cryosections obtained from 3 mm skin biopsies. Apoptosis together with proliferation was
investigated using antibodies against active caspase-3 and Ki-67 respectively. Moreover, b1
integrin and active caspase-3 double staining were performed in order to determine
localisation of apoptotic cells. These results indicate that proliferation index (PI) is about two
times greater in young than in aged epidermis. However, after the acute sun exposure, while
proliferation is greatly inhibited in young epidermis (PI from 216 to 68), it slightly decreased in
aged epidermis (PI from 115 to 85). No spontaneous apoptosis in young and aged volunteers
was observed without any acute UV exposure. 24 hours following sun exposure, apoptosis
was strongly induced in both groups with a greater sensitivity of the young volunteers as
opposed to aged ones. Double staining with b1 integrin indicated that percentage of caspase-
3 active cells in basal cell compartment is greater in aged volunteers than in younger. Taken
together, these results indicate that an acute UV exposure to 3 MED induced apoptosis more
strongly in young than in aged epidermis and that this greater sensitivity of young epidermis is
associated with an arrest of basal cell proliferation.
A50 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
303
Microarray Analysis of Chronically Sun-Damaged Human Skin
J Urschitz, G S Okimoto, S Iobst, K M Pusic, M H Heller, K Schilling and C D Boyd
The Pacific Biomedical Research Center, University of Hawaii, Honolulu, HI Unilever
Research U.S., Inc., Edgewater, NJ
Intrinsic, environmental, and lifestyle factors all contribute to the process of skin aging.
Photoaging, a remodeling of the dermis that arises as a result of repeated exposure of skin to
UV-light has been identified as the predominant contributing factor to the prematurely aged
appearance of sun-exposed skin.
To study the phenotypic changes in human skin associated with chronic sun exposure at
the transcription level, we had previously undertaken a Serial Analysis of Gene Expression
(SAGE) of sun-damaged and sun-protected skin from a single patient undergoing elective
facial plasty. We detected 34 genes with altered mRNA levels between the two full-thickness
skin samples. Prior to a detailed study of the functional relevance to photoaging of some of
these genes, it was critical to determine the inter-individual differences in gene expression
profiles. We have used RNA preparations from skin obtained from 11 Caucasian patients with
moderate sun-damage and analyzed the changes in mRNA levels encoded by more than
22,000 different genes represented on the Affymetrix U133A chip. We developed an algorithm
that exploits dependencies between control and test chips by computing a paired t-statistic
for each gene as a measure of differential expression and a false discovery rate for lists of
genes called significantly changed based on permutation testing. Using this algorithm, we
were able to identify 566 mRNAs with consistently altered steady-state levels as a
consequence of chronic sun exposure. Here we also demonstrate that for one of the genes,
a consistent change in the protein expression level was detected. The protein was localized
to the epidermis by Immunohistochemistry (IHC) and the same trends that were seen in the
Western blot analysis were maintained in IHC.
In conclusion, in this study, we were able to expand the number of genes assessed to more
than 22,000. Furthermore, these results support the changes that were previously reported
using SAGE for an individual patient and are reflective of a larger population of chronically
photodamaged individuals.
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Heat Shock Inhibits UVA-Induced Cell Death
M Der-Petrossian, G Klosner, C Kokesch, H Merwald, H Ho¨nigsamnn, F Trautinger
Department of Dermatology, Division of Special and Environmental Dermatology, Universitiy
of Vienna
The ability of heat shock to inhibit UVB-induced cell death is well documented in human
keratinocytes. In the present study we investigated the influence of heat pretreatment on
UVA-induced cell death. The human squamous carcinoma cell line A431 and the human
fibrosarcoma cell line HT1080 were exposed to heat shock (3 h at 421 C) and subsequently to
UVA from a metal halide source (315–390 nm, 40–113 J/cm2, Mutzhas Supersun 5000,
Germany). Viability, lipidperoxidation and 8-oxoguanine were determined after UVA-exposure
by an MTT assay, TBARS measurement, and immunocytochemistry (OxyDNA, Biotrin),
respectively. At 24 h after UVA-exposure the survival rate was markedly increased in heat
pretreated A431 compared to controls at all dosages. This effect was highest when heat
shock was applied 2 h before irradiation, and decreased continuously with increasing
intervals. In contrast, heat shock applied 2 h before irradiation had no effect on TBARS and
formation of 8-oxoguanine. Heat pretreatment in HT1080 showed no effect.
These results for the first time demonstrate that heat shock is able to inhibit UVA-induced
cell death. The observed time course indicates that heat shock proteins might be related to
this protective effect, which seems to be tissue specific. Initial data suggest that the heat
related increase of survival occures independently of lipid peroxidation and oxidative DNA-
damage.
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Experimental Study of Photo-Protection of Hydroxychloroqine and TCMs on Human
Keratinocytes Damaged from Ultraviolet-B Irradiation
D Luo, W Min, X Lin, D Wu
Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, NanJing,
PR China
Objective. To evaluate photo-protective efficiency of hydroxychloroqine and traditional
Chinese medicines (EGCG, szechwan lovge rhizome and baikal skullcap root) on human
keratinocytes (HaCaT cells) damaged from UVB irradiation and their mechanisms.Methods:
1. HaCaT cells were cultured in RMPI-1640 media with 10% fetal bovine serum and plated
in 3.5 cm dishs with a equal amount (106).
2. Subconfluent HaCaT cells were shammed or irradiated with different dosages of UVB
irradiation 30, 60, 90 mJ/cm2 and treated with above TCM agents and (or) hydroxychloroqine.
3. Flow cytometric analysis was performed and cells in the G1, S, and G2/M phase of the
cell cycle and apoptotic rate were determined with flow cytometery.
4. The mRNA expression levels of p53, p21, c-fos and GADPH gene were evaluated by
reverse transcription-polymerase chain reaction (RT-PCR), the scanned intensity of each
gene band to the corresponding band of GAPDH PCR product and normalized to the control
sample.
Results. 1. UVB-induced apoptosis of HaCaT cells were dose-dependent, from 0.21% (0 mJ/
cm2) to 71.18% (90 mJ/cm2); HCQ and TCMs showed protective effect on UVB-induced
apoptosis, the apoptotic rate was reduced in all irradiating dosage levels.
2. UVB-irradiation caused S-phase arrest with an increase amount of cells in S-phase in
30 mJ/cm2 level; but with increase of irradiated dosage, the amount of cells in S-phase
descended rapidly. The intervention of the tested drugs could inhibit S-phase arrest induced
by UVB.
3. UVB irradiation could induce mRNA expression of p53, p21 and c-fos in cultured HaCaT
cells; and mRNA levels of p53, p21 and c-fos were decreased after TCM intervention in UVB
irradiation group.
Conclusions. The cell cycle arrest and apoptosis induced by UVB irradiation on HaCaT cells
could be inhibited with the intervention of HCQ and TCMs. The photo-protective mechanisms
of above medicines may be partly related to inhibition of the expression changes of p53, p21,
c-fos gene.
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The Effectiveness of PUVA Treatment in Severe Psoriasis is Impressively Increased by
Addition of Several UVB 308 nm Excimer Laser Sessions
J Trott, W Gerber, H M Ockenfels
Dept. of Dermatology and Allergology, Klinikum Stadt Hanau, Germany
Objectives. Both UV-light therapies of psoriasis, the one using psoralen and UV A (PUVA)
and the other using narrow-band UVB 311 nm are one of the most successful treatments
inducing clearance of psoriatic lesions. Unfortunately, both therapies need a number of more
than 25 treatment sessions to clear up psoriasis and UV dosages depends on the MED
testing in not involved skin. In contrast, excimer laser derived 308 nm UVB radiation targets
only the involved skin, less than 12 treatments are necessary and the UVB dosages can
exactly applied in the psoriatic lesions starting with the MED-I dosage. Although the UVB
laser treatment were performed only in moderate psoriasis with an involved skin o20%, we
were interested to combine UVB 308 nm excimer radiation and PUVA in severe psoriasis.
Methods. To analyze if the combination of the two phototherapies are more effective than
PUVA alone, a prospective study was performed: 256 patients (170 men and 105 women,
mean age 50 years) with severe psoriasis where included in the study. 113 patients were
treated with PUVA, during the second group with 143 patient were treated with PUVA and
several sessions of 308 nm excimer Laser. Clinical improvement and relapse was
documented by PASI over a time period of 4 months.
Results. In the PUVA treated group there was a clearance of 67,3% (76/113), 23,0% (26/113)
partial clearance and 9,7% (11/113) non-responder. 26  7 treatments were necessary to get
a complete clearance. The cumulative dose of UV A was 53,2 J/cm2  26,3 J/cm2 and the
average time of treatment was 6,5 weeks.
In the PUVA and excimer laser treated group, the rate of clearance with 63,6% (91/143),
partial clearance 28,0% (40/143) and non-responders 8,4% (12/143) were similar. But the
number of treatments in the clearance group was much lower (15  6) and the cumulative
UVA dose decreased to 22.9 J/cm2  5,8 J/cm2 and the average time was 4,2 weeks. The
number of the additionally applied treatments with Excimer Laser was 3,8  1,9 with a dose
of 4070 mJ  3293 mJ.
Conclusion: Clearance of psoriatic lesions can be achieved dramatically, very fast and with
57% reduction of UVA dosages if PUVA-treatment is combined with several sessions of 308
nm laser derived UVB light.
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The First Cutaneous T-Cell Lymphoma (CTCL)-Associated Gene Aberration
L Karenko, S Hahtola, R Karhu, M Ka¨hko¨nen, B Nedoszytko, S Kyto¨la¨, M Pesonen, N
Nupponen, H Nevala, H Sihto, J Roszkiewicz, P Peterson, T Visakorpi, A Ranki
Dept of Dermatology and Venereology or Oncology Helsinki University and HUCH Helsinki
and Dept of Clinical Genetics and Laboratory of Cancer genetics and IMT, University and
TAYS Tampere, Finland; Dept of Dermatology, Medical University of Gdansk, Poland
Patients with cutaneous T-cell lymphoma (CTCL) show a large variety of chromosomal
aberrations with no previously known common or specific aberration. We have now identified
a common aberration detectable in the majority of CTCL cases and the gene involved.
Multicolour fluorescent in situ hybridization (multicolour FISH) was used to identify acquired
chromosomal aberrations in 12 patients with mycosis fungoides (MF) or Sezary syndrome
(SS), the most common forms of primary cutaneous T-cell lymphoma (CTCL). The most
frequently affected chromosome was 12, which showed clonal deletions or translocations
with a break point in 12q21 or 12q22 in 5 of 7 SS patients and clonal monosomy in the sixth
patient. The distal and proximal breakpoints of two deletions were fine mapped to 12q21, and
the breakpoint of a balanced translocation t(12;18)(q21;q21.2), was found in the minimal
common region of these two deletions. The breakpoint was further fine-mapped by locus-
specific FISH, and was found to disrupt a single gene. This gene, neuron navigator 3 (NAV3),
also named POMFIL1, a newly described human homologue of unc-53 in C. elegans, is
located in 12q21.1. A missense mutation in the remaining NAV3 allele was found in one of two
SS cases studied with a deletion. With locus-specific FISH, we have demonstrated NAV3
deletions in touch samples of the skin lesions of 4 of 8 (50%) patients with early MF (stages
IA-IIA) and a deletion or a translocation in the skin or lymph node in 11 of 13 (85%) patients
with advanced MF or SS. Thus, NAV3 is a novel putative target tumour suppressor gene,
disrupted in most cases of as well early as advanced MF and SS patients. The demonstration
of NAV3 deletion in clinical samples may provide a new, specific diagnostic test for CTCL.
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Conditional Deletion of VEGF Impairs SOS-Dependent Skin Tumour Development in
Transgenic Mice
B Lichtenberger and M Sibilia
DIAID, Department of Dermatology, Medical University of Vienna, Vienna, Austria
The vascular endothelial growth factor (VEGF) is a key mediator for normal and abnormal
angiogenesis and is implicated in the development of many epidermal tumours. K5-SOS
transgenic mice expressing a constitutively active form of the Ras activator Son of Sevenless
(SOS) in the basal layers of the epidermis develop skin papillomas at 100% penetrance in a
wild-type epidermal growth factor receptor (EGFR) background, whereas in a hypomorphic
(wa2) EGFR background tumour development is severely impaired and can be induced by
wounding.
To address the role of VEGF during skin tumourigenesis, we generated K5-SOS transgenic
mice carrying a conditional (floxed) VEGF allele in an EGFR wild-type (EGFRwa2/þ ) and
hypomorphic (EGFRwa2/wa2) background. Our studies show that deletion of VEGF in basal
keratinocytes with a K5-Cre transgenic line severely impairs SOS-dependent skin tumour
development. Whereas all EGFRwa2/þ K5-SOS mice develop tumours by 7 weeks of age,
80% of EGFRwa2/þ K5-SOS mice lacking VEGF in the epidermis (VEGFDep) were still tumour
free at this age. Although by 12 weeks, all EGFRwa2/þ K5-SOS VEGFDep mice had
developed tumours, their average tumour volume was significantly smaller than in EGFRwa2/
þ K5-SOS mice. The number of blood vessels present in EGFRwa2/þ K5-SOS VEGFDep
skin tumours was significantly reduced suggesting that the delay in SOS-dependent skin
tumour development is due to impaired angiogenesis. Surprisingly, in a hypomorphic EGFR
background the lack of VEGF expression in keratinocytes completely inhibited SOS-
dependent skin tumour development. Even after wounding, EGFRwa2/wa2 K5-SOS VEGFDep
mice remained tumour free for at least 9 months. Interestingly, mice lacking only one VEGF
allele started to develop tumours after wounding at the same time as EGFRwa2/wa2 K5-SOS
mice, but their tumour volume was significantly smaller. These results show that VEGF
deletion in the epidermis severely impairs SOS-dependent tumour growth in a wild-type
EGFR background and completely inhibits tumour development in a mutant EGFR
background even after wounding. The molecular and cellular mechanisms responsible for
these phenotypes will be presented.
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Targeting Melanoma Cells and Melanomas in a Nude Mouse Model by Proapoptotic
Genes
J Eberle1, L F Fecker1, A M Hossini1, M Oppermann1, B Gillissen2, P T Daniel2, C E
Orfanos1, C C Geilen1
1Department of Dermatology, Charite´ – Universita¨tsmedizin Berlin, Campus Benjamin
Franklin, Berlin 2Department of Hematology, Charite´ – Universita¨tsmedizin Berlin, Campus
Berlin-Buch, Berlin-Buch
Apoptosis resistance is a critical feature of tumor cells and may often be the cause for therapy
resistance. The CD95/Fas signalling system is of general importance for the regulation of
apoptosis as are pro- and antiapoptotic Bcl-2-related proteins which control the release of
mitochondrial proapoptotic factors at the level of the mitochondrial membrane.
In melanoma cell lines, expression of the receptor (CD95) but not of the ligand (CD95L) was
found at the mRNA and at the protein level. Overexpression of CD95 did not trigger apoptosis
by itself but enhanced sensitivity to agonistic receptor activation, after transient over-
expression. On the other hand, melanoma cells responded with increased apoptosis both
after transient and after stable transfection and expression of CD95L in a tetracycline-
inducible expression system. Activation of the downstream signalling cascade (cleavage of
caspase-8, Bid and caspase-3 as well as release of cytochrome c) was confirmed. In nude
mice CD95L-transfected melanoma cells lost tumorigenicity when CD95L expression was
induced, and partial regression of pre-existing melanomas was also achieved. Both
sensitization to chemotherapeutics and a bystander effect due to CD95L overexpression
were shown in vitro.
Similarly, melanoma cells turned out as critically sensitive to overexpression of
proapoptotic Bcl-2 proteins as shown by transient and stable transfection of Bcl-XS, Bax
or Bik/NBK, and the combination with proapoptotic agents as etoposide, pamidronate, and
ceramide resulted in additive proapoptotic effects. Also adenoviral expression of Bik/NBK
triggered apoptosis in all melanoma cell lines, investigated. In the in vivo model, induced
expression of Bcl-XS was also able to significantly reduce the size of xenotransplanted
melanomas. On the other hand, stable overexpression of Bcl-2 and of Bcl-XL converted
apoptosis-sensitive melanoma cells resistant to proapoptotic signals (agonistic CD95
activation, ceramide). With respect to the signalling cascade following overexpression of
proapoptotic Bcl-2-related proteins we found strong DNA fragmentation and nuclear
condensation after Bcl-XS induction.
Thus, melanoma cells and melanomas in the mouse model can be directly targeted by
proapoptotic genes, and death ligands as CD95L or proapoptotic Bcl-2-related proteins
represent powerful tools especially against melanoma cells, when transfected or transduced
by viral vectors. Selective expression and selective induction of apoptosis can be mediated
by applying tyrosinase-derived promoters as we demonstrated by a tyrosinase promoter
CD95L construct. Combined use of selective promoters and proapoptotic genes appear as
suitable strategies for future melanoma therapies.
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Insights Into Mechanisms Regulating the Growth Response of Melanoma Cell Lines to
Vitamin D Analogs In Vitro
M Moeini, M Rech, K Querings, M Seifert, W Tilgen, J Reichrath
Dept. of Dermatology, The Saarland University Hospital, Homburg/Saar, Germany
Vitamin D analogs inhibit proliferation and induce differentiation in a broad variety of cell
types, including human melanocytes. For unknown reasons however, various tumor cell lines
fail to respond to the antiproliferative effects of these compounds. We studied the effects of
25(OH)D3, 1,25(OH)2D3, and the vitamin D analog seocalcitol (EB 1089) on the growth of
various melanoma cell lines (SK-Mel-5, SK-Mel-28, MeWo, MelJuso) using a WST-1 based
colorimetric assay. We studied mRNA expression of vitamin D receptor (VDR), vitamin D-25-
hydroxylase (25OHase), 25(OH)D3-1a-hydroxylase (1aOHase), and 1,25(OH)2D3-24-hydro-
xylase (24OHase) using real-time PCR. Our results show that the majority of melanoma cell
lines analyzed responds to antiproliferative effects of vitamin D analogs (e.g. MeWo), while
the minority is nonresponsive (e.g. SkMel5). A strong induction (up to 7000-fold) of 24OHase
mRNA was detected in responsive cell lines, indicating functional integrity of VDR-mediated
transcriptional activity. In contrast, induction of 24OHase was much lower in nonresponsive
cell lines (up to 70-fold). Responsive and nonresponsive cell lines did not differ in VDR-
expression, that was induced in both groups up to 3-fold along with vitamin D treatment.
However, responsive and nonresponsive cell lines differed in the effects of vitamin D analogs
on antiproliferative activity mediated by calpain inhibitors or trichostatin A, an inhibitor of
histone deacetylation. Flow cytometry (bcl-2, bcl-xl, bcl-xs, bcl-x, bax, CD95), a cell death
detection kit, and analysis of annexin/Pi revealed no induction of apoptosis by 1,25(OH)2D3
(107 M) or its analogs in responsive or nonresponsive cell lines. We also report the
expression of vitamin D-activating enzymes 25OHase and 1aOHase in all cell lines analyzed.
Different alternate slice variants of the 1aOHase gene were detected. In conclusion,
metastasizing melanoma represents a promising target for palliative treatment with new
vitamin D analogs that exert little calcemic side effects and for pharmacological modulation of
calcitriol synthesis/metabolism.
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Skin Cancer Prevention, UV-Exposition, and Vitamin D: How Much Sunlight do we Need?
K Querings, W Tilgen, J Reichrath
Hautklinik und Poliklinik, Universita¨tsklinikum des Saarlandes, Homburg, Germany
UV-exposition is the the main reason for the development of skin cancer. In consequence,
strict sun protection recommendations represent a fundamental part of skin cancer
prevention programs. However, 90% of all requisite Vitamin D is formed within the skin
through the action of the sun – a real dilemma, for a connection between Vitamin D deficiency
and various types of cancer (e.g. colon-, prostate- and breast cancer) has been confirmed in
a whole number of studies. These cancer protective effects of vitamin D most likely depend
on extrarenal, local production of 1a,25(OH)2D3, that has been shown in various tissues.
Increasing evidence indicates that the lack of sunlight exposure even leads to more than
thinning bones and an increased risk for cancer–there are added benefits of vitamin D that
include control of blood pressure and cholesterol serum levels. We have now analysed serum
25-hydroxyvitamin D levels in patients under photoprotection, including patients with
xeroderma pigmentosum (XP), basal cell nevus syndrome (BCNS), and transplant recipients
under immunosuppressive therapy. Serum 25-hydroxyvitamin D levels were decreased in
these patients under photoprotection. We conclude that vitamin D serum levels have to be
monitored carefully in patients under photoprotection, and that vitamin D deficiency should
be treated, e.g. via oral substitution. We discuss our present knowledge about the relevance
of vitamin D deficiency for the increased occurrence of certain malignancies and discuss
possible consequences for sun protection recommendations that represent a fundamental
part of skin cancer prevention programs.
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Modulation of Phosphorylated Histon H2AX (cH2AX) Foci by UV- and X-Irradiation in
hMSH2/ and Wild Type Cells
J Reichrath1, S Scherer3, N Rieff2, M Lo¨brich2, W Tilgen1, M Seifert1
1Dept. of Dermatology and 2Institute of Biophysics, The Saarland University Hospital, 66421
Homburg/Saar, Germany. 3Department of Cell Biology, Albert-Einstein-College of Medicine,
New York
Skin tumors are frequently a result of UV-induced DNA damage. The hMSH2 gene plays a
central role in DNA mismatch repair. Its promoter has been shown to be upregulated in
various cell types in response to UV irradiation due to specific binding of a p53/cJun
heterodimer, that we have shown previously. Significance of mismatch repair pathways for
the repair of UV-light induced DNA damage was confirmed by demonstrating specific binding
of human hMSH2/hMSH6 complexes to DNA incorporating thymine or uracil containing UV-
light photoproducts. Furthermore, human cells with mutations in particular mismatch repair
genes were likewise found to have a deficiency in transcription coupled repair of UV-induced
pyrimidine dimers. Of all the forms of DNA damage, double strand breaks (DSBs) are
potentially the most problematic, since they may lead to broken or rearranged chromosomes,
cell death or cancer. Increase in phosphorylated histon H2AX (gH2AX) foci have been shown
to signal the presence of DNA damage, in particular double strand breaks. hMSH2 deficient
tumor cell lines lost most of their ability to accurately repair plasmid DNA double-strand
breaks by homologous recombination. UV-light does not directly produce DNA double-strand
breaks but rather produces pyrimidin dimers and other photoproducts, that must be removed
or bypassed to prevent arrest of the replication fork. UV induced replication arrest in the
Xeroderma pigmentosum variant (XPV) but not in normal cells leads to an accumulation of
phosphorylated histon H2AX (gH2AX). We have now analyzed effects of UV- and X-irradiation
on expression of phosphorylated gH2AX in hMSH2-defective (hMSH2/) and hMSH2 wild
type cells using a specific mAB directed against gH2AX (Trevigen) and immunocytochemical
and flow cytometry. We found that X-irradiation induces nuclear foci of gH2AX-immunor-
eactivity while UV-irradiation results in homogeneous nuclear staining. Our results indicate
that hMSH2 status modulates the level of gH2AX in response to irradiation, most pronounced
to X-irradiation. While gH2AX immunoreactivity in response to X-irradiation has been shown
to correlate with DNA double-strand breaks, our results indicate that gH2AX immunoreactivity
in response to UV-treatment correlates with induction of apoptosis.
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E2f1 is a Pivotal Regulator of UVB Induced Apoptosis and Restores Cancer Resistance to
Trp53-Deﬁcient Mice
N M Wikonkal1, E Remenyik2, D Knezevic3, W Zhang3, M Liu3, D G Johnson4, and
D E Brash3
1Semmelweis University School of Medicine, Budapest, Hungary, 2University Medical
School of Debrecen, Debrecen, Hungary, 3Yale School of Medicine, New Haven, 4M.D.
Anderson Cancer Center, Smithville, TX
The Rb-E2f checkpoint is critical for allowing cells to enter S phase; this decision if closely
regulated by transcriptional activation of several genes. E2f1 also has a unique pro-apoptotic
activity, independent of its control over S-phase entry. Since E2f1 is DNA damage-inducible,
we inquired whether its pro-apoptotic function is an element of the known Trp53-dependent
pathway for UV-induced apoptosis, important in preventing UV-induced mutations in the
epidermis. Contrary to expectation, we find that E2f1/ mice show enhanced keratinocyte
apoptosis after UV. Similarly, epidermis-specific overexpression of E2F1 suppresses UV-
induced apoptosis. E2f1/; Trp53/ mice exhibit elevated apoptosis similar to that of
seen in E2f1/ alone, a great contrast to the profound apoptosis defect seen in Trp53/
animals. Double-knockout mice also exhibit a striking annulment of two major developmental
aberrations of Trp53/ mice: the abnormal sex ratio and early-onset tumors. A similar effect
of E2f1 is in primary keratinocytes and fibroblasts, but not thymocytes and not after ionizing
radiation. These findings demonstrate that E2f1 functions as a suppressor of an apoptosis
pathway initiatable by UV and possibly genetic abnormalities. Trp53 opposes this
suppression and is dispensable when E2f1 is absent.
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Silencing of Membrane-Type 1 Metalloprotease (MT1-MMP) by Speciﬁc siRNAs
Suppresses the Angiogenic Phenotype of Dermal Endothelial Cells and Inhibits Type I
Collagen Invasion by Melanoma Cells
H El Mourabit, A Fahem, W Hornebeck, P Bernard, G Bellon
UMR 6198 CNRS, IFR53 Biomolecules, Faculty of Medicine, Reims, France
Focalized proteolysis by matrix metalloproteinase (MMP) can plays a crucial role in the cell
invasive program. The importance of one member of the membrane-anchored MMP
subfamily, i.e. MT1-MMP (MMP-14) in angiogenesis and melanoma invasion was recently
delineated. Indeed, MT1-MMP is involved in pericellular collagenolysis, pro-gelatinase A
(MMP-2) and avb3 integrin activation and CD44 or LRP shedding events and therefore might
be considered as one main target in skin cancer. We thus developed the siRNA approach to
invalidate MT1-MMP expression in dermal endothelial cells and invasive melanoma cells
(M3Da). Among siRNAs tested, only siRNAs (25–50 mM) targeted regions 107–207 and 228–
248 of MT1-MMP mRNA synthesized by in vitro transcription proved to inhibit by 480 per
cent MT1-MMP expression at the mRNA and protein levels in both cell types. It also impaired
PMA-mediated pro-Gelatinase A (MMP2) activation in endothelial cells. Elastin fragments
were recently reported to stimulate the rate of pseudotubes formation by endothelial cells in
the Matrigels assay and to increase the invasion of type I collagen by melanoma cells in a
Transwells model, both through MT1-MMP up regulation. Preliminary data indicated that
MT1-MMP mRNA107-207 transfection of endothelial cells and M3Da cells abolished the
elastin-induced angiogenic phenotype and collagen invasive capacity, respectively.
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Transfection with siRNA Suppresses Expression of DNA-Mismatch Repair Enzyme
hMSH2 in Melanoma Cell Lines Thereby Modulating Repair of UV-Induced DNA-Damage
as well as UV- and Chemotherapy-Induced Apoptosis and Cell Death
M Seiferta, S Schererb, W Edelmannb, V Meinekec, W Tilgena, J Reichratha
aDepartment of Dermatology, The Saarland University Hospital, Homburg, Germany;
bDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA;
and cInstitute of Radiobiology, Federal Armed Forces Medical Academy, Munich; Germany.
Human MSH2 is a well characterized component of the DNA repair system. The MSH2 gene
is part of the post-replicative mismatch repair system that prevents the accumulation of
spontaneous mutations and, thereby, ensures the integrity and stability of the genome. It is
the most frequently impaired gene in hereditary nonpolyposis colorectal cancer (HNPCC).
Ultraviolet (UV) radiation plays a pivotal role in skin damage and photocarcinogenesis. The
mechanism how hMSH2 is involved in the complex response mechanisms to UV damage is
not completely clear. We have now analyzed the importance of hMSH2 for UV- and
chemotherapy-induced apoptosis and cell death. Using quantitative ‘‘real time’’ PCR, we
detected strong hMSH2 mRNA expression in melanoma (MM) cell lines. In contrast to a
cutaneous squamous carcinoma cell line (SCL-1) that showed considerable activation of the
promoter and increase of hMSH2 mRNA in cells after UVB treatment, MM cell lines revealed
only weak differences in hMSH2 mRNA and protein amount in response to UV-B. Transfection
of hMSH2 siRNA into human melanoma cells resulted in a dose-dependent inhibition of
hMSH2 expression (up to 80%). When pCMV-b-Gal-plasmid DNA was irradiated with 1 kJ/m2
UV-B and transfected to melanoma cells, b-Gal activity was reduced in hMSH2 siRNA treated
cells as compared to untreated cells. When UV-B-irradiated pCMV-b-Gal-plasmid DNA was
transfected in MEF hMSH2 wt vs. / cells, -Gal activity was 20% reduced in / cells as
compared to wt cells after 24 h. Transfection of hMSH2 siRNA into human melanoma cell
lines resulted in an increase of UV-B-induced apoptosis and in increased chemosensitivity.
Our results suggest that hMSH2 may be of importance for pathogenesis of MM and that
hMSH2-targeted siRNAs are effective inhibitors of hMSH2 expression and may have
therapeutic potential in the treatment of metastasizing MM by themselves or as
chemosensitizers in combination with other compounds.
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RhoC as a Determinant of Metastases in Human: Potential Downstream Targets
Y Xu, D Norris, M Fujita, D Marr, and Y Shellman
Department of Dermatology, University of Colorado Health Science Center, Denver, CO.
80262, USA
Over-expression of RhoC in various human cancers has been correlated with the metastatic
stage of tumor progression and has also been identified as one of the genes that enhance
metastasis in both human and mouse melanoma lines (Clark et al, 2000, Nature). The
purpose of this work was to understand how RhoC over-expression contributes to human
melanoma metastasis.
We have established stable transfectants over-expressing RhoC, using human melanoma
cell lines representing distinct stages in melanoma progression: WM35, WM278 and
WM1617, representing radial growth phase, vertical growth phase and metastatic phase in
melanoma progression respectively. To identify potential downstream targets of over-
expression of RhoC in WM35 cells in a global way, we performed Affymetrix microarray
assays using human U133A chip. We identified 73 potential genes as downstream targets of
RhoC over-expression. Some of these genes are tumor progression markers, and some of
them have functions in migration, detachment, and invasion of cells. We have used functional
invasion and attachment assays to verify the importance of these genes.
Unexpectedly, we also found that some of the genes are involved in immune surveillance.
Our preliminary FACS analysis confirmed that over-expression of RhoC down-regulated these
genes involved in immune surveillance. These data suggest that RhoC over-expression might
promote melanoma metastasis in part by enhancing tumor immune escape. These studies
identified a potential novel way for over-expressing RhoC to promote melanoma metastasis.
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BRAF Kinase Gene V599E Mutation in Growing Melanocytic Lesions
R Loewe1, H Kittler1, G Fischer2, I Fae´2, K Wolff1,3 and P Petzelbauer1,3
1Department of Dermatology, Division of General Dermatology, and 2Department for Blood
Group Serology and Transfusion Medicine, Medical University of Vienna, Austria and
3Ludwig Boltzmann Institute for Angiogenesis, Microcirculation and Inflammation, Vienna,
Austria
Mutations in the BRAF-gene are found in benign and malignant melanocytic lesions, 490%
being a V599E mutation. This mutation results in constitutively active kinase function and
increased colony formation in vitro. The biological impact of this mutation in vivo is still
debated. To address this question, we used our digital epiluminescence image archive and
retrospectively selected 49 melanocytic lesions, which did not meet the criteria of melanoma
at the initial presentation. Mean 12 months later these lesions were excised because of
increased size or changed structure and BRAFV599E mutations were analyzed. Among 36
growing lesions, BRAFV599E mutations were found in 16 (11 melanomas and 5 nevi). Among
13 lesions with structural changes, BRAFV599E mutations were found in 4 (3 melanomas and 1
nevus). 35 randomly selected additional lesions with no changes during follow-up served as
controls, all nevi by histology, and 2 of them showed a BRAFV599E mutation. Statistics
revealed odds for the presence of the BRAFV599E mutation being 7 times higher in lesions with
structural changes and 13 times higher in growing lesions as compared with lesions without
changes. This raises the question if the V599E mutation determines lesions at risk developing
into melanoma and if not, what is the mechanisms controlling growth stop in benign lesions.
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Nerve Growth Factor Receptors Modulates Apoptosis in Melanoma Cell Lines
F Truzzi, A Marconi, P Atzei, M Pignatti, L French and C Pincelli
Department of Dermatology, Geneva University Hospital, Geneva, Switzerland and Institute
of Dermatology, Department of Medicine, University of Modena and Reggio Emilia, Modena,
Italy
Melanocytes are neural crest-derived cells and respond to nerve growth factor (NGF)
stimulation by increased dendricity. It has been shown that neurotrophins (NT) are potent
inducer of melanoma brain metastases, in that they exert chemotactic activity for human
melanoma cells. However, little is known on the signaling mechanism underlying this activity,
and in particular the role of both the low-affinity (p75NTR) and the high-affinity (trk) NT
receptors remains to be clarified. As the balance between p75NTR and trk determines
survival or death in neuronal and non-neuronal cells, we wanted to evaluate the expression
and function of NT receptors in malignant melanoma. To this purpose, several melanoma cell
lines from both primary and metastatic melanomas were cultured with or without the addition
of the chemotherapeutic agent carmustine. We first demonstrated that A375, Mewo, Me 272,
WM115, WM266-4 and SK-MEL-4 cell lines express p75 and the high-affinity NGF receptor
trkA mRNA and protein, though at different levels, by PCR and western blotting. By contrast,
melanoma cell lines do not express mRNA of trkB and trkC, the high-affinity receptor of brain-
derived neurotrophic factor (BDNF) and NT-3, respectively. We also confirmed by flow
cytometry that melanoma cell lines express different levels of p75, and in particular 21% in
A375, 48% in Mewo, 0.7% in 272, 64% in WM115, 75% in WM266-4 and 12% in SK-mel4.
WM115, WM266-4 and SK-mel4 cell lines underwent apoptosis upon treatment with
carmustine (50 mg/ml) at 48 hrs (po0.01). The degree of cell death (WM115¼ 55%; WM266-
4¼ 69%; SK-mel4¼ 47%) well correlated with the level of the death receptor p75NTR. In
addition, carmustine up-regulated the expression of p75 by western blotting in many cell
lines, including WM115 and WM266-4, but not in SK-mel-4. On the other hand, carmustine
reduced trkA levels in SK-mel-4 as well as in other melanoma cell lines. These results seem to
suggest that the balance between p75NTR and trkA influences the apoptotic signal induced
by the chemotherapeutic agent carmustine in melanoma.
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UVB Fingerprint Mutations at the INK4a-ARF Locus in Merkel Cell Carcinoma
P Wolf, E Heitzer, A Lassacher, H Kreimer-Erlacher, B Ba¨ck, L Cerroni, H Kerl
Unit of Photodermatology, Department of Dermatology, Medical University Graz, Graz,
Austria
Merkel cell carcinoma is rare tumor of putative neuroendocrine origin, primarily affecting
elderly persons at sun-exposed sites. The mortality rate of this tumor is substantial and the 5-
year survival rate is about 50 to 70 percent. Similar to non melanoma skin cancers, especially
squamous cell carcinoma, exposure to ultraviolet (UV) radiation seems to be a risk factor for
Merkel cell carcinoma. However, the exact molecular mechanisms by which UV radiation may
lead to the formation of Merkel cell carcinoma remain to be determined. For instance, unlike
in squamous cell carcinoma typical UV(B) fingerprint mutations (i.e., C to T transitions at
dipyrimidine sites) at the tumor suppressor gene p53 are not frequent in Merkel cell
carcinoma. Thus, other genes than p53 may be the primary targets for Merkel cell
carcinogenesis. One candidate gene is INK4a-ARF. This locus on the human chromosome
9p21 encodes the alternative reading frame proteins p16INK4a (exons 1-alpha, 2, and 3) and
p14ARF (exons 1-beta, 2, and 3), both of which are involved in the negative control of cell
proliferation by a tumor suppressor function. In this study, we analyzed Merkel cell
carcinomas from 15 patients (13 females and 2 males; mean age, 79 years; age range, 77
to 88 years). Direct sequence analysis of the INK4a-ARF locus revealed a total of 9 missense
mutations in 7 of 15 (47%) tumors. Six of 9 (67%) mutations were C to T transitions at
dipyrimidine sites (i.e., UV fingerprint mutations). Six of 9 (67%) mutations affected exon 1-
alpha and 3 (33%) mutations exon 2. All 9 mutations affected the amino acid sequence of
p16INK4a and one affected both p16INK4a and p14ARF. Taken together, our results suggest
that UV(B) causes mutations at the INK4a-ARF locus, mainly affecting the p16INK4a protein.
These mutations may play a causative role in the tumorigenesis of a substantial portion of
Merkel cell carcinomas.
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Speciﬁc Immune Responses to HPV5 Antigens in Patients with Epidermodysplasia
Verruciformis (EV) Associated with Mutations in EVER2 Gene
S. Majewski, S. Jablonska, M. Malejczyk, M. Favre, and G. Orth
Department of Dermatology and Venereology, Warsaw School of Medicine, Warsaw, Poland,
Unite des Papillomavirus, Institut Pasteur, Paris, France
Recently, nonsense mutations in two novel genes (EVER1 and EVER2) have been identified
in patients with EV, i.e. cutaneous disease characterized by an abnormal susceptibility to
human papillomaviruses (HPVs). These genes belong to a transmembrane channel-like (TMC)
gene family, and transmembrane EVER proteins seem to be tightly coupled to the same
pathway in the endoplasmic reticulum suggestive of their involvement in the immune control
of HPV infection. Therefore the aim of the study was to find out cell-mediated immunity and
cytokine production in response to HPV5 VLPs (virus-like particles) in patients with EV and
EVER2 mutations (n¼ 5) as compared to healthy controls (n¼ 10). T lymphocytes were
cultured for 14 days in the presence of HPV5a VLPs and IL-2, and studied for their
proliferative responses to the VLPs presented by freshly isolated, X-ray irradiated peripheral
blood mononuclear cells (PBMC). We found that T lymphocytes from EV patients with EVER2
mutations, in contrast to the healthy subjects, did not respond to HPV5a VLPs, as measured
by the proliferative assay and IFNg production. PBMC from EV patients, when stimulated with
HPV5 VLPs produced significantly higher level of IL10 and decreased amount of IFNg, as
compared to controls. To find out whether this defect could be reversed, we studied local and
systemic cell mediated immunity and production of specific antibodies after intradermal
application of highly purified HPV5 VLPs. In one patient local CMI became positive and in this
case the initially lowered IFNg production by PBMC was found increased after VLP
administration. Stimulation of specific immunity with HPV5 VLPs was found also beneficial for
prevention of EV progression in early familial cases, as shown in a granddaughter of an EV
patient with a severe form of the disease. The study showed that in spite of EVER2
mutations, found in all our patients, the specific immune defect could be partially overcome
by HPV5 VLP stimulation.
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Stable Overexpression of Smad7 in Human Melanoma Cells Speciﬁcally Alters their
Invasive Phenotype In Vitro
D Javelaud, M Mo¨ller, S Menashi, and A Mauviel
INSERM U532, Saint-Louis Hopital, Paris, France
Previous identification of constitutive Smad signaling cascade activation in human melanoma
cells despite resistance to TGF-beta control of cell proliferation lead us to investigate the
effect of inhibitory Smad7 overexpression on melanoma cell behavior. Stable expression of
Smad7 resulted in reduced Smad3/4 binding to DNA when cells were treated with TGF-beta,
accompanied with drastically reduced Smad3/4-driven gene transactivation, as measured
using transfected Smad3/4-specific reporter gene constructs. Smad7 overexpression,
however, did not alter the proliferative capacity and resistance to TGF-beta-driven growth
inhibition, nor the resistance to drug-induced apoptosis, of several human melanoma cell
lines. On the other hand, dramatic reduction in their capacity to invade Matrigel or to cross a
collagen gel placed onto a porous membrane in a Boyden migration chamber was observed.
Gelatin zymography identified reduced MMP2 and MMP9 production by Smad7-transfected
melanoma cells as compared to mock-transfected cells. Work is in progress to determine
whether Smad7 overexpression alters melanoma cell capacity to (a), form tumors in nude
mice when injected subcutaneously, and (b), to metastasize to the lungs.
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Association of Novel and Stable Translocations with Oncogene Expression in Malignant
Melanoma
I Okamoto, C Pirker, W Berger, C Marosi, O Haas, K Wolff, H Pehamberger
Vienna, Austria
Cytogenetics has not only precipitated the discovery of several oncogenes, but also led to the
molecular classification of numerous malignancies. The correct identification of aberrations in
many tumors has, however, been hindered by extensive tumor complexity and the limitations
of molecular cytogenetic techniques. In this study we have investigated 5 malignant
melanoma cell lines from at least three different passages using high resolution R-banding
and the recently developed methods of CGH, and M-FISH. We subsequently detected nine
consistent translocations, seven of which were novel: dic(1;11)(p10;q14), der(9)t(3;9)
(p12;p11), der(4)t(9;4;7)(q33::p15-q23::q21), der(14)t(5;14)(q12;q32), der(9)t(9;22)(p21;q11),
der(19)t(19;20)(p13.3;p11), der(10)t(2;12;7;10)(q31::p12 ! pter::q11.2 ! q31::q21), der(19)
t(10;19) (q23;q13) and der(20)t(Y;20)(q11.23;q13.3). Furthermore, using the human HG-U133A
GeneChip, positive expression levels of oncogenes or tumor related genes located at the
regions of chromosomal breakpoints were identified including AKT1, BMI1, CDK6, CTNNB1,
E2F1, GPNMB, GPRK7, KBRAS2, LDB2, LIMK1, MAPK1, MEL, MP1, MUC18, NRCAM,
PBX3, RAB22A, RAB38, SNK and STK4 indicating an association between chromosomal
breakpoints and altered gene expression. Since the majority of these breakpoints have been
reported previously in malignant melanoma, our results support the idea of common
mechanisms in this disease.
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Distinct Types of Primary Cutaneous Large B-Cell Lymphoma Identiﬁed by Gene
Expression Proﬁling
M H Vermeer1, J J Hoefnagel1, R Dijkman1, K Basso2, P M Jansen3, C Hallermann4, R
Willemze1, C P Tensen1
1Departments of Dermatology and 3Pathology, Leiden University Medical Center, Leiden,
The Netherlands, 2Institute for Cancer Genetics, Columbia University, New York, USA and
4Department of Dermatology and Allergology, Hannover Medical University, Hannover,
Germany.
In the EORTC classification two types of primary cutaneous large B-cell lymphoma (PCLBCL)
are distinguished: primary cutaneous follicle center cell lymphomas (PCFCCL) and PCLBCL
of the leg (PCLBCL-leg). Distinction between both groups is considered important because of
differences in prognosis (5-year survival 495% and 52%, respectively) and the first choice of
treatment (radiotherapy or systemic chemotherapy, respectively), but is not generally
accepted.
To establish a molecular basis for this subdivision in the EORTC classification we
investigated the gene expression profiles of 21 PCLBCL by oligonucleotide microarray
analysis. Hierarchical clustering based on a B-cell signature (7450 genes) classified PCLBCL
into two distinct subgroups consisting of respectively 8 PCFCCL and 13 PCLBCL-leg.
PCLBCL-leg showed increased expression of genes associated with cell proliferation, the
proto-oncogenes Pim-1, Pim-2 and c-Myc, and the transcription factors Mum1/IRF4 and
Oct-2. In the group of PCFCCL high expression of SPINK2 was observed. Further analysis
suggested that PCFCCL and PCLBCL-leg have expression profiles similar to that of germinal
center B-cell-like and activated B-cell-like diffuse large B-cell lymphoma, respectively. The
results of this study suggest that different pathogenetic mechanisms are involved in the
development of PCFCCL and PCLBCL-leg and provide molecular support for the subdivision
used in the EORTC classification.
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Expression Pattern of Fibroblast Activation Protein (FAP) and Endosialin/TEM-1 (Tumor
Endothelial Marker 1 in Stromal Compartments of Human Skin Cancers
M A Huber1,2, N Kraut3, N Schweifer3, R U Peter1, R D Schubert1, K Scharffetter-
Kochanek1, H Pehamberger2 and P Garin-Chesa4
1Department of Dermatology and Allergology, University of Ulm, Ulm, Germany; 2Depart-
ment of Dermatology, Vienna Medical University, Vienna, Austria; 3Boehringer Ingelheim
Austria GmbH, Department NCE Lead Discovery, Vienna, Austria; 4Department of Clinical
Pathology, Vienna Medical University, Vienna, Austria
Growth and metastasis of solid neoplasms require the recruitment of a supporting tumor
stroma. A highly consistent trait of tumor stromal fibroblasts in most epithelial cancers and, as
recently demonstrated, in melanocytic skin tumors, is the induction of fibroblast activation
protein (FAP), a member of the serine protease family. Endothelial cells represent another
important cell type of the reactive tumor stroma. The cell surface glycoprotein endosialin is
selectively expressed by tumor blood vessel endothelium in a broad range of human cancers.
Endosialin is identical to TEM-1 (Tumor Endothelial Marker 1), which has been linked to tumor
endothelium by serial analysis of gene expression (SAGE) profiling.
The present study was designed to (i) analyze the protein expression pattern of FAP and
endosialin in a series of melanocytic and epithelial skin tumors and (ii) to test the suitability of
in silico derived cancer associated profiles for the identification of tumor stroma relevant
genes, by comparing the protein expression patterns of FAP and endosialin with transcript
profiles derived from in silico analysis.
FAP-positive fibroblasts were detected immunohistochemically in variable amounts in the
reactive stromal fibroblasts of all the tissues tested, including cases of melanocytic nevi
(n¼ 28), metastatic melanoma (n¼ 22), basal cell carcinoma (n¼ 7) and squamous cell
carcinoma (n¼ 2). Two distinct FAP-expressing stroma compartments were identified in
melanoma metastases: a strong peritumoral stroma compartment and a patterned
intratumoral compartment in the immediate vicinity to the tumor cells. FAP induction was
also seen in dermal fibroblasts in morphologically normal skin adjacent to melanoma
metastases. Expression of Endosialin was restricted to subsets of small and medium sized
tumor blood vessels in metastatic melanomas and in the two SQCC tested. In addition,
scattered endosialin-positive stromal fibroblasts were seen in many of the cases including
melanocytic and non-melanocytic tumors. Analyzing gene expression data from proprietary
databases, we found a direct correlation between protein expression and mRNA levels for
FAP in human skin cancers. For endosialin, changes in expression levels could not be
detected by in silico analysis, as the specific signals derived from tumor endothelial cells are
masked due to the heterogeneity of the tissue samples (tumor cellsþ stromaþblood
vessels).
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K5-SOS-F Induce Increased Migration in Mouse Primary Keratinocytes
C Frank and M Sibilia
DIAID, Department of Dermatology, Medical University of Vienna, Brunnerstrasse 59, A-
1235 Vienna, Austria
K5-SOS-F transgenic mice develop skin tumors dependent on the presence of a functional
epidermal growth factor receptor (EGFR), which provides an essential survival signal in these
tumors. We have characterized primary keratinocytes from K5-SOS-F transgenic mice for
their adhesive properties and the expression of downstream signaling molecules. We found
that the protein levels of the non-receptor protein tyrosine kinase Src and of the adhesion
molecule b1-integrin are increased in primary keratinocytes expressing K5-SOS-F. Since Src
is a downstream signaling protein of many membrane receptors including EGFR and
integrins, it could play an important role in the crosstalk between both these receptors. First
experiments show that the adhesion of keratinocytes to collagen might be EGFR-dependent
since in an EGFR hypomorphic (wa2) background the adhesion to collagens is reduced but
can be rescued by expression of the K5-SOS-F transgene. An increased polarization of actin
filaments and a decrease in the number of focal adhesions is also observed in K5-SOS-F
transgenic keratinocytes. Consistent with these observations, we also found an increased
migration of K5-SOS-F transgenic keratinocytes which is abolished by inhibition of EGFR,
MAP kinase and Src with specific inhibitors. Moreover, the increased migration of these
keratinocytes is growth factor-dependent since under serum free conditions migration is
inhibited and can only partially be rescued by the addition of EGF. Therefore, it seems that
EGFR-dependent tumor formation in K5-SOS-F transgenic mice is not only caused by
increased survival but also by increased migration of transgenic keratinocytes. We are
currently investigating how the increased protein levels of Src and b1-integrin are affecting
adhesion and migration of K5-SOS-F transgenic keratinocytes and the results of these
experiments will be presented.
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Expression and Phosphorylation of Src-Type Tyrosine Kinases in Cutaneous T Cell
Lymphoma (CTCL)
U Do¨bbeling, J Kamarashev, R, Dummer and G Burg
Department of Dermatology, University Hospital Zurich, Switzerland
Mycosis fungoides (MF) and its leukemic variant Se´zary syndrome (SS) are the most frequent
types of cutaneous T cell lymphomas (CTCL). We recently found that CTCL cells contain
constitutive NFkB activities, which could be down-regulated by agents that inhibit src-type
tyrosine kinases. The src gene family contains members that mediate T-cell receptor signals
and known oncogenes.
We therefore investigated MF and SS cell lines and skin lesions for src-type tyrosine kinase
expression by Western blotting and Immunohistochemistry respectively. Western blot
experiments with antibodies specific for c-src, c-fgr, c-yes, lck, and fyn showed that c-src,
c-yes, and fyn were expressed in all four tested cell lines. The T-cell receptor associated src-
type kinase lck was expressed only in one cell line, indicating that this protein was not
involved in NFkB activation in MF and SS cell lines. The c-fgr gene was expressed in no cell
line. When we tested MF and SS skin lesions for the expression of the c-src and c-yes
oncogenes, we found that c-src was already expressed in early (patch/plaque) stages,
whereas c-yes was only expressed in late (tumor) stages. Since c-Src has to be activated by
phosphorylation, we also tested CTCL skin lesions for phosphorylated c-Src and found that
activated c-Src is present only in the tumor stage.
Our results show that the c-src and c-yes tyrosine kinases, which are not expressed in
normal T cells, are present in MF and SS cells. Since src-type tyrosine kinase inhibitors like
herbimycin A and PP2 inhibit the constitutive NFkB activities, we suppose that c-src and c-
yes are involved in constitutive activation of NFkB in MF and SS cells, which in turn may lead
to the expression of further genes that promote the cancerogenesis of CTCL.
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DNp63 Transcription is Regulated by p53 and p73 upon DNA Damage in Keratinocytes
M Papoutsaki, M Lanza, B Marinari, S Chimenti and A Costanzo
Department of Dermatology, University of Rome ‘‘Tor Vergata’’
The p63 gene belongs to the p53 gene family of tumor suppressor genes and encodes for
sequence specific transcription factors that act either as activators or as repressors of
transcription. The expression of a specific isoform of the p63 gene, namely the DNp63a
isoform, is thought to identify the cells belonging to the staminal compartment of the
epidermis and cutaneous adnexa and was found to be upregulated in squamous cell
carcinomas. Indeed DNp63a may act as a master controller of staminal keratinocytes
proliferation by regulating the transcription of specific genes involved in cell cycle arrest and
differentiation such as the cdk inhibitor p21 and the 14-3-3sigma genes. DNp63a is also
regulated by DNA damage: UV irradiation induces its phosphorylation and causes the
detachment from cell cycle related and apoptosis related p53 dependent promoters. We have
investigated the effects of other kind of DNA damaging agents in the regulation of DNp63 in
keratinocytes and found that DNp63 transcription is tightly regulated by other members of the
p53 family being repressed by the activatory TA isoforms and activated by DN isoforms.
DNp63 expression is also regulated by the mutational status and by the polymorphism at
position 72 of the tumour suppressor gene p53. The selective interference with specific
components of this activatory/repressory loop leads to significant changes in DNp63
expression and in the biological outcome of DNA damage. Taken together our data suggest
that modulation of DNp63 transcription by the other members of the p53 family may
contribute to cell transformation and to the resistance to chemotherapy in skin cancer.
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Identiﬁcation of Novel Non-Melanoma Skin Cancer Molecular Markers by Micro Array
Technology
I Nindl1, C Dang1, T Schmook1, R J Kuban2, T Meyer3, W Sterry1, E Stockfleth1
1Department of Dermatology, Charite´, University Hospital, Berlin, Germany 2Institute of
Biochemistry, Charite´, University Hospital, Berlin, Germany 3IPM-HH, Hamburg, Germany
Objective. Carcinogenesis is a multi-step process indicated by several genes up- or down-
regulated during tumor progression. The type and number of genes involved in human non-
melanoma skin cancer (NMSC) are still unclear. This study examined and identified different
expressed genes and pathways involved in this process.
Patients and Methods. Fifteen snap-frozen biopsies of 5 immunosuppressed organ-
transplanted recipients each normal skin, actinic keratosis (AK) and invasive squamous cell
carcinoma (SCC) were collected and analysed. All 5 extracted RNA specimens of normal skin
and 2 of AK were pooled. In addition, we have included 5 normal skin specimens from age-
matched non-immunosuppressed patients. Thus, we have examined 6 normal skin, 4 skin
pre-cancer (AK), and 5 skin cancer (SCC) and all biopsies were confirmed by histology. Total
RNA was used for hybridization with Affymetrix HG-U133A gene expression DNA-microarrays
containing 22,283 known genes. Confocal scanner evaluated the signals twice and data
analysis was performed by bioinformatics. The cut-off was more than 2.0-fold changes in
gene expression confirmed by t test. Quantitative verification of 13 up- or down-regulated
genes was performed by real-time RT-PCR and genes were confirmed by sequencing.
Results. Broad coherent patterns in normal skin vs AK and/or SCC were observed for 119
genes. Some of the genes (e.g. annexin, metalloproteinases, and lamin) up-regulated in
carcinomas in our study have previously reported as over-expressed in NMSC. In total 44
genes were up-regulated and 75 genes were down-regulated in non-melanoma skin cancer,
including proliferation and cell cycle antigens, transcription factors, growth factors, and
genes regulating the immune system. Eighty-five percent (11 of 13) of verified genes by real-
time RT-PCR showed significant different expression (po0.05) in normal skin tissue vs skin
(pre)cancer.
Conclusions. The majority of genes identified have not been previously reported different
expressed during non-melanoma skin carcinogenesis. Microarray analysis of human skin
biopsies without microdissection allows the identification of differentially expressed genes
that may prove useful as early detection or progression markers.
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Fluorescence In Situ Hybridisation (FISH) Analysis of Chromosome 7 and 8 Aberrations
in Cutaneous T-Cell Lymphomas
T C Fischer1, A Carbone2, A Do¨hler1, S Gellrich1, and W Sterry1
1Dept of Dermatology and Allergy, Charite´ School of Medicine, Berlin, Germany, and 2Dept
of Dermatology Universita` Cattolica`, Rome, Italy
In cutaneous T-cell lymphomas (CTLC), a characteristic pattern of chromosomal aberrations
(6q-7-8q-13q) was described. In the present study, chromosomes 7 and 8 were screened for
numerical and structural aberrations in 19 patients with CTLC using fluorescence in situ
hybridisation (FISH). Centromeric probes were used for chromosome 7 and 8. For the
analysis of candidate tumor genes probes for the regions 7q34-35 (encoding the T-cell
receptor beta region) and 8q24 (encoding the myc-oncogen) were chosen. Minimum and
maximum signals of 2–4% of labeled nuclei were regarded as a cut of levels for the probes,
respectively. For chromosome 7 centromeric probes, aberrations were observed in 8 of 19
patients, for chromosome 8 in 9 out of 19 patients. The patients identified by CGH were
confirmed by FISH and, moreover, additional patients were identified. 6 out of 10 patients
revealed aberrations of the region 7q34-35, and 4 out 10 patients for 8q24. Sequential
analysis of tumor samples obtained from patients during the course of the disease revealed a
consistent occurence of the aberrations. The results of this study demonstrate that FISH
analysis of tumor samples of CTLC is a reliable and reproducable technique. The prognostic
relevance of frequent aberrations remains to be determined.
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Thalidomide Combined with Dacarbazine Enhances the Anti-Tumor Activity in a Human
Melanoma Xenotransplantation Model
E Heere-Ress, J Boehm, C Hoeller, V Wacheck, C Thallinger, K Wolff, B Jansen,
H Pehamberger
Department of Dermatology, University of Vienna, Austria and Prostate Centre, University of
British Columbia, Canada
Malignant melanoma is a well known example of a tumor responding poorly to conventional
adjuvant treatment modalities including chemotherapy. Anti-angiogenic therapy represents a
promising treatment modality for various human cancer. For thalidomide it has been
demonstrated that its anti-angiogenic properties result in clear anti-tumor activity in multiple
human malignancies. Furthermore, combinations of anti-angiogenic drugs and chemother-
apeutics are an increased applied treatment strategy for multiple malignancies. In human
melanoma, little is known about the therapeutic potential and mechanism of thalidomide.
Recently, a Phase II showed promising results combining thalidomide and temozolomide for
the treatment of patients with human melanoma.
To determine the anti-tumor activity and the mechanism of action we studied thalidomide in
a human melanoma SCID mouse xenotransplantation model. Single agent activity of
thalidomide as well as combination with dacarbazine (DTIC), still the single most effective
agent used in melanoma therapy, were tested.
Thalidomide combined with dacarbazine treatment markedly enhanced the anti-tumor
effect and showed a significant tumor reduction relative to the dacarbazine-only group (61%)
and even more tumor reduction (74%) compared to the solvent group. A significantly lower
microvessel density was encountered in the thalidomide treatment groups (thalidomide alone
or combined with DTIC) underscoring the anti-angiogenic effect of thalidomide in this model.
In line with these results, we observed a nearby three fold increase of apoptosis for the
combination of thalidomide and DTIC. These data underline the rationale for combining
dacarbazine – a cytotoxic agent – and thalidomide – an anti-angiogenic cytostatic agent as a
promising option for treatment of malignant melanoma.
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5-Fluoruracil Treatment Alters Ferredoxin-reductase-mRNA Splice Variant Ratios in
Colorectal Cancer Patients: Impact on Therapeutical Response
M Schneider1, M Tanaka2, S Kato2, B Blo¨meke3
1Department of Dermatology, University Hospital RWTH Aachen, Germany, 2Department of
Surgery, Nippon Medical School Tokyo, Japan, 3Dept. of Ecotoxicology/Toxicology, Science
Park, University Trier, Germany
Success rates of 5-Fluoruracil (5-FU) based chemotherapy remain still low. Recently, it has
been reported that both mRNA and protein levels of ferredoxin reductase (FDXR) increased
drastically after 5–FU treatment in colorectal cancer cell lines (HCT 116). Therefore, we
hypothesized that induction of the ferredoxin reductase mRNA levels may be a good marker
for successful 5-FU chemotherapy. Fourty patients with advanced colorectal carcinoma were
treated with 50DFUR – a prodrug of 5-FU – for 14 days. Biopsies of tumor and surrounding
normal tissues were collected before treatment, and surgical specimens of tumor and normal
tissues were taken at the time of tumor removal. FDXR-mRNA levels of the two alternative
splice variants characterized by the presence (þ18-form) or absence of 18 base pairs (–18-
form) were estimated by real-time PCR. These two forms are usually found at a ratio of 100 to
1, irrespective of the tissue studied. The therapeutical success was evaluated by histological
investigations of the tissues before and after treatment (n¼ 40). Prior to treatment, total FDXR
mRNA levels and the –18–form were about 2-fold higher in normal tissues compared to the
tumor for (n¼ 38), while the þ 18-form was slightly increased in tumors (1.9). The previously
reported 100:1 ratio for the splice variants or even higher ratios were found in 44.4% of
normal tissues, and 94.7% of the tumors studied. 5-FU-prodrug treatment for 14 days did not
change levels of the 18-form significantly. In the 40 cases studied by us, we did not detect
the above mentioned large increase of FDXR-mRNA levels from in vitro studies (Hwang, Bunz
et al, 2001). Unexpectedly, ratios of þ 18-and –18-form were shifted by 5-FU treatment
towards the þ18-form both in tumors (18-fold increase), and in normal tissues (31-fold). In a
subgroup (n¼ 5), the levels of the þ 18-form were similar to 18-form (ratio 18/þ 18
between 0.1 and 2). The latter was clearly associated with resistance to 5-FU treatment.
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Elastin-Derived Peptides Upregulate IL-1b Expression in Melanoma Cells
R Debret#y, R Le Naoury, W Hornebeck#, P Bernard# and F Antonicelli#
#CNRS UMR 6198, yCNRS EA 2070, IFR 53 Biomolecules, University of Reims,
Champagne-Ardenne, France
In a previous work, we reported an up-regulation of matrix metalloproteinases -1 and -2
(MMP-1 and -2) expression and activation in melanoma cells in vitro and showed the
contribution of elastin-derived peptides (EDPs) in these effects. We hypothesized that EDPs,
following interactions with elastin receptor, could modulate expression of other mediators
involved in cancer progression. Thus, in this study, we investigated the contribution of EDPs
in cytokines expression.
Our results first evidenced that EDPs treatment of melanoma cells presenting a high
tumorigenic potential (M3Da cells) led to a strong and rapid enhancement in IL-1b mRNA
expression whereas GRO-1 mRNA was barely affected. The effects of EDPs on those
melanoma cells were found to be mediated, at least in part, by receptor occupancy, as being
suppressed by lactose and reproduced by cell stimulation with the VGVAPG peptide. The role
of transduction pathways in mediating this effect was assessed with the specific chemical
inhibitors U0126, SB203580, LY294002 of the Erk1/2, p38 and PI3K pathways respectively,
using western-blot analysis. Binding of EDPs to their receptor induced a prolonged activation
of Erk and a transient activation of p38 but not PI3K pathways. Concomitantly, we
demonstrated that stimulation by EDPs affected the regulation of AP-1, NF-kB and SP-1
transcription factors. Upon EDPs stimulation, nuclear translocation and DNA binding of AP-1
and NF-kB were enhanced. Interestingly, SP-1 nuclear translocation was reduced.
Comparison of potential responsive elements from the different cytokine promoters
underlined the prominent role of transcription factors in selective cytokine expression. On this
basis, it is possible that EDPs activation of NF-kB is responsible for IL-1b up-regulation on
tumorigenic melanoma cells whereas, a combined-antagonized effect of NF-kB and SP-1,
which is down-regulated, would explain the lack of responsiveness of GRO-1 promoter.
Further examinations are still needed to unravel the molecular mechanisms induced by EDPs
and evaluate the precise role of each transcription factor in the expression of a specific
cytokine.
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Differential Expression of the Lymphatic Marker Podoplanin in Human Squamous Cell
Carcinomas and Basal Cell Carcinomas
V Schacht1, S S Dadras2,3, B Kremer1, L Bruckner-Tuderman1 and M Detmar2
1Department of Dermatology, University of Freiburg, Germany, 2Cutaneous Biology
Research Center and Department of Dermatology, Massachusetts General Hospital and
Harvard Medical School, Charlestown, Massachusetts; 3Department of Pathology, Massa-
chusetts General Hospital and Harvard Medical School, Boston, Massachusetts
The mucin-type glycoprotein podoplanin is specifically expressed by lymphatic, but not
blood vascular endothelial cells, in culture and in tumor-associated lymphangiogenesis. Our
previous studies showed that podoplanin deficiency results in congenital lymphedema and
impaired lymphatic vascular patterning, and that podoplanin enhances migration and
adhesion of endothelial cells by reorganization of the cytoskeleton. However, its expression in
normal tissues and in human malignancies has remained unknown. Using tissue arrays of
normal human tissues and of a number of human cancers, we found that – in addition to
lymphatic endothelium – podoplanin is also expressed by bile duct cells of the liver,
peritoneal mesothelial cells, osteocytes, glandular myoepithelial cells, ependyma cells, and
by stromal reticular cells and follicular dendritic cells of lymphoid organs. In normal human
skin podoplanin is focally expressed by basal keratinocytes, as shown using different
antibodies. Immunohistochemical staining of paraffin embedded tissues revealed strongly
induced podoplanin expression in 62 out of 77 squamous cell carcinomas (SCC). The
expression pattern was dependent on the level of differentiation of the tumors. In contrast, no
podoplanin expression was observed in 20 basal cell carcinomas. Activation of the epidermal
growth factor receptor (EGFR) has been proposed to enhance the metastatic potential of
SCC, and podoplanin expression is known to be increased by EGF in keratinocytes in vitro.
Therefore, based on the present findings of podoplanin expression in SCC – but not in BCC –
we conclude that podoplanin may play an active role in epithelial tumor progression.
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Differential Effects of Class I/II Versus Class III Histone Deacetylases Inhibitors (HDACi)
in Primary Sezary’ Cells
M Papoutsaki1, C Scotta`2, M Lanza1, S Nistico`1, V Marzano2, S Chimenti1 and A Costanzo1
1Department of Dermatology, University of Rome ‘‘Tor Vergata’’, Rome, Italy 2Department of
Cellular and Developmental Biology, University of Rome ‘‘La Sapienza’’, Rome, Italy
Remodeling of chromatin as well as the dynamic changes at the nucleosome level play a key
role in the regulation of gene expression influencing cellular proliferation, differentiation and
apoptosis. One of the most important mechanisms implicated in chromatin remodeling is the
post-trascriptional modification of the histones by acetylation of their N-terminal tails. The
acetylation is mediated by enzymes with acetyl-transferase activity (HAT) while deacetylation
is mediated by histone deacetylase enzymes either of the HDAC family or of the Sir2 family.
The alteration of both histone acetylation and deacetylation mechanisms are often involved in
the pathogenesis of tumors. The histone deacetylase inhibitors represent a new class of
antitumoral drugs capable of modulating the ratio between acetilation/deacetylation
intensifying in that way the activity or a great number of antineoplastic drugs driving,
previously resistant cells, to apoptosis. Valproic acid (VPA), is a drug largely used in the long
term treatment of epilepsy, und demonstrates a strong inhibitory activity towards the
deacetylases of the HDAC class while Nicotinamide and Sirtinol inhibit the Sir2 deacetylases
family. We have studied the anti-neoplastic activity of deacetilase inhibitors in the Sezary’
Sindrome cell line (HUT-78) and in Sezary’ cells isolated from a patient in the early stage of the
disease. The treatment with Valproic acid has induced high levels of apoptosis in both cell
lines studied. Moreover low doses of VPA sensitized, these previously resistant cells, to
apoptosis induced by cisplatin. On the other side the deacetylase inhibitors of the Sir2 family
have induced the cell-cycle arrest without influencing the levels of apoptosis. Our results
suggest that the deacetylase inhibitors of the HDAC class may be useful in order to enhance
the effect of the chemotherapic drugs commonly used in the treatment of cutaneous
lymphomas.
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New Frequent Polymorphism 1765 C-4T in the Gene Coding Transcriptional Repressor
Oncoprotein Gﬁ-1 in Cutaneous T-Cell Lymphomas (CTCL)
JA Vasˇku˚, V Vasˇku˚, L Izakovie`ova´ Holla´, A Vasˇku˚
Masaryk University, Brno, Czech Republic
Introduction: Gfi-1 encodes transcriptional repressor oncoprotein identified in a retroviral
insertion mutagenesis screen for tumor progression in rat T-cell lymphoma lines. The aim of
our study was to test the association of new identified 1765 C-4T polymorphism with CTCL
in the Czech population.
Materials and methods. The heteroduplex analysis followed by capillary as well as
radioisotopic sequencing identified alteration in Gfi-1 non-coding 30 sequence that proved
to be the 1765 C-4T transition. As a following step, we developed a simple restriction
analysis method using AvrII enzyme that enables the rapid detection of this new
polymorphism. The genotype distributions as well as allelic frequencies of the polymorphism
were compared between 61 patients with CTCL and a group of 93 healthy individuals of
similar age and gender distribution.
Results. No significant difference in allelic frequencies of examined polymorphism 1765 C-
4T in patients with CTCL (T¼36.9%) against the controle subjects (T¼ 44.1%; p¼ 0.209)
was proved. We did not found any significant difference in the genotype distributions of the
examined polymorphism between the patients with CTCL and the controls (p¼ 0.227).
However, the odds ratio of the TT genotype in CTCL patients was 0.546 (95% confidential
interval¼0.22-1.14, p¼0.07). Therefore, the TT genotype of 1765 C-4T polymorphism of
Gfi-1 gene may have potentially protective effect against CTCL.
Discussion. Gfi-1 is supposed to be able to act as a dominant oncogene and cooperates in
the process of lymphomagenesis with Myc and Pim-1. It is likely to inhibit apoptosis by
means of its repression of multiple proapoptotic regulators. The allelic variant T od 1765 C-
4T polymorphism is characterized by extinction of the binding site for AP-1 protein in
3’region of Gfi-1 gene. From this point of view, it is interesting that the homozygote genotype
of this allelic variant (TT) seems to be associated with lower OR for CTCL.
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Cutaneous T Cell Lymphoma and Toll-like Receptors
V Jarrousse, G Quereux, S Marques, A Khammari, AC Knol and B Dreno
Nantes, France
Cutaneous T cell Lymphoma (CTCL) is characterized by a proliferation of activated CD4þ T
cells in the skin. The origin of this pathology remains unknown but the implication of viruses is
highly suspected. Toll-like Receptors (TLRs) are innate immune receptors. They constitute the
first line against infections and they trigger the specific immune response. TLR 2, TLR 4 and
TLR 9 are expressed by keratinocytes.
The aim of this work was to look for a new way of T cells activation in CTCL, in particular the
keratinocytes TLRs expression in this pathology. In a first part, the expression of TLR 2
(GRAMþ specific), TLR 4 (LPS and GRAM–specific) and TLR 9 (viral and bacterial DNA
specific) was studied by immunohistochemistry on cutaneous section of CTCL patients
before treatment. This study was performed on paraffin-embedded skin biopsies of normal
skin (five), parapsoriasis (six), mycosis fungoides (ten patients at stage Ib and IIb) and sezary
syndrome (nine). In a second part, the expression of TLRs was studied by immunohis-
tochemistry on cutaneous section of CTCL patients after treatment with Puvatherapy and
Interferon alpha. This study was performed on paraffin-embedded skin biopsies of mycosis
fungoides (seven patients at stage Ib and IIb) and sezary syndrome (eight).Before treatment:
in parapsoriasis skin, TLR 2, 4 and 9 were expressed at levels similar to that observed in
normal skin. By contrast, in MF skin we observed a strong intensity of labelling with the three
TLRs, therefore there was no difference according the stage of MF, paradoxically this intensity
decreased on SS skin.
Our results suggest two hypotheses:
Firstly, we can suppose that TLRs are internalised in keratinocytes in response to
overstimulation in SS skin.
Secondly, a default of TLRs expression may exist in SS skin. This default could contribute
on SS development and therefore explain the infections sensibility (staphylococcus, herpes)
in these patients.
After treatment with puvatherapy and interferon alpha: in MF skin, TLRs 2, 4 and 9 were
expressed at lower levels to that observed before treatment. TLRs expression in MF skin was
inhibited by treatment. In contrast, in SS skin the three TLRs were expressed at similar levels
to that observed before treatment.
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TNFR1- and IFN-c-Signaling Determine whether T Cells Promote or Arrest Multistage
Carcinogenesis
H Braumu¨ller1, B J Pichler2, N Mu¨ller-Hermelink1, M Kneilling1, K Ghoreschi1, R Haubner2,
M Ro¨cken1
1Department of Dermatology, Eberhard Karls University of Tuebingen and 2Department of
Nuclear Medicine, Technical University of Munich, Germany
The reprogramming of somatic cells during tumorigenesis leads to expression of new tumor
associated antigens (TAA) that can elicit specific T cell responses. Even though cytolytic
CD8þ T cells (CTL) are considered to be important in anti-tumor immunity, recent data show
that adaptive immune responses may control tumor growth also through mechanisms
different from CTL-mediated killing or direct tumor cell lysis. In addition, independent studies
unraveled that TAA-specific, IFN-g-producing CD4þ T cells prevent growth and development
of transplanted tumors more efficiently than CTL. As the pro-inflammatory in vivo functions of
Th1 cells strictly depend on the coordinated interaction of two cytokines, IFN-g and TNF, we
investigated the effects of IFN-g- and TNFR1-signaling on multistage carcinogenesis, in RIP1-
Tag2-mice expressing oncogenic T antigen (Tag) in pancreatic islets. We generated Tag-
specific Th1 cells in vitro by stimulating CD4þ cells from Tag-T cell receptor (TCR) transgenic
C3H mice. Starting week 7, the time when islets have transformed into adenomas, we treated
RIP1-Tag2-mice with 107 Tag-Th1 cells weekly. Tag-Th1 cells enriched selectively inside the
Tag-expressing pancreas and tumor-draining lymph node. Through combined TNFR1- and
IFN-g-signaling, Tag-Th1 cells arrested multistage carcinogenesis, induced anti-angiogenic
chemokines and prevented avb3 integrin-expressing tumor vessels. Arresting multistage
carcinogenesis was independent of CD8þ cells or significant destruction of Tag-expressing
islet cells. Surprisingly, in TNFR10/0xRip1-Tag2 mice the same T cells paradoxically
accelerated cancer development and progression. Similarly, inactivating IFN-g with mAb
did not only abolish the therapeutic effect of Tag-Th1 cells. While decline of blood glucose
and death occurred as rapidly as in untreated mice, tumor growth and angiogenesis were at
least two times more pronounced than in untreated mice. Thus, tumor-specific T cells can not
only kill tumor cells, tumor vessels or tumor stroma, the data provided here strongly suggest
that they directly survey multistage carcinogenesis through cytokine-signaling.
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Immunohistochemical Localization of Cathepsin L and Cystatin A in Normal Skin and
Skin Tumors
P Palungwachira, M Kakuta, M Yamazaki, H Yaguchi, R Tsuboi, K Takamori
and H Ogawa
Srinakharinwirot University Skin Center, Srinakharinwirot University, Bangkok, Thailand.
Department of Dermatology, Juntendo University Urayasu Hospital, Urayasu, Chiba
Japan. Department of Dermatology, Juntendo University, School of Medicine, Bunkyo-
ku, Japan
Cathepsin L, a cysteine proteinase, and cystatin A, an inhibitor of cysteine proteinases, are
thought to regulate the invasion and metastasis of malignant cells. In this study, the
expression of cathepsin L and cystatin A in skin tumors was investigated immunohisto-
chemically in order to examine the relationship between these two enzymes in the
pathophysiology of malignant cells. Formalin-fixed and paraffin embedded specimens from
normal skin, seborrheic keratoses, and squamous cell carcinomas were reacted with
polyclonal antibodies against rat cathepsin L or cystatin A which cross-react to human
cathepsin L and cystain A, respectively. The consequent immmunostaining of these enzymes
was observed to be strong in normal skin (4 cases) and seborrheic keratosis (6 cases). In well-
differentiated squamous cell carcinoma (SCC) (9 cases), staining of cathepsin L and cystatin
A was moderately positive in differentiated tumor cells and negative in undifferentiated SCC
(5 cases). The degree of staining of these enzymes was inversely correlated with the
differentiation of the malignant cells. These results suggest that the immunohistochemical
analysis of cathepsin L and cystatin A is a useful indicator for an aspect of malignancy in
human epidermal keratinocytes.
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Connexins 26 and 43 are Differentially Induced in Skin Tumors and the Adjacent
Epidermis
N K Haassy#, E Wladykowski#, S Kief#, I Moll#, J M Brandner#
yThe Wistar Institute, Philadelphia, PA, USA #Department of Dermatology and Venerology,
University Hospital Hamburg-Eppendorf, Hamburg, Germany
Gap Junctions have been shown to play a role in tumor progression including a variety of
keratinocyte-derived and non-keratinocyte-derived skin tumors. We here show that the
synthesis of the gap junction proteins Connexin 26 and 30 (Cx26 and Cx30) is induced in
keratinocyte-derived epithelial skin tumors while there is either no change or a down-
regulation of Cx43. Cx26, Cx30 and Cx43 are absent in non-epithelial skin tumors. Further,
Cx26 and Cx30 are induced in the epidermis adjacent to malignant melanoma but absent in
the epidermis adjacent to benign non-epithelial skin tumors (melanocytic nevi and angioma).
The keratinocyte-derived skin tumors are very heterogeneous concerning the Cx26/Cx30
pattern in the epidermis at the periphery of the tumors. We did not observe any difference in
the localization of the very similar proteins Cx26 and Cx30 but a variation in intensity of
immunoreactivity. As the staining patterns of Cx26 and Cx30 antibodies are not identical with
those of CK6, a marker of hyperproliferation, and CK17, a marker for trauma, we discuss that
the induction of these gap junctional proteins exceeds reflection of reactive hyperproliferative
or traumatized epidermis. We further discuss the putative roles of these gap junctional
proteins in tumor progression.
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The Steroid Receptor Co-Activator-1 (SRC-1) Potentiates TGF-beta/Smad Signaling by
Enhancing Smad3-p300/CBP Interactions
F Verrecchia, V Pendaries, C Tacheau, M Costas, and A Mauviel
INSERM U532, Skin Research Institute, Saint-Louis Hospital, Paris, France, and Laboratorio
de Fisiologia y Biologia Molecular, Universidad de Buenos Aires, Argentina
The three related 160-kDa proteins, SRC1, TIF2, and RAC3, which form the p160 family of
coactivators, were initially identified as factors interacting with nuclear receptors (NRs). They
have also been reported to potentiate the activity of a number of other transcription factors,
including AP-1 and NF-kappaB. The aim of this work was to identify whether SRC-1 also
interferes with the TGF-beta/Smad signaling pathway, and if so, to identify its underlying
mechanisms of action. Transient cell transfection experiments performed in human dermal
fibroblasts using the artificial Smad3/4-specific (SBE)4-lux reporter construct, as well as
p800-lux, which harbors 800 bp of the human PAI-1 promoter driving the expression of
luciferase, we determined that overexpression of SRC-1 enhances TGF-beta-induced,
Smad-mediated, transcription. Likewise, SRC-1 overexpression potentiated TGF-beta-
induced upregulation of PAI-1 steady-state mRNA levels. Using a mammalian two-hybrid
system approach, we demonstrated that SRC-1 interacts with the trasncriptional co-
activators p300/CBP, but not with Smad3. Overexpression of the adenovirus E1A
oncoprotein, an inhibitor of CBP/p300 activity, prevented the enhancing effect of SRC-1 on
Smad3/4-mediated transcription, indicating that p300/CBP may be required for SRC-1 effect.
Indeed, such hypothesis was validated, as overexpression of a mutant form of SRC-1 lacking
the CBP/p300-binding site failed to upregulate Smad3/4-dependent transcription. In
addition, using a mammalian two-hybrid approach, we found that SRC-1 potentiates p300
Smad3 interactions while not binding Smad3 directly. Together, these results identify SRC-1
as a novel Smad3/4 transciptional partner facilitating the functional link between Smad3 and
p300/CBP, resulting in the enhancement of TGF-beta/Smad3-mediated transcription.
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HB-EGF Shedding is Essential for UV-Induced EGFR Phosphorylation and Epidermal
Hyperplasia
Y Shirakata, S Tokumaru, Y Yahata, M Tohyama, Y Hanakawa, K Sayama, K Hashimoto
Department of Dermatology, Ehime University School of Medicine, Ehime, Japan
UV irradiation has various biological effects on skin. One is EGF receptor (EGFR)
phosphorylation and the subsequent activation of MAP kinase, leading to epidermal
hyperplasia. However, the cross-talk mechanism linking UV irradiation and EGFR phosphor-
ylation remains unclear. Recently, it was reported that EGFR transactivation by G-coupled-
protein receptors is mediated via HB-EGF shedding, the conversion of HB-EGF from a
membrane anchored form to a soluble form. So we hypothesized that UV-induced EGFR
phosphorylation is mediated via HB-EGF shedding. First we examined the effect of UV
irradiation on EGFR phosphorylation in human keratinocytes. UV irradiation (30 mJ/cm2)
induced EGFR phosphorylation in a time dependent manner, optimally 2.1 fold at 20 min.
Next we examined whether UV irradiation induces HB-EGF shedding from the keratinocyte
cell surface. Biotinylated membrane-anchored HB-EGF on the cell surface disappeared
almost completely 10 min after UV irradiation. The soluble form of EGFR ligands in culture
medium was measured by bioassay. Soluble EGFR ligands increased optimally 1.5 fold at 5
min after UV irradiation. An inhibition assay identified 77% of the soluble EGFR ligands as
HB-EGF. Furthermore, R8301, a specific inhibitor of HB-EGF shedding, inhibited UV-induced
HB-EGF shedding completely at 1 mM. We also confirmed the HB-EGF inhibitors such as
R8301, anti-HB-EGF blocking antibody and CRM197, a specific inhibitor of soluble HB-EGF,
completely inhibited UV-induced EGFR phosphorylation. Finally, we examined the involve-
ment of HB-EGF in UV-induced epidermal hyperplasia using keratinocyte-specific HB-EGF
knockout mice generated by Cre/loxP technology. In HB-EGF knockout mice, UV-induced
epidermal hyperplasia was completely inhibited. In conclusion, we clearly demonstrated that
UV irradiation-induced EGFR phosphorylation and epidermal hyperplasia are mediated via
HB-EGF shedding, the conversion of HB-EGF from a membrane-anchored form to a soluble
form.
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Keratin5-Cre/LoxP Mediated Deletion of Vascular Endothelial Growth Factor Severely
Compromises Mammary Gland Function in Association with Reduced Blood Vessel
Density and Duct Development
H Rossiter1, C Barresi1, M Ghannaddan1, M Mildner1, F Gruber1, E F Wagner2 and E
Tschachler1,3
1DIAID, Univ. of Vienna Medical School, Vienna; 2I.M.P. Vienna, Austria, 3CE.R.I.E.S., Neuilly,
France
In the adult, the process of blood vessel formation, or angiogenesis, is restricted to settings of
increased vascular requirements, such as wound healing, tumor growth and the female
reproductive tract during pregnancy and lactation. Expression of the blood vessel endothelial
cell mitogen, Vascular Endothelial Growth Factor (VEGF), is upregulated in keratinocytes
during wound healing and epidermal tumors, and has been shown to be regulated in concert
with mammary gland development during pregnancy and lactation, suggesting that this
factor is important for angiogenesis in these settings. Using the Cre/LoxP system under the
control of the keratin5 promoter, we have generated mice in which VEGF has been inactivated
in all keratin5 expressing tissues, including the female reproductive tract. We have shown
previously that these mutant mice (K5/Cre VEGF F/F), in addition to impaired wound healing
and tumor formation, display severely compromised mammary gland function: they were
unable to adequately nourish their young, and mammary gland duct development was
reduced during pregnancy and lactation. We now report that this retarded development in the
mutant mammary glands during pregnancy and lactation is associated with a failure to
upregulate production of VEGF, and with impaired angiogenesis. Histomorphometric analysis
revealed that blood vessels occupied a significantly smaller area in mutant mice and
appeared thinner and less well organized than those of controls. The composition of the milk
itself showed no differences in the major protein components, nor was there a difference in
casein content as judged by silver staining and Western blotting respectively. We conclude,
firstly, that the mammary gland epithelial cells, and not stromal cells, are the major source of
VEGF during pregnancy and lactation. Secondly, in the absence of epithelial cell derived
VEGF, mammary gland duct and blood vessel proliferation is reduced during these
processes, resulting in reduced milk production, and inadequately nourished offspring.
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Simultaneous Inhibition of VEGFR1 and VEGFR2 Signaling is Required for Suppression
of Experimental Melanoma Metastases
B Boehme, A Aicher, A Gaumann, D J Hicklin, P Bohlen, S Dimmeler, R Kaufmann, G Breier,
J Gille
Dept. of Dermatology, Frankfurt a.M. [B.B., R.K., J.G.]; Dept. Molecular Cardiology,
Frankfurt a.M. [A.A., S.D.]; Dept. of Molecular Biology, Max-Planck-Institute, Bad Nauheim,
Germany [A.G., G.B., J.G.]; Dept. of Immunology, ImClone Systems Inc., New York, USA
[D.J.H., P.B.]
The propensity of tumor cells to colonize remote organs is greatly affected by active tumor-
host interactions. Accumulating evidence suggests that the host microenvironment is also
influenced by bone marrow-derived hematopoietic and endothelial stem/progenitor cells,
prone to collaborate on promoting tumor cell survival and neovessel-dependent tumor
growth. As metastasis continues to be the major cause of morbidity and mortality in
malignancies, we sought to extend the understanding about the role of vascular endothelial
growth factor-positive (VEGFRþ ) bone marrow-derived progenitors in malignancies by
employing an experimental melanoma metastasis assay. Our studies reveal that experimental
metastasis formation mobilizes both VEGFR1þ myloid cells and VEGFR2þ endothelial
progenitors. In transplantation studies utilizing genetically marked bone marrow, however,
examination of lung metastases showed recruitment primarily of myelomonocytic and
megakaryocytic bone marrow-derived cells, whereas endothelial progenitors failed to
considerably integrate in metastases. We therefore explored whether inhibition of VEGFR1
or VEGFR2 signaling leads to distinct suppressive effects on metastasis formation.
Remarkably however, only simultaneous antibody-mediated inhibition of VEGFR1 and
VEGFR2 signaling suppressed lung metastasis formation. While our data suggest that the
anti-metastatic effects achieved by combined inhibition of VEGFR1 and VEGFR2 signaling
are mediated via targeting cell populations other than bone marrow-derived progenitors, we
herein provide first evidence that combined anti-VEGFR1 and anti-VEGFR2 strategies could
potentially open up further prospects to interfere with metastatic growth in secondary organs.
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Convergence of the p38/ERK/MSK1 and SMAD Signaling Pathways in the Induction of c-
fos Gene Expression by Interleukin-1b and TGF-b
M Schiller and A Mauviel
INSERM U532, Institut de Recherche sur la Peau, Hoˆpital Saint-Louis, Paris, France;
Department of Dermatology, University of Mu¨nster, Mu¨nster, Germany
Interleukin-1b (IL-1b) plays a central role in acute and chronic inflammation. At the
transcriptional level, IL-1b promotes expression of a variety of immediate-early-response
genes like c-fos. In turn, immediate-early-response genes influence the expression of
secondary response genes contributing to the phenotypic response of the cell to
proinflammatory stimuli. It is known that stimulus-dependent gene transcription of c-fos, is
mediated via several cis-acting elements, including at least three cAMP response elements
and a serum response element. However, the precise mechanisms by which IL-1b induce c-
fos gene expression remain unclear. Here we show that inhibition of either ERK or p38
mitogen-activated protein kinases (MAPK) abolished IL-1b-induced c-fos gene expression in
human HaCaT keratinocytes as revealed by northern blotting and by use of a c-fos-promoter-
containing reporter construct. We further provide evidence that the p38-MAPK- and ERK-
activated kinase MSK-1 is required for full c-fos gene transcription, as well as for the
phosphorylation of cAMP response element-binding protein (CREB). In addition, we
demonstrate that IL-1b-induced c-fos gene transcription is potentiated by TGF-b through a
mechanism involving SMAD activation. In conclusion these results show that MSK1 and
downstream CREB-phosphorylation are important p38-MAPK- and ERK-activated mediators
of IL-1b-stimulated c-fos induction. In addition, these studies provide evidence that following
IL-1b and TGF-b stimuli, both the p38/ERK/MSK1 and the Smad pathways converge to the
regulation of the prototypical immediate-early-response gene c-fos.
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TGF-beta and TNF-alpha: Antagonistic Cytokines Controlling Connexin 43 Gene
Expression
J Laboureau, C Tacheau, J Fontaine A Mauviel and F Verrecchia
INSERM U532, Skin Research Institute, Saint-Louis Hospital, Paris, France
Among the structures mediating cell-cell interactions, gap junctional intercellular commu-
nications (GJIC) are unique in that cells directly transfer small water-soluble molecules
(Mro1000) from the inside of one cell to that of neighboring cells. Gap junctional channels are
composed of two connexons, each composed of six subunit proteins termed connexins (Cx).
A wealth of independent observations implies that changes in the proliferation program of
keratinocytes coincide with a dynamically regulated switch of the pattern of Cx expression in
the skin. The aim of this work was to examine the effect of two antagonistic cytokines
implicated in the control of keratynocyte proliferation, TGF-beta and TNF-alpha, on the
expression the connexin43, the most abundant Cx in human epidermis, not only expressed
throughout the spinous and granular cell layers, but also focally in the basal epidermal layer.
Using transient cell transfections of the human keratinocyte cell line HaCat with Cx43
promoter/reporter gene constructs, we determined that TGF-beta increases Cx43 transcrip-
tion whereas TNF-alpha represses Cx43 promoter activity. The physiological relevance of
these observations was confirmed as modulation of Cx43 steady-state mRNA and protein
levels by these cytokines paralleled that of the Cx43 promoter. Next, using expression
vectors for either a dominant-negative form of Smad3 or for antisense cJun and/or JunB
mRNA, we demonstrated that enhancement of Cx43 transcription by TGF-beta requires both
Smad3/4 and Jun/AP-1 signaling pathways. On the other hand, using either a pharmaco-
logical approach or overexpression of dominant-negative upstream kinases to inhibit the
JNK, ERK and p38 MAP kinase pathways, we identified both JNK and p38 as critical for
decreased Cx43 transcription by TNF-alpha. Further studies are required to determine the
link between these regulatory pathways, Cx43 expression, and the control of keratinocyte
proliferation by TGF-beta and TNF-alpha.
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Impaired Wound Contraction in Murine Leukocyte-Adhesion Deﬁciency 1 Relies on
Decreased TGF-b1 Secretion and Impaired Differentiation of Myoﬁbroblasts
T Peters*1, R Hinrichs*1, B Hinz2, T Veleva-Oreshkova1, E Al-Azzeh1, S Sulyok1, J Schu¨ller1,
K Holzwarth3 and K Scharffetter-Kochanek1
1Department of Dermatology and Allergology, 3University of Ulm, Ulm; Centre for Molecular
Medicine (CMMC), 2University of Cologne, Cologne, Germany; Faculty of Basic Sciences
(FSB), Federal Polytechnical School of Lausanne (EPFL), Lausanne, Swizerland; both
authors contributed equally
The b2 leukocyte integrins are heterodimers, composed of a common b chain (CD18) and one
out of four distinct a chains (CD11). They are pivotal for migration and signalling of
hematopoietic cells during inflammatory processes and immune responses. Lack of
functional b2 integrin causes leukocyte-adhesion deficiency type 1 (LAD1), a life-threatening
primary immunodeficiency syndrome with severe recurrent microbial infections, leukocytosis
and impaired wound healing.
Initial data revealed significantly increased wound sizes in a murine model for LAD1
(CD18/) from day 5 to 14 after application of full thickness wounds on mouse backs. We
now addressed the question whether this impairment in wound healing was a consequence
of reduced wound contraction potentially caused by disturbed myofibroblast recruitment.
Therefore, we analyzed expression of markers critical for myofibroblast differentiation by
immunohistochemistry and Western blotting. We found that both splice variant ED-A of
fibronectin and a-smooth muscle actin were substantially reduced in CD18/ mice at day 5
and 7 after wounding, respectively, indicating impaired myofibroblast differentiation.
Interestingly, TGF-b1 and its receptor TGF-bRII were also largely decreased. Since TGF-b1
is a key factor for granulation tissue formation and promotes wound contraction, we
supplemented TGF-b1 by subcutaneously injecting two different doses (0.45 mg, 0.1 mg) into
the wound margins at day 1, 3 and 5 after wounding of CD18/ and wild-type mice. As a
result, we observed a rescued wound closure in CD18/, similar to wild-type mice.
Considering the essential requirement for CD18 in neutrophil extravasation and migration
into wound tissue, we hypothesize that due to the absence of neutrophils in wounds of
CD18/ mice, macrophages were not able to phagocytose apoptotic neutrophils and thus,
they lacked the critical stimulus to secrete TGF-b1. Deviant from former views, our data
demonstrate that growth factors released by neutrophils in a paracrine fashion are important
for wound contraction and healing. It remains to be seen whether CD18 is also involved in
migration of myofibroblast precursors.
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Small Rho GTP Binding Proteins Regulate Vascular Endothelial Growth Factor-2
Expresssion In Endothelial Cells
M Meissner1; M Stein1; R Kaufmann1; J Gille1,2
1Dept. Of Dermatology, J.W. Goethe-Universita¨t, Frankfurt/M.; 2Dept. of Molecular Biology,
Max-Planck-Institut, Bad Nauheim
Recent evidence suggests, that rho-family small GTPases play a significant role in the
regulation of different endothelial cell functions, implicated in capillary network formation.
Whereas Rho-family small GTPases are primarily known to control actin-based motility
processes, RhoA, Rac1 and Cdc42 have been shown to regulate other cellular activities as
well, such as membrane transport and gene transcription. As vascular endothelial growth
factor receptor-2 (VEGFR2) expression is necessary for angiogenic responses to occur, we
hypothesized that Rho-family small GTPases may affect VEGFR2 expression by cultured
endothelial cells (ECs). Overexpression of dominant negative mutants N17Rac1 and
N19RhoA were seen to significantly inhibit VEGFR2 protein expression by HUVEC, whereas
transfection of mutant N17Cdc42 failed to affect VEGFR2 levels. As N17Rac1 and N19RhoA
also supressed VEGFR2 mRNA accumulation, we subsequently examined their effects on
VEGFR2 transcriptional activation. Analyses of a different 50-deletional VEGFR2 promoter-
based reporter gene constructs revealed that inhibition by N17Rac1 and N19RhoA is
conveyed by distinct gene regulatory elements. Whereas N17 Rac1-mediated supression is
confined to a GC-rich region between bp -77 and -60, N19RhoA-mediated inhibition appears
to be conferred by an element located between bp -225 and -160, harboring a consensus E-
box binding site. We were able to show by EMSA analysis, that constitutive Sp1-dependent
DNA binding to the GG-rich region is decreased by N17Rac1 transfection, indicating that
inhibition of rac1 may interfere with Sp1-dependent VEGFR2 transcription. Therefore,
different members of the Rho-family small GTPases exert diverse effects on VEGFR2
expression. Significantly, inhibition of VEGFR2 transcription by N17Rac1 and N19RhoA
involves distinct molecular mechanisms as different elements seem to be engaged. In
conclusion, control of capillary network formation by Rho-family small GTPases may likely be
mediated in part via modulation of VEGFR2 expression.
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BDNF upregulates TGFb2 and Induces Keratinocyte Apoptosis and Regression of
Cultured Human Anagen Hair Follicles
E M J Peters1, M G Hansen2, R W Overall1, M Nakamura3, P Pertile2, B F Klapp1, P Arck1,
and R Paus2
1Department of Internal Medicine, Biomedical Research Center, University Medicine
Charite´, Campus Virchow Hospital, Berlin, Germany; 2Department of Dermatology,
University Hospital Hamburg-Eppendorf, Hamburg, Germany; 3Department of Dermatology,
Kyoto University, Kyoto, Japan
Neurotrophins are important modulators of epithelial-mesenchymal interactions. Previously,
we had shown that brain derived neurotrophic factor (BDNF) and its high affinity receptor
(TrkB) are prominently involved in the control of murine hair follicle cycling (FASEB J 13: 395,
1999). We now show that BDNF and TrkB are also expressed in the human hair follicle in a
manner that is both hair cycle-dependent and suggestive of epithelial-mesenchymal cross-
talk between BDNF secreting dermal papilla fibroblasts of anagen hair follicles and
subpopulations of TrkBþ hair follicle keratinocytes. As first functional evidence for an
involvement of BDNF/TrkB in human hair growth control, we show that 50 ng/ml BDNF
significantly inhibits hair shaft elongation in organ-cultured human anagen hair follicles and
induces premature catagen development. Hair follicle regression is associated with induction
of keratinocyte apoptosis – as evidenced by nick-end-labeling – and inhibition of keratinocyte
proliferation. Immunohistochemistry and quantitative realtime rtPCR analysis demonstrates
up-regulation of the potent catagen inducer, tumor growth factor b2 (TGFb2) by BDNF.
Catagen induction by BDNF was partially reversible through co-administration of TGFb-
neutralizing antibody, and this treatment downregulated TGFb2-expression in the hair bulb by
immunohistochemistry. These findings suggest, that TrkB-mediated-signaling promotes the
switch between anagen and catagen at least in part via up-regulation of TGFb2. Thus, human
scalp hair follicles are both a source and target of bioregulation by BDNF, which invites to
target TrkB-mediated signaling for therapeutic hair growth modulation.
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Nerve Growth Factor Regulates Hair Cycle Progression in Humans and Mice
E Milena J Peters1, V Botchkarev2, S Mu¨ller-Ro¨ver3, G Go¨lz3, B F Klapp1, P Clara Arck1,
R Paus4
1Department of Internal Medicine, Biomedical Research Center, University Medicine
Charite´, Campus Virchow Hospital, Berlin, Germany; 2Department of Dermatology, Boston
University Medical School, Boston, USA; 3Institute of Cell Biology and Neurobiology,
University-Medicine Charite´, Center for Anatomy, Berlin, Germany; 4Department of
Dermatology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Neurotrophins are more than nerve growth factors. Ample evidence proves, e.g. that the
prototypic nerve growth factor (NGF) promotes proliferation of keratinocytes via its high
affinity receptor tyrosine kinase A (TrkA). In contrast, its precursor pro-NGF, which is spliced
from the same mRNA promotes apoptosis via p75, a member of the tumor necrosis factor
receptor family. p75 has a low affinity for NGF and a high affinity for pro-NGF. Interestingly,
pro-NGF is contained in all commercially available NGF-preparations. Recently, we were also
able to demonstrate a role for NGF in stress-triggered hair growth termination. Here we show,
that NGF and its receptors TrkA and p75 are expressed in human and murine hair follicles with
distinct expression patterns in respect to anatomical structure and hair cycle stage. E.g. by
mRNA pro-NGF/NGF level peaks in early anagen, dramatically decreases towards high
anagen and recovers in catagen while by Elisa, pro-NGF/NGF protein peaks in catagen. By
immunohistochemistry, NGF and TrkA are found in the outer root sheath throughout the hair
cycle in man and mice with the strongest expression in the proliferative basal layer. Strong
pro-NGF expression is found in the inner root sheath and p75 is detectable in the dermal
papilla of late anagen hair follicles prior to the onset of catagen and in the regressing epithelial
strand of human and murine catagen hair follicles. These distribution patterns suggest a role
for NGF/TrkA interactions in follicular keratinocyte proliferation and hair growth as well as a
role for pro-NGF/p75 interactions in keratinocyte apoptosis and hair follicle regression. In
accordance with these data we could show that NGF promoted anagen in organ cultured
murine early anagen hair follicles. In contrast, catagen was induced by NGF in organ cultured
human and murine late anagen hair follicles. We thus conclude, that NGF live and death
decisions in hair growth control depend on NGF-processing and availability of high and low
affinity receptors. The development of NGF-preparations exclusively containing NGF or pro-
NGF may provide a promising strategy for the development of new therapeutic approaches to
treat hair growth disorders.
350
The Changing Role of TGFb1 During Wound Repair
C Vigor, K Rolfe, J Richardson, R Sanders and C Linge
The RAFT Institute of Plastic Surgery, Mount Vernon Hospital, Middlesex, UK
Healing of cutaneous wounds proceeds via a fibro-proliferative process. Fibroblasts migrate
into the wound, proliferate, differentiate into myofibroblasts, and synthesise ECM proteins,
forming early granulation tissue. This first phase of wound repair is influenced by the TGFb
family of pleiotropic factors. Nevertheless TGF-b1 levels remain high well beyond the
completion of the fibroproliferative phase, suggestive of a further role. On transition of late
stage granulation tissue into mature scar, redundant cells are eliminated from the maturing
tissue via apoptosis (induction mechanism unknown). It is possible that TGF-b also
modulates the remodelling/apoptosis phase of wound repair as it is an effector of apoptosis
in a variety of cell types. We hypothesise that TGF-b1 modulates the entire wound healing
process. The pleiotropic roles being directed by the cell type present, cell density, matrix
environment, integrins, enzymes and peptides present at any given time. To investigate this
theory we embedded dermal fibroblasts derived from normal skin (n¼5) into a variety of
growth environments simulating the different phases of wound healing and studied the effects
of different doses of TGF-b1 in relation to cell proliferation, morphology, differentiation and
apoptosis. Fibroblasts cultured in anchored fibrin and collagen gels showed completely
different morphology after treatment with TGF-b1: cells in fibrin exhibited a striking increase
in cell–cell contact. Induction of myofibroblasts differentiation by TGFb was equivalent in both
matrices. Surprisingly, we found TGF-b1 at 2 ng/ml significantly (po0.001) induced apoptosis
(450%) of fibroblasts embedded in 3-D collagen matrices irrespective of whether the cells
were allowed to contract/remodel the matrix or not. No apoptosis was detected in 3-D fibrin
matrices. Higher concentrations of TGF-b1 had a mitogenic effect (48 ng/ml). This
apoptosis-inducing effect of TGF-b1 was reliant on the three dimensional nature of the
collagen gels and not simply integrin binding to collagen as TGF-b1-treatment of cell
monolayers cultured on collagen-coated plastic did not elicit an apoptotic response. These
results suggest for the first time a potential role for the involvement of TGF-b1 in the induction
of apoptosis during wound repair.
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Heparin-Binding EGF (HB-EGF) Induces the Pro-Angiogenic VEGF-Coreceptor Neuropi-
lin-1 in HaCaT Keratinocytes by Downregulating the Repressor Transcription Factor
NRSF (Neural-Restrictive Silencing Factor)
P Kurschat, M Rossignol, D Bielenberg, and M Klagsbrun
Boston, USA
Neuropilin-1 (NRP-1), a cell surface receptor for secreted semaphorins as well as for
VEGF165, has been shown to be necessary for both developmental and tumor angiogenesis.
The regulation of neuropilin-1 is only poorly understood. Here we show evidence that a
consensus binding sequence in the neuropilin-1 promoter known as a neural restrictive
silencer element (NRSE) is implicated in the transcriptional repression of NRP-1. This binding
site is recognized by the neural restrictive silencing factor NRSF, also known as RE-1
silencing transcription factor (REST). In HaCaT keratinocytes mutation of the NRSE leads to
increased promoter activity, as shown by luciferase reporter gene assays. By electromobility
shift assays it could be demonstrated that NRSF protein binds to NRSE in the NRP-1
promoter. HaCaT keratinocytes stably overexpressing NRSF had decreased NRP-1 levels,
whereas blocking of NRSF activity by a truncated, dominant-negative NRSF protein caused
derepression of NRP-1. Similar results were obtained when cells were treated with the
histone deacetylase inhibitor trichostatin A, an inhibitor of NRSF silencing activity.
Furthermore, when HaCaT cells were stimulated with HB-EGF, a strong inducer of NRP-1
expression, increase of NRP-1 gene expression was accompanied by a decrease in NRSF
mRNA and protein levels. Taken together, these results indicate that NRP-1 expression is
negatively regulated by NRSF. It is concluded that despite its main function of repressing
neuronal genes in non-neuronal cells NRSF might have an important role in the regulation of
vascular development and angiogenesis, representing the first known negative regulator of
the isoform-specific VEGF-coreceptor neuropilin-1 in a physiological context.
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Evidence for Expression of Multiple Members of the Family of Suppressors of Cytokine
Signalling in Normal and Transformed Human Melanocytes
Z Li, T A Luger and M Bo¨hm
Department of Dermatology and Ludwig Boltzmann Institute for Cell Biology and
Immunobiology of the Skin, University of Mu¨nster, Germany
Suppressors of cytokine signalling (SOCS) define a newly identified family of negative
regulators of cytokine signalling. At present, this family consists of 8 structurally related
members, SOCS-1 to -7, and CIS. We recently observed that SOCS-1 is a progression
marker of human melanoma. Here we investigated the expression of additional members of
the SOCS family in normal human melanocytes (NHM) and 8 human melanoma cell lines by
multi-probe ribonuclease protection assay. CIS, SOCS-5 and -7 were similarly expressed in
all of the melanoma cell lines and NHM. RNA levels of SOCS-6 were significantly higher in
NHM compared with all melanoma cell lines. Most interestingly, SOCS-3 expression was
silenced in NHM. In most melanoma cell lines (6 out of 8) SOCS-3 was highly expressed while
in 2 melanoma cell lines SOCS-3 expression was marginal. To assess the relevance of these
findings, the in vitro interferon (IFN-alpha) and interleukin 6 (IL-6) sensitivities of the various
melanoma cell lines were determined by proliferation assays. There was no correlation
between the IFN-alpha sensitivity and SOCS-3 expression. On the other hand, the IL-6
sensitivity closely correlated with SOCS-3 mRNA expression. At the protein level SOCS-3
expression was absent in NHM as shown by Western immunoblotting. In melanoma cell lines
SOCS-3 protein expression correlated with expression of Pim-2, a serine/threonine kinase
previously implicated in stability and phosphorylation of the SOCS-1 protein. In summary, our
findings, for the first time, show that multiple members of the SOCS family are expressed in
human pigment cells. SOCS-3 gene expression tightly correlates with IL-6 sensitivity in
melanoma cells in vitro. Further studies are needed to determine if SOCS-3 RNA knock-out
can restore IL-6 sensitivity, and if SOCS-3 is expressed in melanoma in situ.
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NFjB Selectively Enhances UVB-Induced Apoptosis Via Differential Gene Regulation
B Po¨ppelmann, E Strozyk, T Schwarz , D Kulms
Department of Dermatology, University of Muenster, Muenster; + Department of Dermatol-
ogy, University of Kiel, Kiel
Activation of the transcription factor nuclear factor-kB (NFkB) by interleukin 1 (IL-1) is
generally associated with the induction of antiapoptotic pathways within the cell. Accordingly,
NFkB was shown to suppress death ligand-induced apoptosis through transcriptional up-
regulation of antiapoptotic proteins IAPs (inhibitor of apoptosis proteins) and FLIP (I-FLICE).
In contrast, we could demonstrate that UVB-mediated cell death was significantly enhanced
upon NFkB activation. Enhancement of UVB-induced apoptosis coincided with a release of
about 100 pg/ml of the proapoptotic cytokine TNFa. Surprisingly, co-stimulation of cells with
the same dose of TNFa and UVB or application of supernatants of IL-1plus UVB-treated cells
to UVB-irradiated cells resulted only in a rather weak enhancement of UVB-induced
apoptosis, indicating that other intracellular components have to be involved in the
proapoptotic effect of NFkB. Gene chip arrays revealed that, in contrast to the NFkB-
dependent transcriptional up-regulation of TNFa, NFkB-dependent transcription of c-IAP and
FLIP was completely inhibited by UVB radiation. In addition, members of the TRAF (tumor
necrosis factor receptor-associated factor) protein family which contain NFkB consensus
elements within their promoters were shown to be significantly down-regulated upon UVB
exposure. TRAF proteins are upstream adapter proteins associated with the cell death
receptor TNFR-1. Upon activation by TNFa TNFR-1 can transduce either pro- or
antiapoptotic signals depending on the distribution of certain adapter proteins. Whereas
recruitment of the proapoptotic adapter protein FADD results in induction of apoptotic cell
death, the recruitment of TRAF proteins activate antiapoptotic signalling pathways mediating
cell survival. Conclusively the downregulation of TRAF proteins results in promotion of the
proapoptotic pathway triggered by TNFR-1, thereby enhancing UVB-induced apoptosis.
Taken together, NFkB activation in association with UVB exposure results in up-regulation of
the proapoptotic death ligand TNFa. In addition, it results in transcriptional inhibition of
antiapoptotic cIAP and FLIP genes and of TNFR-1 related antiapoptotic adapter proteins
TRAFs. In contrast to the general assumption, NFkB in combination with UVB radiation has
the potential to act in a proapoptotic fashion.
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Blockade of b1 Integrin Activates Caspase-8 Apoptotic Pathway without Fas/FasL
Modulation in Human Keratinocytes
A Marconi, R Lotti, C Panza, T Wachter, M Leverkus, A Giannetti and C Pincelli
Department of Dermatology, University of Wurzburg Medical School, Germany, Institute of
Dermatology, Department of Medicine, University of Modena and Reggio Emilia, Modena,
Italy
Anoikis is a mode of cell death that occurs after detachment from the extracellular matrix. We
have previously shown that transit amplifying cells, but not keratinocyte stem cells undergo
anoikis after disruption of b1 integrin signal. We intended to further evaluate the mechanism
underlying this phenomenon. Normal human keratinocytes were cultured from neonatal
foreskin and either left in suspension or provided with anti-b1 integrin neutralizing antibody.
We showed by TUNEL technique that the addition of anti-b1 integrin significantly accelerates
anoikis in keratinocytes, as compared to merely suspended cells. In order to dissect which
apoptotic pathway is involved in keratinocyte anoikis, we evaluated the hierarchical activation
of caspases after treatment with anti-b1 integrin. Caspase-8 activation and cytochrome c
release from mitochondria were observed at 3 hrs, while caspase-9 was activated at 6 hrs.
Caspase-9 inhibitor zLEDH-fmk failed to block caspase-8, -10, -3 and Bid activation. On the
contrary, caspase-8 inhibitor zIETD-fmk delayed the activation of caspase-9 and -3, and
blocked the activation of Bid. Anti-b1 integrin failed to cleave Bid, to release cytochrome c
and to activate caspase-9 in c-FLIP (FLICE/caspase-8 inhibitory protein) overexpressing
keratinocytes. Finally, anti b1 integrin induced anoikis in c-FLIP transfected keratinocytes to a
lesser degree, as compared to mock cells (po0.01). These results seem to indicate that the
caspase-8 activated (extrinsic) apoptotic pathway is the prevailing mechanism in anoikis. As
the extrinsic apoptotic pathway is triggered by death receptor signal and anoikis has been
shown to be dependent from Fas/Fas ligand system, we evaluated the expression of Fas and
Fas ligand in keratinocytes after addition of anti-b1 integrin. Blockade of b1 integrin failed to
up-regulate either Fas or Fas ligand in keratinocytes, as shown by flow cytometry. These
results suggest that blocking b1 integrin activates caspase-8 pathway without the involve-
ment of Fas/FasL.
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IgE-Dependent Signalling in Human Basophils is Dependent on PLC-mediated p38 MAPK
Activation but not Affected by cJun N-Terminal Kinase
BF Gibbs, D Zillikens and J Grabbe
University of Lu¨beck, Germany
In allergic diseases, such as atopic dermatitis, basophils migrate into affected tissues where
they secrete both inflammatory (e.g. histamine, LTC-4) and immunomodulatory mediators
(e.g. IL-4, IL-13) upon contact with allergen. To date, the intracellular signals responsible for
controlling the IgE-dependent release of the above mediators are poorly understood which
has stifled attempts at developing pharmacological strategies that inhibit their function. In
mast cells, which in some respects are tissue-fixed compatriots of basophils, IgE-dependent
activation crucially involves phosphilipase C (PLC), protein kinase C (PKC) and the
phosphorylation of cJun N-terminal kinase (JNK). Here, we characterised the involvement
of the above signalling components in basophils following IgE-receptor activation. Basophils
were obtained from healthy blood donors and purified to over 95% purity by a three-step
procedure involving Ficoll-density centrifugation, elutriation and magnetic cell sorting. The
activities of various MAPK enzymes following stimulation with anti-IgE for various periods
were assessed by Western blotting. The results showed that, while p38 MAPK was rapidly
phosphorylated in basophils, together with a slower onset of ERK1&2 activation, JNK and its
downstream transcription factor cJun were not activated in the cells. Additionally, use of
specific antagonists confirmed that, while p38 MAPK controls the production of all basophil
mediator types and ERK1&2 only LTC-4 secretion, JNK is not involved in mediator release.
Further, we observed that p38 MAPK activation is completely abolished by PLC inhibitors
while it is less affected by specific PKC antagonism. We conclude that p38 MAPK is the most
important MAPK family member involved in IgE-dependent signalling in basophils and is
regulated by PLC, and subsequent calcium mobilization, but not by PKC. The data also
highlights major differences between basophils and mast cells regarding the control of
mediator secretion by MAPK.
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Insulin-like Growth Factor-I (IGF-I) Enhances Invasive Activity of Malignant Triton Tumor
Cells
M Kawashima, T Takahashi, Y Fujisawa, Y Nakamura, Y Kawachi and F Otsuka
Ibaraki, Japan
Malignant triton tumor (MTT) is a rare variant of malignant peripheral nerve sheath tumor
(MPNST) with rhabdomyoblastic change. This rare tumor shows the poorer prognosis than
MPNST. Five year survival rate has been reported to be 3–10% in MTT whereas it is 50–60%
in MPNST. The malignant behavior of MTT cells has not yet been evaluated in vitro
presumably because of its rarity. In this study, we evaluated the aggressive invasion of MTT
cells into extracellular matrix and the effect of some growth factors on their invasive activity.
Invasive assay using modified Boyden chamber showed the higher invasive activity of MTT
cells than neurofibroma cells, fibroblasts and dermatofibrosarcoma cells. The aggressive
invasion of MTT cells was enhanced by IGF-I but not by epidermal growth factor, basic
fibroblast growth factor and hepatocyte growth factor. In accordance to the finding, IGF-I
augmented a3 integrin subunit expression on MTT cell surface and enhanced attachment of
MTT cells to type I collagen, fibronectin and laminin. The induction of a3 integrin expression
attained a maximal level at a concentration of 10 ng/ml and after 36 h exposure of IGF-I. The
results suggest the contribution of IGF-I to augmentation of invasive and metastatic potential
of MTT cells and poor prognosis in MTT patients.
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Wound Healing and Skin Barrier Repair are Unaffected in IL-15 Deﬁcient Mice
F Scholz, S Bulfone-Pausy, E Proksch
Department of Dermatology, University of Kiel, Germany, yDepartment of Immunology and
Cell Biology, Research Center Borstel, Borstel, Germany
Wound repair, the restoration of permeability barrier against excessive water loss and the
entry of pathogenic microbes after injury, is an essential for survival. Wound healing is a
complex process which involves different cell types, cytokines, and growth factors. It has
been demonstrated that gd-dendritic epidermal T-cells (DETC) are important to ensure a
correct growth factor environment for wound healing and provide KGF for keratinocyte
proliferation; DETCs need IL-15 to survive. The IL-15 receptor (IL-15 R) consist of three
subunits, the IL-15 a-chain, IL-2b-chain and the IL-2 gc-common chain. Deletions in the IL-15,
IL-15 Ra or IL-2b locus lead to an impaired development of gd-T cells in epithelia (Ye et al,
2001; Suzuki et al, 1997; Lodolce et al, 1998). Transplanted gd-DETC were not able to survive
in the skin of IL-15 knock out mice. It has been described that mice lacking gd-DETC in the
skin showed a delayed wound repair. We investigated the effect of IL-15 deficiency in mice on
the repair of superficial and full thickness skin wounds. Superficial wounds were induced by
tape-stripping and the repair rate was determined by the recovery in transepidermal water
loss as a marker of barrier function. The repair rate in full thickness wounds 10 mm in
diameter on the flank of the mice was determined by measurements of the wound size using a
computerized digital imaging system. In addition, wound contraction and reepithelization was
evaluated. The repair rate in superficial wounds of IL-15 deficient mice did not show
significant differences compared to wild type mice. Also, the healing rate in full thickness
wounds, neither overall wound size nor wound contraction or reepithelization were different in
deficient compared to wild type mice. Our results suggest that alternative pathway to set the
required cytokine environment for wound healing. The function of gd-DETC may be
compensated by other mechanisms.
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Reduced Reepithelialisation of Human Neoepidermis by a Small-molecular Epidermal
Growth Factor Receptor Inhibitor
S Forsberg, A O¨stman and O Rollman
Uppsala and Stockholm, Sweden
Psoriasis and several epidermal tumours are characterised by abnormal keratinocyte
proliferation and epidermal growth factor receptor (EGFR) overexpression. Consequently,
EGFR is recognised as a potential target for psoriasis and skin cancer therapy. Although
EGFR-inhibiting compounds reduce the mitotic activity of keratinocytes in monolayer culture,
this class of drugs is not widely investigated in 3-D skin models or clinically in
hyperproliferative or malignant dermatoses. The aim of this study was to assess the dynamic
and morphological effects of EGFR inhibition on multilayered neoepidermis produced from
skin explants grown on deepidermised dermis at air-liquid interface in classical medium. The
small-molecular inhibitor of EGFR (HER1) and HER2 tyrosine kinases, PKI166, was applied at
0.5-5 mM for 10 days in culture. The surface area of newly formed epidermis was determined
repeatedly by fluorescence imaging of reepithelialisation (‘FIRE’) technique and related to the
effects of PKI166 on receptor autophosphorylation, tissue morphology, and BrdU labelling
index. Addition of ligand (EGF) increased neoepidermal outgrowth rate and mitotic activity,
whereas PKI166 decreased EGFR activation and rate of resurfacing irrespective of
exogenous EGF. The dynamic effects of PKI166 were dose-dependent, and no histological
signs of neoepidermal drug toxicity were observed. The study illustrated the utility of
fluorescence imaging in quantifying living neoepidermis, and emphasised the potential of
EGFR inhibition in decreasing outgrowth of human epidermis on deepidermised dermis.
Therapeutic intervention of EGFR signalling by selective tyrosine kinase inhibitors might be a
feasible approach in hyperproliferative states of the epidermis.
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Fetal Fibroblasts Respond Quicker but More Transiently in the IGF-I and TGF-b1
Intracellular Signaling Pathways
KJ Rolfe, C Vigor, J Richardson, R Sanders, C Linge
RAFT, Institute of Plastic Surgery, Mount Vernon Hospital, Northwood. Middlesex UK
Cutaneous wound healing in early fetuses occurs rapidly and leads to perfect regeneration of
tissue architecture rather than the formation of scar tissue, which is characteristic of
postnatal healing. Pro-fibrotic growth factors such as TGF-b1 have been shown to play a role
in fetal wound healing. Little is yet understood regarding the intracellular signalling pathways
involved in wound healing in the fetus. We aimed to study the intracellular pathways of both
IGF-I and TGF-b1. Following local ethical approval we have established primary cell lines of
fetal dermal fibroblasts (FDF; o14 week gestation n¼ 5) and postnatal dermal fibroblasts
(DF; o9 years of age n¼5). We used immunohistochemical staining using a commercially
available antibody for smooth muscle actin and established that FDF do differentiate into
myofibroblasts unlike previously believed. We have also studied the intracellular signalling
pathways for IGF-I and TGF-b1 using SDS-PAGE/Western Blotting and immunoprecipitation
using commercially available antibodies and have shown for a number of proteins involved in
these pathways e.g. p-JNK, p-Smad2/3 and pERK that fetal signalling appears quicker but
more transient. As previously shown endocytosis of receptors has been suggested to slow
intracellular signalling, we have therefore studied the IGF-I receptor function in FDF and
preliminary work has indicated that unlike DF cells endocytosis of the IGF-IR is not required.
Our work has indicated that FDF activate the IGF-I and TGFb1 signalling pathways, but this
activation is rapid and transient. FDF also differentiate into myofibroblasts but again this
differentiation is rapid but transient.
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Agonist-Induced Ca2þ Oscillations and Ca2þ Entry in Keratinocytes
K Ross and N J Reynolds
Dermatological Sciences, University of Newcastle, Newcastle upon Tyne, UK
Several independent studies have provided evidence of a mitogenic effect of extracellular
ATP and UTP on primary keratinocytes. Two classes of extracellular nucleotide receptors
have been established: the P2X family ATP gated ion channels and the metabotropic P2Y
family of G-protein coupled receptors (GPCRs). Stimulation of GPCRs activates PLC-b,
leading to the production of inositol 1,4,5-triphosphate (IP3), release of [Ca
2þ ]i from
intracellular stores. Depletion of the stores in turn leads to activation of store-operated
channels in the plasma membrane. The relationship between agonist-induced store depletion
and Ca2þ influx in HaCaT and normal human keratinocytes (NHKs) has not been fully
characterized. Here, we show that stimulation with UTP or ATP elicited pronounced Ca2þ
influx in HaCaT keratinocytes under low (70 mM) Ca2þ conditions. In contrast, cytosolic Ca2þ
rapidly returned to resting levels in NHKs stimulated with UTP or ATP. Chelation of
extracellular Ca2þ with EGTA indicated that modest Ca2þ influx occurred following the initial
Ca2þ transient, but this was significantly less than the Ca2þ entry observed in HaCaTs. Only
a single Ca2þ transient was detected in most NHKs exposed to ATP or UTP. However, in a
subset of cells, a second or third Ca2þ transient was observed at later time points. The
amplitudes of the later Ca2þ transients were smaller than that of the initial Ca2þ signal. When
extracellular Ca 2þ was raised to physiologically relevant levels (1.2 mM), stimulation with
ATP or UTP resulted in prolonged Ca2þ entry. This was not observed in cells in which [Ca 2þ ]i
release was not detected. Together our data demonstrate that (1) the effects of extracellular
nucleotides on primary cultured keratinocytes may involve Ca2þ oscillations in a subset of
cells and (2) elevation of extracellular Ca2þ facilitates agonist-induced Ca2þ entry in
response to ATP-induced store depletion.
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Variations in the Genes Encoding the Peroxisome Proliferator-Activated Receptors a and
c in Psoriasis
R Mo¨ssner,1 R Kaiser,2 P Matern,2 U Kru¨ger,1 G A Westphal,3 J Brockmo¨ller,2 A Ziegler,4 C
Neumann,1 Inke R Ko¨nig,4 K Reich1
Departments of 1Dermatology, 2Pharmacology and 3Occupational Health, Georg-August-
University Go¨ttingen 4Institute of Medical Biometry and Statistics, University of Lu¨beck
The three peroxisome proliferator-activated receptor (PPAR) subtypes a, b (or d), and g belong
to the group of nuclear receptors that act as ligand-activated transcription factors. Recently,
expression of PPARa and g in keratinocytes has been demonstrated, and ligands of PPARa
and g were found to enhance epidermal maturation and protect against cutaneous
inflammation. There is first evidence for a possible role of PPARs in psoriasis, as expression
of PPARa and g is decreased in lesional skin and treatment with PPARg agonists improves
psoriatic keratinocyte pathology in vitro and in vivo. We performed a case-control study to
search for possible associations between variations in the genes encoding PPARa and g and
psoriasis. Seven variations in these genes were analyzed in 192 patients with chronic plaque-
type psoriasis and 330 healthy controls by PCR-based methods. No association between any
of the investigated PPAR variants and psoriasis was found. Our findings argue against a
significant contribution of the investigated PPAR variations to the genetic basis of psoriasis.
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The Activity of the MAP-Kinases p38 and ERK1/2 are Increased in Lesional Psoriatic Skin
C Johansen, K Kragballe, M Westergaard, J Henningsen, K Kristiansen and L Iversen
Aarhus and Odense, Denmark
Alterations in specific signal transduction pathways may explain the hyperproliferation and
abnormal differentiation of the keratinocytes as well as the increased expression of
inflammatory cytokines seen in psoriasis. Major signaling pathways used by eukaryotic cells
to transduce extra cellular signals into cellular responses impinge on the mitogen-activated
protein kinases (MAPKs).
The purpose of this study was to investigate the expression of the MAP-kinases p38, extra
cellular signal-regulated kinase (ERK) and c-Jun NH2-terminal kinase (JNK) in psoriatic skin.
Using Western blotting we demonstrated increased levels of the activated (phosphorylated)
form of p38 and ERK1/2 in lesional psoriatic skin compared to non-lesional psoriatic skin. No
abnormality was found in the activation or expression of JNK1/2. Ex vivo kinase assays
confirmed the increased activation of p38, and furthermore demonstrated increased kinase
activity of the p38 isoforms p38a, p38b and p38d in lesional compared to non-lesional
psoriatic skin. p38g was not detected in the psoriatic skin. Clearance of the psoriatic lesions,
induced by climatotherapy at the Dead Sea for four weeks, lead to a normalization in the
activity of both p38 and ERK1/2. Taken together, our results demonstrated that the activity of
the MAP-kinases p38a, b and d and ERK1/2 are increased in lesional psoriatic skin compared
to non-lesional psoriatic skin, and that clearance of psoriasis normalizes the p38 and ERK1/2
activity. Thus, p38 and ERK1/2 might be potential targets in the treatment of psoriasis.
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The effects of Neuropeptides Galanin, Vasoactive Intestinal Polypeptide, Substance P
and Calcitonin Gene-Related Peptide on the Productions of Nerve Growth Factor and
Inﬂammatory Cytokines in HaCaT cells and Cultured Human Keratinocytes
A Dallos, M Kiss, S Husz, L Keme´ny, A Dobozy
Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary
There is increasing evidence that the cutaneous neurosensory system can modulate
physiological and inflammatory responses in the skin via the release of neuropeptides. Nerve
growth factor (NGF) is an essential agent for the optimal function of keratinocytes and free
cutaneous nerve endings. Since inflammatory cytokines play an important role in cutaneous
inflammation, as does NGF in normal keratinocyte proliferation and wound healing, the effects of
the neuropeptides galanin (GAL), vasoactive intestinal polypeptide (VIP), substance P (SP) and
calcitonin gene-related peptide (CGRP) on NGF, IL-1a, IL-8 and TNF-a production were studied.
Cultures of HaCaT cells and normal human keratinocytes were treated with 1018 M GAL, VIP,
SP or CGRP for 30 minutes. After washing, the cells were fed with fresh medium and their total
RNA was isolated after 1, 3, 6, 12 and 24 h and subjected to reverse transcription. Quantitative
real-time PCR reactions were performed with specific primer pairs and 18SrRNA as internal
control. The NGF protein production was determined in the protein extracts of the cells by
Western blotting and NGF secretion was measured by an ELISA technique. The results
demonstrated that the neuropeptides have different effects on NGF production. In HaCaT cells,
GAL and SP upregulated NGF mRNA expression, but CGRP and VIP caused no alterations. The
positive effect of GAL on NGF protein production was verified by the Western blot assay, which
showed more than a 2-fold protein amount after 24 h in GAL-treated cells. Interestingly, an
increased NGF secretion could not be demonstrated in the cell culture supernatants. The
positive effect of GAL on the keratinocyte NGF mRNA production was more marked, but the
NGF secretion exhibited only a slight increase in the cell culture supernatants. Surprisingly, in
contrast with previous results, none of SP, CGRP, GAL or VIP was able to influence the IL-1a, IL-
8 and TNF-a mRNA levels significantly in HaCaT cells and cultured human keratinocytes.
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Immunohistochemical Analysis of EGFR and HER-2 in Patients with Metastatic
Squamous Cell Carcinoma of the Skin
E Maubec, P Duvillard, V Velasco, and M-F Avril
Departments of Dermatology and Pathology, Institut Gustave Roussy, Villejuif, France
Background. Metastatic squamous cell carcinoma of the skin often raise difficult
therapeutic problems. EGFR and HER-2, which belong to the epidermal growth factor
receptor family, are overexpressed in the most common tumors. Strategies have been
developed to target HER-2 and EGFR with tyrosine kinase inhibitors. Few data are
available about expression of EGFR and HER-2 in SCC of the skin. Overexpression of
EGFR and of HER-2 proteins has been reported.
Objectives. The purpose of present study was to investigate the expression of EGFR and
HER-2 in a series of metastatic SCC of the skin.
Methods. EGFR and HER-2 expression was studied by immunochemistry on 12 specimen of
metastatic recurrence of SCC of the skin and on 2 primary lesions of these tumors.
Results. All metastatic SCCs of the skin had a strong membranous expression of EGFR.
EGFR was also expressed in the two primary SCCs which were studied. HER-2 was weakly
expressed in one third of the specimen only with a membrane expression in 2 cases.
Conclusions. In our study, EGFR was overexpressed in all samples of metastatic SCCs of the
skin. Therefore, these metastatic tumors appear as suitable targets for treatment with
tyrosine kinase inhibitors. Additional studies are warranted to establish whether or not HER-2
is expressed in SCC of the skin.
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Signiﬁcance of Circulating T-Cell Clones in the Blood of Se´zary Syndrome Patients
N Ortonne, C Gaudez, D Huet, M Bagot, E Poszepczynska-Guigne, P Musette, A
Bensussan
INSERM U448, Cre´teil, France
Se´zary syndrome (SS) is characterized by a circulating clonal CD4þT cell population with skin
homing properties. Recently, new phenotypic markers of Se´zary cells have been described:
CD158k/KIR3DL2, a MHC class I antigen receptor of the killer cell immunoglobulin-like receptor
family, and SC5, a transmembrane receptor that is also over-expressed by normal activated T
cells. CD158k has been shown to be a highly sensitive and specific marker of Se´zary cells.
Detection of clonal TCR gene rearrangement in the blood of SS patient is common. Whether
circulating clonal T cells in SS are only malignant, or comprise normal activated lymphocytes is
unknown. T-cell clonality is however widely used for the diagnosis and follow up of SS. The aim
of this study was to determine the significance of circulating T cell clones in SS, using anti-
TCRVB antibodies and the newly described phenotypic markers CD158k and SC5.
Thirteen SS patients were included in the study. Determination of T-cell clones was performed on
peripheral blood mononuclear cells (PBMC) using a sensitive TCRVB complementarity-determining
region 3 (CDR3) spectratyping and sequencing approach. One and two-color flow cytometry
(FACS) analysis was used for TCR VB subfamily, CD158k and SC5 phenotyping on PBMC.
In all patients, one color FACS analysis showed that a major subset of CD4þ lymphocytes
expressed CD158k and SC5. A total of 31 T-cell clones were identified by CDR3 spectratyping and
sequencing. Unique (monoclonal) or multiple (monoclonal and oligoclonal) TCRVB subfamily CDR3
spectratype patterns were identified. Among these 31 T-cell clones, 19 were studied using the
corresponding anti-TCRVB subfamily antibodies, and 13 were shown to be expressed. Two-color
FACS analyses results were as follow : 1-) In 6 patients, coexpression of one clonal TCRVB with
CD158k was present, thus identifying the malignant T-cell clone. In 3 of these patients however,
CDR3 analyses identified, in addition to the malignant CD158kþT-cell clone, one or two minor T-
cell clones. In all 6 patients, the malignant clonal population expressed SC5. 2-) In 5 patients, only
normal T-cell clonal population were identified, characterized by a CD158k – SC5þphenotype. In
these patients, no CD158kþSC5þmalignant T-cell clone could be characterized. In one of these
5 patients, the T-cell clone remained detectable by CDR analyses even after clinical remission was
obtained. 3-) In 2 patients, in whom 3 and 5 T-cell clones were detected by TCRVB CDR3 analysis
respectively, TCRVB phenotyping failed to detect any of the clone.
This study shows that circulating clonal CD4þT cells in SS can be either malignant or normal
activated T-cell populations. TCRVB CDR3 analysis also identifies T-cell clones, either with
monoclonal or oligoclonal CDR3 spectratype patterns, that are not phenotypically expressed.
These findings may incite to limit the use of clonality and TCRVB phenotyping for the identification
and follow-up of malignant T cells in SS, and rather perform CD158k and SC5 phenotyping.
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Fluctuations in Recent Thymic Emigrants in Peripheral Blood Measured Over Time,
Correlates With Disease Activity in Atopic Dermatitis
H Just, M Deleuran, B Deleuran, K Thestrup-Pedersen
Aarhus, Denmark
T-cell receptor excision circles (TREC) is an episomal DNA circle produced during T-cell
receptor rearrangement and is used as a marker for recent thymic emigrants. To investigate
peripheral T-lymphocyte turnover in patients with Atopic Dermatitis (AD), TREC in CD4þ and
CD8þ T-cells was measured over time in a group of 8 patients.
Each patient was clinically scored with SCORAD and blood samples were obtained once a
month over a period of six month. Peripheral blood mononuclear cells (PBMC) were isolated
from the blood samples and subsequently CD4þ and CD8þ T-cells were isolated by positive
immunoselection using Dyna-Beads. TREC levels were analyzed by real-time quantitative
PCR. To normalize for input of DNA, the Ca constant region and b2microglobulin were
amplified in every sample tested. Correlations to disease activity parameters were done by
Sperman Rank Order Correlation test.
The TREC content in CD8þ T-cells declined with increasing AD disease activity judged
by ‘‘Intensity’’ (CC¼0.37, p¼ 0.018) and ‘‘Extent’’ (CC¼0.35, p¼0.023), but not by
SCORAD (p¼ 0.06). The same trend but no significant correlations were seen between the
TREC content in CD4þ T-cells and AD disease parameters. Furthermore, there is a good
correlation between the variations in the TREC content in CD4þ and CD8þ T-cells over time
(CC¼ 0.9, p¼ 0.000). As we have shown before the TREC content declines with increasing
age.
These findings support our view that patients with AD can have an increased thymic output
combined with an increased peripheral proliferation of their T-cells. The decline in CD8þ
TREC does not seem to be caused by mere dilution due to increase in leukocytes, as these
were normal in AD. These new observations together with the previous findings support that
there are severe changes in the T-cell homeostasis in the peripheral T lymphocyte system of
AD patients.
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Evaluation of Treatment Efﬁcacy in a Cohort of 281 Patients with Stevens-Johnson
Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN)
J Schlingman, M Mockenhaupt, J-P Fagot, A Flahault, J-C Roujeau
For the EuroSCAR study group. Freiburg, Germany, Cre´teil and Paris, France
None of the treatments proposed for SJS or TEN has been yet proven efficient. Having
conducted a large case-control study of risk factors of these reactions, we also analyzed the
impact of treatments given to these patients.
A total of 379 cases of SJS and TEN had been included, after the diagnosis and severity of the
disease had been validated without information on risk factors, consecutive treatments and final
issue. Systematic collection of information on the treatments given after hospitalization was
organized for the 304 cases from Germany and France. Data were obtained in 281 cases
(92.4%). In this cohort we evaluated the risk of dying in relation with the treatments administered,
using a linear regression model including country and all variables that had an impact on
prognosis, i.e. age and extent of illness. Among the 281 patients, 119 had been treated only with
steroids, 75 had received high-dose intravenous immunoglobulins (IVIg) either alone (35 cases),
or in addition to steroids (40 cas), 87 had supportive management only. Treatment modalities
significantly differed between France (supportive 54%, steroids 19%) and Germany (supportive
12%, steroids 87%). The overall death rate in the group of patients analyzed was 22.1%, (62/281)
i.e. similar to that of the 304 German and French patients (22%) and of the total EuroSCAR cases
(21.6%). The risk of dying was significantly associated to age (OR¼ 3.3 [1.5–7.5] for 40–70 years
et OR¼8.9 [3.7–21] above 70), to extent of disease (OR¼ 2.3 [1.0–5.1] for SJS-TEN overlap and
OR¼5.6 [2.4–13] for TEN). Mortality stratified by treatment
Mortality (%) OR Univariate OR multivariate
Supportive only 22/87 (25%) 1 1
IVIG alone 12/35 (34%) 1.5 (0.7–3.6) 1.6 (0.6–4.3)
IVIG þ steroids 7/40 (18%) 0.6 (0.2–1.6) 0.5 (0.1–1.5)
Steroids alone 21/119 (18%) 0.6 (0.3–1.2) 0.4 (0.2–1.1)
This is the largest cohort ever analyzed. With the limitations inherent to observational studies
this is the best available evidence. The results show that IVIG confer no benefit towards
supportive care and that steroids may deserve formal therapeutic trials.
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In Vitro IL-5 Release in Patients with Cutaneous Adverse Drug Reactions – A Comparison
with In Vitro IFNc Release
R Zeligson, N Grossman and S Halevy
Beer-Sheva, Israel
Drug specific T-cells may orchestrate the inflammatory skin reactions in cutaneous adverse
drug reactions (CADRs) through release and induction of different cytokines. The diagnostic
value of IFNg (a Th1-type cytokine) release test has been reported in Th1 and Th2-type
reactions. IL-5 (a Th2-type cytokine) may also be of diagnostic value in CADRs.
This study was conducted in order to determine in vitro secretion of IL-5 by patients with
different CADRs after in vitro challenge with the suspected drugs and furthermore to compare
the in vitro IL-5 release test with the in vitro IFNg release test.
Sixteen patients who were diagnosed as having CADRs after taking 17 different drugs (1–5
drugs per patient), were included in this study. The CADRs were divided into Th1-type
reactions: maculopapular rash (5 patients), Th2-type reactions: urticaria (5 patients) and
immune complex reactions: vasculitis (6 patients). Sixteen patients who took 15 different
drugs (1–5 drugs per patient), without developing an adverse reaction served as controls.
Peripheral blood lymphocytes were incubated with the suspected drugs. The concentration
of IFNg and IL-5 in the supernatants was determined by ELISA commercial kits. The increase
of cytokine concentration after in vitro challenge with the suspected drugs was calculated for
patients and controls. A value higher than the average cytokine secretion by the controls plus
two standard deviations was defined as a positive cytokine release test. 33 cytokine release
tests (IL-5 and IFNg) were performed in the group of patients as compared to 24 tests in the
controls. IL-5 test results were compared to IFNg test results of the same patients. The study
was conducted in a double blind manner.
IL-5 secretion was significantly higher (po0.0001) in patients compared to controls.
Positive IL-5 responses were obtained for a variety of drugs and CADRs: sensitivity 62.5%;
specificity 93.7%. The distribution of positive IL-5 responses according to the type of CADR
was: urticaria 80% (4/5), maculopapular rash 40% (2/5), vasculitis 66.6% (4/6). Positive IFNg
responses were obtained for a variety of drugs and CADRs: sensitivity 81.25%; specificity:
87.5%. The distribution of positive IFNg according to the type of CADR was: urticaria 80% (4/
5), maculopapular rash 60% (3/5), vasculitis 100% (6/6). Agreement between IL-5 test and
IFNg test results was 42.5% (kappa¼ 0.11; poor agreement).
The results of this study indicate that IL-5 is released in vitro after challenge with a variety of
drugs in Th1-type and Th2-type CADRs. IL-5 test is less sensitive than IFNg test and is more
sensitive in patients with Th2-type CADRs compared to patients with Th1-type CADRs.
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Chemosensitization of Malignant Melanoma by Bcl-2 siRNA
V Wacheck1, D Losert1, S Strommer1,2, B Jansen1,2, and H Pehamberger2
1Clinical Pharmacology, Sect of Exp. Oncology/Mol. Pharmacology, 2Dept of Dermatology
Medical University of Vienna, Vienna, Austria
Malignant melanoma is a highly chemoresistant type of tumor and with currently available
treatment options the prognosis is poor: dacarbazine (DTIC), as the only FDA approved
chemotherapeutic agent for melanoma, results in low response rates and the duration of
responses is short. Even with innovative combinatorial treatment regimes, no fundamental
breakthrough has been reached. More than 90% of all melanomas express the anti-apoptotic
protein Bcl-2 shown to contribute to a chemoresistant phenotype in melanoma and a variety
of other malignancies. We have previously demonstrated, that inhibition of Bcl-2 by antisense
oligonucleotides provides a promising strategy to sensitize malignant melanoma to several
apoptosis inducing treatment modalities. Over the last couple of years, small interfering RNA
(siRNA) emerged as a novel and even more powerful technique for targeted downregulation
of target mRNA. We therefore evaluated synthetic siRNA molecules targeting Bcl-2 as
strategy to silence Bcl-2 expression in malignant melanoma cells. In a screening approach we
identified two siRNA with high potency for specific downregulation of Bcl-2 expression in
melanoma cells. These siRNA resulted in an up to 15 fold reduction of bcl-2 mRNA levels and
only still barely detectable Bcl-2 protein expression at low nanomolar concentrations. In cell
growth experiments, silencing of Bcl-2 in melanoma cells by both siRNAs resulted in only
moderate inhibition of cell growth and apoptotic cell decay, respectively. In contrast, if siRNA
targeting Bcl-2 were combined with low doses of the apoptosis inducing chemotherapeutic
cisplatin, a massive increase of apoptotic cell death compared to controls was observed.
Notably, the combination of the Bcl-2 targeting siRNA with low dose cisplatin resulted in a
nearly complete suppression of cell growth whereas cell growth of cisplatin only treated cells
was only modestly affected (97% vs. 24%; po0.001).
Our findings underline a key role for Bcl-2 in conferring chemoresistance to melanoma and
highlight Bcl-2 siRNA strategies as novel and highly effective tools with the potential for future
targeted therapy of malignant melanoma.
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Somatostatin Receptor Scintigraphy with 111 In-DOTA–Lanreotide and 111In–DOTA –Tyr3 -
Octreotide in Patients with Melanoma Stage IV: In Vitro and In Vivo Results
J Valencak, E Heere-Ress, T Traub-Weidinger, M Raderer, A Schneeberger, T Thalhammer,
S Aust, G Hamilton, I Virgolini and H Pehamberger
Depts. of Dermatology, Nuclear Medicine, Internal Medicine I, Pathophysiology, Ludwig
Boltzmann Institute of Clinical Oncology; University of Vienna, Vienna, Austria
Background. The overexpression of somatostatin receptors (SST-R) on various tumor cells
provides the molecular basis for the successful use of radiolabelled SST analogues in clinical
oncology. The aim of this study was to evaluate the tumor binding of 111In-DOTA-Lanreotide
(DOTA-LAN) and 111In-DOTA-Tyr3-Octreotide (DOTA-OCT) in patients with melanoma stage
IV. In addition, we have performed in vitro evaluations of potential antiproliferative effects of
SST analogues along with assessment of the functionality of SST-R in malignant melanoma.
Patients and Methods. A total of 22 patients with advanced metastatic melanoma underwent
scintigraphy with a radiolabelled SST-analogue. In addition, in vitro binding, growth inhibition
and influence of the SST analogues LAN and OCT on cell cycle distribution were performed in
four melanoma cell lines (SK-MEL28, 518A2, JUSO, 607B).
Results. Thirty-eight out of 57 lesions were positively imaged with 111In-DOTA-LAN (67%),
while the remaining 19 (33%) were negative. With 111In-DOTA-OCT scintigraphy, 8 (44%) of
the 18 documented lesions were imaged, whereas the remaining 10 (55%) had no uptake. In
vitro, cell lines (n¼ 4) showed no inhibition of growth in presence of LAN or OCT, and no
influence on cell cycle distribution was found despite detection of mRNA for SSTR1, 2 and 4
using PCR. Fluorescence-labelled LAN was not internalised after binding to the cell surface of
the melanoma cell lines.
Conclusions. 111In-DOTA-LAN and 111In-DOTA-OCT were able to visualize melanoma
metastases in a high proportion of patients. By contrast, in vitro experiments did not reveal
functional surface SST-R in the four cell lines investigated, and SST-analogues did not
influence growth or cell cycle distribution.
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Imiquimod Treatment Induces Opioid Growth Factor Receptor Expression – a New Way
to Defeat the Tumor?
M Urosevic, P A Oberholzer, T Maier, J Hafner, E Laine, G Burg and R Dummer
Zurich, Switzerland
Imiquimod is a local immune response modifier that has demonstrated efficacy in clearing
superficial basal cell carcinoma (sBCC). Via interaction with Toll-like receptor 7 on immune
cells, imiquimod induces local production of cytokines, such as interferon (IFN)-a. To more
closely define and elucidate mechanisms leading to BCC clearance in vivo, we examined
gene expression profiles of skin sBCC before and after treatment with 5% imiquimod cream
(Aldara
s
, 3M Pharmaceuticals, St. Paul, MN) by using Affymetrixt HG-U95A high-density
oligonucleotide arrays that contain approx. 12’000 genes. Imiquimod predominantly induces
genes involved in different aspects of immune response. In addition, array data indicated that
imiquimod treatment induces expression of opioid growth factor receptor (OGFr), a molecule
with anti-proliferative properties recently reported to be a target for anti-tumor antibody
responses. By using quantitative PCR (LightCyclert) we confirm OGFr up-regulation in Aldara-
treated sBCC skin samples. Immunohistochemistry revealed in vivo up-regulation of OGFr
protein on tumor and on infiltrating cells after Aldara treatment. By using BCC cell lines treated
with IFN-a or imiquimod, we show that up-regulation of OGFr mRNA as well as OGFr protein is
IFN-a- rather then directly imiquimod-mediated. By using tissue microarray containing 52
BCCs, we demonstrate OGFr expression in almost half of the cases. Expression of OGFr
correlated with a longer recurrence-free period in BCC that recurred after radiotherapy.
Through IFN-a–mediated up-regulation of OGFr, imiquimod might not be only suppressing
tumor growth but it might as well increase tumor immunogenicity.
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Monocyte Derived Dendritic Cells Mature in Response to the TLR7 Agonist Loxoribine
A Farkas, G Burg, F O Nestle
University Hospital Zu¨rich, Department of Dermatology, Zu¨rich, Switzerland
Introduction: Dendritic cells (DCs) are potent antigen-presenting cells recognizing micro-
organisms, secreting pro-inflammatory cytokines and stimulating primary T cell immune
responses. Therefore DCs are potential candidates in the immunotherapeutic approaches for
cancer. Current vaccination trials have tested myeloid DCs in advanced tumour patients.
Optimal DC vaccination parameters in humans remain to be established. One of the open
questions is the optimal maturation of DC preparations. A group of transmembrane proteins
called Toll-like receptors (TLRs) can relay critical signals for regulating DC functions such as
maturation status. Monocyte derived myeloid DCs express a whole set of TLRs but there is
controversy concerning their TLR7 expression. Substituted low-molecular-weight nucleo-
sides activate immune cells and lead to cytokine secretion. Loxoribine, a potent guanosine
analog, which signals through TLR7, shows antiviral and anti-tumor activity in murine animal
models and has entered phase I clinical trials.
Aims Of The Study. To define the TLR7 expression of myeloid DCs and to define the
maturation status of myeloid DC preparations after loxoribine incubation.
Materials And Methods. Monocyte derived DC cultures were set up using IL-4 and GM-CSF.
At day 7 immature DC cultures were treated with a standard maturation cocktail (IL-4, GM-
CSF, TNF-alpha, IL-1beta, IL-6) and/or different loxoribine concentrations. A maturation
cocktail without IL-6 was also tested with or without different loxoribine concentrations. FACS
analysis of surface co-stimulatory molecules of DCs was performed on day 10. In other sets
of experiments RNA was isolated from monocytes and from DC cultures at different time
points. After reverse transcription real time quantitative PCR was performed using specific
human TLR7 primers.
Results And Discussion. Loxoribine treatment of DCs resulted in increased cell surface
expression of CD80, CD83 and CD86. DCs stimulated with TNF-alpha, IL-1beta plus
loxoribine had a similar phenotypic characteristics as of DCs stimulated with the standard
maturation cocktail and their CD86 expression was even higher. Our real time PCR results
showed that purified monocytes and myeloid DCs derived from them express TLR7 on the
mRNA level and that myeloid DCs upregulate their TLR7 mRNA expression after loxoribine
treatment. These results suggest that loxoribine is a likely candidate for use as an adjuvant for
DC-based cancer immunotherapy.
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An Investigation of PIIINP as a Marker of Hepatic Fibrosis in Psoriasis: Does the Arthritis
Affect PIIINP Levels?
K Lindsay1, A Gough2, A Layton1, M Goodfield2, A Fraser1
1Leeds General Infirmary, Leeds, West Yorkshire, United Kingdom 2Harrogate District
Hospital, Harrogate, West Yorkshire, United Kingdom
Background: A serum marker of collagen turnover, Procollagen III
N terminal peptide (PIIINP) is used principally by dermatologists as a marker of hepatic
fibrosis to reduce the need to perform liver biopsies. Serial negative values have been found
to be of value in excluding hepatic fibrosis in psoriatic skin disease.1 Absolute PIIINP level is
used to make dosage decisions on psoriatic patients in the Dermatology department which
impacts on arthritis disease activity. PIIINP is found in the joint fluid in active arthritis and has
been reported as elevated in active psoriatic arthritis, reducing its utility in this group. For
patients with known hepatic histology we investigated its relation to joint disease activity to
investigate the hypothesis that any elevation in PIIINP may be due to joint disease activity.
Methods: We recruited 57 psoriasis patients under joint review by dermatologists and
rheumatologists, who were scheduled to have a liver biopsy performed to monitor long-term
methotrexate from Oct 2002 to March 2004. All patients were clinically assessed for joint
disease activity by tender joint count, swollen joint count and entheseal index. This was
compared to the serum PIIINP level on the day of the assessment, prior to liver biopsy. CRP
was also measured. Results: 48 patients with treated psoriatic arthritis and 9 with psoriasis
alone (6 male 3 female). Total 57. 16 (33%) of 48 arthritis patients had one or more of the
following: 5 or more swollen joints, 5 or more painful joints or an entheseal index greater than
5 to suggest disease activity. There was no correlation between PIIINP value swollen joint
count (P¼0.99) tender joint count (P¼ 0.74) entheseal index (P¼ 0.56), or CRP (P¼ 0.90).
There was a marginally significant difference between the PIIINP values of patients scoring 1,
2 and 3 on the Roenigk scale (Kruskal-Wallis test P¼ 0.06). There was a significant trend
towards higher PIIINP being associated with higher Roenigk score (Spearman correlation
P¼0.02 Conclusions: This group of patients are representative of those under follow-up by
rheumatologists across the UK with psoriatic arthritis treated with long term methotrexate. In
this study the PIIINP level was often elevated but this was not explained by either liver fibrosis
or by the presence or severity of psoriatic arthritis. Elevated levels occurred in the absence of
either arthritis or hepatic fibrosis. Regular PIIINP monitoring may still be of use in psoriatic
arthritis.
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The Incidence of Methotrexate Induced Hepatotoxicity in Psoriatic Arthritis
K Lindsay1, A Gough2, M Goodfield1, A Layton2, A Fraser1, M Walker2, F Reid1
1Leeds General Infirmary, Leeds, West Yorkshire, United Kingdom 2Harrogate District
Hospital, Harrogate, West Yorkshire, United Kingdom
Background: The aims of this study were to investigate the incidence of hepatic fibrosis in
psoriatic skin and joint disease treated with long-term methotrexate therapy. In addition we
aimed to assess known risk factors for MTX induced hepatotoxicity as well as those for
steatohepatitis (NASH), a new clinical entity seen in obesity which may confound histological
appearances. Methods During a 2 year period in two hospitals patients attending both
rheumatology and dermatology outpatients (n¼ 57) on a stable dose of long-term
methotrexate had liver biopsies performed in accordance with British society of Dermatol-
ogist guidelines. Clinical examination including BMI, waist and hip measurement, urine
dipstick to exclude diabetes. Laboratory analysis including LFT’s, clotting studies, CRP, FBC
and a PIIINP (procollagen III-N terminal peptide) Results 57 patients with psoriatic disease
had liver biopsies. Males¼32 Females¼ 25. Five males and 4 females had skin disease only.
Median age was 55 (range 30–78). Mean cumulative dose (4334mg). Mean weekly dose
14.8mg. Mean BMI 30.7. 14 patients had BMI greater than 30. Four patients had type 2
diabetes, 4 had renal impairment.
Results of liver biopsy showed that 13 patients of 5 (22.8%) had mild early fibrosis while 1
of those had bridging septal fibrosis. There were no cases of clinical liver disease or cirrhosis
found. Comparing those with presence of hepatic fibrosis and those without hepatic fibrosis
there was no significant difference with regard to age, sex, weekly dose or duration of
therapy. Patients with hepatic fibrosis had significantly lower cumulative dose and also
consumed fewer units per week of alcohol than those without. Those patients with a greater
number of recognised risk factors for hepatic fibrosis were more likely to have fibrosis (renal
impairment, DM, Obesity). Conclusions This study shows that the incidence of subclinical
mild hepatic fibrosis on methotrexate therapy is as common as previously shown. There was
no evidence that this was linked to methotrexate therapy alone. Neither is it suggestive of
alcohol as a major aetiological factor. The aetiology of fibrosis in these patients may be
multifactorial including non-alcoholic steatohepatitis.
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Cumulative Skin Irritation Potential of XMP.629, a New Antimicrobial Peptide for the
Treatment of Acne Vulgaris
K Beutner1, S Lemke1, S Hallett2, H Leung2, G F Vanhove2
1Solano Clinical Research, USA and 2XOMA (US) LLC, USA
Antibiotics are not as useful as they once were for acne treatment as Propionibacterium acnes
(P. Acnes) has developed antibiotic resistance. A significant opportunity exists for innovative,
effective, and safe topical agents that have no side effects and avoid antibiotic resistance.
XMP.629 is a nine amino acid peptide derived from bactericidal/permeability-increasing
protein (BPI), a human host defense protein localized within the azurophilic granules of
neutrophils. It has potent antibacterial activity against P. acnes and neither clindamycin nor
erythromycin resistance influences the sensitivity of P. acnes to XMP.629.
This phase I, single center, evaluator-blind study assessed the cumulative skin irritation
potential of XMP.629 gel (0.1%), vehicle and positive control (0.3% sodium lauryl sulfate)
following repeated topical applications to 35 healthy subjects. The test articles were applied
with occlusive patches to the subjects’ backs over 3 weeks. Patches were removed after 48
hours (72 hours when applied on Fridays) and evaluations of skin reactions on the test site
were made on a six-point scale. There were a total of 9 readings during the 3-week period.
Mean irritation scores were tabulated by test article and evaluation day and summed
across days for each test article. The cumulative irritation score for each test article is the
total irritation score divided by the highest theoretical score. No sites were discontinued due
to the severity of the irritation and no subjects were discontinued for any reason. Subjects
with barely perceptible erythema (score of 0.5) were counted as having slight erythema (score
of 1). The mean cumulative irritation score was tested pair-wise for product differences using
Fisher’s protected least significant differences in the context of the two-way analysis of
variance (ANOVA).
The results demonstrated that the mean cumulative irritation score for XMP.629 gel (0.1%)
was 0.08. This score was comparable to the mean cumulative irritation score for vehicle gel
(0.07) and markedly lower than the mean cumulative irritation score for the positive control
0.3% sodium lauryl sulfate, 0.25 (po0.001).
We conclude that XMP.629 acetate gel (0.1%) is well tolerated and should continue to be
evaluated for the treatment of acne vulgaris.
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Pruritic Skin Conditions During Pregnancy: Serum Bile Acid Levels are a Highly Reliable
Parameter to Diagnose Intrahepatic Cholestasis of Pregnancy (ICP)
CM Rudolph, M Trauner, H Kerl, RR Mu¨llegger
Graz, Austria
Pruritic skin changes are a common condition during pregnancy. Most of them are benign
and self-limiting with no impact on fetal outcome. ICP, however, may cause severe fetal
distress and carries a risk for stillbirth and preterm delivery. Early diagnosis and treatment
are therefore essential. Its clinical presentation with pruritus and secondary skin lesions
(excoriations, prurigo) in late pregnancy is unspecific and may be confused with specific
dermatoses of pregnancy and atopy-related skin changes.
To evaluate the significance of elevated serum bile acid (SBA) levels in the diagnosis of ICP.
SBA levels (assessed by RIA; normal range 0–6mmol/l) of 75 female patients (mean age
28.7y, range 15–44y) seen from 1999–2004 for pruritic skin changes during pregnancy at a
specialized dermatologic pregnancy clinic in a university-based hospital were retrospectively
analysed with special interest to diagnosis and clinical presentation. Dermatologic diagnoses
were as follows: specific dermatoses of pregnancy (14pts.), ICP (11), atopy-related skin
changes (46) and others (4): drug reaction (1), pityrasis rosea (1), psoriasis (2).
Elevated SBA levels were found exclusively in all patients with ICP (mean 37.4mmol/l, range
7.3–138mmol/l) compared to the other diseases (mean 2.3mmol/l, range 0.4–4.5mmol/l)
[w2¼75, p¼ 0.000].
As the clinical presentation of ICP is overlapping with other pruritic skin conditions during
pregnancy, the diagnosis should be based on elevated SBA levels, which have proven to be a
highly reliable parameter.
377
Sentinel Lymph Node Biopsy in Melanoma Patients with Clinically Negative Regional
Lymph Nodes – Analysis and Importance of Sentinel Node Status
F Roka, H Kittler, P Cauzig, C Hoeller, G Hinterhuber, K Wolff, H Pehamberger, E Diem
Vienna, Austria
Sentinel lymph node biopsy has become a widely accepted standard procedure in staging
and treatment of patients with cutaneous melanoma and absence of lymph node metastases,
despite there is no final proof that sentinel node biopsy may influence overall survival of these
patients. This study investigated the accuracy of this procedure and the clinical outcome of
patients after a mean follow up of 22 months.
Between 1998 and 2003, sentinel node biopsy was performed in 309 consecutive patients.
Patients with one or more positive sentinel nodes, identified by concurrent histopathology
and immunohistochemistry, were subjected to completion elective lymph node dissection.
Survival analyses were performed using the Kaplan-Meier approach. A Cox-proportional
hazard analysis was used for univariate and multivariate analysis to explore the effect of
variables on survival.
One or more sentinel nodes were identified in 299 of 309 patients (success rate: 96,8%). Of
these, 69 (23%) had a positive sentinel node. The false-negative rate was 10%. Recurrence of
disease to the regional lymph node basin (3.5%) and to the locoregional skin (2,6%) was
rare in SLN- negative patients in contrast to SLN- positive patients (7.2%, and 17.4%,
respectively). Three-year disease-specific survival was 93% and 83% for SLN-negative and
SLN-positive patients, respectively. Upon multivariate analysis, sentinel node status
(po0.001), Breslow thickness (po0.02), and ulceration (po0.026) were all found to be inde-
pendent prognostic factors in respect to disease-free survival, whereas Breslow thickness
proofed to be the only significant factor in respect to disease-specific survival.
SNB proofed to be a reliable procedure for accurate staging of nodal status in melanoma
patients without evidence of nodal disease. Our data indicate that the status of the SLN node
is predictive for disease-free survival but not for disease- specific survival, upon multivariate
analysis. Final results from ongoing trials are needed to clarify the role of lymphatic mapping
and sentinel node biopsy on overall survival for patients with malignant melanoma.
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Electrically Evoked Itch Indicates the Existence of Novel C-Nerves for Itch
A Ikoma, Y Miyachi, H Handwerker and M Schmelz
Kyoto, Japan and Erlangen and Mannheim, Germany
Histamine is the best known pruritogen. Previous studies investigating itch mechanism
in human beings were based mainly on histamine and histamine-releasing substances.
Recently, a specific neuronal pathways for histamine-induced itch have been identified.
However, antihistamines are of limited value in many pruritic diseases like atopic dermatitis,
suggesting a minor role of histamine as a clinical pruritogen. The purpose of this study was to
investigate mechanism of non-histaminergic itch evoked by a newly developed electrical
stimulation on human skin.
Electrical stimulation with constant current (2 ms, 50 Hz) was applied via a 0.1  7 mm
electrode to non-lesional wrist skin in ten patients with atopic dermatitis and ten healthy
volunteers. As a control, histamine iontophoresis was applied through a 0.1 to 0.2  7 mm
slit to the wrist skin of the same ten healthy volunteers. The axon-reflex flare was measured
by a laser Doppler imager. The area of alloknesis (itch evoked by non-itchy mechanical
stimuli) was planimetrically measured. Electrical stimulation with different pulse duration (80
micros to 8 ms) and frequency (2 Hz to 200 Hz) was also applied and the intensity of evoked
sensation was compared among them.
Itch was the main sensation evoked by electrical stimulation and always perceived with a
time lag of approximately one second compared to the stimulation. There was no significant
difference observed in evoked reactions between healthy volunteers and patients. Itch
intensity was controlled by varying current intensity. Electrically evoked itch was not
accompanied by axon-reflex flare, while histamine iontophoresis provoked a marked flare
reaction. The area of alloknesis induced by electrical stimulation was larger than by histamine
iontophoresis. At a given current intensity, 2 ms or longer pulse duration was found to be
necessary to evoke itch sensation. The intensity of itch sensation was proportional to the
frequency of stimulation.
Itch can be evoked by our newly developed electrical stimulation without any involvement
of peripheral chemical mediators like histamine. The time lag between stimulation and itch
sensation and the necessity of longer pulse duration for evoking itch suggest that C-fibers are
responsible for electrically evoked itch. However, these fibers are not identical to the
previously described histamine sensitive fibers, because their low electrical threshold and the
absence of an axon reflex erythems. It can be concluded that this method is useful to
investigate non-histaminergic itch mechanism.
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Cutaneous Field Stimulation; Effects on Skin and Spinal Ganglia in Rat
J Wallengren,1 K Moller,2 F Sundler3
1Department of Dermatology, 2Medical Neurochemistry and 3Physiological Sciences,
Section for Neuroendocrine Cell Biology niversity Hospital, Lund, Sweden
Cutaneous field stimulation is used to treat localized itch. The aim of the present study was to
determine whether such treatment induces morphological and neurochemical changes in the
dorsal root ganglia in 30 rats. Electrical stimulation using 0.13 mA or 0.53 mA, 30 min a day
for 10 days. Punch biopsies from the thoracal skı´n and the corresponding dorsal root ganglia
were collected post mortem. In both experimental groups, cutaneous electrical stimulation
induced a proliferation of sensory nerve fibers in the skin. The mean number of PGP 9.5-IR
nerve fibers was 31252 and 29167, respectively vs. 20947 in the controls, the number
of CGRP-IR nerve fibers being 6619 and 6616, respectively vs 4014 in the controls.
Only stimulation by 0.53 mA induced an upregulation of sensory neuron markers in the dorsal
root ganglia, the lower stimulation intensity having no visible effect on ganglia. The mean ratio
of pos/neg PGP-IR cells was 418% vs 356 in controls, the mean ratio of pos/neg CGRP-
IR cells was 376% vs. 335, and the mean ratio of pos/neg VR1-IR cells was 466% vs.
425. We conclude that serial cutaneous electrical stimulation by a moderate current in rat
does not induce morphological and neurochemical changes in the dorsal root ganglia.
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Unique Distribution of Cytochrome P450 1B1 and 2A6 in Extramammary Paget’s Disease
Y Kawakubo, Y Sato, E Yoshinaga, H Suwabe and S Izaki
Department of Dermatology, Saitama Medical Center, Saitama Medical College, Kawagoe,
Japan
Cytochrome P450 1B1 (CYP1B1) is a recently cloned dioxin-inducible form of CYPs and now
known to be expressed as enzyme protein not only in malignant tumor cells but also in several
normal cells including neurons, astrocytes and glandular epithelial cells of the breast. The
enzyme is responsible for metabolic activation of procarcinogens. Cytochrome P450 2A6
(CYP2A6) activates several anti-cancer drugs such as Tegafur metabolically. Therefore the
investigation on the expression profile of these enzymes in skin cancers may provide useful
clinical information and realize a rational anti-cancer therapy.
Thirty-six cases of extramammary Paget’s disease (EMPD) were studied by immunohisi-
tochemical technique using anti-human CYP1B1-specific peptide rabbit serum (Gentest, MA,
USA) and anti-human CYP2A6 mice monoclonal antibody (Gentest, MA), respectively. Anti-
CYP1B1 antiserum consisitently reacted with smooth muscle cells and eccrine sweat gland
cells in the skin so that they could be used as positive internal control. Tumor cells of EMPD
were well stained with good contrast towards surrounding epidermal keratinocytes which
showed less or no immunoreactivity (24 cases/total 36 cases). Eccrine gland secretory cells
were positively reacted by anti-CYP2A6 antibody. In case of EMPD, tumor cells in 21 cases
were positive for anti-CYP2A6 antibody. These data will be helpful for the development of
new effective method for diagnosis and drug therapy in EMPD.
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An Examination of Pigmentary and Non Pigmentary Response to UV Radiation in
Humans
A Hennessy1, C Oh1, B Diffey2, J Rees1
1Department of Dermatology, Edinburgh University, Edinburgh, 2Medical Physics, New-
castle General Hospital, Newcastle, UK
The roles of pigmentation and hyperplasia in the photoprotection of skin are not completely
understood; although, it is known that both play a vital role in the protection of skin cells from
UV insult. An attempt has been made here to increase the understanding of these processes
using UV absorption spectroscopy. Suction blisters were removed from the lower back of
volunteers, and placed into a saline filled cavity within a quartz cuvette. Equal UV doses were
applied to 21 healthy volunteers including 4 asians and 17 caucasians, of whom 3 had red
hair. The absorption spectrum (250nm–400nm) of the irradiated area was compared with that
of an adjacent control area in each case.
A mathematical model allowed the calculation of the thickness ratios and the melanin ratios
of any two pieces of skin. Different responses were observed for different skin types.
Caucasian skins showed no increase in melanin, but a significant increase in thickness when
normalised to a given skin sample: 0.99 (SEM 0.07) to 1.27 (SEM 0.08) (p¼ 0.004), while asian
skins showed no thickness increase yet a melanin increase, although this was not significant:
2.75 (SEM 0.57) to 2.98 (SEM 0.46) (p40.01).
Probability of DNA damage, P, was calculated (Setlow 3363–66), and the asian skins had
the lowest P overall: 1.16107 (SEM 0.08107); however, the red haired caucasian skins
showed the greatest decrease in P on tanning: 2.49107 (SEM 0.17107) to 1.47107
(SEM 0.18107) (p¼ 0.002), indicating greatest levels of photoprotection. When split into
the individual components of melanin, scatter and thickness, the results mirrored those
obtained using the ratio calculations.
Correlation between the two models was excellent, although poorer in general for the
darker skins; however, since sun damage and related skin cancers are found almost
exclusively amongst the caucasian populations, the model provides an accurate measure of
the effect of UV exposure on epidermal hyperplasia and pigmentary response for those at
most risk from sun damage. Both pigmentation and hyperplasia can play a role in
photoprotection; however, hyperplasia resulted in red haired caucasians exhibiting the
highest levels of photoprotection on irradiation.
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Possible Mechanisms of Action of Iloprost in the Treatment of Patients with Systemic
Sclerosis – Inﬂuence on the Expression of Adhesion Molecules and T-cell Proliferation
P Rehberger, P Beckheinrich, E Wandel, U -F Haustein, M Sticherling
Department of Clinical and Experimental Dermatology, University of Leipzig, Leipzig
Iloprost is a stable prostacyclin analogue commonly employed in the treatment of peripheral
vascular disease: It has also been used successfully in the treatment of severe Raynaud’s
phenomenon (RP) associated with systemic sclerosis (SSc). Several mechanisms of action of
the drug other than vasodilation and antiplatelet effects have been demonstrated that may be
involved in its clinical efficacy.
The aim of the present study was to investigate the long-term influence of Iloprost infusions on
disease activity related factors like expression of soluble adhesion molecules and T-cell reactivity.
Serum blood samples were collected before therapy and at time points 0, 1, 2, 3 and 6 months
after therapy and examined for Endothelin-1 (ET-1), Vascular Endothelial Growth Factor (VEGF)
and soluble adhesion molecules sICAM-1, sVCAM-2 and sE-Selectin using specific enzyme-
linked immunoassays.
Human PBMC of patients with systemic sclerosis were incubated with three stimuli to cover
different ways of T-cell activation: non-specific (PHA), receptor mediated (IL-2) and antigen specific
receptor mediated (tetanus toxoid (TT)). Activation of PBMC was evaluated by measuring the
proliferation in a BrdU-ELISA as well as cytokine production by either an IFNg or IL-4 ELISA.
All patients showed a clinical reduction in severity and number of Raynaud attacks. Mean serum
levels of sE-Selectin, sVCAM-1, sICAM-1 and ET-1 were reduced after therapy with Iloprost. This
effect persisted at least for two months (ICAM-1). Serum levels of sE-Selectin, VCAM-1 and ET-1
were still reduced at the end of the study period after 6 months. Serum concentration of VEGF was
found to be elevated after infusion with Iloprost reaching the initial level 2 months after infusion.
The effect of Iloprost on the proliferation of PBMC showed great interindividual differences.
However, stimulated with 150 ng/ml Iloprost, 10 of 11 patients showed a decreased pro-
liferation. Similar effects – although not as pronounced – could be seen when cells were
stimulated with TT and IL-2. Comparison of the mean values of PBMC proliferation obtained
from the same patients after treatment with Iloprost revealed reduced proliferation when
stimulated by PHA and no changes when stimulated by TT and PHA. No effects of Iloprost on
the cytokine production could be seen at any time-point.
These results give further evidence of the previously described clinical benefit of Iloprost
infusions above all on RP in patients with SSc. Our study suggests that these effects might be
related to changes in serum levels of disease activity related markers and T cell proliferation
and can be followed for a prolonged interval after infusion therapy.
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Successful Treatment of Hereditary Angioedema with a Bradykinin Receptor Antagonist
K Bork, G Meng, K Wiest, B Grundt, V Schneiders
Department of Dermatology, University of Mainz, Germany
Bradykinin seems to play an important role in the pathogenesis of hereditary angioedema due
to C1 inhibitor deficiency: Bradykinin plasma levels are increased during acute attacks and in
a recently developed C1 inhibitor knock-out mouse model, it has been shown that Icatibant, a
bradykinin B2 receptor antagonist, reduced fluid extravasation and edema formation. We
treated 11 acute edema attacks, moderate or severe, in 10 patients with hereditary
angioedema with Icatibant (Jerini AG, Berlin, Germany), a dekapeptide which is highly
specific for the bradykinin B2 receptor. Treatment was started less than 10 hours after the
beginning of the edema episodes. The patients received Icatibant (8 patients 0.4 mg/kg body
weight; 3 patients 0.4 mg/kg body weight) intravenously as an infusion. The course of the
treated edema episodes was evaluated using questionnaires, visual analogue scales and
photodocumentation. We compared the usual course and duration of the treated skin and
abdominal attacks with that of edema attacks that had occurred previously in the same
patients at the same location as the current attack (10 to 600 attacks per patient). Treatment
with Icatibant considerably shortened the time between beginning of the attack and of the
resolution of symptoms (untreated attacks: mean: 41.3 hrs, treated attacks: mean: 10.7 hrs).
The duration of the treated attacks was also shorter than that of previous, untreated attacks
(untreated attacks: mean: 73.5 hrs, treated attacks: mean: 24 hours). No drug-related adverse
effects were reported. The drug may be of considerable therapeutic value for patients with
hereditary angioedema.
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Certain Severity-Related Parameters in Atopic Dermatitis: Possible Candida Role and its
Theraputic Response
A H Ahmed1 and M El-naggar2
1Dermatology, Venereology & Andrology Department, 2Medical Microbiology and Immunol-
ogy Department, Faculty of Medicine, Mansoura University, Egypt
Objective: To evaluate certain severity-related markers of atopic dermatitis (AD) in relation to
Severity Scoring (SCORAD) and to clarify the relationship between Candida albicans
colonization and severity of AD with the effect of antifungal treatment on previous markers.
Design. A prospective study included 82 AD patients and 20 healthy controls. Patients were
grouped into two groups according to the severity of the disease. SCORAD index was detected
for each. Blood samples were taken for detection of total eosinophilic count, total IgE , Candida
albicans specific IgE, intercellular adhesion molecule-1 (ICAM-1) and eosinophil cationic protein
(ECP). Isolation and identification of Candida albicans was done, then an oral antifungal drug
(Fluconazole) was given for 4 weeks with monitoring changes in these parameters.
Results. There was significant increase in ECP, ICAM-1, total eosinophilic count, total IgE
levels in AD patients as compared with control especially the severe group (Po.001). Serum
levels of ECP, ICAM-1 represented high significant positive correlation with SCORAD.
Significant high incidence of C. albicans isolates were detected in both AD groups (Severe
group 40%, mild-moderate group 36.7%) with significant increase in C. albicans specific IgE
that could be correlated with SCORAD (Po.001). With Fluconazole, there was mild to moderate
significant improvement of SCORAD, decrease of ECP & ICAM-1 with high sgnificant decrease
in C. albicans specific IgE.
Conclusions. Eosinophils are important effector cells in AD. The serum levels of ECP and ICAM-
1 have been proven to be high significant predictors of disease severity. Isolation of Candida
albicans and high level of its specific IgE especially in severe AD group that could be correlated
with SCORAD confirms a possible role of antifungal treatment of AD with positive C. albicans
isolation.
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What Factors may Contribute to the High Degree of Variation in Erythemal Response to
Ultraviolet Radiation (UVR) at Different Body Sites?
K Waterston, L Naysmith, J L Rees
Systems Group Dermatology, University of Edinburgh, Scotland
We have previously reported a fivefold variation in erythemal response to UVR at different
body sites within one person. We have explored two possible reasons for this; firstly, that
body site variation in constitutive pigmentation partly determines some of this variability;
secondly, that resting dermal microvasculature flow variation may relate to the UVR induced
vascular response at a particular site.
To explore variation in pigmentation and its relation to erythema we irradiated 4 volunteers
with 10 doses (38–300mJ/cm2) of broadband UVB (PLS 9w/12) at 12 paired body sites (240
potential data points per person) and measured the melanin index (MI) on closely adjacent
unirradiated skin. Erythema was measured at 24hrs using reflectance. To see if basal
pigmentation at one site could predict erythema at other body sites we irradiated 15
volunteers at 3 sites with 5 doses of UVB (119–300mJ/cm2) and recorded the colour of sun
protected buttock skin with tristimulus colorimetry (Lab) and MI. Erythema was measured
at 24hrs using laser Doppler flowmetry. To see if variation could be explained by differences in
regional basal blood flux differences we recorded Doppler flowmetry at 9 body sites in 9
volunteers.
When the MI was recorded adjacent to the irradiated body site, simple regression of
erythema on MI was highly significant for each individual (all po0.001, R2 of 0.75–0.83) for the
highest dose (300mJ/cm2). Yet Lab and MI measurements of basal (buttock) skin colour
showed a poor correlation with erythema at other sites (Spearman’s rank correlationo0.3)
suggesting that basal skin colour cannot usefully predict erythema elsewhere. Baseline blood
flux showed a mean 3-fold variation (range 16–52) but the ranking of sites differed from that of
irradiated body sites. Therefore, baseline variation in flux cannot account for the degree of
variation in UVR induced erythema.
We conclude that body site variation in pigmentation, as measured by the MI, is a major
contributory factor to the variation in erythemal response to UVR within a person at different
body sites.
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Efalizumab for Patients with Moderate to Severe Chronic Plaque Psoriasis: Results of the
International Randomised, Controlled Phase III Clinical Experience Acquired with Raptiva
(Clear) Trial
W Sterry, L Dubertret L, K Papp, S Chimenti, and CG Larsen
Berlin, Germany; Paris France; Waterloo, Ontario, Canada; Roma, Italy; Aarhus C, Denmark
Psoriasis is a chronic immune-mediated skin condition that requires treatment over decades. No
curative agents are available, and long-term administration of the most effective systemic agents
or phototherapy is generally limited due to toxicity. Efalizumab is a recombinant humanised
monoclonal IgG1 antibody that inhibits key T-cell processes that contribute to the pathogenesis
of plaque psoriasis. Previous clinical trials of efalizumab have demonstrated the efficacy, safety
and tolerability of efalizumab for treating moderate to severe chronic plaque psoriasis. The
present Phase III trial was designed to further evaluate the safety and efficacy of efalizumab in
patients with moderate to severe chronic plaque psoriasis in 54 international centres in Australia,
Canada, Europe and Russia. This double-blind, placebo-controlled trial randomised 793 patients
in a 2:1 ratio to receive subcutaneous efalizumab 1 mg/kg monotherapy (n¼ 529) or placebo
(n¼264) weekly for 12 weeks. This included 526 ‘‘high need’’ patients (342 randomized to
efalizumab, 184 to placebo) for whom at least 2 systemic therapies were unsuitable due to lack of
efficacy, intolerance or contraindication. Efficacy analyses were performed on the intent-to-treat
population (n¼ 793); safety analyses were performed on the as-treated population (n¼ 793).
Efficacy and safety endpoints are discussed herein; health-related quality-of-life endpoints are
discussed in another abstract. At week 12, significantly more efalizumab-treated patients than
placebo achieved the primary endpoint, X75% improvement from baseline in their Psoriasis
Area and Severity Index (PASI-75; 31% vs 4%, Po.001). At week 12, 54% and 14% of
efalizumab-treated and placebo patients, respectively, achieved a 50% PASI improvement PASI.
Significantly more efalizumab-treated patients than placebo (27% vs 4%, Po.001) achieved a
static Physician’s Global Assessment of ‘‘excellent’’ or ‘‘clear’’ at week 12, the main secondary
endpoint. At week 12, the mean percent PASI improvement was 48% in the efalizumab group (vs
9% placebo, P o.001) with statistically significant differences between the treatment groups
noted at week 2. Adverse events were generally mild to moderate in severity. The most
commonly reported events (X5% of patients in either group) in efalizumab-treated and placebo
patients included headache (26% and 14%), ‘influenza-like illness’ (10% and 7%), pyrexia (8%
and 1%), arthralgia (7% and 3%), rigors (5%, both groups), myalgia (6% and 3%),
nasopharyngitis (5% and 4%), and pruritus (4% and 6%). The majority of these events reflect
the ‘acute adverse events’ associated with the first 1 or 2 doses of efalizumab, defined as
headache, chills, fever, nausea, vomiting or myalgia occurring within 48 hours of dosing. These
results are generally consistent with results from previous efalizumab studies, providing
confirmation of the efficacy and safety in patients with psoriasis. Once weekly efalizumab
monotherapy results in substantial improvement, demonstrating significant treatment effects on
both clinical and quality-of-life measures with an acceptable safety profile, indicating a
favourable benefit:risk ratio in adult patients with moderate to severe plaque psoriasis.
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Etanercept Therapy Results in a Sustained Improvement in Skin and Joint Disease in
Patients With Psoriatic Arthritis
B Goffe, AB Gottlieb, M Lebwohl, B Randazzo
Minor and James Medical, PLLC, Seattle WA; UMDNJ – Robert Wood Johnson Medical
School, New Brunswick NJ; Mount Sinai School of Medicine, New York, NY; Wyeth
Research, Collegeville, PA, USA
Etanercept (Enbrel) has demonstrated clinically significant benefits to patients with psoriatic
arthritis (PsA) and psoriasis. Following completion of a 24-week, double-blind, placebo-
controlled study of etanercept, 168 patients with PsA and psoriasis (81 originally on placebo;
87 originally on etanercept) enrolled in a 1-year open-label extension study. Psoriasis was
evaluated by target lesion score and Dermatologist Static Global Assessment (DSGA) of
target lesions, and Psoriasis Area and Severity Index (PASI) for patients with psoriasis X3%
body surface area. Arthritis was evaluated according to American College of Rheumatology
(ACR) criteria and PsA response criteria (PsARC). To date, total mean exposure to etanercept
was 27 weeks for placebo patients and 64 weeks for etanercept patients (maximum 97
weeks). Patients receiving etanercept maintained improvements in both PsA and psoriasis after
enrolment in the extension study, while patients originally receiving placebo demonstrated
similar improvement after receiving etanercept therapy. At 36 weeks of etanercept therapy
(n¼ 119), 49% of patients had ‘‘clear’’ or ‘‘almost clear’’ DSGA, 60% achieved ACR20, 37%
achieved ACR50, and 15% achieved ACR70. Of 72 patients evaluable for PASI, 64% achieved
a 50% improvement from baseline and 32% achieved a 75% improvement. Etanercept
continued to be well tolerated, with no increase in serious adverse events or infections.
Etanercept continues to be safe and effective in PsA and provides sustained improvement in
skin and joint disease for up to 97 weeks without the need for dose modification.
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Clinical and Pathologic Improvements in Patients with Psoriasis Following Etanercept
Monotherapy
AB Gottlieb, K Gordon, AA Gaspari, B Randazzo
Dermatology Department, Northwestern University, Chicago, IL, UMDNJ-RWJMS, New
Brunswick, NJ. University of Maryland, Baltimore Wyeth Research, Collegeville PA
Etanercept (Enbrel), a fully human soluble TNF receptor, significantly improved psoriatic
skin disease in patients with psoriatic arthritis. The purpose of this study was to determine
the clinical and pathologic improvements following etanercept treatment in a subgroup of
patients with psoriasis who underwent a skin biopsy. One hundred and twelve patients with
stable chronic psoriasis were enrolled in a multicenter, blinded, randomized 24-week study
and received either etanercept 25 mg (57 patients), or placebo (55 patients) by subcutaneous
injection twice weekly. The primary efficacy endpoint was 75% improvement in the psoriasis
area and severity index (PASI) at 12 weeks. Skin biopsy specimens were taken in a subgroup
of 31 patients (17 in the etanercept group, and 14 in the placebo group) at baseline and at
week 12. Biopsies were evaluated for epidermal Ki67 and keratin 16 expression, and
epidermal thickness. Biopsies from 11 patients were additionally evaluated for total CD3
count and keratinocyte ICAM-1 expression. Baseline disease severity and response to
etanercept were similar in the biopsied patients and those in the study as a whole. A
significantly higher percentage of patients who received etanercept achieved PASI 75 at 12
weeks (30%) compared with patients who received placebo (2%; po0.0001). Efficacy
continued to improve with longer treatment, with 54% of etanercept-treated patients and 5%
of patients who received placebo reaching the PASI 75 at 24 weeks (po0.0001). Statistically
significant improvements in patient global, physician global, and target lesion assessments,
and DLQ1 were also observed. Clinical efficacy was mirrored by improvements in biopsy
parameters at week 12 compared to baseline. Mean percent reduction in epidermal thickness
was significantly greater in the etanercept group versus the placebo group (44% versus 7%,
respectively; po0.05). Reduction in Ki67 and CD3 positive cells, and keratinocyte ICAM-1
and keratin 16 expression was also observed. Enbrel monotherapy was efficacious and well
tolerated in the treatment of psoriasis. Clinical efficacy was associated with improvement in
several important markers of inflammation including reduction in keratinocyte adhesion
protein expression and epidermal T cell infiltration, a decrease in epidermal thickness, and
diminished expression of keratinocyte activation and proliferation markers. Inhibition of TNF
activity with etanercept may prove useful in the management of psoriasis.
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Etanercept Efﬁcacy Results from an Integrated Multistudy in Patients With Psoriasis
PCM van der Kerkhof, W Sterry, J-P Ortonne, J Berth-Jones, B Randazzo
Universitair Medisch Centrum, Nijmegen, Netherlands; Charite Klinik fur Dermatologie,
Berlin, Germany; Hopital de l’Archet, Nice, France; University of Warwick, Coventry UK;
Wyeth Research, Collegeville, PA, USA
The purpose was to evaluate etanercept (Enbrel) efficacy in patients (n¼ 1187) with chronic
plaque psoriasis by pooling data from a phase 2 and two phase 3 studies. The results from
patients who received etanercept 25 mg BIW (N¼ 415) and placebo (N¼ 414), pooled from all
3 studies, and those who received etanercept 50-mg BIW (N¼358) and placebo (N¼ 359),
pooled from phase 3 studies were compared using a 2-sided Cochran-Mantel-Haenszel test
stratified by study. The primary endpoint for all 3 studies was a X75% improvement from
baseline in the Psoriasis Area and Severity Index (PASI75) at 12 weeks. A significantly higher
proportion of etanercept-treated patients achieved a PASI75 (33% of 25 mg BIW, po0.0001)
at week 12 than placebo, while 49% of those receiving 50 mg BIW etanercept in the 2 studies
achieved a PASI75 (po0.0001). Other measurements, such as physician/dermatologist-
reported endpoints including PASI 50 and 90 responses, percentage improvement from
baseline in PASI, Dermatologist’s Static Global Assessment of clear or almost-clear psoriasis,
and subject-reported endpoints, such as the Dermatology Life Quality Index (DLQI) and all
DLQI subscales, were significantly better in patients receiving etanercept than in those
receiving placebo. A higher degree of clearing at week 12 (PASI90¼ 21%) compared with
placebo (1%) was seen in patients receiving etanercept 50 mg BIW. There were no serious or
significant safety issues appearing in these trials and safety results were consistent with the
existing large database of RA patient experience. Results of this integrated analysis
demonstrated consistent, robust efficacy of etanercept therapy (25 mg BIW and 50 mg BIW)
for chronic plaque psoriasis. A high degree of psoriasis clearing, improvement in both
physician- and patient-reported outcomes, and significant impact on quality of life were seen
in patients in the studies.
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Age-Related Dermoscopic Prevalence of Clark Nevi
I Zalaudek, S Grinschgl, E Richtig, I H Wolf, A Blum, G Argenziano, +H Kerl, H P Soyer,
R Hofmann-Wellenhof
Department of Dermatology, University of Graz; Graz, Austria Department of Dermatology,
University of Tuebingen; Tuebingen, Germany + Department of Dermatology, Second
University of Naples; Naples, Italy
Background: The dermoscopic classification of Clark nevi (atypical melanocytic nevi) is
useful for the examination and the management of individuals with Clark nevi. Objective: To
evaluate whether individuals prone a predominant dermoscopic type of Clark nevi in relation
to their age. Design: Each lesion was photographed dermoscopically using Molemax
(Dermainstruments, Vienna, Austria). All digitized images were evaluated according to the
dermoscopic classification of Clark nevi (homogeneous, reticular, globular, homogeneous-
reticular, globular-reticular, and globular-homogeneous) and distribution of pigmentation (uni-
form, central hypopigmented, peripheral hypopigmented, central hyperpigmented, peripheral
hypopigmented, and multifocal). Lesions lacking any of these features were classified as not
specific. Setting: In a prospective setting individuals were recruited from our pigmented skin
lesion clinic in Graz between July 2000 and February 2001. Patients: All consecutive
individuals showing more than 10 Clark nevi were subdivided into 10 individuals per 5
designated age groups (0 to 15 years, 15 to 30 years, 31 to 45 years, 46 to 60 years, and
individuals older than 60years). During the data-evaluation we additionally invented a sixth
age group (summarizing all individuals older than 15 years) that was not included into the
primarily study design. Results: A total of 1268 Clark nevi was analyzed. There was a
continuously increase of nevi count with age, reaching the maximum in individuals aged from
46 to 60 years, but decreased again in the oldest age group. Among all Clark nevi, the
homogeneous-reticular type was most frequent (35.6%), followed by the homogeneous,
reticular and globular-homogeneous types (20.8%, 16.4%, 15.8%, respectively), whereas the
globular-reticular and globular types were seen in less than 7% and 5%, respectively. Only
2 nevi were classified as not specific. Most of Clark nevi revealed a uniform distribution
of pigmentation, followed by a central hyperpigmentation and multifocal pigmentation. An
eccentric hyperpigmentation, which is considered to represent an important melanoma
simulator, was seen in only 5.4% among all Clark nevi, but in about 30% of Clark nevi from
the globular-homogeneous type. Variations on the theme of the globular pattern were the
predominant dermoscopic features (globular-homogeneous, globular and reticular-globular
type in 36.2%, 24.3% and 21.1%, respectively) in the youngest age group, whereas the
homogeneous, the reticular and/or combinations of these two patterns were the predominant
types in the adulthood. The probability of the globular type of being presented in individuals
younger than 15 years was approximately 70%, but reached 97.8%, 97% and 96.2% for the
homogeneous-reticular, homogeneous and reticular types, respectively in individuals aged
more than 15 years.
Conclusion: Clark nevi in childhood and young adolescence exhibit variations of the
globular patterns, whereas the reticular and/or homogeneous types are the predominant
dermoscopic findings in adults. Clark nevi seem to be dynamic lesions that might change
their dermoscopic patterns during lifetime from the globular patterns in the early stage of
growth to the reticular in their midlife and, the homogeneous patterns at their late stage of
growth.
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Palmoplantar Pustulosis – Improvement after Cessation of Smoking
E Hagforsen and G Michae¨lsson
Uppsala, Sweden
Ninety-five percent of the patients with palmoplantar pustulosis (PPP) are smokers at the
onset of the disease. It is not known if cessation of smoking can improve PPP, and if smoking
is the only cause of PPP. Fifty percent of PPP sera produce immuno-fluorescence (IF) of the
endothelium from normal palmar skin which might also have a pathogenetic relevance. The
aim of this study has been to answer some questions concerning the role of smoking in PPP.
Among 82 patients with PPP the age at the start of PPP was 43  12 years in those who
had started to smoke before 20 years of age and 53  5 in those starting to smoke after 30
years of age. It was equally common with mild, moderate and severe PPP in current smokers.
Four patients had never smoked and had mild PPP and among 13 former smokers only two
had severe PPP.
Fifteen patients managed to stop smoking and were examined before and after cessation in
parallel with13 who failed or did not want to stop. There was a significant reduction in number
of pustules as well as significant decrease in erythema and desquamation in those who
stopped smoking whereas there was no improvement in those who continued to smoke. Two
patients had a total clearance and some others impressive improvement of previously severe
PPP. In another part of the study eight patients who stopped smoking and eight who did not,
filled in protocols once weekly with the number of pustules and estimation of the PPP severity
on a VAS scale. After three months there was a significant decrease in the number of pustules
and of the severity in those who stopped smoking but no improvement in those who did not.
Despite pronounced improvement after smoking cessation, PPP sera gave the same IF of
normal palmar endothelium as before cessation of smoking, which indicates that smoking is
not the primary cause of PPP. Further studies are needed to identify the underlying
abnormality in palmar skin and in particular in the endothelium and the eccrine sweat duct.
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Sera from Patients with Autoimmune Diseases do not have Circulating IgA Antibodies
Against Tissue Transglutaminase
M Sa´rdy,w, M Csiko´s, C Geisenz, K Preisz, Z Kornsee´, E Tomsitsy, U To¨xz,
J Wieslander k , S Ka´rpa´ti, M Paulssonw, N Smythw
Dept. of Dermato-Venereology and -Oncology as well as yDept. of Pediatrics II,
Semmelweis University, Budapest, Hungary; wInst. for Biochemistry II, zInst. for Clinical
Chemistry, and zDept. of Internal Medicine IV, Medical Faculty, University of Cologne,
Cologne, Germany; kWieslab Co., Ideon, Lund, Sweden
After the identification of tissue transglutaminase (TGc) as the predominant endomysial
autoantigen of coeliac disease and dermatitis herpetiformis, diagnostic ELISAs were
produced. Sera from patients with a broad spectrum of autoimmune diseases or with non-
autoimmune diseases involving enhanced apoptosis, cell lysis and/or putative secondary
autoimmune processes showed false positive reactions in these assays, as detected by a
number of investigators. Sera from 605 patients and controls were tested in a human TGc
ELISA including 304 patients with autoimmune and 122 with other diseases. Anti-gliadin and
anti-endomysium antibodies were also determined in 70 patients chosen at random.
Overall 49% of all autoimmune sera were false positive in the human TGc ELISA. The
difference between the median titers of the autoimmune and the control sera was significant
in every case except for the pemphigus vulgaris sera (bullous pemphigoid, p¼ 0.012;
pemphigus vulgaris, p¼ 0.152; SLE, p¼ 0.0005; antiphospholipid syndrome, p¼ 0.0002; for
each of the other groups po0.0001). Significant differences were also found in serum titers
between controls and patients with hepatitis C (po0.0001), psoriatic arthritis (p¼0.0065),
and malignancies (p¼ 0.0005). Altogether 25% of the sera from patients with hepatitis C,
psoriatic arthritis, and malignancies were positive in the human TGc ELISA. In contrast,
testing 70 of the false positive patients for total serum IgA levels, AGA and EMA reactivity as
well as immunoblots showed that no association of these conditions with gluten sensitive
enteropathy can be confirmed. However, further purification of the TGc protein preparation
used for coating and elevation of ionic strength in the buffers could eliminate false positive
signals.
The currently used method for TGc ELISA allows nonspecific positivity of certain sera from
patients having circulating IgA of high affinity against impurities. Thus it is evident that
positivity of a TGc ELISA should not alone be taken as the basis for a diagnosis of coeliac
disease or dermatitis herpetiformis.
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Hepatitis-C-Treatment Associated Dermatitis as an Example of Iatrogenic Eczema
J Lu¨bbe, K Kerl-Bullani, F Negro
Departments of Dermatology and Gastroenterology, eneva University Hospital, Switzerland
Objective Characterization of eczematous dermatitis associated with combination treatment
of hepatitis C with peg-interferon-alfa and Ribavirin.Background
In a previous survey of 52 patients undergoing combination treatment, we have found de
novo skin lesions in 23% of patients. The clinical features of this adverse phenomenon remain
to be defined.
Materials and Methods. A dermatologic outpatient structure for prompt referral of patients
presenting with cutaneous symptoms during combination treatment for hepatitis C was
created. Clinical assessment was completed by allergologic and histopathologic analyses in
selected cases.
Results. Overall, 36 patients were referred. All patients complained of pruritus and dry skin.
Eczema was the most frequent diagnosis (33 cases), and confirmed by skin biopsy in 5 cases.
Most cases presented with diffuse, generalised dermatitis, while 5 patients had nummular
eczema, and 3 eczema craquele´. Sequential analyses of total and specific IgE levels in 8
patients showed no correlation with combination treatment. A positive atopy patch test result
was found in 5 (of 22 tested) patients; in four of them, the test became negative when
repeated after the end of combination treatment. Most patients responded well to topical
anti-inflammatory and emollient therapy, and none had to abandon his combination
treatment. One case with acantholytic dermatitis, and one case with porphyria cutanea
tarda required dose reductions. After the end of combination treatment, cutaneous
symptoms resolved in all except two patients.
Discussion. Our observations suggest that the cutaneous side effects of combination
treatment for hepatitis C are clinically homogenous, with pruritus, xerosis, and eczematous
lesions as key features. Perception of hepatitis-C-associated dermatitis as an iatrogenic
eczema may facilitate implementation of preventive and curative measures, and improve
compliance with long-term combination treatment regimens. The observed modulation of the
atopy patch test result by combination therapy may reflect an immunomodulatory
pathomechanism, that warrants further investigation.
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Limb Worn Digital Accelerometers used as Quantiﬁers of Disease Activity in Pruritic
Conditions
C S Murray, C Bringhurst, J L Rees
Systems Group, Department of Dermatology, The University of Edinburgh, UK
Our group has previously reported work to demonstrate that digital accelerometers can be
used to monitor limb activity in children with atopic dermatitis and that the measurements act
as a proxy for itch. The method was successfully validated against infrared videoing of
subjects at night. These initial studies were confined to children with atopic dermatitis
between the ages of 2 and 4. In the present study we report on the wider applicability of this
measure in a larger group of children and in adults with a range of pruritic conditions. We have
studied 112 participants: 34 adults, age 20–87 (median 50.5) 19 of whom had eczema, 5 liver
disease and 10 with a range of other disorders including leukaemia and urticaria pigmentosa.
The control adult group comprised 30 healthy adults age 27–74 (median 38.) A further 29
children, age 2–13 (median 6) with 28 with atopic dermatitis and 1 with lichen planus were
studied, along with 20 healthy child controls age 2–15 (median 10.5.) There were obvious
differences between cases and controls for adults with activity medians approximately twice
as high in cases as controls (po0.01.) Similar 2–3 fold variations were seen for children
between active cases and controls (po0.01.) Absolute scores for cases were 30% higher in
adults than children. The relation between subjective measures, SCORAD scores and
objective recorded activity was imperfect with much variation unaccounted for – in particular,
in adults but not children we found a negative correlation between objective movement
activity and self reported quality of sleep. We have studied the temporal pattern throughout
he night, and also observed night-to-night variation. Variation occurred from night to night but
there was still an obvious person (or disease state) factor effect. These analyses will inform
use of the measure in clinical trials.
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Dermoscopic Classiﬁcation and Follow-up of Halo Nevi
I Kolm1, A Di Stefani2, I Zalaudek1, R Fink-Puches1, IH Wolf1, E Richtig1, A Gerger1,
J Smolle1, H Kerl1, R Hofmann-Wellenhof1
1Department of Dermatology, Medical University of Graz, Graz, Austria 2Department of
Dermatology, University Tor Vergata of Rome, Rome, Italy
Halo nevi (HN) are melanocytic nevi surrounded by a depigmented area. These nevi – also
termed Sutton’s nevi – are characterized by a typical course.
We carried out a dermoscopic classification of HN and studied their changes in size during
a follow-up period.
Moreover we investigated regression in melanoma in comparison with HN.
In a retrospective study we classified digital dermoscopic images of HN according to main
dermoscopic structural patterns. Images were selected from a database containing 29 383
digital dermoscopic images of 6079 patients.
Whenever we had a record of follow-up digital dermoscopic images of a HN we calculated
the percentage of the changes in size of the nevus and the halo component during the follow-
up period.
Additionally we studied digital dermoscopic images from the same database of
histopathologically confirmed melanoma concerning signs and localization of regression.
We classified 141 halo nevi on 88 patients (median age of 22.4 years). The majority (88.7%)
of HN was localized on the trunk. The most common dermoscopic structural pattern was the
homogeneous-globular (58 nevi, 41.1%), followed by the homogeneous (32 nevi, 22.7%), and
the globular pattern (24 nevi, 17%).
We studied the follow-up of 36 HN. During the first six months of the follow-up period the
reduction of the area of nevi was 5.2%. For the remaining follow-up period of 25 months
(range 4–61 months) the reduction decreased to 2% per month. The analysis of the halo
component showed an increase in 11 HN and a reduction in 18 HN.
We classified 382 digital images of melanoma. 214 melanoma had no signs of regression,
100 melanoma had an eccentric, and 66 melanoma had a central regression. In two
melanoma we observed an encircling ‘‘halo-like’’ regression.
Melanoma encircled by a ‘‘halo-like’’ regression is rare. Moreover the images of both
melanoma in the study displayed all melanoma specific dermoscopic features and therefore
could easily be distinguished from HN. 80% of the 141 HN showed a homogeneous and/or
globular pattern, which is generally associated with benign pigmented skin tumors. We found
a significant higher reduction of the nevus area during the first six months of the follow-up
period. Based on those observations we conclude that a digital dermoscopic follow-up of HN
longer than six months is not required.
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Protection by Sunscreens Against Ultraviolet-Induced Lupus Erythematosus
T Herzinger, G Plewig, M Ro¨cken
Department of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, and
Department of Dermatology, Eberhard-Karl-University, Tuebingen, Germany
Since photosensitivity is a hallmark of cutaneous and systemic lupus erythematosus (LE),
sunscreens may provide a protective measure against the development of disfiguring
cutaneous LE lesions. We performed a retrospective evaluation of 66 patients who had
undergone diagnostic photoprovocation-testing with a combination of ultraviolet A and B
irradiation. Roughly 75 percent of our LE patients showed a positive reaction to the UV-
challenge. Only those patients who showed photosensitivity (n¼ 52) were analyzed further.
Most of these patients had discoid or tumidus type LE. We found the combined irradiation
with UVA and UVB to be most effective in triggering cutaneous LE (98%). In fact, 30% reacted
to the combined irradiation only, and neither to UVA or UVB when applied alone, suggesting a
synergistic effect of the combination in some patients. In 19% of the patients, both UVA and
UVB induced LE lesions. UVA alone induced LE only in 17 patients (33%). UVB induced LE in
48% of the patients. 96% of the patients that had developed LE in the UVA/UVB field were
entirely protected against the development of LE or LE-like lesions by the sunscreen.
Protected patients showed either no reaction or pigmentation only. Thus, the capacity of the
sunscreen in preventing UV-induced LE was higher than the protective action against UV-
induced pigmentation. Our data show that modern sunscreens that efficiently protect against
both UVA and UVB are very effective in protecting against UV-induced LE. Preliminary data
suggest that daily application of high-potency sunscreens also protects patients against UV-
induced LE by natural sun-light. Physicians involved in the management of lupus patients
should therefore be encouraged to instruct their patients to use high-potency sunscreens.
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Impact of Efalizumab on Health-Related Quality-of-Life Outcomes in Patients with
Moderate to Severe Chronic Plaque Psoriasis: Results of the International Randomised,
Controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) Trial
JP Ortonne, W Sterry, N Shear, S Shumack, G Duru, and A Beresniak
Nice, France; Berlin, Germany; Toronto, Ontario, Canada; Kogarah, Australia; Villeurbanne,
France; and Geneva, Switzerland
Psoriasis can have a significant adverse impact on health-related quality of life (HRQL). The
impact on HRQL is multifactorial and can be influenced by disease-, patient-, or treatment-
related factors. In order to fully appreciate the impact of psoriasis on patients’ lives and to
assess the effectiveness of psoriasis therapies, patients should be assessed using measures
that encompass both physical and psychological measures. Efalizumab is a targeted
recombinant humanised monoclonal IgG1 antibody that inhibits key processes in the
pathogenesis of plaque psoriasis. The present Phase III, double-blind, placebo-controlled
trial was undertaken to evaluate the impact of efalizumab treatment on HRQL in patients with
moderate to severe chronic plaque psoriasis. Patients (n¼790) from 54 international centres
were randomised in a 2:1 ratio to receive subcutaneous efalizumab 1 mg/kg monotherapy or
placebo weekly for 12 weeks. Interim analyses based on 377 patients who received 12 weeks
of efalizumab (n¼ 252) or placebo (n¼ 125) are available. Efficacy and safety analyses
are reported in an alternate abstract; HRQL analyses are reported herein. The effects of
efalizumab on HRQL were assessed using multiple measures: the Dermatology Life Quality
Index (DLQI), the Psoriasis Symptom Assessment (PSA), the Short Form 36 questionnaire
(SF-36), and a 10-cm visual analogue itching scale. Efalizumab resulted in significantly
greater mean (  SD) improvements in each HRQL endpoint following the first 12-week
treatment period compared with placebo. The improvement in DLQI, a measure that
assesses the impact of psoriasis and treatment on patient’s functioning and well-being, for
efalizumab-treated and placebo patients, respectively, was 6.2 (7.7) vs 2.5 (6.9)
(Po.001). Improvement in the PSA frequency 5.7 (6.2) vs 1.8 (5.8) (Po.001) and PSA
severity 6.5 (  6.6) vs 1.6 (  6.4) (Po.001) scores indicated that the frequency and severity
of psoriasis symptoms were significantly decreased in the efalizumab-treated patients
relative to placebo. Improvement in the itching score was 2.7 (3.2) vs 0.6 (2.6) (Po.001),
corresponding to a 37% vs 10% mean improvement, consistent with the improvement noted
on the PSA subscales. Improvement in the SF-36 summary score was 64.1 (165.0) vs 8.8
(141.0) (P¼ .013). Quality of life instruments in the efalizumab-treated patients showed
improvement in patients’ perceptions of their health and of the social and emotional impact of
their disease. In summary, once-weekly efalizumab monotherapy demonstrated significant
treatment effects on multiple quality of life measures as well as clinical measures with an
acceptable safety profile, indicating a favourable benefit:risk ratio in adult patients with
moderate to severe plaque psoriasis. The final results for the entire patient cohort from this
12-week treatment period will be presented.
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Do Features of Skin Ageing Differ Between Asian and Caucasian Women?
F Morizota, S Guehennneuxa, S Dheurlea, E Maugera, C Guinota, M Binderb and
E Tschachlera,b
aCE.R.I.E.S., Neuilly sur Seine, France, bDepartment of Dermatology, University of Vienna,
Vienna, Austria
Background. Features associated with skin ageing have been extensively investigated in
women of different ethnic backgrounds. However, to the best of our knowledge a detailed
comparison of the visual features of skin ageing between women of different ethnicity has not
yet been performed.
Objectives. Our objectives were (1) to investigate whether the same photographic scales
could be used to document and grade the visual features of ageing on the face of both
Caucasian and Asian women and if so, (2) to compare their rate of occurrence between the
two groups.
Methods. Photographic reference scales documenting visual features associated with ageing
such as wrinkles in different locations, pigmented spots and signs of tissue slackening were
established from high quality photographs of French women ranging in age from 20 to 80.
After confirming that they allowed for acceptable reproducibility of the assessment of
different grades of skin ageing, the scales were used to evaluate the visual features of skin
ageing on high resolution facial images of 256 Japanese and 281 French women aged from
20 to 80 years old.
Results. Our photographic reference scales allowed for an acceptable strength of agreement
(kappa values40.55) in the assessment of visual features of facial skin ageing in Japanese
and French women.
In both populations, the different grades of severity (from grade 0 to 5) of the features
related to pigmented changes, wrinkling and tissue slackening were represented. However,
we’ve confirmed that differences in age of appearance and rate of aggravation of most of the
age-related features do exist between Japanese and French women. Wrinkles occur earlier in
French women than in Japanese with all the features related to wrinkles visible in women
older than 35 in French and 50 in Japanese excepted for wrinkles located on the upper lip.
The features related to wrinkles demonstrated a similar pattern of aggravation in both
populations with a more pronounced rate of aggravation for furrows between the eyebrows.
Pigmented spots occur earlier and demonstrate a more pronounced aggravation with age
in Japanese women than in French with 4,8% of Asian women up to 34 years old with already
visible age spots on the cheek (grade41) and up to 80% of the women older than 50 with
visible age spots. However, only 20% of the oldest Asian women presented with higher
grades of severity (grades 4 to 5). Tissue slackening was found to be more pronounced on the
naso-labial fold in Japanese women and on the lower part of the face in French.
Our results demonstrate that differences in facial wrinkles and tissue slackening between
Caucasian and Japanese women are rather reflected by their rate of occurrence than by their
morphological aspect.
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Objective Severity Measures and Quality of Life in Patients with Psoriasis
M Suchan, S Jenisch, R Bugdahl, E Christophers, M Weichenthal
Kiel, Germany
Psoriasis is a chronic inflammatory skin disease of uncertain origin with typical clinical and
histologic features. Although the extent of skin involvement can be well defined by the means
of PASI and other scoring methods, it is unclear how this appearance correlates with the
patients’ quality of life.
In a prospective study we have obtained clinical data from patients with psoriasis visiting
the dermatological department. Patients with chronic plaque-type and guttate psoriasis were
included, and additional features like psoriatic arthritis (PsA) and palmoplantar pustulosis
were noted. Clinical severity was assessed by PASI, total disease area, involvement of hands
and face, type and duration of the disease as well as the number of hospital based
treatments, and the use of systemic treatment. The DLQI (Dermatology life quality index) and
2 simple visual analogue scores on health and psoriasis intensity perception were recorded at
admission and one week after discharge.
One hundred and twenty one adult patients (74 male 47 female) with a median age of 51
years (range 19 to 85) were included. Mean PASI at admission was 11.9 (range 0.4–56.4) and
DLQI 9.0 (range 0–30). Regarding quality of life, subjective symptoms like itching (90%) and
feelings of embarresment (63%) were most prevalent. Impairments in personal relationships
and sexual difficulties were reported least frequent. Although parts of the DLQI (Items 1,2 and
4) showed a significant correlation with the PASI, the overall DLQI score only showed a very
weak correlation with PASI (r¼0.17; p¼ 0.06). Regarding determinats of life quality in
psoriasis patients, the affected body surface area and presence of arthritis appeared to be
significant factors. Treatment resulted in a mean reduction of PASI of 69% (po0.0001), and
quality of life was markedly improved (mean reduction of 4.4 in DLQI). However, both
measures correlated poorly.
Our results imply, that both scores measure different aspects of the disease and are not
interchangeable in describing the overall severity of Psoriasis. Although the PASI score may
well be used as a severity measure in clinical trials, it may be insufficient to reflect the
impairment in quality of life in affected patients.
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Imiquimod Treatment of Lentigo Maligna Induces Complete Tumor Regression
I H Wolf, L Cerroni, H Kerl
Department of Dermatology, Medical University-Graz, Austria
The term lentigo maligna (LM) is used as a synonym for melanoma in situ in sun-damaged
skin. Five patients (age 67–80years) with 6 biopsy-proven LM (location: face 5x, shoulder 1x)
in whom standard surgical therapy was contraindicated were treated with 5% imiquimod (IQ)
cream once a day from 5 to 13 weeks. The complete response rate, based on both clinical
and histopathological findings for all LM was 100%.
The immunohistological effects of topical IQ, studied at various time points, revealed an
inflammatory cell infiltrate composed of T-helper lymphocytes mixed with a significant
number of cytotoxic cells and monocytes/macrophages. These results indicate that IQ
induces a cytotoxic T-cell-mediated immune response.
The patients have been followed up for 3 to 18 months without evidence of recurrence. IQ,
a local immune response modifier appears to be an excellent therapeutic option for carefully
selected patients with LM. Close evaluation of patients, including post-therapy histopatho-
logical investigation is essential.
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Safe Psoriasis Control: Evaluation of a New Approach to Assessing Efﬁcacy of Psoriasis
Treatments
CEM Griffiths, W Sterry, and E Henninger
Manchester, United Kingdom; Berlin, Germany; and Geneva, Switzerland
Psoriasis is a chronic, incurable disease marked by an unpredictable pattern of remission and
spontaneous relapse. Responses to current therapies can be unpredictable, and safety concerns
may limit the long-term use of the currently approved systemic therapies and phototherapy. There
are several new agents in clinical development, and it is sometimes difficult to determine their true
therapeutic benefit-risk. The US Food and Drug Administration and the European Agency for the
Evaluation of Medicinal Products efficacy benchmark is the proportion of patients achieving a 75%
reduction in Psoriasis Area and Severity Index (PASI-75). Although useful, PASI-75 is a relative
endpoint that does not reflect the actual control of psoriasis nor the fact that response to therapy is
a continuous variable. Furthermore, PASI-75 as a sole indicator of treatment benefit ignores
information such as quality-of-life improvements as well as safety and tolerance of medication. A
comprehensive approach that evaluates overall disease control, including physician, patient, and
safety assessments, would be a more robust way of estimating the true benefit-risk ratio of novel
psoriasis therapies. Efalizumab, an antibody that modulates various T-cell–mediated events
underlying the pathogenesis of psoriasis, has been studied in clinical trials including43000 patients
(Phase III trials) and has demonstrated superiority over placebo. Data from efalizumab trials have
been further analysed to examine the distributions of endpoints and the relationship between these
parameters; this confirmed that physician-measured (eg, PASI) and quality-of-life (Dermatology Life
Quality Index; DLQI) outcomes are two separate components of efficacy providing complementary
information about the benefit of therapy. The anchor-based method was used to calculate the
absolute PASI and DLQI scores, based on Patient’s Global Psoriasis Assessment (PGPA) category,
required to reflect control of the disease. Effect size was used to validate the cut-off values of PASI
and DLQI for the control level. Safety assessments were combined with the efficacy measures,
generating a new Good Safe Control approach defined as:
PASIp8, and DLQIp6, and no serious adverse events, and no severe AE related to study drug,
and not withdrawn.
As an additional validation, results generated using the anchor-based method were compared to
cut-off levels presented in external papers. Safe Control results were determined for the first 12-
week treatment period of Phase III efalizumab trials. Good Safe Control was achieved in 39% of
patients treated with efalizumab 1.0 mg/kg/wk (n¼763) compared with 10% of patients receiving
placebo (n¼ 479). The Safe Control approach allows a comprehensive evaluation of a new
treatment’s benefit-risk profile, and the stringent levels of control take into account the
multidimensional aspects of psoriasis and the inter- and intra-patient variability associated with
responses to treatment.
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Toxic Epidermal Necrolysis/Stevens Johnson Syndrome: Positive Outcome after
Treatment with Dexamethasone Pulse Therapy
SH Kardaun
University Hospital, Groningen, The Netherlands
To reduce mortality in toxic epidermal necrolysis (TEN) and Stevens Johnson syndrome (SJS),
short courses of high dosed corticosteroids at an early stage of the disease appear to be a
rational option in order to influence the immune system that leads to apoptosis and
necrolysis, TEN and SJS are acute, rare and life-threatening, most often drug-induced
mucocutaneous reactions, belonging to the same spectrum. SJS may progress to TEN, both
can be caused by the same type of drugs. Reported mortality rates vary, but are generally
high (up to 30% or more). In TEN/SJS epidermal necrosis and detachment result in loss of
skin barrier function. Consequently, shock and sepsis are feared complications and the main
cause of death.
Besides elimination of the offending drug and maintaining specific intensive care
procedures, we applied dexamethasone pulse therapy (DPT), consisting of one i.v. dose of
1,5 mg/kg during three consecutive days. We included 12 consecutive patients with TEN/SJS
in this study. Diagnosis was based on the classification by Bastuji-Garin et al in 1993. The
average severity score (SCORTEN) was 2.5, varying from 0 to 5, median 2. Based on the body
surface area (BSA) with detachment, we classified 1 patient as SJS, 7 as TEN and 4 as SJS/
TEN-overlap. As soon as the diagnosis was established, we started DPT.
Within 5 days (average 3 days) the progression of the BSA with detachment was arrested in
all patients. In all but two cases cutaneous and mucosal lesions healed within 3 weeks. In
those 2 patients healing was prolonged, probably due to disseminated cutaneous HSV-
infection. One of them also had pre-existent burn cicatrisation.
DPT in combination with specific intensive care treatment appears to promote a positive
outcome in SJS/TEN. Compared to mortality prediction according to the SCORTEN-score
our results were significantly better.
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Safety of Extended and Long-Term Efalizumab Therapy for Plaque Psoriasis: Results
from Phase III Clinical Trials
W Carey, A Menter, C Leonardi, C Lynde, J Ouellet, D Toth, L Rosoph, and K Papp
Montreal, Quebec, Canada; Dallas, Texas, United States; St. Louis, Missouri, United States;
Markham, Ontario, Canada; Sherbrooke, Quebec, Canada; Windsor, Ontario, Canada; North
Bay, Ontario, Canada; and Waterloo, Ontario, Canada
The average age at onset of psoriasis is the late 20s, and the disease typically follows a
waxing and waning course. Psoriasis is principally an immune-mediated disorder that
involves sustained activation of T cells in the dermis and epidermis. Traditional systemic
therapies and phototherapy for moderate to severe plaque psoriasis, although effective, all
have toxicity issues that affect other organ systems, thus limiting their long-term use or
requiring intensive ongoing laboratory monitoring. Because psoriasis is a chronic condition
usually requiring treatment over many decades, agents that are safe and effective for long-
term use are needed. Efalizumab is a recombinant humanised IgG1 monoclonal antibody that
targets the T-cell functions associated with the pathogenesis of psoriasis. It binds to the
CD11a site on the leukocyte function–associated antigen (LFA)-1 expressed on T cells, and
prevents LFA-1 from binding to intercellular adhesion molecule (ICAM)-1 on antigen-
presenting cells, endothelium, and keratinocytes, thus inhibiting T-cell activation, trafficking
into psoriatic skin, and reactivation therein. In two Phase III trials, extended treatment with
efalizumab over 24 weeks (Weeks 1–12 were placebo-controlled, Weeks 13–24 were open-
label) and long-term treatment for up to 36 months (open-label), for which interim 24-month
data are available, have been evaluated. Efficacy outcomes for these two trials are presented
in a companion poster; safety data will be presented and discussed in this poster. In one of
these Phase III clinical trials, subcutaneous injections of efalizumab 1 mg/kg/wk for 24
consecutive weeks was generally safe and well tolerated. Adverse events (AE) observed in
X5% of patients during Weeks 13–24 were nonspecific infection (11.1%), headache (6.1%),
and arthritis (5.6%). In the other Phase III trial, the ongoing study assessing the safety of
efalizumab 1 mg/kg/wk over 36 months, for which 24 months data are available, has shown
that long-term therapy with efalizumab is generally well tolerated. The overall incidence of AE
did not increase over time, and compared with the first 3-month period, no new types of
common (X5% of patients) AE occurred up to Month 24. The incidence of serious AE, AE
leading to withdrawal, infection, psoriasis-related AE, and malignancy, remained low and
relatively stable during the 24-month treatment period. There was no evidence of cumulative
toxicity, hepatotoxicity, or nephrotoxicity. The targeted activity of efalizumab, which is devoid
of the global immunosuppressive effects of traditional systemic therapies for this debilitating
condition, provides the first treatment for continuous long-term treatment of patients with
moderate to severe chronic plaque psoriasis without increasing toxicity over time.
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Thermographic Analysis of Psoriatic Skin Lesions
A Zalewska, B Wiecek, A Sysa-Jedrzejowska, G Gralewicz, G Owczarek
Department of Dermatology, Medical University of Lodz; Institute of Electronics, Technical
University of Lodz; Central Institute for Labour Protection – National Research Institute,
Warsaw, Poland
Thermal imaging methods gain more and more applications in medicine including evaluation
of allergic tests, morphea, chilblains, port wein stains, burn depth, Raynaud’s phenomenon,
pneumonia development or arthropathy. Psoriasis is characterized by hyperparakeratosis,
inflammatory infiltrate and vascular changes. All of these features could influence body
temperature measurements. Microvascular abnormalities and inflammation are considered to
be of key importance in the development of psoriatic plaques. So the aim of our study was o
evaluate usefulness of thermography in estimation of psoriatic lesion activity.
A series of newly admitted in-patients with plaque type psoriasis vulgaris were included in
the study. A total of 350 psoriatic lesions were analysed in a 4-week period. Thermocamera
ThermaCam Inframetrics 290E was employed in the study. Temperature resolution was
0.1oC, temperature rage, mean and standard deviation were calculated for the examined
plaques. Both thermal and visual images of the patients were recorded. Plaque Severity
Score (PSS) was introduced for skin lesions evaluation.
We observed an inter-individual variation of temperature measurements between
individuals presenting plaques of comparable parameters as regards erythema and
induration (ranged from 1 to 4). Severe desquamation, evaluated as 4, seemed to act as a
isolator for proper temperature measurement. We also noted that active, progressing lesions
demonstrated increased temperature over the plaques themselves and broad surroundings,
which did not correspond to the clinically visible shape of the lesions. To the contrary, stable
not progressing lesions presented increased temperature virtually only over the plaques
themselves and the shape of individual lesions was mostly preserved. No significant
differences were noted between temperature measurements over active and stable lesions.
In conclusion, thermography of psoriatic lesions performed before treatment implementa-
tion may be very useful in identifying active, progressing lesion which would require a more
potent regimen from the very beginning of therapeutic intervention.
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Evaluating Patient Self-Assessment of Melanoma Risk
A Harbauer1, S Dreiseitl2, H Kittler3, H Pehamberger3, M Binder3
1Dept. of Dermatology, Medical University Vienna 2Dept. of Software Engineering, University
of Applied Sciences Upper Austria 3Dept. of Dermatology, Center of Excellence
Telemedicine, Medical University Vienna
Background. Incidence rates of malignant melanomas are growing rapidly in the Western
world; however, this cancer is treatable when diagnosed at an early stage of progression.
High-risk individuals would therefore benefit from consulting dermatologists more frequently.
Purpose. To evaluate whether patients can use a questionnaire to correctly identify whether or
not they belong to a population group that is at high risk of developing melanoma.
Material And Methods. We conducted a case-control study of 404 persons, with 202 persons
with diagnosed melanomas building the case group, and 202 controls matched to the cases
according to age and gender. To help build a model for assessing melanoma risk, both groups
completed a questionnaire asking about skin and eye color, skin type, skin reaction to sun,
number of sun burns, sun exposure, personal assessment of skin damage, number of
pigmented skin lesions, and number of congenital large lesions. Furthermore, a physician
recorded her observations of these items to determine how well patients are able to answer
these questions by themselves.
Results. Logistic regression analysis revealed that the three factors ‘‘sun damage’’, ‘‘number
of lesions’’ and ‘‘skin type’’ were all independently associated with the melanoma group.
There was good agreement between the models built from the patients’ and the physician’s
answers to the questionnaire, as measured by the area under the ROC curve of the logistic
regression models (0.71 vs. 0.75, difference not significant). The patients’ sensitivity and
specificity of risk-group assessment was 63.5% and 70.8%, respectively. For a trichotomous
division into high/medium/low risk, the odds ratio of belonging to the melanoma group was
11.68 for the high risk, and 3.42 for the medium risk patients.
Conclusion. Three primary factors that allow patients to individually assess their risk of
developing melanoma were identified. This risk assessment can be performed by a simple
questionnaire.
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Measuring Physician Reaction to a Decision Support System for the Diagnosis of
Pigmeted Skin Lesions
S Dreiseitl1, H Kittler2, H Pehamberger2, M Binder2
1Dept. of Software Engineering, University of Applied Sciences Upper Austria 2Dept. of
Dermatology, Center of Excellence Telemedicine, Medical University Vienna
Background: The early diagnosis of melanoma is difficult even for experienced dermatol-
ogists. A decision support system could help physicians by providing a second opinion.
Purpose. To conduct a pilot study that measures how physicians react when a decision
support system either supports or contradicts their initial diagnosis.Material And Methods:
52 volunteer dermatologists of varying experience levels participated in the study. 25 lesion
images obtained by epiluminescence microscopy were presented by a computer program
that asked the study participants to rate the malignancy of the lesions shown on the images,
and to give a dichotomous excise/no excise recommendation. After providing this initial
opinion, the decision support system gave its recommendation, and the physicians were
given the option to revise their initial opinion. Of the 25 lesion images shown, 14 were
pigmented skin lesions, and 11 were cutaneous melanomas at early stages of progression.
Results. Averaging over all 52 study participants and 25 lesion images, there was a change of
opinion in 24.51% of the cases when the physician’s initial excise recommendation was
contradicted by the decision support system. A slight negative correlation between physician
experience and susceptibility to following the system’s excise recommendation was
observed (Kendall tau¼0.2, P¼ 0.047). There was no correlation between susceptibility
to accepting the system’s opinion and the subjective difficulty assessment of the lesion, nor
was there a correlation between the physician’s susceptibility and whether the system
recommendation was benign or malignant. Due to the small sample size, it is difficult to
measure whether some physicians are significantly more susceptible than others.
Conclusions. In more than 75% of the cases, the study participants were reluctant to accept
the computer system’s recommendation. This can be attributed to the fact that the system’s
characteristics were not made public to the study participants beforehand, and the
participants had to develop a ‘‘feel’’ for the system’s performance while working with it.
Bayesian modelling of the physicians’ opinion of the system, and thus his/her confidence in it,
will provide a deeper understanding of the results observed in this study.
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Pharmacological and Clinical Activities of 5-Alpha Avocuta : Application for the
Management of Androgenic Disorders
N Piccardi1, A Piccirilli1, JC Choulot1, B Chadoutaud2 and P Msika1
1R&D Center, Laboratoires Expanscience, France. 2Clinical Research Consultant, France
Androgen-dependent disorders, such as seborrhoea, acne and alopecia are among the most
common diseases encountered by dermatologists in daily practice. These pathologies are in
part related to an hyper-activity of 5-alpha reductase, the enzyme that metabolises
testosterone into dihydrotestosterone (DHT) a major potent androgen in human skin. In this
work, we have investigated the efficacy of a lipidic fatty ester: 5-alpha Avocuta (butyl
avocadate). Butyl avocadate is obtained from refined avocado oil through a biotechnological
process, and is purified by molecular distillation.
We have demonstrated using dermal fibroblasts in culture that 5-alphaAvocuta is a potent
inhibitors of 5-alpha reductase type I activity (49% for the smallest dose tested 0.01%).
A multi-centric clinical evaluation, under dermatologist control, was conducted on 27
volunteers. The purpose of this study was to test the efficiency of a shampoo (1% of 5-acute
Aocuta) after 3 weeks of application (1 application/2 days). Analysis of sebum secretion
(Sebufixs F16) by visual scoring and by image analysis (Skin Visiometers, SV600, CK,
Germany) demonstrate that this shampoo is able to significantly reduce sebaceous
production. Clinical investigations by the dermatologist (analogic scale) show that the
shampoo clearly improves greasy hair aspect, and is able to reduce itching and pruritus, as
well as dandruffs. The auto-evaluation by the volunteers confirms these data. The efficiency
of 5-alphaAvocuta, formulated at 2% in a skin care, has been also demonstrated in the
management of the hyper-seborrhoea of the face. After 3 weeks (application twice a day), this
specific formulation was able to reduce the sebum production (30%) at the level of the face,
to improve all the clinical parameters (31% in average) and to reduce the number of open
comedons. The volunteers have also approved the efficiency of the product (78% good
opinion), and they have reported an improvement of their quality of life.
5-alpha Avocuta is a new and original inhibitor of 5-alpha-reductase type I activity with
proven efficiency on human scalp and skin disorders related to hyper-seborrhoea. This
natural active ingredient may open the way to the formulation of original and efficient
products dedicated to the treatment of androgenic disorders.
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Etanercept Improves Quality of Life of Patients with Chronic Plaque Psoriasis: A Meta-
Analytic Summary of Randomized Clinical Trials of Etanercept
PCM van der Kerkhof1, W Sterry2, J-P Ortonne3, B Randazzo4, A Singh4, R Ganguly4,
H Wang5
1Universitair Medisch Centrum, Nijmegen, Netherlands; 2Charite Klinik fur Dermatologie,
Berlin, Germany; 3Hopital de l’Archet, Nice, France; 4Wyeth Research, Collegeville, USA,
5Amgen Thousand Oaks, USA
In psoriasis, there exists a diverse set of clinical criteria for assessing both severity and the
effectiveness of treatment including Quality of Life (QoL). Three randomized, double-blind,
placebo-controlled clinical trials (RDBPCTs) have shown separately that etanercept provides
significant improvement in psoriatic skin disease and QoL among patients with moderate to
severe chronic plaque psoriasis. Using meta-analytic techniques, the efficacy of 2 dose
regimens of etanercept (Enbrel) (25 mg or 50 mg twice weekly) compared with placebo in
improves QoL as measured by the Dermatology Life Quality Index (DLQI) at 12 weeks. We
report efficacy of etanercept in improving QoL in 1187 patients across one phase 2 and two
phase 3 RDBPCTs. These studies had similar inclusion and exclusion criteria. Comparisons
presented between the 25 mg twice weekly dose (N¼ 415) and placebo (N¼ 414) used
summary data pooled across all 3 studies. Comparisons between the 50 mg twice weekly
dose (N¼358) and placebo (N¼ 359) used summary data pooled across the phase 3 studies.
The percentage improvement at week 12 from baseline in DLQI total score and subscales
was analyzed using fixed-effects inverse variance meta-analysis. A two-sided Z-test was
used at a significance level of 0.01 to test whether etanercept 25 mg or 50 mg twice weekly
was statistically significantly different from placebo. The mean baseline values of DLQI were
similar at baseline across treatment groups and studies. The mean percentage improvement
in DLQI scores from baseline were 51.5% (95% CI: 44.6, 58.1) and 59.1% (95% CI: 51.6, 66.6)
for the etanercept 25 mg and 50 mg twice weekly groups respectively compared to placebo
(po0.0001). Further, the percentage improvement from baseline at week 12 for each of the 6
subscales of the DLQI was statistically significantly superior for both etanercept 25 mg and
50mg twice weekly doses. This meta-analysis of the three RDBPCTs confirms etanercept 25
mg and 50 mg twice weekly provided consistent, robust efficacy in improving patients’ QoL.
Our results are also consistent with the findings of previously reported individual RDBPCTs.
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Clinically Meaningful Improvement in Dermatology Life Quality Index in Patients With Chronic
Plaque Psoriasis: A Meta-Analytic Summary of Randomized Clinical Trials of Etanercept
A Singh, R Ganguly, R Sato
Wyeth Research, Collegeville, USA
Three randomized, double-blind, placebo-controlled clinical trials (RDBPCTs) have shown
that etanercept (Enbrel) provides Clinically Meaningful Improvement (CMI) in Quality of Life
(QoL) among patients with moderate to severe chronic plaque psoriasis. Using meta-analytic
techniques, we assessed the efficacy of the 2 dose regimens of etanercept (25 mg and 50 mg
twice weekly) compared with placebo in improving QoL as measured by the Dermatology Life
Quality Index (DLQI) at 12 weeks. All three RDBPCTs of etanercept were included in the meta-
analysis: (1) two-arm phase 2 study of etanercept 25 mg twice weekly (N¼ 57) or placebo
(N¼55); (2) four-arm phase 3 study of etanercept 25 mg once-weekly (N¼159) or twice
weekly (N¼ 161), etanercept 50 mg twice weekly (N¼163) or placebo (N¼ 166); (3) three-arm
phase 3 study of etanercept 25 mg twice weekly (N¼ 194) or 50 mg twice weekly (N¼194) or
placebo (N¼ 193). These studies had similar inclusion criteria. Subjects had stable plaque
psoriasis involving at least 10% body surface area and had received prior systemic or
phototherapy, or were considered candidates for systemic or phototherapy. The CMI in DLQI
total score was defined as 5 points. Odds of achieving CMI in DLQI total scores were
analyzed using the pooled Mantel-Haenszel odds ratio method. A two-sided Z-test was used
at a significance level of 0.01 to test whether etanercept 25 mg or 50 mg twice weekly was
statistically significantly different from placebo. The mean baseline values of DLQI total were
similar across treatment groups and across studies. The pooled Mantel-Haenszel odds ratio
for achieving CMI in DLQI was estimated to be 4.20 (95% confidence interval: 3.14, 5.63) and
5.87 (95% confidence interval: 4.25, 8.10) for etanercept 25 mg and 50 mg, twice weekly
respectively compared to placebo (po0.0001). This implies that odds of achieving CMI in
DLQI total scores were 4 to 5 times higher for either etanercept 25 mg twice weekly or 50 mg
twice weekly compared with placebo. This meta-analysis of three RDBPCTs confirms the
efficacy of etanercept in providing CMI in DLQI.
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Efﬁcacy Outcomes During Extended and Long-term Use of Efalizumab in Patients with
Moderate to Severe Chronic Plaque Psoriasis
K Papp, A Menter, C Leonardi, C Lynde, J Ouellet, D Toth, L Rosoph, and W Carey
Waterloo, Ontario, Canada; Dallas, Texas, United States; St. Louis, Missouri, United States;
Markham, Ontario, Canada; Sherbrooke, Quebec, Canada; Windsor, Ontario, Canada; North
Bay, Ontario, Canada; Montreal, Quebec, Canada
With the current unmet medical needs for agents that can be safely used continuously in
patients with psoriasis, and advances in our understanding concerning psoriasis pathogen-
esis, a number of targeted biological therapies are in various stages of development and
approval for psoriasis. These new therapies are providing physicians and patients with new
therapeutic options. Efalizumab, a recombinant humanised monoclonal IgG1 antibody, is a
targeted biological therapy that inhibits the T-cell processes that underlie the pathogenesis of
psoriasis, including T-cell activation in the lymph nodes, T-cell trafficking from the circulation
into psoriatic skin, and reactivation therein. In one Phase III trial, after 24 weeks of continuous
therapy with efalizumab, more patients achieved X75% improvement in their Psoriasis Area
and Severity Index (PASI-75) relative to Week 12 (44% vs 27%; 95% CI 38.6%, 49.0%). Mean
percent PASI improvement continued to increase through Weeks 13 to 24 to reach 67% after
24 weeks of continuous treatment with efalizumab. In addition, improvements in all health-
related quality-of-life (HRQL) measures achieved at Week 12 were maintained through Week
24. An alternate open-label Phase III study is ongoing to assess the efficacy of continuous
efalizumab over 36 months. Interim 24-month data are available: the proportion of patients
who received up to 24 months of continuous efalizumab therapy and achieved PASI-50,
PASI-75, and PASI-90 was 64%, 47%, and 27% (intent-to-treat analysis; n¼339),
respectively. The results of these 2 trials demonstrate that efalizumab provides continuing
PASI improvement through 24 weeks of treatment, and the 24-month results indicate that
once-weekly subcutaneous efalizumab can provide continuous control of the symptoms of
moderate to severe chronic plaque psoriasis over the long term.
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Clinical and Etiologic Differences Between Toxic Epidermal Necrolysis (TEN) and
Generalized Bullous Fixed Drug Eruption (GBFDE)
M Grosber, J Schlingmann, M Mockenhaupt
Dokumentationszentrum schwerer Hautreaktionen (dZh), Department of Dermatology,
University of Freiburg, Germany
In the spectrum of severe adverse skin reactions that present with blister formation toxic
epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS) and generalized bullous fixed
drug eruption (GBFDE) are important differential diagnoses. SJS and TEN are acute life-
threatening conditions with various amounts of skin detachment and hemorragic erosions of
mucous membranes mainly caused by drugs. In contrast, GBFDE is an important differential
diagnosis that can be separated by clinical means, but not in terms of the histopathology.
GBFDE presents with generalized well demarcated red or brownish plaques with blisters.
Mucous membranes may be affected in a mild way; the overall condition of the patient is
good. Frequently GBFDE is induced by cotrimoxazole (trimethoprim/sulfamethoxazole),
which is also known to induce SJS and TEN, and a previous adverse reaction is often
reported to the same drug.
The following analysis was undertaken to elucidate the differentiation between cases of
SJS/TEN and GBFDE. Therefore, a re-review of cases using more specific criteria to
differentiate between SJS/TEN and GBFDE should allow to detect misclassification of cases.
984 cases of SJS, SJS/TEN overlap and TEN were ascertained by the population-based
registry in Germany between 1990 and 1999, of which 131 had taken cotrimoxazole within
two weeks before the onset of the adverse reaction. From these cases as well as 38 cases
with suspected GBFDE a random sample of 57 cases (44 SJS and TEN, 13 GBFDE) was
taken and re-reviewed. In this analysis specific emphasis was given to the time latency
between beginning of drug use and onset of the adverse reaction.
For definite cases of SJS or TEN the median between beginning of cotrimoxazole use and
onset of the adverse reaction is 9 days (25% quartile 6 days, 75% quartile 14 days). In
doubtful cases the time latency is only 2 (2–9). For definite cases of GBFDE the time is one
day (1–2) and thus by far shorter.
The high amount of doubtful cases after the re-review reveals the difficulty to apply
approved detailed definitions to the variety of clinical patterns of cutaneous adverse
reactions. We could confirm a high correlation of time latency between beginning of drug use
and onset of SJS and TEN as well as GBFDE for cotrimoxazole. GBFDE should be considered
as diagnosis when drug exposure occurs outside the relevant time latency for SJS and TEN,
especially in cases with widespread epidermolysis and previous episodes.
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The Relationship Between Patient-Rated Quality of Life and Clinicians’ Management
Decisions in Psoriasis – A Prospective Study
R P Katugampola, Y Hongbo and A Y Finlay
Cardiff, United Kingdom
The aim of this study was to prospectively determine the relationship between patient-rated
quality of life (QOL) and clinicians’ management decisions in psoriasis, in current routine
clinical practice. Between July 2003 and March 2004 (35 weeks), all 687 outpatient
consultations for psoriasis management, by 13 clinicians, at the Welsh Institute of
Dermatology, University Hospital of Wales, Cardiff were included in the study. Patients aged
18 years or older were posted a Dermatology Life Quality Index (DLQI) questionnaire that they
received the day after their consultation. This ensured that the DLQI scores were not available
to the clinicians during the consultations. The consenting patients were advised to complete
the DLQI questionnaire that relates to the week preceding completion, within 2 days of the
consultation, ensuring an accurate assessment of the QOL of each patient at the time
management decisions were taken. Case notes were examined and the main management
decision taken for each patient was assigned to one of eleven categories. 383 (55.7%)
completed DLQI questionnaires were included in the analysis of data as follows: No change
to the main therapy type despite an increase in potency, dose or frequency of that therapy
[MD1a](n¼29, DLQI range 1–29, DLQI meanstandard deviation 11.98.1); No change to
main therapy at all [MD1b](n¼199, 0–3, 8.97.2); no change to the main therapy type
despite a decrease in potency, dose or frequency of that therapy [MD1c](n¼27, 0–21,
6.25.8); change from one type of topical to another type of topical therapy [MD2](n¼ 49, 1–
7, 11.26.7); topical to systemic therapy [MD3](n¼14, 3–30, 14.86.9); one type of
systemic to another type of systemic therapy [MD4](n¼ 3, 9–27, 16.79.3); start
photo(chemo)therapy [MD5](n¼ 34, 2–28, 137.4); plan admission to hospital [MD6](n¼9,
5–21, 14.45.0); refer to dermatology day treatment unit [MD7](n¼ 9, 3–20, 8.66.6);
discharge from specialist dermatology to primary care [MD8](n¼ 7, 1–13, 4.04.2).
Statistically significant differences were seen between the mean DLQI scores for MDs 1a &
1b, 6 & 7, (po0.05), 1a & 1c, 1a & 1b, 5 & 1b, 6 & 1b, 2 & 8, 3 & 8, 5 & 8, 6 & 8 (po0.01) and 5
& 1c, 6 & 1c (po0.001) using the Mann-Whitney U test. There was a striking difference in
mean DLQI scores between patients in whom there was no change to therapy at all (MD1b)
and in whom major new interventions were taken i.e. MDs 3þ 4þ 5þ 6 (n¼ 60, DLQI
meanstandard deviation 13.86.9, median 13, p¼ 0.00007). The median DLQI scores seen
in decisions MD 1a (13), MD 3 (14.5), MD4 (14), MD5 (11) and MD6 (13) are consistent with
the proposed DLQI banding of 11–20 indicating a ‘‘very large effect’’ on overall QOL. The
median DLQI scores seen in MD1b (7), MD7 (7) and MD2 (10) are consistent with banding
6–10 indicating a ‘‘moderate effect’’, and low scores in MD1c (4) and MD8 (3) consistent
with banding 2–5 indicating only a ‘‘small effect’’ on patient’s overall QOL. This study
demonstrates an overall relationship between patient-rated QOL and the nature of manage-
ment decisions taken in psoriasis. The wide score scatter for each decision seen in this study
indicates that clinicians’ management decisions may not have been appropriate in some
patients. This study also highlights the importance of including formal QOL assessments in
addition to physical measures when clinical decisions are taken over psoriasis management,
for example, the use of systemic and new potent biological therapy, with its potential side
effects. The initial data from this study are important in developing such criteria to aid
clinicians make management decisions tailored to each individual patient.
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The Farnsworth panel D 15 test – a Simple Instrument to Detect High Risk Melanoma
Patients? First Results of a Study Including 300 Patients with Malignant Melanoma
C Pfo¨hler, S Tscho¨p, K Rass, W Tilgen
The Saarland University Hospital, Department of Dermatology, Homburg/Saar
Melanoma-associated retinopathy (MAR) is a paraneoplastic syndrome in patients with
malignant melanoma, that is rarely seen with all its clinical signs and symptoms. The
pathomechanism is supposed to result from antibody production against melanoma antigens
which cross-react with retinal epitopes. Beside light sensations, night blindness and visual
loss, color loss for blue (tritan dysfunction) has been reported. The onset of MAR symptoms is
correlated with a rapid progress of disease and a worse prognosis for progress-free and
overall survival. Recently performed ophthalomological examinations as well as immuno-
fluorescence assays on retinal tissue using autologous serum samples of melanoma patients
could prove, that subclinical signs as well as the presence of antiretinal antibodies is more
frequent than supposed. As intensive ophthalmological examinations and indirect immuno-
fluorescence on retinal slides are time-consuming and cost-intensive they usually cannot be
performed in melanoma aftercare. The Farnsworth panel D 15 test is a color test which is able
to detect all kinds of color deficiencies. Patients have to arrange 15 different color caps using
a blue reference cap. Mapping of the color sequence in a diagram shows the existence of
color loss. This study including 300 melanoma patients (AJCC stage 0: n¼ 3; stage I: n¼149;
stage II: n¼53; stage III: n¼ 56; stage IV: n¼ 39) and 100 healthy controls was performed to
answer the question if the Farnsworth panel D 15 test alone is able to detect high risk
melanoma patients. 26% of all melanoma patients showed tritan dysfunction, this percentage
was much higher than in the control group (2%). The presence of tritan dysfunction correlated
with stage of disease, tumor thickness, Clark Level and age, but not with sex, S-100 value or
time since first diagnosis. Actually, follow-up examinations are performed and compared with
immunofluorescence experiments with autologous serum on retinal tissue. After this
evaluation is should be possible to state if the Farnsworth panel D 15 test is a simple
instrument to detect high risk melanoma patients in melanoma aftercare.
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Psoriasin (S100A7) Protects Human Skin from E. coli-Infection In Vivo
R Gla¨ser1, J Harder1, H Lange2, H Janen1, E Christophers1, and J-M Schro¨der1
1Department of Dermatology and 2Department of Experimental Surgery, University of
Schleswig-Holstein, Campus Kiel
Human skin is potentially exposed to a variety of microorganisms but surprisingly resistant
towards the gut bacterium E. coli. Recently we identified psoriasin as a major E. coli killing
S100 protein from healthy human stratum corneum extracts. We could demonstrate that the
antimicrobial activity of psoriasin is inhibited by Zn2þ and that psoriasin-mRNA is inducible in
primary keratinocytes by proinflammatory cytokines and contact with bacteria. This study
was initiated to investigate the relevance of psoriasin as antimicrobial protein in vivo.
Immunohistochemical analysis of healthy human skin derived from different body sites
using an anti-psoriasin antibody reveals a focal expression pattern mainly at locations with a
high microbial colonisation rate suggesting a local induction and release. To prove this
hypothesis we artificially applied E. coli ATCC-No. 35218 on the forearms of healthy
volunteers (n¼18) and were able to show a rapid and high effective killing of the bacteria. To
investigate whether psoriasin is responsible for E. coli-killing we developed neutralizing
monoclonal anti-psoriasin antibodies and could show that the monoclonal antibody HL15-4 -
but not the heat-inactivated moAb- inhibits in vitro the E. coli-killing activity of psoriasin.
Pretreatment of the forearm skin with the antibody before experimental application of E. coli
led to a dose-dependent increase of bacterial survival (n¼5). Using a sandwich-ELISA we
could identify significant bactericidal levels of psoriasin in washing fluids derived from the
forearm skin in all persons. The psoriasin amounts present at the skin surface varied
depending on the location.
Our findings show that human skin secretes in vivo in a donor and site-specific fashion the
S100 protein psoriasin as principal E. coli-killing antimicrobial compound explaining the
unexpected resistance of skin towards E. coli, despite its high abundance in the daily life.
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Papillomavirus-like Particles (VLP) Carrying HPV16-L2 Peptides Induce Cross-Neutraliz-
ing Antibodies to Genital HPV 11
K Slupetzky, S Shafti-Keramat, R Kirnbauer
Laboratory of Viral Oncology, DIAID, Department of Dermatology, Univ. of Vienna Medical
School, Vienna, Austria
Vaccination in human trials with papillomavirus-like particles (VLP) of types 16 and 18 has
shown 100% efficiency conferring type-specific protection against these most prevalent HPV
infections and associated neoplasia. However, protection against 13 high-risk HPV types
accounting for additional 30% of cervical cancers remains a challenge. Although peptides of
HPV16 L2 minor capsid protein have been identified that induce cross-neutralizing antibodies
to HPV6, 11 and 18, L2 is poorly immunogenic in the context of L1/L2 VLP. Thus the aim of
this study is to display HPV16L2 epitopes on immunogenic surface loops of L1-VLP, capable
of inducing a strong anti-L2 antibody response with cross-neutralizing activity to other
mucosal types. Two previously described HPV16L2 epitopes (representing amino acids (aa)
69–81 (A) and 108–120 (B)) were engineered into L1 of bovine PV type 1 (BPV1) (between aa
residues 133/134). Chimeric proteins were expressed in insect cells, purified on density
gradients, and antigenicity was verified by Western blot. Electron micrographs demonstrated,
that chimera B self-assembled efficiently into capsomeric VLP similar to wt L1, whereas for
chimera A mainly pentamers or aggregates thereof were observed. Immunization of NZW
rabbits using Freunds adjuvant induced antisera that recognized GST-HPV16L2 with a titer of
1,000–10,000 by ELISA. Importantly, when examined in an RT-PCR transient infectivity assay
using native HPV 11 virions, antisera induced by chimeric protein A, but not B, neutralized this
distantly related type. Induction of cross-neutralizing antibodies by chimeric L1/L2 VLP may
facilitate the generation of broad-spectrum vaccines that protect against a majority of
relevant mucosal HPV and associated neoplasia.
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DC-SIGN-Mediated Infectious Synapse Formation Enhances Transfer of HIV Infection
from Dendritic Cells to T Cells
J-F Arrighi1, M Pion1, T B Geijtenbeek2, M Wiznerowicz3, E Garcia1, D Trono3, Y van Kooyk2,
and V Piguet1
1Department of Dermatology and Venerology, University Hospital of Geneva, Geneva,
Switzerland 2Department of Molecular Cell Biology and Immunology, VUMC, Amsterdam,
The Netherlands 3Department of Genetics and Microbiology, CMU, Faculty of Medicine,
University of Geneva
Dendritic cells (DCs) expressing the DC-specific C-type lectin DC-SIGN capture small
amounts of HIV on mucosal surfaces and facilitate viral transmission to CD4þ T cells in lymph
nodes, where massive viral replication occurs. In order to analyze the role of DC-SIGN in early
events of HIV infection and prevent HIV transmission from DCs to T cells, we disrupted DC-
SIGN function through lentiviral-mediated RNA interference. By suppressing DC-SIGN
expression, we demonstrate that DC-SIGN is a major attachment factor for HIV and the
mycobacterial cell wall component ManLAM on human DCs. Furthermore, DC-SIGN
suppression in DCs impairs infectious synapse formation between DCs and CD4þ T cells.
DC-SIGN-negative DCs are also unable to enhance transfer of HIV infectivity of T cells in
trans. In conclusion, we show that DC-SIGN is required for infectious synapse formation
between DCs and T cells which enables trans-enhancement of HIV infection to T cells.
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C. albicans Activates Human Primary Endothelial Cells by IKK2/IjBa/NF-jB- and p38-
MAP Kinase-Dependent Intracellular Signalling Pathways
V Mu¨ller1, S Schmid1, S Ludwig2, EB Bro¨cker1, M Leverkus1, M Goebeler1
1Department of Dermatology, University of Wu¨rzburg, Wu¨rzburg, Germany, 2Department of
Molecular Medicine, University of Du¨sseldorf, Du¨sseldorf, Germany
Endothelial cells are not only physical barriers between different compartments but are also
capable of actively regulating defence mechanisms against microbial pathogens such as
Candida. We here analyzed the effects of C. albicans (strain SC5314) on different intracellular
signalling pathways which mediate the expression of proinflammatory cytokines, chemokines
and antimicrobial peptides by endothelial cells. Co-culture of C. albicans blastospores with
human umbilical vein endothelial cells (HUVEC) at a MOI of 1 resulted in a significant up-
regulation of IL-8 and ICAM-1 expression. Immune complex kinase assays revealed that C.
albicans induced activation of IKK2 which is followed by degradation of IkBa as determined
by Western blot analysis. However, activation of the NF-kB signalling module appears to be
retarded when compared to activation by TNF-a. To assess the functional relevance of
activation we studied endothelial cells which were retrovirally infected to express a dominant-
negative mutant of IKK2, i.e. IKK2KD. Co-culture of such cells with C. albicans blastospores
no longer resulted in up-regulation of IL-8 and ICAM-1 expression thus confirming the
requirement of NF-kB activation. Another signalling pathway identified to be activated by C.
albicans is the p38 mitogen-activated protein (MAP) kinase pathway. We here demonstrated
activation of p38 by immune complex kinase assay and verified functionality with respect to
IL-8 expression by the use of a highly specific inhibitor. In conclusion, our data demonstrate
that C. albicans activates distinct intracellular signalling pathways in human endothelial cells
which are necessary for the expression of molecules apparently playing prominent roles in the
pathophysiology of Candida infections.
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DC-Derived Antagonistic IL-12 Homodimer Induces Th2-Immunity in Cutaneous Leish-
maniasis
A Nigg, S Zahn, J Ehrchen, F Woelbing, J Knop, and E von Stebut
Department of Dermatology, Mainz, and Department of Dermatology, Muenster, Germany
IL-12 release of infected dendritic cells (DC) is critically involved in Th1-education in various
disease models. In cutaneous leishmaniasis, protection in C57BL/6 mice is the result of Th1-
immunity, whereas susceptible BALB/c mice develop Th2-responses. Bioactive IL-12p70 is a
heterodimer composed of p35 and p40, whereas p40 released in excess can be found in the
inactive p40 monomeric form or as (p40)2 homodimer with inhibitory activity. The ratio
between p40/(p40)2 is regulated by IL-4 in vivo. In this study, we analysed differences in the
release of IL-12 in more detail. In the presence of IL-4, activated bone marrow-derived DC
(generated with GM-CSF) from both resistant and susceptible mice released comparable
amounts of IL-12p70 and p40 confirming previous findings. However, without IL-4 (reflecting
more physiological conditions during DC activation in vivo), BALB/c-derived DC released
significantly more p40 than C57BL/6-DC as detected by ELISA. We next determined, whether
IL-12 was released as monomeric p40 or in the form of the natural inhibitor (p40)2.
Interestingly, in western blot analyses of both C57BL/6 and BALB/c DC-supernatants a large
proportion of anti-IL-12p40 reactivity was detected at 80kDa. We found substantially more
(p40)2 in BALB/c DC-supernatants. To determine the physiological role of IL-12(p40)2 in
cutaneous leishmaniasis, C57BL/6 and BALB/c mice were treated locally with 1 mg
recombinant (p40)2 or PBS intradermally during T-cell priming (days 1–3 post infection with
2  10E5 L. major). Lesions in (p40)2-treated groups were significantly larger in both mouse
strains compared to controls from wk 3 on (e.g. BALB/c mice: 125  20 vs. 63  16 mmE3
at wk 4, n¼ 7, po0.01). In parallel, lesional parasite loads were  2-log higher after (p40)2-
treatment and the cytokine profile at wk3 was shifted towards a Th2 profile. In summary,
genetical differences in the production of IL-12p40 homodimer from infected DC may
contribute to disease outcome in cutaneous leishmaniasis.
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Interferon Resistance Promotes Oncolysis by Inﬂuenza Virus NS1-Deletion Mutants
T Muster1, J Rajtarova1, M Sachet2, H Unger3, I Romirer1, A Grassauer1, A Url4, K Wolff1,
H Pehamberger1 and M Bergmann2
1Dept of Dermatology 2Dept. of Surgery, 3University of Vienna, Dept. of Virology, 4Dept of
Pathology, Veterinarian University of Vienna
The NS1 protein of influenza virus is a virulence factor that counteracts type I interferon (IFN)-
mediated antiviral response by the host. A recombinant influenza A virus which lacks the NS1
protein only replicates efficiently in systems that contain defective IFN pathways. In this
contribution we demonstrate that the conditional replication properties of NS1-modified
influenza A virus mutants can be exploited for the virus-mediated oncolysis of IFN-resistant
tumor cells. IFN resistance in analyzed tumor cell lines correlated with a reduced expression
of STAT1. Addition of exogenous IFN or supernatant of virus-infected endothelial cells
inhibited viral oncolysis in IFN-sensitive but not in IFN-resistant cell lines. The oncolytic
potential of NS1-modified influenza A virus mutants could be exploited in vivo in a SCID
mouse model of a subcutaneously implanted human IFN-resistant melanoma. The data
indicate that IFN-resistant tumors are a suitable target for oncolysis induced by NS1-modified
influenza virus mutants. STAT1 might serve as a marker to identify these IFN-resistant tumors.
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An Infectious Endogenous Retrovirus Derived from Human Melanoma Cells
A Waltenberger, A Grassauer, S Hirschl, I Romirer, D Fo¨dinger, H Pehamberger, T Muster,
and K Wolff
Department of Dermatology, Division of General Dermatology, University of Vienna Medical
School, Vienna, Austria
We show that human melanoma cells produce retrovirus-like particles that exhibit reverse-
transcriptase activity, package sequences homologous to human endogenous retrovirus K
(HERV-K), and contain mature forms of the Gag and Env proteins. We also demonstrate
expression of the pol gene and of Gag, Env and Rec proteins in human melanomas and
metastases but not in melanocytes or normal lymph nodes. The melanoma-derived particles
are infectious for Madin-Darby bovine kidney cells. The data suggest that expression of
retroviral genes and production of infectious retroviral particles is activated during
development of melanoma.
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Consistent Human Papillomavirus Infections in Different Non-Melanoma Skin Cancer and
their Recurrences
A Ko¨hler1, T Meyer2, T Schmook1, C Ulrich1, E Stockfleth1, I Nindl1
1Department of Dermatology, Charite´, University Hospital, Berlin, Germany 2IPM-HH,
Hamburg, Germany
Objective: Ultraviolet radiation is the major risk factor of non-melanoma skin cancer (NMSC)
and cutaneous HPV types seems to play a role during skin carcinogenesis. We examined the
presence of cutaneous HPV and their variants in NMSC and their recurrences.
Patients and Methods. Twenty-four biopsies of 4 patients with invasive NMSC were analyzed
by a HPV L1 PCR-based method to detect all 24 cutaneous HPVs of the B1 and B2 group
followed by typing using reverse line blotting. In a retrospective study with prospective value
recurrent NMSC were followed up between 8 and 37 months. HPV typing of selected cases
were verified by E6 type-specific PCR followed by primer cycle sequencing (HPV 8, #184–
656; HPV 14, #218–325; HPV 21, #209–432; HPV 36, #210–316).
Results. Consistent single and multiple HPV infections were detected in 2 of 4 patients. All 7
NMSC of one immunosuppressed patient developed at sun-exposed sites after 4, 8, 9, 11,
and 37 months were infected with HPV 21 and HPV 36 until 11 months of follow-up. The HPV
36 E6 variant 311T was detected until 9 months of follow-up and the metastatic squamous
cell carcinoma (SCC) developed after 11 months was infected with the E6 variant [311T, 261C
(L21S)]. The same HPV 21 E6 variant [226C, Del (244–273, AA16–25)] was identified in the
primary SCC and recurrences after 4, 8, 9, and 11 months. In another immunocompetent
patient both the primary SCC and the metastasis developed after 8 months were infected
with HPV 14. Squamous cell carcinomas of two non-immunosuppressed patients showed no
consistent HPV infections. One of three and 7 of 9 SCC were HPV negative.
Conclusions. Consistent HPV infections in invasive SCC and their recurrences suggest a role
of cutaneous HPV during skin carcinogenesis in a subset of NMSC. The spatial localization of
HPV will be examined.
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After Challenge with Leishmania major, Strain-Dependent Differences in Inﬂammatory
Immune Responses are Most Prominent at the Site of Infection
K Moelle, S Lopez, J Knop, and E von Stebut
Department of Dermatology, University of Mainz, Germany
Healing in cutaneous leishmaniasis is associated with IL-12-dependent IFN-g-producing
CD4/Th1 cells as observed in resistant C57BL/6 mice. In contrast, susceptible BALB/c mice
succumb to infection because of Th2 immunity which fails to eliminate intracellular parasites.
During physiological low dose infections with Leishmania major protection by CD8þ /Tc1-
cells in C57BL/6 mice was also achieved. We described previously that fusion proteins of
HIV-1 TAT and Leishmania-antigen LACK efficaciously vaccinate against progressive disease
by facilitating MHC class I-dependent induction of Leishmania-specific CD8þ T-cells. Thus,
activation of CTL may be beneficial for protective immunity. In contrast to C57BL/6, the
physiological role of CD8þ T-cells in BALB/c mice during leishmaniasis is not known yet. To
do this, we analyzed the inflammatory infiltrate of infected ears as well as draining lymph
nodes (LN). Infections were initiated using 2x105 infectious-stage promastigotes. Infected
ears and LN were collected weekly and inflammatory cells were characterized by FACS. In LN
as well as dermis of BALB/c mice significantly more total cells were found than in C57BL/6
mice correlating to increased lesion volumes. In dermal lesions, no strain-dependent
differences regarding recruitment of CD4þ and CD8þ T-cells were observed, whereas BALB/
c showed a 2-fold increase of CD4þ cells in LN compared to C57BL/6 mice. The number of
CD4þ cells was 2-fold higher than of CD8þ cells independent of the strain studied and
immigration of lesional CD8þ T-cells was delayed compared to CD4þ cells (wk3 vs. wk5).
Interestingly, significant increases (3-fold) were found in the number of lesional neutrophils
and CD11cþ DC in BALB/c mice suggesting that DC alone are not sufficient for protection. In
summary, susceptibility of BALB/c mice against infection with Leishmania major is not
caused by impaired recruitment of lesional T-cells. Most strain-specific differences were
found in dermal lesions suggesting that relevant immune responses occur directly at the site
of infection.
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Expression Proﬁling Reveals Sets of Genes Regulated Differentially in HaCaT
Keratinocytes Following Exposure to Secreted Pseudomonas Products
B Goethel, R Haesler, L Schwichtenberg, J Schro¨der, J Bartels
Kiel, Germany
We have shown previously, that the skin is able to defend infection by constitutive and
upregulated production of antimicrobial peptides and that the extent of microbial induced
keratinocyte defense gene expression also depends on microbial strains and growth
conditions. For a better understanding of the mechanisms in the hostile interaction between
keratinocytes and Pseudomonas aeruginosa and to determine the parameters for successful
protection against infection we compared alterations of (HaCaT) keratinocyte gene
expression upon exposure to supernatants of P. aeruginosa differing in their ability to induce
expression of the antimicrobial peptide hBD2.
Differentially expressed keratinocyte genes were identified using an inflammation specific
DNA array. The results were validated using real-time (kinetic) reverse transcription-
polymerase chain reaction (RT-PCR). From 376 genes present on the inflammation specific
DNA-array 36 were identified to differ in keratinocyte expression by a factor of at least 2
following stimulation. The identified genes could be grouped according to their expression
pattern in genes upregulated following stimulation with the hBD2-inducing P. aeruginosa
supernatant (‘‘Set 1’’: e.g. Psoriasin, Calgranulin), genes upregulated following stimulation
with a mixture of hBD2 inducing and hBD2 not inducing P. aeruginosa supernatant (‘‘Set 2’’:
e.g. MCP1, IL-8) and in genes down regulated following stimulation with this P. aeruginosa
supernatant mixture (‘‘Set 3’’: Integrin 4, HSPB1).
Depending on strain and growth conditions, secreted Pseudomonas factors obviously
include factors which induce or inhibit keratinocyte expression of antimicrobial peptides.
Upregulation of genes like MCP1 or IL-8 following keratinocyte stimulation with a mixture of
hBD2 inducing and not-inducing Pseudomonas supernatants (which results in reduced
expression of antimicrobial peptides) indicates that keratinocytes are able to activate
additional defense mechanisms under conditions restricting local innate defense mechan-
isms. Future experiments will focus on the identification of those P. aeruginosa factors
specifically affecting keratinocyte innate defense gene expression and on the identification of
further keratinocyte genes specifically affected in their expression by these factors.
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Immunoblot Analysis of Various Protein Fractions of Borrelia burgdorferi, Including
Variable Major Protein – Like Sequence Expressed during the Course of Erythema
migrans Disease
M Glatz,1 B Wilske,2 H Kerl,1 R R Muellegger1
1Department of Dermatology, Graz, Austria; 2Max-von-Pettenkofer-Institute, Munich,
Germany
To examine the immune response against different proteins of Borrelia burgdorferi (Bb) in
erythema migrans (EM) patients before and after therapy by an immunoblot test (IB) including
the Variable major protein-like sequence, expressed (VlsE).
In 50 adult EM patients, Bb IgG and IgM antibodies were analyzed in a median of 5 serum
samples consecutively obtained before and during a median of 513d (range, 414–1185d) after
therapy by recombinant IB. The antigens used in the IgG IB were Outer surface protein (Osp)
17, p41i, OspC, VlsE, p39, p58, p100. In the IgM IB p41i, OspC, p39, and p100 were used. All
serum samples were also tested by a standard IgG and IgM ELISA.
The IgG IB gave positive results in 50% before and in 57% directly after therapy (ELISA: IgG
22% and 25%, respectively). The respective values for IgM testing were: IB 36% and 43%;
ELISA 42% and 61%. By the end of the follow-up period, IgG and IgM IB gave positive results
in 44% and 12%, respectively. In acute and convalescence phase sera, VlsE was the most
sensitive protein in the IgG IB (60% and 70% positive, respectively). In the IgM IB, p41i (46%
and 57%) and OspC (40% and 55%) were the most sensitive proteins. By the end of follow-
up, only the IgM response to p41i was significantly decreased to 24% (vs. 46% before
therapy) (p¼ .036). The immune response to all other proteins did not change significantly
over the follow-up.
The IgG IB was more sensitive than the IgG ELISA, whereas the IgM IB was less sensitive
than the IgM ELISA. VlsE in the IgG IB and p41i and OspC in the IgM IB were the most
sensitive proteins in acute and convalescence phase sera. During long-term follow up, only
the immune response to p41i decreased significantly. Thus, the immune response against
different Bb antigens is not influenced by antibiotic therapy.
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Expression of Toll-like Receptors in Normal Human Skin and Virus-Infected Skin Lesions
Y M Park J K Ku, M-Y Kim, H O Kim, H Kang
Department of Dermatology, Kangnam St. Mary’s Hospital, St. Paul’s Hospital, College of
Medicine, The Catholic University of Korea
The surface epithelium of skin plays a key role as the first line of defense against pathogenic
microorganisms. Recent studies suggest that some of toll-like receptors (TLRs) are
functionally expressed in normal human keratinocytes in vitro, although there have been
controversies. However, little is known about the expression of TLRs in normal human skin in
vivo and common virus infected skin lesions. In this study RT-PCR analysis was used to
examine the mRNA expression of 5 TLRs (TLR2, TLR3, TLR4, TLR7, TLR9) in the normal
human skin and the lesions of verruca vulgaris and molluscum contagiosum. Immunohis-
tochemical staining was also performed to examine the pattern of TLR expression in normal
human skin and viral lesions. Homogenized normal human skin constitutionally express
TLR2, TLR4, TLR7, but not TLR3, TLR9. TLR7 was also expressed in the homogenized
samples from verruca vulgaris and molluscum contagiosum. Immunohistochemical staining
showed the strong expression of TLR2, TLR4, and TLR7 in whole epidermis of normal human
skin. TLR3 and TLR9 were weakly expressed in the basal layer of normal human skin. TLR3
expression was diffusely augmented in the hyperkeratotic epidermis of verruca vulgaris and
in the vicinity of molluscum bodies. There was little difference in the expression of other TLRs
between normal human epidermis and viral lesions. These findings suggest that some TLRs
can be implicated in the pathogenesis of skin viral infections such as verruca vulgaris and
molluscum contagiosum.
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Proprionibacterium acnes Surface Proteins are Recognized by Extracellular Matrix
Proteins and Keratin
P A Grange1, N Dupin1,2
1Laboratoire de Microbiologie Cutane´e,2Service de Dermatologie-Ve´ne´rologie, Hoˆpital
Cochin – Pavillon Tarnier, Universite´ Paris V, France
Acne is a multifactorial disease of the skin, particularly the pilosebaceous unit. Acne lesions
can be divided into noninflammatory and inflammatory lesions where the inflammatory
lesions consit of papules, pustules and nodules where the follicular epithelium is damaged
with a dermal inflammation. One of the factors promoting the development of inflammatory
acne is the bacterial colonization of the pilosebaceus duct by the anaerobic Proprionibacter-
ium acne (P. acnes) strain. In this study, we investigated the capability of P. acnes surface
proteins to be recognized by extracelular proteins (collagens, fibrinogen) and keratin which is
the major protein constituant produced in the keratinocytes. Two P. acnes strains, isolated
from acne lesions, were used and grown on liquid and solid reinforced clostridium medias
(RCM) containing or not Tween 80 and on solid blood agar. P. acnes surface proteins were
heat extracted in presence of detergent and with LiCl, and then electrophoretically separated
and tested for their capabilities to be recognized by biotinylated purified collagen I, IV, VI, VII ;
fibrinogen and keratin. Overlay analysis of surface proteins extracted from bacteria grown on
solid RCM showed, a band ranging from 62 to 70 kDa depending of the bacterial strain,
recognized strongly by keratin, fibrinogen and weakly by collagen VI while Collagen I, IV and
VIII were not. When comparing the extraction methods, only the LiCl based-extraction gave
better recovery. These results indicate that P. acnes strain possess surface proteins able to
be recognized by proteins synthetized in the keratinocytes. Proteomic characterizations of
these surface proteins are underway.
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Characterization and Typing of Trichophyton raubitschekii Isolates. First Report from the
South-East Region of Europe
M Arabatzis, A Velegraki, D Rigopoulos, T Kantardjiev, V Stavrakieva, A Katsambas
Athens, Greece and Plovdiv, Bulgaria
Trichophyton raubitschekii is classically isolated from African, South East Asian and
Australian aboriginal patients with tinea corporis or tinea cruris. It is a debated dermatophyte
species, differentiated from Trichophyton rubrum principally by its positive urease activity and
production of profuse macroconidia and microconidia in culture. This study was undertaken
to screen Greek and Bulgarian clinical isolates characterized as T. rubrum for T. raubitschekii
and to delineate these strains by two molecular methods used for the first time in T. rubrum
epidemiological studies.
Ninety-five Greek strains and 10 Bulgarian strains, originating from various body sites,
initially identified as Trichophyton rubrum, were screened for urease activity in Christensen’s
urea agar. Subsequently, all urease positive strains were tested for lack of bacterial
contamination, histidine growth independence and lack of in vitro hair perforation as well as
for NaCl intolerance. Their morphology was studied in Sabouraud dextrose agar, potato
dextrose agar and by slide cultures. Strains were delineated with PCR-ribotyping amplifying
repeat elements of the Intergenic Spacer region (IGS) and by PCR fingerprinting utilizing a
decameric minisatellite oligonucleotide sequence.
In total, five Greek and one Bulgarian T. raubitschekii strains were identified comprising
isolates from patients with tinea manuum (1), tinea corporis (1), tinea cruris (1) and
onychomycoses (3). Although all strains produced macroconidia, only one strain had the
classical T. raubitschekii microscopic morphology, the other 5 presented a dominant
arthroconidial phenotype. Only 3/6 T. raubitschekii strains originated from tinea corporis
cases, whereas the majority of T. rubrum were onychomycosis isolates. Both typing methods,
though not used before in dermatophyte typing, clustered all T. raubitschekii and T. rubrum
isolates in the same group indicating strain homogeneity.
The surprising large autochthonous incidence of T. raubitschekii in the Balkan and in S.E.
Mediterranean regions extends the geographical distribution of this species. This finding also
highlights the importance of accurately recording the anatomical site of lesions caused by
Trichophyton isolates, so as to perform pertinent differential biochemical tests for the reliable
characterization of isolates. Although T. rubrum and T. raubitschekii infections are regarded
as relatively known clinical entities, still a lot remains to be elucidated on their epidemiology
and their respective response to treatment through phenotypic and genetic studies.
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Isolation of Quinolone-Resistant Ureaplasma Urealyticum and Identiﬁcation of Gene
Mutaions in Quinolone Resistant Determining Regions
Y Xu, D Luo, Y Miao, W Sun2, X Chen
Department of Dermatology and Venereology, the First Affiliated Hospital of Nanjing Medical
University, Nanjing, China. 2Department of Dermatology and Venereology, Yangzhong
Renmin Hospital, Yangzhong, China
Objectives: To isolate quinolone-resistant UU (Ureaplasma Urealyticum) from clinical isolates
and further to determine the gene mutations in QRDRs (quinolone-resistant determining
regions) in such resistant isolates.
Methods. Two kinds of drug susceptibility test kits were used to determine the quinolone-
resistant UU isolates from 44 clinical isolates. Those isolates with color changes from yellow
to pink or red in both media with and without quinolones were considered as the resistant
ones. Broth dilution method was used to dilute four kinds of quinolones with a series of
concentrations from 0.125mg/ml to 128mg/ml in 96 well plates. The MIC was used to evaluate
UU3 reference strain and clinical isolates. The isolates with MICs four times higher than those
of UU3 for the same drugs were considered as resistant isolates. Two pairs of specific primers
were used to amplify gyrA and parC, two major genes in QRDRs of UU. PCR was performed
and the expected fragments for gyrA parC should be 336bp and 309bp respectively. The
positive amplicons were sequenced and the results were compared with the reference
strains.
Results. Of 34 tested isolates, 10 were resistant to both OFX (ofloxacin) and SPX
(sparfloxacin), 15 only resistant to OFX and 1 resistant to SPX. Eight isolates were sensitive
to both drugs. Of another 10 tested isolates, 6 were found resistant to CFX (ciprofloxin), and 3
resistant to SPX. For 4 kinds of quinolones tested, MICs of UU3 reference strain were 1mg/ml
for LFX (Levofloxacin), 4ı´g/ml for CFX, 8mg/ml for NFX and 2mg/ml for SPX. MICs of 2 out of 22
UU isolates were found four times higher than those of the reference strain. The amplified
fragments with 336bp (gyrA) and 309bp (parC) were observed in 3 out of 6 resistant strains, 1
with positive parC band. Compared with the reference strain, the sequenced results revealed
a C to A change at 87nt of gyrA in 1 isolate , a C to T change at 50nt of parC in 1 isolate and
both changes in 1 isolate.
Conculsions. The results of drug susceptibility tests are important for clinical therapy in UU
infection because of drug-resistant isolates. Drug susceptibility kits are easier and more
convenient to apply than broth dilution method for further and wider usage. It is urgent to
standardize the NGU therapy in the light of the susceptibility results. It can be implied that
resistance of UU to quinolones may have some relation to the gene mutations in QRDRs such
as gyrA and/or parC.
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Adjuvant IFNa Therapy Stimulates Transporter Proteins Associated with Antigen
Processing and Proteasome Activator 28 in Patients with Malignant Melanoma
F Abuzahra, R Heise, S Joussen, A Dreuw, M, Neis, HF Merk, G Zwadlo-Klarwasser and JM
Baron
Aachen, Germany
The use of cytokines, especially of interferon alfa (IFNa) for the treatment of metastatic
melanoma was evaluated in several clinical trials. Although IFNa shows a broad spectrum of
immunmodulatory and antiproliferative effects in a variety of malignancies the mechanisms of
its antitumor effect and its action in adjuvant melanoma therapy remained unclear. In this
clinical study we showed that expression of transport proteins associated with antigen
processing (TAP1 and TAP2) and proteasome activator 28 (11S REG) was significantly
upregulated by i.v. adjuvant treatment with 10 million IU/m2 IFNa in 13 patients with malignant
melanoma (stage III, UICC). This strong stimulatory effect was seen in blood mononuclear
cells (PBMC) both on the RNA level using RT-, Real time- PCR and on the protein level using
immunohistochemistry and immunoblotting. Depending on the patient analyzed, 2- to 5-fold
upregulation of TAP1 mRNA expression could be detected by Real time- PCR. The finding
that IFNa stimulates the cytotoxic effector functions in PBMC of patients receiving
intermediate high dose immunotherapy by enhancing TAP expression and proteasome
activity contributes to the understanding of the immunoregulatory role of type 1 interferons
and may help to explain the efficacy of IFNa in the treatment of tumors. These parameters will
also provide a new clinical tool for measuring the efficiency of INFa therapy in vivo and will
give further information about the most effective dose and the duration of IFNa
administration.
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Anti-Inﬂammatory Activities of the p38 MAP Kinase Inhibitor EO1606 in Dermatological
Disease Models
T K Petersen, H Aaes, T Skak-Nielsen, E R Ottosen, E Bramm
LEO Pharma, Denmark
The amino-benzophenone EO1606 is a new, potent and selective inhibitor of p38 MAP kinase
(isoforms a and b) and of the upstream kinase MKK6. In vitro, EO1606 inhibits the production
of inflammatory cytokines such as interleukin (IL)-1b and tumor necrosis factor (TNF)-a from
human mononuclear leukocytes. The anti-inflammatory effect of EO1606 was tested and
characterized in the following dermatological disease models in vivo: In the acute oxazolone
induced contact hypersensitivity and TPA-induced chronic irritant contact eczema models,
the anti-inflammatory effect was comparable to that of group II/III corticosteroids. In the
passive cutaneous anaphylaxis model, the effect was comparable to levocabastine
hydrochloride. In the UV-B induced erythema model, the anti-inflammatory effect was by
far more potent than ketoprofen. In the magnesium deficient induced dermatitis model, the
effect was comparable to that of FK506. In the superantigen induced dermatitis model,
no anti-inflammatory effect was observed. In summary, EO1606 shows a broad anti-
inflammatory effect in vivo which may be beneficial in a number of human dermatological
diseases.
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Dissociation of Transactivation from Transrepression Activity by a Selective Glucocorti-
coid Receptor Agonist (SEGRA) Leads to Separation of Therapeutic Effects From Side
Effects
H Scha¨cke, A Schottelius, W-D Do¨cke, P Strehlke, S Jaroch, N Schmees, H Rehwinkel, H
Hennekes, K Asadullah
Corporate Research, Schering AG.
Glucocorticoids (GCs) are the most commonly used anti-inflammatory and immunosuppres-
sive drugs. Their outstanding therapeutic effects, however, are often accompanied by severe
and sometimes irreversible side effects. Thus, the goal of GC pharmacological research is the
development of new drugs which show a reduced side effect profile while maintaining the
anti-inflammatory and immunosuppressive properties of classical GCs. GCs affect gene
expression either by transactivation or transrepression mechanisms. The anti-inflammatory
effects are mediated to a major extent via transrepression while many side effects are
induced by a transactivation mechanism. Therefore, we aimed to identify ligands of the
glucocorticoid receptor (GR) that preferentially induce transrepression while avoiding or at
least strongly reducing transactivation. Here we describe a selected non-steroidal selective
GR-agonist (SEGRA), ZK 216348, which shows a significant dissociation of transrepression
and transactivation activities both in vitro and in vivo. In a murine model of skin inflammation
ZK 216348 is anti-inflammatorily active comparable to prednisolone after both systemic and
topical application. A remarkable superior side effect profile was found with regard to blood
glucose induction, spleen involution and to a lesser extend skin atrophy but not to ACTH
suppression. Accordingly ZK 216348 should have a lower risk e.g. for induction of diabetes
mellitus. Thus, the SEGRAs represent a promising new class of drug candidates with an
improved effect/side effect profile in comparison to classical GCs. Moreover, they are
attractive tool compounds for further investigating the mechanisms of GR-action.
432
Ultraviolet Radiation and Bradykinin Induce Erythema in Man Independently Through a
Nitric Oxide-Dependent Pathway
DA McKay, A Fitzpatrick, A Turnbull and R Weller
Edinburgh, United Kingdom
Bradykinin (BK) is a small peptide hormone released at sites of inflammation, and is an
inducer of cutaneous erythema. Tissue culture and animal work has suggested BK-induced
erythema may utilise nitric oxide (NO) as the final common pathway, but there are no human
studies to substantiate this. Ultraviolet radiation (UVR) is also thought to induce erythema
through production of NO, and in animal work, BK. We investigated the effect of the NO
synthase inhibitor N-nitro-L-arginine methyl ester (L-NAME) and the constitutive BK
antagonist HOE 140 on BK and UVR-induced erythema in human volunteers.
Increasing concentrations of BK alone, or BK with L-NAME were infused into human
forearm skin using cutaneous microdialysis catheters. UVR-exposed skin (UVB, xenon arc
lamp, Lotoriel, UK) was infused with L-NAME or HOE-140. Erythemal response was
measured as a function of cutaneous blood flow using laser doppler flowmetry (Moor
Instruments, UK).
BK infusion resulted in cutaneous erythema at concentrations as low as 10 mM, and
demonstrated an erythemal effect in a dose-dependent manner. BK-induced erythema was
suppressed by the BK antagonist HOE-140. L-NAME inhibited the effect of BK-induced
erythema at concentrations of BK up to 100 mM. This effect was pronounced, with erythema
typically returning to near baseline levels. Infusion of the inactive isomer D-NAME with BK
had no such effect. Thus inhibition of nitric oxide synthase abolished the ability of BK to
induce cutaneous erythema. UVR-mediated erythema was inhibited by L-NAME infusion, but
not by HOE-140.
The mechanism through which BK mediates erythema has been the subject of speculation.
This is the first study in humans to demonstrate BK acting through a NO-dependent pathway,
and that this occurs in a dose-dependent fashion. BK may induce NO production directly, or
through a downstream product such as prostaglandin. Furthermore, we have shown that
UVR-induced erythema acts independently of BK, but still through the NO pathway.
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Stimulation of Purinoceptors Induces the Release of Cytokines from Human Epidermal
Keratinocytes
K Inoue, M Denda, and S Fuziwara
Shiseido Research Center, Yokohama, Japan
In response to cell damage by mechanical stimulation, ATP is released from keratinocytes.
We examined the effect of extracellular nucleotides on the induction and release of cytokines
in cultured normal human epidermal keratinocytes (NHEK). Extracellular nucleotides
increased the release of cytokines (IL-6 and IL-8) in a concentration-dependent manner.
The order of potency for IL-6 release was ADP4ATP42-methylthio ADPUDP. Release of
IL-6 was not induced by UTP or a, b-methylene ATP. The order of potency for IL-8 release was
ATP¼UDP¼2-methylthio ADP4 or¼ADPUTP. Release of IL-8 was not induced by a, b -
methylene ATP. These effects of ATP (0.3 mM) were inhibited by P2 receptor antagonist
suramin (0.1 mM) and P2Y receptor antagonist reactive blue 2 (0.03 and 0.1 mM), but not by
P2X receptor antagonist pyridoxal-phosphate-6-azophenyl-2’, 4’-disulphonate (PPADS). ATP
also increased the expression of IL-6 and IL-8 mRNA using quantitative RT-PCR methods.
These expressions were inhibited by suramin and reactive blue 2, but not by PPADS. Though
release of IL-6 and IL-8 was increased in NHEK after UVB irradiation, these increases were
also inhibited by suramin and reactive blue 2 and further, the augmentative expression of IL-6
mRNA by UVB was inhibited by suramin and reactive blue 2. Additionally UVB irradiation
evoked the release of ATP from NHEK. In this study, we demonstrated that extracellular ATP
could specifically stimulate expression and release of IL-6 and IL-8 by mediating through P2Y
receptors in NHEK. These results indicated that there is a possibility that controlling
purinoceptors may inhibit skin inflammation during disease processes.
434
T-Cell Proliferation in Human Peripheral Blood Mononuclear Cells: Synergistic Inhibition
by Combinations of Pimecrolimus with Corticosteroids
A Winiski, B Schwendinger, A Stuetz
Novartis Institute for Biomedical Research Vienna, Austria
Corticosteroids have been the mainstay of therapy for inflammatory skin diseases, (e.g.,
atopic dermatitis and psoriasis), as well as other chronic inflammatory conditions, where
T-cell activation plays a key role. However, corticosteroid resistance has been reported
frequently. Pimecrolimus (ASM) is an ascomycin macrolactam derivative specifically de-
signed and developed to treat inflammatory skin diseases. Some in vitro T-cell systems (e.g.,
stimulated with superantigen and anti-CD3/CD28) have been documented to exhibit
resistance to corticosteroids and/or calcineurin inhibitors. In this study we examined the
effects of corticosteroids and pimecrolimus on T-cell proliferation in human peripheral blood
mononuclear cells (PBMC) stimulated with the superantigen staphylococcal enterotoxin B
(SEB) or with the combination of anti-CD3 plus anti-CD28 mAb for 72 hr. Proliferation was
measured via incorporation of 5-bromo-2’-deoxyuridine (BrdU).
When used as single agents in the present study, the corticosteroids dexamethasone (Dex)
and betamethasone 17-valerate (Beta) at 300 nM and hydrocortisone (HC) at 10,000 nM, as
well as pimecrolimus at 30 nM exerted, at most, only partial inhibitory effects on T-cell
proliferation. However, combinations of the corticosteroids with pimecrolimus (at the
concentrations indicated above) exhibited strong and synergistic inhibition of proliferation.
The following ranges of inhibition (stimulated control¼ 0%) were observed: SEB-induced
proliferation: corticosteroid (p15%), ASM (4–33%), corticosteroid plus ASM (p93%). Anti-
CD3þanti-CD28-induced proliferation: corticosteroid (p25%), ASM (p21%), corticosteroid
plus ASM (61–95%). These results suggest that combination therapy may be efficacious to
overcome corticosteroid resistance and/or for indications, where corticosteroid or pimecro-
limus monotherapy is insufficient.
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Transungual Delivery of Drugs: New Perspectives
R Baran and F Maillandy
Nail Disease Center, Cannes, France; yPolichem S.A., Scientific Dept., Lugano, Switzerland
Antimycotic nail lacquers show a rather low rate of clinical successes in patients with
onychomycosis, despite their proven in vitro activity. The formulations available till now have
the disadvantage of poor nail permeation of the active principles, as well as need of weekly
removal of the old layers. Both mechanical removal and organic solvents, besides being
uncomfortable to patients, may cause a potential damage to the nail structure, by rendering
the newly growing nail less resistant to the diffusion of the dermatophytes. The use of nail
penetration enhancers, besides improving the nail permeation, may further damage the nail
structure as a result of dysulphur bond breaking.
A new proprietary technology of ‘‘transungual’’ water solutions has been developed, acting as a
carrier at the nail level, by employing chitin derived hydrosoluble amino-polysaccharides. The new
technology is based on hydroalcoholic solutions of hydroxypropyl chitosan (HPCH), a water soluble
semi-synthetic derivative of chitosan, which acts as a film forming agent. HPCH dissolves in high
percentage in water, has affinity to air, is a highly plastic substance and forms a highly elastic film, it
increases the dispersion of other ingredients, it is an excellent carrier, finally it has neither toxicity
nor irritation. An 8% ciclopirox solution in the new formulation vehicle was able to permeate 150
mm bovine hoof membranes as in vitro model of human nails, with a lag time of 3.36  0.46 hours
and a flux of 4.70  0.60 mg/cm2.h, compared to a lag time of 12.48  1.31 hours and a flux of
3.05  0.63 mg/cm2.h of a reference solution containing a reference solution of a traditional
polyvinyl resin as a film forming agent. After 30 hours from a single application of the new
formulation, 11% of the applied ciclopirox amount was already penetrated into the nail
membranes. In our experience, HPCH alone, unlike other chitosans, did not show any antimycotic
property, but it potentiated the inhibiting activity of several antimycotic agents on the in vitro growth
of T. mentagrophytes. In vitro studies on MICs of new ciclopirox formulation showed MIC
p0.0015% for T.rubrum,p0.0015% for C. parapsilosis and¼ 0.2% for S. brevicaulis, as ciclopirox
percentage. In vitro experimental infections on bovine hooves showed an excellent activity of the
new ciclopirox formulation both in the preventive and in the curative test (100% of both) in
experimental infections by T. menta-grophytes, by T. rubrum as well as by M. canis. An
investigation in healthy volunteers showed that a 30% of the applied dose of CPX was detected in
fingernails washed by water and soap already 6 hours after a single application of ciclopirox and
HPCH solution 10 ml. The ciclopirox concentrations found in those subjects after washing were in
the order of magnitude of mg/mg, far above (4103) the above MICs.
Chitosan and its derivatives possess adhesive properties towards different biological tissues due
to their positive charge. Moreover, the free hydroxypropyl groups of HPCH may interact with
keratin, by hydrogen bonding and other weak interactions that could contribute to the improved
drug transport and release. The nail application of the new formulation, even for chronic treatments
like in onychomycosis, is easy and accepted by the patients due to the simple (rinsing) removal
procedure and no need of nail filing.
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EO1606 – a p38 MAP Kinase Inhibitor as a Potential Treatment of Acne
T Skak-Nielsen, T K Petersen, A Fullerton, H Aaes, M Fjording, J R Hansen, E R Ottosen, M
W Madsen
Leo-Pharma, Denmark
The amino-benzophenone EO1606 is a new, potent and selective inhibitor of p38 MAP kinase
(isoforms a and b) and of the upstream kinase MKK6. The compound has a broad anti-
inflammatory activity, inhibiting the production of a number of inflammatory cytokines
including interleukin 1b and tumour necrosis factor-a. We tested this compound in an animal
model of non-inflammatory acne, the rhino mouse. Dermal application of EO1606 decreased
the number of pseudo comedones and induced a normalisation of the follicular unit in the
skin. The changes were associated with epidermal hyperplasia. The efficacy of EO1606 in the
rhino mouse is comparable to that of the retinoids, which are established as very efficacious
treatments of acne. Immunohistochemical staining of rhino mouse skin showed phospho-p38
staining of single scattered cells in the basal layer of the epidermis. No staining was seen in
EO1606-treated skin.
Acne vulgaris is a multifactorial disease characterised by increased sebum production,
comedone formation, infection with P. Acnes and inflammation.
EO1606 targets two of these factors, inflammation and comedone formation, and its
efficacy for acne vulgaris was tested in a clinical trial. However, EO1606 did not prove
efficacious in this trial.
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Efalizumab – A Targeted Modulator of T-Cell Activity for the Treatment of Plaque
Psoriasis
D Jullien, JC Prinz, RGB Langley, and P Natta
Lyon, France; Munich, Germany; Halifax, Nova Scotia, Canada; and Geneva, Switzerland
Psoriasis is a chronic, immune-mediated skin disease affecting as many as 1 in 50 people. It
is characterized by thickened, erythematous plaques covered in silvery scales that arise from
excessive proliferation and abnormal differentiation of keratinocytes in the epidermis.
Underlying the pathogenesis of psoriasis is an abnormal, sustained immune response
mediated primarily via CD8þT cells. The antigen(s) responsible for activating the T cells has
yet to be identified. Standard systemic therapies for treating moderate to severe psoriasis all
suppress T-cell activity, but they also all have serious adverse effects on other cells in the
body that limit their long-term use. Efalizumab is a recombinant humanised IgG1 monoclonal
antibody targeted against the CD11a site of leukocyte function–associated antigen (LFA)-1,
the predominant integrin expressed on T cells. LFA-1 normally binds to intercellular adhe-
sion molecule (ICAM)-1 expressed on antigen-presenting cells (APC), endothelium, and
keratinocytes. LFA-1 is a key element in the mature immunological synapse, forming a ring of
adhesion molecules (the P-SMAC) around a stable central cluster of T-cell receptors (the C-
SMAC). Disruption of LFA-1/ICAM-1 binding by efalizumab inhibits multiple T-cell functions
associated with the pathogenesis of psoriasis, including activation of T cells by APC, the
trafficking of T cells to the dermis and epidermis, and interaction of T cells with keratinocytes.
Blockade of LFA-1 may also prevent the cytotoxic activity of fully differentiated CD8þT
cells on keratinocytes in lesional epidermis. In patients, efalizumab rapidly saturates and
downregulates expression of CD11a sites within 24–48 hours after a subcutaneous (SC)
dose. Weekly SC doses of efalizumab 1 mg/kg completely downmodulates CD11a on T cells,
effectively preventing T-cell activation and trafficking and reversing the histological skin
changes seen in psoriatic lesions. Because efalizumab is T-cell sparing, it potentially offers a
safer alternative to currently available therapies and requires less monitoring in clinical
practice.
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tetra-Isopalmitoyl Ascorbic Acid as an Anti-Aging Agent
H Masaki, K Kurihara, K Obayashi, Y Kurata, Y Okano
Nikkol Group, Cosmos Techinical Center Co. Ltd.
Deep/fine wrinkles and pigmented spots characterize aging of facial skin. Environmental UV
light largely contributes to the acceleration of skin aging. Reactive oxygen species (ROS) are
proposed as one of mechanisms of UV-accelerated skin aging (also called photoaging of
skin) from various investigations. From the evidence, antioxidants such as ascorbic acid
(ASA), dl-a-tocopherol, glutathione and cysteine derivatives are widely used to prevent the
formation of photoaging skin. It is well known that AsA in antioxidants is a multi-functional
vitamin on skin homeostasis. Certainly, the antioxidative property of AsA exhibits the
protection of skin from various oxidative stresses such as UV irradiation and reactive oxygen
species (ROS). AsA has also been used as a typical skin lightning agent in cosmetic field due
to its inhibitory effect against a key enzyme of melanin formation, tyrosinase. In addition, AsA,
which plays a critical role in dermal construction, stimulates collagen synthesis of dermal
fibroblasts. In recent study, it was documented that AsA regulated epidermal differentiation
due to regulation of differentiation-relating genes. Although AsA exhibits these effects on skin
homeostasis, there are still some obstacles to wide application of AsA: e.g. AsA hardly
penetrates to the target cells through the skin and has lower stability in formulations. In the
point of stability, phosphoryl ascorbate magnesium salt (VCPMg) has been developed and
widely used, although the problem of penetration from skin surface still remains. Then, we
synthesized tetra-Isopalmitoyl ascorbic acid (VC-IP) to minimize the disadvantages of AsA. In
this presentation, we will discuss the potential of VC-IP as an anti-aging agent, focusing on its
anti-oxidative effect.
At first, we examined whether VC-IP exhibited reduction effect on various oxidative stress
using cultured HaCaT cells. In general, UVB generates ROS in cells through several
pathways, and consequently UVB causes oxidative stress into cells. As well established, ROS
injure DNA, lipids and proteins in the cells, and ultimately lead to cell death. Therefore, we
checked the reduction of DNA damage induced by UVB irradiation using Comet assay. VC-IP
significantly suppressed the elongation of comet tail suggesting the reduction of the DNA
damage. In addition, VC-IP showed the decrease of cell death after UVB exposure. ROS
generate peroxides in the cells by attacking lipids and proteins. It is well established that
UVB-irradiated cells show the higher peroxide level. The treatment of cells by VC-IP before
UVB irradiation significantly reduced intracellular peroxide level. In addition, it was found that
VC-IP reduced other oxidative stress initiated by exposure of ROS, superoxide anion,
hydrogen peroxide and singlet oxygen. From these results, we can expect VC-IP to act as an
effective anti-aging agent.
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Anti-Aging Effects of d-d-Tocopheryl Retinoate – Evaluation Using Cultured Skin Cells
Y Okano, S Kaburagi, S Yahagi, K Kurihara, K Obayashi, Y Kurata, H Masaki
Nikkol Group. Cosmos Technical Center Co. Ltd.
Skin aging, which is characterised by wrinkles and sagging is caused by structural alterations
of dermis, decrease of collagen and denaturation of elastin. It is well established that these
alterations are accelerated by UV light. All-trans-retinoic acid (RA) is widely prescribed for
treatments of various diseases, and also used for treatment of photoaged skin. However,
since RA expresses severe skin irritation, its general application in drugs and cosmetics is
difficult. To improve this disadvantage, we synthesised a new RA-derivative, d-d-tocopheryl
retinoate (TR), and evaluated its potential as anti-aging agent focusing on collagen condition.
First of all, to examine whether TR exhibits same effect as RA, we evaluated hyaluronan
(HA) synthesis in keratinocytes. TR showed an effective elevation of the hyaluronan synthesis
at both HA synthase-3 mRNA level and HA amount. The result indicated that TR possesses
the potential of RA.
In the skin exposed to UVB, ROS generation through few pathways has been established.
ROS stimulate several cell functions, which lead to alterations of dermal collagen statue. First of
all, UVB damages DNA by photo-chemical reaction and ROS. The effects of TR on DNA damage
of HaCaT cells was examined by comet assay. TR suppressed the elongation of comet tail,
suggesting reduction of UVB-induced DNA damage. It is well known that dermal collagen statue
is regulated by a balance of synthesis and digestion. TR suppressed expressions of both matrix
metalloproteinase (MMP)-2 and MMP-9 of HaCaT cells following UVA irradiation. In addition, TR
elevated type I collagen synthesis of human dermal fibroblasts.
Recently, it has been demonstrated that the decrease of collagen in aged skin is caused by
excessive expression of MMPs and decrease of collagen synthesis. Therefore, our test results
prove that TR works as a new anti-aging agent through regulating the balance of collagen
synthesis and digestion and can be utilized as a substitute of RA.
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The Human Haarscheibe Revisited
C M Reinisch and E Tschachler
Department of Dermatology, University of Vienna Medical School, Vienna, Austria
The Haarscheibe, also referred to as touch dome is a structure within hairy skin considered to
be a slowly adapting mechanoreceptor. Whereas it has been well characterized in hairy skin
of cats and rats, only few studies address its presence in human skin. Using dermal sheet
preparations we were able for the first time to identify and analyse entire Haarscheiben in
human hairy skin in situ by confocal laser scanning microscopy. They appear as dense
convolutes of the subepidermal nerve plexus and are present in the papillary dermis at a
frequency of 1 to 2 per cm2. Corresponding epidermal sheets show dense aggregations of
Merkel cells with a mean number of  140 Merkel cells per Haarscheibe, embedded in a
characteristic epidermal architecture. Surprisingly both myelinated and unmyelinated fibers
supply the Haarscheibe. At least 2 myelinated fibers enter each receptor structure and the
myelin sheath extends up to 10 mm below the dermo-epidermal junction. Each myelin sheath
contains a neurofilament positive fiber, which after loss of its myelin sheath further divides
into smaller fibres. In contrast to the myelinated fibers the unmyelinated ones are present as
both neurofilament positive and negative. In conclusion, we were able to demonstrate for the
first time the anatomical structure of the human Haarscheibe in its entirety. Our additional
data on the diversity of nerve fibers present within the human Haarscheibe suggest that this
unique nervous structure has the potential to serve as receptor for other sensorial qualities in
addition to it attributed function as mechanical sensor.
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Gap Junctional Intercellular Communication and Cx43 Expression in Human Melano-
cytes and Melanocytic Lesions
E Kandyba, M Edward, DA Greenhalgh and MB Hodgins
Dermatology, Division of Cancer Sciences and Molecular Pathology, University of Glasgow,
Scotland, UK
During development, melanocytes migrate from the embryonic neural crest into the basal
layer of human epidermis where they synthesise melanin for transfer, via melanosomes, to
keratinocytes. In the epidermis, melanocytes and keratinocytes form heterocellular associa-
tions primarily based upon E-Cadherin. These are disrupted during nevus formation and in
the development of malignant melanoma, in favour of melanocyte-melanocyte or melano-
cyte-fibroblast interactions. Keratinocytes are connected throughout human epidermis via
gap junction channels that allow intercellular communication between neighbouring cells.
Within the epidermis, keratinocytes have a regulatory function over melanocytes in the basal
layer, helping maintain the integrity of the Epidermal Melanin Unit. However, it is unclear
whether or not melanocytes, nevocytes or melanoma cells are integrated within the gap
junction network of human skin.
In this study, Cx43 expression in melanocytes was evaluated in normal epidermis, various
types of melanocytic lesions, progressive stages of malignant melanoma and also by
employing differing culture conditions.
Using double immunofluorescence analysis of Cx43 – in conjunction with melanocytic
markers – melanocyte-keratinocyte cocultures, melanocyte monocultures and excised
paraffin embedded melanocytic lesion materials, were evaluated for Cx43 gap junction
expression. Potential cell-cell communication between melanocytes in monoculture and
coculture with keratinocytes was determined via the intracellular iontophoresis of Lucifer
Yellow and Alexafluor 350. Additionally, also employing dye transfer assays, the study
investigated whether the application of forskolin, an agent known to increase cAMP levels
and promote gap junctional communication in some cell lines, had any effect upon
melanocyte cell-cell communication.
The results showed that in normal epidermis, Cx43 did not co-localise to melanocytes in
the basal layer, to nevocytes in the majority of benign nevi or to melanoma cells in progressive
malignant melanoma lesions, but, Cx43 was expressed in the deeper regions of compound
nevi where it co-localised with many nevocytes. Indeed, Cx43 co-localisation was also
observed in melanocyte monocultures, where a minority of cells showed perinuclear
intracellular stores of Cx43. Moreover, dye transfer studies involving the application of
forskolin to such cultures, demonstrated that both Lucifer Yellow and Alexafluor 350 were
successfully transferred between a minority population of melanocytes in monoculture.
However, in coculture with keratinocytes there was no successful dye transfer.
Under normal conditions, melanocytes do not appear to be integrated within the epidermal
gap junction network. However, this study reports that in conditions when keratinocytes are
absent or unable to exert a regulatory effect, in some instances, melanocytes can form
functional Cx43 incorporated gap junctional communication channels with one another, both
in vitro and in vivo.
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Is There a Potential Role for Dermal Mast Cells in the Hyperpigmentary Mechanism of
Cafe´-au-Lait Maculae in Neuroﬁbromatosis Type 1 Patients?
J Boucneau, S De Schepper, JM Naeyaert, J Lambert
Department of Dermatology, Ghent University, Ghent, Belgium
The etiopathogenesis of hyperpigmentary cafe´-au-lait macules (CALMs) in Neurofibromatosis
type 1 (NF1) patients is still very obscure. It has been suggested that increased secretion of
cytokines (SCF/HGF) by dermal fibroblasts might be associated with accentuated epidermal
hyperpigmentation in NF1 CALMs. Whether increased melanogenesis and/or melanocytic
proliferation in NF1 CALMs is directly influenced by these fibroblast-derived cytokines or
whether other cells (mast cells) could function as intermediate actors, is still unknown. In
trying to answer this last question, we set up a quantitative study of the epidermal melanocyte
and dermal mast cell population. Two parameters (with two values each) were included:
genotype (non-NF1/NF1) and ‘skin type’ (normal/CALM). This enabled us to generate four
groups: non-NF1 normal skin, non-NF1 CALM skin, NF1 normal skin, NF1 CALM skin.
Immunohistochemistry was performed on paraffin embedded skin sections, using melan-A
and c-kit antibodies to visualize melanocytes and mast cells, respectively. In-house counting
and measuring software was developed and a standardized work flow was set up to
accurately determine the number of melanocytes per mm basal membrane and mast cells per
mm2 dermis. This two-by-two factorial design was analyzed by a two-way ANOVA statistical
approach splitting our main question in three: does genotype affect the number of cells? Do
the number of cells change between skin types? Is genotype effect the same at the different
‘skin types’ (interaction)? We observed a main genotype effect on melanocyte number,
showing a  1.5 to 2-fold increase in NF1 skin compared to non-NF1 skin (non-NF1 normal
skin: 11.280.82 (n¼6); non-NF1 CALM skin: 11.671.59 (n¼ 8); NF1 normal skin:
17.820.45 (n¼ 3); NF1 CALM skin: 19.341.19 (n¼ 6)). However, the number of
melanocytes did not change between skin type (no main skin type effect) and the observed
increase due to genotype was independent of skin type, showing no significant difference
between normal and CALM skin within each genotypic background (no interaction). There
was also a genotypic effect on dermal mast cell number showing a  2-fold increase in NF1
skin (non-NF1 normal skin: 33.387.34 (n¼ 6); non-NF1 CALM skin: 62.043.81 (n¼ 8); NF1
normal skin: 69.846.85 (n¼ 3); NF1 CALM skin: 64.114.56 (n¼3)). However, the number
of mast cells did not significantly change between skin type (no main skin type effect) but the
observed increase due to a genotype effect was not the same on all skin type levels, showing
a significant difference between normal and CALM skin within a non-NF1 genotypic
background compared to NF1. The number of mast cells in NF1 normal skin was elevated
compared to non-NF1 normal skin but the number of mast cells in CALM skin did not
significantly differ between the two genotypes (interaction between genotype and skin type
with main genotype effect). These observations may suggest that the mechanism of
epidermal hyperpigmentation in CALMs, whether they are from a non-NF1 or NF1 patient,
may be associated with an increase in dermal infiltrated mast cells (and associated cytokine
secretion) and might be independent of NF1 heterozygosity.
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The Role of Fas System [Fas-FasL] as an Inducer of Apoptosis in Cutaneous
Leishmaniasis: A Combined Human and Experimental Study
S Nassar1, S El-Kowrany2, F Sallam3, H Ismail2 AND M Eissa
Departments of Dermatology and Venereal Diseases1, Parasitology2 Pathology3, Faculties of
Medicine, Tanta and AlexandriaUniversities, Egypt
Aim: To investigate the role of Fas system (Fas-FasL) as an inducer of apoptosis and other
leishmanicidal cytokines in the disease development in cutaneous leishmaniasis.
Material and Method. Leishmanial skin and serum from both infected human and Swiss-
albino mice were collected, Soluble Fas was estimated by ELISA, other leishmanicidal
cytokines were detected by immunohistochemistry and tissue mRNA Fas by RT-PCR.
Results. Significant increase in interferon gamma, tumor necrosis factor-alpha, nitric oxide
and soluble Fas in both infected human and mice. Tissue Fas showed marked expression in
human samples while in human samples; the expression was reduced in chronic infected
mice than in the late acute infected animals.
Conclusion. This study confirms the role of Fas expression in development of leishmanial
lesion and show that Fas-Fas L pathway is a potent inducer of apoptosis which can help in
complete resolution of cutaneous leishmaniasis. Therefore the future use of Fas-FasL as a
novel therapeutic regimen may accelerate healing of leishmanial lesions.
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Clinical, Molecular and Immunohistological Assessment of Cutaneous Vasculitis in
Chronic HCV Infection: Implications for Pathogenesis
S Nassar, A Hasan, M EL Batsh, A El Shafey, T Ab EL Hamid and E Rewisha
Dermatology, Microbiology & Clinical Immunology, Biochemistry and Pathology Depart-
ments, National Liver Institute, Tanta and Menofia Universities
Introduction. Cutaneous vasculitis (CV) presents a diagnostic and therapeutic challenge.
Hepatitis C virus (HCV) has been recognized in association with various forms of cutaneous
vasculitic eruptions.
Aim. To detect the presence of HCV-RNA in skin of CV and to investigate its role in the
pathogenesis of CV. Therefore, nuclear factor Kappa B (N-KappaB) and vascular endothelial
growth factor expressions were evaluated. To clarify the role of infiltrating cells, endothelium
and virus in CV with chronic HCV.
Patients & Methods. Classified into 3 groups .GpI included 27 HCV RNA positive patients
with CV. GpII consisted of 11 HCV RNA negative patients with CV.GpIII 25 HCV RNA positive
patients without vasculitis. Skin specimens were divided into 3 parts; one was kept frozen for
N-KappaB. The second was fixed in formalin for immunohistology and PCR in situ
hybridization. The third was prepared for electron microscopic study. The blood was
subjected for circulating VEGF and N-KappaB.
Results. Revealed the presence of HCV-RNA in skin of 78% of GPI, none in GPII and 48% in
GPIII. HCV particles were detected by EM in vascular endothelial and epithelial cells. There
was significant expression of NF kappa B and circulating VEGF in Gp I, III then II respectively.
The extent of histological changes is predictive of local clinical severity only but not
correlated with the severity of liver damage.
Conclusion. HCV plays a major role in the pathogenesis and clinical recurrence of CV. HCV –
RNA potentiates NF- kappa B in most cell types which in turn contribute to the chronically
activated persistent stat of HCV infection in liver and frequent recurrence of CV. Therefore
better understanding of these molecular events will provide a basis for rational design
controlling frequent recurrence of CV and targeting HCV and its immunological sequels.
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Contractile Force and a-Smooth Muscle Actin Expression in Cultured Fibroblasts from
Striae Distensae
C Viennet1, AC Goydadin1, V Armbruster2, J Bride1, T Gharbi2, P Humbert1
1Engineering and Cutaneous Biology Laboratory, School of Medicine, 2Optical Laboratory,
School of Science, F- Besanc¸on
Striae distensae are characterized by linear, smooth bands of atrophic-appearing skin that
are reddish at first and finally white. They are due to stretching of the skin, as in rapid weight
gain, or mechanical stress, as in weight lifting. The pathogenesis of striae distensae is
unknown but probably relates to changes in the fibroblast phenotype. In order to characterize
striae distensae fibroblasts, a-smooth muscle actin expression (a-SM actin) and contractile
forces were studied. Five healthy women with early erythematous striae on the thigh and five
healthy women with older striae were selected. Paired biopsies were taken from the center of
lesional striae and adjacent normal skin. Fibroblasts were obtained by an explant technique
and expanded in vitro in Dulbecco’s modified Eagle’s medium. a-SM actin expression was
studied by immunofluorescence labelling of cells cultured in monolayer. Contractile forces
generated by fibroblasts in collagen latttices were measured with the Glasboxs device
developed in our laboratory. Fibroblasts from early striae distensae were the richest cells in a-
SM actin filaments and generated the highest contractile forces. Their peak contractile force
was 26% greater than normal fibroblasts. In contrast, there was no significant difference in
force generation between old striae fibroblasts and normal fibroblasts with cells expressing
no a-SM actin. The contractile properties of fibroblasts from striae distensae varies
depending on the stage of the disease. In early striae distensae, fibroblasts acquire a more
contractile phenotype, corresponding to that of myofibroblasts.
446
Contractile Properties of Cultured Human Fibroblasts from Chronic Venous Leg Ulcers
C Viennet1, AC Goydadin1, V Armbruster2, J Bride1, T Gharbi2, P Humbert1
1Engineering and Cutaneous Biology Laboratory, School of Medicine, 2Optical Laboratory,
School of Science, F- Besanc¸on
The tissue contraction phenomenon associated with wound healing is of prime importance
for wound closure. Contractile properties of human fibroblasts from chronic venous leg ulcers
were compared to those of normal fibroblasts using in vitro models. Biopsies were taken from
the uninvolved skin of the thigh, the epithelialized ulcer edge and the non-epithelialized ulcer
center of 4 patients. Fibroblasts were obtained by an explant technique and expanded in vitro
in Dulbecco’s modified Eagle’s medium. Alpha-smooth muscle actin expression (a-SM actin)
was studied by immunofluorescence labelling of cells cultured in monolayer. Contractile
forces generated by fibroblasts in collagen latttices were measured with the Glasboxs device
developed in our laboratory. Fibroblasts from the ulcer centre were the richest cells in actin
filaments. The peak contractile force developed by fibroblasts from the ulcer centre and the
ulcer edge were respectively 30% and 18% greater than normal fibroblasts. Fibroblasts from
venous ulcers have greater contractile capacity than normal fibroblasts. Fibroblasts from the
ulcer center develop more stress fibers than fibroblasts from the ulcer edge; this could be
responsible for the highest contractile force produced by fibroblasts from the ulcer center.
The force of wound contraction is probably generated by actin filaments and transmitted to
the sides of the wound. Contraction, which is a wound healing functional parameter, seems
not to be affected in chronic venous ulcers.
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Expression of Cathepsin L and its Inhibitor Hurpin in Normal and Diseased Skin
M Bylaite1,2, H Moussali1, M Walz1, I Marciukaitiene2, T Ruzicka1
1Department of Dermatology, Heinrich-Heine-University, Duesseldorf, Germany 2Depart-
ment of Dermatovenereology, Vilnius University, Vilnius, Lithuania
Hurpin (serpin B 13; PI13) is an intracellular, differentially spliced member of the serpin
superfamily that has been linked to differentiation and apoptosis of human keratinocytes. It is
transiently downregulated by UV light and overexpressed in psoriatic skin lesions. Recent
reports indicate that hurpin is a potent and selective inhibitor of the lysosomal cysteine
proteinase cathepsin L (Cat L). It is proposed that a physiological role of hurpin is to protect
epithelial cells from ectopic Cat L.
Cat L, the papain-like lysosomal cysteine protease is known to be involved in apoptosis,
tumor progression and metastasis, chronic inflammation and bone resorption. It is thought
that Cat Ls ability to degrade extracellular matrix and basement membranes lets tumor cells
to penetrate the interstitial tissue.
The expression of Cat L and hurpin in normal and diseased skin was investigated by
immunohistochemistry and polymerase chain reaction (PCR) in order to better understand
their pathophysiological role. Formalin-fixed and paraffin-embedded tissues from normal and
psoriatic skin, lichen planus, verruca seborrhoica, actinic keratosis, squamous cell
carcinoma, basal cell carcinoma and malignant melanoma were studied using an antibody
against Cat L and newly generated monoclonal antibodies against hurpin. Additionally,
expression was analysed by polymerase chain reaction (PCR) using RNA from normal and
diseased skin biopsies.
We found that hurpin is overexpressed and redistributed in diseased compared to normal
skin.
Whereas hurpin is mainly expressed in the basal layer in normal skin, we detected hurpin in
the granular and squamous cell layer in diseased skin. Suprisingly, the distribution of Cat L
did not correlate to that of hurpin. The highest expression of Cat L was found in the squamous
cell layer with no profound differences between normal and diseased skin. For both proteins,
we detected inter-individual differences in the expression level. Results from immunohis-
tochemistry were confirmed by PCR data. Discordant expression of hurpin and Cat L
suggests additional functions for this inhibitor. Inactivation of other intrinsic or extrinsic
proteases might be important for the protective activity of the skin against infections.
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Diagnostic Applicability of In Vivo Confocal Laser Scanning Microscopy in Melanocytic
Skin Tumors
A Gerger, S Koller, K Steiger, C Massone, T Kern, E Richtig, J Smolle
Graz, Austria
In vivo confocal laser scanning microscopy (CLSM) represents a novel imaging tool that
allows examining skin morphology in real-time at a resolution equal to that of the conventional
microscopes used to view histology slides. The imaging procedure, however, is non-invasive
and does not require the use of fluorescence, dyes or stains.
The aim of the study was to test the applicability of CLSM to the diagnostic discrimination
of benign common nevi (BN) and malignant melanoma (MM) by means of morphologic
features.
In total, 117 melanocytic skin tumors (90 benign common nevi and 27 malignant
melanomas) were imaged using a commercially available, near-infrared, reflectance confocal
laser scanning microscope (VIVASCOPE 1000, Lucid Inc., NY, USA). At least 5 images
comprising all epidermal layers and the papillary dermis were recorded in each case. 5
independent observer (2 residents, 1 senior physician and 2 dermatopathologists) without
previous experience in CLSM received a standardized instruction about diagnostic CLSM
features of nevi and melanoma. Diagnostic features comprised melanocyte cytology (round-
oval, monomorphic in BN versus large and polymorphic cells in MM), architecture (regularly
arranged nevus cell nests versus architectural disarray in MM), brightness of image
(homogeneous brightness in BN versus irregularly scattered brightness in MM), dendrites
(infrequent, simple branching in BN versus frequent, complex branching in MM) and
keratinocyte cell borders (readily detected in BN versus poorly defined in MM). For diagnostic
assessment, 2 diagnostic images in each case were shown to the observer on the computer
screen and evaluated as belonging either to benign nevi or malignant melanoma. Additionally,
presence or absence of each of the features were assessed by two of the observers.
Interobserver reliability data were produced in the form of the kappa statistic for each feature.
Best performance was achieved by the two residents with a sensitivity value of 96.3%
and specificity of 100 and 98.9%, respectively, followed by the senior physician without
dermatopathologic qualification with 92.6 and 98.0%. Sensitivity of 96.3 and 56.3% and
specificity of 93.3 and 95.6% was reached by the two dermatopathologists. When the
presence or absence of morphologic features were assessed, it turned out that mainly
architecture, cytology and keratinocyte cell border should be taken into account for diag-
nostic decisions, whereas image brightness and dendrites were rarely useful.
To our knowledge, this is the first study dealing with sensitivity and specificity in diagnostic
assessment of CLSM images of melanocytic skin tumors. Obviously, a considerable high
diagnostic performance could be achieved. The fact that observers without specific
dermatopathology experience performed better than trained dermatopathologists indicates
that micromorphologic features relevant in paraffin histology cannot directly be related to
CLSM images. An unprejudiced approach of the observer seems to be more successful with
respect to diagnostic accuracy.
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Cyclosporin A Induces Anagen and Increases the Number of Dermal Papilla Fibroblasts
in Nude(Foxn1nu/nu) Mice
B Tychsen, F Conrad, E Bodo, H Kobayashi, T Biro and R Paus
Hamburg, Germany and Debrecen, Hungary.
Phenotypically nude(Foxn1nu/nu) mice have no thymus and show hair and nail abnormalities.
Hair shafts bend and coil when they enter the hair canal, dilating the infundibulum and the hair
shaft does not penetrate the epidermis. In nude mice, the immunosuppressant cyclosporin A
(CsA), which causes hypertrichosis in man, induces macroscopically visible hair growth. In
normal C57BL/6 mice, CsA induces anagen and inhibits catagen. The current study aimed at
finding out whether CsA has any influence on hair follicle cycling and on dermal papilla cell
number in the hair follicles of NMRIFoxn1nu/nu mice. Homozygous NMRIFoxn1nu/nu mice were
treated with CsA (30 mg/kg/d i.p.) or vehicle (corn oil) for 14 days. Back skin was harvested,
snap-frozen/paraffin-embedded and analysed for quantitative immunohistomorphometry.
Cell proliferation and apoptosis were assessed by Ki67 and TUNEL immunostains. The
number of DAPI-positive dermal papilla fibroblasts was counted in early anagen hair follicles
of CsA-treated and control mice. CsA-induced anagen in telogen hair follicles of NMRIFoxn1nu/nu
mice and partially normalized hair shaft structure, thus allowing it to penetrate the epidermis.
No differences were noted in the rates of keratinocyte proliferation or apoptosis between CsA-
treated and control NMRIFoxn1nu/nu mice. However, in early anagen hair follicles of CsA-treated
NMRIFoxn1nu/nu mice, a significant increase in the number of DAPI-positive dermal papilla cells
was visible compared to control mice, suggesting increased migration of fibroblasts from the
connective tissue sheath (CTS) to the DP. These findings underscore the migratory activity of
specialized hair follicle fibroblasts between CTS and DP (Tobin et al, JID120:895–904, 2003).
Also they suggest that CsA may stimulate immigration of morphogenically active fibroblasts
into the DP. Together with its anagen-inducing effects, this may underlie the hypertrichosis-
inducing effects of CsA seen in clinical practise.
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LEKTI, Terminal Differentiation of Keratinocytes and Skin Barrier Formation
C Ong1, WL Di1, J Mazereeuw1, R Callard1, EA O’Toole2, JI Harper1
1Institute of Child Health, University College London, London, UK. 2Centre for Cutaneous
Research, Queen Mary University, London, UK
LEKTI (LymphoEpithelial Kazal Type serine protease Inhibitor) is encoded by the SPINK5
gene, mutations of which caused Netherton’s syndrome (NS) as a result of non-expression of
functional LEKTI. Clinically, NS has similarities to atopic dermatitis (AD) which include chronic
inflammation of the skin, multiple allergies and high IgE levels. Genetic polymorphisms in the
SPINK5 gene have been demonstrated in AD. The biological role of LEKTI is currently
unknown and it is hoped that a better understanding of its function may provide an insight
into the pathogenesis of AD. Skin barrier function in NS is severely compromised. LEKTI is
expressed in the stratum granulosum of normal skin, absent in NS and abnormal in AD. This
places LEKTI at a strategic position to influence the skin barrier and given the clinical features
of NS, we postulate that LEKTI may play a role in influencing terminal differentiation of
keratinocytes and skin barrier formation. Using immunofluorecence techniques, we
investigated the process of keratinisation in normal skin (n¼ 4), NS (n¼ 4) and AD (n¼ 3).
Expression patterns of differentiation markers, such as involucrin, transglutaminase 1,
loricrin, keratin 6 and 14 were studied. To further evaluate the biological role of LEKTI,
cultured keratinocytes were stimulated with calcium and epidermal growth factor (EGF). The
response of LEKTI to these stimuli was analysed by flow cytometry. Skin specimens from NS
patients showed an abnormal expression of involucrin and loricrin. In normal skin, these
proteins were expressed in the stratum corneum in a membranous pattern whereas in NS,
they were expressed in the cytoplasm and found in most of the suprabasal layers. K6
expression was increased and K14 reduced when compared to normal controls. These
findings suggest a disrupted process of keratinisation and terminal differentiation in NS. In
AD, expression of K6 was increased similar to NS but all other proteins were normal. The flow
cytometry data revealed that LEKTI level was increased when keratinocytes were stimulated
with calcium and EGF which are well known modulators of keratinocytes differentiation. Up-
regulation of LEKTI by these two factors suggests that LEKTI is involved in keratinocyte
differentiation. These findings combined with the abnormal staining results in NS suggest that
LEKTI may influence terminal differentiation through the calcium metabolism pathway for
example via PAR-2 and subsequently modulate transglutiminase activity.
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Limitations of Dermatoscopy in the Diagnosis of Melanoma
M Dawid, L Teban, M Binder, H Kittler
Department of Dermatology, Medical University Vienna, Austria
The aim of this study was to compare dermatoscopic features of melanocytic nevi with those
of early melanomas, which were not excised initially because of their uncharacteristic clinical
and dermatoscopic appearance. We included the dermatoscopic images of 325 melanocytic
skin lesions, which were followed by digital dermatoscopy and finally excised because of
changes over-time and compared the base-line images of 63 melanomas and 262
melanocytic nevi by pattern analysis, the ABCD rule, and the 7-point checklist. The patterns
of dermatoscopic features observed in the base-line images of those melanocytic lesions,
which were finally diagnosed as melanomas during follow-up, did not differ substantially from
the patterns observed in the base-line images of melanocytic nevi. Pattern analysis, the
ABCD rule, and the 7-point checklist failed to achieve a satisfying diagnostic accuracy for
melanoma. In retrospect, no dermatoscopic feature or pattern of features could be identified,
which reliably differentiated between melanomas and melanocytic nevi at the time of the first
presentation of the patient. In conclusion dermatoscopy depends on the appearance of
classic dermatosopic features and is therefore limited in the diagnosis of very early and
mainly featureless melanomas.
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Alterations of Basement Membrane Zone in Lichen Planus Differ from that in Lichen
Sclerosus
C Kowalewski, M Go´rska, A Kozlowska, K Wozniak
Medical University of Warsaw, Poland
The etiopathogenesis of lichen sclerosus (LS) is not clear but an association with various
autoimmune diseases and lichen planus (LP) has been documented. In some of the cases
with LS first skin lesions resemble those of LP and histology is often not conclusive. An
ultrastructural studies provide the evidence of the defects in the basement membrane zone
(BMZ) integrity in both disorders. The aim of the study was to compare the alterations of
various regions of the BMZ in LS and LP using laser scanning confocal microscopy. Ten cases
of LS and five cases of LP were included to this study. Biopsies from patients’ skin and a
control biopsy from normal human skin were cut into 40 mm thick slides and labeled with
antibodies against beta-4 intergin (lamina lucida marker), collagen IV and N-terminal end of
collagen VII (lamina densa markers) using routine immunofluorescence. Three-dimensional
(3D) reconstruction of various regions of BMZ showed decreased number and size of the
dermal papillae in both LS and LP as compared to normal skin. In LS numerous invaginations
and holes were present in BMZ at the level of lamina lucida and lamina densa. Computer
animation of 3D projection revealed that thickness of lamina densa observed under the light
microscopy is an optical artifact dependent on periodical tortion of lamina densa along its
axis. Torsions and invaginations of BMZ are equally responsible for phenomenon of artificial
reduplication of the lamina densa observed at the ultrastructural level. IF labeling with
antibody against N-terminal end of collagen VII – disclosed presence of a large holes in the
lamina densa and the presence of granular material in deep dermis suggestive of partial
degradation of lamina densa at the level of anchoring fibers. In LP torsions of BMZ along its
axis, invaginations and holes were noticed similarly to those observed in LS. In contrast to LS
there was absence of the granular material composed of collagen VII in the dermis. 3D
reconstruction of BMZ revealed different alterations in LP and LS at the level of collagen VII
and its may serve as a valuable investigative tool for differentiation of both entities, especially
in the onset of morbid process where is a diagnostic doubt.
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MMP-21, Unlike MMP-26 and MMP-28, is Induced at Early Stages of Melanoma
Progression, but Disappears with More Aggressive Phenotype
T Kuivanen1, K Ahokas1, S Virolainen2, T Jahkola3, R Tammi4, E Ho¨ltta¨2, O Saksela1 and U
Saarialho-Kere5
1Departments of Dermatology, 2Pathology and 3Plastic Surgery, Helsinki University Central
Hospital and Biomedicum Helsinki, Helsinki, Finland; 4Department of Anatomy, University of
Kuopio, Kuopio, Finland; 5Department of Dermatology, Karolinska Institutet at Stockholm
Soder Hospital, Stockholm, Sweden
The expression pattern of matrix metalloproteinases (MMPs) is frequently altered during
malignant transformation. Our objective was to examine the expression of three recently
cloned MMPs, MMP-21, MMP-26 and -28, in melanomas in vivo and in culture. MMPs-9, -13,
and their inhibitor, TIMP-3, were studied as controls based on previous reports on their
expression and prognostic significance in melanoma. Immunohistochemical analyses in
melanoma specimens from 35 patients were performed. Based on the results of sentinel node
biopsies, eighteen samples were from non-metastatic and seventeen from melanomas with
nodal micrometastases. MMP-21 was expressed in melanoma cells in 22/35 cases and its
expression was stronger in melanoma samples without micrometastases. 7/10 in situ
melanomas were positive while five nevus samples were negative for MMP-21. MMP-26 and
-28 were not generally detected in melanoma or nevus cells. MMP-13 was detected in
melanoma cells in 27/35 samples and the number of MMP-13 positive melanoma cells
correlated to sentinel node positivity. MMP-9 was expressed by melanoma cells in only 10/35
samples, while positive neutrophils were detected in fourteen and macrophages in nine
samples. No correlation of TIMP-3 expression to the status of lymph nodes was found. MMP-
21 mRNA was expressed by RT-PCR in Bowes and ML852 melanoma lines while lower levels
were apparent also in WM164, WM165, and G361 cells. MMP-26 was detected only at low
levels in ML852 and WM165 cells. Our results suggest that expression of MMP-21 may serve
as a marker of malignant transformation of melanocytes, but does correlate with prognosis.
While the expression of MMPs-7, -9, -26 and -28 does not correlate with the presence of
micrometastases, the number of MMP-13 positive cells may correlate to more aggressive
disease.
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Antioxidant Enzyme and Methionine Sulfoxide Reductase Expression in Lichen
Sclerosus
C S Sander,w I Ali, D Dean, J J Thiele,z F Wojnarowska
Dermatology Department, The Churchill Hospital, Old Road, Oxford OX3 7LJ Oxford, UK
wDepartment of Dermatology, Friedrich Schiller University Jena, Germany zDepartment of
Dermatology, Northwestern University, Chicago, USA
Lichen sclerosus (LS) is a chronic inflammatory skin disease of unknown aetiology. The
mechanisms which lead to the immunological changes in all levels of the skin and the
alterations of the dermal extracellular matrix are poorly understood. We have recently
demonstrated an involvement of oxidative stress in the pathogenesis of LS. In this study, we
investigated antioxidant defense mechanisms and the expression of the oxidative damage
repair enzyme methionine sulfoxide reductase A (MSRA) in LS.
Skin biopsies from 16 patients with untreated, histologically confirmed vulval LS were
examined immunohistochemically. Antioxidant enzyme expression of catalase (Cat), copper-
zinc superoxide dismutase (CuZnSOD) and manganese SOD (MnSOD) was investigated as
well as the distribution of the oxidative damage repair enzyme methionine sulfoxide
reductase A (MSRA). Normal vulval tissue from 16 subjects served as control.
In lichen sclerosus tissue the enzymatic antioxidant defense was disturbed as demon-
strated by a significantly reduced expression of MnSOD within the stratum corneum and
epidermis, and an increased expression of Cat in epidermal and dermal layers. Furthermore,
MSRA was shown to be increased in dermal layers of LS lesions suggesting the involvement
of a recently described oxidative protein damage repair mechanism.
This is the first study investigating the antioxidant defense and oxidative damage repair
capacities in LS. Further studies are required to elucidate the role of the observed modulation
in the enzymatic antioxidant system in order to provide new insight into the possibilities of
antioxidant therapeutic strategies.
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Pathological Changes in Human Skin Caused by Arthropods from Genera Argas and
Simulium
L Chomicz, J ’ebrowska, Z S´widerski and C Kowalewski
Department of Medical Biology, Medical University of Warsaw, Poland, W.Stefanski Institute
of Parsitology, Polish Academy of Sciences, Chair and Department of Dermatology, Warsaw,
Poland
During the last few years, increased attack frequency of the blood sucking ectoparasites on
humans was observed in a vicinity of human habitation in suburban areas of Warsaw in
Poland. In this report we present and compare cases of skin changes in humans caused by
ectoparasites from genera Simulium and Argas. 15 persons, 18–60 years old from Warsaw
areas with symptoms of arthropod bites, were clinically assessed for pretreatment skin
status. All persons examined showed symptoms of dermal alterations of various intensity.
However, local skin changes differed depending on kind of causative organism. Black fly
bites, usually numerous, resulting in pruritus and surface, small, painful bleeding blisters,
caused strong skin reaction, with inflammatory process, damages of the blood capillaries,
sometimes with fever and local allergic reaction. In the ultrastructural study, advanced
process of rebuilding in the dermal cell region with intensive neoangiogenesis was revealed.
The cutaneous changes were healing fully after a symptomatic treatment. Argas bites were
initially painless, however, they were marked deeper than those of Simulium and caused
diffuse erythema (oval, round in shape) maintaining during several days. Some sites of the
mite bites were susceptible even after many months. As time passed, poor regeneration
process appeared; finally, most of the damages scarred. The differences in human reaction
after the arthropod bites observed by us are connected, among other, with 1) specific
adaptations in mouthparts morphophysiology that enable the arthropods to feed the blood, 2)
human immunity status during exposition to the ectoparasite infestation. It should be also
taken into consideration, that environmental factors may promote frequent attacks of the
hematophagic arthropods on man, and, thus, subsequent serious viral and parasitic disease.
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VEGF and CCL27 Expression in Alopecic Patient Before and After Diphencyprone
Treatment: An Immunohistochemical Study
O Simonetti, G Lucarini, G Biagini, A Offidani
Clinica Dermatologica, Istituto di Morfologia Umana Normale, Universita` Politecnica delle
Marche. Italy
Alopecia areata is a relatively common inflammatory form of non-scarring hair loss affecting
about 2 or 3% of new patients attending dermatology clinics. Vascular endothelial growth
factor (VEGF), essential for angiogenesis and vascular permeability, may be responsible for
maintaining proper vasculature around hair follicle, moreover a number of studies provide
evidence that apoptosis is a central element in the regulation of vascular injury and vascular
remodeling. The cutaneous lymphocyte-associated antigen (CLA) and the skin-associated
chemokine CCL27 highlight an important role for epithelial cells in controlling homeostatic
lymphocyte trafficking.
Topical immunotherapy, using a potent contact allergen such as diphencyprone (DPC), is
currently considered the most effective mode of treatment. However, the way in which DPC
operates on hair follicles in AA still remains to be elucidated. Therefore the aim of our study
was to evaluate the expression pattern of VEGF, Factor VIII, survivin, CD4, CD8, CLA and
CCL27 in alopecic skin before and after treatment with DPC.
Our data suggest that topical immunotherapy exert an important role in angiogenesis,
upregulating VEGF in human hair follicle keratinocytes and survivin to preserve endothelial
cell viability. Moreover it considerably alters the peribulbar CD4/CD8 ratio restoring a
condition close to normal scalp skin.
ABSTRACTS A77123 : 2 AUGUST 2004
